,CUI1,CUI2
0,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Flat Biliary Intraepithelial Neoplasia
1,Borderline Lesion,Desmoplastic trichoepithelioma
2,Intracytoplasmic Eosinophilic Inclusion,alveolar rhabdomyosarcoma of orbit
3,Tubular Pattern,Ampulla of Vater Villous Adenoma
4,Chronic Clinical Course,Infant Acute Undifferentiated Leukemia
5,Indolent Clinical Course,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
6,Indolent Clinical Course,Glioblastoma with Primitive Neuronal Component
7,Dermal Involvement,Stage 0 Cutaneous Melanoma AJCC v6 and v7
8,Nuclei of Various Sizes and Shapes Present,Lobular Neoplasia Type A
9,Mixed Neoplastic Glandular and Squamous Cell Population,Intraepithelial Neoplasia in Barrett Esophagus
10,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
11,Indolent Clinical Course,Childhood Clear Cell Sarcoma of Soft Parts
12,Seminomatous Component Present,Childhood Central Nervous System Teratoma
13,Indolent Clinical Course,Childhood Cerebral Anaplastic Astrocytoma
14,Precise Histogenesis Unknown,Recurrent Childhood Optic Nerve Glioma
15,Liver Cirrhosis,Fibrolamellar Hepatocellular Carcinoma
16,Grade 4 Lesion,Recurrent Childhood Gemistocytic Astrocytoma
17,Prominent Schwannian Stroma Present,Mediastinal Neuroblastoma
18,Intermediate Filaments Present,Intracranial Extraskeletal Myxoid Chondrosarcoma
19,Severe cytologic atypia,Small Intestinal Carcinoid Tumor
20,Benign Cellular Infiltrate,Esophageal Well Differentiated Squamous Cell Carcinoma
21,Solid Growth Pattern,ROSE Cluster 4
22,Benign Cellular Infiltrate,Secondary malignant neoplasm of rectum
23,Mixed Neoplastic Glandular and Squamous Cell Population,basaloid squamous cell carcinoma of vulva
24,Mucoid Stroma Formation,Vulvar Warty Carcinoma
25,Low Grade Lesion,Mediastinal Angiosarcoma
26,Seminomatous Component Present,Stage III Ovarian Teratoma AJCC v6 and v7
27,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Adenocarcinoma of Sweat Gland Type
28,Indolent Clinical Course,Retroperitoneal sarcoma
29,Mitotic Activity,Protoplasmic astrocytoma
30,Precise Histogenesis Unknown,Adult Spinal Cord Ependymoma
31,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Basaloid Carcinoma
32,Mucoid Stroma Formation,Papillary carcinoma in situ
33,Borderline Lesion,Warty dyskeratoma
34,Solid Growth Pattern,Benzene-Related Acute Myeloid Leukemia
35,High Mitotic Activity,Leiomyoma of Gallbladder
36,Borderline Lesion,Ureter Inverted Papilloma
37,Benign Cellular Infiltrate,Gallbladder Leiomyosarcoma
38,Intermediate Filaments Present,Gallbladder Leiomyosarcoma
39,Local disease,Lymphangioleiomyomatosis of skin
40,Dysplasia,Pilomatrixoma
41,Dysplasia,Benign Dermal Neoplasm
42,Invasive Lesion,Low Grade Squamous Intraepithelial Neoplasia
43,Metastatic Lesion,Benign Testicular Sertoli Cell Tumor
44,Solid Growth Pattern,Recurrent Adult Acute Lymphoblastic Leukemia
45,High Mitotic Activity,malignant gastrinoma of pancreas
46,Benign Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7
47,High Grade Lesion,Chondroid chordoma
48,Chronic Clinical Course,Acute Myeloid Leukemia with Myelodysplasia-Related Changes
49,Intermediate Filaments Present,Skin Angiosarcoma
50,Benign Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v7
51,Benign Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v7
52,Favorable Clinical Outcome,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
53,Indolent Clinical Course,Anaplastic Ependymoma
54,Invasive Lesion,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia
55,Intermediate Filaments Present,Kaposi's sarcoma of extrahepatic bile duct
56,Favorable Clinical Outcome,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
57,Invasive Lesion,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia
58,Chronic Clinical Course,Mixed phenotype acute leukemia T/myeloid
59,Capsular Invasion,Aldosterone-Producing Adrenal Cortex Adenoma
60,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Lung Adenocarcinoma AJCC v7
61,Dysplasia,Pyogenic granuloma of skin and subcutaneous tissue
62,Indolent Clinical Course,Childhood Angiosarcoma
63,Tumor Vascular Invasion,Androgen-Producing Adrenal Cortex Adenoma
64,Intracytoplasmic Eosinophilic Inclusion,Cardiac Biphasic Synovial Sarcoma
65,Necrotic changes (finding),Mixed Oligodendroglioma-Astrocytoma
66,Intermediate Filaments Present,Cardiac Monophasic Synovial Sarcoma
67,Borderline Lesion,Squamous Papilloma of the Nasopharynx
68,Intracytoplasmic Eosinophilic Inclusion,embryonal rhabdomyosarcoma of prostate
69,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma of lung, stage IV"
70,Encapsulated Mass,neurofibroma of esophagus
71,Mixed Neoplastic Glandular and Squamous Cell Population,Lung squamous cell carcinoma stage I
72,Benign Cellular Infiltrate,Malignant neoplasm of anus
73,Favorable Clinical Outcome,Melanoma Arising in Giant Congenital Nevus
74,Precise Histogenesis Unknown,Secondary Supratentorial Anaplastic Astrocytoma
75,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
76,CD21-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
77,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
78,Keratin pearl formation,Nasopharyngeal lymphoepithelioma stage III
79,Intermediate Filaments Present,Ewings sarcoma
80,Solid Growth Pattern,Acute monoblastic leukemia
81,Borderline Lesion,Trichilemmoma
82,Leukoerythroblastic Reaction,"Polycythemia Vera, Polycythemic Phase"
83,Focal dysplasia,Filiform Serrated Adenoma
84,Mixed Neoplastic Glandular and Squamous Cell Population,Perihilar Intrahepatic Cholangiocarcinoma
85,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of breast with squamous metaplasia
86,Mucoid Stroma Formation,Subglottic Verrucous Carcinoma
87,Intracytoplasmic Eosinophilic Inclusion,Extra-osseous Ewing's sarcoma
88,Mixed Neoplastic Glandular and Squamous Cell Population,Posterior Tongue Squamous Cell Carcinoma
89,"Amorphus, Eosinophilic, and Acellular Deposit",Heavy Chain Deposition Disease
90,Indolent Clinical Course,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
91,Intermediate Filaments Present,"Leiomyosarcoma, Epithelioid"
92,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Papillary Cystadenoma
93,Benign Cellular Infiltrate,Rectal Carcinoma
94,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
95,Immunologic Deficiency Syndromes,Cerebral Lymphoma in Immunocompetent Host
96,Intermediate Filaments Present,Fibromyxosarcoma
97,Intracytoplasmic Eosinophilic Inclusion,Rhabdomyosarcoma of the orbit
98,Diffuse Lesion,Pedunculated conjunctival papilloma
99,Acute Clinical Course,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
100,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Transitional Cell Tumor
101,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, metastatic"
102,Melanin Pigment Present,"Melanoma, Amelanotic"
103,Precise Histogenesis Unknown,Recurrent Childhood Anaplastic Oligodendroglioma
104,Secondary Lesion,Primary solid type intraosseous squamous cell carcinoma
105,Mass of body structure,Microscopic Thymoma
106,Severe cytologic atypia,Descending Colon Neuroendocrine Tumor G1
107,Chronic Clinical Course,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
108,Seminomatous Component Present,Adult Central Nervous System Mature Teratoma
109,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Mature Teratoma
110,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Teratoma
111,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of Vessels
112,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
113,Hemorrhagic Neuroblastic Nodules Present,"Ganglioneuroblastoma, Intermixed"
114,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
115,Intracytoplasmic Eosinophilic Inclusion,Bladder Sarcoma
116,Mixed Neoplastic Glandular and Squamous Cell Population,Upper Gingival Squamous Cell Carcinoma
117,Indolent Clinical Course,Central Nervous System Choriocarcinoma
118,Intestinal metaplasia,Small Intestinal Signet Ring Cell Carcinoma
119,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Eccrine Porocarcinoma
120,High Mitotic Activity,Subependymal Glioma
121,Chronic Clinical Course,Mixed phenotype acute leukemia
122,Indolent Clinical Course,Stage IV Uterine Sarcoma AJCC v7
123,Squamous Differentiation,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
124,Infiltrative Growth Pattern,Gardner Fibroma
125,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of esophagus
126,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Carcinoma
127,Premalignant Lesion,carcinosarcoma of lung
128,Tissues Derived from Two or Three Embryonic Layers Present,Monodermal teratoma
129,Chronic Clinical Course,Core binding factor acute myeloid leukemia
130,Malignant Germinomatous Cellular Infiltrate,choriocarcinoma of mediastinum
131,Borderline Lesion,Esophageal squamous papilloma
132,Benign Cellular Infiltrate,fibrosarcoma of small intestine
133,Benign Cellular Infiltrate,Small intestine adenocarcinoma metastatic NOS
134,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal squamous cell carcinoma recurrent
135,Mucoid Stroma Formation,Breast Papillomatosis
136,Mucoid Stroma Formation,"Carcinoma, Papillary"
137,Intermediate Filaments Present,Stage I Bone Sarcoma AJCC v7
138,Mixture of Germ Cell Neoplastic Components Present,Childhood Ovarian Choriocarcinoma
139,Intermediate Filaments Present,leiomyosarcoma of kidney
140,Indolent Clinical Course,Chondroblastic osteosarcoma
141,Intracytoplasmic Eosinophilic Inclusion,Rectal Kaposi Sarcoma
142,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Hurthle Cell Carcinoma
143,Borderline Lesion,Renal Pelvis Inverted Papilloma
144,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Mucinous Neoplasm
145,Benign Cellular Infiltrate,Malignant tumor of small intestine
146,Mixed Neoplastic Glandular and Squamous Cell Population,Clear cell squamous cell carcinoma of skin
147,Intestinal metaplasia,Bile duct signet-ring cell carcinoma
148,Borderline Lesion,Oral Cavity Pleomorphic Adenoma
149,Histiocytosis,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
150,Borderline Lesion,Desmoplastic trichilemmoma
151,Stromal Invasion,Pancreatic Intraductal Tubulopapillary Neoplasm
152,Intracytoplasmic Eosinophilic Inclusion,Esophageal Malignant Peripheral Nerve Sheath Tumor
153,atypia morphology,Pericardial Adenomatoid Tumor
154,Grade 4 Lesion,Recurrent Childhood Cerebral Astrocytoma
155,Intermediate Filaments Present,Osteosarcoma Arising in Paget Disease of Bone
156,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma Arising in Paget Disease of Bone
157,Chronic Clinical Course,Acute Myeloid Leukemia with t(11;17)(q23;q21)
158,Diffuse Lesion,"Papilloma, Squamous Cell"
159,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of small intestine
160,Diffuse Lesion,Lung Mixed Squamous Cell and Glandular Papilloma
161,Pancreatobiliary-Type Malignant Cells Present,Ampulla of Vater Intestinal-Type Adenocarcinoma
162,Benign Cellular Infiltrate,Recurrent Rectal Cancer
163,Intracytoplasmic Eosinophilic Inclusion,Stage IB Soft Tissue Sarcoma AJCC v7
164,Mixed Neoplastic Glandular and Squamous Cell Population,Anal margin Paget's disease
165,Necrotic changes (finding),Benign Intraocular Schwannoma
166,Solid Growth Pattern,Adult Acute Monoblastic and Monocytic Leukemia
167,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of rectum
168,Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
169,Deep Lesion,Atypical Lipoma
170,Indolent Clinical Course,Adult Clear Cell Sarcoma of Soft Parts
171,Benign Cellular Infiltrate,Grade 1 Colon Adenocarcinoma
172,Microvascular Proliferation,Childhood Cerebral Anaplastic Astrocytoma
173,Chronic Clinical Course,Acute Undifferentiated Leukemia
174,Locally Aggressive Lesion,Nasopharyngeal Angiofibroma
175,Invasive Lesion,Esophageal dysplasia
176,High Mitotic Activity,Duodenal Gastrin-Producing Neuroendocrine Tumor
177,Invasive Lesion,Dermal Duct Tumor
178,Intracytoplasmic Eosinophilic Inclusion,Adult Pleomorphic Rhabdomyosarcoma
179,Chronic Clinical Course,ROSE Cluster 2
180,Invasive Lesion,Eccrine Poroma
181,Squamous Differentiation,Undifferentiated carcinoma of stomach
182,Intracytoplasmic Eosinophilic Inclusion,Small Intestinal Angiosarcoma
183,Local disease,Intravenous leiomyomatosis
184,Intracytoplasmic Eosinophilic Inclusion,Cervical Malignant Peripheral Nerve Sheath Tumor
185,Intracytoplasmic Eosinophilic Inclusion,Metastatic Ewing's Sarcoma
186,Indolent Clinical Course,FNCLCC Sarcoma Grade 1
187,Indolent Clinical Course,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
188,Mucoid Stroma Formation,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
189,Solid Growth Pattern,Adult Acute Megakaryoblastic Leukemia
190,Invasive Lesion,"Adenoma, Basal Cell"
191,Capsular Invasion,Pituitary Gland Oncocytic Adenoma
192,Invasive Lesion,Grade II Penile Intraepithelial Neoplasia
193,Intermediate Filaments Present,Malignant fibrous histiocytoma recurrent
194,Borderline Lesion,Hereditary Kidney Oncocytoma
195,Solid Growth Pattern,Leukemic Phase of Non-Hodgkin's Lymphoma
196,Invasive Lesion,Biliary Intraepithelial Neoplasia-2
197,Mixture of Germ Cell Neoplastic Components Present,Mature Testicular Teratoma
198,Intermediate Filaments Present,sarcoma of oral cavity
199,High Grade Lesion,Hemangioendothelioma
200,Invasive Lesion,High-Grade Squamous Intraepithelial Lesions
201,Mixed Neoplastic Glandular and Squamous Cell Population,Penile intraepithelial neoplasia
202,Precise Histogenesis Unknown,Anaplastic astrocytoma
203,Favorable Clinical Outcome,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
204,High Mitotic Activity,Leiomyomatosis peritonealis disseminata
205,Macrofollicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
206,Junctional Proliferation,Cervical Blue Nevus
207,Favorable Clinical Outcome,Apocrine breast carcinoma
208,High Mitotic Activity,leiomyoma of extrahepatic bile duct
209,Intracytoplasmic Eosinophilic Inclusion,Esophageal Liposarcoma
210,Intermediate Filaments Present,Childhood Fibrosarcoma
211,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
212,Necrotic changes (finding),Benign Mediastinal Psammomatous Schwannoma
213,Papillary Pattern,"Carcinoma, Cribriform"
214,Invasive Lesion,Cervical high grade squamous intraepithelial lesion
215,Nuclear Clearing,Thyroid Gland Follicular Adenoma
216,Indolent Clinical Course,Adult Anaplastic Ependymoma
217,Intracytoplasmic Eosinophilic Inclusion,Telangiectatic osteosarcoma
218,Intracytoplasmic Eosinophilic Inclusion,Cardiac Malignant Fibrous Histiocytoma
219,Papillary Pattern,Hard Palate Pleomorphic Adenoma
220,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of liver
221,Benign Cellular Infiltrate,Stage IB Distal Bile Duct Cancer AJCC v7
222,Severe cytologic atypia,Extrahepatic Bile Duct Carcinoid Tumor
223,Indolent Clinical Course,Malignant Synovial Neoplasm
224,Mixed Neoplastic Glandular and Squamous Cell Population,Sporadic Gastric Adenocarcinoma
225,Solid Growth Pattern,Acute myeloid leukemia with mutated NPM1
226,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline serous tumor of ovary
227,Precise Histogenesis Unknown,Brain Stem Glioma
228,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma refractory
229,Squamous Differentiation,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
230,Benign Cellular Infiltrate,Colorectal Angiosarcoma
231,Benign Cellular Infiltrate,Colorectal Signet Ring Cell Carcinoma
232,Solid Growth Pattern,T-Cell Prolymphocytic Leukemia
233,Precise Histogenesis Unknown,Fibrillary Astrocytoma
234,Benign Cellular Infiltrate,Stage IIB Colorectal Cancer AJCC v7
235,Premalignant Lesion,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
236,Premalignant Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
237,Mixed Neoplastic Glandular and Squamous Cell Population,Distal 1/3 of the Common Bile Duct Adenocarcinoma
238,Benign Cellular Infiltrate,Small cell carcinoma of esophagus
239,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal squamous cell carcinoma recurrent
240,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary Papillary Renal Carcinoma
241,Mixture of Germ Cell Neoplastic Components Present,Stage I Immature Testicular Teratoma AJCC v6 and v7
242,Intracytoplasmic Eosinophilic Inclusion,Inflammatory malignant fibrous histiocytoma
243,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
244,Mixed Epithelial Cell Population,Pedunculated conjunctival papilloma
245,Mixed Neoplastic Glandular and Squamous Cell Population,Breast Columnar Cell Mucinous Carcinoma
246,Benign Cellular Infiltrate,Stage I Gastric Carcinoma
247,Indolent Clinical Course,Myxoinflammatory fibroblastic sarcoma
248,Favorable Clinical Outcome,BCLC Stage C Hepatocellular Carcinoma
249,Intermediate Filaments Present,Undifferentiated spindle cell sarcoma
250,Indolent Clinical Course,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
251,Benign Cellular Infiltrate,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
252,Syncytial Pattern,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
253,High Mitotic Activity,Pancreatic Neuroendocrine Tumor G1
254,Glandular Differentiation,large cell neuroendocrine carcinoma of gallbladder
255,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Hepatocellular Carcinoma
256,Seminomatous Component Present,Pineal Region Mature Teratoma
257,Extensive Necrosis,Childhood Brain Oligodendroglioma
258,Well-Circumscribed Lesion,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
259,Mixed Neoplastic Glandular and Squamous Cell Population,Spindle Cell Oncocytoma of the Adenohypophysis
260,Histiocytosis,Centroblastic lymphoma stage II
261,Mixed Neoplastic Glandular and Squamous Cell Population,Postcricoid Squamous Cell Carcinoma
262,Mixed Cellular Population,Squamous cell papilloma of skin
263,Well Differentiated Lesion,High Grade Appendix Mucinous Adenocarcinoma
264,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
265,Mixed Neoplastic Glandular and Squamous Cell Population,Skin Squamous Cell Carcinoma In Situ
266,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Hepatocellular Carcinoma AJCC v7
267,Mucoid Stroma Formation,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
268,High Mitotic Activity,Fibroid Tumor
269,Intermediate Filaments Present,Prostate Sarcoma
270,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
271,Diffuse Lesion,Hemangioma of liver
272,Indolent Clinical Course,Stage IIIB Uterine Sarcoma AJCC v7
273,Intermediate Filaments Present,Colon Sarcoma
274,Indolent Clinical Course,Fusion-Positive Alveolar Rhabdomyosarcoma
275,Indolent Clinical Course,Malignant neoplasm of meninges
276,Mucoid Stroma Formation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
277,Premalignant Lesion,Stage IIB Lung Small Cell Carcinoma AJCC v7
278,Squamous Differentiation,Laryngeal Giant Cell Carcinoma
279,Benign Cellular Infiltrate,Small intestine carcinoma metastatic
280,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Fallopian Tube Mucinous Tumor
281,Solid Growth Pattern,Acute Lymphoblastic Leukemia by ROSE Cluster
282,Increased Cellularity Present,Renal Pelvis Inverted Papilloma
283,Benign Cellular Infiltrate,Hepatic lymphoma
284,Mixed Neoplastic Glandular and Squamous Cell Population,Exophytic Schneiderian Papilloma
285,Benign Cellular Infiltrate,Malignant Esophageal Neoplasm by Topographic Region
286,Increased Cellularity Present,Urethral Urothelial Papilloma
287,CD35-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
288,Indolent Clinical Course,Sarcoma of soft tissue
289,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary serous cystadenocarcinoma
290,Invasive Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant"
291,Indolent Clinical Course,Stage II Osteosarcoma AJCC v7
292,Mixed Neoplastic Glandular and Squamous Cell Population,Inverting papilloma of the paranasal sinus
293,Pushing Tumor Margin,Low Grade Endometrioid Stromal Sarcoma of the Vagina
294,Papillary Pattern,Intraductal Cribriform Breast Adenocarcinoma
295,Precise Histogenesis Unknown,Childhood Fibrillary Astrocytoma
296,Microvascular Proliferation,Childhood Gemistocytic Astrocytoma
297,Intermediate Filaments Present,Stromal sarcoma
298,Diffuse Lesion,Hemangioma of orbit
299,CD15-Positive Neoplastic Cells Present,Nodular Lymphocyte Predominant Hodgkin Lymphoma
300,Necrotic changes (finding),Benign Bone Schwannoma
301,Precise Histogenesis Unknown,Childhood Giant Cell Glioblastoma
302,Dysplasia,Hidradenoma Papilliferum
303,Invasive Lesion,Syringocystadenoma Papilliferum
304,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
305,Invasive Lesion,Sebaceous adenoma
306,Solid Growth Pattern,Chronic Neutrophilic Leukemia
307,Intermediate Filaments Present,Childhood Myxoid Chondrosarcoma
308,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal adenocarcinoma metastatic
309,Intracytoplasmic Eosinophilic Inclusion,"Sarcoma, Epithelioid"
310,Mixed Neoplastic Glandular and Squamous Cell Population,undifferentiated carcinoma of pancreas
311,Favorable Clinical Outcome,Adult Hepatocellular Carcinoma
312,Indolent Clinical Course,WHO Grade III Glioma
313,Benign Cellular Infiltrate,Stage II Esophageal Cancer AJCC v7
314,Benign Cellular Infiltrate,Cystadenocarcinoma of pancreas
315,Encapsulated Mass,Cardiac neurofibroma
316,Metastatic Lesion,Parotid Gland Warthin Tumor
317,High Mitotic Activity,Ependymoma of spinal cord
318,Benign Cellular Infiltrate,Secondary malignant neoplasm of esophagus
319,Dysplasia,Eccrine spiradenoma
320,Solid Growth Pattern,Chronic lymphocytic leukemia stage 0
321,Seminomatous Component Present,Ovarian Dermoid Cyst with Leiomyosarcoma
322,Chronic Clinical Course,Childhood Acute Basophilic Leukemia
323,Diffuse Lesion,Cervical Squamous Papilloma
324,Solid Growth Pattern,Acute myeloid leukemia with abnormal marrow eosinophils
325,Severe cytologic atypia,Esophageal Neuroendocrine Tumor
326,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Colon Adenocarcinoma
327,Squamous Differentiation,Small Intestinal Large Cell Neuroendocrine Carcinoma
328,Invasive Lesion,Atypical Breast Papilloma
329,Mixed Neoplastic Glandular and Squamous Cell Population,Adenoid cystic eccrine carcinoma
330,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Mucinous cystadenoma of ovary
331,Glandular Differentiation,Parotid Gland Undifferentiated Carcinoma
332,Locally Aggressive Lesion,Enchondroma
333,Intermediate Filaments Present,Stage III Osteosarcoma AJCC v7
334,Intermediate Filaments Present,Small Intestinal Angiosarcoma
335,Solid Growth Pattern,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
336,Mixed Neoplastic Glandular and Squamous Cell Population,Infiltrating papillary adenocarcinoma
337,Invasive Lesion,Cervical intraepithelial neoplasia grade 1
338,Indolent Clinical Course,Breast Extraskeletal Osteosarcoma
339,Pain,Bone island
340,Mucoid Stroma Formation,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
341,Mixed Epithelial Cell Population,Maxillary Sinus Schneiderian Papilloma
342,Indolent Clinical Course,Angiosarcoma NCI Grade 2
343,Mixed Neoplastic Glandular and Squamous Cell Population,Colon Serrated Adenocarcinoma
344,Indolent Clinical Course,Kaposi Sarcoma NCI Grade 3
345,Multilayered Rosette Formation,Medulloblastoma
346,High Mitotic Activity,Mixed Oligodendroglioma-Astrocytoma
347,Benign Cellular Infiltrate,Small Intestinal Kaposi Sarcoma
348,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, diffuse type"
349,Intracytoplasmic Eosinophilic Inclusion,Malignant Gastric Gastrointestinal Stromal Tumor
350,Borderline Lesion,Intraductal Breast Papillomatosis
351,Anaplasia,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
352,High Mitotic Activity,Tanycytic ependymoma
353,Indolent Clinical Course,Central Nervous System Kaposi Sarcoma
354,Glandular Differentiation,Lung Lymphoepithelioma-Like Carcinoma
355,Mixed Epithelial Cell Population,Frontal Sinus Inverted Papilloma
356,Multilayered Rosette Formation,Cerebellar Vermis Medulloblastoma
357,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
358,CD21-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
359,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
360,Intracytoplasmic Eosinophilic Inclusion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
361,Intermediate Filaments Present,Undifferentiated Endocervical Sarcoma
362,Benign Cellular Infiltrate,Anal Canal Mixed Adenoneuroendocrine Carcinoma
363,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Adrenal Cortex Carcinoma
364,Capsular Invasion,Water-clear cell adenoma
365,Locally Aggressive Lesion,Benign Cutaneous Fibroblastic Neoplasm
366,Intracanalicular Growth Pattern,Pericanalicular fibroadenoma
367,Indolent Clinical Course,Colorectal Sarcoma
368,Glandular Differentiation,"Carcinoma, Large Cell"
369,Favorable Clinical Outcome,Aleukemic Acute Lymphoblastic Leukemia Cutis
370,Favorable Clinical Outcome,Primary cutaneous lymphoma
371,Grade 4 Lesion,Pilocytic Astrocytoma
372,Precise Histogenesis Unknown,Optic Nerve Glioma
373,Glandular Differentiation,Large cell lung cancer stage I
374,Papillary Pattern,Invasive Cribriform Breast Carcinoma
375,Glandular Differentiation,Large cell lung cancer stage IV
376,Mixed Neoplastic Glandular and Squamous Cell Population,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
377,Favorable Clinical Outcome,Cutaneous Melanoma
378,Diffuse Lesion,Pyogenic granuloma of skin and subcutaneous tissue
379,Benign Cellular Infiltrate,Crohn Disease-Associated Colorectal Adenocarcinoma
380,Dysplasia,Benign Breast Eccrine Spiradenoma
381,Borderline Lesion,endometrioid adenofibroma of ovary
382,Mixture of Germ Cell Neoplastic Components Present,Stage IVB Gestational Trophoblastic Tumor AJCC v7
383,Premalignant Lesion,"Adenocarcinoma of lung, stage II"
384,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Clear cell adenocarcinoma of ovary
385,Microvascular Proliferation,Grade III Childhood Astrocytoma
386,Blasts of Mixed Phenotype Present,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
387,Indolent Clinical Course,Classical Glioblastoma
388,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fibroadenoma of breast
389,Seminomatous Component Present,Childhood Mature Teratoma
390,Precise Histogenesis Unknown,Brain Stem Glioblastoma
391,Precise Histogenesis Unknown,Ependymoma of brain stem
392,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Erythroid Leukemia
393,Solid Growth Pattern,Adult Acute Promyelocytic Leukemia with PML-RARA
394,Chronic Clinical Course,Childhood Acute Erythroid Leukemia
395,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of fallopian tube
396,Mixture of Germ Cell Neoplastic Components Present,Stage III Testicular Seminoma AJCC v6 and v7
397,Favorable Clinical Outcome,Vulvar Merkel Cell Carcinoma
398,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
399,Metastatic Lesion,Plurihormonal Pituitary Gland Adenoma
400,Necrotic changes (finding),Microcystic/Reticular Schwannoma
401,Precise Histogenesis Unknown,Anaplastic ganglioglioma
402,Benign Cellular Infiltrate,Recurrent Childhood Liver Cancer
403,Intracytoplasmic Eosinophilic Inclusion,Parosteal Osteosarcoma
404,Nuclear Clearing,Follicular thyroid carcinoma
405,Indolent Clinical Course,Adult Central Nervous System Mixed Germ Cell Tumor
406,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of lacrimal gland
407,Solid Growth Pattern,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
408,Indolent Clinical Course,Central Nervous System Teratoma with Malignant Transformation
409,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
410,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Serous Adenofibroma
411,Intracytoplasmic Eosinophilic Inclusion,Low grade myofibroblastic sarcoma
412,Intracytoplasmic Eosinophilic Inclusion,Childhood Conventional Osteosarcoma
413,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,mucinous adenocarcinofibroma of ovary
414,Chronic Clinical Course,Hyperdiploid B Acute Lymphoblastic Leukemia
415,Favorable Clinical Outcome,apocrine adenocarcinoma of vulva
416,Indolent Clinical Course,Malignant neoplasm of pituitary gland
417,Acinar Cell Differentiation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
418,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
419,Intracytoplasmic Eosinophilic Inclusion,mesenchymal chondrosarcoma of bone
420,Favorable Clinical Outcome,Fibroepithelioma of Pinkus
421,Mixed Neoplastic Glandular and Squamous Cell Population,Urethral Villous Adenoma
422,Mixed Neoplastic Glandular and Squamous Cell Population,intraepithelial glandular neoplasia of cervix
423,Mixed Neoplastic Glandular and Squamous Cell Population,High grade cervical glandular intraepithelial neoplasia
424,Benign Cellular Infiltrate,Stage III Colorectal Cancer
425,Benign Cellular Infiltrate,Gallbladder Cancer by AJCC v7 Stage
426,Intracytoplasmic Eosinophilic Inclusion,Superior Vena Cava Leiomyosarcoma
427,Cellular Pleomorphism,"Perivascular epithelioid tumor, benign"
428,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Lobular Breast Carcinoma
429,Cytologic atypia,Colon Hyperplastic Polyp
430,Precise Histogenesis Unknown,Chordoid Glioma of the Third Ventricle
431,Locally Aggressive Lesion,benign fibrous histiocytoma of bone
432,Indolent Clinical Course,pineoblastoma
433,Indolent Clinical Course,leiomyosarcoma
434,"Undifferentiated ""Fetal-Type"" Tissues Present",Ovarian Solid Teratoma
435,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Chorioangioma
436,Premalignant Lesion,Stage IA Lung Large Cell Carcinoma AJCC v7
437,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal squamous papilloma
438,Intermediate Filaments Present,Stage IV Osteosarcoma AJCC v7
439,Premalignant Lesion,Bronchioloalveolar Adenocarcinoma
440,Aggressive Clinical Course,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma
441,Low Mitotic Activity,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
442,Indolent Clinical Course,Recurrent Childhood Central Nervous System Embryonal Neoplasm
443,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal squamous cell carcinoma recurrent
444,Well-Circumscribed Lesion,Chest Wall Fibromatosis
445,Intermediate Filaments Present,Fusion-Negative Rhabdomyosarcoma
446,Mixed Neoplastic Glandular and Squamous Cell Population,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
447,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
448,Locally Aggressive Lesion,Nodular fasciitis
449,Tubular Pattern,Small Intestinal Villous Adenoma
450,Benign Cellular Infiltrate,Bile duct clear cell adenocarcinoma
451,Intermediate Filaments Present,fibrosarcoma of kidney
452,Diffuse Lesion,Venous hemangioma
453,Intracytoplasmic Eosinophilic Inclusion,Stage II Osteosarcoma AJCC v7
454,Aggressive Clinical Course,Liver Mucosa-Associated Lymphoid Tissue Lymphoma
455,Solid Growth Pattern,Acute bilineal leukemia
456,Polymorphic Cellular Infiltrate,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
457,Severe cytologic atypia,Distal-Type Epithelioid Sarcoma
458,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
459,Mixed Neoplastic Glandular and Squamous Cell Population,ENSAT Stage I Adrenal Cortex Carcinoma
460,Histiocytosis,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
461,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma in situ of prostate
462,Locally Aggressive Lesion,lipoma of bone
463,Locally Aggressive Lesion,Vulvar Cellular Angiofibroma
464,Favorable Clinical Outcome,Intrahepatic Cholangiocarcinoma
465,Chronic Clinical Course,Adult Erythroleukemia
466,Mixed Neoplastic Glandular and Squamous Cell Population,cystadenocarcinoma of salivary gland
467,Invasive Lesion,Intraepithelial Neoplasia
468,atypia morphology,Follicular Myxoma
469,Premalignant Lesion,Stage IA Lung Adenosquamous Carcinoma AJCC v7
470,High Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G1
471,Mixed Neoplastic Glandular and Squamous Cell Population,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
472,Severe cytologic atypia,Somatostatinoma
473,Benign Cellular Infiltrate,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
474,Indolent Clinical Course,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
475,Mixed Neoplastic Glandular and Squamous Cell Population,Mucin-producing adenocarcinoma
476,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Brenner Tumor
477,Mucoid Stroma Formation,"Transitional cell papilloma, benign"
478,Benign Cellular Infiltrate,Malignant neoplasm of esophagus
479,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
480,Benign Cellular Infiltrate,mixed acinar-endocrine carcinoma of pancreas
481,Anaplasia,Childhood Infratentorial Ependymoma
482,Benign Cellular Infiltrate,AIDS-Related Gastric Kaposi Sarcoma
483,Benign Cellular Infiltrate,Intestinal Cancer
484,Papillary Pattern,Flat Ductal Epithelial Atypia of the Breast
485,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage B Adult Hepatocellular Carcinoma
486,Benign Cellular Infiltrate,Small Intestinal Neuroendocrine Carcinoma
487,Villous Pattern,Tubular adenoma
488,Benign Cellular Infiltrate,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
489,Indolent Clinical Course,Low Grade Malignant Peripheral Nerve Sheath Tumor
490,Mucoid Stroma Formation,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
491,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Sarcoma
492,High Mitotic Activity,Gastric Neuroendocrine Tumor G2
493,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma stage I
494,Squamous Differentiation,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
495,Invasive Lesion,Squamous Lung Dysplasia
496,Mucoid Stroma Formation,Papillary serous cystadenocarcinoma
497,Benign Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v6 and v7
498,High Mitotic Activity,Uterine Corpus Myxoid Leiomyosarcoma
499,Squamous Differentiation,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
500,Indolent Clinical Course,Central Nervous System Ganglioneuroblastoma
501,Mixed Neoplastic Glandular and Squamous Cell Population,Villous adenocarcinoma
502,Indolent Clinical Course,Uterine Corpus Endometrial Stromal Sarcoma
503,Squamous Differentiation,Recurrent Oropharyngeal Undifferentiated Carcinoma
504,Glandular Differentiation,Recurrent Oropharyngeal Undifferentiated Carcinoma
505,Blasts Expressing CD56 and Immature T-Cell Markers Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
506,Benign Cellular Infiltrate,Malignant Gastric Soft Tissue Neoplasm
507,Intracytoplasmic Eosinophilic Inclusion,Childhood Alveolar Soft Part Sarcoma
508,Mixed Neoplastic Glandular and Squamous Cell Population,signet ring cell carcinoma of gallbladder
509,Intracytoplasmic Eosinophilic Inclusion,Childhood Rhabdomyosarcoma
510,Locally Aggressive Lesion,Cementoma
511,Diffuse Lesion,Frontal Sinus Inverted Papilloma
512,Favorable Clinical Outcome,Skin Nodular Basal Cell Carcinoma
513,Grade 4 Lesion,Recurrent Childhood Pleomorphic Xanthoastrocytoma
514,Anaplasia,Recurrent Childhood Pleomorphic Xanthoastrocytoma
515,Intracytoplasmic Eosinophilic Inclusion,"Sarcoma, Spindle Cell"
516,Grade 4 Lesion,Recurrent Childhood Protoplasmic Astrocytoma
517,Benign Cellular Infiltrate,Colon Carcinoma Metastatic in the Liver
518,Mucoid Stroma Formation,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
519,Solid Growth Pattern,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
520,Borderline Lesion,Fallopian Tube Metaplastic Papillary Tumor
521,Benign Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v7
522,Intracytoplasmic Eosinophilic Inclusion,Spindle cell rhabdomyosarcoma
523,Mixture of Germ Cell Neoplastic Components Present,Stage IV Gestational Trophoblastic Tumor AJCC v7
524,Chronic Clinical Course,Mixed phenotype acute leukemia B/myeloid
525,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatocellular Carcinoma by AJCC v7 Stage
526,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Carcinoma of Unknown Primary
527,Necrotic changes (finding),Pleural Schwannoma
528,Capsular Invasion,Androgen-Producing Adrenal Cortex Adenoma
529,Blasts of Mixed Phenotype Present,NK-lymphoblastic leukemia/lymphoma
530,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of lung stage IIIA
531,Mixture of Germ Cell Neoplastic Components Present,Stage IA Gestational Trophoblastic Tumor AJCC v7
532,Solid Growth Pattern,Cutaneous Chronic Lymphocytic Leukemia
533,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
534,Chronic Clinical Course,Adult Acute Lymphocytic Leukemia
535,Mucoid Stroma Formation,Squamous Papilloma of the Nasopharynx
536,Mixed Epithelial Cell Population,Squamous Papilloma of the Nasopharynx
537,Precise Histogenesis Unknown,Childhood Oligodendroglioma
538,Extensive Necrosis,Childhood Oligodendroglioma
539,Intracytoplasmic Eosinophilic Inclusion,Lung Monophasic Synovial Sarcoma
540,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal squamous papilloma
541,Indolent Clinical Course,Extraskeletal osteosarcoma recurrent
542,Intermediate Filaments Present,Prostate Leiomyosarcoma
543,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
544,Benign Cellular Infiltrate,Sporadic Gastric Adenocarcinoma
545,Indolent Clinical Course,rhabdomyosarcoma of testis
546,Intermediate Filaments Present,rhabdomyosarcoma of testis
547,Favorable Clinical Outcome,Stage 0 Merkel Cell Carcinoma AJCC v7
548,Indolent Clinical Course,Colorectal Kaposi Sarcoma
549,Mucoid Stroma Formation,Nasopharyngeal Papillary Adenocarcinoma
550,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Serous Adenocarcinoma
551,Necrotic changes (finding),Childhood Cerebral Diffuse Astrocytoma
552,Squamous Differentiation,"Lung Large Cell Carcinoma, Clear Cell Variant"
553,Favorable Clinical Outcome,"Lymphoma, T-Cell, Cutaneous"
554,High Grade Lesion,Epithelioid hemangioendothelioma of lung
555,Tumor Vascular Invasion,"Leydig cell tumor, benign"
556,Indolent Clinical Course,Choroid Plexus Carcinoma
557,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenoma, Villous"
558,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
559,Mixed Neoplastic Glandular and Squamous Cell Population,Subglottic Verrucous Carcinoma
560,Aggressive Clinical Course,Ann Arbor Stage III Grade 1 Follicular Lymphoma
561,Benign Cellular Infiltrate,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
562,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
563,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Carcinoma with Lymphoid Stroma
564,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Immature Teratoma
565,Diffuse Lesion,Angioma serpiginosum
566,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of appendix
567,Benign Cellular Infiltrate,Stage IV Esophageal Cancer AJCC v7
568,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian serous cystadenofibroma
569,Invasive Lesion,Prostatic Intraepithelial Neoplasias
570,Precise Histogenesis Unknown,Cerebellar Glioblastoma
571,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1
572,Tubular Structures Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified"
573,Mixed Neoplastic Glandular and Squamous Cell Population,Condylomata Acuminata
574,Well-Circumscribed Lesion,Elastofibroma
575,Favorable Clinical Outcome,Stage IB Merkel Cell Carcinoma AJCC v7
576,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Cohesive Gastric Carcinoma
577,Pagetoid Proliferation,Nevoid Melanoma
578,Nuclear Clearing,Thyroid Gland Oncocytic Adenoma
579,Birbeck Granules Present,"Dendritic Cell Sarcoma, Follicular"
580,Invasive Lesion,canalicular adenoma of salivary gland
581,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Parathyroid Gland Carcinoma
582,Favorable Clinical Outcome,Hepatocellular Carcinoma by AJCC v6 Stage
583,Intermediate Filaments Present,Conventional Extraskeletal Myxoid Chondrosarcoma
584,Benign Cellular Infiltrate,Gallbladder Mixed Adenoneuroendocrine Carcinoma
585,Invasive Lesion,Squamous cell papilloma of skin
586,Nuclear Clearing,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
587,Solid Growth Pattern,Acute Basophilic Leukemia
588,Well-Circumscribed Lesion,pineoblastoma
589,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Endocervical Adenocarcinoma
590,Intermediate Filaments Present,Stage IA Uterine Sarcoma AJCC v7
591,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Verrucous Carcinoma
592,Intermediate Filaments Present,Epithelioid Sarcoma NCI Grade 2
593,Benign Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
594,Homer Wright Rosette Formation,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
595,Invasive Lesion,Eccrine hidrocystoma
596,Intracytoplasmic Eosinophilic Inclusion,Liver Extraskeletal Osteosarcoma
597,Intermediate Filaments Present,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
598,Intermediate Filaments Present,Secondary osteosarcoma
599,Mixture of Germ Cell Neoplastic Components Present,choriocarcinoma of mediastinum
600,Ineffective hematopoiesis,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
601,Premalignant Lesion,Stage IIB Lung Large Cell Carcinoma AJCC v7
602,Diffuse Lesion,Senile angioma
603,Borderline Lesion,Thyroid Gland Clear Cell Follicular Adenoma
604,Tubular Pattern,villous adenoma of stomach
605,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
606,Malignant Germinomatous Cellular Infiltrate,Mediastinal teratoma
607,Precise Histogenesis Unknown,Malignant Glioma
608,Benign Cellular Infiltrate,Small Intestinal T-Cell Non-Hodgkin Lymphoma
609,Indolent Clinical Course,Medulloblastoma with Leptomeningeal Spread
610,Squamous Differentiation,Undifferentiated carcinoma of nasopharynx
611,Necrotic changes (finding),Prostate Stromal Proliferation of Uncertain Malignant Potential
612,Invasive Lesion,Oral Cavity Pleomorphic Adenoma
613,Neuroendocrine Differentiation,Carcinoma in situ of skin
614,Mixed Neoplastic Glandular and Squamous Cell Population,Frontal Sinus Squamous Cell Carcinoma
615,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
616,Benign Cellular Infiltrate,Appendix Kaposi Sarcoma
617,atypia morphology,Benign melanocytic nevus
618,Intermediate Filaments Present,alveolar rhabdomyosarcoma of orbit
619,Precise Histogenesis Unknown,Recurrent Childhood Cerebral Astrocytoma
620,Dysplasia,Acantholytic acanthoma
621,Indolent Clinical Course,Gastrointestinal Stromal Sarcoma
622,Villous Pattern,Ampulla of Vater Tubular Adenoma
623,Hemorrhagic,Uterine Corpus Cellular Leiomyoma
624,Premalignant Lesion,Stage IB Lung Adenosquamous Carcinoma AJCC v7
625,Mixed Cellular Population,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
626,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the prostate metastatic
627,Mitotic Activity,Benign Cardiac Germ Cell Tumor
628,Chronic Clinical Course,Adult Acute Monoblastic and Monocytic Leukemia
629,Anaplasia,Ependymoma of spinal cord
630,Chronic Clinical Course,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
631,Necrotic changes (finding),Ureter Schwannoma
632,Malignant Germinomatous Cellular Infiltrate,Testicular embryonal carcinoma
633,Seminomatous Component Present,Testicular embryonal carcinoma
634,Mucoid Stroma Formation,Vaginal Mullerian Papilloma
635,Glandular Differentiation,undifferentiated carcinoma of appendix
636,Mucoid Stroma Formation,Invasive micropapillary carcinoma of breast
637,Chronic Clinical Course,Childhood Acute Megakaryoblastic Leukemia
638,Benign Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v7
639,Microvascular Proliferation,Childhood Cerebellar Anaplastic Astrocytoma
640,High Mitotic Activity,Esophageal Neuroendocrine Tumor
641,Precise Histogenesis Unknown,Rosette-forming glioneuronal tumor of the fourth ventricle
642,Indolent Clinical Course,Childhood Central Nervous System Choriocarcinoma
643,Indolent Clinical Course,Spindle Cell/Sclerosing Rhabdomyosarcoma
644,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma recurrent
645,High Mitotic Activity,Well Differentiated Oligodendroglioma
646,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
647,Intracytoplasmic Eosinophilic Inclusion,Parotid Gland Kaposi Sarcoma
648,Severe cytologic atypia,Duodenal Gastrin-Producing Neuroendocrine Tumor
649,Intermediate Filaments Present,Inflammatory Leiomyosarcoma
650,Benign Cellular Infiltrate,Gastric Squamous Cell Carcinoma
651,Mixture of Germ Cell Neoplastic Components Present,Testicular embryonal carcinoma stage II
652,Necrotic changes (finding),Peripheral Nerve Schwannoma
653,Benign Cellular Infiltrate,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
654,Indolent Clinical Course,Mediastinal Angiosarcoma
655,Intracytoplasmic Eosinophilic Inclusion,Retroperitoneal sarcoma
656,Intracytoplasmic Eosinophilic Inclusion,FNCLCC Sarcoma Grade 1
657,Indolent Clinical Course,Angiosarcoma of spleen
658,Invasive Lesion,Pancreatic intraepithelial neoplasia
659,Indolent Clinical Course,Stage IB Adult Soft Tissue Sarcoma AJCC v7
660,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Gastric Intraepithelial Neoplasia
661,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
662,Favorable Clinical Outcome,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
663,Benign Cellular Infiltrate,Gastrointestinal lymphoma
664,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary Lung Adenocarcinoma
665,Benign Cellular Infiltrate,Gallbladder Goblet Cell Carcinoid
666,Mucoid Stroma Formation,Papillary mucinous cystadenocarcinoma
667,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Teratoma
668,Diffuse Lesion,Breast Epithelioid Hemangioma
669,Indolent Clinical Course,Anaplastic Medulloblastoma
670,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Ovarian Teratoma
671,Glandular Differentiation,Sinonasal undifferentiated carcinoma
672,Intestinal metaplasia of gastric mucosa,"Gastric Adenoma, Gastric-Type"
673,Invasive Lesion,Tumor of follicular infundibulum
674,Anaplasia,Papillary ependymoma
675,Intermediate Filaments Present,Metastatic Extraskeletal Myxoid Chondrosarcoma
676,High Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Cervix
677,Severe cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix
678,Indolent Clinical Course,Undifferentiated Endocervical Sarcoma
679,Pushing Tumor Margin,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
680,Invasive Lesion,Bile Duct Biliary Intraepithelial Neoplasia
681,Neuronal Differentiation,Desmoplastic infantile astrocytoma
682,Indolent Clinical Course,Anaplastic astrocytoma
683,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric dysplasia
684,Mucoid Stroma Formation,Gallbladder papillary adenocarcinoma
685,Indolent Clinical Course,Osteosarcoma
686,Indolent Clinical Course,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
687,Benign Cellular Infiltrate,"Carcinoid, Goblet Cell"
688,Extensive Necrosis,Oligodendroglioma of spinal cord
689,Intermediate Filaments Present,Pleural Monophasic Synovial Sarcoma
690,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of duodenum
691,Benign Cellular Infiltrate,Childhood Small Intestinal Leiomyosarcoma
692,Precise Histogenesis Unknown,Childhood Pilocytic Astrocytoma
693,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
694,Indolent Clinical Course,Malignant neoplasm of acoustic nerve
695,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Prolactinoma
696,Chronic Clinical Course,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
697,Borderline Lesion,Aldosterone-Producing Adrenal Cortex Adenoma
698,Intermediate Filaments Present,Cardiac Synovial Sarcoma
699,Indolent Clinical Course,Malignant Meningioma
700,Indolent Clinical Course,Alveolar rhabdomyosarcoma
701,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx
702,Indolent Clinical Course,Prostate Kaposi Sarcoma
703,Intracytoplasmic Eosinophilic Inclusion,Adult Liposarcoma
704,Indolent Clinical Course,Cardiac Fibrosarcoma
705,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
706,Mixed Epithelial Cell Population,Vaginal Squamous Papilloma
707,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with Gene Mutations
708,Indolent Clinical Course,Kaposi's sarcoma of penis
709,Indolent Clinical Course,Adult Anaplastic (Malignant) Meningioma
710,Anaplasia,Benign Childhood Brain Neoplasm
711,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Esophageal Adenocarcinoma AJCC v7
712,Intracytoplasmic Eosinophilic Inclusion,Colorectal Angiosarcoma
713,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Signet Ring Cell Carcinoma
714,Chronic Clinical Course,Adult Acute Myeloblastic Leukemia
715,Invasive Lesion,Soft Palate Pleomorphic Adenoma
716,Papillary Pattern,Soft Palate Pleomorphic Adenoma
717,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
718,Intermediate Filaments Present,Well Differentiated Leiomyosarcoma
719,Intermediate Filaments Present,Extra-osseous Ewing's sarcoma
720,Benign Cellular Infiltrate,Stage I Liver Carcinoma
721,Mucoid Stroma Formation,Supraglottic Verrucous Carcinoma
722,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Serous cystadenocarcinoma ovary
723,Extracutaneous Dissemination of Disease,Skin Mastocytoma
724,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of salivary gland
725,Solid Growth Pattern,Breast Mucinous Cystadenocarcinoma
726,Intracytoplasmic Eosinophilic Inclusion,synovial sarcoma
727,Superficial Lesion,Extra-abdominal fibromatosis
728,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Mucinous Tumor
729,Histiocytosis,Anaplastic large B-cell lymphoma
730,Neuroendocrine Differentiation,Stage IVC Basal Cell Lip Carcinoma
731,Intracytoplasmic Eosinophilic Inclusion,Pulmonary Artery Leiomyosarcoma
732,Neuroendocrine Differentiation,Stage IVA Basal Cell Lip Carcinoma
733,Composite Lesion,Metaplastic thymoma
734,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma recurrent
735,Low Grade Lesion,Uterine Angiosarcoma
736,Premalignant Lesion,Lung Cancer by AJCC v6 Stage
737,Favorable Clinical Outcome,Stage III Merkel Cell Carcinoma AJCC v7
738,Invasive Lesion,Usual ductal hyperplasia of breast
739,Borderline Lesion,benign myoepithelioma of salivary gland
740,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Phyllodes Tumor
741,Benign Cellular Infiltrate,Colon Hodgkin Lymphoma
742,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
743,Indolent Clinical Course,gliosarcoma
744,Mixed Neoplastic Glandular and Squamous Cell Population,Well Differentiated Prostate Adenocarcinoma
745,Metastatic Lesion,Mammosomatotroph Adenoma
746,Glandular Differentiation,Colorectal Undifferentiated Carcinoma
747,Squamous Differentiation,Colorectal Undifferentiated Carcinoma
748,Chronic Clinical Course,Childhood Acute Lymphoblastic Leukemia
749,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous cystadenocarcinoma of ovary
750,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Adenocarcinoma
751,Benign Cellular Infiltrate,mucoepidermoid carcinoma of esophagus
752,Benign Cellular Infiltrate,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
753,Premalignant Lesion,Lung Hilum Carcinoma
754,Mixed Neoplastic Glandular and Squamous Cell Population,"Papillary renal cell carcinoma, sporadic"
755,Mucoid Stroma Formation,verrucous carcinoma of bladder
756,Borderline Lesion,Superficial Epithelioma with Sebaceous Differentiation
757,Aggressive Clinical Course,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
758,Benign Cellular Infiltrate,Small Intestinal Squamous Cell Carcinoma
759,Increased red cell mass,Post polycythaemia vera myelofibrosis
760,Chronic Clinical Course,Acute Lymphoblastic Leukemia by ROSE Cluster
761,Chronic Clinical Course,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
762,Diffuse Lesion,Exophytic Schneiderian Papilloma
763,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of rectum
764,Benign Cellular Infiltrate,Stage II Colon Cancer AJCC v7
765,Inflammation,Beta-Catenin-Activated Hepatocellular Adenoma
766,Seminomatous Component Present,Choriocarcinoma of the Testis
767,Benign Cellular Infiltrate,Stage III Colorectal Cancer AJCC v7
768,Mixed Neoplastic Glandular and Squamous Cell Population,Condyloma Acuminatum with Dysplasia
769,Intracytoplasmic Eosinophilic Inclusion,Kidney Extraskeletal Osteosarcoma
770,Diffuse Lesion,Verrucous keratotic hemangioma
771,Necrotic changes (finding),Ganglioneuroma
772,Invasive Lesion,Desmoplastic trichilemmoma
773,Tubular Pattern,Villous adenoma of duodenum
774,Ineffective hematopoiesis,"Leukemia, Myeloid, Chronic-Phase"
775,Cytologic atypia,Gallbladder Hyperplastic Polyp
776,Borderline Lesion,Apocrine adenoma
777,High Mitotic Activity,Uterine Corpus Epithelioid Leiomyoma
778,Chronic Clinical Course,recurrent childhood acute myeloid leukemia
779,Auer Rods Present,Juvenile Myelomonocytic Leukemia
780,Intracytoplasmic Eosinophilic Inclusion,Adult Mesenchymal Chondrosarcoma
781,Solid Growth Pattern,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
782,Benign Cellular Infiltrate,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
783,Intracytoplasmic Eosinophilic Inclusion,Adult Myxoid Chondrosarcoma
784,Benign Cellular Infiltrate,AIDS-Related Anal Non-Hodgkin Lymphoma
785,Benign Cellular Infiltrate,Anal Adenocarcinoma within Anorectal Fistula
786,Mixed Neoplastic Glandular and Squamous Cell Population,Serous cystadenocarcinoma of pancreas
787,Benign Cellular Infiltrate,Gastric Large Cell Neuroendocrine Carcinoma
788,Invasive Lesion,High Grade Anal Canal Squamous Intraepithelial Neoplasia
789,Indolent Clinical Course,Gallbladder Sarcoma
790,Mucoid Stroma Formation,Bladder Papillary Urothelial Neoplasm
791,Intermediate Filaments Present,Adult Angiosarcoma
792,Intermediate Filaments Present,Anaplastic Embryonal Rhabdomyosarcoma
793,Severe cytologic atypia,Pancreatic Gastrin-Producing Neuroendocrine Tumor
794,Mixed Neoplastic Glandular and Squamous Cell Population,Rectal Micropapillary Adenocarcinoma
795,Favorable Clinical Outcome,Stage IIIC Adult Liver Cancer AJCC v7
796,Benign Cellular Infiltrate,Stage IIIC Adult Liver Cancer AJCC v7
797,Benign Cellular Infiltrate,Anal margin basal cell carcinoma
798,Mixed Neoplastic Glandular and Squamous Cell Population,Paget's disease of penis
799,Mixed Neoplastic Glandular and Squamous Cell Population,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
800,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,mucinous adenocarcinoma of ovary
801,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 4 Clear Cell Renal Cell Carcinoma
802,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Uterine Sarcoma AJCC v7
803,Malignant Germinomatous Cellular Infiltrate,Testicular embryonal carcinoma stage II
804,Mixed Cellular Population,"Carcinoma, Lobular"
805,Intracytoplasmic Eosinophilic Inclusion,Metastatic Bone Ewing Sarcoma
806,Benign Cellular Infiltrate,Esophageal Rhabdomyosarcoma
807,Chronic Clinical Course,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
808,Low Grade Lesion,Cutaneous Radiation-Related Angiosarcoma
809,Intracytoplasmic Eosinophilic Inclusion,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
810,Well-Circumscribed Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma
811,Indolent Clinical Course,Childhood Medulloblastoma
812,Ineffective hematopoiesis,Chronic eosinophilic leukemia
813,Glandular Differentiation,Oropharyngeal lymphepithelioma
814,Indolent Clinical Course,Stage I Uterine Sarcoma AJCC v7
815,Intracytoplasmic Eosinophilic Inclusion,Kaposi Sarcoma NCI Grade 3
816,Benign Cellular Infiltrate,Stage IIIA Gastric Carcinoma
817,Glandular Differentiation,Lung Basaloid Large Cell Carcinoma
818,Intermediate Filaments Present,Central Nervous System Extraskeletal Osteosarcoma
819,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of bone
820,Malignant Germinomatous Cellular Infiltrate,Ovarian Teratoma
821,Seminomatous Component Present,Immature Ovarian Teratoma
822,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous intraepithelial lesion
823,Diffuse Lesion,Senile hemangioma of lip
824,Invasive Lesion,Esophageal Glandular Intraepithelial Neoplasia
825,Invasive Lesion,Grade II Glandular Intraepithelial Neoplasia
826,Solid Growth Pattern,Childhood B Acute Lymphoblastic Leukemia
827,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7
828,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
829,Perineural spread,Water-clear cell adenoma
830,Encapsulated Mass,"Myositis, Proliferative"
831,Indolent Clinical Course,Myxosarcoma
832,Intermediate Filaments Present,Sarcoma of kidney
833,Benign Cellular Infiltrate,Liver and Intrahepatic Biliary Tract Carcinoma
834,Premalignant Lesion,Small cell carcinoma of lung
835,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of anal canal
836,Invasive Lesion,Benign Eccrine Neoplasm
837,Chronic Clinical Course,Childhood Acute Myeloid Leukemia
838,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the rete testis
839,Intracytoplasmic Eosinophilic Inclusion,Asynchronous Multifocal Osteosarcoma
840,Benign Cellular Infiltrate,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
841,High Mitotic Activity,Degeneration of uterine fibroid
842,Invasive Lesion,Vaginal intraepithelial neoplasia
843,Intracytoplasmic Eosinophilic Inclusion,Dedifferentiated chondrosarcoma
844,Intracytoplasmic Eosinophilic Inclusion,Conventional Fibrosarcoma
845,Favorable Clinical Outcome,Mycosis Fungoides
846,Intermediate Filaments Present,Recurrent Uterine Corpus Sarcoma
847,Indolent Clinical Course,Recurrent Uterine Corpus Sarcoma
848,Prominent Schwannian Stroma Present,Kadish Stage B Olfactory Neuroblastoma
849,Intestinal metaplasia of gastric mucosa,Pyloric Gland Adenoma
850,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Seborrheic Keratosis
851,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Myeloid Leukemia without Maturation
852,Borderline Lesion,Cervical Microglandular Polyp
853,Severe cytologic atypia,Gastric Gastrin-Producing Neuroendocrine Tumor
854,Grade 4 Lesion,Secondary Supratentorial Anaplastic Astrocytoma
855,Intermediate Filaments Present,Anal Kaposi Sarcoma
856,Premalignant Lesion,Stage IB Lung Adenocarcinoma AJCC v7
857,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
858,Indolent Clinical Course,Anaplastic astrocytoma
859,Benign Cellular Infiltrate,Adenocarcinoma of large intestine
860,Homer Wright Rosette Formation,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
861,Mixed Neoplastic Glandular and Squamous Cell Population,Inflammatory Breast Carcinoma
862,Composite Lesion,Malignant Thymoma
863,Borderline Lesion,Childhood Choroid Plexus Papilloma
864,Borderline Lesion,Ovarian Stromal-Leydig Cell Tumor
865,Indolent Clinical Course,Extra-osseous Ewing's sarcoma
866,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Serous cystadenocarcinoma ovary
867,Diffuse Lesion,Inverting papilloma of the nasal cavity
868,Odontogenic Cysts,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
869,High Mitotic Activity,"Leiomyosarcoma, Myxoid"
870,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
871,Intermediate Filaments Present,Uterine Corpus Sarcoma
872,Mucoid Stroma Formation,Pedunculated conjunctival papilloma
873,High Mitotic Activity,Duodenal Somatostatin-Producing Neuroendocrine Tumor
874,Indolent Clinical Course,Kaposi Sarcoma Related to Immunosuppressive Treatment
875,Favorable Clinical Outcome,Recurrent Liver Carcinoma
876,Benign Cellular Infiltrate,Pancreatic Well Differentiated Ductal Adenocarcinoma
877,Solid Growth Pattern,Recurrent Childhood Acute Lymphoblastic Leukemia
878,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the head and neck
879,Malignant Germinomatous Cellular Infiltrate,Nongerminomatous germ cell tumor of the central nervous system
880,Mixed Neoplastic Glandular and Squamous Cell Population,Lower Gingival Squamous Cell Carcinoma
881,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Pericardial Teratoma
882,Seminomatous Component Present,Pineal Region Teratoma
883,Microvascular Proliferation,Anaplastic Diencephalic Astrocytoma
884,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Myeloid Leukemia Not Otherwise Specified
885,Mixed Neoplastic Glandular and Squamous Cell Population,Buccal Mucosa Verrucous Carcinoma
886,Precise Histogenesis Unknown,High Grade Astrocytic Tumor
887,Mucoid Stroma Formation,Laryngeal verrucous carcinoma
888,Favorable Clinical Outcome,Stage IA Merkel Cell Carcinoma AJCC v7
889,Low Mitotic Activity,Pancreatic Large Cell Neuroendocrine Carcinoma
890,Diffuse Lesion,Digestive System Hemangioma
891,Capsular Invasion,Compact Cell Adrenal Cortical Adenoma
892,Solid Growth Pattern,T-Cell Large Granular Lymphocyte Leukemia
893,Indolent Clinical Course,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
894,Severe cytologic atypia,Carcinoid tumor of the liver
895,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Uterine Sarcoma AJCC v7
896,High Mitotic Activity,Piloleiomyoma
897,Intracytoplasmic Eosinophilic Inclusion,Radiation-Related Osteosarcoma
898,Mixed Neoplastic Glandular and Squamous Cell Population,Infiltrating duct and lobular carcinoma
899,Argentaffin Positive Neoplastic Cells Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
900,Benign Cellular Infiltrate,Anal cancer recurrent
901,Aggressive Clinical Course,Ann Arbor Stage IV Grade 2 Follicular Lymphoma
902,Thyroglobulin Positive Neoplastic Cells Present,squamous cell carcinoma of the thyroid gland
903,Nuclear Grooves,Thyroid Hurthle Cell Carcinoma
904,Intermediate Filaments Present,Kaposi Sarcoma
905,Favorable Clinical Outcome,Stage IIIA Hepatocellular Carcinoma AJCC v7
906,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Warty Carcinoma
907,Metastatic Lesion,Benign tumor of salivary gland
908,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Hepatocellular Carcinoma AJCC v7
909,Papillary Pattern,solid type ductal carcinoma in situ of breast
910,Localized Lesion,DS Stage III Plasma Cell Myeloma
911,Mixed Neoplastic Glandular and Squamous Cell Population,Inflammatory carcinoma of breast stage IV
912,Mucoid Stroma Formation,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
913,Pseudogranulomatous Pattern,Proximal-Type Epithelioid Sarcoma
914,Benign Cellular Infiltrate,signet ring cell carcinoma of appendix
915,Glial Differentiation,Ganglioneuroma
916,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous carcinoma of breast
917,Indolent Clinical Course,embryonal rhabdomyosarcoma of orbit
918,Benign Cellular Infiltrate,Ampulla of Vater Signet Ring Cell Carcinoma
919,Invasive Lesion,Epidermolytic acanthoma
920,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic Cholangiocarcinoma
921,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of lung
922,Premalignant Lesion,Carcinoma of lung
923,Mixed Neoplastic Glandular and Squamous Cell Population,"Serous cystadenoma, borderline malignancy"
924,Mixed Neoplastic Glandular and Squamous Cell Population,papillary carcinoma of penis
925,Benign Cellular Infiltrate,Ampulla of Vater Undifferentiated Carcinoma
926,No Evidence of Radiologic Finding,Occult Lung Adenosquamous Carcinoma
927,Intracytoplasmic Eosinophilic Inclusion,Stage IIB Soft Tissue Sarcoma AJCC v7
928,Precise Histogenesis Unknown,Childhood Anaplastic Oligoastrocytoma
929,Precise Histogenesis Unknown,Adult Glioblastoma
930,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of uterus
931,Seminomatous Component Present,Immature Gastric Teratoma
932,Precise Histogenesis Unknown,Recurrent Childhood Brain Stem Glioma
933,Benign Cellular Infiltrate,Stage II Colorectal Cancer AJCC v7
934,Composite Lesion,"Thymoma, type B2"
935,Chronic Clinical Course,"Acute myeloid leukemia, t(8;21) (q22;q22)"
936,Precise Histogenesis Unknown,Childhood Brain Stem Gliosarcoma
937,Precise Histogenesis Unknown,Recurrent Childhood Glioblastoma
938,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in adenomatous polyposis coli
939,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma recurrent
940,Chronic lymphocytic inflammation,cystadenoma of salivary gland
941,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Squamous Neoplasm
942,Intracytoplasmic Eosinophilic Inclusion,Granular Cell Leiomyosarcoma
943,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV
944,Benign Cellular Infiltrate,Gastric Adenosquamous Carcinoma
945,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Villous Adenoma
946,Absence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor
947,Solid Growth Pattern,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
948,Indolent Clinical Course,Localized Bone Ewing Sarcoma
949,Mucoid Stroma Formation,Recurrent Inverted Schneiderian Papilloma
950,Indolent Clinical Course,Sarcoma by FNCLCC Grade
951,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma
952,Solid Growth Pattern,Chronic eosinophilic leukemia
953,Benign Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous"
954,Pushing Tumor Margin,Uterine Corpus Endometrial Stromal Sarcoma
955,Indolent Clinical Course,Angiosarcoma NCI Grade 3
956,Intermediate Filaments Present,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
957,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
958,Intracytoplasmic Eosinophilic Inclusion,Childhood Liposarcoma
959,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma recurrent
960,Intermediate Filaments Present,AIDS-Related Cervical Kaposi Sarcoma
961,Invasive Lesion,Noninfiltrating intraductal papillary adenocarcinoma
962,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Corneal Intraepithelial Neoplasia
963,Epithelioid Component Present,"Synovial sarcoma, spindle cell"
964,Indolent Clinical Course,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
965,High Mitotic Activity,Gastrointestinal Carcinoid Tumor
966,Extensive Stage Lesion,Early Favorable Hodgkin Lymphoma
967,Grade 4 Lesion,Recurrent Childhood Pilocytic Astrocytoma
968,Indolent Clinical Course,Low Grade Endometrioid Stromal Sarcoma of the Cervix
969,Indolent Clinical Course,Childhood Parosteal Osteosarcoma
970,Precise Histogenesis Unknown,Recurrent Childhood Protoplasmic Astrocytoma
971,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
972,Mixed Neoplastic Glandular and Squamous Cell Population,Verrucous carcinoma of the oral cavity recurrent
973,Metastatic Lesion,Non-Functioning Pituitary Gland Microadenoma
974,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of Skene Gland Origin
975,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,serous surface papillary carcinoma of ovary
976,Capsular Invasion,estrogen-producing adrenal cortical adenoma
977,Intermediate Filaments Present,Pleural Synovial Sarcoma
978,Premalignant Lesion,Large cell lung cancer recurrent
979,Intermediate Filaments Present,Pleural Biphasic Synovial Sarcoma
980,atypia morphology,Nevus spilus
981,atypia morphology,Typical Ovarian Thecoma
982,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
983,Solid Growth Pattern,Refractory Hairy Cell Leukemia
984,Acanthosis,Vaginal Papillary Carcinoma
985,Epithelial Component Present,Mixed epithelial-mesenchymal hepatoblastoma
986,Intermediate Filaments Present,Asynchronous Multifocal Osteosarcoma
987,Indolent Clinical Course,Stage II Adult Soft Tissue Sarcoma AJCC v7
988,Indolent Clinical Course,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
989,Prominent Schwannian Stroma Present,Localized Unresectable Neuroblastoma
990,Indolent Clinical Course,Malignant neoplasm of brain
991,Benign Cellular Infiltrate,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
992,Diffuse Lesion,Liver Lymphangioma
993,Mitotic Activity,"Diffuse Astrocytoma, IDH-Mutant"
994,High Mitotic Activity,Leiomyomatosis
995,Necrotic changes (finding),"Gemistocytic Astrocytoma, IDH-Mutant"
996,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Benign Brenner Tumor
997,Indolent Clinical Course,"Endometrial stromal sarcoma, high grade"
998,Dysplasia,Benign neoplasm of skin
999,Ineffective hematopoiesis,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
1000,Chronic Clinical Course,Adult Acute Monocytic Leukemia
1001,Premalignant Lesion,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
1002,Solid Growth Pattern,Acute myeloid leukemia with mutated CEBPA
1003,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
1004,atypia morphology,Spindle cell nevus of Reed
1005,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
1006,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Squamous Cell Carcinoma
1007,Benign Cellular Infiltrate,Pancreatic Medullary Carcinoma
1008,Chronic Clinical Course,Childhood Acute Monocytic Leukemia
1009,Grade 4 Lesion,Diffuse Astrocytoma
1010,Borderline Lesion,Melanoacanthoma
1011,Squamous Differentiation,undifferentiated carcinoma of gallbladder
1012,Favorable Clinical Outcome,BCLC Stage D Hepatocellular Carcinoma
1013,Acute Clinical Course,"T-Cell Prolymphocytic Leukemia, Small Cell Variant"
1014,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
1015,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the paranasal sinus
1016,Favorable Clinical Outcome,Skin Pseudovascular Squamous Cell Carcinoma
1017,Diffuse Lesion,Perineural Hemangioma
1018,Benign Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7
1019,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Sarcoma
1020,Favorable Clinical Outcome,Stage II Hepatocellular Carcinoma AJCC v6 and v7
1021,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Transitional Cell Tumor
1022,Invasive Lesion,Trichoadenoma
1023,Invasive Lesion,Anal Canal Squamous Intraepithelial Neoplasia
1024,Mixed Neoplastic Glandular and Squamous Cell Population,pleomorphic carcinoma of breast
1025,Intermediate Filaments Present,Pulmonary Vein Leiomyosarcoma
1026,Squamous Differentiation,Prostate Undifferentiated Carcinoma
1027,Nuclear Grooves,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
1028,Indolent Clinical Course,Cutaneous Liposarcoma
1029,Borderline Lesion,"Schneiderian papilloma, inverted"
1030,Mixed Neoplastic Glandular and Squamous Cell Population,Adenoma of Minor Vestibular Glands
1031,Intracytoplasmic Eosinophilic Inclusion,Gallbladder Rhabdomyosarcoma
1032,CD21-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
1033,Indolent Clinical Course,Conventional Extraskeletal Myxoid Chondrosarcoma
1034,"Undifferentiated ""Fetal-Type"" Tissues Present",Dermoid cyst of ovary
1035,Monoclonal Eosinophils Present,Hypereosinophilic syndrome
1036,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Serous Tumor with Microinvasion
1037,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern"
1038,Glial Differentiation,Lhermitte-Duclos disease
1039,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Adenofibroma
1040,Intermediate Filaments Present,sarcoma of anus
1041,Metastatic Lesion,Salivary Gland Sebaceous Lymphadenoma
1042,Solid Growth Pattern,Cytogenetically normal acute myeloid leukemia
1043,Intracytoplasmic Eosinophilic Inclusion,fibrosarcoma of small intestine
1044,Well-Circumscribed Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma
1045,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal verrucous carcinoma recurrent
1046,Papillary Pattern,Noninfiltrating Intraductal Carcinoma
1047,High Mitotic Activity,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
1048,Ground Glass Nuclear Inclusion,Thyroid Gland Clear Cell Follicular Adenoma
1049,Intermediate Filaments Present,Recurrent Malignant Peripheral Nerve Sheath Tumor
1050,Indolent Clinical Course,Thymoliposarcoma
1051,Nuclear pleomorphism,Tubular breast carcinoma
1052,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Renal Cell Cancer AJCC v7
1053,Histiocytosis,Stage III Adult Immunoblastic Lymphoma
1054,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, clear cell type"
1055,Neuroendocrine Differentiation,Stage IV Lip Basal Cell Carcinoma
1056,Invasive Lesion,Gastric Intramucosal Adenocarcinoma
1057,Indolent Clinical Course,Transplant-Related Lung Carcinoma
1058,Glandular Differentiation,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
1059,Indolent Clinical Course,Meningeal sarcomatosis
1060,Tubular Pattern,Gallbladder Papillary Adenoma
1061,Mixed Neoplastic Glandular and Squamous Cell Population,Lobular carcinoma in situ of breast
1062,High Grade Lesion,Kaposiform Hemangioendothelioma
1063,Papillary Pattern,Oral Cavity Pleomorphic Adenoma
1064,Microvascular Proliferation,Childhood Fibrillary Astrocytoma
1065,Mixed Neoplastic Glandular and Squamous Cell Population,"Vulvar Intraepithelial Neoplasia, Differentiated Type"
1066,Diffuse Lesion,Brain Hemangioma
1067,Intracytoplasmic Eosinophilic Inclusion,Stage IIB Bone Sarcoma AJCC v7
1068,Intermediate Filaments Present,Appendix Kaposi Sarcoma
1069,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Esophageal Adenocarcinoma AJCC v7
1070,Intermediate Filaments Present,Uterine Corpus Rhabdomyosarcoma
1071,Indolent Clinical Course,Melanotic medulloblastoma
1072,Favorable Clinical Outcome,Old Burn Scar-Related Cutaneous Melanoma
1073,Intermediate Filaments Present,Adult Mesenchymal Chondrosarcoma
1074,Solid Growth Pattern,Infant Acute Biphenotypic Leukemia
1075,Chronic Clinical Course,Infant Acute Biphenotypic Leukemia
1076,High Mitotic Activity,Somatostatinoma
1077,Benign Cellular Infiltrate,Intrahepatic cholangiocarcinoma recurrent
1078,Favorable Clinical Outcome,BCLC Stage D Adult Hepatocellular Carcinoma
1079,Benign Cellular Infiltrate,carcinoma of pancreas with osteoclast-like giant cells
1080,Borderline Lesion,Ureter Urothelial Papilloma
1081,Indolent Clinical Course,Adult Pineoblastoma
1082,Solid Growth Pattern,Hypergranular promyelocytic leukemia
1083,Invasive Lesion,Pancreatic Intraepithelial Neoplasia-1
1084,Indolent Clinical Course,Anaplastic Embryonal Rhabdomyosarcoma
1085,Benign Cellular Infiltrate,Stage III Rectal Cancer AJCC v7
1086,Hypersplenism,Indolent Systemic Mastocytosis
1087,Intracytoplasmic Eosinophilic Inclusion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
1088,Mixed Neoplastic Glandular and Squamous Cell Population,Mammary Analog Secretory Carcinoma of Salivary Gland
1089,Favorable Clinical Outcome,Cutaneous Follicular Lymphoma
1090,Homer Wright Rosette Formation,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
1091,Benign Cellular Infiltrate,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
1092,Intracytoplasmic Eosinophilic Inclusion,Laryngeal Liposarcoma
1093,Locally Aggressive Lesion,Osteochondromatosis
1094,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of pharynx
1095,Intermediate Filaments Present,Granular Cell Leiomyosarcoma
1096,Intermediate Filaments Present,Gallbladder Kaposi's Sarcoma
1097,Benign Cellular Infiltrate,Pancreatic Endocrine Carcinoma
1098,Solid Growth Pattern,Acute myelomonocytic leukemia with abnormal eosinophils
1099,Favorable Clinical Outcome,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
1100,Indolent Clinical Course,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
1101,Squamous Differentiation,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
1102,Precise Histogenesis Unknown,Protoplasmic astrocytoma
1103,Intracytoplasmic Eosinophilic Inclusion,Clear cell sarcoma of kidney
1104,Intermediate Filaments Present,Clear cell sarcoma of kidney
1105,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Penile Intraepithelial Neoplasia
1106,Mesodermal Differentiation,Testicular Mixed Embryonal Carcinoma and Seminoma
1107,Intermediate Filaments Present,"Synovial sarcoma, epithelioid cell"
1108,Indolent Clinical Course,Bone Epithelioid Hemangioendothelioma
1109,Indolent Clinical Course,Central Nervous System Germinoma
1110,Dysplasia,Senile hemangioma of lip
1111,Invasive Lesion,Intramucosal Adenocarcinoma
1112,Mixed Neoplastic Glandular and Squamous Cell Population,Grade II Glandular Intraepithelial Neoplasia
1113,Benign Cellular Infiltrate,Colon Medullary Carcinoma
1114,Favorable Clinical Outcome,Stage I Superficial Spreading Melanoma AJCC v7
1115,Favorable Clinical Outcome,Stage III Superficial Spreading Melanoma AJCC v7
1116,Benign Cellular Infiltrate,Carcinoma duodenum resectable
1117,Rarely Metastasizing Lesion,Intermediate (Locally Aggressive) Blood Vessel Neoplasm
1118,Necrotic changes (finding),Sympathetic Schwannoma
1119,Indolent Clinical Course,Malignant neoplasm of mandible
1120,Premalignant Lesion,Stage IIA Lung Cancer AJCC v7
1121,Mixed Neoplastic Glandular and Squamous Cell Population,Lung squamous cell carcinoma stage II
1122,Mixture of Germ Cell Neoplastic Components Present,Seminoma
1123,Indolent Clinical Course,Central Nervous System Leiomyosarcoma
1124,Composite Lesion,"Childhood Ganglioneuroblastoma, Intermixed"
1125,Intracytoplasmic Eosinophilic Inclusion,"Chondrosarcoma, Clear Cell"
1126,Intracytoplasmic Eosinophilic Inclusion,"Sarcoma, Small Cell"
1127,High Mitotic Activity,Endobronchial Leiomyoma
1128,Solid Growth Pattern,Adult Acute Lymphocytic Leukemia
1129,Intermediate Filaments Present,Lung Monophasic Synovial Sarcoma
1130,Locally Aggressive Lesion,Extrahepatic Bile Duct Fibroma
1131,Nodular Pattern,Neural Glioblastoma
1132,Benign Cellular Infiltrate,Stage IV Liver Cancer
1133,Favorable Clinical Outcome,Hepatic cancer stage IVA
1134,Benign Cellular Infiltrate,Malignant neoplasm of duodenum
1135,Superficial Lesion,"Fibromatosis, Abdominal"
1136,Benign Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v7
1137,Indolent Clinical Course,Epithelioid glioblastoma
1138,Chronic Clinical Course,Adult Acute Erythroid Leukemia
1139,Indolent Clinical Course,"Cancer, Supratentorial"
1140,Solid Growth Pattern,Childhood Acute Erythroid Leukemia
1141,Seminomatous Component Present,"Teratoma, Malignant"
1142,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Myeloid Leukemia without Maturation
1143,Desmoplastic Stroma Formation,Tubulocystic renal cell carcinoma
1144,Invasive Lesion,Colon Intramucosal Adenocarcinoma
1145,Low Grade Lesion,Superior Vena Cava Angiosarcoma
1146,Intermediate Filaments Present,Angiosarcoma of liver
1147,Favorable Clinical Outcome,Pleomorphic Hepatocellular Carcinoma
1148,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Myeloid Leukemia with Maturation
1149,Premalignant Lesion,Combined Lung Carcinoma
1150,Nuclear pleomorphism,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
1151,High Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v7
1152,Invasive Lesion,"Mixed Tumor, Not Otherwise Specified"
1153,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Transitional Cell Tumor
1154,Indolent Clinical Course,Recurrent Childhood Anaplastic Astrocytoma
1155,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma classical type
1156,Benign Cellular Infiltrate,undifferentiated carcinoma of anal canal
1157,Invasive Lesion,Common wart
1158,Mucoid Stroma Formation,Verrucous carcinoma of penis
1159,Intermediate Filaments Present,Sarcoma
1160,Favorable Clinical Outcome,Hutchinson's Melanotic Freckle
1161,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiocarcinoma
1162,Intermediate Filaments Present,Uterine Angiosarcoma
1163,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Tumor
1164,Seminomatous Component Present,Testicular Trophoblastic Tumor
1165,Necrotic changes (finding),Anaplastic Hemispheric Astrocytoma
1166,Premalignant Lesion,Adenoid cystic carcinoma of trachea
1167,"Undifferentiated ""Fetal-Type"" Tissues Present",Pineal Region Mature Teratoma
1168,Malignant Germinomatous Cellular Infiltrate,Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
1169,Benign Cellular Infiltrate,Recurrent Cancer of Gallbladder
1170,Borderline Lesion,canalicular adenoma of salivary gland
1171,CD35-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
1172,Seminomatous Component Present,Benign Mediastinal Germ Cell Tumor
1173,Metastatic Lesion,Pleomorphic adenoma of parotid gland
1174,Mixed Neoplastic Glandular and Squamous Cell Population,Thymic Squamous Cell Carcinoma
1175,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of cervix uteri
1176,Intracytoplasmic Eosinophilic Inclusion,Prostate Sarcoma
1177,Giant Mitochondria Present,Mixed Somatotroph and Lactotroph Adenoma
1178,Indolent Clinical Course,Stage IA Uterine Sarcoma AJCC v7
1179,Indolent Clinical Course,Familial Adenomatous Polyposis Associated Medulloblastoma
1180,Squamous Differentiation,Undifferentiated Fallopian Tube Carcinoma
1181,High Mitotic Activity,Colorectal Neuroendocrine Tumor
1182,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Benign Prostate Phyllodes Tumor
1183,Benign Cellular Infiltrate,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
1184,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Ductal and Lobular Carcinoma
1185,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma stage III
1186,CD35-Positive Neoplastic Cells Present,Letterer-Siwe Disease
1187,Mixed Cellular Population,Bladder Squamous Papilloma
1188,Diffuse Lesion,Intraductal papilloma of breast
1189,Superficial Lesion,Chest Wall Fibromatosis
1190,Squamous Differentiation,undifferentiated carcinoma of liver
1191,Mixed Neoplastic Glandular and Squamous Cell Population,Sebaceous Breast Carcinoma
1192,Intracytoplasmic Eosinophilic Inclusion,Fusion-Negative Rhabdomyosarcoma
1193,Infiltrative Growth Pattern,Cellular angiofibroma
1194,Nuclear Clearing,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
1195,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Basaloid Carcinoma
1196,Mixed Neoplastic Glandular and Squamous Cell Population,Infiltrating duct and lobular carcinoma
1197,Indolent Clinical Course,Transplant-Related Carcinoma
1198,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Hepatocellular Carcinoma AJCC v7
1199,Mucoid Stroma Formation,Vaginal Warty Carcinoma
1200,Benign Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v7
1201,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,"Acute myeloid leukemia, minimal differentiation"
1202,Mixed Neoplastic Glandular and Squamous Cell Population,Transplant-Related Hepatocellular Carcinoma
1203,Mucoid Stroma Formation,"Transitional cell carcinoma, micropapillary"
1204,Precise Histogenesis Unknown,Dysembryoplastic neuroepithelial tumor
1205,Invasive Lesion,Colorectal Intraepithelial Neoplasia
1206,Dilated Vascular Space Formation,Solid Glomus Tumor
1207,Dysplasia,Paraganglioma-Like Dermal Melanocytic Tumor
1208,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
1209,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
1210,Mucoid Stroma Formation,intraductal micropapillary carcinoma of breast
1211,Histiocytosis,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
1212,Indolent Clinical Course,alveolar rhabdomyosarcoma of orbit
1213,Indolent Clinical Course,Uterine Corpus Rhabdomyosarcoma
1214,Indolent Clinical Course,Childhood Gliomatosis Cerebri
1215,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Serous Adenocarcinoma
1216,Acute Clinical Course,Chronic Neutrophilic Leukemia
1217,Glandular Differentiation,undifferentiated carcinoma of cervix
1218,Intracytoplasmic Eosinophilic Inclusion,Adult Alveolar Soft Part Sarcoma
1219,High Mitotic Activity,Pancreatic Gastrin-Producing Neuroendocrine Tumor
1220,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Squamous Cell Carcinoma
1221,Squamous Differentiation,Ampulla of Vater Undifferentiated Carcinoma
1222,Indolent Clinical Course,liposarcoma of vulva
1223,Borderline Lesion,Cervical Squamous Papilloma
1224,Favorable Clinical Outcome,Cutaneous Malignant Melanoma 2
1225,Precise Histogenesis Unknown,Childhood Mixed Glioma
1226,Seminomatous Component Present,Testicular Non-Seminomatous Germ Cell Tumor
1227,Intermediate Filaments Present,Childhood Undifferentiated Pleomorphic Sarcoma
1228,Intracytoplasmic Eosinophilic Inclusion,Mediastinal Synovial Sarcoma
1229,Benign Cellular Infiltrate,Bile duct cancer resectable
1230,Intracytoplasmic Eosinophilic Inclusion,"Liposarcoma, well differentiated"
1231,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma
1232,Solid Growth Pattern,Chronic lymphocytic leukemia stage 1
1233,Borderline Lesion,inverted ductal papilloma of salivary gland
1234,Benign Cellular Infiltrate,Stage IA Gastric Carcinoma
1235,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Teratoma AJCC v6 and v7
1236,Indolent Clinical Course,Grade II Chondrosarcoma
1237,Intermediate Filaments Present,Mediastinal Angiosarcoma
1238,Intracytoplasmic Eosinophilic Inclusion,Recurrent Bone Ewing Sarcoma
1239,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion
1240,Secondary Lesion,de novo Myelodysplastic Syndrome
1241,Intermediate Grade Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
1242,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Sebaceous Adenoma
1243,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma stage II
1244,Intermediate Filaments Present,Recurrent Extraskeletal Myxoid Chondrosarcoma
1245,Invasive Lesion,Low Grade Esophageal Glandular Intraepithelial Neoplasia
1246,Intermediate Filaments Present,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
1247,Benign Cellular Infiltrate,Gastric carcinoma stage IV
1248,Benign Cellular Infiltrate,AIDS-related anal cancer recurrent
1249,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7
1250,Indolent Clinical Course,Primary cerebral lymphoma
1251,Intracytoplasmic Eosinophilic Inclusion,Childhood Epithelioid Sarcoma
1252,Single Type of Tissue Derived from One Embryonic Layer Present,Immature Ovarian Teratoma
1253,High Mitotic Activity,Bladder Leiomyoma
1254,Severe cytologic atypia,Anal Canal Neuroendocrine Tumor G1
1255,Intermediate Filaments Present,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
1256,Chronic Clinical Course,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
1257,Mixed Neoplastic Glandular and Squamous Cell Population,cystadenocarcinoma of intrahepatic bile duct
1258,Chronic Clinical Course,Childhood B Acute Lymphoblastic Leukemia
1259,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
1260,Severe cytologic atypia,Non-Functioning Pancreatic Neuroendocrine Tumor G2
1261,Presence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G2
1262,Dysplasia,Dartoic myoma
1263,Mixed Neoplastic Glandular and Squamous Cell Population,Growth Hormone-Producing Pituitary Gland Carcinoma
1264,Benign Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v7
1265,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenoma, Serous"
1266,Indolent Clinical Course,Esophageal Liposarcoma
1267,Grade 4 Lesion,Childhood Pilocytic Astrocytoma
1268,Intermediate Filaments Present,Soft Tissue Angiosarcoma
1269,Tubular Pattern,Villous adenoma of rectum
1270,Benign Cellular Infiltrate,Anal squamous cell carcinoma
1271,Mucoid Stroma Formation,Intrahepatic Bile Duct Papillary Neoplasm
1272,Prominent Schwannian Stroma Present,Stage 2 Neuroblastoma
1273,Intracytoplasmic Eosinophilic Inclusion,Conventional Leiomyosarcoma
1274,Squamous Differentiation,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
1275,Intermediate Filaments Present,Conventional Fibrosarcoma
1276,Intermediate Filaments Present,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
1277,Invasive Lesion,Benign neoplasm of skin
1278,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Variant Thyroid Gland Papillary Carcinoma
1279,Intermediate Filaments Present,Metastatic leiomyosarcoma
1280,Indolent Clinical Course,Cardiac Kaposi's Sarcoma
1281,Intermediate Filaments Present,Cardiac Kaposi's Sarcoma
1282,Benign Cellular Infiltrate,Malignant neoplasm of duodenum recurrent
1283,Intermediate Filaments Present,Liposarcoma metastatic
1284,Benign Cellular Infiltrate,Anal Kaposi Sarcoma
1285,Intermediate Filaments Present,High grade surface osteosarcoma
1286,Seminomatous Component Present,Childhood Testicular Mature Teratoma
1287,Seminomatous Component Present,Childhood Testicular Choriocarcinoma
1288,Borderline Lesion,Benign Ovarian Luteinized Thecoma
1289,Keratin pearl formation,Nasopharyngeal lymphoepithelioma stage II
1290,Solid Growth Pattern,Adult Acute Monoblastic Leukemia
1291,Mixture of Germ Cell Neoplastic Components Present,Fallopian Tube Gestational Choriocarcinoma
1292,Invasive Lesion,Stage 0 Cervical Cancer AJCC v6
1293,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Clear Cell Adenocarcinoma
1294,High Mitotic Activity,Malignant Pancreatic Vipoma
1295,Aggressive Clinical Course,Marginal zone lymphoma stage III
1296,Benign Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
1297,Indolent Clinical Course,Giant Cell Fibrous Histiocytoma
1298,Seminomatous Component Present,Childhood Testicular Non-Seminomatous Germ Cell Tumor
1299,Secondary Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
1300,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Mature Teratoma
1301,atypia morphology,Neuronevus
1302,Precise Histogenesis Unknown,Subependymal Giant Cell Astrocytoma
1303,Mixed Neoplastic Glandular and Squamous Cell Population,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
1304,Mixed Neoplastic Glandular and Squamous Cell Population,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
1305,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in situ in tubular adenoma
1306,Indolent Clinical Course,Rhabdomyosarcoma of the orbit
1307,Mixed Neoplastic Glandular and Squamous Cell Population,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
1308,Cystic Change,Breast Columnar Cell Mucinous Carcinoma
1309,High Mitotic Activity,Choroid Plexus Papilloma
1310,Severe cytologic atypia,Duodenal Somatostatin-Producing Neuroendocrine Tumor
1311,Indolent Clinical Course,Secondary malignant neoplasm of brain stem
1312,Diffuse Lesion,Hemangioma of Peripheral Nerve
1313,Squamous Differentiation,Lymphoepithelial malignant thymoma
1314,High Mitotic Activity,Ascending Colon Neuroendocrine Tumor G1
1315,Invasive Lesion,Appendix Low Grade Intraepithelial Neoplasia
1316,Composite Lesion,Sclerosing thymoma
1317,Glandular Differentiation,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
1318,Solid Growth Pattern,Philadelphia chromosome positive chronic myelogenous leukemia
1319,Nuclear Pseudoinclusion,Thyroid Gland Oncocytic Adenoma
1320,Capsular Invasion,Thyroid Gland Oncocytic Adenoma
1321,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Squamous Cell Tumor
1322,Mitotic Activity,"Perivascular epithelioid tumor, benign"
1323,Precise Histogenesis Unknown,Central Neurocytoma
1324,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Endometrioid Adenocarcinoma
1325,Invasive Lesion,Benign tumor of choroid plexus
1326,Invasive Lesion,Vulvar Syringoma
1327,Benign Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v7
1328,Benign Cellular Infiltrate,Submucosal Invasive Colon Adenocarcinoma
1329,Benign Cellular Infiltrate,Neuroendocrine carcinoma of appendix
1330,Benign Cellular Infiltrate,undifferentiated carcinoma of extrahepatic bile duct
1331,Intracytoplasmic Eosinophilic Inclusion,Stage IA Uterine Sarcoma AJCC v7
1332,Premalignant Lesion,Stage III Lung Cancer AJCC v7
1333,Solid Growth Pattern,Childhood Acute Lymphoblastic Leukemia
1334,Malignant Germinomatous Cellular Infiltrate,Testicular yolk sac tumor stage II
1335,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma Of Esophagus
1336,Locally Aggressive Lesion,Proliferative fasciitis
1337,Indolent Clinical Course,Liver Extraskeletal Osteosarcoma
1338,Intracytoplasmic Eosinophilic Inclusion,sarcoma of small intestine
1339,Intermediate Filaments Present,Metastatic Childhood Soft Tissue Sarcoma
1340,Diffuse Lesion,Esophageal squamous papilloma
1341,Indolent Clinical Course,Stage IVA Osteosarcoma AJCC v7
1342,Invasive Lesion,Superficial Epithelioma with Sebaceous Differentiation
1343,Borderline Lesion,Thyroid Gland Lipoadenoma
1344,Favorable Clinical Outcome,undifferentiated carcinoma of liver
1345,Mucoid Stroma Formation,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
1346,Villous Pattern,Rectal Tubular Adenoma
1347,Diffuse Lesion,Parotid Gland Lymphangioma
1348,Malignant Germinomatous Cellular Infiltrate,Malignant Ovarian Teratoma
1349,Endobronchial Lesion,Adenoma of lung
1350,Chronic Clinical Course,"Acute myeloid leukemia, minimal differentiation"
1351,Precise Histogenesis Unknown,Diffuse Intrinsic Pontine Glioma
1352,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
1353,Intracytoplasmic Eosinophilic Inclusion,Fascial fibrosarcoma
1354,Benign Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7
1355,Low Grade Lesion,Central Nervous System Angiosarcoma
1356,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar adenocarcinoma
1357,Indolent Clinical Course,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
1358,Intermediate Filaments Present,Cardiac Rhabdomyosarcoma
1359,Chronic Clinical Course,"Acute myeloid leukemia, t(16;16)(p13;q22)"
1360,Gastric-Type Epithelial Differentiation,tubulovillous adenoma of stomach
1361,Indolent Clinical Course,Esophageal Malignant Peripheral Nerve Sheath Tumor
1362,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Clear Cell Adenocarcinoma
1363,Intermediate Filaments Present,leiomyosarcoma of lung
1364,Indolent Clinical Course,Osteosarcoma Arising in Paget Disease of Bone
1365,Sheets of Interfollicular Plasma Cells Present,"Castleman Disease, Hyaline-Vascular Type"
1366,Tumor Vascular Invasion,Parathyroid Gland Lipoadenoma
1367,Severe cytologic atypia,Pancreatic Gastrin-Producing Neuroendocrine Tumor
1368,Squamous Differentiation,lymphoepithelial squamous cell carcinoma of salivary gland
1369,Grade 4 Lesion,Childhood Pilomyxoid Astrocytoma
1370,Invasive Lesion,Intracystic Papillary Breast Carcinoma
1371,Indolent Clinical Course,sarcoma of rectum
1372,Intracytoplasmic Eosinophilic Inclusion,Stage IB Bone Sarcoma AJCC v7
1373,Indolent Clinical Course,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
1374,Favorable Clinical Outcome,Lentigo maligna recurrent
1375,Fibrotic Stroma Formation,Acinar cell cystadenocarcinoma
1376,Benign Cellular Infiltrate,Mucinous adenocarcinoma gastric
1377,Mixed Epithelial Cell Population,Cervical Squamous Papilloma
1378,Intermediate Filaments Present,Adrenal Gland Angiosarcoma
1379,Borderline Lesion,Serous surface papilloma
1380,Pathological fracture,Indolent Systemic Mastocytosis
1381,Benign Cellular Infiltrate,Mixed Ductal-Endocrine Carcinoma
1382,Indolent Clinical Course,Adult Gliosarcoma
1383,Metastatic Lesion,Benign neoplasm of parotid gland
1384,High Mitotic Activity,Esophageal Neuroendocrine Tumor G2
1385,Precise Histogenesis Unknown,Recurrent Childhood Giant Cell Glioblastoma
1386,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenocarcinoma, Serous"
1387,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Transitional Cell Carcinoma
1388,High Grade Lesion,"Liposarcoma, well differentiated"
1389,Benign Cellular Infiltrate,carcinosarcoma of extrahepatic bile duct
1390,Benign Cellular Infiltrate,Gastric Burkitt Lymphoma
1391,Aggressive Clinical Course,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
1392,Intermediate Filaments Present,Stage IIA Osteosarcoma AJCC v7
1393,Benign Cellular Infiltrate,Stage II Colon Cancer
1394,High Mitotic Activity,Benign Metastasizing Leiomyoma of the Uterine Corpus
1395,More than 10 Mitoses per 10HPF,Carcinoid tumor of lung
1396,Keratin Present,Schneiderian carcinoma
1397,Borderline Lesion,Recurrent Inverted Schneiderian Papilloma
1398,Intracytoplasmic Eosinophilic Inclusion,Cutaneous Radiation-Related Angiosarcoma
1399,Benign Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
1400,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of extrahepatic bile duct
1401,Necrotic changes (finding),Cartilaginous exostosis
1402,Favorable Clinical Outcome,Sweat gland adenocarcinoma
1403,Histiocytosis,Thyroid Immunoblastic Lymphoma
1404,Intracytoplasmic Eosinophilic Inclusion,Post-Radiotherapy Breast Angiosarcoma
1405,Indolent Clinical Course,Childhood Liposarcoma
1406,Indolent Clinical Course,Stage IVA Uterine Sarcoma AJCC v7
1407,Invasive Lesion,Benign Dermal Schwannoma
1408,Intermediate Filaments Present,Malignant Gastric Gastrointestinal Stromal Tumor
1409,Indolent Clinical Course,Gallbladder Leiomyosarcoma
1410,Squamous Differentiation,Lung Lymphoepithelioma-Like Carcinoma
1411,Indolent Clinical Course,Kaposi's sarcoma of skin
1412,Indolent Clinical Course,Kaposi's sarcoma of lung
1413,Mixed Cellular Population,Hard Palate Monomorphic Adenoma
1414,Mixed Neoplastic Glandular and Squamous Cell Population,Basaloid squamous cell carcinoma
1415,Multilayered Rosette Formation,Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma
1416,High Mitotic Activity,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
1417,Precise Histogenesis Unknown,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
1418,Benign Cellular Infiltrate,Signet Ring Cell Intrahepatic Cholangiocarcinoma
1419,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of kidney
1420,Precise Histogenesis Unknown,Oligodendroglioma of spinal cord
1421,Indolent Clinical Course,Pituitary carcinoma
1422,Indolent Clinical Course,Gastric Kaposi's Sarcoma
1423,Precise Histogenesis Unknown,Recurrent Childhood Subependymal Giant Cell Astrocytoma
1424,Borderline Lesion,Benign Apocrine Neoplasm
1425,Superficial Lesion,Deep Leiomyoma
1426,Indolent Clinical Course,Cardiac Biphasic Synovial Sarcoma
1427,Intracytoplasmic Eosinophilic Inclusion,"Endometrial stromal sarcoma, high grade"
1428,Mucoid Stroma Formation,Cervical Warty Carcinoma
1429,Mucoid Stroma Formation,Vestibular Papilloma
1430,Hypercalcemia,Chronic Adult T-Cell Leukemia/Lymphoma
1431,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of penis
1432,Necrotic changes (finding),Secondary Supratentorial Anaplastic Astrocytoma
1433,Aggressive Clinical Course,Splenic marginal zone lymphoma recurrent
1434,Intracytoplasmic Eosinophilic Inclusion,AJCC Grade 3 Sarcoma
1435,CD35-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
1436,Mucoid Stroma Formation,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
1437,Invasive Lesion,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
1438,Low Mitotic Activity,Colorectal Small Cell Neuroendocrine Carcinoma
1439,Seminomatous Component Present,Benign Extragonadal Germ Cell Tumor
1440,High Mitotic Activity,Cellular Ependymoma
1441,Mixed Neoplastic Glandular and Squamous Cell Population,Colon Intramucosal Adenocarcinoma
1442,Indolent Clinical Course,Rhabdomyosarcoma with ganglionic differentiation
1443,Squamous Differentiation,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
1444,Premalignant Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
1445,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Nongerminomatous Germ Cell Tumor
1446,Favorable Clinical Outcome,Stage II Liver Cancer
1447,Infiltrative Growth Pattern,Dermal Fibroma
1448,Intracytoplasmic Eosinophilic Inclusion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
1449,Macrofollicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
1450,Intracytoplasmic Eosinophilic Inclusion,Non-Metastatic Childhood Soft Tissue Sarcoma
1451,Diffuse Lesion,Cavernous hemangioma of retina
1452,Diffuse Lesion,Sclerosing Breast Papilloma
1453,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
1454,High Mitotic Activity,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
1455,Pushing Tumor Margin,Condyloma acuminata of vulva
1456,Premalignant Lesion,Non-small cell lung cancer recurrent
1457,Intracytoplasmic Eosinophilic Inclusion,Malignant fibrous histiocytoma metastatic
1458,Favorable Clinical Outcome,Malignant melanoma in precancerous melanosis
1459,Dysplasia,Eccrine acrospiroma
1460,Malignant Germinomatous Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma
1461,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Mucinous Adenocarcinoma
1462,Nuclear Atypia,Benign Glomus Tumor
1463,Mixed Cellular Population,Metastatic Lobular Breast Carcinoma
1464,Premalignant Lesion,Lung Pleomorphic Carcinoma
1465,High Mitotic Activity,Carcinoid tumor of the liver
1466,Solid Growth Pattern,Acute Erythroblastic Leukemia
1467,Benign Cellular Infiltrate,Esophageal Leiomyosarcoma
1468,Intracytoplasmic Eosinophilic Inclusion,Intracranial Liposarcoma
1469,Indolent Clinical Course,Iatrogenic Kaposi Sarcoma
1470,Ground Glass Nuclear Inclusion,Thyroid Gland Lipoadenoma
1471,Premalignant Lesion,Colon Carcinoma Metastatic in the Lung
1472,Borderline Lesion,Metanephric adenoma
1473,Compartmentalized Pattern,Sebaceoma
1474,Intracytoplasmic Eosinophilic Inclusion,Fusion-Positive Rhabdomyosarcoma
1475,Invasive Lesion,Stage 0 Esophageal Cancer AJCC v6
1476,Benign Cellular Infiltrate,Stage 0 Colon Cancer AJCC v6 and v7
1477,Calcitonin Positive Neoplastic Cells Present,squamous cell carcinoma of the thyroid gland
1478,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma in situ of trachea
1479,CD30-Positive Neoplastic Cells Present,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype"
1480,Solid Growth Pattern,Splenic Manifestation of Chronic Lymphocytic Leukemia
1481,Encapsulated Mass,Atypical neurofibroma
1482,Diffuse Lesion,Glandular papilloma
1483,Favorable Clinical Outcome,Stage IVA Hepatocellular Carcinoma AJCC v7
1484,CD30-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
1485,Invasive Lesion,solid type ductal carcinoma in situ of breast
1486,Benign Cellular Infiltrate,Stage III Adult Liver Cancer AJCC v7
1487,High Mitotic Activity,Ampulla of Vater Gangliocytic Paraganglioma
1488,Metastatic Lesion,Oral Cavity Pleomorphic Adenoma
1489,Indolent Clinical Course,Distal-Type Epithelioid Sarcoma
1490,Intermediate Filaments Present,Adult Rhabdomyosarcoma
1491,Severe cytologic atypia,Appendix Tubular Carcinoid
1492,Endobronchial Lesion,Lung Mucous Gland Adenoma
1493,Benign Cellular Infiltrate,Cecum Carcinoma
1494,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of prostate
1495,Invasive Lesion,Gallbladder Papillary Biliary Intraepithelial Neoplasia
1496,More than 10 Mitoses per 10HPF,Malignant carcinoid tumor of lung
1497,Mixed Neoplastic Glandular and Squamous Cell Population,Infiltrating duct and lobular carcinoma
1498,Favorable Clinical Outcome,Hepatoma resectable
1499,High Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor
1500,Invasive Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma
1501,Mixed Epithelial Cell Population,"Papilloma, Squamous Cell"
1502,Intermediate Filaments Present,Adult Epithelioid Sarcoma
1503,Mixed Neoplastic Glandular and Squamous Cell Population,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
1504,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic cholangiocarcinoma recurrent
1505,Mixed Neoplastic Glandular and Squamous Cell Population,Secretory breast carcinoma
1506,Severe cytologic atypia,Carcinoid tumor of rectum
1507,Borderline Lesion,Classic Type Trichilemmoma
1508,Chronic Clinical Course,Hypergranular promyelocytic leukemia
1509,Invasive Lesion,Parotid Gland Sebaceous Lymphadenoma
1510,Chronic Clinical Course,Childhood Acute Myelomonocytic Leukemia
1511,Chronic Clinical Course,Acute myeloid leukemia with abnormal marrow eosinophils
1512,Premalignant Lesion,Asbestos-Related Lung Carcinoma
1513,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Growth Hormone-Secreting Pituitary Adenoma
1514,Favorable Clinical Outcome,Malignant tumor of dermis
1515,Benign Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7
1516,Intracytoplasmic Eosinophilic Inclusion,Primary Bone Osteosarcoma
1517,Intermediate Filaments Present,Ewing's sarcoma of bone
1518,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenocarcinoma, Papillary"
1519,Intermediate Filaments Present,"Liposarcoma, well differentiated"
1520,Intracytoplasmic Eosinophilic Inclusion,Meningothelial sarcoma
1521,No Evidence of Radiologic Finding,Occult Lung Small Cell Carcinoma
1522,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma stage III
1523,Indolent Clinical Course,Epithelioid Malignant Peripheral Nerve Sheath Tumor
1524,Precise Histogenesis Unknown,Adult Astrocytic Tumor
1525,High Mitotic Activity,Functioning Pancreatic Neuroendocrine Tumor
1526,Seminomatous Component Present,Testicular embryonal carcinoma stage II
1527,Precise Histogenesis Unknown,Desmoplastic infantile ganglioglioma
1528,Locally Aggressive Lesion,benign neoplasm of lower jaw bone
1529,Seminomatous Component Present,Testicular embryonal carcinoma stage I
1530,Low Grade Lesion,Small Intestinal Angiosarcoma
1531,High Mitotic Activity,Oral Cavity Leiomyoma
1532,Mucoid Stroma Formation,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
1533,Borderline Lesion,Cervical Mullerian Papilloma
1534,Intermediate Filaments Present,leiomyosarcoma of extrahepatic bile duct
1535,Mitotic Activity,Cartilaginous exostosis
1536,Borderline Lesion,Maxillary Sinus Schneiderian Papilloma
1537,Diffuse Lesion,"Lymphangioma, Cystic"
1538,Anaplasia,Adult Spinal Cord Ependymoma
1539,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
1540,Papillary Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma
1541,Metaplasia of Malignant Cells Present,Bladder Squamous Cell Carcinoma
1542,Intracytoplasmic Eosinophilic Inclusion,Low Grade Sarcoma
1543,Intermediate Filaments Present,Kaposi's sarcoma of cornea
1544,Invasive Lesion,Gastrointestinal Intraepithelial Neoplasia
1545,Mixed Neoplastic Glandular and Squamous Cell Population,Biliary Intraepithelial Neoplasia-2
1546,Grade 4 Lesion,Anaplastic Pleomorphic Xanthoastrocytoma
1547,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Glandular Neoplasm
1548,High Grade Lesion,Bone Epithelioid Hemangioendothelioma
1549,Severe cytologic atypia,Gastrointestinal Carcinoid Tumor
1550,Intracytoplasmic Eosinophilic Inclusion,Ameloblastic fibrosarcoma
1551,Nuclear Grooves,Thyroid Gland Hyperfunctioning Adenoma
1552,Borderline Lesion,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
1553,Borderline Lesion,Parathyroid Gland Oncocytic Adenoma
1554,Indolent Clinical Course,Childhood Periosteal Osteosarcoma
1555,Grade 4 Lesion,Childhood Brain Anaplastic Astrocytoma
1556,Well-Circumscribed Lesion,"Dermatofibrosarcoma Protuberans, Myxoid"
1557,Invasive Lesion,Penile intraepithelial neoplasia
1558,Prominent Schwannian Stroma Present,Olfactory Neuroblastoma
1559,Precise Histogenesis Unknown,Infratentorial Glioblastoma
1560,Necrotic changes (finding),Recurrent Childhood Protoplasmic Astrocytoma
1561,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Gastric Intraepithelial Neoplasia
1562,Benign Cellular Infiltrate,Primary Peritoneal High Grade Serous Adenocarcinoma
1563,Benign Cellular Infiltrate,Lung Carcinoma Metastatic in the Liver
1564,Benign Cellular Infiltrate,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
1565,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal squamous cell carcinoma stage I
1566,Indolent Clinical Course,Malignant neoplasm of brain stem
1567,Benign Cellular Infiltrate,Esophageal Cancer by AJCC v7 Stage
1568,Precise Histogenesis Unknown,Anaplastic Brain Stem Glioma
1569,High Mitotic Activity,Ependymoma
1570,Mixed Neoplastic Glandular and Squamous Cell Population,Early Invasive Cervical Squamous Cell Carcinoma
1571,Localized Lesion,Osteosclerotic Plasma Cell Myeloma
1572,Intermediate Filaments Present,Prostate Angiosarcoma
1573,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Childhood Hepatocellular Carcinoma AJCC v7
1574,Anaplasia,Recurrent Childhood Oligodendroglioma
1575,Melanin Pigment Present,Mixed epithelial-mesenchymal hepatoblastoma
1576,Tubular Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
1577,Benign Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v7 Stage
1578,Premalignant Lesion,Stage IIIB Lung Cancer AJCC v7
1579,Intracytoplasmic Eosinophilic Inclusion,AJCC Grade 4 Sarcoma
1580,Borderline Lesion,Thyroid Gland Follicular Adenoma
1581,Tumor Vascular Invasion,Thyroid Gland Follicular Adenoma
1582,Borderline Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma
1583,Indolent Clinical Course,Skin Lymphangiosarcoma
1584,Indolent Clinical Course,Fibrosarcoma
1585,Invasive Lesion,Cervical Squamous Intraepithelial Neoplasia 1
1586,Intermediate Filaments Present,Conventional Angiosarcoma
1587,Precise Histogenesis Unknown,Mixed Oligodendroglioma-Astrocytoma
1588,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Clear Cell Cystadenocarcinoma
1589,Carcinomatous Component Present,Hard Palate Pleomorphic Adenoma
1590,Intracytoplasmic Eosinophilic Inclusion,Lung Synovial Sarcoma
1591,Benign Cellular Infiltrate,Stage IA Distal Bile Duct Cancer AJCC v7
1592,Dilated Thin-Walled Vascular Space Formation,Vaginal Myofibroblastoma
1593,Indolent Clinical Course,Lung Biphasic Synovial Sarcoma
1594,Locally Aggressive Lesion,Esophageal Fibroma
1595,Favorable Clinical Outcome,Recurrent Merkel Cell Carcinoma
1596,Mucoid Stroma Formation,Clear Cell Variant Thyroid Gland Papillary Carcinoma
1597,Benign Cellular Infiltrate,Stage IIIC Hepatocellular Carcinoma AJCC v7
1598,Locally Aggressive Lesion,Kidney Fibroma
1599,Indolent Clinical Course,Brain Stem Glioblastoma
1600,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Ovarian Serous Adenocarcinoma
1601,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Papillary Pattern"
1602,Glandular Differentiation,Nasopharyngeal lymphoepithelioma stage III
1603,Indolent Clinical Course,"Glioblastoma, IDH-Mutant"
1604,Premalignant Lesion,"Lung Large Cell Carcinoma, Clear Cell Variant"
1605,Indolent Clinical Course,Malignant myoepithelioma
1606,Glandular Differentiation,undifferentiated carcinoma of gallbladder
1607,Necrotic changes (finding),Tubulocystic renal cell carcinoma
1608,Invasive Lesion,Childhood Choroid Plexus Papilloma
1609,Tubular Pattern,"Adenoma, Villous"
1610,Benign Cellular Infiltrate,Childhood Rectal Carcinoma
1611,Benign Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v7
1612,Mixed Neoplastic Glandular and Squamous Cell Population,Supraglottic Verrucous Carcinoma
1613,Mixed Neoplastic Glandular and Squamous Cell Population,Corneal intraepithelial neoplasia
1614,Intracytoplasmic Eosinophilic Inclusion,"Leiomyosarcoma, Epithelioid"
1615,Scattered Collections of Differentiating Neuroblasts Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
1616,Dysplasia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
1617,Borderline Lesion,Ovarian Serous Adenofibroma
1618,High Mitotic Activity,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
1619,Intermediate Filaments Present,Osteosarcoma localised
1620,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with metaplasia
1621,Invasive Lesion,Appendix Intraepithelial Neoplasia
1622,Severe cytologic atypia,Pancreatic Neuroendocrine Tumor G1
1623,Favorable Clinical Outcome,Nevoid Melanoma
1624,Invasive Lesion,Cutaneous neurofibroma
1625,Anaplasia,Childhood Brain Oligodendroglioma
1626,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal High Grade Intraepithelial Neoplasia
1627,Dysplasia,Vulvar Syringoma
1628,Grade 4 Lesion,Diencephalic Astrocytoma
1629,Benign Cellular Infiltrate,Gastric Body Carcinoma
1630,Solid Growth Pattern,Chronic Lymphocytic Leukemia
1631,Precise Histogenesis Unknown,gliosarcoma
1632,Glandular Differentiation,large cell neuroendocrine carcinoma of appendix
1633,Intermediate Filaments Present,Small cell osteosarcoma
1634,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
1635,Indolent Clinical Course,rhabdomyosarcoma of liver
1636,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Squamous Cell Carcinoma
1637,Favorable Clinical Outcome,Malignant neoplasm of skin
1638,Solid Growth Pattern,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
1639,Cytologic atypia,Colorectal Microvesicular Hyperplastic Polyp
1640,High Mitotic Activity,Malignant Vipoma
1641,Metaplasia of Malignant Cells Present,Barrett's Adenocarcinoma
1642,Dysplasia,Senile angioma
1643,Single Type of Tissue Derived from One Embryonic Layer Present,Grade 1 Ovarian Teratoma
1644,Borderline Lesion,Benign Ovarian Seromucinous Tumor
1645,Metastatic Lesion,Benign neoplasm of sublingual gland
1646,Benign Cellular Infiltrate,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
1647,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with osseous metaplasia
1648,Intracytoplasmic Eosinophilic Inclusion,Stage IA Osteosarcoma AJCC v7
1649,Benign Cellular Infiltrate,Small intestine carcinoma
1650,Mucoid Stroma Formation,"Lung Squamous Cell Carcinoma, Papillary Variant"
1651,Favorable Clinical Outcome,Advanced Adult Hepatocellular Carcinoma
1652,Borderline Lesion,Thyroid Gland Signet Ring Cell Follicular Adenoma
1653,Mixed Neoplastic Glandular and Squamous Cell Population,Sphenoid Sinus Squamous Cell Carcinoma
1654,Grade 4 Lesion,Childhood Gemistocytic Astrocytoma
1655,Invasive Lesion,"Vulvar Intraepithelial Neoplasia, Differentiated Type"
1656,Infiltrative Growth Pattern,Desmoplastic fibroblastoma
1657,Chronic Clinical Course,Adult Pure Erythroid Leukemia
1658,Indolent Clinical Course,Intraocular Malignant Peripheral Nerve Sheath Tumor
1659,Indolent Clinical Course,Childhood Gliosarcoma
1660,Endophytic Tumor Growth,Common wart
1661,Invasive Lesion,Mild epithelial dysplasia
1662,Mixed Neoplastic Glandular and Squamous Cell Population,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
1663,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Esophageal Adenocarcinoma AJCC v7
1664,Glandular Differentiation,undifferentiated carcinoma of larynx
1665,Presence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
1666,CD30-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
1667,Biphasic Pattern,Childhood Pilomyxoid Astrocytoma
1668,Mixed Neoplastic Glandular and Squamous Cell Population,cloacogenic carcinoma of rectum
1669,Mixed Neoplastic Glandular and Squamous Cell Population,Intracystic Papillary Breast Carcinoma
1670,Dysplasia,Hidroacanthoma simplex
1671,Benign Cellular Infiltrate,Malignant neoplasm of gastrointestinal tract
1672,Indolent Clinical Course,leiomyosarcoma of rectum
1673,Favorable Clinical Outcome,Stage II Lentigo Maligna Melanoma AJCC v6 and v7
1674,Indolent Clinical Course,Adrenal Gland Angiosarcoma
1675,Borderline Lesion,Inverted papilloma of urinary bladder
1676,Auer Rods Present,Adult Acute Myeloid Leukemia with Minimal Differentiation
1677,Indolent Clinical Course,Recurrent Childhood Giant Cell Glioblastoma
1678,Grade 4 Lesion,Childhood Visual Pathway Astrocytoma
1679,Indolent Clinical Course,Stage IB Bone Cancer AJCC v7
1680,Premalignant Lesion,Stage IIIB Lung Small Cell Carcinoma AJCC v7
1681,Squamous Differentiation,"Carcinoma, Giant Cell"
1682,Histiocytosis,Stage IV Adult Immunoblastic Lymphoma
1683,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Rhabdomyosarcoma
1684,Aggressive Clinical Course,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
1685,Metastatic Lesion,inverted ductal papilloma of salivary gland
1686,Mixed Neoplastic Glandular and Squamous Cell Population,Minimally Invasive Mucinous Lung Adenocarcinoma
1687,High Mitotic Activity,oligodendroglioma
1688,Mixed Neoplastic Glandular and Squamous Cell Population,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
1689,Diffuse Lesion,Esophageal hemangioma
1690,Indolent Clinical Course,Colon Kaposi Sarcoma
1691,Indolent Clinical Course,Recurrent Bone Ewing Sarcoma
1692,Benign Cellular Infiltrate,Early Hepatocellular Carcinoma
1693,Benign Cellular Infiltrate,Malignant tumor of rectosigmoid junction
1694,Intracytoplasmic Eosinophilic Inclusion,Mesenchymal Chondrosarcoma
1695,Glandular Differentiation,Combined Lung Large Cell Neuroendocrine Carcinoma
1696,Precise Histogenesis Unknown,Anaplastic Pleomorphic Xanthoastrocytoma
1697,Mixed Epithelial Cell Population,Sphenoid Sinus Inverted Papilloma
1698,Mucoid Stroma Formation,Papillary neoplasm
1699,Indolent Clinical Course,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
1700,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
1701,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Mixed Adenocarcinoma
1702,Mitotic Activity,Recurrent Childhood Protoplasmic Astrocytoma
1703,Invasive Lesion,"Glandular intraepithelial neoplasia, low grade"
1704,Favorable Clinical Outcome,Cholangiolocellular Carcinoma
1705,Intracytoplasmic Eosinophilic Inclusion,Myxosarcoma
1706,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Adrenal Cortex Carcinoma AJCC v7
1707,Benign Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v7
1708,Intracytoplasmic Eosinophilic Inclusion,Skin Angiosarcoma
1709,Intracytoplasmic Eosinophilic Inclusion,Gastric Liposarcoma
1710,Mixture of Germ Cell Neoplastic Components Present,Stage IIIA Gestational Trophoblastic Tumor AJCC v7
1711,Favorable Clinical Outcome,Recurrent Adult Liver Carcinoma
1712,Solid Growth Pattern,Childhood Acute Monoblastic Leukemia
1713,Scattered Collections of Differentiating Neuroblasts Present,Childhood Ganglioneuroblastoma
1714,Intermediate Filaments Present,Central Nervous System Leiomyosarcoma
1715,Benign Cellular Infiltrate,Stage II Esophageal Cancer
1716,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of lung (disorder)
1717,Mixed Neoplastic Glandular and Squamous Cell Population,Rete Ovarii Cystadenoma
1718,Seminomatous Component Present,Childhood Teratoma
1719,Precise Histogenesis Unknown,"Diffuse Astrocytoma, IDH-Mutant"
1720,Borderline Lesion,Tubular adenoma of breast
1721,Benign Cellular Infiltrate,Kaposi's sarcoma of liver
1722,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal Squamous Cell Carcinoma
1723,Intracytoplasmic Eosinophilic Inclusion,rhabdomyosarcoma of extrahepatic bile duct
1724,Mixed Neoplastic Glandular and Squamous Cell Population,Clear cell adenocarcinoma of ovary
1725,Mucoid Stroma Formation,Cervical Verrucous Carcinoma
1726,Diffuse Lesion,Vaginal Squamous Papilloma
1727,Solid Growth Pattern,Smoldering Adult T-Cell Leukemia/Lymphoma
1728,Aggressive Clinical Course,Stage IV Indolent Adult Non-Hodgkin Lymphoma
1729,Intermediate Filaments Present,Kaposi's sarcoma of penis
1730,Intermediate Filaments Present,Monophasic Synovial Sarcoma
1731,Invasive Lesion,Serous Tubal Intraepithelial Carcinoma
1732,Mixed Neoplastic Glandular and Squamous Cell Population,Paget's Disease of the Nipple
1733,Dysplasia,External Auditory Canal Ceruminous Adenoma
1734,Dysplasia,Trichilemmoma
1735,High Mitotic Activity,Brain Oligodendroglioma
1736,Indolent Clinical Course,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
1737,Indolent Clinical Course,Multifocal Glioblastomas
1738,Indolent Clinical Course,Medulloepithelioma
1739,Indolent Clinical Course,Adult Medulloblastoma
1740,Benign Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v7
1741,Fibrotic Stroma Formation,Acinar cell carcinoma of pancreas
1742,Intermediate Filaments Present,Superior Vena Cava Angiosarcoma
1743,Invasive Lesion,Corneal intraepithelial neoplasia
1744,Prominent Schwannian Stroma Present,Differentiating Neuroblastoma
1745,Odontogenic Cysts,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
1746,Grade 4 Lesion,Adult Brain Stem Astrocytoma
1747,Indolent Clinical Course,"Leiomyosarcoma, Epithelioid"
1748,Intracytoplasmic Eosinophilic Inclusion,Stage IIB Uterine Sarcoma AJCC v7
1749,Intracytoplasmic Eosinophilic Inclusion,"Leiomyosarcoma, Myxoid"
1750,Borderline Lesion,Benign Ovarian Thecoma
1751,Benign Cellular Infiltrate,Adenocarcinoma of rectum
1752,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
1753,Benign Cellular Infiltrate,Burkitt's lymphoma of small intestine
1754,Benign Cellular Infiltrate,Gastric Body Carcinoma In Situ AJCC v6 and v7
1755,Intermediate Filaments Present,Sarcoma by NCI Grade
1756,Generalized Dysplasia,Appendix Sessile Serrated Adenoma/Polyp
1757,Mucoid Stroma Formation,Gallbladder Papillomatosis
1758,Benign Cellular Infiltrate,Localized Unresectable Adult Hepatocellular Carcinoma
1759,Solid Growth Pattern,Hyperdiploid B Acute Lymphoblastic Leukemia
1760,Dysplasia,Benign epithelial neoplasm of skin
1761,Necrotic changes (finding),Schwannoma of the Twelfth Cranial Nerve
1762,Benign Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7
1763,Mixed Neoplastic Glandular and Squamous Cell Population,Craniopharyngioma
1764,High Mitotic Activity,Carcinoid tumor of pancreas
1765,Indolent Clinical Course,Renal Vein Leiomyosarcoma
1766,Necrotic changes (finding),Degenerated Schwannoma
1767,Mixed Neoplastic Glandular and Squamous Cell Population,eccrine adenocarcinoma of vulva
1768,Indolent Clinical Course,Pineal Region Choriocarcinoma
1769,Metastatic Lesion,Sparsely Granulated Somatotroph Adenoma
1770,Aggressive Clinical Course,Splenic Marginal Zone B-Cell Lymphoma
1771,Tumor Vascular Invasion,Heavily Pigmented Adrenal Cortical Adenoma
1772,Mixed Epithelial Cell Population,Squamous Papilloma of the Larynx
1773,Intestinal metaplasia,Rectosigmoid Signet Ring Cell Carcinoma
1774,Metastatic Lesion,"Testicular Sertoli Cell Tumor, Lipid Rich Variant"
1775,Seminomatous Component Present,Extragonadal primary malignant teratoma
1776,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Phyllodes Tumor of Prostate
1777,Benign Cellular Infiltrate,Colorectal Large Cell Neuroendocrine Carcinoma
1778,Intracytoplasmic Eosinophilic Inclusion,Primary Childhood Soft Tissue Sarcoma
1779,Benign Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v6 and v7
1780,Favorable Clinical Outcome,Moderately Differentiated Hepatocellular Carcinoma
1781,Benign Cellular Infiltrate,Secondary malignant neoplasm of colon
1782,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Ovarian Mature Teratoma
1783,Capsular Invasion,Thyroid Gland Clear Cell Follicular Adenoma
1784,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of ovary
1785,Benign Cellular Infiltrate,Stage IIIA Small Intestinal Cancer AJCC v7
1786,High Mitotic Activity,Leiomyoma of ciliary body
1787,Invasive Lesion,Carcinoma in situ of trachea
1788,Solid Growth Pattern,Adult Acute Myelomonocytic Leukemia
1789,High Grade Lesion,Mastocytoma
1790,Nuclear Atypia,HNF1alpha-Inactivated Hepatocellular Adenoma
1791,Mucoid Stroma Formation,Biliary papillomatosis
1792,Benign Cellular Infiltrate,Small Intestinal Diffuse Large B-Cell Lymphoma
1793,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of soft tissue
1794,Invasive Lesion,Intraepithelial Squamous Cell Carcinoma
1795,Mixed Neoplastic Glandular and Squamous Cell Population,Paget's disease and intraductal carcinoma of breast
1796,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Tubulopapillary Neoplasm
1797,Benign Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7
1798,Benign Cellular Infiltrate,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
1799,Indolent Clinical Course,Adult Central Nervous System Embryonal Carcinoma
1800,More than 10 Mitoses per 10HPF,Lung Typical Carcinoid Tumor
1801,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Adult Hepatocellular Carcinoma
1802,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
1803,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, Endometrioid"
1804,Benign Cellular Infiltrate,cloacogenic carcinoma of rectum
1805,Mixed Neoplastic Glandular and Squamous Cell Population,Paget disease of anal canal
1806,Solid Growth Pattern,Alkylating Agent-Related Acute Myeloid Leukemia
1807,Pineocytomatous Rosette Formation,Adult Pineoblastoma
1808,Ineffective hematopoiesis,"Leukemia, Myeloid, Accelerated Phase"
1809,Mixed Neoplastic Glandular and Squamous Cell Population,Minor Salivary Gland Adenocarcinoma
1810,Borderline Lesion,Eccrine spiradenoma
1811,Benign Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma
1812,Invasive Lesion,"Glandular intraepithelial neoplasia, grade III"
1813,Squamous Differentiation,Undifferentiated Carcinoma of Unknown Primary
1814,Mucoid Stroma Formation,Stage 0a Ureter Cancer AJCC v7
1815,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Vulvar Phyllodes Tumor
1816,Well-Circumscribed Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
1817,Nuclear Pseudoinclusion,minimally invasive follicular carcinoma of the thyroid gland
1818,Infiltrative Growth Pattern,Gingival Angiofibroma
1819,Mixed Cellular Population,Spindle Cell/Sclerosing Rhabdomyosarcoma
1820,Benign Cellular Infiltrate,Small Intestinal Large Cell Neuroendocrine Carcinoma
1821,Diffuse Lesion,Atypical Breast Papilloma
1822,atypia morphology,Vaginal Blue Nevus
1823,Indolent Clinical Course,Primary bone lymphoma
1824,Intermediate Filaments Present,Grade II Chondrosarcoma
1825,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Adenocarcinoma of Mammary Gland Type
1826,Thrombocytosis,Refractory anemia with ringed sideroblasts
1827,Tubular Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
1828,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
1829,Benign Cellular Infiltrate,Stage IIA Pancreatic Cancer AJCC v6 and v7
1830,Intermediate Filaments Present,Localized Ewing Sarcoma
1831,"Undifferentiated ""Fetal-Type"" Tissues Present",Vaginal Dermoid Cyst
1832,Mixed Neoplastic Glandular and Squamous Cell Population,Cystadenoma of pancreas
1833,Diffuse Lesion,Maxillary Sinus Schneiderian Papilloma
1834,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor
1835,Indolent Clinical Course,Extraskeletal osteosarcoma metastatic
1836,Intracytoplasmic Eosinophilic Inclusion,Kaposi Sarcoma NCI Grade 2
1837,Metastatic Lesion,Stage IV Major Salivary Gland Carcinoma without Metastasis
1838,Intermediate Filaments Present,Peritoneal Desmoplastic Small Round Cell Tumor
1839,Indolent Clinical Course,Conventional Alveolar Rhabdomyosarcoma
1840,Solid Growth Pattern,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
1841,High Mitotic Activity,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
1842,Diffuse Lesion,Intracystic papillary adenoma
1843,Indolent Clinical Course,leiomyosarcoma of breast
1844,Nuclear Grooves,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
1845,Benign Cellular Infiltrate,Anal Canal Small Cell Neuroendocrine Carcinoma
1846,Favorable Clinical Outcome,Desmoplastic Neurotropic Melanoma
1847,Well-Circumscribed Lesion,Dermatofibrosarcoma protuberans with myoid differentiation
1848,Mixed Neoplastic Glandular and Squamous Cell Population,Rectal Medullary Carcinoma
1849,Intracytoplasmic Eosinophilic Inclusion,Childhood Parosteal Osteosarcoma
1850,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Gastric Teratoma
1851,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Brenner Tumor
1852,Benign Cellular Infiltrate,Stage IVB Gallbladder Carcinoma
1853,Squamous Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct
1854,CD21-Positive Neoplastic Cells Present,Eosinophilic Granuloma
1855,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal squamous cell carcinoma stage III
1856,Acute Clinical Course,Refractory Hairy Cell Leukemia
1857,Seminomatous Component Present,Benign Struma Ovarii
1858,Premalignant Lesion,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
1859,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Parathyroid Gland Carcinoma
1860,Intracytoplasmic Eosinophilic Inclusion,Fibrosarcoma
1861,Mucoid Stroma Formation,papillary carcinoma of renal pelvis
1862,Indolent Clinical Course,leiomyosarcoma of vagina
1863,Mixed Neoplastic Glandular and Squamous Cell Population,Opisthorchis Viverrini-Related Cholangiocarcinoma
1864,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Benign phyllodes neoplasm of breast
1865,Intracytoplasmic Eosinophilic Inclusion,Fibrosarcoma metastatic
1866,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline serous tumor of ovary
1867,Papillary Pattern,Gallbladder Cribriform Carcinoma
1868,Intracytoplasmic Eosinophilic Inclusion,Liposarcoma metastatic
1869,Microvascular Proliferation,"Anaplastic Astrocytoma, IDH-Wildtype"
1870,Favorable Clinical Outcome,Superficial spreading malignant melanoma of skin
1871,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of anus
1872,Benign Cellular Infiltrate,Childhood Colorectal Carcinoma
1873,Infiltrative Growth Pattern,calcifying aponeurotic fibroma
1874,Indolent Clinical Course,Anaplastic Oligoastrocytoma
1875,Benign Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v7
1876,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
1877,Grade 4 Lesion,Recurrent Childhood Cerebellar Astrocytoma
1878,Pushing Tumor Margin,Buschke-Lowenstein Tumor
1879,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage 0 Adult Hepatocellular Carcinoma
1880,Birbeck Granules Present,Histiocytic sarcoma
1881,Favorable Clinical Outcome,External Ear Basal Cell Carcinoma
1882,Glial Differentiation,Hypothalamic Gangliocytoma
1883,Benign Cellular Infiltrate,Gastrointestinal carcinoma
1884,Indolent Clinical Course,anaplastic large cell lymphoma of central nervous system
1885,Chronic Clinical Course,Refractory Adult Acute Lymphoblastic Leukemia
1886,Benign Cellular Infiltrate,Adenocarcinoma of ampulla of Vater
1887,Indolent Clinical Course,Childhood Central Nervous System Mixed Germ Cell Tumor
1888,Benign Cellular Infiltrate,Stage II Ampulla of Vater Cancer AJCC v7
1889,Malignant Germinomatous Cellular Infiltrate,Gastric Choriocarcinoma
1890,Indolent Clinical Course,Non-Metastatic Childhood Soft Tissue Sarcoma
1891,High Mitotic Activity,Adult Brain Oligodendroglioma
1892,Glandular Differentiation,Vulvar Large Cell Neuroendocrine Carcinoma
1893,Intracytoplasmic Eosinophilic Inclusion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
1894,Indolent Clinical Course,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
1895,Tubular Structures Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type"
1896,Glandular Differentiation,Lymphoepithelial carcinoma
1897,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of ureter
1898,Diffuse Lesion,Hemangioma acquired
1899,Seminomatous Component Present,Mediastinal Immature Teratoma
1900,Benign Cellular Infiltrate,Ampulla of Vater Invasive Papillary Adenocarcinoma
1901,Indolent Clinical Course,Anaplastic Diencephalic Astrocytoma
1902,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Signet Ring Cell Carcinoma
1903,HMB-45-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Follicular"
1904,Invasive Lesion,Small Intestinal Low Grade Intraepithelial Neoplasia
1905,Nuclear Grooves,Macrofollicular adenoma
1906,Indolent Clinical Course,Recurrent Peripheral Primitive Neuroectodermal Tumor
1907,Necrotic changes (finding),Trigeminal schwannoma
1908,Benign Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
1909,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Tumor
1910,Benign Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v7
1911,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
1912,Favorable Clinical Outcome,Skin-associated lymphoid tissue lymphoma
1913,Solid Growth Pattern,Splenic Manifestation of Hairy Cell Leukemia
1914,Malignant Germinomatous Cellular Infiltrate,Extragonadal primary malignant teratoma
1915,Mixed Neoplastic Glandular and Squamous Cell Population,Paget's disease of vulva
1916,Metastatic Lesion,Testicular Large Cell Calcifying Sertoli Cell Tumor
1917,Indolent Clinical Course,Stage IIIC Uterine Sarcoma AJCC v7
1918,Ground Glass Nuclear Inclusion,Thyroid Gland Mucinous Follicular Adenoma
1919,Grade 4 Lesion,Childhood Cerebellar Astrocytoma
1920,Necrotic changes (finding),Gastric Schwannoma
1921,Diffuse Lesion,Strawberry nevus of skin
1922,Favorable Clinical Outcome,Poorly Differentiated Hepatocellular Carcinoma
1923,Solid Growth Pattern,leukemia
1924,Mixed Cellular Population,Invasive Lobular Breast Carcinoma
1925,Mixed Neoplastic Glandular and Squamous Cell Population,Bowen's Disease
1926,Severe cytologic atypia,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
1927,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
1928,Indolent Clinical Course,Olfactory Neuroblastoma
1929,Pushing Tumor Margin,Condyloma acuminata of vagina
1930,Indolent Clinical Course,Fibrosarcoma non-metastatic
1931,Mixture of Germ Cell Neoplastic Components Present,Choriocarcinoma of the Testis
1932,Invasive Lesion,Benign oncocytoma of salivary gland
1933,Premalignant Lesion,Non-small cell lung cancer stage I
1934,Increased Cellularity Present,Prostate Stromal Proliferation of Uncertain Malignant Potential
1935,Extracutaneous Dissemination of Disease,Urticaria Pigmentosa
1936,Intestinal metaplasia,Ampulla of Vater Signet Ring Cell Carcinoma
1937,Intermediate Filaments Present,Adult Desmoplastic Small Round Cell Tumor
1938,Invasive Lesion,Moderate epithelial dysplasia
1939,Dysplasia,Hemangioma of skin
1940,Invasive Lesion,Stage 0 Esophageal Adenocarcinoma AJCC v7
1941,Benign Cellular Infiltrate,Ampulla of Vater Clear Cell Adenocarcinoma
1942,Mixed Neoplastic Glandular and Squamous Cell Population,"Invasive Lobular Breast Carcinoma, Solid Variant"
1943,Chronic Clinical Course,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
1944,Mucoid Stroma Formation,Intracystic Papillary Breast Carcinoma
1945,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Urachal Squamous Cell Carcinoma
1946,Grade 4 Lesion,Childhood Pleomorphic Xanthoastrocytoma
1947,Precise Histogenesis Unknown,Astrocytoma
1948,Invasive Lesion,Classic Type Trichilemmoma
1949,Precise Histogenesis Unknown,Ependymoma of spinal cord
1950,Mixed Neoplastic Glandular and Squamous Cell Population,Hurthle Cell Tumor
1951,Premalignant Lesion,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
1952,Chronic Clinical Course,Acute promyelocytic leukemia - hypogranular variant
1953,Mucoid Stroma Formation,Stage 0a Renal Pelvis Cancer AJCC v7
1954,Benign Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma
1955,Increased Cellularity Present,Inverted papilloma of urinary bladder
1956,Mucoid Stroma Formation,Invasive papillary breast carcinoma
1957,High Mitotic Activity,Intestinal Neuroendocrine Tumor
1958,Favorable Clinical Outcome,Merkel cell carcinoma
1959,Invasive Lesion,Benign neoplasm of parotid gland
1960,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage A Adult Hepatocellular Carcinoma
1961,Indolent Clinical Course,Childhood Undifferentiated Pleomorphic Sarcoma
1962,Necrotic changes (finding),Recurrent Childhood Gemistocytic Astrocytoma
1963,Low Mitotic Activity,Small Intestinal Large Cell Neuroendocrine Carcinoma
1964,Distortion of the Hair Follicle,Perifollicular fibroma
1965,Mitotic Activity,Low Grade Ductal Breast Carcinoma In Situ
1966,Indolent Clinical Course,CIC-DUX Sarcoma
1967,Invasive Lesion,Moderate pancreatic duct dysplasia
1968,Dysplasia,Sporadic Cylindroma
1969,Intracytoplasmic Eosinophilic Inclusion,FNCLCC Sarcoma Grade 3
1970,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) stage II
1971,Indolent Clinical Course,Adult Pleomorphic Rhabdomyosarcoma
1972,Metastatic Lesion,cystadenoma of salivary gland
1973,Locally Aggressive Lesion,Solitary Osteochondroma
1974,Indolent Clinical Course,AJCC Grade 1 Sarcoma
1975,Chronic Clinical Course,ROSE Cluster 5
1976,Favorable Clinical Outcome,Basal cell carcinoma - adenoid
1977,Intermediate Filaments Present,AIDS with Kaposi's sarcoma
1978,Seminomatous Component Present,Stage I Ovarian Teratoma AJCC v6 and v7
1979,Indolent Clinical Course,Malignant Fibrohistiocytic Neoplasm
1980,Indolent Clinical Course,Esophageal Synovial Sarcoma
1981,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of Unknown Primary
1982,Intermediate Filaments Present,Cutaneous Radiation-Related Angiosarcoma
1983,Multilayered Rosette Formation,Childhood Medulloblastoma
1984,Histiocytosis,Stage I Adult Immunoblastic Lymphoma
1985,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in villous adenoma
1986,Indolent Clinical Course,Recurrent Extraskeletal Myxoid Chondrosarcoma
1987,Intracytoplasmic Eosinophilic Inclusion,Recurrent Extraskeletal Myxoid Chondrosarcoma
1988,Low Grade Lesion,Angiosarcoma of spleen
1989,Grade 4 Lesion,Adult Anaplastic Astrocytoma
1990,Intermediate Filaments Present,sarcoma of accessory sinus
1991,Intracytoplasmic Eosinophilic Inclusion,sarcoma of accessory sinus
1992,Borderline Lesion,Benign epithelial tumor of ovary
1993,Solid Growth Pattern,Infant Acute Lymphoblastic Leukemia
1994,Indolent Clinical Course,Alveolar soft part sarcoma metastatic
1995,Tubular Pattern,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
1996,Ground Glass Nuclear Inclusion,Thyroid Gland Hyperfunctioning Adenoma
1997,Mucoid Stroma Formation,Upper Gingival Verrucous Carcinoma
1998,Local disease,Advanced Favorable Hodgkin Lymphoma
1999,Benign Cellular Infiltrate,Carcinoma in situ of cecum
2000,High Mitotic Activity,Uterine Corpus Lipoleiomyoma
2001,Malignant Germinomatous Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
2002,Encapsulated Mass,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
2003,Benign Cellular Infiltrate,Cholangiocarcinoma resectable
2004,Diffuse Lesion,Hemangioma of subcutaneous tissue
2005,Favorable Clinical Outcome,Morpheic basal cell carcinoma
2006,Low Mitotic Activity,large cell neuroendocrine carcinoma of anal canal
2007,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Angiosarcoma
2008,Intermediate Filaments Present,Gastric Kaposi's Sarcoma
2009,Benign Cellular Infiltrate,Gastric Kaposi's Sarcoma
2010,Benign Cellular Infiltrate,Mixed epithelial-mesenchymal hepatoblastoma
2011,Intermediate Filaments Present,Multifocal osteosarcoma
2012,Benign Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v7
2013,Indolent Clinical Course,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
2014,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Cervical Squamous Intraepithelial Neoplasia
2015,Intermediate Filaments Present,Sarcoma of ovary
2016,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Parathyroid Gland Carcinoma
2017,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of rete ovarii
2018,Tubular Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
2019,Borderline Lesion,Papilloma
2020,Benign Cellular Infiltrate,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma
2021,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Vulvar Carcinoma
2022,Indolent Clinical Course,Childhood Atypical Teratoid/Rhabdoid Tumor
2023,Borderline Lesion,Hard Palate Pleomorphic Adenoma
2024,Precise Histogenesis Unknown,Neuronal and mixed neuronal-glial tumor
2025,Premalignant Lesion,Non-small cell lung cancer stage IIIB
2026,Favorable Clinical Outcome,Malignant melanoma in junctional nevus
2027,Mixed Neoplastic Glandular and Squamous Cell Population,Oncocytic Variant Thyroid Gland Papillary Carcinoma
2028,Favorable Clinical Outcome,Sarcoma of skin
2029,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of palate
2030,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,High Grade Ovarian Serous Adenocarcinoma
2031,Premalignant Lesion,Adenosquamous cell lung cancer stage I
2032,Seminomatous Component Present,Childhood Testicular Embryonal Carcinoma
2033,High Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
2034,Invasive Lesion,Skin Cavernous Hemangioma
2035,Mixed Neoplastic Glandular and Squamous Cell Population,Sarcomatoid Hepatocellular Carcinoma
2036,Mixture of Germ Cell Neoplastic Components Present,Stage III Immature Testicular Teratoma AJCC v6 and v7
2037,Invasive Lesion,Trichilemmoma
2038,Generalized Dysplasia,Colorectal Sessile Serrated Adenoma/Polyp
2039,Mixed Neoplastic Glandular and Squamous Cell Population,Peripheral Intrahepatic Cholangiocarcinoma
2040,Necrotic changes (finding),Pituitary Gland Gangliocytoma
2041,Favorable Clinical Outcome,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
2042,Indolent Clinical Course,Superior Vena Cava Angiosarcoma
2043,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
2044,Intermediate Filaments Present,Chondrosarcoma metastatic
2045,Intermediate Filaments Present,Stage IIA Uterine Sarcoma AJCC v7
2046,Borderline Lesion,Ovarian Papillary Cystadenoma
2047,Severe cytologic atypia,Well Differentiated Pancreatic Endocrine Tumor
2048,Intermediate Filaments Present,Leiomyosarcoma of Deep Soft Tissue
2049,Precise Histogenesis Unknown,Adult Brain Glioblastoma
2050,Seminomatous Component Present,Central Nervous System Teratoma with Malignant Transformation
2051,Intermediate Filaments Present,Inflammatory malignant fibrous histiocytoma
2052,Invasive Lesion,Anal Papillary Hidradenoma
2053,Indolent Clinical Course,Secondary Cerebral Hodgkin Lymphoma
2054,Favorable Clinical Outcome,Cutaneous Melanoma by AJCC v7 Stage
2055,Mixture of Germ Cell Neoplastic Components Present,"Testicular Seminoma, Pseudoglandular Variant"
2056,High Mitotic Activity,Carcinoid tumor of ileum
2057,High Mitotic Activity,Pericardial Leiomyoma
2058,Borderline Lesion,Eccrine acrospiroma
2059,Favorable Clinical Outcome,Signet Ring Melanoma
2060,Borderline Lesion,Apocrine adenoma
2061,Dysplasia,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
2062,Seminomatous Component Present,Testicular Mixed Yolk Sac Tumor and Teratoma
2063,Favorable Clinical Outcome,Aleukemic Leukemia Cutis
2064,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Endometrial Mucinous Adenocarcinoma
2065,Blasts of Mixed Phenotype Present,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
2066,Encapsulated Mass,Proliferative fasciitis
2067,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Mucinous cystadenocarcinoma of ovary
2068,Solid Growth Pattern,Acute panmyelosis with myelofibrosis
2069,Solid Growth Pattern,Core binding factor acute myeloid leukemia
2070,Solid Growth Pattern,Splenic Manifestation of Prolymphocytic Leukemia
2071,Indolent Clinical Course,Sarcoma NCI Grade 2
2072,Intermediate Filaments Present,Osteosarcoma of bone
2073,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of prostate
2074,Malignant Germinomatous Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma
2075,Indolent Clinical Course,sarcoma of lung
2076,Benign Cellular Infiltrate,Esophageal adenocarcinoma recurrent
2077,Glandular Differentiation,Laryngeal Giant Cell Carcinoma
2078,Ineffective hematopoiesis,Prefibrotic/Early Primary Myelofibrosis
2079,Premalignant Lesion,Carcinoma in situ of trachea
2080,Benign Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v7
2081,Solid Growth Pattern,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
2082,Diffuse Lesion,Hemangioma of choroid
2083,Intracytoplasmic Eosinophilic Inclusion,Cardiac Sarcoma
2084,Intermediate Filaments Present,sarcoma of mediastinum
2085,CD21-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
2086,Indolent Clinical Course,Diffuse melanocytosis
2087,Favorable Clinical Outcome,Stage III Adult Liver Cancer AJCC v7
2088,Indolent Clinical Course,Peripheral primitive neuroectodermal tumor of soft tissue
2089,Mitotic Activity,Prostate Stromal Proliferation of Uncertain Malignant Potential
2090,Precise Histogenesis Unknown,Adult Ependymal Tumor
2091,Invasive Lesion,Verrucous keratotic hemangioma
2092,Diffuse Lesion,Hemangioma of retina
2093,High Mitotic Activity,Vulvar Leiomyoma
2094,Indolent Clinical Course,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
2095,Mixed Neoplastic Glandular and Squamous Cell Population,Sweat gland carcinoma
2096,Favorable Clinical Outcome,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7
2097,Chronic Clinical Course,Acute Leukemia of Ambiguous Lineage
2098,CD35-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
2099,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Pure Erythroid Leukemia
2100,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
2101,No Evidence of Radiologic Finding,Occult Lung Large Cell Carcinoma
2102,Squamous Differentiation,Occult Lung Large Cell Carcinoma
2103,Locally Aggressive Lesion,Chondroblastoma
2104,Benign Cellular Infiltrate,sarcoma of rectum
2105,Microvascular Proliferation,Childhood Protoplasmic Astrocytoma
2106,Precise Histogenesis Unknown,Childhood Protoplasmic Astrocytoma
2107,Aggressive Clinical Course,Waldenstrom Macroglobulinemia
2108,Benign Cellular Infiltrate,Stage III Esophageal Cancer AJCC v7
2109,Ineffective hematopoiesis,"Myeloid Leukemia, Chronic"
2110,Favorable Clinical Outcome,Malignant Eccrine Neoplasm
2111,Benign Cellular Infiltrate,mucinous adenocarcinoma of rectum
2112,Precise Histogenesis Unknown,RELA fusion-positive ependymoma
2113,Borderline Lesion,Breast Ductal Adenoma
2114,Favorable Clinical Outcome,"Carcinoma, Skin Appendage"
2115,High Mitotic Activity,Small Intestinal Neuroendocrine Tumor G2
2116,Benign Cellular Infiltrate,Stage IIA Esophagus Carcinoma
2117,Precise Histogenesis Unknown,Adult Ependymoma
2118,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Fibrosarcoma
2119,Glandular Differentiation,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
2120,Mucoid Stroma Formation,Digital papillary eccrine carcinoma of skin
2121,Favorable Clinical Outcome,Skin Clear Cell Basal Cell Carcinoma
2122,Intracytoplasmic Eosinophilic Inclusion,liposarcoma of breast
2123,Extracutaneous Dissemination of Disease,Pure Cutaneous Mastocytosis
2124,Mucoid Stroma Formation,Ethmoid Sinus Schneiderian Papilloma
2125,Intermediate Filaments Present,Mediastinal Extraskeletal Osteosarcoma
2126,Intracytoplasmic Eosinophilic Inclusion,Mediastinal Extraskeletal Osteosarcoma
2127,Intermediate Filaments Present,Cervical Malignant Peripheral Nerve Sheath Tumor
2128,Borderline Lesion,Sphenoid Sinus Schneiderian Papilloma
2129,Mixed Epithelial Cell Population,Sphenoid Sinus Schneiderian Papilloma
2130,Mixture of Germ Cell Neoplastic Components Present,Testicular choriocarcinoma stage III
2131,Papillary Pattern,Colon Cribriform Comedo-Type Adenocarcinoma
2132,Mixed Neoplastic Glandular and Squamous Cell Population,Pituitary Gland Oncocytic Adenoma
2133,Well-Circumscribed Lesion,Conventional Alveolar Rhabdomyosarcoma
2134,Mixed Neoplastic Glandular and Squamous Cell Population,"Papillary squamous cell carcinoma, non-invasive"
2135,Favorable Clinical Outcome,Mycosis Fungoides Variant
2136,Auer Rods Present,Refractory cytopenia with multilineage dysplasia
2137,Mixed Neoplastic Glandular and Squamous Cell Population,Salivary duct carcinoma
2138,Intermediate Filaments Present,Alveolar soft part sarcoma recurrent
2139,Intracytoplasmic Eosinophilic Inclusion,Extra-osseous Ewing's sarcoma non-metastatic
2140,Mixed Epithelial Cell Population,Ethmoid Sinus Inverted Papilloma
2141,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
2142,Well-Circumscribed Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
2143,Papillary Pattern,Oral Cavity Monomorphic Adenoma
2144,Indolent Clinical Course,Secondary malignant neoplasm of nervous system
2145,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
2146,Benign Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v7
2147,Metastatic Lesion,LH-Producing Gonadotroph Adenoma
2148,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiocarcinoma non-resectable
2149,Mitotic Activity,Typical Ovarian Thecoma
2150,Precise Histogenesis Unknown,Mesenchymal Glioblastoma
2151,Invasive Lesion,Benign Apocrine Neoplasm
2152,Capsular Invasion,Thyroid Gland Follicular Adenoma
2153,Favorable Clinical Outcome,Sweat Gland Tubular Carcinoma
2154,Scattered Collections of Differentiating Neuroblasts Present,Childhood Central Nervous System Ganglioneuroblastoma
2155,Mixed Neoplastic Glandular and Squamous Cell Population,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
2156,Favorable Clinical Outcome,Stage I Merkel Cell Carcinoma AJCC v7
2157,Intracytoplasmic Eosinophilic Inclusion,Conventional Angiosarcoma
2158,Indolent Clinical Course,Conventional Angiosarcoma
2159,High Mitotic Activity,Anal Leiomyoma
2160,Premalignant Lesion,Lung Synovial Sarcoma
2161,Borderline Lesion,Benign Brenner Tumor
2162,Mucoid Stroma Formation,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
2163,Diffuse Lesion,Oropharyngeal squamous papilloma
2164,Intracytoplasmic Eosinophilic Inclusion,Cardiac Fibrosarcoma
2165,Indolent Clinical Course,Kadish Stage B Olfactory Neuroblastoma
2166,Precise Histogenesis Unknown,Mixed Astrocytoma-Ependymoma-Oligodendroglioma
2167,Chronic Clinical Course,Adult Acute Myeloid Leukemia without Maturation
2168,Grade 4 Lesion,Adult Subependymal Giant Cell Astrocytoma
2169,CD30-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
2170,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Microcystic Pattern"
2171,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Microcystic Pattern"
2172,Favorable Clinical Outcome,Recurrent Hepatocellular Carcinoma
2173,Benign Cellular Infiltrate,Colorectal Mucinous Adenocarcinoma
2174,Squamous Differentiation,Nasopharyngeal lymphoepithelioma stage II
2175,Benign Cellular Infiltrate,Sarcomatoid Hepatocellular Carcinoma
2176,Precise Histogenesis Unknown,Anaplastic Oligoastrocytoma
2177,Intermediate Filaments Present,"Liposarcoma, Pleomorphic"
2178,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
2179,Invasive Lesion,Epithelioid hemangioma of skin
2180,Dysplasia,Epithelioid hemangioma of skin
2181,Premalignant Lesion,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
2182,Benign Cellular Infiltrate,BCLC Stage D Hepatocellular Carcinoma
2183,Infiltrative Growth Pattern,Periosteal fibroma
2184,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of conjunctiva
2185,Mixed Neoplastic Glandular and Squamous Cell Population,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor
2186,Malignant Germinomatous Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
2187,Indolent Clinical Course,Meningeal Leukemia
2188,Cutaneous Involvement,Extracutaneous Mastocytoma
2189,Seminomatous Component Present,Childhood Immature Teratoma
2190,Mixed Neoplastic Glandular and Squamous Cell Population,Polymorphous low grade adenocarcinoma of salivary gland
2191,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Fibrolamellar Carcinoma
2192,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of ampulla of Vater
2193,Seminomatous Component Present,Stage I Immature Testicular Teratoma AJCC v6 and v7
2194,Perineural spread,Parathyroid transitional clear cell adenoma
2195,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage A Hepatocellular Carcinoma
2196,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Clear Cell Hidradenocarcinoma
2197,Follicular Cell Differentiation,Trabecular adenocarcinoma
2198,Intermediate Filaments Present,Angiosarcoma recurrent
2199,Mixed Neoplastic Glandular and Squamous Cell Population,Liver carcinoma
2200,Encapsulated Mass,Cutaneous neurofibroma
2201,Indolent Clinical Course,leiomyosarcoma of liver
2202,Mixed Neoplastic Glandular and Squamous Cell Population,Bartholin Gland Adenomyoma
2203,Indolent Clinical Course,Childhood Central Nervous System Neuroblastoma
2204,Intermediate Filaments Present,Extraskeletal Myxoid Chondrosarcoma
2205,Malignant Germinomatous Cellular Infiltrate,Dermoid cyst of ovary
2206,Dysplasia,Benign Outer Hair Sheath and Infundibulum Neoplasm
2207,Intracytoplasmic Eosinophilic Inclusion,sarcoma of penis
2208,Malignant Germinomatous Cellular Infiltrate,Testicular choriocarcinoma stage II
2209,Giant Mitochondria Present,Somatotroph/Lactotroph Adenoma
2210,Locally Aggressive Lesion,Gardner Fibroma
2211,Mixture of Germ Cell Neoplastic Components Present,Testicular yolk sac tumor stage I
2212,Capsular Invasion,Clear Cell Adrenal Cortical Adenoma
2213,Low Mitotic Activity,Colorectal Neuroendocrine Carcinoma
2214,Mixture of Germ Cell Neoplastic Components Present,Placental Choriocarcinoma
2215,Mixed Neoplastic Glandular and Squamous Cell Population,lipid-rich carcinoma of breast
2216,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar Prostate Mucinous Adenocarcinoma
2217,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Mature Teratoma
2218,Favorable Clinical Outcome,Ductal Eccrine Carcinoma with Spindle Cell Elements
2219,Indolent Clinical Course,Gliomatosis Cerebri Type I
2220,Borderline Lesion,Large cell acanthoma
2221,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Renal Cell Cancer AJCC v7
2222,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hepatocellular Carcinoma AJCC v7
2223,Intermediate Filaments Present,Stage IB Osteosarcoma AJCC v7
2224,Carcinomatous Component Present,cystic mucinous tumor of pancreas with moderate dysplasia
2225,Intracytoplasmic Eosinophilic Inclusion,Proximal-Type Epithelioid Sarcoma
2226,Precise Histogenesis Unknown,Childhood Subependymal Giant Cell Astrocytoma
2227,Indolent Clinical Course,Secondary Chondrosarcoma
2228,Mucoid Stroma Formation,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
2229,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Neoplasms
2230,Intracytoplasmic Eosinophilic Inclusion,Radiation-Related Angiosarcoma
2231,Solid Growth Pattern,Adult Pure Erythroid Leukemia
2232,Intermediate Filaments Present,Intraocular Malignant Peripheral Nerve Sheath Tumor
2233,Local disease,Steroid Lipomatosis
2234,Precise Histogenesis Unknown,Childhood Gliomatosis Cerebri
2235,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Esophageal Adenocarcinoma AJCC v7
2236,Benign Cellular Infiltrate,Stage II Esophageal Adenocarcinoma AJCC v7
2237,Intracytoplasmic Eosinophilic Inclusion,Major Salivary Gland Sarcoma
2238,Metaplasia of Malignant Cells Present,Ampulla of Vater Intestinal-Type Adenocarcinoma
2239,Glandular Differentiation,lymphoepithelial squamous cell carcinoma of salivary gland
2240,Glandular Differentiation,large cell neuroendocrine carcinoma of thymus
2241,Indolent Clinical Course,Glioblastoma
2242,Favorable Clinical Outcome,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
2243,Necrotic changes (finding),Childhood Protoplasmic Astrocytoma
2244,Solid Growth Pattern,Recurrent Chronic Lymphoid Leukemia
2245,Desmoplastic Stroma Formation,Classic Type Trichilemmoma
2246,Mixed Epithelial Cell Population,Schneiderian papilloma
2247,Borderline Lesion,"Transitional cell papilloma, inverted"
2248,Benign Cellular Infiltrate,Adenocarcinoma of the gastroesophageal junction
2249,Low Mitotic Activity,Small Intestinal Neuroendocrine Carcinoma
2250,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Keratoacanthoma
2251,Mixed Neoplastic Glandular and Squamous Cell Population,signet ring cell carcinoma of pancreas
2252,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous cystadenoma of ovary
2253,Solid Growth Pattern,ROSE Cluster 3
2254,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Squamous Cell Carcinoma
2255,Mixed Neoplastic Glandular and Squamous Cell Population,Nonencapsulated sclerosing tumor
2256,Favorable Clinical Outcome,Stage II Cutaneous Melanoma AJCC v6 and v7
2257,Metastatic Lesion,Functioning Pituitary Gland Macroadenoma
2258,Intermediate Filaments Present,Recurrent Bone Ewing Sarcoma
2259,Benign Cellular Infiltrate,Stage IV Colon Carcinoma
2260,Neuroectodermal Differentiation,Localized Bone Ewing Sarcoma
2261,Intracytoplasmic Eosinophilic Inclusion,Poorly Differentiated Angiosarcoma
2262,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Esophageal Squamous Intraepithelial Neoplasia
2263,Mixed Neoplastic Glandular and Squamous Cell Population,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
2264,Malignant Germinomatous Cellular Infiltrate,benign mature teratoma of pancreas
2265,Benign Cellular Infiltrate,Rectosigmoid cancer
2266,Indolent Clinical Course,Sarcoma NCI Grade 3
2267,Microvascular Proliferation,Mixed Oligodendroglioma-Astrocytoma
2268,Intermediate Filaments Present,Uterine Corpus High Grade Endometrial Stromal Sarcoma
2269,Borderline Lesion,Adenoma of the nipple
2270,Metastatic Lesion,Hard Palate Monomorphic Adenoma
2271,Metastatic Lesion,Benign neoplasm of pituitary gland
2272,Low Grade Lesion,Hemangiosarcoma
2273,Ineffective hematopoiesis,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
2274,Premalignant Lesion,BALT lymphoma
2275,Premalignant Lesion,Occult Lung Carcinoma
2276,Benign Cellular Infiltrate,carcinosarcoma of liver
2277,Borderline Lesion,Renal Pelvis Urothelial Papilloma
2278,Composite Lesion,Encapsulated Thymoma
2279,Benign Cellular Infiltrate,Stage IVA Appendix Carcinoma AJCC v7
2280,Benign Cellular Infiltrate,Small Cell Undifferentiated Hepatoblastoma
2281,Pushing Tumor Margin,Vaginal Papillary Carcinoma
2282,Squamous Differentiation,large cell neuroendocrine carcinoma of anal canal
2283,Favorable Clinical Outcome,Well Differentiated Hepatocellular Carcinoma
2284,Intracytoplasmic Eosinophilic Inclusion,Skin Lymphangiosarcoma
2285,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of vagina
2286,Metastatic Lesion,Salivary Gland Pleomorphic Adenoma
2287,Benign Cellular Infiltrate,Recurrent Digestive System Carcinoma
2288,Indolent Clinical Course,Extraskeletal Osteosarcoma
2289,Indolent Clinical Course,Adult Anaplastic Oligodendroglioma
2290,Chronic Clinical Course,Acute Myeloid Leukemia with FLT3/ITD Mutation
2291,Chronic Clinical Course,Aleukemic Acute Lymphoblastic Leukemia
2292,Invasive Lesion,Vaginal intraepithelial neoplasia grade 2
2293,Mucoid Stroma Formation,Cervical Squamotransitional Carcinoma
2294,High Mitotic Activity,Gastric Gastrin-Producing Neuroendocrine Tumor
2295,Borderline Lesion,Childhood Epithelioid Hemangioendothelioma
2296,CD30-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
2297,Indolent Clinical Course,High grade surface osteosarcoma
2298,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
2299,Intermediate Filaments Present,leiomyosarcoma of fallopian tube
2300,Mixed Neoplastic Glandular and Squamous Cell Population,Breast Carcinoma with Osteoclastic Giant Cells
2301,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Hepatocellular Carcinoma
2302,Microvascular Proliferation,Diffuse Astrocytoma
2303,Solid Growth Pattern,Hairy Cell Leukemia
2304,Intermediate Filaments Present,sarcoma of spinal cord
2305,Diffuse Lesion,Childhood Choroid Plexus Papilloma
2306,Low Mitotic Activity,Colon Small Cell Neuroendocrine Carcinoma
2307,Precise Histogenesis Unknown,Hypothalamic Gangliocytoma
2308,Intermediate Filaments Present,Rhabdomyosarcoma with ganglionic differentiation
2309,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
2310,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Placental polyp
2311,Well-Circumscribed Lesion,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
2312,Ineffective hematopoiesis,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
2313,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Colorectal Adenocarcinoma
2314,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated spindle cell sarcoma
2315,Squamous Differentiation,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
2316,Intermediate Filaments Present,Vulvar Proximal-Type Epithelioid Sarcoma
2317,Intracytoplasmic Eosinophilic Inclusion,Bone Surface (Peripheral) Osteosarcoma
2318,Indolent Clinical Course,Kadish Stage C Olfactory Neuroblastoma
2319,Solid Growth Pattern,Philadelphia chromosome negative chronic myelogenous leukemia
2320,Seminomatous Component Present,Pineal Region Immature Teratoma
2321,Cystic Change,Pancreatic Solid Serous Adenoma
2322,Intracytoplasmic Eosinophilic Inclusion,Lymphadenopathic Kaposi Sarcoma
2323,Nuclear Pseudoinclusion,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
2324,Indolent Clinical Course,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
2325,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
2326,Glandular Differentiation,Oropharyngeal lymphoepithelioma stage I
2327,Benign Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v6
2328,Nuclear Palisading,Papillary craniopharyngioma
2329,Intermediate Filaments Present,leiomyosarcoma
2330,Aggressive Clinical Course,Mycosis fungoides stage II
2331,Seminomatous Component Present,Testicular yolk sac tumor stage III
2332,Indolent Clinical Course,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
2333,Benign Cellular Infiltrate,Primary Intestinal Follicular Lymphoma
2334,Intermediate Filaments Present,fibrosarcoma of small intestine
2335,Indolent Clinical Course,fibrosarcoma of small intestine
2336,Glandular Differentiation,Stage IB Lung Large Cell Carcinoma AJCC v7
2337,Premalignant Lesion,Stage IB Lung Large Cell Carcinoma AJCC v7
2338,Histiocytosis,Centroblastic lymphoma recurrent
2339,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Endometrioid Adenocarcinoma
2340,Indolent Clinical Course,Recurrent Malignant Peripheral Nerve Sheath Tumor
2341,Intracytoplasmic Eosinophilic Inclusion,sarcoma of lung
2342,Intracytoplasmic Eosinophilic Inclusion,Alveolar Soft Part Sarcoma
2343,Invasive Lesion,Carcinoma in situ of fallopian tube
2344,Mixed Neoplastic Glandular and Squamous Cell Population,atypical medullary carcinoma of breast
2345,Favorable Clinical Outcome,basal cell carcinoma of scrotum
2346,Indolent Clinical Course,"Undifferentiated Sarcoma, Not Otherwise Specified"
2347,Mucoid Stroma Formation,papillary squamous cell carcinoma of larynx
2348,Mucoid Stroma Formation,Juvenile papillomatosis of breast
2349,Favorable Clinical Outcome,Eccrine porocarcinoma
2350,Mucoid Stroma Formation,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
2351,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Acinar Cell Neoplasm
2352,Benign Cellular Infiltrate,Stage I Adult Liver Cancer AJCC v7
2353,Mixed Neoplastic Glandular and Squamous Cell Population,solid type ductal carcinoma in situ of breast
2354,Vascular proliferation,Cellular fibroma
2355,Indolent Clinical Course,Skull Base Chordoma
2356,Benign Cellular Infiltrate,Hepatitis Virus-Related Hepatocellular Carcinoma
2357,Indolent Clinical Course,Stage IIA Bone Sarcoma AJCC v7
2358,Mucoid Stroma Formation,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
2359,Dysplasia,Desmoplastic trichoepithelioma
2360,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Pure Erythroid Leukemia
2361,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary carcinoma of the breast
2362,Benign Cellular Infiltrate,Hepatitis C Virus-Related Hepatocellular Carcinoma
2363,Precise Histogenesis Unknown,Childhood Myxopapillary Ependymoma
2364,Invasive Lesion,Benign neoplasm of sweat gland
2365,Borderline Lesion,Benign neoplasm of sweat gland
2366,Solid Growth Pattern,Infant Acute Undifferentiated Leukemia
2367,Favorable Clinical Outcome,Intrahepatic cholangiocarcinoma recurrent
2368,Indolent Clinical Course,Stage IB Soft Tissue Sarcoma AJCC v7
2369,Chronic Clinical Course,Pure Erythroid Leukemia
2370,Metaplasia of Malignant Cells Present,Bladder Urachal Squamous Cell Carcinoma
2371,Mucoid Stroma Formation,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
2372,Intestinal metaplasia,Hereditary Diffuse Gastric Adenocarcinoma
2373,Benign Cellular Infiltrate,Gastric Cardia Adenocarcinoma
2374,Diffuse Lesion,Respiratory papilloma
2375,Absence of a Hormonal Syndrome,Pancreatic ACTH-Producing Neuroendocrine Tumor
2376,Diffuse Lesion,Serous surface papilloma
2377,Solid Growth Pattern,Adult Acute Myeloid Leukemia with Minimal Differentiation
2378,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Villous Adenoma
2379,Invasive Lesion,Benign neoplasm of sebaceous gland
2380,Benign Cellular Infiltrate,Metastatic Carcinoma in the Liver
2381,Benign Cellular Infiltrate,Rectal Micropapillary Adenocarcinoma
2382,Diffuse Lesion,Central Breast Papilloma
2383,Nuclear Grooves,minimally invasive follicular carcinoma of the thyroid gland
2384,Metastatic Lesion,Benign neoplasm of minor salivary gland
2385,Infiltrative Growth Pattern,Perifollicular fibroma
2386,Intermediate Grade Lesion,Grade I Chondrosarcoma
2387,Intracytoplasmic Eosinophilic Inclusion,CIC-DUX Sarcoma
2388,Borderline Lesion,Sporadic Cylindroma
2389,Precise Histogenesis Unknown,Childhood Cerebral Astrocytoma
2390,Fibrovascular Septa Present,Solid Alveolar Rhabdomyosarcoma
2391,Mitotic Activity,Osteochondromatosis
2392,Benign Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma
2393,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Cancer by AJCC v7 Stage
2394,Favorable Clinical Outcome,Skin Sarcomatoid Basal Cell Carcinoma
2395,Glandular Differentiation,Undifferentiated carcinoma of stomach
2396,Precise Histogenesis Unknown,Adult Myxopapillary Ependymoma
2397,Premalignant Lesion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
2398,Chronic Clinical Course,Adult Acute Basophilic Leukemia
2399,Favorable Clinical Outcome,Cutaneous B Lymphoblastic Leukemia/Lymphoma
2400,Chronic Clinical Course,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
2401,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Erythroleukemia (Erythroid/Myeloid)
2402,Prominent Schwannian Stroma Present,Disseminated neuroblastoma
2403,Mucoid Stroma Formation,Noninfiltrating intraductal papillary adenocarcinoma
2404,High Mitotic Activity,Appendix Leiomyoma
2405,Intracytoplasmic Eosinophilic Inclusion,Primary chondrosarcoma of bone
2406,Indolent Clinical Course,fibrosarcoma of breast
2407,Mixed Neoplastic Glandular and Squamous Cell Population,Frontal Sinus Inverted Papilloma
2408,CD30-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
2409,Solid Growth Pattern,recurrent adult acute myeloid leukemia
2410,Dysplasia,Hyperplastic Polyp
2411,Premalignant Lesion,Lung Carcinoma Metastatic in the Liver
2412,Intracytoplasmic Eosinophilic Inclusion,Hemangiosarcoma
2413,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Serous Adenofibroma
2414,Benign Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v7
2415,atypia morphology,Juxta-Articular Myxoma
2416,Intracytoplasmic Eosinophilic Inclusion,Pleural Monophasic Synovial Sarcoma
2417,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7
2418,Dentin formation,Ameloblastic fibroma
2419,Benign Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v7
2420,No Evidence of Metastatic Disease,Metastasizing Chondroblastoma
2421,Intermediate Filaments Present,Childhood Osteosarcoma
2422,Intracytoplasmic Eosinophilic Inclusion,Adult Synovial Sarcoma
2423,Blasts Expressing CD56 and Immature T-Cell Markers Present,Mixed phenotype acute leukemia T/myeloid
2424,Mucoid Stroma Formation,Papilloma
2425,Intermediate Filaments Present,Alveolar rhabdomyosarcoma
2426,Borderline Lesion,Benign Ovarian Neoplasm
2427,Favorable Clinical Outcome,Cutaneous Mantle Cell Lymphoma
2428,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,clear cell adenocarcinofibroma of ovary
2429,Infiltrative Growth Pattern,Extrahepatic Bile Duct Fibroma
2430,Infiltrative Growth Pattern,Desmoplastic fibroma
2431,Nuclear Clearing,Clear Cell Variant Thyroid Gland Follicular Carcinoma
2432,Squamous Differentiation,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
2433,Benign Cellular Infiltrate,Stage IIA Esophageal Adenocarcinoma AJCC v7
2434,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
2435,Malignant Germinomatous Cellular Infiltrate,Vaginal Yolk Sac Tumor
2436,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal squamous cell carcinoma stage II
2437,Benign Cellular Infiltrate,Pancreatic carcinoma resectable
2438,Nuclear pleomorphism,Giant Cell Tumor of Soft Tissue
2439,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Erythroid Leukemia
2440,Precise Histogenesis Unknown,"Glioblastoma, IDH-Wildtype"
2441,Benign Cellular Infiltrate,"Gallbladder Adenocarcinoma, Biliary Type"
2442,Benign Cellular Infiltrate,Colon Intramucosal Adenocarcinoma
2443,Benign Cellular Infiltrate,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
2444,Infiltrative Growth Pattern,Fibroma of tendon sheath
2445,Mucoid Stroma Formation,Inverting papilloma of the nasal cavity
2446,Secondary Lesion,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
2447,Aggressive Clinical Course,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
2448,Mixed Neoplastic Glandular and Squamous Cell Population,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
2449,Locally Aggressive Lesion,Calcifying Fibrous Pseudotumor
2450,Squamous Differentiation,Vulvar Large Cell Neuroendocrine Carcinoma
2451,Indolent Clinical Course,Stage II Soft Tissue Sarcoma AJCC v7
2452,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Mucinous Tumor
2453,Benign Cellular Infiltrate,Recurrent Liver Carcinoma
2454,Odontogenic Cysts,Primary solid type intraosseous squamous cell carcinoma
2455,Keratin pearl formation,Nasopharyngeal Differentiated Carcinoma
2456,Endophytic Tumor Growth,Condylomata Acuminata
2457,Benign Cellular Infiltrate,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
2458,Invasive Lesion,Lymphangioma of skin
2459,Indolent Clinical Course,Stage I Bone Cancer AJCC v7
2460,Benign Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma
2461,Squamous Differentiation,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
2462,Malignant Germinomatous Cellular Infiltrate,Monodermal Testicular Teratoma
2463,Mixture of Germ Cell Neoplastic Components Present,Central Nervous System Choriocarcinoma
2464,Benign Cellular Infiltrate,leiomyosarcoma of liver
2465,Histiocytosis,Centroblastic lymphoma refractory
2466,Malignant Germinomatous Cellular Infiltrate,yolk sac tumor of mediastinum
2467,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Clear Cell Cystadenofibroma
2468,Indolent Clinical Course,High Grade Astrocytic Tumor
2469,Mixed Neoplastic Glandular and Squamous Cell Population,Glottic Squamous Cell Carcinoma
2470,Mixture of Germ Cell Neoplastic Components Present,Good Prognosis Metastatic Gestational Trophoblastic Tumor
2471,Borderline Lesion,"Adenoma, Sweat Gland"
2472,Indolent Clinical Course,Anaplastic (Malignant) Intraspinal Meningioma
2473,Benign Cellular Infiltrate,Stage I Rectosigmoid Cancer AJCC v6 and v7
2474,Dysplasia,Eccrine hidrocystoma
2475,Invasive Lesion,Salivary Gland Sebaceous Lymphadenoma
2476,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Adenofibroma
2477,Malignant Germinomatous Cellular Infiltrate,Testicular yolk sac tumor stage III
2478,Indolent Clinical Course,Rhabdomyosarcoma
2479,Favorable Clinical Outcome,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
2480,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with Neuroblastoma
2481,Benign Cellular Infiltrate,Colon Sarcoma
2482,Benign Cellular Infiltrate,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
2483,Mucoid Stroma Formation,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
2484,Intracytoplasmic Eosinophilic Inclusion,Metastatic Malignant Peripheral Nerve Sheath Tumor
2485,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic signet ring cell carcinoma
2486,Intermediate Filaments Present,Undifferentiated Epithelioid Sarcoma
2487,Chronic Clinical Course,Acute Lymphoblastic Leukemia by Gene Expression Profile
2488,Mucoid Stroma Formation,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia
2489,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
2490,Benign Cellular Infiltrate,Hepatoblastoma with Pure Fetal Epithelial Differentiation
2491,Nuclear Grooves,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
2492,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Mucinous Tumor
2493,Diffuse Lesion,Oncocytic Schneiderian papilloma
2494,Ineffective hematopoiesis,Overt Primary Myelofibrosis
2495,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Hepatocellular Carcinoma AJCC v6
2496,Mature Neutrophils Present,Blastic Granulocytic Sarcoma
2497,Borderline Lesion,Urethral Urothelial Papilloma
2498,Indolent Clinical Course,Stage IA Osteosarcoma AJCC v7
2499,Neuroendocrine Differentiation,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
2500,Intracytoplasmic Eosinophilic Inclusion,Meningeal sarcomatosis
2501,High Mitotic Activity,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
2502,Mucoid Stroma Formation,Inverting papilloma of the paranasal sinus
2503,Favorable Clinical Outcome,Carcinoma in situ of skin
2504,Intermediate Filaments Present,Kidney Extraskeletal Osteosarcoma
2505,Mucoid Stroma Formation,verrucous carcinoma of vulva
2506,Benign Cellular Infiltrate,Hodgkin's lymphoma of small intestine
2507,Papillary Pattern,Gallbladder Flat Biliary Intraepithelial Neoplasia
2508,Indolent Clinical Course,Stage III Bone Sarcoma AJCC v7
2509,Seminomatous Component Present,Malignant Testicular Non-Seminomatous Germ Cell Tumor
2510,Necrotic changes (finding),Lung Typical Carcinoid Tumor
2511,Mucoid Stroma Formation,Papillary Epithelial Neoplasm
2512,Mixed Neoplastic Glandular and Squamous Cell Population,Serous papillary cystic tumor of borderline malignancy
2513,Tubular Pattern,Villous adenoma of colon
2514,Indolent Clinical Course,Adult Alveolar Soft Part Sarcoma
2515,Indolent Clinical Course,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
2516,Mucoid Stroma Formation,Lung Mixed Squamous Cell and Glandular Papilloma
2517,Endobronchial Lesion,Lung Mucinous Cystadenoma
2518,Borderline Lesion,Seborrheic keratosis of eyelid
2519,Benign Cellular Infiltrate,Ampulla of Vater Mucinous Adenocarcinoma
2520,Mixed Neoplastic Glandular and Squamous Cell Population,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
2521,Mass in breast,Lobular Neoplasia Type B
2522,Solid Growth Pattern,"Myeloid Leukemia, Chronic"
2523,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
2524,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Aggressive Systemic Mastocytosis
2525,Solid Growth Pattern,Childhood Acute Basophilic Leukemia
2526,Benign Cellular Infiltrate,Grade 1 Rectal Adenocarcinoma
2527,Chronic Clinical Course,Adult Acute Myeloid Leukemia with Minimal Differentiation
2528,Solid Growth Pattern,Treatment related leukaemia
2529,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of anal canal
2530,Invasive Lesion,Benign neoplasm of adnexa of skin
2531,Severe cytologic atypia,Small Intestinal Neuroendocrine Tumor G2
2532,Benign Cellular Infiltrate,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
2533,Benign Cellular Infiltrate,Adenocarcinoma of colon
2534,Invasive Lesion,Stage 0 Renal Pelvis Cancer AJCC v7
2535,Mixed Neoplastic Glandular and Squamous Cell Population,"Bronchiolo-alveolar carcinoma, non-mucinous"
2536,Squamous Differentiation,Esophageal Large Cell Neuroendocrine Carcinoma
2537,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma stage IV
2538,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in situ in villous adenoma
2539,Blasts of Mixed Phenotype Present,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
2540,Intermediate Filaments Present,Grade III Chondrosarcoma
2541,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Mullerian Papilloma
2542,Mixed Neoplastic Glandular and Squamous Cell Population,clear cell adenocarcinoma of bladder
2543,Invasive Lesion,Esophageal High Grade Intraepithelial Neoplasia
2544,Seminomatous Component Present,Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma
2545,Benign Cellular Infiltrate,Colorectal Cribriform Comedo-Type Adenocarcinoma
2546,Malignant Cellular Infiltrate,Pre-Malignant Skin Epithelial Lesion
2547,Squamous Differentiation,Combined Lung Large Cell Neuroendocrine Carcinoma
2548,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Juvenile fibroadenoma of breast
2549,Mixed Epithelial Cell Population,Maxillary Sinus Inverted Papilloma
2550,Indolent Clinical Course,"Synovial sarcoma, spindle cell"
2551,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of oral cavity
2552,Mixed Neoplastic Glandular and Squamous Cell Population,Early Invasive Cervical Adenocarcinoma
2553,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of skin
2554,Grade 4 Lesion,Recurrent Childhood Pilomyxoid Astrocytoma
2555,Precise Histogenesis Unknown,Supratentorial Glioblastoma
2556,Mixed Neoplastic Glandular and Squamous Cell Population,TSH-Producing Pituitary Gland Carcinoma
2557,Intermediate Filaments Present,Myxoid chondrosarcoma
2558,Grade 4 Lesion,Anaplastic Brain Stem Astrocytoma
2559,Favorable Clinical Outcome,Aleukemic Monocytic Leukemia Cutis
2560,Benign Cellular Infiltrate,Adenocarcinoma of duodenum
2561,Benign Cellular Infiltrate,Undifferentiated Carcinoma of Colon
2562,Mixture of Germ Cell Neoplastic Components Present,Stage III Gestational Trophoblastic Tumor AJCC v7
2563,Seminomatous Component Present,Ovarian Dermoid Cyst with Angiosarcoma
2564,Indolent Clinical Course,Soft Tissue Angiosarcoma
2565,Metastatic Lesion,Prolactinoma
2566,Tubular Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
2567,Premalignant Lesion,Stage IIB Lung Cancer AJCC v7
2568,Low Mitotic Activity,Primary hepatic neuroendocrine carcinoma
2569,Prominent Schwannian Stroma Present,Stage 1 Neuroblastoma
2570,Premalignant Lesion,Combined Lung Small Cell and Squamous Cell Carcinoma
2571,Mucoid Stroma Formation,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
2572,Intracytoplasmic Eosinophilic Inclusion,Intraosseous well differentiated osteosarcoma
2573,Intermediate Filaments Present,Fibrosarcoma
2574,Diffuse Lesion,Papilloma
2575,Mixed Neoplastic Glandular and Squamous Cell Population,Crohn Disease-Associated Colorectal Adenocarcinoma
2576,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of buccal mucosa
2577,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma stage IV
2578,Intracytoplasmic Eosinophilic Inclusion,Cardiac Synovial Sarcoma
2579,Well-Circumscribed Lesion,Embryonal Rhabdomyosarcoma
2580,Grade 4 Lesion,Astrocytoma of brain stem
2581,Precise Histogenesis Unknown,Childhood Brain Stem Astrocytoma
2582,Intracytoplasmic Eosinophilic Inclusion,Prostate Leiomyosarcoma
2583,Aggressive Clinical Course,Stage III Indolent Adult Non-Hodgkin Lymphoma
2584,Premalignant Lesion,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
2585,Solid Growth Pattern,Adult Acute Monocytic Leukemia
2586,Intracytoplasmic Eosinophilic Inclusion,Duodenal Extraskeletal Osteosarcoma
2587,Mixed Neoplastic Glandular and Squamous Cell Population,Vestibular Papilloma
2588,Indolent Clinical Course,Recurrent Medulloblastoma
2589,Aggressive Clinical Course,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
2590,Intestinal metaplasia,Colorectal Signet Ring Cell Carcinoma
2591,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Embryonal Carcinoma
2592,Solid Growth Pattern,Childhood Acute Monocytic Leukemia
2593,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Serous Adenocarcinoma
2594,Extensive Necrosis,Brain Oligodendroglioma
2595,Chronic Clinical Course,Burkitt Leukemia
2596,Carcinomatous Component Present,Cellular Pleomorphic Adenoma
2597,Indolent Clinical Course,Giant Cell Glioblastoma
2598,Solid Growth Pattern,Hairy cell leukemia variant
2599,Metastatic Lesion,Gonadotroph adenoma
2600,Favorable Clinical Outcome,Squamous cell carcinoma of scrotum
2601,Mucoid Stroma Formation,Childhood Choroid Plexus Papilloma
2602,Diffuse Lesion,Cavernous hemangioma of the face
2603,Borderline Lesion,Vestibular Micropapillomatosis
2604,Indolent Clinical Course,lymphoma of spinal cord
2605,Precise Histogenesis Unknown,Adult Brain Stem Mixed Glioma
2606,Squamous Differentiation,Nasopharyngeal lymphoepithelioma recurrent
2607,Invasive Lesion,Vulvar Papillary Hidradenoma
2608,Benign Cellular Infiltrate,Adult Pleomorphic Hepatocellular Carcinoma
2609,Locally Aggressive Lesion,Nuchal-type fibroma
2610,Seminomatous Component Present,Childhood Central Nervous System Immature Teratoma
2611,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
2612,Benign Cellular Infiltrate,Adenocarcinoma of appendix
2613,Solid Growth Pattern,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL
2614,Benign Cellular Infiltrate,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
2615,Indolent Clinical Course,"Malignant Mixed Tumor, Not Otherwise Specified"
2616,Solid Growth Pattern,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
2617,High Mitotic Activity,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
2618,Dysplasia,Common wart
2619,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Serous Adenocarcinoma
2620,Favorable Clinical Outcome,Vulvar Sebaceous Carcinoma
2621,Papillary Pattern,Poorly Differentiated Thyroid Carcinoma
2622,Invasive Lesion,Clear cell hidradenoma
2623,Superficial Lesion,Deep histiocytoma
2624,Mixed Neoplastic Glandular and Squamous Cell Population,HPV positive oropharyngeal squamous cell carcinoma
2625,Mucoid Stroma Formation,Urethral Verrucous Carcinoma
2626,Premalignant Lesion,sarcoma of trachea
2627,Grade 4 Lesion,Anaplastic Diencephalic Astrocytoma
2628,Intermediate Filaments Present,Gallbladder Rhabdomyosarcoma
2629,Mitotic Activity,Benign Mediastinal Germ Cell Tumor
2630,Moderate dysplasia,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
2631,Indolent Clinical Course,Childhood Meningeal Melanoma
2632,Mixed Neoplastic Glandular and Squamous Cell Population,Preinvasive Neoplasm of the Ampullary Region
2633,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
2634,Benign Cellular Infiltrate,sarcoma of anus
2635,Benign Cellular Infiltrate,Liver Fibrosarcoma
2636,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Clear Cell Adenocarcinoma
2637,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Clear Cell Adenocarcinoma
2638,Glandular Differentiation,Undifferentiated Fallopian Tube Carcinoma
2639,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
2640,Dysplasia,Fibrofolliculoma
2641,Favorable Clinical Outcome,"Carcinoma, Basosquamous"
2642,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,High Grade Broad Ligament Serous Adenocarcinoma
2643,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma ex Eccrine Spiradenoma
2644,Intermediate Filaments Present,Pancreatic sarcoma
2645,Intermediate Filaments Present,leiomyosarcoma of ovary
2646,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
2647,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Bone Sarcoma AJCC v7
2648,Mixed Neoplastic Glandular and Squamous Cell Population,Supraglottic Squamous Cell Carcinoma
2649,Seminomatous Component Present,Mediastinal teratoma
2650,Intermediate Filaments Present,Radiation-Related Sarcoma
2651,Acute Clinical Course,Splenic Manifestation of Chronic Lymphocytic Leukemia
2652,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
2653,Solid Growth Pattern,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
2654,Favorable Clinical Outcome,Stage II Adult Liver Cancer AJCC v7
2655,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
2656,Cellular Pleomorphism,Prostate Stromal Proliferation of Uncertain Malignant Potential
2657,Invasive Lesion,Pancreatic Intraepithelial Neoplasia-1B
2658,Intracytoplasmic Eosinophilic Inclusion,Vaginal Undifferentiated Sarcoma
2659,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of appendix
2660,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Differentiated Prostate Adenocarcinoma
2661,Intracytoplasmic Eosinophilic Inclusion,Stage III Bone Sarcoma AJCC v7
2662,Benign Cellular Infiltrate,Pancreatic carcinoma recurrent
2663,Precise Histogenesis Unknown,Childhood Diffuse Astrocytoma
2664,Invasive Lesion,Acantholytic acanthoma
2665,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Choriocarcinoma
2666,Indolent Clinical Course,Adult Central Nervous System Choriocarcinoma
2667,"Undifferentiated ""Fetal-Type"" Tissues Present",Dermoid Cyst
2668,Solid Growth Pattern,recurrent childhood acute myeloid leukemia
2669,Mixed Epithelial Cell Population,Lung Glandular Papilloma
2670,Mucoid Stroma Formation,"Papillary mucinous cystadenoma, borderline malignancy"
2671,Mucoid Stroma Formation,Squamous cell papilloma of eyelid
2672,Diffuse Lesion,Squamous cell papilloma of eyelid
2673,Indolent Clinical Course,Stage III Bone Cancer AJCC v7
2674,Indolent Clinical Course,Stage IA Soft Tissue Sarcoma AJCC v7
2675,Intermediate Filaments Present,leiomyosarcoma of rectum
2676,Metastatic Lesion,Parotid Gland Sebaceous Lymphadenoma
2677,Chronic Clinical Course,ROSE Cluster 6
2678,Borderline Lesion,Vaginal Mullerian Papilloma
2679,Mixed Neoplastic Glandular and Squamous Cell Population,Serous surface papillary carcinoma
2680,Severe cytologic atypia,Glucagonoma
2681,Benign Cellular Infiltrate,Anaplastic Carcinoma of the Rectum
2682,Benign Cellular Infiltrate,Intestinal Neuroendocrine Carcinoma
2683,Indolent Clinical Course,Childhood Brain Stem Gliosarcoma
2684,Intracytoplasmic Eosinophilic Inclusion,FNCLCC Sarcoma Grade 2
2685,Solid Growth Pattern,ROSE Cluster 1
2686,Invasive Lesion,Eccrine mixed tumor of skin
2687,Favorable Clinical Outcome,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
2688,Acute Clinical Course,Chronic lymphocytic leukemia stage 2
2689,Increased Cellularity Present,Solitary Osteochondroma
2690,Mucoid Stroma Formation,Endolymphatic sac tumor
2691,Malignant Germinomatous Cellular Infiltrate,Testicular choriocarcinoma stage I
2692,Favorable Clinical Outcome,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
2693,Low Mitotic Activity,small cell carcinoma of extrahepatic bile duct
2694,Indolent Clinical Course,liposarcoma of mediastinum
2695,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
2696,Intracytoplasmic Eosinophilic Inclusion,Secondary Peripheral Chondrosarcoma
2697,Indolent Clinical Course,Secondary Peripheral Chondrosarcoma
2698,Intermediate Filaments Present,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
2699,Intracytoplasmic Eosinophilic Inclusion,Adult Fibrosarcoma
2700,Solid Growth Pattern,Adult Acute Basophilic Leukemia
2701,Low Grade Lesion,Angiosarcoma NCI Grade 3
2702,Local disease,Lymphangioleiomyomatosis
2703,Glandular Differentiation,Large cell lung cancer stage III
2704,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemias
2705,Solid Growth Pattern,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
2706,Mixed Neoplastic Glandular and Squamous Cell Population,Rectal Serrated Adenocarcinoma
2707,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Basaloid Squamous Cell Carcinoma
2708,Mucoid Stroma Formation,Ureter Inverted Papilloma
2709,Multilayered Rosette Formation,Large cell medulloblastoma
2710,Intracytoplasmic Eosinophilic Inclusion,"Synovial sarcoma, epithelioid cell"
2711,Presence of a Hormonal Syndrome,Pancreatic Neuroendocrine Microadenoma
2712,Benign Cellular Infiltrate,Gastric Hodgkin's Lymphoma
2713,Mixed Neoplastic Glandular and Squamous Cell Population,Dysplasia of anus
2714,Precise Histogenesis Unknown,Cerebellar Astrocytoma
2715,Invasive Lesion,Stage 0 Vaginal Cancer AJCC v7
2716,Mixed Cellular Population,Anal Canal Squamous Papilloma
2717,Indolent Clinical Course,"Sarcoma, Spindle Cell"
2718,Benign Cellular Infiltrate,Non-hodgkin lymphoma of colon
2719,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Peritoneal Low Grade Serous Adenocarcinoma
2720,Benign Cellular Infiltrate,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
2721,Pericanalicular Growth Pattern,Intracanalicular fibroadenoma
2722,Dysplasia,Benign Cutaneous Fibroblastic Neoplasm
2723,Intracytoplasmic Eosinophilic Inclusion,Colorectal Sarcoma
2724,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Giant fibroadenoma of breast
2725,Benign Cellular Infiltrate,Colorectal Leiomyosarcoma
2726,Intracytoplasmic Eosinophilic Inclusion,Malignant Giant Cell Tumor of Bone
2727,Chronic Clinical Course,Aleukemic Acute Lymphoblastic Leukemia Cutis
2728,Nuclear pleomorphism,Classical Low Grade Fibromyxoid Sarcoma
2729,Indolent Clinical Course,Low-grade fibromyxoid sarcoma
2730,Intracytoplasmic Eosinophilic Inclusion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
2731,Favorable Clinical Outcome,carcinosarcoma of liver
2732,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with apocrine metaplasia
2733,Mixed Neoplastic Glandular and Squamous Cell Population,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia
2734,Mucoid Stroma Formation,Papillary renal cell carcinoma type 2
2735,Favorable Clinical Outcome,Primary Cutaneous Plasmablastic Lymphoma
2736,Mixed Neoplastic Glandular and Squamous Cell Population,Anal squamous cell carcinoma
2737,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, Granular Cell"
2738,Indolent Clinical Course,Diffuse large B-cell lymphoma of central nervous system
2739,Mixed Neoplastic Glandular and Squamous Cell Population,Sweat Gland Tubular Carcinoma
2740,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Intraepithelial Neoplasia 1
2741,Low Mitotic Activity,Small Intestinal Small Cell Neuroendocrine Carcinoma
2742,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of floor of mouth
2743,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Clear Cell Cystadenocarcinoma
2744,Intracytoplasmic Eosinophilic Inclusion,Cardiac Monophasic Synovial Sarcoma
2745,Intermediate Filaments Present,rhabdomyosarcoma of prostate
2746,Indolent Clinical Course,Glioblastoma by Gene Expression Profile
2747,Intracytoplasmic Eosinophilic Inclusion,Stage IV Adult Soft Tissue Sarcoma AJCC v7
2748,Solid Growth Pattern,Acute myeloid leukemia with recurrent genetic abnormality
2749,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7
2750,Precise Histogenesis Unknown,Classical Glioblastoma
2751,Premalignant Lesion,Lung squamous cell carcinoma stage I
2752,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Teratoma
2753,Mixed Neoplastic Glandular and Squamous Cell Population,"Cervical Mucinous Adenocarcinoma, Gastric Type"
2754,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma stage II
2755,Seminomatous Component Present,Stage II Immature Testicular Teratoma AJCC v6 and v7
2756,Seminomatous Component Present,Stage III Immature Testicular Teratoma AJCC v6 and v7
2757,Solid Growth Pattern,Adult Acute Myeloblastic Leukemia
2758,Localized Lesion,ISS Stage III Plasma Cell Myeloma
2759,Locally Aggressive Lesion,Infantile digital fibromatosis
2760,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Teratoma
2761,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary adenocarcinoma
2762,Glial Differentiation,Pituitary Gland Gangliocytoma
2763,Premalignant Lesion,Superior Sulcus Lung Carcinoma
2764,Localized Lesion,ISS Stage II Plasma Cell Myeloma
2765,Dysplasia,Vulvar Inverted Follicular Keratosis
2766,Precise Histogenesis Unknown,Adult Infiltrating Astrocytoma
2767,Benign Cellular Infiltrate,Clear Cell Intrahepatic Cholangiocarcinoma
2768,Indolent Clinical Course,"Liposarcoma, Dedifferentiated"
2769,Necrotic changes (finding),Recurrent Childhood Anaplastic Astrocytoma
2770,Generalized Dysplasia,Rectal Sessile Serrated Adenoma/Polyp
2771,Favorable Clinical Outcome,Stage IIA Cutaneous Melanoma AJCC v6 and v7
2772,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
2773,Glandular Differentiation,Lymphoepithelial malignant thymoma
2774,Invasive Lesion,High-Grade Prostatic Intraepithelial Neoplasia
2775,Squamous Differentiation,large cell neuroendocrine carcinoma of gallbladder
2776,Low Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder
2777,Prominent Schwannian Stroma Present,Extracranial Neuroblastoma
2778,Metastatic Lesion,Testicular Sclerosing Sertoli Cell Tumor
2779,Favorable Clinical Outcome,Stage IIIB Merkel Cell Carcinoma AJCC v7
2780,Microvascular Proliferation,Anaplastic Hemispheric Astrocytoma
2781,Indolent Clinical Course,Recurrent Kaposi Sarcoma
2782,Benign Cellular Infiltrate,Stage IV Colorectal Cancer
2783,Dysplasia,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
2784,Intracytoplasmic Eosinophilic Inclusion,Pulmonary Artery Angiosarcoma
2785,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Ductal Breast Carcinoma
2786,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the oral cavity stage III
2787,Acute Clinical Course,Chronic Lymphocytic Leukemia
2788,Neuroendocrine Differentiation,Skin Squamous Cell Carcinoma In Situ
2789,Favorable Clinical Outcome,Vulvar Eccrine Porocarcinoma
2790,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Mixed Adenocarcinoma
2791,Intermediate Filaments Present,sarcoma of penis
2792,Tumor Vascular Invasion,Macrofollicular adenoma
2793,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell choriocarcinoma stage I
2794,Aggressive Clinical Course,Marginal Zone B-Cell Lymphoma
2795,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Uterine Sarcoma AJCC v7
2796,Benign Cellular Infiltrate,non-Hodgkin's lymphoma of small intestine
2797,Indolent Clinical Course,Esophageal Leiomyosarcoma
2798,Acute Clinical Course,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia
2799,Indolent Clinical Course,Transplant-Related Hematologic Malignancy
2800,Severe cytologic atypia,Malignant Pancreatic Insulinoma
2801,Low Mitotic Activity,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
2802,Mucoid Stroma Formation,Papillary Renal Cell Carcinoma
2803,Indolent Clinical Course,Glioblastoma
2804,Solid Growth Pattern,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
2805,Intermediate Filaments Present,Stage IVA Osteosarcoma AJCC v7
2806,CD30-Positive Neoplastic Cells Present,Letterer-Siwe Disease
2807,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Squamous Papilloma
2808,Indolent Clinical Course,Recurrent tumors of the Ewing's family
2809,Indolent Clinical Course,Fusion-Positive Rhabdomyosarcoma
2810,Indolent Clinical Course,Ovarian Rhabdomyosarcoma
2811,Neuroendocrine Differentiation,Bowen's Disease
2812,Severe cytologic atypia,Gastrinoma
2813,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Micropapillary Adenocarcinoma
2814,Low Mitotic Activity,Rectal Small Cell Neuroendocrine Carcinoma
2815,Diffuse Lesion,Parotid Gland Hemangioma
2816,Mucoid Stroma Formation,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia
2817,Mucoid Stroma Formation,Urethral Urothelial Papilloma
2818,Diffuse Lesion,Urethral Urothelial Papilloma
2819,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in Situ
2820,High Mitotic Activity,Leiomyoma of small intestine
2821,Infiltrative Growth Pattern,Cellular fibroma
2822,Mixed Neoplastic Glandular and Squamous Cell Population,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
2823,Polymorphic Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
2824,Localized Lesion,Plasma cell myeloma recurrent
2825,Mixed Epithelial Cell Population,Inverting papilloma of the paranasal sinus
2826,Intermediate Filaments Present,Vaginal Undifferentiated Sarcoma
2827,Scattered Collections of Differentiating Neuroblasts Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
2828,Favorable Clinical Outcome,Malignant Proliferating Pilar Tumor
2829,Acute Clinical Course,"Leukemia, Myeloid, Chronic-Phase"
2830,Prominent Schwannian Stroma Present,Neuroblastoma
2831,Intermediate Filaments Present,Major Salivary Gland Sarcoma
2832,Mixed Neoplastic Glandular and Squamous Cell Population,"Papilloma, Squamous Cell"
2833,Intermediate Filaments Present,Childhood Extraskeletal Osteosarcoma
2834,Mucoid Stroma Formation,"Papillary cystadenoma, borderline malignancy"
2835,Mucoid Stroma Formation,Ureter Urothelial Papilloma
2836,Borderline Lesion,"Transitional cell papilloma, benign"
2837,Benign Cellular Infiltrate,PRETEXT Stage 4 Hepatoblastoma
2838,Solid Growth Pattern,Acute Myeloid Leukemia with t(17;17)(q21;q21)
2839,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Mullerian Papilloma
2840,Invasive Lesion,Stage 0a Ureter Cancer AJCC v7
2841,Intracytoplasmic Eosinophilic Inclusion,Adrenal Gland Angiosarcoma
2842,Favorable Clinical Outcome,Primary Cutaneous Follicle Center Lymphoma
2843,Benign Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7
2844,Solid Growth Pattern,Acute Undifferentiated Leukemia
2845,Mixed Neoplastic Glandular and Squamous Cell Population,Intermediate Grade Ductal Breast Carcinoma In Situ
2846,Superficial Lesion,"Liposarcoma, well differentiated"
2847,Indolent Clinical Course,Meningothelial sarcoma
2848,Benign Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric
2849,Invasive Lesion,Classical Poroma
2850,Dysplasia,Eccrine mixed tumor of skin
2851,Favorable Clinical Outcome,Localized Resectable Adult Liver Carcinoma
2852,Anaplasia,Childhood Ependymoma
2853,Benign Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma
2854,Diffuse Lesion,Paranasal Sinus Schneiderian Papilloma
2855,Intermediate Filaments Present,Sarcoma by FNCLCC Grade
2856,Diffuse Lesion,Frontal Sinus Schneiderian Papilloma
2857,Mucoid Stroma Formation,Frontal Sinus Schneiderian Papilloma
2858,Premalignant Lesion,Adenosquamous cell lung cancer recurrent
2859,Low Mitotic Activity,Recurrent Pancreatic Neuroendocrine Carcinoma
2860,Benign Cellular Infiltrate,basaloid carcinoma of anus
2861,Borderline Lesion,"Adenoma, Basal Cell"
2862,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma
2863,Auer Rods Present,Refractory anemias
2864,Favorable Clinical Outcome,Malignant Breast Eccrine Spiradenoma
2865,Indolent Clinical Course,Peritoneal Desmoplastic Small Round Cell Tumor
2866,Benign Cellular Infiltrate,Digestive System Hodgkin Lymphoma
2867,Indolent Clinical Course,Intimal sarcoma
2868,Intermediate Filaments Present,Childhood Epithelioid Sarcoma
2869,Seminomatous Component Present,Ovarian Teratoma
2870,Benign Cellular Infiltrate,Undifferentiated carcinoma of esophagus
2871,Indolent Clinical Course,sarcoma of oral cavity
2872,Dysplasia,Tumor of follicular infundibulum
2873,Indolent Clinical Course,Metastatic Extraskeletal Myxoid Chondrosarcoma
2874,Indolent Clinical Course,Breast Carcinoma Metastatic in the Bone
2875,Anaplasia,Ganglioglioma
2876,Precise Histogenesis Unknown,Childhood Brain Anaplastic Astrocytoma
2877,Intestinal metaplasia of gastric mucosa,Foveolar-Type Adenoma
2878,Indolent Clinical Course,Cerebral Non-Hodgkin Lymphoma
2879,Benign Cellular Infiltrate,Cholangiolocellular Carcinoma
2880,Mucoid Stroma Formation,Verrucous carcinoma of the oral cavity recurrent
2881,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
2882,Mixed Neoplastic Glandular and Squamous Cell Population,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
2883,Favorable Clinical Outcome,Signet Ring Cell Intrahepatic Cholangiocarcinoma
2884,Aggressive Clinical Course,Primary Cutaneous Anaplastic Large Cell Lymphoma
2885,Aggressive Clinical Course,"Bone Cysts, Aneurysmal"
2886,Diffuse Lesion,Papilloma of nasal vestibule
2887,Indolent Clinical Course,Intracranial Germinoma
2888,Benign Cellular Infiltrate,Gastric Cancer by AJCC v7 Stage
2889,Mixed Neoplastic Glandular and Squamous Cell Population,Pituitary carcinoma
2890,Homer Wright Rosette Formation,Ependymoblastoma
2891,Premalignant Lesion,Large cell lung cancer stage IV
2892,Precise Histogenesis Unknown,Anaplastic Ependymoma
2893,Mixture of Germ Cell Neoplastic Components Present,Gestational Ovarian Choriocarcinoma
2894,Tissues Derived from Two or Three Embryonic Layers Present,Benign Struma Ovarii
2895,Borderline Lesion,Benign Ovarian Sex Cord-Stromal Tumor
2896,Invasive Lesion,Hard Palate Pleomorphic Adenoma
2897,Intracytoplasmic Eosinophilic Inclusion,Embryonal Rhabdomyosarcoma
2898,Intracytoplasmic Eosinophilic Inclusion,Adult Leiomyosarcoma
2899,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Clear Cell Tumor
2900,Precise Histogenesis Unknown,Glioblastoma by Gene Expression Profile
2901,Intermediate Filaments Present,"Perineurioma, malignant"
2902,Mixed Neoplastic Glandular and Squamous Cell Population,Adrenocortical carcinoma
2903,Necrotic changes (finding),Cerebellopontine Angle Schwannoma
2904,Precise Histogenesis Unknown,Brain Oligodendroglioma
2905,Intracytoplasmic Eosinophilic Inclusion,"Liposarcoma, Pleomorphic"
2906,Favorable Clinical Outcome,Unresectable Hepatocellular Carcinoma
2907,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder adenocarcinoma
2908,Benign Cellular Infiltrate,Stage III Carcinoma of Stomach
2909,Benign Cellular Infiltrate,Low grade appendiceal mucinous neoplasm
2910,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Clear Cell Adenocarcinoma
2911,Indolent Clinical Course,sarcoma of spinal cord
2912,Composite Lesion,Thymoma Type B
2913,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
2914,Seminomatous Component Present,Testicular embryonal carcinoma stage III
2915,Squamous Differentiation,undifferentiated carcinoma of ureter
2916,Invasive Lesion,Angioma serpiginosum
2917,Dysplasia,Benign Pilar-Associated Mesenchyme Neoplasm
2918,Intermediate Filaments Present,synovial sarcoma
2919,Papillary Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
2920,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
2921,Severe cytologic atypia,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
2922,Mesenchymal Component Present,Parathyroid mixed cell type adenoma
2923,Tumor Vascular Invasion,Parathyroid mixed cell type adenoma
2924,Indolent Clinical Course,Sarcoma NCI Grade 1
2925,Neuroendocrine Differentiation,Stage IVB Basal Cell Lip Carcinoma
2926,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, keratinizing"
2927,Invasive Lesion,High Grade Cervical Intraepithelial Neoplasia
2928,Nuclear Pseudoinclusion,Childhood Thyroid Gland Follicular Carcinoma
2929,Favorable Clinical Outcome,Stage IIC Merkel Cell Carcinoma AJCC v7
2930,Diffuse Lesion,Deep Hemangioma
2931,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Cell Carcinoma In Situ
2932,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
2933,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of ovary
2934,Invasive Lesion,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
2935,Nuclear Atypia,Lipofibromatosis
2936,Metastatic Lesion,Hodgkin's lymphoma of CNS
2937,Severe cytologic atypia,Gallbladder Neuroendocrine Tumor G2
2938,Indolent Clinical Course,undifferentiated sarcoma of soft tissue
2939,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
2940,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
2941,Squamous Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma
2942,Benign Cellular Infiltrate,Localized Extrahepatic Bile Duct Carcinoma
2943,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
2944,Benign Cellular Infiltrate,Stage IIIC Gastric Cancer AJCC v7
2945,Composite Lesion,"Thymoma, type A, malignant"
2946,Intermediate Filaments Present,Recurrent Childhood Soft Tissue Sarcoma
2947,Intracytoplasmic Eosinophilic Inclusion,Fusion-Positive Alveolar Rhabdomyosarcoma
2948,High Mitotic Activity,"Gastrinoma, malignant"
2949,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
2950,Premalignant Lesion,Non-Small Cell Lung Carcinoma
2951,Benign Cellular Infiltrate,Stage IIIA Adult Liver Cancer AJCC v7
2952,Composite Lesion,Thymoma
2953,Mucoid Stroma Formation,Bladder Squamous Papilloma
2954,Invasive Lesion,Senile angioma
2955,Mixed Neoplastic Glandular and Squamous Cell Population,Seminal Vesicle Cystadenoma
2956,Locally Aggressive Lesion,Sternal Chondromyxoid Fibroma
2957,Indolent Clinical Course,Stage IVA Bone Sarcoma AJCC v7
2958,Indolent Clinical Course,Rectal Kaposi Sarcoma
2959,Metastatic Lesion,Primary central nervous system lymphoma
2960,Invasive Lesion,Benign neoplasm of sublingual gland
2961,Invasive Lesion,Subcutaneous Nodular Fasciitis
2962,Tubular Pattern,Pancreatic Intraductal Papillary-Mucinous Adenoma
2963,HMB-45-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
2964,Solid Growth Pattern,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
2965,atypia morphology,Peritoneal Well Differentiated Papillary Mesothelioma
2966,Polymorphic Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
2967,HMB-45-Positive Neoplastic Cells Present,Histiocytic and Dendritic Cell Neoplasm
2968,Necrotic changes (finding),Childhood Gemistocytic Astrocytoma
2969,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Villous Adenoma
2970,Mixed Neoplastic Glandular and Squamous Cell Population,ENSAT Stage III Adrenal Cortex Carcinoma
2971,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Papillary Biliary Intraepithelial Neoplasia
2972,Locally Aggressive Lesion,fibroma of testis
2973,Intracytoplasmic Eosinophilic Inclusion,Childhood Extraskeletal Osteosarcoma
2974,Chronic Clinical Course,Acute Myeloid Leukemia with t(5;17)(q35;q21)
2975,Polymorphic Cellular Infiltrate,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
2976,Benign Cellular Infiltrate,Adenocarcinoma of cecum
2977,Intracytoplasmic Eosinophilic Inclusion,Childhood Embryonal Rhabdomyosarcoma
2978,Benign Cellular Infiltrate,Anal margin Paget's disease
2979,Benign Cellular Infiltrate,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
2980,Dysplasia,Classic Type Trichilemmoma
2981,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Mesonephric Adenocarcinoma
2982,Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v7
2983,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary serous cystadenoma
2984,Acute Clinical Course,Chronic lymphocytic leukemia stage 0
2985,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the gastroesophageal junction
2986,Mucoid Stroma Formation,Papillary adenoma
2987,Severe cytologic atypia,Esophageal Neuroendocrine Tumor G2
2988,Intermediate Filaments Present,Spindle Cell/Sclerosing Rhabdomyosarcoma
2989,Borderline Lesion,Atypical Breast Papilloma
2990,Mixed Neoplastic Glandular and Squamous Cell Population,Familial Nonmedullary Thyroid Gland Carcinoma
2991,Intermediate Filaments Present,FNCLCC Sarcoma Grade 2
2992,Mixed Neoplastic Glandular and Squamous Cell Population,Serous cystadenoma of ovary
2993,Intestinal metaplasia,Signet-ring cell adenocarcinoma gastric
2994,Intermediate Filaments Present,Transplant-Related Kaposi Sarcoma
2995,Benign Cellular Infiltrate,Localized Gallbladder Carcinoma
2996,Mixed Epithelial Cell Population,Frontal Sinus Schneiderian Papilloma
2997,Mucoid Stroma Formation,Sphenoid Sinus Schneiderian Papilloma
2998,Locally Aggressive Lesion,Bone island
2999,Benign Cellular Infiltrate,Colon cancer recurrent
3000,Mass in breast,Atypical Lobular Breast Hyperplasia
3001,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Breast Eccrine Spiradenoma
3002,Solid Growth Pattern,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
3003,Mixed Neoplastic Glandular and Squamous Cell Population,Serous adenofibroma
3004,Intracytoplasmic Eosinophilic Inclusion,Malignant fibrous histiocytoma recurrent
3005,Indolent Clinical Course,Childhood Rhabdomyosarcoma
3006,Intracytoplasmic Eosinophilic Inclusion,AIDS-Related Cervical Kaposi Sarcoma
3007,Pushing Tumor Margin,Uterine Corpus High Grade Endometrial Stromal Sarcoma
3008,CD35-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
3009,Intracytoplasmic Eosinophilic Inclusion,Gallbladder Leiomyosarcoma
3010,Local disease,Uterine Corpus Diffuse Leiomyomatosis
3011,High Mitotic Activity,Anal Canal Neuroendocrine Tumor
3012,Neuroectodermal Differentiation,Extra-osseous Ewing's sarcoma non-metastatic
3013,Mixed Neoplastic Glandular and Squamous Cell Population,Ethmoid Sinus Inverted Papilloma
3014,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Intraepithelial Neoplasia
3015,Sclerotic Pattern,Childhood Spindle Cell Rhabdomyosarcoma
3016,Plexiform Vasculature Present,Undifferentiated Endocervical Sarcoma
3017,atypia morphology,Cutaneous myxoma
3018,Severe cytologic atypia,Stage I Appendix Neuroendocrine Tumor AJCC v7
3019,Indolent Clinical Course,Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma
3020,Precise Histogenesis Unknown,Desmoplastic infantile astrocytoma
3021,Indolent Clinical Course,Supratentorial Glioblastoma
3022,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary serous endometrial carcinoma
3023,Grade 4 Lesion,Pilocytic astrocytoma of cerebellum
3024,Favorable Clinical Outcome,melanoma of scrotum
3025,Intracytoplasmic Eosinophilic Inclusion,Pleural Synovial Sarcoma
3026,atypia morphology,Common blue nevus of skin
3027,Mucoid Stroma Formation,Verrucous carcinoma
3028,Benign Cellular Infiltrate,Esophageal Liposarcoma
3029,Necrotic changes (finding),Colorectal Schwannoma
3030,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical intraepithelial neoplasia grade 2
3031,Congenital Abnormality,Vulvar Acquired Melanocytic Nevus
3032,Indolent Clinical Course,Telangiectatic osteosarcoma
3033,Keratin Present,"Squamous cell carcinoma, small cell, nonkeratinizing"
3034,Grade 4 Lesion,"Gemistocytic Astrocytoma, IDH-Mutant"
3035,Metaplasia of Malignant Cells Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
3036,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Clear cell adenocarcinoma of ovary
3037,Precise Histogenesis Unknown,"Diffuse Astrocytoma, IDH-Wildtype"
3038,Borderline Lesion,Oropharyngeal squamous papilloma
3039,Intermediate Filaments Present,Extraskeletal osteosarcoma recurrent
3040,Precise Histogenesis Unknown,Recurrent Childhood Brain Stem Astrocytoma
3041,Seminomatous Component Present,Intrapulmonary teratoma
3042,Favorable Clinical Outcome,Stage IV Skin Cancer
3043,Borderline Lesion,Vaginal Squamous Papilloma
3044,Indolent Clinical Course,Cardiac Leiomyosarcoma
3045,Benign Cellular Infiltrate,Colon Cancer by AJCC v6 Stage
3046,Benign Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v7
3047,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Choriocarcinoma
3048,Precise Histogenesis Unknown,Gemistocytic astrocytoma
3049,Locally Aggressive Lesion,calcifying aponeurotic fibroma
3050,Precise Histogenesis Unknown,Multifocal Glioblastomas
3051,Dysplasia,Melanoacanthoma
3052,Grade 4 Lesion,Adult Diffuse Astrocytoma
3053,Benign Cellular Infiltrate,Malignant neoplasm of stomach stage III
3054,Invasive Lesion,Carcinoma in situ of penis
3055,Mixed Neoplastic Glandular and Squamous Cell Population,Broad Ligament Serous Cystadenofibroma
3056,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
3057,Invasive Lesion,Dermal Fibroma
3058,Malignant Germinomatous Cellular Infiltrate,Liver Teratoma
3059,High Mitotic Activity,Well Differentiated Pancreatic Endocrine Tumor
3060,Indolent Clinical Course,Leiomyosarcoma of Deep Soft Tissue
3061,Squamous Differentiation,large cell neuroendocrine carcinoma of breast
3062,Intracytoplasmic Eosinophilic Inclusion,"Liposarcoma, Dedifferentiated"
3063,Indolent Clinical Course,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
3064,Favorable Clinical Outcome,Stage IVC Basal Cell Lip Carcinoma
3065,Intracytoplasmic Eosinophilic Inclusion,Sarcomatosis
3066,Intracytoplasmic Eosinophilic Inclusion,Sarcoma NCI Grade 1
3067,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Well Differentiated Ductal Adenocarcinoma
3068,Chronic Clinical Course,Recurrent Childhood Acute Lymphoblastic Leukemia
3069,Mixed Neoplastic Glandular and Squamous Cell Population,Trabecular adenocarcinoma
3070,Geographic Necrosis,Benign Childhood Germ Cell Tumor
3071,Benign Cellular Infiltrate,Childhood Gastric Carcinoma
3072,Dysplasia,Apocrine adenoma
3073,Seminomatous Component Present,Central Nervous System Mature Teratoma
3074,Seminomatous Component Present,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
3075,Bilateral Disease,Retinoblastoma unilateral
3076,Indolent Clinical Course,Gallbladder Rhabdomyosarcoma
3077,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Neoplasms
3078,CD1a-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
3079,Polymorphic Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
3080,Indolent Clinical Course,Rhabdomyosarcoma of cervix uteri
3081,Mucoid Stroma Formation,Glottis Verrucous Carcinoma
3082,Geographic Necrosis,Benign germ cell neoplasm
3083,Intermediate Filaments Present,Cervical Angiosarcoma
3084,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Ovarian Serous Tumor
3085,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hilar Cholangiocarcinoma AJCC v7
3086,Intracytoplasmic Eosinophilic Inclusion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
3087,Invasive Lesion,Low Grade Anal Canal Squamous Intraepithelial Neoplasia
3088,Indolent Clinical Course,Endemic African Kaposi Sarcoma
3089,Invasive Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant"
3090,Intermediate Filaments Present,Stage IVB Osteosarcoma AJCC v7
3091,Benign Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma
3092,Intermediate Filaments Present,Alveolar Soft Part Sarcoma
3093,Premalignant Lesion,Stage II Lung Small Cell Carcinoma AJCC v7
3094,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
3095,Locally Aggressive Lesion,Solitary Adult Fibroma
3096,Squamous Differentiation,large cell neuroendocrine carcinoma of ovary
3097,Borderline Lesion,Glandular papilloma
3098,Seminomatous Component Present,Mature Teratoma
3099,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of epididymis
3100,Benign Cellular Infiltrate,Small Intestinal Follicular Lymphoma
3101,Invasive Lesion,Lobular carcinoma in situ of breast
3102,Borderline Lesion,Inverting papilloma of the paranasal sinus
3103,Intracytoplasmic Eosinophilic Inclusion,Cardiac Rhabdomyosarcoma
3104,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Ductal Breast Carcinoma In Situ
3105,Intermediate Filaments Present,Angiosarcoma Associated with Lymphedema
3106,Mixed Neoplastic Glandular and Squamous Cell Population,clear cell adenocarcinoma of gallbladder
3107,Benign Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v6 and v7
3108,Blasts Expressing CD56 and Immature T-Cell Markers Present,Acute biphenotypic leukemia
3109,Dysplasia,Gallbladder Hyperplastic Polyp
3110,Dysplasia,Apocrine adenoma
3111,Localized Lesion,Smoldering myeloma
3112,Benign Cellular Infiltrate,Malignant neoplasm of ampulla of Vater
3113,Solid Growth Pattern,Precursor B-cell lymphoblastic leukemia
3114,Precise Histogenesis Unknown,Adult Mixed Glioma
3115,Acute Clinical Course,Aggressive natural killer-cell leukemia
3116,Favorable Clinical Outcome,Stage III Lentigo Maligna Melanoma AJCC v7
3117,Premalignant Lesion,Malignant neoplasm of respiratory system
3118,Indolent Clinical Course,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
3119,Absence of a Hormonal Syndrome,Pancreatic Vipoma
3120,Mitotic Activity,Recurrent Childhood Fibrillary Astrocytoma
3121,Malignant Germinomatous Cellular Infiltrate,Dermoid cyst of skin
3122,Indolent Clinical Course,Childhood Brain Germinoma
3123,Intracytoplasmic Eosinophilic Inclusion,Malignant fibrous histiocytoma of skin
3124,Indolent Clinical Course,Chondrosarcoma recurrent
3125,Invasive Lesion,Sporadic Cylindroma
3126,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma stage I
3127,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma stage II
3128,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma stage IV
3129,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Dermoid Cyst
3130,Low Grade Lesion,Grade III Chondrosarcoma
3131,Chronic Clinical Course,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
3132,Indolent Clinical Course,Botryoid-Type Embryonal Rhabdomyosarcoma
3133,Metastatic Lesion,Parotid monomorphic adenoma
3134,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma of spleen
3135,Indolent Clinical Course,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
3136,Indolent Clinical Course,Desmoplastic Medulloblastoma
3137,Low Grade Lesion,Gallbladder Angiosarcoma
3138,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Cutaneous Mucinous Carcinoma
3139,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,serous adenocarcinofibroma of ovary
3140,Mucoid Stroma Formation,Intraductal Breast Papillomatosis
3141,CD35-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
3142,CD21-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
3143,Tumor Vascular Invasion,Parathyroid Gland Oncocytic Adenoma
3144,Intermediate Filaments Present,Spindle cell liposarcoma
3145,Pineocytomatous Rosette Formation,Recurrent Childhood Pineoblastoma
3146,Indolent Clinical Course,Malignant Soft Tissue Tumor of Uncertain Differentiation
3147,Diffuse Lesion,Anal Canal Squamous Papilloma
3148,High Mitotic Activity,"Dermatofibrosarcoma Protuberans, Myxoid"
3149,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7
3150,Mesenchymal Component Present,Mixed cell adenoma
3151,Metastatic Lesion,Functioning Pituitary Gland Microadenoma
3152,Indolent Clinical Course,Adult Extraskeletal Osteosarcoma
3153,Composite Lesion,Minimally Invasive Thymoma
3154,Intermediate Filaments Present,Esophageal Liposarcoma
3155,Dysplasia,Benign Eccrine Neoplasm
3156,Seminomatous Component Present,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
3157,Benign Cellular Infiltrate,Colorectal Sarcomatoid Carcinoma
3158,Indolent Clinical Course,Cardiac Monophasic Synovial Sarcoma
3159,Mixed Cellular Population,"Adenoma, Monomorphic"
3160,Keratin pearl formation,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
3161,Indolent Clinical Course,Lung Synovial Sarcoma
3162,Intracytoplasmic Eosinophilic Inclusion,Prostate Kaposi Sarcoma
3163,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma of lung, stage II"
3164,Intracytoplasmic Eosinophilic Inclusion,Prostate Stromal Sarcoma
3165,Precise Histogenesis Unknown,Glial tumor of spinal cord
3166,Mixed Cellular Population,Plantar wart
3167,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Papilloma of the Nasopharynx
3168,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, microinvasive"
3169,Necrotic changes (finding),Grade III Childhood Astrocytoma
3170,Intermediate Filaments Present,embryonal rhabdomyosarcoma of prostate
3171,Malignant Germinomatous Cellular Infiltrate,Intrapulmonary teratoma
3172,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
3173,Intermediate Filaments Present,Colorectal Angiosarcoma
3174,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Lung Adenocarcinoma AJCC v7
3175,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
3176,Capsular Invasion,Adrenal Cortical Adenoma
3177,Squamous Differentiation,Nasopharyngeal lymphoepithelioma stage IV
3178,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage D Hepatocellular Carcinoma
3179,Benign Cellular Infiltrate,Stage II Anal Canal Cancer AJCC v6 and v7
3180,Favorable Clinical Outcome,Perihilar Intrahepatic Cholangiocarcinoma
3181,Benign Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v6 and v7
3182,Precise Histogenesis Unknown,Adult Oligodendroglioma
3183,Indolent Clinical Course,Childhood Central Nervous System Yolk Sac Tumor
3184,HMB-45-Positive Neoplastic Cells Present,Fibroblastic reticular cell tumor
3185,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III renal cell cancer
3186,Intermediate Filaments Present,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
3187,Indolent Clinical Course,Parosteal Osteosarcoma
3188,Mixed Neoplastic Glandular and Squamous Cell Population,Breast Carcinoma with Choriocarcinomatous Features
3189,Mucoid Stroma Formation,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
3190,High Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v7
3191,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Hepatocellular Carcinoma AJCC v6 and v7
3192,Chronic Clinical Course,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL
3193,Small Lesion,malignant steroid cell tumor of ovary
3194,Biphasic Pattern,Undifferentiated spindle cell sarcoma
3195,Mixed Neoplastic Glandular and Squamous Cell Population,Condyloma acuminata of vulva
3196,Indolent Clinical Course,Sarcomatosis
3197,Aggressive Clinical Course,Ann Arbor Stage I Grade 1 Follicular Lymphoma
3198,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
3199,Mixed Neoplastic Glandular and Squamous Cell Population,Prostate Acinar Adenocarcinoma
3200,Nuclear Clearing,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
3201,Benign Cellular Infiltrate,Liver carcinoma
3202,Invasive Lesion,intraepithelial glandular neoplasia of cervix
3203,Benign Cellular Infiltrate,Stage II Colorectal Cancer
3204,Invasive Lesion,Eccrine acrospiroma
3205,Mixed Neoplastic Glandular and Squamous Cell Population,Perianal Squamous Intraepithelial Neoplasia
3206,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Mature Teratoma
3207,Invasive Lesion,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
3208,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma stage IV
3209,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the oral cavity stage II
3210,Chronic lymphocytic inflammation,"Thymoma, type A"
3211,Mixture of Germ Cell Neoplastic Components Present,Pineal Region Choriocarcinoma
3212,Favorable Clinical Outcome,Skin Squamous Cell Carcinoma In Situ
3213,Indolent Clinical Course,Leiomyosarcoma of cervix uteri
3214,Squamous Differentiation,Oropharyngeal lymphoepithelioma stage III
3215,Borderline Lesion,Benign Germinative Follicular Epithelium Neoplasm
3216,Mixed Neoplastic Glandular and Squamous Cell Population,Oncocytic Neoplasm
3217,Glandular Differentiation,Colorectal Large Cell Neuroendocrine Carcinoma
3218,Polymorphic Cellular Infiltrate,Transplant-Related Hematologic Malignancy
3219,CD30-Positive Neoplastic Cells Present,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
3220,Severe cytologic atypia,Malignant Vipoma
3221,Mixed Neoplastic Glandular and Squamous Cell Population,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
3222,Glandular Differentiation,undifferentiated carcinoma of liver
3223,Benign Cellular Infiltrate,Stage IIA Small Intestinal Cancer AJCC v7
3224,Locally Aggressive Lesion,Cellular angiofibroma
3225,Composite Lesion,Ectopic Cervical Thymoma
3226,Indolent Clinical Course,Synovial sarcoma recurrent
3227,Premalignant Lesion,Lung Micropapillary Adenocarcinoma
3228,Seminomatous Component Present,Ovarian Cystic Teratoma
3229,Favorable Clinical Outcome,Stage IV Lip Basal Cell Carcinoma
3230,Favorable Clinical Outcome,Stage IV Hepatocellular Carcinoma AJCC v6
3231,Mixed Neoplastic Glandular and Squamous Cell Population,Transplant-Related Skin Squamous Cell Carcinoma
3232,Infiltrative Growth Pattern,Fascial fibroma
3233,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
3234,Well-Circumscribed Lesion,Peyronie Disease
3235,Premalignant Lesion,Stage IIB Lung Adenosquamous Carcinoma AJCC v7
3236,Premalignant Lesion,"Lung Squamous Cell Carcinoma, Papillary Variant"
3237,Mass in breast,Lobular carcinoma in situ of breast
3238,Intermediate Filaments Present,Stage II Osteosarcoma AJCC v7
3239,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Esophageal Adenocarcinoma AJCC v7
3240,atypia morphology,Pleural Well Differentiated Papillary Mesothelioma
3241,Mixed Cellular Population,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
3242,Diffuse Lesion,Hemangioma of intracranial structure
3243,Mucoid Stroma Formation,Pancreatic Intraductal Tubulopapillary Neoplasm
3244,Indolent Clinical Course,Appendix Kaposi Sarcoma
3245,Intracytoplasmic Eosinophilic Inclusion,Stage IIA Bone Sarcoma AJCC v7
3246,Locally Aggressive Lesion,Desmoplastic fibroblastoma
3247,Borderline Lesion,Hidradenoma Papilliferum
3248,Precise Histogenesis Unknown,Childhood Gliosarcoma
3249,Indolent Clinical Course,Childhood Desmoplastic Small Round Cell Tumor
3250,Squamous Differentiation,Endometrial Large Cell Neuroendocrine Carcinoma
3251,Encapsulated Mass,Cranial Nodular Fasciitis
3252,Tissues Derived from Two or Three Embryonic Layers Present,"Struma ovarii, malignant"
3253,Benign Cellular Infiltrate,Ampulla of Vater Neuroendocrine Carcinoma
3254,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
3255,Benign Cellular Infiltrate,Ampulla of Vater Intestinal-Type Adenocarcinoma
3256,Glandular Differentiation,large cell carcinoma of salivary gland
3257,Benign Cellular Infiltrate,Colloid Carcinoma of the Pancreas
3258,Benign Cellular Infiltrate,Paget disease of anal canal
3259,Intracytoplasmic Eosinophilic Inclusion,liposarcoma of vulva
3260,Mixed Neoplastic Glandular and Squamous Cell Population,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
3261,Intermediate Filaments Present,Ovarian Low Grade Endometrioid Stromal Sarcoma
3262,Metastatic Lesion,Benign neoplasm of submaxillary gland
3263,Indolent Clinical Course,Stage IVB Bone Cancer AJCC v7
3264,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Mesonephric Adenocarcinoma
3265,Intermediate Filaments Present,Desmoplastic Small Round Cell Tumor
3266,Mixed Neoplastic Glandular and Squamous Cell Population,Minor Salivary Gland Squamous Cell Carcinoma
3267,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive micropapillary carcinoma of breast
3268,Indolent Clinical Course,Meningeal Gliomatosis
3269,Hepatomegaly,Indolent Systemic Mastocytosis
3270,Diffuse Lesion,Inverted papilloma of urinary bladder
3271,Benign Cellular Infiltrate,Klatskin Tumor
3272,Microvascular Proliferation,Recurrent Childhood Diffuse Astrocytoma
3273,Indolent Clinical Course,Childhood Anaplastic Oligodendroglioma
3274,Microvascular Proliferation,Recurrent Childhood Fibrillary Astrocytoma
3275,Mucoid Stroma Formation,Central Breast Papilloma
3276,Indolent Clinical Course,Adult Giant Cell Glioblastoma
3277,Mucoid Stroma Formation,Atypical Breast Papilloma
3278,Locally Aggressive Lesion,Perifollicular fibroma
3279,Intermediate Filaments Present,Malignant fibrous histiocytoma of skin
3280,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Transitional Cell Carcinoma
3281,Precise Histogenesis Unknown,Recurrent Childhood Gliomatosis Cerebri
3282,Borderline Lesion,Ancell-Spiegler cylindromas
3283,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Serous cystadenoma of ovary
3284,Intermediate Filaments Present,Central Nervous System Fibrosarcoma
3285,Malignant Cellular Infiltrate,Bowenoid papulosis
3286,Chronic Clinical Course,ROSE Cluster 4
3287,Indolent Clinical Course,Stage IIA Osteosarcoma AJCC v7
3288,Severe cytologic atypia,Functioning Pancreatic Neuroendocrine Tumor
3289,Low Mitotic Activity,Pancreatic Endocrine Carcinoma
3290,High Mitotic Activity,Childhood Ependymoma
3291,Intermediate Filaments Present,Esophageal Rhabdomyosarcoma
3292,Mixed Neoplastic Glandular and Squamous Cell Population,Paranasal Sinus Schneiderian Papilloma
3293,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Myxoid Leiomyosarcoma
3294,Indolent Clinical Course,Cervical Malignant Peripheral Nerve Sheath Tumor
3295,Invasive Lesion,Parotid monomorphic adenoma
3296,Metastatic Lesion,Densely Granulated Lactotroph Adenoma
3297,Metastatic Lesion,Central Nervous System T-Cell Non-Hodgkin Lymphoma
3298,Metastatic Lesion,Sparsely Granulated Lactotroph Adenoma
3299,High Mitotic Activity,Carcinoid tumor of the cecum
3300,Favorable Clinical Outcome,Skin Metatypical Carcinoma
3301,Intermediate Filaments Present,Alveolar soft part sarcoma metastatic
3302,Dysplasia,Benign Dermal Schwannoma
3303,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,serous adenocarcinofibroma of ovary
3304,Precise Histogenesis Unknown,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
3305,Intermediate Filaments Present,Leptomeningeal sarcoma
3306,Intracytoplasmic Eosinophilic Inclusion,Gastric Synovial Sarcoma
3307,Undifferentiated Lesion,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor
3308,High Mitotic Activity,Pancreatic Neuroendocrine Microadenoma
3309,Severe cytologic atypia,Pancreatic Neuroendocrine Tumor G2
3310,Indolent Clinical Course,Recurrent Childhood Pineoblastoma
3311,Favorable Clinical Outcome,cystadenocarcinoma of intrahepatic bile duct
3312,Benign Cellular Infiltrate,Primary Peritoneal Low Grade Serous Adenocarcinoma
3313,Mixed Neoplastic Glandular and Squamous Cell Population,serous surface papillary carcinoma of ovary
3314,High Mitotic Activity,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
3315,Benign Cellular Infiltrate,Stage IB Esophageal Cancer AJCC v7
3316,Benign Cellular Infiltrate,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation
3317,Aggressive Clinical Course,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid
3318,Malignant Germinomatous Cellular Infiltrate,Nongerminomatous Germ Cell Tumor
3319,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
3320,Benign Cellular Infiltrate,Esophageal Melanoma
3321,Solid Growth Pattern,Chemotherapy-Related Leukemia
3322,Benign Cellular Infiltrate,Childhood Esophageal Carcinoma
3323,Precise Histogenesis Unknown,Angiocentric glioma
3324,Locally Aggressive Lesion,Giant Cell Lesion of Small Bones
3325,Mucoid Stroma Formation,Ovarian Papillary Tumor
3326,Intracytoplasmic Eosinophilic Inclusion,Childhood Fibrosarcoma
3327,Metastatic Lesion,Sclerosing Polycystic Adenosis
3328,Borderline Lesion,Lactating adenoma
3329,Mixed Neoplastic Glandular and Squamous Cell Population,Adenoma of rete ovarii
3330,Nodular lesions,"Childhood Ganglioneuroblastoma, Intermixed"
3331,Premalignant Lesion,Stage IIB Lung Adenocarcinoma AJCC v7
3332,Indolent Clinical Course,Secondary malignant neoplasm of pituitary gland
3333,Invasive Lesion,Atypical Ductal Breast Hyperplasia
3334,Metastatic Lesion,Hard Palate Pleomorphic Adenoma
3335,Intracytoplasmic Eosinophilic Inclusion,Stage III Uterine Sarcoma AJCC v7
3336,Mucoid Stroma Formation,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
3337,Mixture of Germ Cell Neoplastic Components Present,Spermatocytic seminoma
3338,Benign Cellular Infiltrate,Colorectal Cancer by AJCC v6 Stage
3339,Aggressive Clinical Course,Recurrent Indolent Adult Non-Hodgkin Lymphoma
3340,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
3341,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
3342,Grade 4 Lesion,Fibrillary Astrocytoma
3343,Favorable Clinical Outcome,Pagetoid reticulosis
3344,Microvascular Proliferation,Adult Diffuse Astrocytoma
3345,Benign Cellular Infiltrate,Carcinoma of ampulla of Vater
3346,Diffuse Lesion,Mediastinal Lymphangioma
3347,High Mitotic Activity,Childhood Choroid Plexus Papilloma
3348,Benign Cellular Infiltrate,Distal 1/3 of the Common Bile Duct Adenocarcinoma
3349,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
3350,Locally Aggressive Lesion,Fibroma of lung
3351,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Carcinoma In Situ of the Nipple
3352,Malignant Germinomatous Cellular Infiltrate,Childhood Embryonal Carcinoma
3353,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Hepatocellular Carcinoma AJCC v6 and v7
3354,Mixture of Germ Cell Neoplastic Components Present,Pulmonary Artery Choriocarcinoma
3355,Favorable Clinical Outcome,Stage IVA Basal Cell Lip Carcinoma
3356,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of gallbladder
3357,Nuclear Grooves,Thyroid Gland Oncocytic Adenoma
3358,Indolent Clinical Course,Anaplastic Hemispheric Astrocytoma
3359,Favorable Clinical Outcome,Skin Nodular Solid Basal Cell Carcinoma
3360,Indolent Clinical Course,Thyroid Angiosarcoma
3361,Necrotic changes (finding),Anaplastic Diencephalic Astrocytoma
3362,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,squamous cell carcinoma of ovary
3363,Intermediate Filaments Present,Pulmonary Artery Angiosarcoma
3364,Metastatic Lesion,Spindle Cell Oncocytoma of the Adenohypophysis
3365,Indolent Clinical Course,Malignant Diencephalic Neoplasm
3366,Borderline Lesion,Papilloma of eyelid
3367,Intracytoplasmic Eosinophilic Inclusion,undifferentiated sarcoma of soft tissue
3368,Favorable Clinical Outcome,Acantholytic squamous cell carcinoma of skin
3369,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Mucinous Adenocarcinoma
3370,Dysplasia,Colon Hyperplastic Polyp
3371,Invasive Lesion,Appendix High Grade Intraepithelial Neoplasia
3372,Intermediate Filaments Present,Leiomyosarcoma of cervix uteri
3373,Glandular Differentiation,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
3374,Mixed Neoplastic Glandular and Squamous Cell Population,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant"
3375,Benign Cellular Infiltrate,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
3376,Intermediate Filaments Present,leiomyosarcoma of vulva
3377,Acute Clinical Course,T-Cell Large Granular Lymphocyte Leukemia
3378,Malignant Germinomatous Cellular Infiltrate,Testicular yolk sac tumor stage I
3379,Intracytoplasmic Eosinophilic Inclusion,Liver Fibrosarcoma
3380,Capsular Invasion,Heavily Pigmented Adrenal Cortical Adenoma
3381,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Mucinous Adenofibroma
3382,Malignant Germinomatous Cellular Infiltrate,Ovarian Solid Teratoma
3383,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Cystadenofibroma
3384,Diffuse Lesion,Congenital Cystic Hygroma
3385,Benign Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v7
3386,Tumor Vascular Invasion,Clear Cell Adrenal Cortical Adenoma
3387,Solid Growth Pattern,"Leukemia, Mast-Cell"
3388,Indolent Clinical Course,Stage IIIA Uterine Sarcoma AJCC v7
3389,Diffuse Lesion,Mucous Membrane Hemangioma
3390,Malignant Germinomatous Cellular Infiltrate,embryonal carcinoma of mediastinum
3391,Acute Clinical Course,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
3392,Borderline Lesion,Ovarian Mucinous Cystadenofibroma
3393,High Mitotic Activity,Colon Neuroendocrine Tumor G1
3394,Intermediate Filaments Present,fibrosarcoma of ovary
3395,Solid Growth Pattern,Acute Lymphoblastic Leukemia by Gene Expression Profile
3396,Infiltrative Growth Pattern,Giant cell angiofibroma
3397,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal Basaloid Carcinoma
3398,High Mitotic Activity,Pancreatic Vipoma
3399,Squamous Differentiation,Small Intestinal Undifferentiated Carcinoma
3400,Invasive Lesion,Scrotal Hemangioma
3401,Indolent Clinical Course,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
3402,Premalignant Lesion,Stage III Lung Small Cell Carcinoma AJCC v7
3403,Benign Cellular Infiltrate,Gallbladder Neuroendocrine Carcinoma
3404,Vascular proliferation,Ovarian Cellular Fibroma
3405,Chronic Clinical Course,Adult Acute Myelomonocytic Leukemia
3406,Diffuse Lesion,Bone Epithelioid Hemangioma
3407,Benign Cellular Infiltrate,AIDS-Related Anal Carcinoma
3408,Intracytoplasmic Eosinophilic Inclusion,sarcoma of mediastinum
3409,Malignant Germinomatous Cellular Infiltrate,Cystic teratoma
3410,Invasive Lesion,Paraganglioma-Like Dermal Melanocytic Tumor
3411,Mixed Neoplastic Glandular and Squamous Cell Population,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
3412,Severe cytologic atypia,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
3413,"Amorphus, Eosinophilic, and Acellular Deposit",Light chain disease
3414,Rarely Metastasizing Lesion,Kaposiform Hemangioendothelioma
3415,Mixed Neoplastic Glandular and Squamous Cell Population,Parotid Gland Acinic Cell Carcinoma
3416,Invasive Lesion,Intraductal Non-Comedo Breast Adenocarcinoma
3417,Tubular Structures Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified"
3418,Grade 4 Lesion,Childhood Subependymal Giant Cell Astrocytoma
3419,Intracytoplasmic Eosinophilic Inclusion,Low Grade Endometrioid Stromal Sarcoma of the Vagina
3420,Mitotic Activity,Childhood Fibrillary Astrocytoma
3421,Intermediate Filaments Present,Childhood Pleomorphic Rhabdomyosarcoma
3422,Favorable Clinical Outcome,Squamous Cell Carcinoma of Anal Margin
3423,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Carcinoma of Anal Margin
3424,Aggressive Clinical Course,Ann Arbor Stage IV Grade 1 Follicular Lymphoma
3425,Encapsulated Mass,Diffuse neurofibroma
3426,Microvascular Proliferation,Childhood Oligoastrocytoma
3427,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatitis Virus-Related Hepatocellular Carcinoma
3428,Well-Circumscribed Lesion,embryonal rhabdomyosarcoma of orbit
3429,Infiltrative Growth Pattern,Vulvar Cellular Angiofibroma
3430,Mixed Neoplastic Glandular and Squamous Cell Population,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
3431,Superficial Lesion,Inflammatory liposarcoma
3432,Intermediate Filaments Present,sarcoma of extrahepatic bile duct
3433,Mixed Neoplastic Glandular and Squamous Cell Population,Adenoma of the Colon with Intramucosal Adenocarcinoma
3434,atypia morphology,Recurrent Nevus
3435,Diffuse Lesion,Liver Cavernous Hemangioma
3436,Local disease,Intravenous leiomyomatosis
3437,Indolent Clinical Course,Adamantinoma
3438,Chronic Clinical Course,Acute Megakaryocytic Leukemias
3439,Chronic Clinical Course,"Leukemia, Myelocytic, Acute"
3440,Mixed Neoplastic Glandular and Squamous Cell Population,Cystadenocarcinoma of pancreas
3441,No Evidence of Radiologic Finding,Occult Lung Squamous Cell Carcinoma
3442,Intermediate Filaments Present,Undifferentiated Stromal Sarcoma
3443,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated Stromal Sarcoma
3444,Diffuse Lesion,Subglottic Hemangioma
3445,Benign Cellular Infiltrate,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma
3446,Nuclear Clearing,minimally invasive follicular carcinoma of the thyroid gland
3447,Papillary Pattern,Intermediate Grade Ductal Breast Carcinoma In Situ
3448,Indolent Clinical Course,FNCLCC Sarcoma Grade 3
3449,Borderline Lesion,Dermal Duct Tumor
3450,Mixture of Germ Cell Neoplastic Components Present,Testicular Pure Germ Cell Tumor
3451,Anaplasia,Adult Ependymoma
3452,Chronic Clinical Course,ROSE Cluster 3
3453,Mitotic Activity,Benign germ cell tumor of ovary
3454,Mucoid Stroma Formation,Papillary thyroid carcinoma
3455,Indolent Clinical Course,AIDS with Kaposi's sarcoma
3456,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, Lobular"
3457,Invasive Lesion,Conjunctival intraepithelial neoplasia
3458,Intracytoplasmic Eosinophilic Inclusion,Esophageal Rhabdomyosarcoma
3459,High Mitotic Activity,Small Intestinal Neuroendocrine Tumor
3460,Intermediate Filaments Present,Poorly Differentiated Angiosarcoma
3461,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
3462,Locally Aggressive Lesion,Mammary-Type Myofibroblastoma
3463,Indolent Clinical Course,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
3464,Intestinal metaplasia,Signet-ring cell adenocarcinoma of colon
3465,Invasive Lesion,Warty dyskeratoma
3466,Favorable Clinical Outcome,Malignant Hair Follicle Neoplasm
3467,Indolent Clinical Course,Childhood Pineoblastoma
3468,Mixed Neoplastic Glandular and Squamous Cell Population,Differentiated Thyroid Gland Carcinoma
3469,Spindle Cell Component Present,"Synovial sarcoma, epithelioid cell"
3470,Capsular Invasion,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
3471,Mixed Cellular Population,Oral Cavity Monomorphic Adenoma
3472,High Mitotic Activity,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
3473,Premalignant Lesion,Primary Lung Lymphoma
3474,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian adenocarcinoma
3475,Intermediate Filaments Present,Ovarian Liposarcoma
3476,Indolent Clinical Course,Low Grade Endometrial Stromal Sarcoma
3477,High Mitotic Activity,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
3478,Severe cytologic atypia,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
3479,Benign Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v7
3480,Benign Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v7
3481,Confluent Sheets of Neoplastic B-Lymphocytes Present,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
3482,Mixed Neoplastic Glandular and Squamous Cell Population,Localized Parathyroid Gland Carcinoma
3483,Encapsulated Mass,Spinal Cord Neurofibroma
3484,Mixed Neoplastic Glandular and Squamous Cell Population,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
3485,Invasive Lesion,Pyogenic granuloma of skin and subcutaneous tissue
3486,Mixture of Germ Cell Neoplastic Components Present,Stage I Gestational Trophoblastic Tumor AJCC v7
3487,Premalignant Lesion,Occult Lung Adenocarcinoma
3488,Precise Histogenesis Unknown,Astrocytoma of brain stem
3489,Mixed Cellular Population,Oropharyngeal squamous papilloma
3490,Favorable Clinical Outcome,Cutaneous Lymphomatoid Granulomatosis
3491,Intermediate Filaments Present,AJCC Grade 3 Sarcoma
3492,High Mitotic Activity,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
3493,Premalignant Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
3494,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mature Teratoma
3495,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Papillary Pattern"
3496,High Mitotic Activity,Ependymoma of brain stem
3497,Microvascular Proliferation,Gemistocytic astrocytoma
3498,Mucoid Stroma Formation,Bladder papilloma
3499,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Medullary Carcinoma
3500,Malignant Germinomatous Cellular Infiltrate,Sacrococcygeal teratoma
3501,Indolent Clinical Course,Ewings sarcoma
3502,Benign Cellular Infiltrate,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
3503,Benign Cellular Infiltrate,Unresectable Hepatocellular Carcinoma
3504,Osteosclerosis,"Polycythemia Vera, Polycythemic Phase"
3505,Intracytoplasmic Eosinophilic Inclusion,liposarcoma of bone
3506,Intracytoplasmic Eosinophilic Inclusion,Osteoblastic Osteosarcoma
3507,Glandular Pattern,Medullary carcinoma of breast
3508,Cellular Pleomorphism,Benign Uterine Corpus PEComa
3509,Aggressive Clinical Course,"Lymphoma, Mixed-Cell, Follicular"
3510,Benign Cellular Infiltrate,Gastric Small Cell Carcinoma
3511,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Hepatoid Adenocarcinoma
3512,Intermediate Filaments Present,liposarcoma
3513,Seminomatous Component Present,Central Nervous System Immature Teratoma
3514,Benign Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v7
3515,Indolent Clinical Course,Sarcoma of breast
3516,Borderline Lesion,Common wart
3517,Intermediate Filaments Present,Kaposi Sarcoma Related to Immunosuppressive Treatment
3518,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,mucinous adenocarcinofibroma of ovary
3519,Mixed Neoplastic Glandular and Squamous Cell Population,Warty Carcinoma of the Penis
3520,Severe cytologic atypia,Jejunal Neuroendocrine Tumor G1
3521,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Differentiated Thyroid Carcinoma
3522,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
3523,Mixed Neoplastic Glandular and Squamous Cell Population,Verrucous carcinoma of oral cavity
3524,Benign Cellular Infiltrate,Stage IV Anal Canal Cancer AJCC v6 and v7
3525,Ineffective hematopoiesis,Blast Phase
3526,Indolent Clinical Course,Metastatic angiosarcoma
3527,Borderline Lesion,Inverted Papilloma
3528,Mixed Neoplastic Glandular and Squamous Cell Population,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant"
3529,Nuclear Pseudoinclusion,Microfollicular adenoma
3530,Severe cytologic atypia,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
3531,Nuclear Pseudoinclusion,Macrofollicular adenoma
3532,Benign Cellular Infiltrate,Colorectal Undifferentiated Carcinoma
3533,Mucoid Stroma Formation,Human Papillomavirus-Related Verrucous Carcinoma
3534,Mucoid Stroma Formation,Multicentric Thyroid Gland Papillary Carcinoma
3535,Mixed Neoplastic Glandular and Squamous Cell Population,Multicentric Thyroid Gland Papillary Carcinoma
3536,Benign Cellular Infiltrate,Squamous cell carcinoma of esophagus
3537,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Carcinoma
3538,Premalignant Lesion,Tracheal Carcinoma
3539,Diffuse Lesion,Squamous Papilloma of the Larynx
3540,Borderline Lesion,Eccrine hidrocystoma
3541,Intracytoplasmic Eosinophilic Inclusion,Esophageal Leiomyosarcoma
3542,Squamous Differentiation,Large cell lung cancer stage II
3543,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Squamous Cell Breast Carcinoma
3544,Premalignant Lesion,large cell neuroendocrine carcinoma of lung
3545,Cytologic atypia,Colorectal Mucin Poor Hyperplastic Polyp
3546,Intestinal metaplasia,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
3547,Mucoid Stroma Formation,Laryngeal verrucous carcinoma recurrent
3548,Premalignant Lesion,Stage IA Lung Small Cell Carcinoma AJCC v7
3549,Single Type of Tissue Derived from One Embryonic Layer Present,Childhood Ovarian Mature Teratoma
3550,Intracytoplasmic Eosinophilic Inclusion,Stage II Bone Sarcoma AJCC v7
3551,Premalignant Lesion,Stage IB Lung Small Cell Carcinoma AJCC v7
3552,Favorable Clinical Outcome,Eccrine ductal carcinoma
3553,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Mucinous Adenocarcinoma
3554,Intermediate Filaments Present,Ovarian Myxoid Liposarcoma
3555,High Mitotic Activity,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
3556,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with cartilaginous and osseous metaplasia
3557,Intermediate Filaments Present,fibrosarcoma of soft tissue
3558,Tumor Vascular Invasion,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
3559,Mucoid Stroma Formation,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
3560,Mixed Cellular Population,Lobular carcinoma in situ of breast
3561,Premalignant Lesion,Small cell lung cancer limited stage
3562,Invasive Lesion,Paget's disease and intraductal carcinoma of breast
3563,Composite Lesion,"Thymoma, type AB"
3564,Benign Cellular Infiltrate,Malignant neoplasm of gallbladder localized
3565,Intracytoplasmic Eosinophilic Inclusion,Appendix Kaposi Sarcoma
3566,Intracytoplasmic Eosinophilic Inclusion,embryonal rhabdomyosarcoma of orbit
3567,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Embryonal Carcinoma
3568,Benign Cellular Infiltrate,Stage IB Esophageal Adenocarcinoma AJCC v7
3569,Solid Growth Pattern,Sezary Syndrome
3570,High Mitotic Activity,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
3571,Local disease,mediastinal lipomatosis
3572,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Cystadenocarcinoma
3573,Carcinomatous Component Present,Lung Pleomorphic Adenoma
3574,Precise Histogenesis Unknown,Adult Subependymoma
3575,Mixed Cellular Population,"Papilloma, Squamous Cell"
3576,Intermediate Filaments Present,Leiomyosarcoma of small intestine
3577,Localized Lesion,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
3578,Mucoid Stroma Formation,"Papillomatosis, glandular"
3579,Malignant Germinomatous Cellular Infiltrate,Ovarian Embryonal Carcinoma
3580,Indolent Clinical Course,Stage IIA Soft Tissue Sarcoma AJCC v7
3581,Diffuse Lesion,Ureter Urothelial Papilloma
3582,Mass in breast,Lobular Neoplasia Type A
3583,Invasive Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
3584,Low Mitotic Activity,Gastric Neuroendocrine Carcinoma
3585,Squamous Differentiation,Submandibular Gland Undifferentiated Carcinoma
3586,Indolent Clinical Course,Laryngeal Leiomyosarcoma
3587,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Lung Squamous Cell Carcinoma AJCC v7
3588,Squamous Differentiation,Large cell carcinoma with rhabdoid phenotype
3589,Indolent Clinical Course,Undifferentiated Stromal Sarcoma
3590,Plexiform Vasculature Present,Undifferentiated Stromal Sarcoma
3591,Solid Growth Pattern,Aggressive natural killer-cell leukemia
3592,Solid Growth Pattern,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
3593,Seminomatous Component Present,Teratoma of testis
3594,Intracytoplasmic Eosinophilic Inclusion,Desmoplastic Small Round Cell Tumor
3595,Intermediate Filaments Present,Stage IV Soft Tissue Sarcoma AJCC v7
3596,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Adenoma
3597,Indolent Clinical Course,Primary Non-Hodgkin Lymphoma of Bone
3598,Intracytoplasmic Eosinophilic Inclusion,AIDS-Related Gastric Kaposi Sarcoma
3599,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Myeloid Leukemia with Minimal Differentiation
3600,High Mitotic Activity,Regional Digestive System Neuroendocrine Tumor G1
3601,Favorable Clinical Outcome,Carcinoma of anal margin
3602,Benign Cellular Infiltrate,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
3603,Aggressive Clinical Course,Grade 2 Diffuse Follicular Lymphoma
3604,Indolent Clinical Course,Intracranial Extraskeletal Myxoid Chondrosarcoma
3605,Mixed Neoplastic Glandular and Squamous Cell Population,intestinal type adenocarcinoma of extrahepatic bile duct
3606,Indolent Clinical Course,sarcoma of larynx
3607,Borderline Lesion,Eccrine mixed tumor of skin
3608,Indolent Clinical Course,Granular Cell Leiomyosarcoma
3609,Indolent Clinical Course,Inflammatory Leiomyosarcoma
3610,Seminomatous Component Present,Benign germ cell tumor of ovary
3611,Precise Histogenesis Unknown,Childhood Ependymal Tumor
3612,Benign Cellular Infiltrate,Esophageal Mixed Adenoneuroendocrine Carcinoma
3613,Precise Histogenesis Unknown,Recurrent Childhood Ependymoma
3614,Chronic Clinical Course,Treatment related acute myeloid leukaemia
3615,Neuroectodermal Differentiation,Metastatic Ewing's Sarcoma
3616,Benign Cellular Infiltrate,Cloacogenic carcinoma
3617,Scattered Collections of Differentiating Neuroblasts Present,Central Nervous System Ganglioneuroblastoma
3618,Intermediate Filaments Present,Angiosarcoma NCI Grade 2
3619,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor
3620,Intermediate Filaments Present,Angiosarcoma NCI Grade 3
3621,Intermediate Filaments Present,Extraskeletal osteosarcoma metastatic
3622,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
3623,Giant Mitochondria Present,Densely Granulated Lactotroph Adenoma
3624,Favorable Clinical Outcome,Cutaneous T Lymphoblastic Leukemia/Lymphoma
3625,Benign Cellular Infiltrate,carcinosarcoma of gallbladder
3626,Benign Cellular Infiltrate,Gastric Papillary Adenocarcinoma
3627,Indolent Clinical Course,Malignant fibrous histiocytoma recurrent
3628,Intermediate Filaments Present,Childhood Leiomyosarcoma
3629,CD21-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
3630,Benign Cellular Infiltrate,Gallbladder Angiosarcoma
3631,High Grade Lesion,Polymorphus Hemangioendothelioma
3632,Malignant Germinomatous Cellular Infiltrate,Immature Ovarian Teratoma
3633,Neuroectodermal Differentiation,Extra-osseous Ewing's sarcoma metastatic
3634,Generalized illness,Early Favorable Hodgkin Lymphoma
3635,Multilayered Rosette Formation,Anaplastic Medulloblastoma
3636,Indolent Clinical Course,Extra-osseous Ewing's sarcoma non-metastatic
3637,Precise Histogenesis Unknown,Gliomatosis cerebri
3638,Neuroectodermal Differentiation,Extra-osseous Ewing's sarcoma recurrent
3639,Extensive Stage Lesion,Early Unfavorable Hodgkin Lymphoma
3640,Borderline Lesion,Oral Cavity Monomorphic Adenoma
3641,Invasive Lesion,Oral Cavity Monomorphic Adenoma
3642,Localized Lesion,Multiple Myeloma
3643,High Mitotic Activity,Non functioning pancreatic endocrine tumor
3644,Intermediate Filaments Present,"Sarcoma, Spindle Cell"
3645,Premalignant Lesion,Lung Carcinoma Metastatic in the Bone
3646,Microvascular Proliferation,Anaplastic astrocytoma
3647,Premalignant Lesion,Prostate Carcinoma Metastatic in the Lung
3648,Intermediate Filaments Present,Myxosarcoma
3649,Precise Histogenesis Unknown,Anaplastic Brain Stem Astrocytoma
3650,Intracytoplasmic Eosinophilic Inclusion,Colorectal Leiomyosarcoma
3651,Glandular Differentiation,Undifferentiated Carcinoma of Colon
3652,Intracytoplasmic Eosinophilic Inclusion,Prostate Angiosarcoma
3653,Mixture of Germ Cell Neoplastic Components Present,Testicular Typical Seminoma
3654,Intracytoplasmic Eosinophilic Inclusion,Cardiac Malignant Peripheral Nerve Sheath Tumor
3655,Intracytoplasmic Eosinophilic Inclusion,Stage II Adult Soft Tissue Sarcoma AJCC v7
3656,Intermediate Filaments Present,AJCC Grade 4 Sarcoma
3657,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Adenoma
3658,Borderline Lesion,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
3659,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Tumor
3660,Encapsulated Mass,Colorectal Perineurioma
3661,Mixture of Germ Cell Neoplastic Components Present,Stage 0 Testicular Seminoma AJCC v6 and v7
3662,Mixed Neoplastic Glandular and Squamous Cell Population,Helicobacter Pylori-Related Gastric Adenocarcinoma
3663,Benign Cellular Infiltrate,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
3664,Acute Clinical Course,Cutaneous Chronic Lymphocytic Leukemia
3665,Dysplasia,Plantar wart
3666,CD30-Positive Neoplastic Cells Present,Disseminated Juvenile Xanthogranuloma
3667,Intermediate Filaments Present,Low Grade Paranasal Sinus Sarcoma
3668,Indolent Clinical Course,Prostate Leiomyosarcoma
3669,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Warty Carcinoma
3670,Indolent Clinical Course,Fibrosarcoma metastatic
3671,Invasive Lesion,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
3672,atypia morphology,Cellular Myxoma
3673,Intermediate Filaments Present,Liposarcoma non-metastatic
3674,Benign Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v7
3675,Necrotic changes (finding),Gemistocytic astrocytoma
3676,Mixed Neoplastic Glandular and Squamous Cell Population,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
3677,High Mitotic Activity,Childhood Cerebral Ependymoma
3678,Mitotic Activity,Childhood Cerebral Diffuse Astrocytoma
3679,Severe cytologic atypia,Stage IV Appendix Neuroendocrine Tumor AJCC v7
3680,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease of the Breast without Invasive Carcinoma
3681,Focal dysplasia,Colorectal Filiform Serrated Adenoma
3682,Benign Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v6
3683,Borderline Lesion,Adenolymphoma
3684,Mitotic Activity,Benign Extragonadal Germ Cell Tumor
3685,Geographic Necrosis,Benign Extragonadal Germ Cell Tumor
3686,HMB-45-Positive Neoplastic Cells Present,Indeterminate dendritic cell tumor
3687,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal squamous cell carcinoma stage I
3688,Necrotic changes (finding),Adult Ganglioglioma
3689,Indolent Clinical Course,Stage IIA Uterine Sarcoma AJCC v7
3690,Benign Cellular Infiltrate,Gastric Hepatoid Adenocarcinoma
3691,Keratin pearl formation,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
3692,Benign Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v7
3693,Borderline Lesion,Ovarian Surface Papilloma
3694,Favorable Clinical Outcome,Stage I Hepatocellular Carcinoma AJCC v6 and v7
3695,High Mitotic Activity,Colorectal Neuroendocrine Tumor G2
3696,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
3697,Diffuse Lesion,Hobnail Hemangioma
3698,Glandular Differentiation,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
3699,Intracytoplasmic Eosinophilic Inclusion,Sarcoma
3700,Glandular Differentiation,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
3701,Premalignant Lesion,Childhood Lung Non-Small Cell Carcinoma
3702,Indolent Clinical Course,"Intracranial Embryonal Tumor, Not Otherwise Specified"
3703,Mixed Cellular Population,Papilloma of buccal mucosa
3704,Invasive Lesion,High Grade Intraepithelial Neoplasia
3705,Benign Cellular Infiltrate,Small Intestinal Enteropathy-Associated T-Cell Lymphoma
3706,Borderline Lesion,Adenoma of Minor Vestibular Glands
3707,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of tonsil
3708,Malignant Germinomatous Cellular Infiltrate,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor
3709,Invasive Lesion,Small Intestinal Intraepithelial Neoplasia
3710,Invasive Lesion,Vulvar Nodular Hidradenoma
3711,Carcinomatous Component Present,Pleomorphic adenoma of parotid gland
3712,Indolent Clinical Course,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
3713,Generalized Dysplasia,Sessile Serrated Adenoma/Polyp
3714,High Mitotic Activity,Cervical Leiomyoma
3715,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma
3716,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Papilloma of the Larynx
3717,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Serous Cystadenofibroma
3718,Seminomatous Component Present,Monodermal teratoma
3719,Solid Growth Pattern,Aleukemic leukemia
3720,Indolent Clinical Course,Colon Sarcoma
3721,Invasive Lesion,Apocrine cystadenoma
3722,Benign Cellular Infiltrate,Secondary malignant neoplasm of stomach
3723,Metastatic Lesion,Parotid Gland Lymphangioma
3724,Intermediate Filaments Present,Angiosarcoma non-metastatic
3725,Borderline Lesion,Oncocytic Schneiderian papilloma
3726,Encapsulated Mass,Subcutaneous Nodular Fasciitis
3727,Benign Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v7
3728,Mucoid Stroma Formation,Glandular papilloma
3729,Seminomatous Component Present,Cystic teratoma
3730,CD30-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
3731,Indolent Clinical Course,Meningeal melanomatosis
3732,Mixed Cellular Population,Benign oncocytoma of salivary gland
3733,Invasive Lesion,Thymoma malignant noninvasive
3734,CD30-Positive Neoplastic Cells Present,Histiocytic and Dendritic Cell Neoplasm
3735,Histiocytosis,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
3736,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatitis B Virus-Related Hepatocellular Carcinoma
3737,Benign Cellular Infiltrate,Stage IA Esophageal Adenocarcinoma AJCC v7
3738,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Breast Phyllodes Tumor
3739,Benign Cellular Infiltrate,Stage 0 Esophageal Adenocarcinoma AJCC v7
3740,Borderline Lesion,Lung Glandular Papilloma
3741,Mucoid Stroma Formation,papillary carcinoma of penis
3742,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage D Adult Hepatocellular Carcinoma
3743,Favorable Clinical Outcome,Childhood Hepatocellular Carcinoma
3744,Benign Cellular Infiltrate,Adult Hepatocellular Carcinoma
3745,Intracytoplasmic Eosinophilic Inclusion,Stage IIA Soft Tissue Sarcoma AJCC v7
3746,Dysplasia,Benign Hair Follicle Neoplasm
3747,Benign Cellular Infiltrate,Gallbladder Lymphoma
3748,Benign Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas
3749,Invasive Lesion,Transitional cell carcinoma in situ
3750,Benign Cellular Infiltrate,Acinar cell cystadenocarcinoma
3751,Intracytoplasmic Eosinophilic Inclusion,Stage IV Soft Tissue Sarcoma AJCC v7
3752,Diffuse Lesion,Bladder Urothelial Papilloma
3753,Mucoid Stroma Formation,Serous surface papilloma
3754,Solid Growth Pattern,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
3755,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Colon Adenocarcinoma
3756,Favorable Clinical Outcome,Carcinoma Metastatic to the Skin
3757,Mixed Neoplastic Glandular and Squamous Cell Population,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
3758,Benign Cellular Infiltrate,Esophageal Poorly Differentiated Squamous Cell Carcinoma
3759,Benign Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v6 and v7
3760,Chronic Clinical Course,Acute myelomonocytic leukemia with abnormal eosinophils
3761,Indolent Clinical Course,Esophageal Rhabdomyosarcoma
3762,Benign Cellular Infiltrate,Bile duct cystadenocarcinoma
3763,Intermediate Filaments Present,Uterine Corpus Myxoid Leiomyosarcoma
3764,Intracytoplasmic Eosinophilic Inclusion,Sarcoma by FNCLCC Grade
3765,Well Differentiated Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
3766,Intermediate Filaments Present,Angiosarcoma of spleen
3767,Malignant Germinomatous Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy
3768,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Serrated Adenocarcinoma
3769,Favorable Clinical Outcome,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
3770,Intracytoplasmic Eosinophilic Inclusion,Peritoneal Desmoplastic Small Round Cell Tumor
3771,Intracytoplasmic Eosinophilic Inclusion,Sarcoma by AJCC Grade
3772,Localized Lesion,Non-Secretory Plasma Cell Myeloma
3773,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Adenocarcinoma
3774,Increased Cellularity Present,Urethral Inverted Papilloma
3775,Mucoid Stroma Formation,Urethral Inverted Papilloma
3776,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Conjunctival Intraepithelial Neoplasia
3777,Tubular Pattern,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
3778,Intracytoplasmic Eosinophilic Inclusion,Extra-osseous Ewing's sarcoma metastatic
3779,Solid Growth Pattern,Leukemic infiltration of skin
3780,Benign Cellular Infiltrate,AIDS-Related Malignant Anal Neoplasm
3781,Borderline Lesion,Bone Epithelioid Hemangioendothelioma
3782,Premalignant Lesion,Lung Lymphoepithelioma-Like Carcinoma
3783,Intermediate Filaments Present,Ameloblastic fibrosarcoma
3784,Seminomatous Component Present,Mature Testicular Teratoma
3785,Indolent Clinical Course,Region 17p13 Allelic Loss Associated Medulloblastoma
3786,Aggressive Clinical Course,Grade 1 Diffuse Follicular Lymphoma
3787,Intracytoplasmic Eosinophilic Inclusion,Childhood Spindle Cell Rhabdomyosarcoma
3788,Benign Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v6
3789,Infiltrative Growth Pattern,Ovarian Fibromata
3790,Infiltrating Tumor Margins Present,Endometrial stromal nodule
3791,Precise Histogenesis Unknown,Childhood Astrocytoma
3792,High Mitotic Activity,Low Grade Endometrial Stromal Sarcoma
3793,Necrotic changes (finding),Anaplastic Brain Stem Astrocytoma
3794,Intermediate Filaments Present,Low-grade fibromyxoid sarcoma
3795,Benign Cellular Infiltrate,Stage IIIB Small Intestinal Cancer AJCC v7
3796,Increased Cellularity Present,Renal Pelvis Urothelial Papilloma
3797,Mixed Neoplastic Glandular and Squamous Cell Population,Apocrine breast carcinoma
3798,Low Grade Lesion,Prostate Angiosarcoma
3799,Aggressive Clinical Course,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
3800,Solid Growth Pattern,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
3801,Benign Cellular Infiltrate,Rectosigmoid Cancer by AJCC v7 Stage
3802,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary renal cell carcinoma type 2
3803,Blasts Expressing CD56 and Immature T-Cell Markers Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
3804,Invasive Lesion,Cutaneous Fibrous Histiocytoma
3805,Benign Cellular Infiltrate,Recurrent Adult Liver Carcinoma
3806,Favorable Clinical Outcome,Hepatocellular Carcinoma by AJCC v7 Stage
3807,Favorable Clinical Outcome,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
3808,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Monoblastic Leukemia
3809,Solid Growth Pattern,Mixed phenotype acute leukemia T/myeloid
3810,Tumor Vascular Invasion,Aldosterone-Producing Adrenal Cortex Adenoma
3811,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Breast Fibroepithelial Neoplasm
3812,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of anal glands
3813,Indolent Clinical Course,Conventional Fibrosarcoma
3814,Intermediate Filaments Present,Lung Biphasic Synovial Sarcoma
3815,Grade 4 Lesion,"Diffuse Astrocytoma, IDH-Wildtype"
3816,Intermediate Filaments Present,Stage III Uterine Sarcoma AJCC v7
3817,Intracytoplasmic Eosinophilic Inclusion,Melanotic malignant nerve sheath tumor
3818,Premalignant Lesion,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
3819,Metastatic Lesion,ductal papilloma of salivary gland
3820,Mixed Cellular Population,Vaginal Squamous Papilloma
3821,Dysplasia,Vulvar Seborrheic Keratosis
3822,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
3823,Mixed Neoplastic Glandular and Squamous Cell Population,Rectosigmoid Adenocarcinoma
3824,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Solid Pattern"
3825,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Solid Pattern"
3826,Borderline Lesion,External Auditory Canal Ceruminous Adenoma
3827,Benign Cellular Infiltrate,Stage IIIB Gallbladder Cancer AJCC v7
3828,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal Papillary Adenocarcinoma
3829,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Hilar Cholangiocarcinoma AJCC v7
3830,atypia morphology,Giant Cell Tumor of Soft Tissue
3831,Chronic Clinical Course,Adult Acute Monoblastic Leukemia
3832,Invasive Lesion,Seborrheic keratosis
3833,Malignant Germinomatous Cellular Infiltrate,"Teratoma, Malignant"
3834,Acute Clinical Course,Hairy Cell Leukemia
3835,Solid Growth Pattern,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7
3836,Necrotic changes (finding),"Leydig cell tumor, benign"
3837,Mixed Neoplastic Glandular and Squamous Cell Population,Broad Ligament Serous Cystadenoma
3838,Precise Histogenesis Unknown,Anaplastic Astroblastoma
3839,High Mitotic Activity,Adult Oligodendroglioma
3840,Low Grade Lesion,Angiosarcoma of liver
3841,Indolent Clinical Course,Childhood Choroid Plexus Carcinoma
3842,Benign Cellular Infiltrate,Grade 3 Colorectal Adenocarcinoma
3843,Endophytic Tumor Growth,Common wart
3844,Syncytial Pattern,Nasopharyngeal Differentiated Carcinoma
3845,Intracytoplasmic Eosinophilic Inclusion,Aortic Angiosarcoma
3846,Solid Growth Pattern,Acute Adult T-Cell Leukemia/Lymphoma
3847,Borderline Lesion,Benign Ovarian Clear Cell Tumor
3848,Malignant Germinomatous Cellular Infiltrate,Pineal Region Immature Teratoma
3849,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Solid Serous Adenoma
3850,Indolent Clinical Course,Hodgkin's lymphoma of CNS
3851,Chronic Clinical Course,Acute Basophilic Leukemia
3852,Benign Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v7
3853,Capsular Invasion,Macrofollicular adenoma
3854,Low Mitotic Activity,Neuroendocrine carcinoma of appendix
3855,Benign Cellular Infiltrate,Colorectal Medullary Carcinoma
3856,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of vulva
3857,Intermediate Filaments Present,Anal Rhabdomyosarcoma
3858,Benign Cellular Infiltrate,Stage IIA Gastric Cancer AJCC v7
3859,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute panmyelosis with myelofibrosis
3860,Intermediate Filaments Present,Stage IIIB Uterine Sarcoma AJCC v7
3861,Acute Clinical Course,Splenic Manifestation of T-Cell Prolymphocytic Leukemia
3862,Precise Histogenesis Unknown,Childhood Cerebellar Astrocytoma
3863,Dysplasia,Trichodiscoma
3864,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Mucinous Cystadenofibroma
3865,Intermediate Filaments Present,Fusion-Positive Rhabdomyosarcoma
3866,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Transitional Cell Tumor
3867,Mucoid Stroma Formation,Recurrent respiratory papillomatosis
3868,Solid Growth Pattern,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
3869,Mixed Neoplastic Glandular and Squamous Cell Population,Condyloma acuminata of vagina
3870,Prominent Schwannian Stroma Present,Stage 4S neuroblastoma
3871,Indolent Clinical Course,sarcoma of mediastinum
3872,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal Basaloid Carcinoma
3873,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Adult Hepatocellular Carcinoma
3874,Capsular Invasion,Thyroid Gland Signet Ring Cell Follicular Adenoma
3875,Benign Cellular Infiltrate,Stage III Esophageal Adenocarcinoma AJCC v7
3876,Carcinomatous Component Present,Oral Cavity Pleomorphic Adenoma
3877,Intracytoplasmic Eosinophilic Inclusion,Secondary Chondrosarcoma
3878,Mixed Neoplastic Glandular and Squamous Cell Population,verrucous carcinoma of vulva
3879,Dysplasia,Desmoplastic trichilemmoma
3880,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, Scirrhous"
3881,Indolent Clinical Course,Inflammatory liposarcoma
3882,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of urethra
3883,Squamous Differentiation,undifferentiated carcinoma of cervix
3884,Mixed Neoplastic Glandular and Squamous Cell Population,Ceruminous adenocarcinoma
3885,Low Mitotic Activity,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
3886,Squamous Differentiation,undifferentiated carcinoma of larynx
3887,Dysplasia,Seborrheic keratosis of eyelid
3888,Benign Cellular Infiltrate,recurrent gastric cancer
3889,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the prostate stage II
3890,Villous Pattern,Appendix Tubular Adenoma
3891,Glandular Differentiation,Large cell neuroendocrine carcinoma
3892,High Mitotic Activity,Pancreatic Somatostatinoma
3893,Solid Growth Pattern,ROSE Cluster 7
3894,Mixed Neoplastic Glandular and Squamous Cell Population,Flat Ductal Epithelial Atypia of the Breast
3895,Invasive Lesion,Dermoid cyst of skin
3896,Acinar Cell Differentiation,signet ring cell carcinoma of pancreas
3897,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Ductal Breast Carcinoma In Situ
3898,Favorable Clinical Outcome,Malignant fibrous histiocytoma of skin
3899,Fibrotic Stroma Formation,"Hodgkin lymphoma, nodular sclerosis, cellular phase"
3900,No Evidence of Radiologic Finding,Occult Lung Non-Small Cell Carcinoma
3901,Chronic Clinical Course,ROSE Cluster 1
3902,Borderline Lesion,Inverted urothelial papilloma
3903,Solid Growth Pattern,Chronic lymphocytic leukemia stage 3
3904,Focal dysplasia,Colon Traditional Serrated Adenoma
3905,Intermediate Filaments Present,Stage IIB Osteosarcoma AJCC v7
3906,Seminomatous Component Present,Central Nervous System Dermoid Cyst
3907,Seminomatous Component Present,Stage II Ovarian Teratoma AJCC v6 and v7
3908,Mixed Neoplastic Glandular and Squamous Cell Population,Ethmoid Sinus Schneiderian Papilloma
3909,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct mucinous adenocarcinoma
3910,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Melanoma
3911,Diffuse Lesion,Recurrent Inverted Schneiderian Papilloma
3912,Neuroectodermal Differentiation,Localized Ewing Sarcoma
3913,Indolent Clinical Course,Stage II Uterine Sarcoma AJCC v7
3914,Chronic Clinical Course,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
3915,Mucoid Stroma Formation,"Papillary squamous cell carcinoma, non-invasive"
3916,Precise Histogenesis Unknown,Anaplastic Oligoastrocytoma
3917,Benign Cellular Infiltrate,Carcinoma of anal canal
3918,Intestinal metaplasia,"Carcinoma, diffuse type"
3919,Indolent Clinical Course,Classic medulloblastoma
3920,Intracytoplasmic Eosinophilic Inclusion,Alveolar soft part sarcoma non-metastatic
3921,Mixed Neoplastic Glandular and Squamous Cell Population,Fetal Lung Adenocarcinoma
3922,Mixed Neoplastic Glandular and Squamous Cell Population,Sphenoid Sinus Inverted Papilloma
3923,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of lung
3924,Intracytoplasmic Eosinophilic Inclusion,Low Grade Endometrioid Stromal Sarcoma of the Cervix
3925,Pushing Tumor Margin,Low Grade Endometrioid Stromal Sarcoma of the Cervix
3926,High Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v7
3927,Premalignant Lesion,Pulmonary Blastoma
3928,Mixed Neoplastic Glandular and Squamous Cell Population,Early gastric cancer
3929,Indolent Clinical Course,Olfactory Neuroblastoma
3930,Favorable Clinical Outcome,Stage II Superficial Spreading Melanoma AJCC v6 and v7
3931,Diffuse Lesion,"Hemangioma, Cavernous, Central Nervous System"
3932,Mucoid Stroma Formation,Papillary squamous cell carcinoma
3933,Intermediate Filaments Present,Osteosarcoma
3934,Diffuse Lesion,Tufted angioma of skin
3935,Junctional Proliferation,Common blue nevus of skin
3936,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Adrenal Cortex Carcinoma AJCC v7
3937,Calcinosis,Nonossifying Fibromyxoid Tumor
3938,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
3939,Malignant Germinomatous Cellular Infiltrate,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
3940,Benign Cellular Infiltrate,Unresectable Esophageal Carcinoma
3941,Premalignant Lesion,"Adenocarcinoma of lung, stage I"
3942,Indolent Clinical Course,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
3943,Chronic Clinical Course,Childhood Acute Monoblastic Leukemia
3944,Borderline Lesion,Benign squamous cell tumor
3945,Indolent Clinical Course,Peripheral neuroepithelioma of bone recurrent
3946,Premalignant Lesion,Adenocarcinoma of lung stage IIIA
3947,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, small cell, nonkeratinizing"
3948,Metastatic Lesion,"Adenoma, Monomorphic"
3949,Indolent Clinical Course,Conventional Leiomyosarcoma
3950,Indolent Clinical Course,Endometrial Stromal Sarcoma
3951,Precise Histogenesis Unknown,Proneural Glioblastoma
3952,Dysplasia,Benign Cutaneous Vascular Neoplasm
3953,Mucoid Stroma Formation,Papillary Urothelial Neoplasm
3954,Intermediate Filaments Present,Sarcoma of skin
3955,Indolent Clinical Course,Primary leiomyosarcoma
3956,Intermediate Filaments Present,Cardiac Leiomyosarcoma
3957,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
3958,Benign Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v7
3959,Grade 4 Lesion,Gemistocytic astrocytoma
3960,Acute Clinical Course,T-Cell Prolymphocytic Leukemia
3961,Benign Cellular Infiltrate,Gallbladder adenocarcinoma
3962,Indolent Clinical Course,Intracranial Melanoma
3963,Benign Cellular Infiltrate,Malignant neoplasm of large intestine
3964,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
3965,Intermediate Filaments Present,Peripheral Intraneural Angiosarcoma
3966,Benign Cellular Infiltrate,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm
3967,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Embryonal Carcinoma
3968,Mixed Neoplastic Glandular and Squamous Cell Population,Vestibular Micropapillomatosis
3969,Anaplasia,Childhood Ganglioglioma
3970,Benign Cellular Infiltrate,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
3971,Dysplasia,Dermal Fibroma
3972,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Immature Teratoma
3973,Invasive Lesion,Stage 0 Vulvar Cancer
3974,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in tubular adenoma
3975,Borderline Lesion,Benign Ovarian Transitional Cell Tumor
3976,Indolent Clinical Course,Kaposi's sarcoma of palate
3977,Intermediate Filaments Present,Sarcoma NCI Grade 1
3978,Composite Lesion,Microscopic Thymoma
3979,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
3980,Low Grade Lesion,Aortic Angiosarcoma
3981,Glandular Differentiation,Prostate Undifferentiated Carcinoma
3982,Differentiating Neuroblasts Present,Undifferentiated Neuroblastoma
3983,High Mitotic Activity,Jejunal Neuroendocrine Tumor G1
3984,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Prostatic Intraepithelial Neoplasia
3985,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Choriocarcinoma
3986,Indolent Clinical Course,Lymphadenopathic Kaposi Sarcoma
3987,Mixed Neoplastic Glandular and Squamous Cell Population,Acantholytic squamous cell carcinoma of skin
3988,Favorable Clinical Outcome,Lip basal cell carcinoma
3989,Tubular Pattern,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
3990,Favorable Clinical Outcome,Primary cutaneous diffuse large cell B-cell lymphoma
3991,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Carcinoma of the Penis, Usual Type"
3992,Single Type of Tissue Derived from One Embryonic Layer Present,Dermoid cyst of ovary
3993,Seminomatous Component Present,Benign germ cell neoplasm
3994,Mixed Neoplastic Glandular and Squamous Cell Population,Moderately Differentiated Prostate Adenocarcinoma
3995,Low Grade Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
3996,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Enteric Pattern"
3997,Local disease,Advanced Favorable Non-Hodgkin Lymphoma
3998,Borderline Lesion,Glomerulosa Cell Adrenal Cortical Adenoma
3999,Solid Growth Pattern,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
4000,Indolent Clinical Course,germinoma of brain
4001,Indolent Clinical Course,Childhood Central Nervous System Embryonal Neoplasm
4002,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Immature Teratoma
4003,Benign Cellular Infiltrate,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
4004,Favorable Clinical Outcome,Carcinoma ex Eccrine Spiradenoma
4005,Aggressive Clinical Course,Thymic Mucosa-Associated Lymphoid Tissue Lymphoma
4006,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal adenocarcinoma recurrent
4007,Well-Circumscribed Lesion,Gliomatosis Cerebri Type I
4008,Indolent Clinical Course,Synovial sarcoma non-metastatic
4009,Mixed Neoplastic Glandular and Squamous Cell Population,Oncocytic Schneiderian papilloma
4010,Indolent Clinical Course,Radiation-Related Sarcoma
4011,Mixed Epithelial Cell Population,Glandular papilloma
4012,Inflammation,HNF1alpha-Inactivated Hepatocellular Adenoma
4013,Premalignant Lesion,Transplant-Related Lung Carcinoma
4014,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
4015,Favorable Clinical Outcome,Mycosis fungoides refractory
4016,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Squamous Cell Carcinoma
4017,Solid Growth Pattern,Progressive Hairy Cell Leukemia Initial Treatment
4018,Mitotic Activity,Childhood Diffuse Astrocytoma
4019,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
4020,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Tumor
4021,Intermediate Filaments Present,Stage IA Adult Soft Tissue Sarcoma AJCC v7
4022,Solid Growth Pattern,Childhood Burkitt Leukemia
4023,Borderline Lesion,Lung Mucinous Cystadenoma
4024,Blasts Expressing CD56 and Immature T-Cell Markers Present,Infant Acute Biphenotypic Leukemia
4025,Blasts of Mixed Phenotype Present,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
4026,Acute Clinical Course,Recurrent Chronic Lymphoid Leukemia
4027,Premalignant Lesion,Occult Lung Squamous Cell Carcinoma
4028,Indolent Clinical Course,Childhood Anaplastic Oligoastrocytoma
4029,Malignant Germinomatous Cellular Infiltrate,Teratoma of testis
4030,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of pancreas
4031,Mixed Neoplastic Glandular and Squamous Cell Population,Intestinal Intraepithelial Neoplasia
4032,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Basophilic Leukemia
4033,High Mitotic Activity,"Somatostatinoma, malignant"
4034,Exophytic Polypoid Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
4035,Benign Cellular Infiltrate,Colorectal Micropapillary Adenocarcinoma
4036,Intermediate Filaments Present,AIDS-Related Gastric Kaposi Sarcoma
4037,Grade 4 Lesion,Childhood Cerebral Anaplastic Astrocytoma
4038,Chronic Clinical Course,Childhood Acute Myeloid Leukemia with Minimal Differentiation
4039,Severe cytologic atypia,Gastro-enteropancreatic neuroendocrine tumor
4040,Benign Cellular Infiltrate,Esophageal carcinoma recurrent
4041,Invasive Lesion,Low Grade Ductal Breast Carcinoma In Situ
4042,Favorable Clinical Outcome,Recurrent Skin Carcinoma
4043,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Sarcoma
4044,Intracytoplasmic Eosinophilic Inclusion,Solid Alveolar Rhabdomyosarcoma
4045,Metastatic Lesion,sialadenoma papilliferum of salivary gland
4046,Premalignant Lesion,"Bronchiolo-alveolar carcinoma, non-mucinous"
4047,Invasive Lesion,Hidrocystoma
4048,Intermediate Filaments Present,Metastatic Ewing's Sarcoma
4049,Invasive Lesion,Biliary Intraepithelial Neoplasia
4050,Microvascular Proliferation,Adult Anaplastic Astrocytoma
4051,Intracytoplasmic Eosinophilic Inclusion,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
4052,Chronic Clinical Course,Childhood Acute Promyelocytic Leukemia with PML-RARA
4053,Mixed Neoplastic Glandular and Squamous Cell Population,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
4054,Intracytoplasmic Eosinophilic Inclusion,Extra-osseous Ewing's sarcoma recurrent
4055,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Squamous Intraepithelial Neoplasia
4056,Invasive Lesion,Acanthoma
4057,Borderline Lesion,Acanthoma
4058,Seminomatous Component Present,Thyroid Gland Teratoma
4059,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Myeloid Leukemia (AML-M2)
4060,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
4061,Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
4062,Invasive Lesion,Trichoepithelioma
4063,Indolent Clinical Course,Prostate Carcinoma Metastatic in the Bone
4064,Locally Aggressive Lesion,Ovarian Fibromata
4065,Glandular Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct
4066,Intermediate Filaments Present,Classical Low Grade Fibromyxoid Sarcoma
4067,Favorable Clinical Outcome,Basal cell carcinoma - adamantinoid
4068,Benign Cellular Infiltrate,Colorectal Cancer by AJCC v7 Stage
4069,Benign Cellular Infiltrate,Secondary malignant neoplasm of pancreas
4070,Diffuse Lesion,Pyogenic granuloma of oral mucosa
4071,Malignant Germinomatous Cellular Infiltrate,Benign Struma Ovarii
4072,Mixture of Germ Cell Neoplastic Components Present,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
4073,Well-Circumscribed Lesion,Cutaneous Fibrous Histiocytoma
4074,Mixed Neoplastic Glandular and Squamous Cell Population,Well Differentiated Hepatocellular Carcinoma
4075,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Childhood Hepatocellular Carcinoma
4076,Invasive Lesion,Stage 0 Ureter Cancer AJCC v7
4077,Diffuse Lesion,Hemangioma of bone
4078,Benign Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma
4079,Borderline Lesion,Ovarian Endometrioid Cystadenofibroma
4080,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma of lung, stage III"
4081,Benign Cellular Infiltrate,Stage IIA Distal Bile Duct Cancer AJCC v7
4082,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Verrucous Carcinoma
4083,Seminomatous Component Present,Dermoid cyst with secondary tumor
4084,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Monocytic Leukemia
4085,Mixed Neoplastic Glandular and Squamous Cell Population,hepatoid adenocarcinoma of gallbladder
4086,Infiltrative Growth Pattern,Kidney Fibroma
4087,Indolent Clinical Course,Monophasic Synovial Sarcoma
4088,Chronic Clinical Course,Acute Myeloid Leukemia with a Variant RARA Translocation
4089,Aggressive Clinical Course,Stage II Indolent Adult Non-Hodgkin Lymphoma
4090,Benign Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7
4091,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Monocytic Leukemia
4092,Squamous Differentiation,Nasopharyngeal lymphoepithelioma stage III
4093,Benign Cellular Infiltrate,Gallbladder Carcinoma
4094,Solid Growth Pattern,Central nervous system leukemia
4095,atypia morphology,Ventricular myxoma
4096,Precise Histogenesis Unknown,Giant Cell Glioblastoma
4097,Increased red cell mass,"Thrombocythemia, Essential"
4098,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal squamous cell carcinoma recurrent
4099,CD30-Positive Neoplastic Cells Present,Indeterminate dendritic cell tumor
4100,Mixed Neoplastic Glandular and Squamous Cell Population,Serous cystadenocarcinoma ovary
4101,Dysplasia,Vulvar Papillary Hidradenoma
4102,Indolent Clinical Course,Childhood Central Nervous System Germinoma
4103,Severe cytologic atypia,Pancreatic Somatostatinoma
4104,Borderline Lesion,Choroid Plexus Papilloma
4105,Favorable Clinical Outcome,Malignant blue nevus of skin
4106,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
4107,Junctional Proliferation,"Nevus, Blue"
4108,Benign Cellular Infiltrate,Cholangiocarcinoma
4109,Borderline Lesion,Papilloma of buccal mucosa
4110,Borderline Lesion,Ovarian Clear Cell Cystadenofibroma
4111,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Endometrial Endometrioid Adenocarcinoma
4112,Invasive Lesion,Small Intestinal High Grade Intraepithelial Neoplasia
4113,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Densely Granulated Somatotroph Adenoma
4114,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal verrucous carcinoma
4115,Mixed Neoplastic Glandular and Squamous Cell Population,Thymic Basaloid Carcinoma
4116,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Peritoneal Serous Adenocarcinoma
4117,Cholesterolosis,Papillary craniopharyngioma
4118,Locally Aggressive Lesion,Intravascular fasciitis
4119,Indolent Clinical Course,Liver Fibrosarcoma
4120,Benign Cellular Infiltrate,Adenocarcinoma Of Esophagus
4121,Composite Lesion,Mediastinal Thymoma
4122,Intestinal metaplasia,Metastatic Signet Ring Cell Breast Carcinoma
4123,Indolent Clinical Course,sarcoma of esophagus
4124,Intracytoplasmic Eosinophilic Inclusion,Endemic African Kaposi Sarcoma
4125,Benign Cellular Infiltrate,Carcinoma of extrahepatic bile duct
4126,Mixed Neoplastic Glandular and Squamous Cell Population,verrucous carcinoma of bladder
4127,Favorable Clinical Outcome,Stage IIIA Adult Liver Cancer AJCC v7
4128,Capsular Invasion,Thyroid Gland Lipoadenoma
4129,Mitotic Activity,Well-differentiated papillary mesothelioma
4130,Aggressive Clinical Course,Malignant lymphoma - lymphoplasmacytic
4131,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Squamous Neoplasm
4132,Intermediate Filaments Present,Stage IVA Bone Sarcoma AJCC v7
4133,Premalignant Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7
4134,Solid Growth Pattern,Adult Acute Myeloid Leukemia with Maturation
4135,Favorable Clinical Outcome,Scrotal Carcinoma
4136,Favorable Clinical Outcome,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
4137,Mature Neutrophils Present,Immature Granulocytic Sarcoma
4138,Squamous Differentiation,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
4139,Malignant Germinomatous Cellular Infiltrate,Choriocarcinoma of the Testis
4140,Indolent Clinical Course,fibrosarcoma of kidney
4141,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, metastatic"
4142,Mixed Neoplastic Glandular and Squamous Cell Population,"Lung Squamous Cell Carcinoma, Small Cell Variant"
4143,Glandular Differentiation,Undifferentiated carcinoma of nasopharynx
4144,Blasts Expressing CD56 and Immature T-Cell Markers Present,Acute bilineal leukemia
4145,Favorable Clinical Outcome,Stage II Lip Basal Cell Carcinoma
4146,Solid Growth Pattern,Acute Myeloid Leukemia with Variant MLL Translocations
4147,Intermediate Filaments Present,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
4148,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
4149,Invasive Lesion,Pancreatic Intraepithelial Neoplasia-3
4150,Mitotic Activity,Childhood Gemistocytic Astrocytoma
4151,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Mucinous Adenocarcinoma
4152,Infiltrative Growth Pattern,Fibroma of prostate
4153,Solid Growth Pattern,Acute leukemia
4154,Invasive Lesion,Follicular Myxoma
4155,Squamous Differentiation,undifferentiated carcinoma of urethra
4156,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Tumor G2
4157,Mixed Neoplastic Glandular and Squamous Cell Population,Villous adenoma of colon
4158,Chronic Clinical Course,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative"
4159,Mixed Neoplastic Glandular and Squamous Cell Population,Sarcomatoid Carcinoma of the Penis
4160,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Hepatocellular Carcinoma
4161,Solid Growth Pattern,Acute Megakaryocytic Leukemias
4162,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
4163,Local disease,Lipoblastomatosis
4164,Borderline Lesion,Syringofibroadenoma
4165,Indolent Clinical Course,Adult Glioblastoma
4166,Benign Cellular Infiltrate,Postsurgical Stage IV Hepatoblastoma
4167,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Leiomyosarcoma
4168,Necrotic changes (finding),Childhood Cerebellar Anaplastic Astrocytoma
4169,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
4170,Benign Cellular Infiltrate,Colon Micropapillary Adenocarcinoma
4171,Solid Growth Pattern,"Acute myeloid leukemia, t(8;21) (q22;q22)"
4172,Intermediate Filaments Present,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
4173,Mixed Neoplastic Glandular and Squamous Cell Population,minimally invasive follicular carcinoma of the thyroid gland
4174,Chronic Clinical Course,Acute myeloid leukemia with multilineage dysplasia
4175,Favorable Clinical Outcome,BCLC Stage B Adult Hepatocellular Carcinoma
4176,Indolent Clinical Course,rhabdomyosarcoma of mediastinum
4177,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct adenocarcinoma
4178,Benign Cellular Infiltrate,signet ring cell carcinoma of pancreas
4179,Mucoid Stroma Formation,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
4180,Indolent Clinical Course,Grade I Chondrosarcoma
4181,Benign Cellular Infiltrate,Gastric lymphoma
4182,Invasive Lesion,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
4183,High Mitotic Activity,Carcinoid tumor of appendix
4184,Increased Cellularity Present,Inverted urothelial papilloma
4185,Borderline Lesion,Hidrocystoma
4186,Low Grade Lesion,Pancreatic Endocrine Carcinoma
4187,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Acinar-Ductal Carcinoma of the Pancreas
4188,Indolent Clinical Course,Mediastinal Extraskeletal Osteosarcoma
4189,Mucoid Stroma Formation,Lung Squamous Cell Papilloma
4190,Mixed Cellular Population,Parotid monomorphic adenoma
4191,Metastatic Lesion,"Adenoma, Basal Cell"
4192,Monoclonal Paraproteinemia,Non-Secretory Plasma Cell Myeloma
4193,Intermediate Filaments Present,Kaposi's sarcoma of conjunctiva
4194,Premalignant Lesion,Solid Lung Adenocarcinoma
4195,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of cornea
4196,Increased Cellularity Present,Ureter Inverted Papilloma
4197,Benign Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm
4198,Precise Histogenesis Unknown,Tanycytic ependymoma
4199,Indolent Clinical Course,Epithelioid sarcoma metastatic
4200,Precise Histogenesis Unknown,Cerebellar Liponeurocytoma
4201,Tumor Vascular Invasion,Thyroid Gland Hyperfunctioning Adenoma
4202,Intracytoplasmic Eosinophilic Inclusion,"Synovial sarcoma, biphasic"
4203,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Ductal Breast Carcinoma
4204,Invasive Lesion,Esophageal Squamous Intraepithelial Neoplasia
4205,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Glandular Intraepithelial Neoplasia
4206,Benign Cellular Infiltrate,Malignant neoplasm of gallbladder
4207,Intermediate Filaments Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
4208,Benign Cellular Infiltrate,Early gastric cancer
4209,Intermediate Filaments Present,Childhood Parosteal Osteosarcoma
4210,Dysplasia,Cutaneous leiomyoma
4211,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiolocellular Carcinoma
4212,Borderline Lesion,Fallopian Tube Papilloma
4213,Locally Aggressive Lesion,"Myositis, Proliferative"
4214,Benign Cellular Infiltrate,Cholangiocarcinoma non-resectable
4215,Mucoid Stroma Formation,Intraductal papillary breast neoplasm
4216,Indolent Clinical Course,Anaplastic Brain Stem Astrocytoma
4217,Benign Cellular Infiltrate,Adenocarcinoma of small intestine
4218,Prominent Collagen Rosette Formation,Classical Low Grade Fibromyxoid Sarcoma
4219,Anaplasia,Ependymoma
4220,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of cervix
4221,Squamous Differentiation,Large cell lung cancer stage I
4222,Benign Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage
4223,Favorable Clinical Outcome,adenosquamous carcinoma of skin
4224,Benign Cellular Infiltrate,Adult Cholangiocarcinoma
4225,Mixed Neoplastic Glandular and Squamous Cell Population,Sporadic Diffuse Gastric Adenocarcinoma
4226,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Leiomyosarcoma
4227,Intermediate Filaments Present,Clear Cell Sarcoma of Soft Tissue
4228,Solid Growth Pattern,Acute Promyelocytic Leukemia
4229,Mixed Cellular Population,Benign squamous cell tumor
4230,Benign Cellular Infiltrate,Helicobacter Pylori-Related Gastric Adenocarcinoma
4231,Borderline Lesion,Androgen-Producing Adrenal Cortex Adenoma
4232,Microvascular Proliferation,Mixed Oligodendroglioma-Astrocytoma
4233,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of skin
4234,Intermediate Filaments Present,Melanotic malignant nerve sheath tumor
4235,Benign Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v7
4236,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
4237,Precise Histogenesis Unknown,Mixed astrocytoma-ependymoma
4238,Microvascular Proliferation,"Anaplastic Astrocytoma, IDH-Mutant"
4239,Solid Growth Pattern,Acute Myeloid Leukemia with a Variant RARA Translocation
4240,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Yolk Sac Tumor
4241,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Mature Teratoma
4242,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of large intestine
4243,Microvascular Proliferation,Childhood Cerebral Diffuse Astrocytoma
4244,Borderline Lesion,Seborrheic keratosis
4245,Squamous Differentiation,Large cell carcinoma of lung
4246,Precise Histogenesis Unknown,Astroblastoma
4247,Mucoid Stroma Formation,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
4248,Intermediate Filaments Present,sarcoma of central nervous system
4249,Severe cytologic atypia,Malignant Pancreatic Vipoma
4250,Favorable Clinical Outcome,Peripheral Intrahepatic Cholangiocarcinoma
4251,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of lacrimal gland
4252,Low Mitotic Activity,small cell carcinoma of gallbladder
4253,Invasive Lesion,Low Grade Corneal Intraepithelial Neoplasia
4254,Indolent Clinical Course,Sarcoma of orbit
4255,Benign Cellular Infiltrate,Hepatocellular Carcinoma by BCLC Stage
4256,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
4257,Aggressive Clinical Course,Mucosa-Associated Lymphoid Tissue Lymphoma
4258,Borderline Lesion,Sclerosing Breast Papilloma
4259,Favorable Clinical Outcome,BCLC Stage A Hepatocellular Carcinoma
4260,Premalignant Lesion,Metastatic Carcinoma in the Lung
4261,Tubular Pattern,Pancreatic Intraductal Papillary Mucinous Neoplasm
4262,Perineural spread,Parathyroid mixed cell type adenoma
4263,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
4264,Intermediate Filaments Present,Malignant fibrous histiocytoma metastatic
4265,Epidermal Involvement,"Nevus, Intradermal"
4266,Locally Aggressive Lesion,Elastofibroma
4267,Favorable Clinical Outcome,Multifocal superficial basal cell carcinoma
4268,Prominent Schwannian Stroma Present,Kadish Stage C Olfactory Neuroblastoma
4269,High Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G1
4270,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of liver
4271,Nuclear Pseudoinclusion,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
4272,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of anus
4273,"Undifferentiated ""Fetal-Type"" Tissues Present",Adult Central Nervous System Mature Teratoma
4274,Follicular Structures Present,Poorly Differentiated Thyroid Carcinoma
4275,Borderline Lesion,Clear cell hidradenoma
4276,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Oncocytic Adenoma
4277,Mixed Neoplastic Glandular and Squamous Cell Population,Papilloma of buccal mucosa
4278,CD30-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Follicular"
4279,Mucoid Stroma Formation,Squamous cell papilloma of skin
4280,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Basophilic Leukemia
4281,Pineocytomatous Rosette Formation,pineoblastoma
4282,Nuclear Clearing,Macrofollicular adenoma
4283,High Mitotic Activity,Colon Leiomyoma
4284,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Erythroblastic Leukemia
4285,Benign Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v7
4286,Dysplasia,Piloleiomyoma
4287,Nuclear Clearing,Thyroid Gland Mucinous Follicular Adenoma
4288,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma of bone
4289,Mitotic Activity,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
4290,Pregnancy Complications,Childhood Ovarian Choriocarcinoma
4291,Favorable Clinical Outcome,Eccrine carcinoma of skin
4292,Benign Cellular Infiltrate,Small intestine carcinoma non-resectable
4293,"Undifferentiated ""Fetal-Type"" Tissues Present",Ovarian Fetiform Teratoma
4294,Benign Cellular Infiltrate,Gallbladder adenosquamous carcinoma
4295,Indolent Clinical Course,Cardiac Sarcoma
4296,Localized Lesion,DS Stage II Plasma Cell Myeloma
4297,CD21-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
4298,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct clear cell adenocarcinoma
4299,Favorable Clinical Outcome,Ocular Sebaceous Carcinoma
4300,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct signet-ring cell carcinoma
4301,Squamous Differentiation,undifferentiated carcinoma of salivary gland
4302,Benign Cellular Infiltrate,Adenosquamous Bile Duct Carcinoma
4303,Mucoid Stroma Formation,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
4304,Diffuse Lesion,Hemangioma of intra-abdominal structure
4305,CD15-Positive Neoplastic Cells Present,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma
4306,Borderline Lesion,Epidermolytic acanthoma
4307,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Tumor
4308,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma
4309,Mixture of Germ Cell Neoplastic Components Present,Adult Central Nervous System Choriocarcinoma
4310,Favorable Clinical Outcome,Pigmented Basal Cell Carcinoma
4311,High Mitotic Activity,Adult Subependymoma
4312,Solid Growth Pattern,Infant T Acute Lymphoblastic Leukemia
4313,Borderline Lesion,Hidroacanthoma simplex
4314,Intermediate Filaments Present,liposarcoma of vulva
4315,Chronic Clinical Course,Alkylating Agent-Related Acute Myeloid Leukemia
4316,Indolent Clinical Course,Stage IIB Soft Tissue Sarcoma AJCC v7
4317,Intermediate Filaments Present,Stage IIB Soft Tissue Sarcoma AJCC v7
4318,Metaplasia of Malignant Cells Present,Intestinal-Type Sinonasal Adenocarcinoma
4319,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraepithelial Neoplasia-1
4320,Extraocular Dissemination of Disease,Intraocular retinoblastoma
4321,Chronic Clinical Course,Acute Myeloid Leukemia with t(17;17)(q21;q21)
4322,Indolent Clinical Course,Stage III Soft Tissue Sarcoma AJCC v7
4323,Intermediate Filaments Present,Adult Clear Cell Sarcoma of Soft Parts
4324,Mixed Neoplastic Glandular and Squamous Cell Population,Rectal Cribriform Comedo-Type Adenocarcinoma
4325,Mixed Cellular Population,Cervical Squamous Papilloma
4326,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Rectal Adenocarcinoma
4327,Well-Circumscribed Lesion,Anaplastic Embryonal Rhabdomyosarcoma
4328,Precise Histogenesis Unknown,Childhood Infratentorial Ependymoma
4329,Solid Growth Pattern,Childhood Acute Megakaryoblastic Leukemia
4330,Absence of a Hormonal Syndrome,Pancreatic Gastrin-Producing Neuroendocrine Tumor
4331,Precise Histogenesis Unknown,Recurrent Childhood Optic Nerve Astrocytoma
4332,Benign Cellular Infiltrate,Solid pseudopapillary tumor of the pancreas
4333,Precise Histogenesis Unknown,Well Differentiated Oligodendroglioma
4334,High Grade Lesion,Grade I Chondrosarcoma
4335,Squamous Differentiation,Endometrial Undifferentiated Carcinoma
4336,Histiocytosis,Adult Immunoblastic Lymphoma
4337,Severe cytologic atypia,Carcinoid tumor of appendix
4338,Invasive Lesion,cystadenoma of salivary gland
4339,Infiltrative Growth Pattern,Cardiac fibroma
4340,Borderline Lesion,Benign germ cell tumor of ovary
4341,Intermediate Filaments Present,Stage IVB Uterine Sarcoma AJCC v7
4342,Indolent Clinical Course,Grade III Chondrosarcoma
4343,Intermediate Filaments Present,Esophageal Synovial Sarcoma
4344,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma
4345,Intermediate Filaments Present,Adult Fibrosarcoma
4346,Mixed Cellular Population,"Adenoma, Basal Cell"
4347,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Non-Keratinizing Squamous Cell Carcinoma
4348,Keratin pearl formation,Cervical Non-Keratinizing Squamous Cell Carcinoma
4349,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Cribriform Comedo-Type Adenocarcinoma
4350,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Papillary Adenocarcinoma
4351,Mucoid Stroma Formation,Clear Cell Papillary Cystadenoma
4352,Chronic Clinical Course,Erythroleukemia (Erythroid/Myeloid)
4353,Borderline Lesion,Inverted Squamous Cell Papilloma
4354,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary Kidney Oncocytoma
4355,Intermediate Filaments Present,Childhood Malignant Peripheral Nerve Sheath Tumor
4356,Intermediate Filaments Present,"Synovial sarcoma, spindle cell"
4357,Benign Cellular Infiltrate,Gastric Synovial Sarcoma
4358,Mucoid Stroma Formation,Ethmoid Sinus Inverted Papilloma
4359,Malignant Germinomatous Cellular Infiltrate,Ovarian Monodermal and Highly Specialized Teratoma
4360,Indolent Clinical Course,Malignant Intracranial Germ Cell Tumor
4361,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated Endocervical Sarcoma
4362,Severe cytologic atypia,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
4363,Mixed Neoplastic Glandular and Squamous Cell Population,Type II Endometrial Adenocarcinoma
4364,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Acinar Adenocarcinoma
4365,Diffuse Lesion,Fallopian Tube Papilloma
4366,Intermediate Filaments Present,Adult Extraskeletal Osteosarcoma
4367,Indolent Clinical Course,hemangioendothelial sarcoma of bone
4368,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma
4369,Aggressive Clinical Course,BALT lymphoma
4370,Borderline Lesion,"Oncocytoma, renal"
4371,Borderline Lesion,Non-Functioning Adrenal Cortex Adenoma
4372,Intermediate Filaments Present,Spindle cell rhabdomyosarcoma
4373,Intermediate Filaments Present,Recurrent Childhood Rhabdomyosarcoma
4374,Mucoid Stroma Formation,Vaginal Papillary Carcinoma
4375,Benign Cellular Infiltrate,Colorectal Burkitt Lymphoma
4376,High Grade Lesion,Intraosseous well differentiated osteosarcoma
4377,Mixed Neoplastic Glandular and Squamous Cell Population,Cecum Villous Adenoma
4378,Acute Clinical Course,"Leukemia, Prolymphocytic, B-Cell"
4379,Favorable Clinical Outcome,Cutaneous Chronic Lymphocytic Leukemia
4380,Carcinomatous Component Present,Breast Pleomorphic Adenoma
4381,Well-Circumscribed Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
4382,Premalignant Lesion,Malignant neoplasm of lung
4383,Squamous Differentiation,Cervical Lymphoepithelioma-Like Carcinoma
4384,Indolent Clinical Course,Liposarcoma metastatic
4385,Precise Histogenesis Unknown,Pineal Gland Astrocytoma
4386,Grade 4 Lesion,"Anaplastic Astrocytoma, IDH-Mutant"
4387,Benign Cellular Infiltrate,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
4388,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Mucinous Adenocarcinoma
4389,Homer Wright Rosette Formation,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
4390,Intermediate Filaments Present,liposarcoma of bone
4391,Premalignant Lesion,Non-small cell lung cancer stage II
4392,Mixture of Germ Cell Neoplastic Components Present,"Seminoma, anaplastic"
4393,Mixed Neoplastic Glandular and Squamous Cell Population,Posterior Pharyngeal Wall Squamous Cell Carcinoma
4394,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
4395,Mucoid Stroma Formation,Vestibular Micropapillomatosis
4396,Invasive Lesion,Vulvar Inverted Follicular Keratosis
4397,Mixed Neoplastic Glandular and Squamous Cell Population,Ductal Breast Carcinoma
4398,Benign Cellular Infiltrate,PRETEXT Stage 1 Hepatoblastoma
4399,Mixture of Germ Cell Neoplastic Components Present,Gastric Choriocarcinoma
4400,Well-Circumscribed Lesion,Extra-abdominal fibromatosis
4401,Indolent Clinical Course,Metastatic osteosarcoma
4402,Aggressive Clinical Course,Subcutaneous panniculitis-like T-cell lymphoma
4403,High Mitotic Activity,leiomyoma of trachea
4404,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage C Hepatocellular Carcinoma
4405,Indolent Clinical Course,Undifferentiated spindle cell sarcoma
4406,atypia morphology,"Nevus, Intradermal"
4407,High Mitotic Activity,Malignant Pancreatic Somatostatinoma
4408,Intermediate Filaments Present,Bladder Sarcoma
4409,Malignant Germinomatous Cellular Infiltrate,Pineal Region Mature Teratoma
4410,atypia morphology,Usual ductal hyperplasia of breast
4411,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
4412,Metastatic Lesion,Pituitary Gland Macroadenoma
4413,High Mitotic Activity,Gallbladder Neuroendocrine Tumor G1
4414,High Mitotic Activity,Childhood Brain Oligodendroglioma
4415,Mixed Neoplastic Glandular and Squamous Cell Population,Spindle cell squamous cell carcinoma
4416,Mucoid Stroma Formation,Papilloma of eyelid
4417,Intracytoplasmic Eosinophilic Inclusion,Conventional Extraskeletal Myxoid Chondrosarcoma
4418,Precise Histogenesis Unknown,Diencephalic Astrocytoma
4419,Indolent Clinical Course,Extraskeletal Myxoid Chondrosarcoma
4420,Indolent Clinical Course,Diencephalic Glioblastoma
4421,Favorable Clinical Outcome,Malignant Outer Hair Sheath and Infundibulum Neoplasm
4422,Indolent Clinical Course,Cervical Angiosarcoma
4423,Indolent Clinical Course,Small cell osteosarcoma
4424,Mixed Neoplastic Glandular and Squamous Cell Population,Inflammatory carcinoma of breast recurrent
4425,Mixture of Germ Cell Neoplastic Components Present,Testicular Teratoma with Somatic-Type Malignancy
4426,Indolent Clinical Course,Stage IC Uterine Sarcoma AJCC v7
4427,Diffuse Lesion,Multiple Lobular Capillary Hemangiomas
4428,Favorable Clinical Outcome,"Carcinoma, Basal Cell"
4429,Glandular Differentiation,large cell neuroendocrine carcinoma of lung
4430,Severe cytologic atypia,"Glucagonoma, malignant"
4431,Indolent Clinical Course,Osteosarcoma of bone
4432,Well-Circumscribed Lesion,Fusion-Negative Alveolar Rhabdomyosarcoma
4433,Nuclear Clearing,Thyroid Gland Lipoadenoma
4434,Locally Aggressive Lesion,Giant cell angiofibroma
4435,High Mitotic Activity,Gastrinoma
4436,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of the thyroid gland
4437,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Myeloid Leukemia with Maturation
4438,Diffuse Lesion,Colon Cavernous Hemangioma
4439,Solid Growth Pattern,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
4440,Malignant Germinomatous Cellular Infiltrate,Teratocarcinoma
4441,Encapsulated Mass,Cellular Neurofibroma
4442,Benign Cellular Infiltrate,Stage II Adult Liver Cancer AJCC v7
4443,Mixed Neoplastic Glandular and Squamous Cell Population,Intraepithelial Squamous Cell Carcinoma
4444,Precise Histogenesis Unknown,Childhood Glioblastoma
4445,Intracytoplasmic Eosinophilic Inclusion,Adult Rhabdomyosarcoma
4446,Intermediate Filaments Present,Esophageal Malignant Peripheral Nerve Sheath Tumor
4447,Favorable Clinical Outcome,Stage IIIB Cutaneous Melanoma AJCC v7
4448,High Mitotic Activity,Metastatic Digestive System Neuroendocrine Tumor G1
4449,Benign Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7
4450,Favorable Clinical Outcome,Recurrent Adult Hepatocellular Carcinoma
4451,Borderline Lesion,"Acanthoma, Clear Cell"
4452,Favorable Clinical Outcome,Malignant vascular tumor of skin
4453,Mixed Neoplastic Glandular and Squamous Cell Population,Benign Ovarian Serous Tumor
4454,Cytologic atypia,Colorectal hyperplastic polyp
4455,CD21-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
4456,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,"Leukemia, Myelocytic, Acute"
4457,Local disease,Diffuse Lipomatosis
4458,Glandular Differentiation,Large cell carcinoma with rhabdoid phenotype
4459,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary Diffuse Gastric Adenocarcinoma
4460,Tubular Pattern,Vaginal Villous Adenoma
4461,Intracytoplasmic Eosinophilic Inclusion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
4462,Low Mitotic Activity,Digestive System Neuroendocrine Carcinoma
4463,Secondary Lesion,Acute myeloid leukemia with multilineage dysplasia
4464,Intermediate Filaments Present,rhabdomyosarcoma of mediastinum
4465,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Renal Cell Carcinoma
4466,Storiform Growth Pattern,Sclerosing rhabdomyosarcoma
4467,Extensive Necrosis,Well Differentiated Oligodendroglioma
4468,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian mucinous tumor
4469,Intermediate Filaments Present,sarcoma of larynx
4470,Well-Circumscribed Lesion,Solid Alveolar Rhabdomyosarcoma
4471,Glandular Differentiation,Minor Salivary Gland Undifferentiated Carcinoma
4472,Borderline Lesion,Eccrine Poroma
4473,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Poorly Differentiated Squamous Cell Carcinoma
4474,Intermediate Filaments Present,Epithelioid Malignant Peripheral Nerve Sheath Tumor
4475,Mitotic Activity,Glomangiomatosis
4476,Intermediate Filaments Present,Colon Kaposi Sarcoma
4477,Intermediate Grade Lesion,Grade III Chondrosarcoma
4478,Mixed Neoplastic Glandular and Squamous Cell Population,Early Hepatocellular Carcinoma
4479,Mixed Epithelial Cell Population,Recurrent Inverted Schneiderian Papilloma
4480,Mixed Neoplastic Glandular and Squamous Cell Population,Frontal Sinus Schneiderian Papilloma
4481,Indolent Clinical Course,Ewing's sarcoma recurrent
4482,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma NCI Grade 3
4483,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma
4484,Benign Cellular Infiltrate,Stage I Anal Canal Cancer AJCC v6 and v7
4485,Mixed Cellular Population,Inverted Squamous Cell Papilloma
4486,Benign Cellular Infiltrate,Gastric Tubular Adenocarcinoma
4487,Chronic Clinical Course,Benzene-Related Acute Myeloid Leukemia
4488,Chronic Clinical Course,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
4489,High Grade Lesion,Composite hemangioendothelioma
4490,Indolent Clinical Course,Childhood Malignant Peripheral Nerve Sheath Tumor
4491,Favorable Clinical Outcome,Mycosis fungoides stage III
4492,Borderline Lesion,Intracystic papillary adenoma
4493,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
4494,Indolent Clinical Course,Atypical Teratoid Rhabdoid Tumor
4495,Favorable Clinical Outcome,Melanoma in Congenital Melanocytic Nevus
4496,Grade 4 Lesion,Cerebellar Astrocytoma
4497,Mucoid Stroma Formation,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
4498,Mixed Neoplastic Glandular and Squamous Cell Population,Papilloma of nasal vestibule
4499,Benign Cellular Infiltrate,Stage IVB Colon Cancer AJCC v7
4500,Increased Cellularity Present,Common blue nevus of skin
4501,Indolent Clinical Course,Childhood Small Intestinal Leiomyosarcoma
4502,Solid Growth Pattern,Mediastinal T Acute Lymphoblastic Leukemia
4503,Squamous Differentiation,Large cell lung cancer stage IV
4504,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of extrahepatic bile duct
4505,Precise Histogenesis Unknown,Childhood Brain Stem Glioma
4506,Intracytoplasmic Eosinophilic Inclusion,Multifocal osteosarcoma
4507,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Liver
4508,Indolent Clinical Course,Stage I Adult Soft Tissue Sarcoma AJCC v7
4509,Prominent Schwannian Stroma Present,Childhood Neuroblastoma
4510,Intracytoplasmic Eosinophilic Inclusion,Childhood Synovial Sarcoma
4511,Mixed Neoplastic Glandular and Squamous Cell Population,Classic Variant of Chromophobe Renal Cell Carcinoma
4512,Benign Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v7
4513,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Adrenal Cortex Carcinoma AJCC v7
4514,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Adrenal Cortex Carcinoma AJCC v7
4515,Intermediate Filaments Present,Embryonal Rhabdomyosarcoma
4516,Plexiform Vasculature Present,"Endometrial stromal sarcoma, high grade"
4517,Intracytoplasmic Eosinophilic Inclusion,Liver Synovial Sarcoma
4518,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Breast Complex Fibroadenoma
4519,Anaplasia,Childhood Oligodendroglioma
4520,Premalignant Lesion,"Adenocarcinoma of lung, stage IV"
4521,Solid Growth Pattern,Aleukemic Acute Lymphoblastic Leukemia
4522,HMB-45-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
4523,Malignant Germinomatous Cellular Infiltrate,Childhood Mature Teratoma
4524,Aggressive Clinical Course,"Lymphoma, Follicular, Grade 1"
4525,Local disease,Encephalocraniocutaneous lipomatosis
4526,Well-Circumscribed Lesion,Metastatic Dermatofibrosarcoma Protuberans
4527,Mitotic Activity,Diffuse Astrocytoma
4528,Precise Histogenesis Unknown,Recurrent Childhood Cerebellar Astrocytoma
4529,Tartrate Resistant Acid Phosphatase Positive Cells Present,Hairy cell leukemia variant
4530,Malignant Cellular Infiltrate,External Ear Actinic Keratosis
4531,Acute Clinical Course,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant"
4532,Benign Cellular Infiltrate,BCLC Stage 0 Adult Hepatocellular Carcinoma
4533,Intermediate Filaments Present,Brain sarcoma
4534,Intracytoplasmic Eosinophilic Inclusion,Stage IIA Uterine Sarcoma AJCC v7
4535,Solid Growth Pattern,Childhood Acute Myeloid Leukemia with Maturation
4536,Mixed Epithelial Cell Population,Inverting papilloma of the nasal cavity
4537,Mucoid Stroma Formation,Ovarian Papillary Cystadenoma
4538,Intracytoplasmic Eosinophilic Inclusion,liposarcoma
4539,Malignant Germinomatous Cellular Infiltrate,Liver Yolk Sac Tumor
4540,Intermediate Filaments Present,Kaposi's sarcoma of palate
4541,Intermediate Filaments Present,Epithelioid sarcoma recurrent
4542,Indolent Clinical Course,"Phosphaturic mesenchymal tumor, malignant"
4543,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Thyroid Gland Papillary Carcinoma
4544,High Mitotic Activity,Descending Colon Neuroendocrine Tumor G1
4545,Indolent Clinical Course,Bone Surface (Peripheral) Osteosarcoma
4546,Nuclear Grooves,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
4547,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Embryonal Carcinoma
4548,Intracytoplasmic Eosinophilic Inclusion,sarcoma of trachea
4549,Chronic Clinical Course,Refractory Childhood Acute Lymphoblastic Leukemia
4550,Indolent Clinical Course,Superior Vena Cava Leiomyosarcoma
4551,Metastatic Lesion,Thyrotroph adenoma
4552,Invasive Lesion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
4553,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
4554,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of retroperitoneum
4555,Tubular Pattern,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
4556,Diffuse Lesion,Infantile hemangioma
4557,Borderline Lesion,Microfollicular adenoma
4558,Intracytoplasmic Eosinophilic Inclusion,Rhabdomyosarcoma of cervix uteri
4559,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor
4560,Squamous Differentiation,large cell neuroendocrine carcinoma of appendix
4561,Glandular Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma
4562,Mixed Neoplastic Glandular and Squamous Cell Population,Thymic Adenocarcinoma
4563,Intracytoplasmic Eosinophilic Inclusion,Stage IB Uterine Sarcoma AJCC v7
4564,Metastatic Lesion,Acidophil Stem Cell Pituitary Gland Adenoma
4565,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell choriocarcinoma stage III
4566,Malignant Germinomatous Cellular Infiltrate,Testicular Teratoma with Somatic-Type Malignancy
4567,Extracutaneous Dissemination of Disease,"Mastocytosis, Diffuse Cutaneous"
4568,Necrotic changes (finding),"Retinoblastoma, spontaneously regressed"
4569,Superficial Lesion,Intramuscular lipoma
4570,Benign Cellular Infiltrate,adenoid cystic carcinoma of esophagus
4571,Chronic Clinical Course,Secondary Acute Myeloid Leukemia
4572,Chronic Clinical Course,Acute panmyelosis with myelofibrosis
4573,Chronic lymphocytic inflammation,"Thymoma, type A, malignant"
4574,Mucoid Stroma Formation,Esophageal squamous papilloma
4575,Intracytoplasmic Eosinophilic Inclusion,Stage IV Osteosarcoma AJCC v7
4576,Invasive Lesion,Trichodiscoma
4577,Benign Cellular Infiltrate,Stage IV Rectal Carcinoma
4578,Tumor Vascular Invasion,Thyroid Gland Lipoadenoma
4579,Composite Lesion,Thymoma malignant invasive
4580,Indolent Clinical Course,Poorly Differentiated Fibrosarcoma
4581,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of kidney
4582,Benign Cellular Infiltrate,Small Intestinal Mucinous Adenocarcinoma
4583,Intermediate Filaments Present,Stage IV Bone Sarcoma AJCC v7
4584,Intracytoplasmic Eosinophilic Inclusion,Ovarian Rhabdomyosarcoma
4585,Necrotic changes (finding),Cellular Schwannoma
4586,Seminomatous Component Present,Teratocarcinoma
4587,Nuclear Clearing,Thyroid Gland Signet Ring Cell Follicular Adenoma
4588,Invasive Lesion,High Grade Ductal Breast Carcinoma In Situ
4589,Severe cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Vagina
4590,Low Mitotic Activity,small cell carcinoma of appendix
4591,Necrotic changes (finding),Childhood Fibrillary Astrocytoma
4592,Indolent Clinical Course,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
4593,Benign Cellular Infiltrate,Malignant lymphomatous polyposis
4594,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
4595,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Diffuse Clear Cell Adenocarcinoma
4596,Mixed Neoplastic Glandular and Squamous Cell Population,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
4597,CD30-Positive Neoplastic Cells Present,Primary cutaneous gamma-delta T-cell lymphoma
4598,Favorable Clinical Outcome,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
4599,Aggressive Clinical Course,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma
4600,Chronic Clinical Course,Acute Myeloid Leukemia with t(11;17)(q13;q21)
4601,High Mitotic Activity,Uterine Corpus Bizarre Leiomyoma
4602,Invasive Lesion,sebaceous adenoma of salivary gland
4603,Intracytoplasmic Eosinophilic Inclusion,Stage IA Bone Sarcoma AJCC v7
4604,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive intraductal papillary-mucinous carcinoma of pancreas
4605,Indolent Clinical Course,undifferentiated sarcoma of ovary
4606,Indolent Clinical Course,Pleomorphic Rhabdomyosarcoma
4607,Aggressive Clinical Course,Recurrent Grade 2 Follicular Lymphoma
4608,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Tubulovillous Adenoma
4609,High Mitotic Activity,Glucagonoma
4610,Necrotic changes (finding),Childhood Cerebral Anaplastic Astrocytoma
4611,Aggressive Clinical Course,Grade 2 Cutaneous Follicular Lymphoma
4612,Intracytoplasmic Eosinophilic Inclusion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
4613,Benign Cellular Infiltrate,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma
4614,Indolent Clinical Course,Primary Bone Osteosarcoma
4615,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of lung
4616,High Mitotic Activity,Recurrent Digestive System Neuroendocrine Tumor G1
4617,Severe cytologic atypia,Carcinoid tumor of intestine
4618,Dysplasia,Classical Poroma
4619,Composite Lesion,Thymoma malignant recurrent
4620,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma stage I
4621,Anaplasia,oligodendroglioma
4622,Mixed Neoplastic Glandular and Squamous Cell Population,Sublingual Gland Adenocarcinoma
4623,Low Grade Lesion,Grade II Chondrosarcoma
4624,High Mitotic Activity,Intravenous leiomyomatosis
4625,Intermediate Filaments Present,High Grade Malignant Peripheral Nerve Sheath Tumor
4626,Benign Cellular Infiltrate,Esophageal Hodgkin Lymphoma
4627,Mixed Epithelial Cell Population,Ethmoid Sinus Schneiderian Papilloma
4628,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct cystadenocarcinoma
4629,Mixed Neoplastic Glandular and Squamous Cell Population,Schneiderian carcinoma
4630,Seminomatous Component Present,Ovarian Dermoid Cyst with Melanoma
4631,Locally Aggressive Lesion,Ivory Exostosis
4632,Mixed Neoplastic Glandular and Squamous Cell Population,Sphenoid Sinus Schneiderian Papilloma
4633,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Basophilic Leukemia
4634,Neuroectodermal Differentiation,Ewing's sarcoma recurrent
4635,Indolent Clinical Course,Adult Anaplastic Astrocytoma
4636,Low Mitotic Activity,neuroendocrine carcinoma of anal canal
4637,Intermediate Filaments Present,Kaposi Sarcoma NCI Grade 3
4638,Benign Cellular Infiltrate,Rectal Serrated Adenocarcinoma
4639,Mixed Neoplastic Glandular and Squamous Cell Population,Grade II Penile Intraepithelial Neoplasia
4640,Favorable Clinical Outcome,Nodulo-ulcerative basal cell carcinoma
4641,Encapsulated Mass,benign neurofibroma of gallbladder
4642,Borderline Lesion,Urethral Inverted Papilloma
4643,Low Grade Lesion,Angiosarcoma of the breast
4644,Indolent Clinical Course,Alveolar soft part sarcoma recurrent
4645,Intracytoplasmic Eosinophilic Inclusion,Vaginal Rhabdomyosarcoma
4646,Necrotic changes (finding),Minimal Deviation Melanoma
4647,Seminomatous Component Present,Mature Ovarian Teratoma
4648,Multilayered Rosette Formation,Region 17p13 Allelic Loss Associated Medulloblastoma
4649,Indolent Clinical Course,Gliomatosis cerebri
4650,Benign Cellular Infiltrate,Malignant Rectal Neoplasm
4651,Borderline Lesion,Hard Palate Monomorphic Adenoma
4652,High Mitotic Activity,Anal Canal Neuroendocrine Tumor G1
4653,Prominent Schwannian Stroma Present,Familial Neuroblastoma
4654,Micropapillary Pattern,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
4655,Invasive Lesion,Low Grade Gastric Intraepithelial Neoplasia
4656,Favorable Clinical Outcome,Grade 1 Cutaneous Follicular Lymphoma
4657,Intracytoplasmic Eosinophilic Inclusion,Low Grade Endometrial Stromal Sarcoma
4658,Indolent Clinical Course,Anaplastic Oligodendroglioma
4659,Favorable Clinical Outcome,Primary Cutaneous Anaplastic Large Cell Lymphoma
4660,Borderline Lesion,Cortisol-Producing Adrenal Cortex Adenoma
4661,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of small intestine
4662,Mixed Neoplastic Glandular and Squamous Cell Population,"Oncocytoma, renal"
4663,Intermediate Filaments Present,Adult Malignant Peripheral Nerve Sheath Tumor
4664,Benign Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v7
4665,Invasive Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia
4666,Well-Circumscribed Lesion,Fibromatosis
4667,Benign Cellular Infiltrate,Recurrent Childhood Hepatocellular Carcinoma
4668,atypia morphology,Vulvar Blue Nevus
4669,Borderline Lesion,Skin appendage adenoma
4670,Dysplasia,Skin appendage adenoma
4671,Tubular Pattern,Cecum Villous Adenoma
4672,Diffuse Lesion,Infantile hemangioma of liver
4673,Invasive Lesion,Stage 0 Vulvar Carcinoma
4674,Benign Cellular Infiltrate,Colorectal Non-Hodgkin Lymphoma
4675,Borderline Lesion,Breast Pleomorphic Adenoma
4676,Locally Aggressive Lesion,Vaginal Myofibroblastoma
4677,Indolent Clinical Course,"Perineurioma, malignant"
4678,Severe cytologic atypia,Pancreatic Delta Cell Neoplasm
4679,Intracytoplasmic Eosinophilic Inclusion,Metastatic leiomyosarcoma
4680,Ground Glass Nuclear Inclusion,Clear Cell Variant Thyroid Gland Follicular Carcinoma
4681,Solid Growth Pattern,Chronic Adult T-Cell Leukemia/Lymphoma
4682,Benign Cellular Infiltrate,Anal Lymphoma
4683,Benign Cellular Infiltrate,Malignant neoplasm of cecum
4684,Benign Cellular Infiltrate,Stage IIB Esophageal Adenocarcinoma AJCC v7
4685,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Embryonal Carcinoma
4686,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Adenocarcinoma
4687,High Mitotic Activity,Fallopian tube leiomyoma
4688,Squamous Differentiation,Giant cell carcinoma of lung
4689,Benign Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v7
4690,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
4691,Precise Histogenesis Unknown,Adult Ganglioglioma
4692,Indolent Clinical Course,liposarcoma
4693,Epidermal Involvement,Neuronevus
4694,Mixture of Germ Cell Neoplastic Components Present,"Testicular Seminoma, Cribriform Variant"
4695,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma
4696,Indolent Clinical Course,Osteosarcoma localised
4697,Intracytoplasmic Eosinophilic Inclusion,Stage I Soft Tissue Sarcoma AJCC v7
4698,Indolent Clinical Course,Stage I Soft Tissue Sarcoma AJCC v7
4699,Precise Histogenesis Unknown,Recurrent Childhood Anaplastic Astrocytoma
4700,Small Lesion,Well Differentiated Ovarian Steroid Cell Tumor
4701,Benign Cellular Infiltrate,Localized Resectable Adult Hepatocellular Carcinoma
4702,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Canal Squamous Intraepithelial Neoplasia
4703,Mixture of Germ Cell Neoplastic Components Present,Uterine Corpus Choriocarcinoma
4704,Indolent Clinical Course,Infantile fibrosarcoma
4705,Aggressive Clinical Course,Waldenstrom's macroglobulinemia recurrent
4706,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
4707,Aggressive Clinical Course,Ann Arbor Stage I Grade 2 Follicular Lymphoma
4708,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Sebaceous Carcinoma
4709,Prominent Schwannian Stroma Present,Regional Neuroblastoma
4710,Indolent Clinical Course,Myxoid/Round Cell Liposarcoma
4711,Premalignant Lesion,Squamous cell carcinoma of trachea
4712,Intracytoplasmic Eosinophilic Inclusion,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
4713,Intracytoplasmic Eosinophilic Inclusion,Childhood Soft Tissue Sarcoma
4714,Borderline Lesion,Ovarian Clear Cell Adenofibroma
4715,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Glandular Neoplasm
4716,Dysplasia,Rectal hyperplastic polyp
4717,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Serous Adenocarcinoma
4718,Seminomatous Component Present,Dermoid cyst of ovary
4719,Generalized illness,Early Unfavorable Non-Hodgkin Lymphoma
4720,Borderline Lesion,Squamous Papilloma of the Larynx
4721,Intermediate Filaments Present,Intracortical osteosarcoma
4722,Macule,"Mastocytosis, Diffuse Cutaneous"
4723,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Anal Canal Squamous Intraepithelial Neoplasia
4724,Histiocytosis,Centroblastic lymphoma stage IV
4725,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Serous Adenoma
4726,Intermediate Filaments Present,Primary Childhood Soft Tissue Sarcoma
4727,Indolent Clinical Course,Secondary osteosarcoma
4728,Indolent Clinical Course,Fusion-Negative Alveolar Rhabdomyosarcoma
4729,Mixed Neoplastic Glandular and Squamous Cell Population,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
4730,Severe cytologic atypia,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
4731,Benign Cellular Infiltrate,Barrett's Adenocarcinoma
4732,atypia morphology,Well-differentiated papillary mesothelioma
4733,Dysplasia,Sebaceoma
4734,Mucoid Stroma Formation,Papillary Eccrine Carcinoma
4735,Premalignant Lesion,sarcoma of lung
4736,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
4737,Benign Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v6
4738,Indolent Clinical Course,Stage I Osteosarcoma AJCC v7
4739,Intermediate Filaments Present,Synovial sarcoma non-metastatic
4740,Benign Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v7
4741,Benign Cellular Infiltrate,Rectal Lymphoma
4742,Benign Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v6
4743,Indolent Clinical Course,"Central Nervous System Embryonal Tumor, Not Otherwise Specified"
4744,Favorable Clinical Outcome,Clear cell squamous cell carcinoma of skin
4745,Intracytoplasmic Eosinophilic Inclusion,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
4746,Mixed Neoplastic Glandular and Squamous Cell Population,signet ring cell carcinoma of appendix
4747,Solid Growth Pattern,"Acute myeloid leukemia, inv(16)(p13q22)"
4748,Papillary Pattern,High Grade Ductal Breast Carcinoma In Situ
4749,Glandular Differentiation,Thymic Undifferentiated Carcinoma
4750,Favorable Clinical Outcome,Hepatitis B Virus-Related Hepatocellular Carcinoma
4751,Grade 4 Lesion,Childhood Diffuse Astrocytoma
4752,Chronic Clinical Course,Acute biphenotypic leukemia
4753,Capsular Invasion,Parathyroid Gland Lipoadenoma
4754,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
4755,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Benign Ovarian Serous Tumor
4756,Severe cytologic atypia,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
4757,Benign Cellular Infiltrate,undifferentiated carcinoma of pancreas
4758,Solid Growth Pattern,Acute monocytic/monoblastic leukemia
4759,Glandular Differentiation,Occult Lung Large Cell Carcinoma
4760,Glandular Differentiation,Gastric Large Cell Neuroendocrine Carcinoma
4761,Mixed Neoplastic Glandular and Squamous Cell Population,Solar Radiation-Related Skin Squamous Cell Carcinoma
4762,Intermediate Filaments Present,Gallbladder Sarcoma
4763,Favorable Clinical Outcome,Stage IV Cutaneous Melanoma AJCC v6 and v7
4764,Benign Cellular Infiltrate,Colon Mantle Cell Lymphoma
4765,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Clear Cell Adenocarcinoma
4766,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of rectum
4767,Severe cytologic atypia,Pancreatic Vipoma
4768,Metaplasia of Malignant Cells Present,"Vulvar Adenocarcinoma, Intestinal-Type"
4769,Benign Cellular Infiltrate,Parietal cell carcinoma
4770,Dysplasia,Benign neoplasm of adnexa of skin
4771,Intracytoplasmic Eosinophilic Inclusion,Low Grade Malignant Peripheral Nerve Sheath Tumor
4772,Aggressive Clinical Course,Monocytoid B-cell lymphoma
4773,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) stage I
4774,Intermediate Filaments Present,Central Nervous System Rhabdomyosarcoma
4775,Indolent Clinical Course,Carcinoma bone
4776,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary thyroid carcinoma
4777,Mixture of Germ Cell Neoplastic Components Present,Testicular embryonal carcinoma stage I
4778,Intermediate Filaments Present,liposarcoma of mediastinum
4779,Intracytoplasmic Eosinophilic Inclusion,Esophageal Synovial Sarcoma
4780,Superficial Lesion,Adult Fibrosarcoma
4781,Mixed Neoplastic Glandular and Squamous Cell Population,Biliary Intraepithelial Neoplasia
4782,Mixed Neoplastic Glandular and Squamous Cell Population,Maxillary Sinus Schneiderian Papilloma
4783,Intermediate Filaments Present,Kaposi Sarcoma NCI Grade 2
4784,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma recurrent
4785,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Clear Cell Renal Cell Carcinoma
4786,Indolent Clinical Course,Low Grade Sarcoma
4787,Endodermal Differentiation,Testicular Mixed Embryonal Carcinoma and Seminoma
4788,Intermediate Filaments Present,fibrosarcoma of breast
4789,Mixed Neoplastic Glandular and Squamous Cell Population,Keratinizing Head and Neck Squamous Cell Carcinoma
4790,Intermediate Filaments Present,Vaginal Rhabdomyosarcoma
4791,CD35-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
4792,Seminomatous Component Present,Ovarian Monodermal and Highly Specialized Teratoma
4793,Borderline Lesion,"Papilloma, Intraductal"
4794,Indolent Clinical Course,Childhood Spindle Cell Rhabdomyosarcoma
4795,Dysplasia,Cutaneous myxoma
4796,Benign Cellular Infiltrate,Rectal Medullary Carcinoma
4797,Microvascular Proliferation,Childhood Brain Anaplastic Astrocytoma
4798,Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v7
4799,Benign Cellular Infiltrate,Periampullary Adenocarcinoma
4800,Chronic Clinical Course,Aleukemic Monocytic Leukemia Cutis
4801,Invasive Lesion,Tufted angioma of skin
4802,Favorable Clinical Outcome,basal cell carcinoma of penis
4803,Indolent Clinical Course,Classical Low Grade Fibromyxoid Sarcoma
4804,Severe cytologic atypia,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
4805,Glandular Differentiation,Large cell lung cancer recurrent
4806,Solid Growth Pattern,Acute Myeloid Leukemia with Myelodysplasia-Related Changes
4807,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Fallopian Tube Serous Adenocarcinoma
4808,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Low Grade Fallopian Tube Serous Adenocarcinoma
4809,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Papillary Carcinoma
4810,Grade 4 Lesion,Recurrent Childhood Subependymal Giant Cell Astrocytoma
4811,Indolent Clinical Course,Breast Carcinoma Metastatic in the Brain
4812,Intracytoplasmic Eosinophilic Inclusion,Stage I Adult Soft Tissue Sarcoma AJCC v7
4813,Benign Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage
4814,Chronic Clinical Course,Acute Promyelocytic Leukemia
4815,Benign Cellular Infiltrate,Small Intestinal Small Cell Neuroendocrine Carcinoma
4816,Microvascular Proliferation,"Diffuse Astrocytoma, IDH-Mutant"
4817,High Mitotic Activity,Leiomyoma of lung
4818,Borderline Lesion,Benign Breast Eccrine Spiradenoma
4819,Intermediate Filaments Present,Extraskeletal Osteosarcoma
4820,Mucoid Stroma Formation,ductal papilloma of salivary gland
4821,Mucoid Stroma Formation,Vaginal Squamous Papilloma
4822,Mixed Neoplastic Glandular and Squamous Cell Population,"Endocervical Adenocarcinoma, Usual Type"
4823,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Hepatocellular Carcinoma AJCC v7
4824,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Microglandular Polyp
4825,Chronic Clinical Course,Acute Myeloid Leukemia with Gene Mutations
4826,Necrotic changes (finding),Anaplastic astrocytoma
4827,Glandular Differentiation,Nasopharyngeal lymphoepithelioma stage II
4828,Neuroectodermal Differentiation,Ewings sarcoma
4829,Glandular Differentiation,Nasopharyngeal lymphoepithelioma stage IV
4830,Necrotic changes (finding),Diffuse Astrocytoma
4831,Indolent Clinical Course,Cerebral Glioblastoma
4832,Mucoid Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
4833,Extensive Necrosis,Adult Oligodendroglioma
4834,Anaplasia,Nonanaplastic Kidney Wilms Tumor
4835,Mixed Epithelial Cell Population,Vestibular Micropapillomatosis
4836,Favorable Clinical Outcome,Nodular melanoma
4837,High Grade Lesion,Extracutaneous Mastocytoma
4838,Indolent Clinical Course,Spinal Cord Melanoma
4839,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Papillary Hidradenoma
4840,Intermediate Filaments Present,Sarcoma of orbit
4841,Malignant Germinomatous Cellular Infiltrate,Childhood Yolk Sac Tumor
4842,Precise Histogenesis Unknown,Childhood Anaplastic Ependymoma
4843,Benign Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v7
4844,Grade 4 Lesion,Subependymal Giant Cell Astrocytoma
4845,Benign Cellular Infiltrate,BCLC Stage A Hepatocellular Carcinoma
4846,Superficial Lesion,Tendon Sheath Lipoma
4847,Intracytoplasmic Eosinophilic Inclusion,Metastatic osteosarcoma
4848,Favorable Clinical Outcome,BCLC Stage B Hepatocellular Carcinoma
4849,Indolent Clinical Course,Cerebellar Glioblastoma
4850,Benign Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v7
4851,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinofibroma of ovary
4852,Locally Aggressive Lesion,Vaginal Angiomyofibroblastoma
4853,Prominent Schwannian Stroma Present,Localized Resectable Neuroblastoma
4854,Seminomatous Component Present,Childhood Ovarian Teratoma
4855,Intermediate Filaments Present,Recurrent Kaposi Sarcoma
4856,Mixed Epithelial Cell Population,Papilloma of buccal mucosa
4857,Intermediate Filaments Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
4858,Intermediate Filaments Present,Thyroid Angiosarcoma
4859,Glandular Differentiation,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
4860,Birbeck Granules Present,"Dendritic Cell Sarcoma, Interdigitating"
4861,Favorable Clinical Outcome,Stage III Hepatocellular Carcinoma AJCC v7
4862,High Grade Lesion,Epithelioid hemangioendothelioma
4863,Ground Glass Nuclear Inclusion,Macrofollicular adenoma
4864,Precise Histogenesis Unknown,Ependymal tumor
4865,Giant Mitochondria Present,Mammosomatotroph Adenoma
4866,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Tumor
4867,Favorable Clinical Outcome,Mycosis fungoides stage II
4868,Mucoid Stroma Formation,Squamous Papilloma of the Larynx
4869,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of colon
4870,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Adenofibroma
4871,Intracytoplasmic Eosinophilic Inclusion,rhabdomyosarcoma of liver
4872,Aggressive Clinical Course,Pediatric nodal marginal zone lymphoma
4873,Borderline Lesion,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis
4874,Acute Clinical Course,Splenic Manifestation of Prolymphocytic Leukemia
4875,Intracytoplasmic Eosinophilic Inclusion,Metastatic Childhood Soft Tissue Sarcoma
4876,Invasive Lesion,Fibrofolliculoma
4877,Mucoid Stroma Formation,"Papillary renal cell carcinoma, sporadic"
4878,Precise Histogenesis Unknown,Glioblastoma
4879,Nuclear Grooves,Thyroid Gland Mucinous Follicular Adenoma
4880,Tumor Vascular Invasion,Thyroid Gland Mucinous Follicular Adenoma
4881,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei
4882,Benign Cellular Infiltrate,undifferentiated carcinoma of liver
4883,Indolent Clinical Course,Stage II Bone Sarcoma AJCC v7
4884,Squamous Differentiation,Laryngeal Lymphoepithelial Carcinoma
4885,Mixed Neoplastic Glandular and Squamous Cell Population,Tubular breast carcinoma
4886,Severe cytologic atypia,Small Intestinal VIP-Producing Neuroendocrine Tumor
4887,Nuclear Clearing,Thyroid Hurthle Cell Carcinoma
4888,Indolent Clinical Course,Primary central nervous system lymphoma
4889,Borderline Lesion,Juvenile papillomatosis of breast
4890,Malignant Germinomatous Cellular Infiltrate,Malignant Mediastinal Non-Seminomatous Germ Cell Tumor
4891,Locally Aggressive Lesion,Bone Epithelioid Hemangioma
4892,Malignant Germinomatous Cellular Infiltrate,Gonadal Teratoma
4893,Benign Cellular Infiltrate,Esophageal Spindle Cell Carcinoma
4894,Favorable Clinical Outcome,Stage IIIA Cutaneous Melanoma AJCC v7
4895,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
4896,Villous Pattern,Small Intestinal Tubular Adenoma
4897,Benign Cellular Infiltrate,Stage I Esophageal Adenocarcinoma AJCC v7
4898,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal clear cell adenocarcinoma
4899,Invasive Lesion,Eccrine dermal cylindroma
4900,Diffuse Lesion,Inverting papilloma of the paranasal sinus
4901,Comedo Necrosis,Intraductal Non-Comedo Breast Adenocarcinoma
4902,Chronic Clinical Course,Acute Myeloid Leukemia with Variant MLL Translocations
4903,Premalignant Lesion,Stage II Lung Cancer AJCC v7
4904,Indolent Clinical Course,Vaginal Undifferentiated Sarcoma
4905,Neuroendocrine Differentiation,Stage III Lip Basal Cell Carcinoma
4906,Indolent Clinical Course,Childhood Giant Cell Glioblastoma
4907,Indolent Clinical Course,leiomyosarcoma of appendix
4908,Benign Cellular Infiltrate,Hepatitis B Virus-Related Hepatocellular Carcinoma
4909,Necrotic changes (finding),Childhood Diffuse Astrocytoma
4910,Intermediate Filaments Present,Sclerosing Epithelioid Fibrosarcoma
4911,Mixed Neoplastic Glandular and Squamous Cell Population,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
4912,Seminomatous Component Present,Adult Central Nervous System Teratoma
4913,Pushing Tumor Margin,Urethral Condyloma Acuminatum
4914,Indolent Clinical Course,Childhood Extraskeletal Osteosarcoma
4915,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Phyllodes tumor, borderline"
4916,Mixed Neoplastic Glandular and Squamous Cell Population,Cystic Oncocytic Neoplasm
4917,Malignant Germinomatous Cellular Infiltrate,Struma Ovarii
4918,Intracytoplasmic Eosinophilic Inclusion,Childhood Alveolar Rhabdomyosarcoma
4919,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Monoblastic and Monocytic Leukemia
4920,Grade 4 Lesion,Childhood Protoplasmic Astrocytoma
4921,Invasive Lesion,Syringofibroadenoma
4922,Solid Growth Pattern,Childhood Acute Myelomonocytic Leukemia
4923,Benign Cellular Infiltrate,Colon Burkitt Lymphoma
4924,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Leiomyosarcoma
4925,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Tubular Adenoma
4926,Intracytoplasmic Eosinophilic Inclusion,Pleomorphic Rhabdomyosarcoma
4927,Severe cytologic atypia,"Somatostatinoma, malignant"
4928,Intermediate Filaments Present,Childhood Clear Cell Sarcoma of Soft Parts
4929,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of urethra
4930,Splenomegaly,Indolent Systemic Mastocytosis
4931,Benign Cellular Infiltrate,Esophageal Diffuse Large B-Cell Lymphoma
4932,Mitotic Activity,Recurrent Childhood Gemistocytic Astrocytoma
4933,Low Mitotic Activity,Esophageal Neuroendocrine Carcinoma
4934,Lesion with Diameter Greater than 2cm,Osteoid osteoma
4935,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the parotid gland
4936,Premalignant Lesion,Occult Lung Non-Small Cell Carcinoma
4937,Benign Cellular Infiltrate,Pancreatic Non-Hodgkin Lymphoma
4938,Mixed Neoplastic Glandular and Squamous Cell Population,cystadenoma of salivary gland
4939,Solid Growth Pattern,Chronic lymphocytic leukemia stage 2
4940,Mucoid Stroma Formation,Inverted urothelial papilloma
4941,Invasive Lesion,intraductal papilloma of salivary gland
4942,Intermediate Filaments Present,Glandular malignant peripheral nerve sheath tumor
4943,Intracytoplasmic Eosinophilic Inclusion,AJCC Grade 1 Sarcoma
4944,Intracytoplasmic Eosinophilic Inclusion,AIDS with Kaposi's sarcoma
4945,Severe cytologic atypia,Meckel Diverticulum Neuroendocrine Tumor G1
4946,Benign Cellular Infiltrate,Stage IIIB Adult Liver Cancer AJCC v7
4947,Intermediate Filaments Present,sarcoma of testis
4948,Squamous Differentiation,Large cell lung cancer stage III
4949,Solid Growth Pattern,Childhood Acute Promyelocytic Leukemia with PML-RARA
4950,Well-Circumscribed Lesion,Pelvic Fibromatosis
4951,Necrotic changes (finding),Benign Dermal Schwannoma
4952,Benign Cellular Infiltrate,Appendix Lymphoma
4953,Diffuse Lesion,Ureter Inverted Papilloma
4954,Premalignant Lesion,Small cell lung cancer recurrent
4955,Indolent Clinical Course,Epithelioid sarcoma non-metastatic
4956,Malignant Germinomatous Cellular Infiltrate,Mature Ovarian Teratoma
4957,CD30-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
4958,HMB-45-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
4959,Benign Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7
4960,Metastatic Lesion,Oral Cavity Monomorphic Adenoma
4961,Necrotic changes (finding),Ganglioglioma
4962,Intermediate Filaments Present,Vulvar Alveolar Rhabdomyosarcoma
4963,Indolent Clinical Course,Infratentorial Glioblastoma
4964,Metastatic Lesion,Cerebral Non-Hodgkin Lymphoma
4965,Borderline Lesion,estrogen-producing adrenal cortical adenoma
4966,Mixed Neoplastic Glandular and Squamous Cell Population,Scirrhous carcinoma of breast
4967,Intermediate Filaments Present,Malignant Giant Cell Tumor of Bone
4968,Squamous Differentiation,Undifferentiated Carcinoma of Colon
4969,Intracytoplasmic Eosinophilic Inclusion,Adult Malignant Peripheral Nerve Sheath Tumor
4970,Precise Histogenesis Unknown,Recurrent Childhood Oligoastrocytoma
4971,Locally Aggressive Lesion,Palisaded Lymph Node Myofibroblastoma
4972,Benign Cellular Infiltrate,Stage III Childhood Hepatocellular Carcinoma AJCC v7
4973,Indolent Clinical Course,Metastasizing Chondroblastoma
4974,Extensive Necrosis,Recurrent Childhood Oligodendroglioma
4975,Precise Histogenesis Unknown,Glioblastoma multiforme of spinal cord
4976,Intermediate Filaments Present,Synchronous Multifocal Osteosarcoma
4977,Indolent Clinical Course,Cardiac Malignant Peripheral Nerve Sheath Tumor
4978,Diffuse Lesion,Cardiac Capillary Hemangioma
4979,Intracytoplasmic Eosinophilic Inclusion,Liposarcoma recurrent
4980,Benign Cellular Infiltrate,Colon Diffuse Large B-Cell Lymphoma
4981,Capsular Invasion,Chief cell adenoma
4982,Mixed Neoplastic Glandular and Squamous Cell Population,verrucous carcinoma of vagina
4983,Intermediate Filaments Present,"Sarcoma, Small Cell"
4984,Intermediate Filaments Present,Childhood Angiosarcoma
4985,Mixed Neoplastic Glandular and Squamous Cell Population,Atypical Ductal Breast Hyperplasia
4986,Intracytoplasmic Eosinophilic Inclusion,rhabdomyosarcoma of prostate
4987,Benign Cellular Infiltrate,Colon Carcinoma
4988,Intermediate Filaments Present,Prostate Stromal Sarcoma
4989,HMB-45-Positive Neoplastic Cells Present,Disseminated Juvenile Xanthogranuloma
4990,High Mitotic Activity,Extrahepatic Bile Duct Carcinoid Tumor
4991,Indolent Clinical Course,Recurrent Adult Soft Tissue Sarcoma
4992,Solid Growth Pattern,"Acute Myeloid Leukemia, M1"
4993,Benign Cellular Infiltrate,Adenocarcinoma of anus
4994,High Mitotic Activity,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
4995,Benign Cellular Infiltrate,Colorectal Kaposi Sarcoma
4996,Carcinomatous Component Present,Soft Palate Pleomorphic Adenoma
4997,Acinar Cell Differentiation,Pancreatic Hepatoid Adenocarcinoma
4998,Mitotic Activity,Tubulocystic renal cell carcinoma
4999,Favorable Clinical Outcome,Stage II Skin Cancer
5000,Premalignant Lesion,Epithelioid hemangioendothelioma of lung
5001,Mixed Neoplastic Glandular and Squamous Cell Population,Rectal Signet Ring Cell Adenocarcinoma
5002,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
5003,Necrotic changes (finding),Hypothalamic Gangliocytoma
5004,Mixed Neoplastic Glandular and Squamous Cell Population,"Mucinous adenocarcinoma, endocervical type"
5005,Favorable Clinical Outcome,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
5006,Liver Cirrhosis,Adult Fibrolamellar Carcinoma
5007,Severe cytologic atypia,Stage II Appendix Neuroendocrine Tumor AJCC v7
5008,Mixed Neoplastic Glandular and Squamous Cell Population,Common wart
5009,Severe cytologic atypia,Colorectal Neuroendocrine Tumor G2
5010,Intermediate Filaments Present,Infantile fibrosarcoma
5011,Solid Growth Pattern,Hypodiploid B Acute Lymphoblastic Leukemia
5012,Indolent Clinical Course,Sarcoma
5013,Invasive Lesion,Hutchinson's Melanotic Freckle
5014,Squamous Differentiation,Undifferentiated carcinoma of ovary
5015,Benign Cellular Infiltrate,Adult Liver Carcinoma
5016,Ineffective hematopoiesis,Philadelphia chromosome negative chronic myelogenous leukemia
5017,Indolent Clinical Course,Thyroid Sarcoma
5018,Intracytoplasmic Eosinophilic Inclusion,Renal Vein Leiomyosarcoma
5019,Tumor Vascular Invasion,Thyroid Gland Oncocytic Adenoma
5020,Premalignant Lesion,Childhood Lung Small Cell Carcinoma
5021,Precise Histogenesis Unknown,Juvenile Pilocytic Astrocytoma
5022,Metastatic Lesion,benign myoepithelioma of salivary gland
5023,Invasive Lesion,Colorectal High Grade Intraepithelial Neoplasia
5024,Seminomatous Component Present,Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
5025,Diffuse Lesion,Papilloma of eyelid
5026,Composite Lesion,"Thymoma, type A"
5027,Mixed Neoplastic Glandular and Squamous Cell Population,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
5028,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell papilloma of skin
5029,Mixed Neoplastic Glandular and Squamous Cell Population,hepatoid adenocarcinoma of bladder
5030,Metastatic Lesion,Somatotroph/Lactotroph Adenoma
5031,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Serous Tumor
5032,Seminomatous Component Present,Testicular yolk sac tumor stage II
5033,Skin Papule,"Mastocytosis, Diffuse Cutaneous"
5034,Intermediate Filaments Present,Esophageal Leiomyosarcoma
5035,Benign Cellular Infiltrate,sarcoma of small intestine
5036,Glandular Differentiation,Stage IA Lung Large Cell Carcinoma AJCC v7
5037,Absence of a Hormonal Syndrome,"Glucagonoma, malignant"
5038,Borderline Lesion,Thyroid Gland Mucinous Follicular Adenoma
5039,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Mucinous Cystadenofibroma
5040,Mixed Neoplastic Glandular and Squamous Cell Population,Moderately Differentiated Hepatocellular Carcinoma
5041,Premalignant Lesion,Stage IIIA Lung Large Cell Carcinoma AJCC v7
5042,Borderline Lesion,Intraductal papilloma of breast
5043,Mixture of Germ Cell Neoplastic Components Present,Non-Gestational Ovarian Choriocarcinoma
5044,Nuclear Pseudoinclusion,Thyroid Gland Clear Cell Follicular Adenoma
5045,Locally Aggressive Lesion,Benign bone neoplasm
5046,Indolent Clinical Course,Malignant neoplasm of spinal cord
5047,Local disease,"Lipomatosis, Multiple Symmetrical"
5048,Intermediate Filaments Present,Recurrent Rhabdomyosarcoma
5049,Precise Histogenesis Unknown,Gliomatosis Cerebri Type I
5050,Intermediate Filaments Present,Stage I Osteosarcoma AJCC v7
5051,Ineffective hematopoiesis,Post polycythaemia vera myelofibrosis
5052,Intracytoplasmic Eosinophilic Inclusion,Chondroblastic osteosarcoma
5053,Mixed Neoplastic Glandular and Squamous Cell Population,Anogenital papillomaviral intraepithelial neoplasia
5054,Favorable Clinical Outcome,Bowen's Disease
5055,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in situ in a polyp
5056,Intermediate Filaments Present,Rectal Kaposi Sarcoma
5057,Chronic Clinical Course,Adult Acute Myeloid Leukemia with Maturation
5058,Encapsulated Mass,neurofibroma
5059,Villous Pattern,Colorectal Tubular Adenoma
5060,Favorable Clinical Outcome,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype"
5061,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
5062,Invasive Lesion,Parotid Gland Hemangioma
5063,Nuclear Pseudoinclusion,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
5064,Benign Cellular Infiltrate,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
5065,Indolent Clinical Course,Transplant-Related Renal Cell Carcinoma
5066,Polymorphic Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
5067,Localized Lesion,Plasma cell myeloma refractory
5068,Benign Cellular Infiltrate,Anal carcinoma
5069,Indolent Clinical Course,Cardiac Rhabdomyosarcoma
5070,Glandular Differentiation,undifferentiated carcinoma of salivary gland
5071,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Mucinous Adenocarcinoma
5072,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary Thyroid Microcarcinoma
5073,Borderline Lesion,Acantholytic acanthoma
5074,Benign Cellular Infiltrate,Stage IIC Colon Cancer AJCC v7
5075,Chronic Clinical Course,Acute leukemia
5076,Mixed Neoplastic Glandular and Squamous Cell Population,Benign Ovarian Mucinous Tumor
5077,Solid Growth Pattern,Acute Myeloid Leukemia with t(11;17)(q23;q21)
5078,Mixed Neoplastic Glandular and Squamous Cell Population,"Papillary cystadenoma, borderline malignancy"
5079,Solid Growth Pattern,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative"
5080,Histiocytosis,Childhood Immunoblastic Lymphoma
5081,Benign Cellular Infiltrate,Childhood Hepatocellular Carcinoma
5082,Acinar Cell Differentiation,carcinoma of pancreas with osteoclast-like giant cells
5083,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Pure Erythroid Leukemia
5084,Intracytoplasmic Eosinophilic Inclusion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5085,Well-Circumscribed Lesion,Childhood Embryonal Rhabdomyosarcoma
5086,Intermediate Filaments Present,Childhood Embryonal Rhabdomyosarcoma
5087,Indolent Clinical Course,Stage IA Bone Sarcoma AJCC v7
5088,Well-Circumscribed Lesion,Adult Pineoblastoma
5089,Benign Cellular Infiltrate,Gastric Mixed Adenoneuroendocrine Carcinoma
5090,Benign Cellular Infiltrate,Adenocarcinoma of pancreas
5091,Intermediate Filaments Present,Stage III Soft Tissue Sarcoma AJCC v7
5092,Intracytoplasmic Eosinophilic Inclusion,Stage III Soft Tissue Sarcoma AJCC v7
5093,Benign Cellular Infiltrate,Postsurgical Stage III Hepatoblastoma
5094,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Aggressive Systemic Mastocytosis
5095,Benign Cellular Infiltrate,Alcohol-Related Hepatocellular Carcinoma
5096,Premalignant Lesion,Stage 0 Lung Cancer AJCC v6 and v7
5097,Mixed Neoplastic Glandular and Squamous Cell Population,Fibrolamellar Hepatocellular Carcinoma
5098,Benign Cellular Infiltrate,Digestive System Neuroendocrine Carcinoma
5099,Benign Cellular Infiltrate,BCLC Stage B Adult Hepatocellular Carcinoma
5100,Locally Aggressive Lesion,Gingival Angiofibroma
5101,Glandular Differentiation,Small Intestinal Large Cell Neuroendocrine Carcinoma
5102,Mixed Neoplastic Glandular and Squamous Cell Population,Mucoepidermoid carcinoma of skin
5103,Severe cytologic atypia,Gastric Neuroendocrine Tumor G2
5104,Intermediate Filaments Present,Solid Alveolar Rhabdomyosarcoma
5105,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Well Differentiated Squamous Cell Carcinoma
5106,Metastatic Lesion,intraductal papilloma of salivary gland
5107,Multifocal Lesion,Colon Traditional Serrated Adenoma
5108,Borderline Lesion,Adenoma of middle ear
5109,Diffuse Lesion,Ethmoid Sinus Schneiderian Papilloma
5110,Intermediate Filaments Present,Breast Extraskeletal Osteosarcoma
5111,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
5112,Indolent Clinical Course,Localized Ewing Sarcoma
5113,Well-Circumscribed Lesion,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
5114,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
5115,Low Grade Lesion,Angiosarcoma NCI Grade 2
5116,Seminomatous Component Present,benign mature teratoma of pancreas
5117,Chronic Clinical Course,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
5118,Indolent Clinical Course,Malignant Cervical Soft Tissue Neoplasm
5119,Indolent Clinical Course,sarcoma of accessory sinus
5120,Indolent Clinical Course,Kaposi Sarcoma NCI Grade 2
5121,Low Grade Lesion,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
5122,Intermediate Filaments Present,Conventional Alveolar Rhabdomyosarcoma
5123,Invasive Lesion,"Papillary squamous cell carcinoma, non-invasive"
5124,Mucoid Stroma Formation,Gastric Papillary Adenocarcinoma
5125,Intermediate Filaments Present,Sarcoma by AJCC Grade
5126,Indolent Clinical Course,Anaplastic Oligoastrocytoma
5127,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of conjunctiva
5128,Indolent Clinical Course,Uterine Corpus High Grade Endometrial Stromal Sarcoma
5129,Intracytoplasmic Eosinophilic Inclusion,Alveolar soft part sarcoma metastatic
5130,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Penile Intraepithelial Neoplasia
5131,Aggressive Clinical Course,Mycosis fungoides stage III
5132,Intracytoplasmic Eosinophilic Inclusion,Adult Soft Tissue Sarcoma
5133,Intermediate Filaments Present,Epithelioid sarcoma metastatic
5134,Diffuse Lesion,Lymphangioma
5135,Squamous Differentiation,Sinonasal undifferentiated carcinoma
5136,Intracytoplasmic Eosinophilic Inclusion,Metastatic Extraskeletal Myxoid Chondrosarcoma
5137,Superficial Lesion,Spindle cell liposarcoma
5138,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Carcinoma
5139,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cystadenofibroma of fallopian tube
5140,Intermediate Filaments Present,Colorectal Leiomyosarcoma
5141,Mixture of Germ Cell Neoplastic Components Present,Recurrent Gestational Trophoblastic Tumor
5142,Indolent Clinical Course,Pleural Synovial Sarcoma
5143,Indolent Clinical Course,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
5144,Intestinal metaplasia,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
5145,Mixture of Germ Cell Neoplastic Components Present,Stage IIIB Gestational Trophoblastic Tumor AJCC v7
5146,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Angiosarcoma
5147,High Mitotic Activity,Recurrent Childhood Oligodendroglioma
5148,Indolent Clinical Course,Childhood Osteosarcoma
5149,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Cholangiocarcinoma
5150,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Mediastinal Teratoma
5151,Anaplasia,Childhood Supratentorial Ependymoma
5152,Mucoid Stroma Formation,papillomatosis of extrahepatic bile duct
5153,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Adenocarcinoma In Situ
5154,Intracytoplasmic Eosinophilic Inclusion,Childhood Angiosarcoma
5155,Benign Cellular Infiltrate,large B-cell diffuse lymphoma of liver
5156,Invasive Lesion,"Adenoma, Monomorphic"
5157,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,clear cell neoplasm of ovary
5158,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Clear Cell Tumor
5159,Indolent Clinical Course,Solitary Osseous Plasmacytoma
5160,Intestinal metaplasia,Diffuse Gastric Adenocarcinoma
5161,Intermediate Filaments Present,Stage IV Adult Soft Tissue Sarcoma AJCC v7
5162,Benign Cellular Infiltrate,Stage IV Rectal Cancer AJCC v7
5163,Borderline Lesion,Adult Epithelioid Hemangioendothelioma
5164,Benign Cellular Infiltrate,Gallbladder Cribriform Carcinoma
5165,Benign Cellular Infiltrate,Small intestine carcinoma stage I
5166,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Papillary Adenocarcinoma
5167,Precise Histogenesis Unknown,Childhood Cerebral Ependymoma
5168,Diffuse Lesion,Epithelioid hemangioma of skin
5169,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
5170,Mixed Neoplastic Glandular and Squamous Cell Population,Bartholin Gland Adenoma
5171,Chronic Clinical Course,Childhood Acute Myeloid Leukemia without Maturation
5172,Benign Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7
5173,Precise Histogenesis Unknown,Brain Glioblastoma
5174,Premalignant Lesion,Stage IB Non-Small Cell Lung Carcinoma AJCC v7
5175,Benign Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v6 and v7
5176,Favorable Clinical Outcome,External Ear Squamous Cell Carcinoma
5177,Well-Circumscribed Lesion,Superficial fibromatosis
5178,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
5179,Mixture of Germ Cell Neoplastic Components Present,Childhood Choriocarcinoma
5180,Diffuse Lesion,Ovarian Surface Papilloma
5181,Invasive Lesion,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
5182,Diffuse Lesion,Capillary hemangioma of retina
5183,High Mitotic Activity,Pancreatic Somatostatinoma
5184,Favorable Clinical Outcome,Trichilemmocarcinoma
5185,Squamous Differentiation,undifferentiated carcinoma of anal canal
5186,Mitotic Activity,Granular Cell Tumor of the Neurohypophysis
5187,Severe cytologic atypia,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
5188,Mixed Neoplastic Glandular and Squamous Cell Population,Endocervical polyp
5189,Diffuse Lesion,Lymphangioendothelioma
5190,Favorable Clinical Outcome,Stage IV Merkel Cell Carcinoma AJCC v7
5191,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
5192,Mixed Neoplastic Glandular and Squamous Cell Population,High-Grade Prostatic Intraepithelial Neoplasia
5193,Neuropil Present,Undifferentiated Neuroblastoma
5194,Benign Cellular Infiltrate,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
5195,Indolent Clinical Course,Leiomyosarcoma of Vessels
5196,Invasive Lesion,Low grade cervical glandular intraepithelial neoplasia
5197,Nuclear pleomorphism,Deep histiocytoma
5198,Indolent Clinical Course,Metastatic Malignant Neoplasm in the Adult Brain
5199,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Invasive Papillary Adenocarcinoma
5200,Indolent Clinical Course,Drop Metastasis in the Spinal Cord
5201,Malignant Germinomatous Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
5202,Precise Histogenesis Unknown,Subependymal Glioma
5203,Mitotic Activity,Benign germ cell neoplasm
5204,Glandular Differentiation,undifferentiated carcinoma of extrahepatic bile duct
5205,Intermediate Grade Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
5206,Premalignant Lesion,Malignant neoplasm of trachea
5207,Seminomatous Component Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
5208,Mitotic Activity,"Retinoblastoma, spontaneously regressed"
5209,Intermediate Filaments Present,Stage IIIC Uterine Sarcoma AJCC v7
5210,Severe cytologic atypia,"Gastrinoma, malignant"
5211,Borderline Lesion,Serous cystadenoma of pancreas
5212,Mixed Neoplastic Glandular and Squamous Cell Population,Acinic Cell Breast Carcinoma
5213,HMB-45-Positive Neoplastic Cells Present,Letterer-Siwe Disease
5214,Borderline Lesion,Bladder Squamous Papilloma
5215,Invasive Lesion,Intraductal papilloma of breast
5216,Indolent Clinical Course,Fusion-Negative Rhabdomyosarcoma
5217,Intracytoplasmic Eosinophilic Inclusion,Synovial sarcoma recurrent
5218,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of nasal cavity
5219,Mixed Neoplastic Glandular and Squamous Cell Population,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
5220,Malignant Germinomatous Cellular Infiltrate,Ovarian Fetiform Teratoma
5221,Indolent Clinical Course,Malignant Glioma
5222,Borderline Lesion,Exophytic Schneiderian Papilloma
5223,Borderline Lesion,Benign tumor of endocrine gland
5224,Chronic Clinical Course,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
5225,Polymorphic Cellular Infiltrate,Langerhans Cell Sarcoma
5226,Aggressive Clinical Course,Mycosis fungoides recurrent
5227,Indolent Clinical Course,Proximal-Type Epithelioid Sarcoma
5228,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, intestinal type"
5229,Favorable Clinical Outcome,Paget Disease of the Scrotum
5230,Pushing Tumor Margin,Condyloma Acuminatum with Dysplasia
5231,Indolent Clinical Course,Low Grade Endometrioid Stromal Sarcoma of the Vagina
5232,Indolent Clinical Course,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
5233,Polymorphic Cellular Infiltrate,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
5234,Invasive Lesion,Gallbladder Flat Biliary Intraepithelial Neoplasia
5235,Squamous Differentiation,Anaplastic thyroid carcinoma
5236,Indolent Clinical Course,Sclerosing liposarcoma
5237,Borderline Lesion,Benign Ovarian Mucinous Tumor
5238,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Glandular Papilloma
5239,Glandular Differentiation,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
5240,Invasive Lesion,Seborrheic keratosis of eyelid
5241,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
5242,Favorable Clinical Outcome,regressing melanoma of skin
5243,Precise Histogenesis Unknown,Childhood Pilomyxoid Astrocytoma
5244,Intracytoplasmic Eosinophilic Inclusion,Mixed Liposarcoma
5245,Well-Circumscribed Lesion,Childhood Alveolar Rhabdomyosarcoma
5246,Benign Cellular Infiltrate,Rectal Sarcomatoid Carcinoma
5247,Intermediate Filaments Present,Stage IA Soft Tissue Sarcoma AJCC v7
5248,Mixed Neoplastic Glandular and Squamous Cell Population,Occult Lung Squamous Cell Carcinoma
5249,Acute Clinical Course,Chronic lymphocytic leukemia stage 4
5250,Mucoid Stroma Formation,Schneiderian papilloma
5251,Solid Growth Pattern,ROSE Cluster 6
5252,Intracytoplasmic Eosinophilic Inclusion,undifferentiated sarcoma of ovary
5253,High Mitotic Activity,Childhood Infratentorial Ependymoma
5254,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Rectal Adenocarcinoma
5255,Metastatic Lesion,Benign neoplasm of major salivary gland
5256,Grade 4 Lesion,Childhood Cerebral Astrocytoma
5257,Benign Cellular Infiltrate,Hepatoblastoma recurrent
5258,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,mucinous adenocarcinoma of ovary
5259,Invasive Lesion,inverted ductal papilloma of salivary gland
5260,Solid Growth Pattern,ROSE Cluster 2
5261,Locally Aggressive Lesion,Chondromyxoid fibroma
5262,Intracytoplasmic Eosinophilic Inclusion,High Grade Sarcoma
5263,Mixture of Germ Cell Neoplastic Components Present,Testicular choriocarcinoma stage I
5264,Precise Histogenesis Unknown,Childhood Ependymoma
5265,Benign Cellular Infiltrate,Colon Kaposi Sarcoma
5266,atypia morphology,Right atrial myxoma
5267,Intracytoplasmic Eosinophilic Inclusion,Mediastinal Angiosarcoma
5268,Intracytoplasmic Eosinophilic Inclusion,Bone Sarcoma
5269,Mucoid Stroma Formation,Intraductal papillary adenocarcinoma with invasion
5270,Benign Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v6 and v7
5271,Intermediate Filaments Present,Ewing's sarcoma recurrent
5272,Mixed Neoplastic Glandular and Squamous Cell Population,Sweat gland adenocarcinoma
5273,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic intraepithelial neoplasia
5274,Malignant Germinomatous Cellular Infiltrate,Testicular choriocarcinoma stage III
5275,Indolent Clinical Course,Sarcoma by AJCC Grade
5276,Intermediate Filaments Present,Small Intestinal Kaposi Sarcoma
5277,Multilayered Rosette Formation,Classic medulloblastoma
5278,Intermediate Filaments Present,Gallbladder Angiosarcoma
5279,Indolent Clinical Course,Malignant Mediastinal Soft Tissue Neoplasm
5280,Borderline Lesion,Maxillary Sinus Inverted Papilloma
5281,Intermediate Filaments Present,leiomyosarcoma of breast
5282,Nuclear Pseudoinclusion,Thyroid Gland Hyperfunctioning Adenoma
5283,Squamous Differentiation,Undifferentiated carcinoma of esophagus
5284,Diffuse Lesion,Ethmoid Sinus Inverted Papilloma
5285,Intermediate Filaments Present,Kaposi's sarcoma of lung
5286,Local disease,Advanced Unfavorable Hodgkin Lymphoma
5287,Chronic Clinical Course,Acute Myeloid Leukemia (AML-M2)
5288,Mucoid Stroma Formation,Anal Canal Squamous Papilloma
5289,Benign Cellular Infiltrate,Gastric Mixed Adenocarcinoma
5290,Intracytoplasmic Eosinophilic Inclusion,Adult Extraskeletal Myxoid Chondrosarcoma
5291,Mixed Neoplastic Glandular and Squamous Cell Population,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
5292,Indolent Clinical Course,Myxoid chondrosarcoma
5293,Indolent Clinical Course,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
5294,Favorable Clinical Outcome,Liver and Intrahepatic Biliary Tract Carcinoma
5295,atypia morphology,Halo nevus
5296,Microvascular Proliferation,Recurrent Childhood Oligoastrocytoma
5297,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Lung Squamous Cell Carcinoma AJCC v7
5298,Mixed Neoplastic Glandular and Squamous Cell Population,Disseminated adenocarcinoma
5299,Intermediate Filaments Present,Stage II Adult Soft Tissue Sarcoma AJCC v7
5300,Intermediate Filaments Present,Skin Lymphangiosarcoma
5301,Benign Cellular Infiltrate,Esophageal carcinoma
5302,Diffuse Lesion,Gastric Lymphangioma
5303,Glandular Differentiation,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
5304,Intermediate Filaments Present,Prostate Kaposi Sarcoma
5305,Intracytoplasmic Eosinophilic Inclusion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
5306,Favorable Clinical Outcome,Stage III Skin Cancer
5307,High Mitotic Activity,Pancreatic Delta Cell Neoplasm
5308,Borderline Lesion,ductal papilloma of salivary gland
5309,Chronic Clinical Course,"Acute Myeloid Leukemia, M1"
5310,Intracytoplasmic Eosinophilic Inclusion,Cardiac Kaposi's Sarcoma
5311,Seminomatous Component Present,Childhood Testicular Teratoma
5312,Mixed Epithelial Cell Population,Vestibular Papilloma
5313,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Lung Squamous Cell Carcinoma AJCC v7
5314,Well-Circumscribed Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
5315,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Testicular Mature Teratoma
5316,Intracytoplasmic Eosinophilic Inclusion,Colorectal Kaposi Sarcoma
5317,Favorable Clinical Outcome,Hereditary Melanoma
5318,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Low Grade Ovarian Serous Adenocarcinoma
5319,Solid Growth Pattern,Adult Acute Erythroid Leukemia
5320,Well-Circumscribed Lesion,Infantile digital fibromatosis
5321,Indolent Clinical Course,Infratentorial Cancer
5322,Well-Circumscribed Lesion,calcifying aponeurotic fibroma
5323,Premalignant Lesion,Giant cell carcinoma of lung
5324,Favorable Clinical Outcome,Stage III Hepatocellular Carcinoma AJCC v6
5325,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) refractory
5326,atypia morphology,"Leydig cell tumor, benign"
5327,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
5328,Indolent Clinical Course,Pineal Region Yolk Sac Tumor
5329,atypia morphology,Balloon cell nevus
5330,Precise Histogenesis Unknown,Adult Brain Ependymoma
5331,Benign Cellular Infiltrate,Grade 2 Colorectal Adenocarcinoma
5332,Mixed Neoplastic Glandular and Squamous Cell Population,Pedunculated conjunctival papilloma
5333,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of breast
5334,Junctional Proliferation,Cellular Blue Nevus
5335,atypia morphology,Cellular Blue Nevus
5336,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Transitional Cell Tumor
5337,Mixed Neoplastic Glandular and Squamous Cell Population,Prostatic Intraepithelial Neoplasias
5338,Histiocytosis,Stage II Adult Immunoblastic Lymphoma
5339,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
5340,atypia morphology,"Nevus, Blue"
5341,Borderline Lesion,Erosive Adenomatosis of the Nipple
5342,Severe cytologic atypia,Carcinoid tumor of ileum
5343,Diffuse Lesion,Lymphangioma of skin
5344,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
5345,Glandular Differentiation,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
5346,Dysplasia,Clear cell hidradenoma
5347,Ground Glass Nuclear Inclusion,Thyroid Gland Oncocytic Adenoma
5348,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of trachea
5349,Mucoid Stroma Formation,"Schneiderian papilloma, inverted"
5350,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
5351,Indolent Clinical Course,"Supratentorial Embryonal Tumor, Not Otherwise Specified"
5352,Well-Circumscribed Lesion,Lipofibromatosis
5353,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the oral cavity stage I
5354,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
5355,Diffuse Lesion,Inverted Papilloma
5356,Mixed Neoplastic Glandular and Squamous Cell Population,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
5357,Invasive Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant"
5358,Indolent Clinical Course,Prostate Sarcoma
5359,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Medullary Carcinoma
5360,Borderline Lesion,Heavily Pigmented Adrenal Cortical Adenoma
5361,Solid Growth Pattern,Secondary Acute Myeloid Leukemia
5362,Glandular Differentiation,Large cell lung cancer stage II
5363,Borderline Lesion,Pancreatic Macrocystic Serous Cystadenoma
5364,Indolent Clinical Course,Primary Childhood Soft Tissue Sarcoma
5365,Intermediate Filaments Present,Colon Leiomyosarcoma
5366,Squamous Differentiation,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
5367,Precise Histogenesis Unknown,Glioma
5368,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Broad Ligament Serous Adenocarcinoma
5369,Benign Cellular Infiltrate,Stage IV Esophageal Adenocarcinoma AJCC v7
5370,Seminomatous Component Present,Childhood Ovarian Mature Teratoma
5371,Metastatic Lesion,Null Cell Pituitary Gland Adenoma
5372,Intermediate Filaments Present,Synovial sarcoma metastatic
5373,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Bone Sarcoma AJCC v7
5374,Mixed Neoplastic Glandular and Squamous Cell Population,Eccrine porocarcinoma
5375,Benign Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v7
5376,Benign Cellular Infiltrate,Malignant Esophageal Neoplasm by Anatomic Region
5377,Chronic Clinical Course,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
5378,Benign Cellular Infiltrate,Small Intestinal B-Cell Non-Hodgkin Lymphoma
5379,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
5380,Squamous Differentiation,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
5381,Ineffective hematopoiesis,Primary Myelofibrosis
5382,Mixed Neoplastic Glandular and Squamous Cell Population,intestinal type adenocarcinoma of gallbladder
5383,Indolent Clinical Course,Undifferentiated (Embryonal) Sarcoma
5384,Indolent Clinical Course,Kidney Extraskeletal Osteosarcoma
5385,Indolent Clinical Course,Stromal sarcoma
5386,Intracytoplasmic Eosinophilic Inclusion,Stromal sarcoma
5387,Premalignant Lesion,Adenosquamous cell lung cancer
5388,Benign Cellular Infiltrate,leiomyosarcoma of appendix
5389,Locally Aggressive Lesion,Fibroma of prostate
5390,Local disease,Pelvic lipomatosis
5391,Intracytoplasmic Eosinophilic Inclusion,Inflammatory liposarcoma
5392,Chronic Clinical Course,Childhood Acute Monoblastic and Monocytic Leukemia
5393,Myxoid Stroma Formation,Benign Notochordal Cell Tumor
5394,Diffuse Lesion,Hemangioma of skin
5395,Diffuse Lesion,Hemangioma of breast
5396,Mixed Cellular Population,"Invasive Lobular Breast Carcinoma, Solid Variant"
5397,Benign Cellular Infiltrate,Malignant neoplasm of lower third of esophagus
5398,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell papilloma of eyelid
5399,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Mucinous Adenocarcinoma
5400,Squamous Differentiation,large cell carcinoma of salivary gland
5401,Precise Histogenesis Unknown,Glioblastoma
5402,Mucoid Stroma Formation,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
5403,Benign Cellular Infiltrate,PRETEXT Stage 2 Hepatoblastoma
5404,Intermediate Filaments Present,Childhood Alveolar Rhabdomyosarcoma
5405,Benign Cellular Infiltrate,Calcifying Nested Epithelial Stromal Tumor of the Liver
5406,Benign Cellular Infiltrate,Gastric Neuroendocrine Carcinoma
5407,Borderline Lesion,Syringoma
5408,Benign Cellular Infiltrate,Rectal Cribriform Comedo-Type Adenocarcinoma
5409,Absence of a Hormonal Syndrome,Pancreatic Somatostatinoma
5410,Increased Cellularity Present,Bladder Urothelial Papilloma
5411,Intracytoplasmic Eosinophilic Inclusion,Childhood Clear Cell Sarcoma of Soft Parts
5412,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Micropapillary Adenocarcinoma
5413,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, Signet Ring Cell"
5414,Intracytoplasmic Eosinophilic Inclusion,Rectal Rhabdomyosarcoma
5415,Mixed Neoplastic Glandular and Squamous Cell Population,Parotid Gland Adenocarcinoma
5416,Severe cytologic atypia,Gastric Carcinoid Tumor
5417,Glandular Differentiation,Endometrial Undifferentiated Carcinoma
5418,Intermediate Filaments Present,Chondrosarcoma recurrent
5419,Favorable Clinical Outcome,Skin Basal Cell Carcinoma with Sebaceous Differentiation
5420,Malignant Germinomatous Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor
5421,Indolent Clinical Course,Solid Alveolar Rhabdomyosarcoma
5422,Invasive Lesion,sialadenoma papilliferum of salivary gland
5423,Favorable Clinical Outcome,Skin Signet Ring Cell Basal Cell Carcinoma
5424,Intracytoplasmic Eosinophilic Inclusion,Stage III Osteosarcoma AJCC v7
5425,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Warty Carcinoma
5426,Malignant Germinomatous Cellular Infiltrate,Testicular embryonal carcinoma stage I
5427,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary serous cystadenocarcinoma
5428,Metastatic Lesion,Non-Functioning Pituitary Gland Macroadenoma
5429,Solid Growth Pattern,Treatment related acute myeloid leukaemia
5430,Intermediate Filaments Present,Uterine Corpus Epithelioid Leiomyosarcoma
5431,Indolent Clinical Course,sarcoma of testis
5432,Necrotic changes (finding),Protoplasmic astrocytoma
5433,Pineocytomatous Rosette Formation,Childhood Pineoblastoma
5434,Intermediate Filaments Present,Alveolar soft part sarcoma non-metastatic
5435,Mixed Neoplastic Glandular and Squamous Cell Population,Maxillary Sinus Inverted Papilloma
5436,High Mitotic Activity,Minimal Deviation Melanoma
5437,Mixed Neoplastic Glandular and Squamous Cell Population,Upper Gingival Verrucous Carcinoma
5438,Invasive Lesion,"Acanthoma, Pilar Sheath"
5439,Gastric-Type Epithelial Differentiation,adenomatous polyp of stomach
5440,Presence of a Hormonal Syndrome,Non functioning pancreatic endocrine tumor
5441,Precise Histogenesis Unknown,Cerebral Astrocytoma
5442,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
5443,Invasive Lesion,Vaginal high grade squamous intraepithelial lesion
5444,Invasive Lesion,Benign Cutaneous Fibroblastic Neoplasm
5445,Mixed Neoplastic Glandular and Squamous Cell Population,Mucin-Producing Intrahepatic Cholangiocarcinoma
5446,Indolent Clinical Course,Chondroid chordoma
5447,High Mitotic Activity,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
5448,Benign Cellular Infiltrate,Gastric Liposarcoma
5449,Mixed Neoplastic Glandular and Squamous Cell Population,Villous adenoma of rectum
5450,Indolent Clinical Course,Primary malignant neoplasm of oculomotor nerve
5451,Mixed Neoplastic Glandular and Squamous Cell Population,Basophilic Adenocarcinoma
5452,Benign Cellular Infiltrate,Stage IVB Liver Cancer
5453,Premalignant Lesion,Stage IIIA Lung Cancer AJCC v7
5454,Indolent Clinical Course,Childhood Synovial Sarcoma
5455,Metastatic Lesion,Cardiac Lymphoma
5456,Benign Cellular Infiltrate,Colorectal Carcinoma
5457,Indolent Clinical Course,PNET of bone localized
5458,Mixed Neoplastic Glandular and Squamous Cell Population,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
5459,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of vulva
5460,Intracytoplasmic Eosinophilic Inclusion,Endometrial Stromal Sarcoma
5461,Invasive Lesion,Benign Cutaneous Vascular Neoplasm
5462,Intracytoplasmic Eosinophilic Inclusion,Recurrent Adult Soft Tissue Sarcoma
5463,Precise Histogenesis Unknown,Diffuse Astrocytoma
5464,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Papillary Squamous Cell Carcinoma
5465,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Renal Cell Carcinoma
5466,Nuclear Grooves,Clear Cell Variant Thyroid Gland Follicular Carcinoma
5467,Indolent Clinical Course,Duodenal Extraskeletal Osteosarcoma
5468,Solid Growth Pattern,Acute Myeloid Leukemia with Gene Mutations
5469,Precise Histogenesis Unknown,"Anaplastic Astrocytoma, IDH-Mutant"
5470,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Lung Adenocarcinoma AJCC v7
5471,Solid Growth Pattern,"Leukemia, Radiation-Induced"
5472,Mixed Neoplastic Glandular and Squamous Cell Population,Bartholin Gland Squamous Cell Carcinoma
5473,Precise Histogenesis Unknown,Epithelioid glioblastoma
5474,Benign Cellular Infiltrate,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
5475,Favorable Clinical Outcome,Pilomatrix carcinoma of skin
5476,Ineffective hematopoiesis,"Polycythemia Vera, Polycythemic Phase"
5477,Invasive Lesion,inverted follicular keratosis
5478,Mixed Neoplastic Glandular and Squamous Cell Population,Tubulocystic renal cell carcinoma
5479,CD21-Positive Neoplastic Cells Present,Histiocytic sarcoma
5480,Intracytoplasmic Eosinophilic Inclusion,Brain sarcoma
5481,Leukoerythroblastic Reaction,"Thrombocythemia, Essential"
5482,Intracytoplasmic Eosinophilic Inclusion,Peripheral Intraneural Angiosarcoma
5483,Mixed Neoplastic Glandular and Squamous Cell Population,External Ear Squamous Cell Carcinoma
5484,Malignant Germinomatous Cellular Infiltrate,Childhood Nongerminomatous Germ Cell Tumor
5485,Intracytoplasmic Eosinophilic Inclusion,Giant Cell Fibrous Histiocytoma
5486,atypia morphology,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
5487,Mixed Neoplastic Glandular and Squamous Cell Population,Breast Carcinoma with Melanotic Features
5488,Dysplasia,Nuchal-type fibroma
5489,Indolent Clinical Course,Childhood Anaplastic Ependymoma
5490,Indolent Clinical Course,Adult Brain Medulloblastoma
5491,Benign Cellular Infiltrate,BCLC Stage 0 Hepatocellular Carcinoma
5492,Intermediate Filaments Present,"Liposarcoma, Dedifferentiated"
5493,Superficial Lesion,Deep Lipoma
5494,Grade 4 Lesion,Recurrent Childhood Anaplastic Astrocytoma
5495,Invasive Lesion,Endometrial intraepithelial neoplasia
5496,Favorable Clinical Outcome,Stage IVB Basal Cell Lip Carcinoma
5497,Mixed Neoplastic Glandular and Squamous Cell Population,Infiltrating duct and lobular carcinoma
5498,Premalignant Lesion,Stage IV Lung Cancer AJCC v6
5499,Indolent Clinical Course,Malignant Peripheral Nerve Sheath Tumor
5500,High Mitotic Activity,Intestinal Neuroendocrine Tumor G2
5501,Low Mitotic Activity,Pancreatic Small Cell Neuroendocrine Carcinoma
5502,Indolent Clinical Course,Uterine Angiosarcoma
5503,Indolent Clinical Course,leiomyosarcoma of anus
5504,Mucoid Stroma Formation,Ampulla of Vater Invasive Papillary Adenocarcinoma
5505,Mucoid Stroma Formation,Verrucous carcinoma of oral cavity
5506,Intracytoplasmic Eosinophilic Inclusion,Metastatic angiosarcoma
5507,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Ductal Adenocarcinoma
5508,Mixed Epithelial Cell Population,Squamous cell papilloma of skin
5509,High Mitotic Activity,Appendix Neuroendocrine Tumor
5510,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
5511,Encapsulated Mass,Intravascular fasciitis
5512,Seminomatous Component Present,Testicular Teratoma with Somatic-Type Malignancy
5513,Benign Cellular Infiltrate,Malignant hepatobiliary neoplasms
5514,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Adenocarcinoma
5515,Seminomatous Component Present,Ovarian Dermoid Cyst with Adenocarcinoma
5516,Mixed Neoplastic Glandular and Squamous Cell Population,Tall Cell Variant Thyroid Gland Papillary Carcinoma
5517,Intermediate Filaments Present,Iatrogenic Kaposi Sarcoma
5518,Benign Cellular Infiltrate,Pancreatic adenocarcinoma metastatic
5519,Absence of a Hormonal Syndrome,Malignant Pancreatic Insulinoma
5520,Intracytoplasmic Eosinophilic Inclusion,Colon Leiomyosarcoma
5521,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Mucinous Adenofibroma
5522,Intermediate Filaments Present,Sarcoma NCI Grade 2
5523,Dysplasia,Colorectal Microvesicular Hyperplastic Polyp
5524,Dysplasia,Superficial Epithelioma with Sebaceous Differentiation
5525,Intermediate Filaments Present,Metastatic Malignant Peripheral Nerve Sheath Tumor
5526,Glandular Differentiation,Stage IIA Lung Large Cell Carcinoma AJCC v7
5527,Tumor Vascular Invasion,Thyroid Gland Clear Cell Follicular Adenoma
5528,Favorable Clinical Outcome,Sebaceous Breast Carcinoma
5529,Benign Cellular Infiltrate,Stage III Rectal Cancer AJCC v6
5530,Benign Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v6
5531,Indolent Clinical Course,Stage IV Bone Sarcoma AJCC v7
5532,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Lobular Breast Carcinoma
5533,Malignant Germinomatous Cellular Infiltrate,Grade 1 Ovarian Teratoma
5534,Benign Cellular Infiltrate,Small Intestinal Medullary Carcinoma
5535,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
5536,Severe cytologic atypia,Pancreatic Vipoma
5537,Aggressive Clinical Course,Mycosis fungoides stage I
5538,Chronic Clinical Course,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
5539,Mixed Neoplastic Glandular and Squamous Cell Population,Transplant-Related Renal Cell Carcinoma
5540,Benign Cellular Infiltrate,Stage II Rectal Cancer AJCC v7
5541,Prominent Schwannian Stroma Present,Adrenal neuroblastoma
5542,High Mitotic Activity,Intestinal Gangliocytic Paraganglioma
5543,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease of the Scrotum
5544,atypia morphology,Adenomatoid tumor of epididymis
5545,Benign Cellular Infiltrate,Appendix Mixed Adenoneuroendocrine Carcinoma
5546,Intermediate Filaments Present,Adult Undifferentiated Pleomorphic Sarcoma
5547,Invasive Lesion,Gallbladder Biliary Intraepithelial Neoplasia
5548,Necrotic changes (finding),Childhood Oligoastrocytoma
5549,Malignant Germinomatous Cellular Infiltrate,Malignant Testicular Non-Seminomatous Germ Cell Tumor
5550,Intermediate Filaments Present,Sclerosing liposarcoma
5551,Borderline Lesion,Parathyroid Gland Lipoadenoma
5552,Benign Cellular Infiltrate,Stage IIIB Esophageal Adenocarcinoma AJCC v7
5553,Mixed Neoplastic Glandular and Squamous Cell Population,Parathyroid Gland Adenocarcinoma
5554,Mixed Epithelial Cell Population,Squamous cell papilloma of eyelid
5555,Mixed Cellular Population,Squamous cell papilloma of eyelid
5556,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute myelomonocytic leukemia
5557,Solid Growth Pattern,Acute Leukemia of Ambiguous Lineage
5558,Chronic Clinical Course,Adult Burkitt Leukemia
5559,Indolent Clinical Course,Malignant medulloepithelioma of ciliary body
5560,Invasive Lesion,Stage 0 Cutaneous Melanoma AJCC v6 and v7
5561,Intracytoplasmic Eosinophilic Inclusion,sarcoma of rectum
5562,Mitotic Activity,Childhood Protoplasmic Astrocytoma
5563,Chronic Clinical Course,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
5564,Intermediate Filaments Present,Leiomyosarcoma of uterus
5565,Malignant Germinomatous Cellular Infiltrate,Gastric Teratoma
5566,Composite Lesion,"Thymoma, type B2, malignant"
5567,Metastatic Lesion,Growth Hormone-Secreting Pituitary Adenoma
5568,Therapy-Related Toxicity,Acute myeloid leukemia with multilineage dysplasia
5569,Indolent Clinical Course,Rectal Rhabdomyosarcoma
5570,Neuroectodermal Differentiation,Ewing's sarcoma of bone
5571,Benign Cellular Infiltrate,Adenocarcinoma of anal canal
5572,Benign Cellular Infiltrate,Bile duct adenocarcinoma
5573,Intermediate Filaments Present,Grade I Chondrosarcoma
5574,Intracytoplasmic Eosinophilic Inclusion,Grade I Chondrosarcoma
5575,Indolent Clinical Course,Stage IIA Bone Cancer AJCC v7
5576,Intracytoplasmic Eosinophilic Inclusion,sarcoma of larynx
5577,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Clear Cell Renal Cell Carcinoma
5578,Favorable Clinical Outcome,Blastic plasmacytoid dendritic cell neoplasm
5579,Necrotic changes (finding),Solitary Osteochondroma
5580,Intermediate Filaments Present,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5581,Indolent Clinical Course,Glandular malignant peripheral nerve sheath tumor
5582,Intermediate Filaments Present,AJCC Grade 1 Sarcoma
5583,Precise Histogenesis Unknown,oligodendroglioma
5584,Indolent Clinical Course,liposarcoma of breast
5585,Neuroectodermal Differentiation,Recurrent Bone Ewing Sarcoma
5586,High Mitotic Activity,Carcinoid tumor of the duodenum
5587,Glandular Differentiation,Cervical Large Cell Neuroendocrine Carcinoma
5588,Intracytoplasmic Eosinophilic Inclusion,Epithelioid Sarcoma NCI Grade 3
5589,Acute Clinical Course,Chronic eosinophilic leukemia
5590,Mucoid Stroma Formation,Maxillary Sinus Schneiderian Papilloma
5591,Mixed Neoplastic Glandular and Squamous Cell Population,"Hepatocellular carcinoma, scirrhous"
5592,Benign Cellular Infiltrate,Mucinous adenocarcinoma of colon
5593,Benign Cellular Infiltrate,Colon Cribriform Comedo-Type Adenocarcinoma
5594,Intestinal metaplasia,signet ring cell carcinoma of gallbladder
5595,Intracytoplasmic Eosinophilic Inclusion,fibrosarcoma of breast
5596,Intracytoplasmic Eosinophilic Inclusion,"Synovial sarcoma, spindle cell"
5597,Mucoid Stroma Formation,Frontal Sinus Inverted Papilloma
5598,High Mitotic Activity,Cerebellar Liponeurocytoma
5599,Indolent Clinical Course,Meningeal Carcinomatosis
5600,Intermediate Filaments Present,Extra-osseous Ewing's sarcoma non-metastatic
5601,High Mitotic Activity,Pancreatic Neuroendocrine Tumor G2
5602,Well-Circumscribed Lesion,Vulvar Alveolar Rhabdomyosarcoma
5603,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7
5604,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of extrahepatic bile duct
5605,Intermediate Filaments Present,Low Grade Endometrial Stromal Sarcoma
5606,Mixed Epithelial Cell Population,Papilloma of nasal vestibule
5607,Indolent Clinical Course,Pleural Biphasic Synovial Sarcoma
5608,Malignant Cellular Infiltrate,Bowenoid papulosis of penis
5609,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,High Grade Fallopian Tube Serous Adenocarcinoma
5610,Favorable Clinical Outcome,Stage III Childhood Hepatocellular Carcinoma AJCC v7
5611,Borderline Lesion,Ovarian Sclerosing Stromal Tumor
5612,Intermediate Filaments Present,Childhood Synovial Sarcoma
5613,Solid Growth Pattern,Mixed phenotype acute leukemia B/myeloid
5614,Mixed Neoplastic Glandular and Squamous Cell Population,Pseudomyxoma Peritonei
5615,Indolent Clinical Course,Osteosarcoma recurrent
5616,Solid Growth Pattern,Prolymphocytic Leukemia
5617,Tumor Vascular Invasion,Chief cell adenoma
5618,Mixed Neoplastic Glandular and Squamous Cell Population,Prolactin-Producing Pituitary Gland Carcinoma
5619,Intermediate Filaments Present,Dedifferentiated chondrosarcoma
5620,Grade 4 Lesion,"Diffuse Astrocytoma, IDH-Mutant"
5621,Squamous Differentiation,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
5622,Intermediate Filaments Present,Liver Synovial Sarcoma
5623,Mixture of Germ Cell Neoplastic Components Present,Stage IIB Gestational Trophoblastic Tumor AJCC v7
5624,Benign Cellular Infiltrate,Localized Non-Resectable Adult Liver Carcinoma
5625,Indolent Clinical Course,Metastatic leiomyosarcoma
5626,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Squamous Papilloma
5627,Anaplasia,Benign Childhood Cerebral Neoplasm
5628,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Teratoma
5629,Indolent Clinical Course,Anal Kaposi Sarcoma
5630,Indolent Clinical Course,"Anaplastic Astrocytoma, IDH-Mutant"
5631,Indolent Clinical Course,Liposarcoma non-metastatic
5632,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Serous Tubal Intraepithelial Carcinoma
5633,Indolent Clinical Course,"Anaplastic Astrocytoma, IDH-Wildtype"
5634,Seminomatous Component Present,Sacrococcygeal teratoma
5635,Mixture of Germ Cell Neoplastic Components Present,Stage II Testicular Seminoma AJCC v6 and v7
5636,Invasive Lesion,Paget Disease of the Breast without Invasive Carcinoma
5637,Indolent Clinical Course,Brain Glioblastoma
5638,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Hepatocellular Carcinoma AJCC v6
5639,Benign Cellular Infiltrate,adenocarcinoma of extrahepatic bile duct
5640,Glandular Differentiation,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
5641,Mucoid Stroma Formation,Plantar Verrucous Skin Carcinoma
5642,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of ureter
5643,Diffuse Lesion,Vestibular Micropapillomatosis
5644,Metastatic Lesion,lymphoma of spinal cord
5645,Borderline Lesion,Vulvar Papillary Hidradenoma
5646,Mixed Neoplastic Glandular and Squamous Cell Population,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
5647,High Mitotic Activity,Adult Brain Ependymoma
5648,Favorable Clinical Outcome,Malignant Germinative Follicular Epithelium Neoplasm
5649,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Intrahepatic Cholangiocarcinoma
5650,Benign Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v6 and v7
5651,Indolent Clinical Course,Inflammatory malignant fibrous histiocytoma
5652,Dysplasia,Anal Papillary Hidradenoma
5653,Benign Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7
5654,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma localised
5655,Well-Circumscribed Lesion,Pigmented villonodular synovitis
5656,Capsular Invasion,Parathyroid mixed cell type adenoma
5657,Benign Cellular Infiltrate,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
5658,Seminomatous Component Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
5659,Intermediate Filaments Present,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5660,Favorable Clinical Outcome,Cutaneous Melanoma by AJCC v6 Stage
5661,Benign Cellular Infiltrate,Pancreatic Mixed Adenoneuroendocrine Carcinoma
5662,Dermal Involvement,Hutchinson's Melanotic Freckle
5663,Presence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G1
5664,Benign Cellular Infiltrate,Sarcoma of liver
5665,Indolent Clinical Course,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
5666,Grade 4 Lesion,Anaplastic Hemispheric Astrocytoma
5667,Scattered Collections of Differentiating Neuroblasts Present,"Ganglioneuroblastoma, Nodular"
5668,Intracytoplasmic Eosinophilic Inclusion,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5669,Mucoid Stroma Formation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
5670,Giant Mitochondria Present,Thyrotroph adenoma
5671,Benign Cellular Infiltrate,Malignant neoplasm of stomach
5672,Mixed Cellular Population,canalicular adenoma of salivary gland
5673,Dysplasia,Vulvar Nodular Hidradenoma
5674,Metastatic Lesion,Non-Metastatic Gestational Trophoblastic Tumor
5675,Indolent Clinical Course,"Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
5676,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Endometrial Endometrioid Adenocarcinoma
5677,Low Mitotic Activity,large cell neuroendocrine carcinoma of appendix
5678,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous neoplasm
5679,Chronic Clinical Course,Acute lymphocytic leukemia
5680,Intestinal metaplasia,signet ring cell carcinoma of breast
5681,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Solid Teratoma
5682,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Signet Ring Cell Breast Carcinoma
5683,Mixed Neoplastic Glandular and Squamous Cell Population,Spindle cell squamous cell carcinoma
5684,Premalignant Lesion,Large cell lung cancer stage II
5685,Mucoid Stroma Formation,Laryngeal verrucous carcinoma stage IV
5686,Focal dysplasia,Colorectal Traditional Serrated Adenoma
5687,Mixed Neoplastic Glandular and Squamous Cell Population,Unclassified Renal Cell Carcinoma
5688,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Differentiated Hepatocellular Carcinoma
5689,Seminomatous Component Present,Ovarian Biphasic or Triphasic Teratoma
5690,Indolent Clinical Course,Alveolar Soft Part Sarcoma
5691,Benign Cellular Infiltrate,Gastrointestinal melanoma
5692,Intermediate Filaments Present,Chondroblastic osteosarcoma
5693,Keratin pearl formation,Vaginal Non-Keratinizing Squamous Cell Carcinoma
5694,Chronic Clinical Course,DDIT4L Acute Lymphoblastic Leukemia
5695,Solid Growth Pattern,"Acute myeloid leukemia, minimal differentiation"
5696,Benign Cellular Infiltrate,Transplant-Related Hepatocellular Carcinoma
5697,Metastatic Lesion,Parotid Gland Hemangioma
5698,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
5699,Solid Growth Pattern,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant"
5700,Melanin Pigment Present,Nonpigmented nevus
5701,Mixed Neoplastic Glandular and Squamous Cell Population,Submandibular Gland Acinic Cell Carcinoma
5702,Benign Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder
5703,Low Grade Lesion,Angiosarcoma Associated with Lymphedema
5704,Neuroendocrine Differentiation,Stage I Lip Basal Cell Carcinoma
5705,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Apocrine Breast Carcinoma
5706,Mixed Neoplastic Glandular and Squamous Cell Population,Common wart
5707,Benign Cellular Infiltrate,Stage IIA Rectal Cancer AJCC v7
5708,Indolent Clinical Course,sarcoma of extrahepatic bile duct
5709,Intracytoplasmic Eosinophilic Inclusion,Stage IA Adult Soft Tissue Sarcoma AJCC v7
5710,Premalignant Lesion,Squamous cell carcinoma of lung
5711,Intracytoplasmic Eosinophilic Inclusion,Adult Desmoplastic Small Round Cell Tumor
5712,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Esophageal Adenocarcinoma AJCC v7
5713,Polymorphic Cellular Infiltrate,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
5714,Intermediate Filaments Present,Adult Myxoid Chondrosarcoma
5715,Benign Cellular Infiltrate,Ampulla of Vater Adenosquamous Carcinoma
5716,Intermediate Filaments Present,Stage IA Bone Sarcoma AJCC v7
5717,Intermediate Filaments Present,sarcoma of rectum
5718,Solid Growth Pattern,"Leukemia, Myeloid, Accelerated Phase"
5719,Mixed Neoplastic Glandular and Squamous Cell Population,"Glandular intraepithelial neoplasia, grade III"
5720,Malignant Germinomatous Cellular Infiltrate,Immature Gastric Teratoma
5721,Intermediate Filaments Present,Pleomorphic Rhabdomyosarcoma
5722,Squamous Differentiation,undifferentiated carcinoma of appendix
5723,Mucoid Stroma Formation,Bladder Urothelial Papilloma
5724,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, Tubular"
5725,Severe cytologic atypia,Intestinal Neuroendocrine Tumor
5726,Favorable Clinical Outcome,Malignant tumor of epidermal appendage
5727,Benign Cellular Infiltrate,Grade 3 Colon Adenocarcinoma
5728,Seminomatous Component Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma
5729,Indolent Clinical Course,Central Nervous System Rhabdomyosarcoma
5730,Diffuse Lesion,Capillary hemangioma of eyelid
5731,Indolent Clinical Course,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5732,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent
5733,Benign Cellular Infiltrate,Gastric T-Cell Non-Hodgkin Lymphoma
5734,Benign Cellular Infiltrate,Gallbladder Kaposi's Sarcoma
5735,Indolent Clinical Course,Dedifferentiated chordoma
5736,Favorable Clinical Outcome,Mycosis fungoides stage IV
5737,Intermediate Filaments Present,Bone Sarcoma
5738,Seminomatous Component Present,Ovarian Dermoid Cyst with Melanocytic Nevus
5739,Benign Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma
5740,Intermediate Filaments Present,Botryoid-Type Embryonal Rhabdomyosarcoma
5741,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Sebaceous Adenoma
5742,Favorable Clinical Outcome,"Hepatocellular carcinoma, scirrhous"
5743,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma
5744,Microvascular Proliferation,Protoplasmic astrocytoma
5745,Intracytoplasmic Eosinophilic Inclusion,Stage IB Adult Soft Tissue Sarcoma AJCC v7
5746,Malignant Germinomatous Cellular Infiltrate,Cervical Yolk Sac Tumor
5747,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
5748,Necrotic changes (finding),Mixed Oligodendroglioma-Astrocytoma
5749,Ectodermal Differentiation,Testicular Mixed Embryonal Carcinoma and Seminoma
5750,Favorable Clinical Outcome,Primary Cutaneous Mucinous Carcinoma
5751,Grade 4 Lesion,Adult Pineal Gland Astrocytoma
5752,Intermediate Filaments Present,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
5753,Intracytoplasmic Eosinophilic Inclusion,Cervical Alveolar Soft Part Sarcoma
5754,Benign Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder
5755,Benign Cellular Infiltrate,Lymphoma of colon
5756,Seminomatous Component Present,Mature Gastric Teratoma
5757,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Tumor G2
5758,Benign Cellular Infiltrate,Mucin-Producing Intrahepatic Cholangiocarcinoma
5759,Severe cytologic atypia,malignant gastrinoma of pancreas
5760,Borderline Lesion,Adrenal Cortex Oncocytic Adenoma
5761,Diffuse Lesion,Hemolymphangioma
5762,Benign Cellular Infiltrate,Colorectal Sarcoma
5763,Diffuse Lesion,Blue rubber bleb nevus syndrome
5764,Intracytoplasmic Eosinophilic Inclusion,hemangioendothelial sarcoma of bone
5765,Favorable Clinical Outcome,Skin Angiosarcoma
5766,Favorable Clinical Outcome,Stage IVB Liver Cancer
5767,Seminomatous Component Present,Fallopian Tube Teratoma
5768,Premalignant Lesion,Stage IV Lung Squamous Cell Carcinoma AJCC v7
5769,Benign Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage
5770,Tumor Vascular Invasion,Sex Hormone-Producing Adrenal Cortex Adenoma
5771,Intermediate Filaments Present,leiomyosarcoma of vagina
5772,Indolent Clinical Course,Malignant Skeletal Muscle Neoplasm
5773,Indolent Clinical Course,Kaposi's sarcoma of liver
5774,Indolent Clinical Course,"Glomus tumor, malignant"
5775,Mixture of Germ Cell Neoplastic Components Present,Stage II Gestational Trophoblastic Tumor AJCC v7
5776,Mucoid Stroma Formation,Oncocytic Variant Thyroid Gland Papillary Carcinoma
5777,Acute Clinical Course,Aleukemic Chronic Lymphocytic Leukemia
5778,Indolent Clinical Course,Leiomyosarcoma recurrent
5779,Indolent Clinical Course,"Peripheral Nerve Neoplasms, Malignant"
5780,Indolent Clinical Course,Clivus Chondroid Chordoma
5781,Malignant Germinomatous Cellular Infiltrate,Intramedullary Spinal Cord Teratoma
5782,Borderline Lesion,Bladder papilloma
5783,Benign Cellular Infiltrate,Malignant neoplasm of pancreas
5784,Keratin pearl formation,Nasopharyngeal lymphoepithelioma stage IV
5785,Glandular Differentiation,Large cell carcinoma of lung
5786,Precise Histogenesis Unknown,"Glioblastoma, IDH-Mutant"
5787,Enamel Formation (finding),Ameloblastic fibrodentinoma
5788,Intracytoplasmic Eosinophilic Inclusion,Well Differentiated Leiomyosarcoma
5789,Anaplasia,Cellular Ependymoma
5790,Prominent Schwannian Stroma Present,Stage 2B Neuroblastoma
5791,Necrotic changes (finding),Childhood Choroid Plexus Papilloma
5792,Bone Marrow Dysplasia Present,"Thrombocythemia, Essential"
5793,Indolent Clinical Course,Chondrosarcoma localised
5794,Small Lesion,"Ovarian Steroid Cell Tumor, Not Otherwise Specified"
5795,Favorable Clinical Outcome,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
5796,Indolent Clinical Course,Adult Brain Stem Gliosarcoma
5797,Necrotic changes (finding),Childhood Ganglioglioma
5798,Superficial Lesion,"Fibromatosis, Aggressive"
5799,Indolent Clinical Course,Adult Brain Glioblastoma
5800,Mucoid Stroma Formation,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
5801,Invasive Lesion,Ectomesenchymal Chondromyxoid Tumor
5802,Focal dysplasia,Rectal Traditional Serrated Adenoma
5803,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of palate
5804,Indolent Clinical Course,Childhood Conventional Osteosarcoma
5805,Glandular Differentiation,undifferentiated carcinoma of anal canal
5806,Intracytoplasmic Eosinophilic Inclusion,Myxoinflammatory fibroblastic sarcoma
5807,Intermediate Filaments Present,Stage II Soft Tissue Sarcoma AJCC v7
5808,Benign Cellular Infiltrate,BCLC Stage B Hepatocellular Carcinoma
5809,Tubular Structures Present,malignant steroid cell tumor of ovary
5810,Favorable Clinical Outcome,Localized Unresectable Adult Hepatocellular Carcinoma
5811,Intracytoplasmic Eosinophilic Inclusion,Infantile fibrosarcoma
5812,Absence of a Hormonal Syndrome,Malignant Pancreatic Somatostatinoma
5813,Intracytoplasmic Eosinophilic Inclusion,Malignant Peripheral Nerve Sheath Tumor
5814,Mucoid Stroma Formation,Warty Carcinoma of the Penis
5815,Dysplasia,Benign fibrohistiocytic neoplasm of skin
5816,Invasive Lesion,Pancreatic Intraepithelial Neoplasia-1A
5817,Benign Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma
5818,Favorable Clinical Outcome,Stage II Merkel Cell Carcinoma AJCC v7
5819,Intermediate Filaments Present,mesenchymal chondrosarcoma of bone
5820,Favorable Clinical Outcome,Adult Liver Carcinoma
5821,Benign Cellular Infiltrate,Small intestine carcinoma recurrent
5822,Mucoid Stroma Formation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
5823,Large Pineocytomatous Rosette Formation,Pineal parenchymal tumor of intermediate differentiation
5824,Intermediate Filaments Present,Lymphadenopathic Kaposi Sarcoma
5825,Cytologic atypia,Rectal hyperplastic polyp
5826,Borderline Lesion,Squamous cell papilloma of skin
5827,Mixed Neoplastic Glandular and Squamous Cell Population,Lung squamous cell carcinoma recurrent
5828,High Mitotic Activity,Bone Leiomyoma
5829,Indolent Clinical Course,Stage IB Uterine Sarcoma AJCC v7
5830,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Adenofibroma
5831,Benign Cellular Infiltrate,Unresectable Extrahepatic Bile Duct Carcinoma
5832,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
5833,Mixed Neoplastic Glandular and Squamous Cell Population,Serous Neoplasm
5834,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
5835,Biphasic Pattern,Thymolipoma
5836,Low Grade Lesion,Ovarian Angiosarcoma
5837,Mixed Neoplastic Glandular and Squamous Cell Population,Sarcomatoid Renal Cell Carcinoma
5838,Indolent Clinical Course,fibrosarcoma of ovary
5839,Intermediate Filaments Present,Stage II Bone Sarcoma AJCC v7
5840,Indolent Clinical Course,leiomyosarcoma of ovary
5841,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma in situ of fallopian tube
5842,Severe cytologic atypia,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
5843,Indolent Clinical Course,Metastatic Malignant Neoplasm to the Leptomeninges
5844,Diffuse Lesion,Scrotal Hemangioma
5845,Malignant Germinomatous Cellular Infiltrate,Embryonal Carcinoma
5846,Favorable Clinical Outcome,Stage IVB Hepatocellular Carcinoma AJCC v7
5847,Severe cytologic atypia,Intestinal Gangliocytic Paraganglioma
5848,Mixed Neoplastic Glandular and Squamous Cell Population,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
5849,Intermediate Filaments Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina
5850,Grade 4 Lesion,Childhood Fibrillary Astrocytoma
5851,Benign Cellular Infiltrate,Stage III Colon Cancer AJCC v7
5852,Indolent Clinical Course,Adult Undifferentiated Pleomorphic Sarcoma
5853,Grade 4 Lesion,Optic Nerve Astrocytoma
5854,Benign Cellular Infiltrate,Liver Adenosquamous Carcinoma
5855,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Biliary Intraepithelial Neoplasia
5856,Premalignant Lesion,adenoid cystic carcinoma of lung
5857,Intermediate Filaments Present,Metachronous Osteosarcoma
5858,Benign Cellular Infiltrate,sarcoma of extrahepatic bile duct
5859,Invasive Lesion,Apocrine adenoma
5860,Metastatic Lesion,Parotid Gland Lipoma
5861,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Benign Ovarian Mucinous Tumor
5862,Dysplasia,"Acanthoma, Clear Cell"
5863,Malignant Germinomatous Cellular Infiltrate,Dermoid Cyst
5864,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrioid adenocarcinoma metastatic
5865,Solid Growth Pattern,Pure Erythroid Leukemia
5866,Chronic Clinical Course,"Leukemia, Myelocytic, Acute"
5867,Invasive Lesion,Benign Hair Follicle Neoplasm
5868,Atypical Mitotic Figures,Chondroblastoma
5869,Pushing Tumor Margin,Ovarian Low Grade Endometrioid Stromal Sarcoma
5870,Glandular Differentiation,Submandibular Gland Undifferentiated Carcinoma
5871,Mixed Neoplastic Glandular and Squamous Cell Population,Schneiderian papilloma
5872,Intracytoplasmic Eosinophilic Inclusion,Gallbladder Sarcoma
5873,Solid Growth Pattern,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement
5874,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Cardia Adenocarcinoma
5875,Premalignant Lesion,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
5876,Grade 4 Lesion,Childhood Cerebellar Anaplastic Astrocytoma
5877,Benign Cellular Infiltrate,Secondary malignant neoplasm of large intestine
5878,Precise Histogenesis Unknown,Adult Gliosarcoma
5879,Necrotic changes (finding),Recurrent Childhood Fibrillary Astrocytoma
5880,Locally Aggressive Lesion,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
5881,Invasive Lesion,Benign neoplasm of major salivary gland
5882,High Mitotic Activity,Localized Digestive System Neuroendocrine Tumor G1
5883,Intracytoplasmic Eosinophilic Inclusion,Chondrosarcoma recurrent
5884,High Mitotic Activity,Jejunal Somatostatin-Producing Neuroendocrine Tumor
5885,Favorable Clinical Outcome,Mucoepidermoid carcinoma of skin
5886,Metastatic Lesion,Pituitary Adenoma
5887,Borderline Lesion,Mucinous cystadenoma of ovary
5888,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of ovary
5889,Necrotic changes (finding),Osteochondromatosis
5890,Intermediate Filaments Present,High Grade Sarcoma
5891,Intracytoplasmic Eosinophilic Inclusion,Colon Kaposi Sarcoma
5892,Locally Aggressive Lesion,Enchondromatosis
5893,High Mitotic Activity,Recurrent Childhood Ependymoma
5894,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
5895,Severe cytologic atypia,Gallbladder Tubular Carcinoid
5896,Benign Cellular Infiltrate,Gastrointestinal carcinoma in situ
5897,Aggressive Clinical Course,Ann Arbor Stage II Grade 2 Follicular Lymphoma
5898,Malignant Germinomatous Cellular Infiltrate,Pancreatic Teratoma
5899,Grade 4 Lesion,Intradural Extramedullary Cauda Equina Astrocytoma
5900,Indolent Clinical Course,Extraskeletal osteosarcoma non-metastatic
5901,Tubular Pattern,Appendix Villous Adenoma
5902,HMB-45-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
5903,Metastatic Lesion,Primary cerebral lymphoma
5904,Mixed Neoplastic Glandular and Squamous Cell Population,Major Salivary Gland Adenocarcinoma
5905,Intermediate Filaments Present,Adult Soft Tissue Sarcoma
5906,Indolent Clinical Course,Leptomeningeal sarcoma
5907,Benign Cellular Infiltrate,Childhood Small Intestinal Carcinoma
5908,Intracytoplasmic Eosinophilic Inclusion,Epithelioid sarcoma metastatic
5909,Intermediate Filaments Present,"Synovial sarcoma, biphasic"
5910,Borderline Lesion,Ethmoid Sinus Inverted Papilloma
5911,Invasive Lesion,Benign Dermal Neoplasm
5912,atypia morphology,Myxoma
5913,Locally Aggressive Lesion,Fibrous Hamartoma of Infancy
5914,Dysplasia,Acanthoma
5915,Severe cytologic atypia,Pancreatic Neuroendocrine Microadenoma
5916,Mixed Neoplastic Glandular and Squamous Cell Population,High-Grade Squamous Intraepithelial Lesions
5917,Solid Growth Pattern,Acute Myeloid Leukemia (AML-M2)
5918,Mixed Neoplastic Glandular and Squamous Cell Population,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
5919,Benign Cellular Infiltrate,cystadenocarcinoma of intrahepatic bile duct
5920,Grade 4 Lesion,Cerebral Astrocytoma
5921,Intracytoplasmic Eosinophilic Inclusion,Ovarian Liposarcoma
5922,Favorable Clinical Outcome,Stage IA Cutaneous Melanoma AJCC v7
5923,Solid Growth Pattern,Adult T Acute Lymphoblastic Leukemia
5924,Mixed Neoplastic Glandular and Squamous Cell Population,Adrenal Cortex Oncocytic Adenoma
5925,Capsular Invasion,Adrenal Cortex Oncocytic Adenoma
5926,Benign Cellular Infiltrate,Stage IVA Colon Cancer AJCC v7
5927,Anaplasia,Oligodendroglioma of spinal cord
5928,Necrotic changes (finding),Recurrent Childhood Oligoastrocytoma
5929,Chronic Clinical Course,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
5930,Favorable Clinical Outcome,Primary hepatic neuroendocrine carcinoma
5931,Indolent Clinical Course,Synchronous Multifocal Osteosarcoma
5932,Diffuse Lesion,Cardiac Cavernous Hemangioma
5933,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
5934,Nuclear Pseudoinclusion,Thyroid Gland Follicular Adenoma
5935,Indolent Clinical Course,Intraosseous well differentiated osteosarcoma
5936,Benign Cellular Infiltrate,Colorectal Lymphoma
5937,Favorable Clinical Outcome,Microcystic adnexal carcinoma
5938,Precise Histogenesis Unknown,"Gemistocytic Astrocytoma, IDH-Mutant"
5939,Mucoid Stroma Formation,Renal papillary adenoma
5940,Intermediate Filaments Present,High Grade Paranasal Sinus Sarcoma
5941,Intermediate Filaments Present,rhabdomyosarcoma of extrahepatic bile duct
5942,Indolent Clinical Course,Stage III Uterine Sarcoma AJCC v7
5943,Favorable Clinical Outcome,Skin carcinoma
5944,Indolent Clinical Course,Neural Glioblastoma
5945,Benign Cellular Infiltrate,Secondary malignant neoplasm of liver
5946,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma recurrent
5947,Intermediate Filaments Present,AJCC Grade 2 Sarcoma
5948,Benign Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v7
5949,Intracytoplasmic Eosinophilic Inclusion,Anal Kaposi Sarcoma
5950,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Solid Pattern"
5951,Intermediate Filaments Present,Colorectal Kaposi Sarcoma
5952,Microvascular Proliferation,Anaplastic astrocytoma
5953,Anaplasia,Childhood Cerebral Ependymoma
5954,Precise Histogenesis Unknown,Astrocytoma
5955,Multilayered Rosette Formation,Medullomyoblastoma
5956,Precise Histogenesis Unknown,Astrocytoma of spinal cord
5957,Malignant Germinomatous Cellular Infiltrate,Dermoid cyst of orbit
5958,Precise Histogenesis Unknown,Recurrent Glioblastoma
5959,Indolent Clinical Course,Recurrent Glioblastoma
5960,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
5961,Intracytoplasmic Eosinophilic Inclusion,Chondrosarcoma localised
5962,Benign Cellular Infiltrate,Stage II Liver Cancer
5963,Nuclear Grooves,Follicular thyroid carcinoma
5964,Glandular Differentiation,undifferentiated carcinoma of ureter
5965,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of Deep Soft Tissue
5966,Benign Cellular Infiltrate,Grade 1 Colorectal Adenocarcinoma
5967,Favorable Clinical Outcome,BCLC Stage 0 Hepatocellular Carcinoma
5968,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Colorectal Adenocarcinoma
5969,Invasive Lesion,Choroid Plexus Papilloma
5970,Intermediate Filaments Present,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5971,Mixed Neoplastic Glandular and Squamous Cell Population,apocrine adenocarcinoma of vulva
5972,High Mitotic Activity,Transverse Colon Neuroendocrine Tumor G1
5973,Malignant Germinomatous Cellular Infiltrate,Testicular Monophasic Choriocarcinoma
5974,Intermediate Filaments Present,Thyroid Sarcoma
5975,Malignant Germinomatous Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
5976,Indolent Clinical Course,Central Nervous System Yolk Sac Tumor
5977,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenoma, Papillary"
5978,Dysplasia,Cutaneous neurofibroma
5979,Invasive Lesion,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
5980,Benign Cellular Infiltrate,Malignant neoplasm of cervical part of esophagus
5981,Atypical Mitotic Figures,Benign Glomus Tumor
5982,Benign Cellular Infiltrate,Malignant neoplasm of abdominal part of esophagus
5983,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Breast Phyllodes Tumor
5984,Intracytoplasmic Eosinophilic Inclusion,Extraskeletal Myxoid Chondrosarcoma
5985,Benign Cellular Infiltrate,Pancreatic Ductal Adenocarcinoma
5986,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Adenocarcinoma
5987,Grade 4 Lesion,Pilomyxoid astrocytoma
5988,Intracytoplasmic Eosinophilic Inclusion,Stage IV Uterine Sarcoma AJCC v7
5989,Glandular Differentiation,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
5990,Premalignant Lesion,Stage IV Lung Cancer AJCC v7
5991,Composite Lesion,Intrapulmonary thymoma
5992,Mixture of Germ Cell Neoplastic Components Present,Testicular yolk sac tumor stage II
5993,Invasive Lesion,Borderline Ovarian Serous Cystadenofibroma
5994,Solid Growth Pattern,Aleukemic Lymphoid Leukemia
5995,Benign Cellular Infiltrate,Colorectal Neuroendocrine Carcinoma
5996,Tumor Vascular Invasion,Oxyphilic Adenoma
5997,High Mitotic Activity,Malignant Pancreatic Insulinoma
5998,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Osteosarcoma AJCC v7
5999,Mixed Neoplastic Glandular and Squamous Cell Population,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant"
6000,Indolent Clinical Course,Stage IVB Osteosarcoma AJCC v7
6001,Intracytoplasmic Eosinophilic Inclusion,"Undifferentiated Sarcoma, Not Otherwise Specified"
6002,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the prostate stage IV
6003,Infiltrative Growth Pattern,Solitary Adult Fibroma
6004,Mucoid Stroma Formation,Oncocytic Schneiderian papilloma
6005,Indolent Clinical Course,Fibrosarcoma of bone
6006,Mixed Neoplastic Glandular and Squamous Cell Population,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
6007,Papillary Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
6008,Plexiform Vasculature Present,Vaginal Undifferentiated Sarcoma
6009,Invasive Lesion,intraductal micropapillary carcinoma of breast
6010,Precise Histogenesis Unknown,Childhood Gemistocytic Astrocytoma
6011,Favorable Clinical Outcome,Hepatitis Virus-Related Hepatocellular Carcinoma
6012,Indolent Clinical Course,Metachronous Osteosarcoma
6013,Solid Growth Pattern,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
6014,Solid Growth Pattern,Acute biphenotypic leukemia
6015,Solid Growth Pattern,Adult Erythroleukemia
6016,Invasive Lesion,Precancerous Polyp
6017,Favorable Clinical Outcome,Sweat gland carcinoma
6018,Intermediate Filaments Present,Childhood Desmoplastic Small Round Cell Tumor
6019,Dysplasia,Follicular Myxoma
6020,Favorable Clinical Outcome,Stage IIIC Cutaneous Melanoma AJCC v7
6021,Macrofollicular Structures Present,Follicular Variant Thyroid Gland Papillary Carcinoma
6022,Intracytoplasmic Eosinophilic Inclusion,Virus-Related Sarcoma
6023,Glandular Differentiation,undifferentiated carcinoma of urethra
6024,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary mucinous cystadenoma
6025,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of cornea
6026,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Extramucosal (Perianal) Adenocarcinoma
6027,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
6028,Pushing Tumor Margin,Condyloma acuminata of cervix
6029,Benign Cellular Infiltrate,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
6030,Invasive Lesion,Hidroacanthoma simplex
6031,Mixture of Germ Cell Neoplastic Components Present,Testicular Seminoma with Syncytiotrophoblastic Cells
6032,Focal dysplasia,Appendix Traditional Serrated Adenoma
6033,Benign Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v6
6034,Chronic Clinical Course,ROSE Cluster 7
6035,Precise Histogenesis Unknown,Childhood Cerebellar Anaplastic Astrocytoma
6036,Precise Histogenesis Unknown,Childhood Anaplastic Oligodendroglioma
6037,Seminomatous Component Present,Gastric Teratoma
6038,Benign Cellular Infiltrate,Fibrolamellar Hepatocellular Carcinoma
6039,Intracytoplasmic Eosinophilic Inclusion,Spindle Cell/Sclerosing Rhabdomyosarcoma
6040,Intracytoplasmic Eosinophilic Inclusion,Ewing's sarcoma of bone
6041,Precise Histogenesis Unknown,Childhood Visual Pathway Astrocytoma
6042,Indolent Clinical Course,Secondary malignant neoplasm of spinal cord
6043,Mixed Neoplastic Glandular and Squamous Cell Population,Conjunctival intraepithelial neoplasia
6044,Benign Cellular Infiltrate,Stage IB Gastric Carcinoma
6045,High Mitotic Activity,Meckel Diverticulum Neuroendocrine Tumor G1
6046,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute myelomonocytic leukemia with abnormal eosinophils
6047,Mass in breast,Lobular Neoplasia
6048,Diffuse Lesion,Cervical Mullerian Papilloma
6049,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Melanoma
6050,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of mouth
6051,Glandular Differentiation,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
6052,Squamous Differentiation,Oropharyngeal lymphepithelioma
6053,Mixed Neoplastic Glandular and Squamous Cell Population,Signet-ring cell adenocarcinoma of colon
6054,Intracytoplasmic Eosinophilic Inclusion,Sarcoma NCI Grade 3
6055,Indolent Clinical Course,Childhood Alveolar Soft Part Sarcoma
6056,Prominent Schwannian Stroma Present,Stage 3 Neuroblastoma
6057,Indolent Clinical Course,Small Intestinal Kaposi Sarcoma
6058,Diffuse Lesion,Urethral Inverted Papilloma
6059,Malignant Germinomatous Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma
6060,Intermediate Filaments Present,Angiosarcoma of the breast
6061,Precise Histogenesis Unknown,Adult Pineal Gland Astrocytoma
6062,Anaplasia,Tanycytic ependymoma
6063,Indolent Clinical Course,Ameloblastic fibrosarcoma
6064,Glandular Differentiation,Undifferentiated carcinoma of esophagus
6065,Solid Growth Pattern,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA
6066,Well-Circumscribed Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans
6067,Seminomatous Component Present,Dermoid Cyst of the Spinal Cord
6068,Intracytoplasmic Eosinophilic Inclusion,Adult Extraskeletal Osteosarcoma
6069,Benign Cellular Infiltrate,Cholangiocarcinoma recurrent
6070,High Grade Lesion,Pleural Epithelioid Hemangioendothelioma
6071,Mixture of Germ Cell Neoplastic Components Present,"Trophoblastic tumor, epithelioid"
6072,Capsular Invasion,Cortisol-Producing Adrenal Cortex Adenoma
6073,CD35-Positive Neoplastic Cells Present,Eosinophilic Granuloma
6074,atypia morphology,Cervical Blue Nevus
6075,atypia morphology,Desmoplastic Nevus
6076,No Evidence of Radiologic Finding,Occult Lung Carcinoma
6077,Nuclear pleomorphism,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
6078,Enamel Formation (finding),Ameloblastic fibroma
6079,Intracytoplasmic Eosinophilic Inclusion,Recurrent Childhood Rhabdomyosarcoma
6080,Indolent Clinical Course,Glioblastoma multiforme of spinal cord
6081,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
6082,Solid Growth Pattern,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
6083,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Serous Tumor
6084,Metastatic Lesion,Diffuse large B-cell lymphoma of central nervous system
6085,Indolent Clinical Course,Clear Cell Sarcoma of Soft Tissue
6086,Borderline Lesion,Chief cell adenoma
6087,Indolent Clinical Course,Prolactin-Producing Pituitary Gland Carcinoma
6088,Indolent Clinical Course,"Chondrosarcoma, Clear Cell"
6089,Mucoid Stroma Formation,verrucous carcinoma of vagina
6090,Precise Histogenesis Unknown,mixed gliomas
6091,Borderline Lesion,Ovarian Seromucinous Cystadenoma
6092,Indolent Clinical Course,Embryonal Rhabdomyosarcoma
6093,Invasive Lesion,Vulval intraepithelial neoplasia
6094,atypia morphology,Junctional nevus
6095,Solid Growth Pattern,Adult Acute Myeloid Leukemia without Maturation
6096,Favorable Clinical Outcome,Stage IIIC Hepatocellular Carcinoma AJCC v7
6097,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Cribriform Carcinoma
6098,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Neoplasms, Fibroepithelial"
6099,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma stage I
6100,Indolent Clinical Course,Colorectal Angiosarcoma
6101,Low Grade Lesion,Colorectal Angiosarcoma
6102,Premalignant Lesion,Stage IA Lung Adenocarcinoma AJCC v7
6103,Acinar Cell Differentiation,Pancreatic Medullary Carcinoma
6104,Mixture of Germ Cell Neoplastic Components Present,"Seminoma of testis, stage 1"
6105,Precise Histogenesis Unknown,Diffuse Astrocytoma
6106,Endophytic Tumor Growth,Buschke-Lowenstein Tumor
6107,Fibrotic Stroma Formation,Plexiform ameloblastoma
6108,Prominent Schwannian Stroma Present,Poorly Differentiated Neuroblastoma
6109,Malignant Germinomatous Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern"
6110,Favorable Clinical Outcome,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
6111,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Serous Endometrial Intraepithelial Carcinoma
6112,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Non-Seminomatous Germ Cell Tumor
6113,Solid Growth Pattern,Chronic leukemia (category)
6114,Benign Cellular Infiltrate,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
6115,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrioid carcinoma ovary
6116,Indolent Clinical Course,Cerebral Primitive Neuroectodermal Tumor
6117,Chronic Clinical Course,Childhood Acute Myeloid Leukemia with Maturation
6118,Invasive Lesion,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
6119,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Benign Ovarian Transitional Cell Tumor
6120,Extensive Necrosis,Adult Brain Oligodendroglioma
6121,Intermediate Filaments Present,Low grade myofibroblastic sarcoma
6122,Intermediate Filaments Present,Childhood Conventional Osteosarcoma
6123,CD4-Positive Neoplastic Cells Present,Hepatosplenic T-cell lymphoma
6124,Premalignant Lesion,Stage I Lung Cancer AJCC v6
6125,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
6126,Composite Lesion,"Thymoma, type B1, malignant"
6127,Histiocytosis,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
6128,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated round cell sarcoma
6129,Benign Cellular Infiltrate,Carcinoma in situ of ampulla of Vater
6130,Mixture of Germ Cell Neoplastic Components Present,Testicular Trophoblastic Tumor
6131,Severe cytologic atypia,Non-Functioning Pancreatic Neuroendocrine Tumor G1
6132,Intermediate Filaments Present,Sarcoma of liver
6133,Nuclear Grooves,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
6134,Mixed Epithelial Cell Population,"Schneiderian papilloma, inverted"
6135,Invasive Lesion,Perianal Squamous Intraepithelial Neoplasia
6136,Intermediate Filaments Present,leiomyosarcoma of liver
6137,Encapsulated Mass,Intraneural perineurioma
6138,Precise Histogenesis Unknown,Childhood Brain Oligodendroglioma
6139,Benign Cellular Infiltrate,Colon Mucosa-Associated Lymphoid Tissue Lymphoma
6140,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the oral cavity stage IV
6141,Premalignant Lesion,Lung Melanoma
6142,Indolent Clinical Course,Localized Askin Tumor
6143,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant phyllodes tumor of breast
6144,Low Grade Lesion,Cervical Angiosarcoma
6145,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Mucinous cystadenocarcinoma of ovary
6146,Favorable Clinical Outcome,Spindle cell squamous cell carcinoma
6147,Squamous Differentiation,Colorectal Large Cell Neuroendocrine Carcinoma
6148,Benign Cellular Infiltrate,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
6149,Mucoid Stroma Formation,Bladder Non-Invasive Papillary Urothelial Neoplasm
6150,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma stage II
6151,Mixed Neoplastic Glandular and Squamous Cell Population,Bronchioloalveolar Adenocarcinoma
6152,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
6153,Serotonin Positive Neoplastic Cells Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
6154,Indolent Clinical Course,Metastatic Malignant Peripheral Nerve Sheath Tumor
6155,Intracytoplasmic Eosinophilic Inclusion,Pancreatic sarcoma
6156,Mucoid Stroma Formation,Intracystic papillary neoplasm with low grade intraepithelial neoplasia
6157,Intracytoplasmic Eosinophilic Inclusion,Synovial sarcoma metastatic
6158,Indolent Clinical Course,liposarcoma of kidney
6159,Benign Cellular Infiltrate,Small Intestinal Undifferentiated Carcinoma
6160,Intracytoplasmic Eosinophilic Inclusion,Synovial sarcoma non-metastatic
6161,Indolent Clinical Course,Malignant neoplasm of muscle
6162,Seminomatous Component Present,Malignant Ovarian Teratoma
6163,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
6164,Intracytoplasmic Eosinophilic Inclusion,fibrosarcoma of soft tissue
6165,Borderline Lesion,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
6166,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Foamy Gland Adenocarcinoma
6167,Intracytoplasmic Eosinophilic Inclusion,Juxtacortical chondrosarcoma
6168,Indolent Clinical Course,Fascial fibrosarcoma
6169,Benign Cellular Infiltrate,non-Hodgkin's lymphoma of liver
6170,CD35-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
6171,Ground Glass Nuclear Inclusion,Thyroid Gland Signet Ring Cell Follicular Adenoma
6172,Mucoid Stroma Formation,Gallbladder Papillary Adenoma
6173,Acute Clinical Course,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant"
6174,Glandular Differentiation,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
6175,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma Associated with Lymphedema
6176,Intermediate Filaments Present,Radiation-Related Angiosarcoma
6177,Mixed Neoplastic Glandular and Squamous Cell Population,Villous adenoma of duodenum
6178,Intracytoplasmic Eosinophilic Inclusion,Childhood Desmoplastic Small Round Cell Tumor
6179,Borderline Lesion,Lung Pleomorphic Adenoma
6180,Intracytoplasmic Eosinophilic Inclusion,Childhood Myxoid Chondrosarcoma
6181,Benign Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma
6182,HMB-45-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
6183,Mixed Neoplastic Glandular and Squamous Cell Population,Condyloma acuminata of cervix
6184,Seminomatous Component Present,Benign Cardiac Germ Cell Tumor
6185,Mixed Neoplastic Glandular and Squamous Cell Population,Ductal Breast Carcinoma with Squamous Metaplasia
6186,Indolent Clinical Course,Childhood Alveolar Rhabdomyosarcoma
6187,Invasive Lesion,Parotid Gland Warthin Tumor
6188,Indolent Clinical Course,Chondrosarcoma
6189,Dysplasia,Syringofibroadenoma
6190,Invasive Lesion,Intraepithelial Neoplasia in Barrett Esophagus
6191,Mucoid Stroma Formation,Papillary serous cystadenoma
6192,High Mitotic Activity,Pancreatic Vipoma
6193,"Undifferentiated ""Fetal-Type"" Tissues Present",Dermoid cyst of skin
6194,Invasive Lesion,Peripheral Breast Papilloma
6195,Infiltrative Growth Pattern,Nasopharyngeal Angiofibroma
6196,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of mediastinum
6197,Severe cytologic atypia,Jejunal Somatostatin-Producing Neuroendocrine Tumor
6198,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma refractory
6199,Benign Cellular Infiltrate,intestinal type adenocarcinoma of extrahepatic bile duct
6200,Indolent Clinical Course,Laryngeal Liposarcoma
6201,Increased Cellularity Present,Osteochondromatosis
6202,Intracytoplasmic Eosinophilic Inclusion,Epithelioid Malignant Peripheral Nerve Sheath Tumor
6203,Solid Growth Pattern,ROSE Cluster 5
6204,Well Differentiated Lesion,Pancreatic Endocrine Carcinoma
6205,High Mitotic Activity,Functioning Pancreatic Neuroendocrine Tumor G2
6206,Borderline Lesion,Paranasal Sinus Schneiderian Papilloma
6207,Favorable Clinical Outcome,Stage IIIB Adult Liver Cancer AJCC v7
6208,High Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma
6209,Squamous Differentiation,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
6210,Intermediate Filaments Present,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
6211,Mixed Neoplastic Glandular and Squamous Cell Population,Colon Cribriform Comedo-Type Adenocarcinoma
6212,Squamous Differentiation,Lung Basaloid Large Cell Carcinoma
6213,Indolent Clinical Course,Clear cell sarcoma of kidney
6214,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous cystadenocarcinoma appendix
6215,Mucoid Stroma Formation,Inverted Squamous Cell Papilloma
6216,Mixed Neoplastic Glandular and Squamous Cell Population,serous adenocarcinofibroma of ovary
6217,Intracytoplasmic Eosinophilic Inclusion,Alveolar soft part sarcoma recurrent
6218,Mixture of Germ Cell Neoplastic Components Present,Malignant teratoma of testis
6219,Indolent Clinical Course,"Synovial sarcoma, biphasic"
6220,Dysplasia,"Acanthoma, Pilar Sheath"
6221,Invasive Lesion,Squamous intraepithelial lesion
6222,High Mitotic Activity,Anal Canal Neuroendocrine Tumor G2
6223,Severe cytologic atypia,Non functioning pancreatic endocrine tumor
6224,Favorable Clinical Outcome,Recurrent Lip Basal Cell Carcinoma
6225,Favorable Clinical Outcome,Primary Cutaneous Hodgkin Lymphoma
6226,Squamous Differentiation,Large cell lung cancer recurrent
6227,Chronic Clinical Course,Mediastinal T Acute Lymphoblastic Leukemia
6228,Intracytoplasmic Eosinophilic Inclusion,Kaposi's sarcoma of esophagus
6229,Favorable Clinical Outcome,Primary Cutaneous Intravascular Large B-Cell Lymphoma
6230,Giant Mitochondria Present,Prolactinoma
6231,Indolent Clinical Course,olfactory neuroblastoma of nasal cavity
6232,Malignant Germinomatous Cellular Infiltrate,Fallopian Tube Teratoma
6233,Intestinal metaplasia,Sporadic Diffuse Gastric Adenocarcinoma
6234,High Mitotic Activity,Deep Leiomyoma
6235,Borderline Lesion,Adenoma of rete ovarii
6236,Benign Cellular Infiltrate,Stage III Esophageal Cancer
6237,Benign Cellular Infiltrate,Stage IIIC Esophageal Cancer AJCC v7
6238,Indolent Clinical Course,Cardiac Synovial Sarcoma
6239,Mixture of Germ Cell Neoplastic Components Present,Stage IVA Gestational Trophoblastic Tumor AJCC v7
6240,Benign Cellular Infiltrate,Malignant Gastric Granular Cell Tumor
6241,Benign Cellular Infiltrate,Liver Synovial Sarcoma
6242,Borderline Lesion,Plantar wart
6243,Solid Growth Pattern,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
6244,Benign Cellular Infiltrate,Diffuse Gastric Adenocarcinoma
6245,Benign Cellular Infiltrate,Gastric Cancer by AJCC v6 Stage
6246,Grade 4 Lesion,Recurrent Childhood Brain Stem Astrocytoma
6247,Invasive Lesion,ductal papilloma of salivary gland
6248,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Neoplasm
6249,Intermediate Filaments Present,Leiomyosarcoma NCI Grade 2
6250,Premalignant Lesion,Stage IIA Lung Adenocarcinoma AJCC v7
6251,Mixture of Germ Cell Neoplastic Components Present,Stage II Immature Testicular Teratoma AJCC v6 and v7
6252,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Hilar Cholangiocarcinoma AJCC v7
6253,Malignant Germinomatous Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7
6254,Borderline Lesion,Soft Palate Pleomorphic Adenoma
6255,Microvascular Proliferation,Fibrillary Astrocytoma
6256,Indolent Clinical Course,Periosteal Osteosarcoma
6257,Diffuse Lesion,Lymphangioma circumscriptum
6258,Benign Cellular Infiltrate,Gastric Intestinal-Type Adenocarcinoma
6259,Dysplasia,inverted follicular keratosis
6260,Metastatic Lesion,Adenolymphoma
6261,CD30-Positive Neoplastic Cells Present,Histiocytic sarcoma
6262,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
6263,Premalignant Lesion,Metastatic non-small cell lung cancer
6264,Indolent Clinical Course,Peripheral Intraneural Angiosarcoma
6265,Intermediate Filaments Present,Giant Cell Fibrous Histiocytoma
6266,Glandular Differentiation,Nasopharyngeal lymphoepithelioma recurrent
6267,Mixed Neoplastic Glandular and Squamous Cell Population,Inverting papilloma of the nasal cavity
6268,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
6269,Indolent Clinical Course,Stage IIB Uterine Sarcoma AJCC v7
6270,Invasive Lesion,"Testicular Intratubular Germ Cell Neoplasia, Unclassified"
6271,Favorable Clinical Outcome,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
6272,Favorable Clinical Outcome,Skin Basaloid Carcinoma
6273,HMB-45-Positive Neoplastic Cells Present,Central Nervous System Histiocytic and Dendritic Cell Neoplasm
6274,Diffuse Lesion,Capillary hemangioma of orbit
6275,Mixed Neoplastic Glandular and Squamous Cell Population,Localized Resectable Adult Hepatocellular Carcinoma
6276,Benign Cellular Infiltrate,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
6277,Dysplasia,Appendix Hyperplastic Polyp
6278,Locally Aggressive Lesion,Vulvar Angiomyofibroblastoma
6279,Mixed Neoplastic Glandular and Squamous Cell Population,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
6280,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
6281,Benign Cellular Infiltrate,Anal cancer metastatic
6282,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Tumor
6283,Tumor Vascular Invasion,Mixed Cell Adrenal Cortical Adenoma
6284,Benign Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma
6285,Geographic Necrosis,Benign Mediastinal Germ Cell Tumor
6286,Borderline Lesion,Vulvar Trichoepithelioma
6287,Invasive Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant"
6288,Nuclear Clearing,Microfollicular adenoma
6289,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Hilar Cholangiocarcinoma AJCC v7
6290,Benign Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
6291,Indolent Clinical Course,Sarcoma of vulva
6292,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Serous Adenofibroma
6293,Intermediate Filaments Present,Stage IC Uterine Sarcoma AJCC v7
6294,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
6295,Chronic Clinical Course,Acute Erythroblastic Leukemia
6296,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Cell Carcinoma
6297,Premalignant Lesion,Stage I Lung Small Cell Carcinoma AJCC v7
6298,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Keratinizing Squamous Cell Carcinoma
6299,Intermediate Filaments Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
6300,Favorable Clinical Outcome,Mycosis fungoides stage I
6301,Locally Aggressive Lesion,Ovarian Cellular Fibroma
6302,Infiltrative Growth Pattern,Ovarian Cellular Fibroma
6303,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Cystic Teratoma
6304,Indolent Clinical Course,Malignant Splenic Soft Tissue Neoplasm
6305,Indolent Clinical Course,Transplant-Related Hepatocellular Carcinoma
6306,Seminomatous Component Present,Gonadal Teratoma
6307,Favorable Clinical Outcome,Stage I Adult Liver Cancer AJCC v7
6308,Mixed Neoplastic Glandular and Squamous Cell Population,Primary serous papillary carcinoma of peritoneum
6309,atypia morphology,Adrenal Cortex Adenomatoid Tumor
6310,Intermediate Filaments Present,Central Nervous System Angiosarcoma
6311,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Squamous Cell Carcinoma of the Penis
6312,Diffuse Lesion,Histiocytoid hemangioma
6313,Indolent Clinical Course,Childhood Pleomorphic Rhabdomyosarcoma
6314,Invasive Lesion,Carcinoma in situ of prostate
6315,Tubular Pattern,Bladder Villous Adenoma
6316,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Serous Neoplasm
6317,Dysplasia,Epidermolytic acanthoma
6318,Borderline Lesion,Syringocystadenoma Papilliferum
6319,Premalignant Lesion,leiomyosarcoma of lung
6320,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Villous Adenoma
6321,Benign Cellular Infiltrate,Malignant neoplasm of thoracic esophagus
6322,Mixed Neoplastic Glandular and Squamous Cell Population,Alcohol-Related Esophageal Squamous Cell Carcinoma
6323,Endobronchial Lesion,Bronchial adenoma
6324,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatoma resectable
6325,Benign Cellular Infiltrate,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
6326,Favorable Clinical Outcome,BCLC Stage C Adult Hepatocellular Carcinoma
6327,Indolent Clinical Course,"Sarcoma, Epithelioid"
6328,High Mitotic Activity,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
6329,Benign Cellular Infiltrate,Stage IIB Esophageal Carcinoma
6330,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Urachal Adenocarcinoma
6331,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the prostate stage I
6332,Precise Histogenesis Unknown,Childhood Pleomorphic Xanthoastrocytoma
6333,Scattered Collections of Differentiating Neuroblasts Present,malignant ganglioneuroblastoma of adrenal gland
6334,Tubular Pattern,Invasive intraductal papillary-mucinous carcinoma of pancreas
6335,Benign Cellular Infiltrate,leiomyosarcoma of rectum
6336,Mucoid Stroma Formation,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
6337,Solid Growth Pattern,Chronic lymphocytic leukemia stage 4
6338,Benign Cellular Infiltrate,Gallbladder Sarcoma
6339,Intestinal metaplasia,Bladder Signet Ring Cell Adenocarcinoma
6340,Mucoid Stroma Formation,"Transitional cell papilloma, inverted"
6341,High Mitotic Activity,Pancreatic Gastrin-Producing Neuroendocrine Tumor
6342,Severe cytologic atypia,insulinoma
6343,Dysplasia,Dermoid cyst of skin
6344,Favorable Clinical Outcome,Stage IV Adult Liver Cancer AJCC v7
6345,Melanin Pigment Present,Amelanotic Skin Melanoma
6346,Intestinal metaplasia,signet ring cell carcinoma of pancreas
6347,Serotonin Positive Neoplastic Cells Present,Gastric Carcinoid Tumor
6348,Precise Histogenesis Unknown,"Optic Nerve Glioma, Childhood"
6349,Mucoid Stroma Formation,inverted ductal papilloma of salivary gland
6350,Intermediate Filaments Present,Laryngeal Liposarcoma
6351,Squamous Differentiation,NUT midline carcinoma
6352,Diffuse Lesion,sialadenoma papilliferum of salivary gland
6353,Tubular Pattern,Colorectal Villous Adenoma
6354,Therapy-Related Toxicity,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
6355,Invasive Lesion,Mild esophageal dysplasia
6356,Low Grade Lesion,Poorly Differentiated Angiosarcoma
6357,Intracytoplasmic Eosinophilic Inclusion,Localized Ewing Sarcoma
6358,Endobronchial Lesion,Alveolar adenoma
6359,Intracytoplasmic Eosinophilic Inclusion,Botryoid-Type Embryonal Rhabdomyosarcoma
6360,Indolent Clinical Course,Epithelioid Sarcoma NCI Grade 3
6361,Indolent Clinical Course,primitive neuroectodermal tumor (PNET) of spinal cord
6362,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma stage II
6363,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
6364,Benign Cellular Infiltrate,Signet-ring cell adenocarcinoma of colon
6365,Favorable Clinical Outcome,Follicular mycosis fungoides
6366,Premalignant Lesion,Lung Basaloid Large Cell Carcinoma
6367,Mixed Neoplastic Glandular and Squamous Cell Population,Head and Neck Basaloid Carcinoma
6368,Mucoid Stroma Formation,Papillary Lung Adenocarcinoma
6369,Indolent Clinical Course,Childhood Epithelioid Sarcoma
6370,Mixed Neoplastic Glandular and Squamous Cell Population,Noninfiltrating intraductal papillary adenocarcinoma
6371,Papillary Pattern,Oral Cavity Adenoma
6372,Mucoid Stroma Formation,Papillary tumor of the pineal region
6373,Intermediate Filaments Present,Childhood Spindle Cell Rhabdomyosarcoma
6374,Dysplasia,Benign neoplasm of scrotum
6375,Mixed Neoplastic Glandular and Squamous Cell Population,Bile Duct Biliary Intraepithelial Neoplasia
6376,Biphasic Pattern,"Sarcoma, Spindle Cell"
6377,Cribriform Pattern,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
6378,Chronic Clinical Course,Recurrent Adult Acute Lymphoblastic Leukemia
6379,High Mitotic Activity,Dartoic myoma
6380,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Intracanalicular fibroadenoma
6381,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiocarcinoma resectable
6382,Malignant Germinomatous Cellular Infiltrate,Testicular Dermoid Cyst
6383,Mucoid Stroma Formation,Bladder Papillary Urothelial Carcinoma
6384,Confluent Sheets of Neoplastic B-Lymphocytes Present,Primary Cutaneous Intravascular Large B-Cell Lymphoma
6385,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Craniopharyngioma
6386,Benign Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
6387,Premalignant Lesion,Adenocarcinoma of lung stage IIIB
6388,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Endometrioid Cystadenoma
6389,Mixed Neoplastic Glandular and Squamous Cell Population,Vulval intraepithelial neoplasia
6390,Premalignant Lesion,Lung Monophasic Synovial Sarcoma
6391,Premalignant Lesion,"Adenocarcinoma of lung, stage III"
6392,Endophytic Tumor Growth,Condyloma anal
6393,Mixed Neoplastic Glandular and Squamous Cell Population,Condyloma anal
6394,Intermediate Filaments Present,Fibrosarcoma metastatic
6395,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma NCI Grade 3
6396,Intracytoplasmic Eosinophilic Inclusion,Monophasic Synovial Sarcoma
6397,Borderline Lesion,Adrenal Cortical Adenoma
6398,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute monoblastic leukemia
6399,Metastatic Lesion,Secretory adenoma of pituitary
6400,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
6401,Mucoid Stroma Formation,Squamous papillomatosis
6402,Chronic Clinical Course,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q
6403,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Renal Cell Cancer
6404,Benign Cellular Infiltrate,Malignant neoplasm of stomach stage IV
6405,Premalignant Lesion,Non-small cell lung cancer stage III
6406,Benign Cellular Infiltrate,Acinar cell carcinoma of pancreas
6407,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor
6408,Seminomatous Component Present,Childhood Testicular Immature Teratoma
6409,Indolent Clinical Course,Cerebral Hodgkin Lymphoma
6410,Mucoid Stroma Formation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
6411,Mucoid Stroma Formation,Sclerosing Breast Papilloma
6412,Mucoid Stroma Formation,Choroid Plexus Papilloma
6413,Tubular Structures Present,Well Differentiated Ovarian Steroid Cell Tumor
6414,Benign Cellular Infiltrate,Grade 3 Rectal Adenocarcinoma
6415,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor
6416,High Mitotic Activity,Digestive System Neuroendocrine Tumor G2
6417,Seminomatous Component Present,Benign Childhood Germ Cell Tumor
6418,Intermediate Filaments Present,Leiomyosarcoma of Vessels
6419,Favorable Clinical Outcome,Malignant Cutaneous Granular Cell Tumor
6420,Invasive Lesion,Colorectal Low Grade Intraepithelial Neoplasia
6421,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatocellular Carcinoma by AJCC v6 Stage
6422,Benign Cellular Infiltrate,Sarcomatoid Intrahepatic Cholangiocarcinoma
6423,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Sparsely Granulated Somatotroph Adenoma
6424,Mixed Neoplastic Glandular and Squamous Cell Population,Glottis Verrucous Carcinoma
6425,Borderline Lesion,Macrofollicular adenoma
6426,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
6427,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
6428,Pseudopapillary Pattern,Adamantinous Craniopharyngioma
6429,Invasive Lesion,Borderline Ovarian Serous Adenofibroma
6430,Intracytoplasmic Eosinophilic Inclusion,sarcoma of anus
6431,Benign Cellular Infiltrate,Rectosigmoid Signet Ring Cell Carcinoma
6432,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
6433,Intracytoplasmic Eosinophilic Inclusion,Rhabdomyosarcoma
6434,Severe cytologic atypia,Colorectal Neuroendocrine Tumor
6435,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic adenocarcinoma metastatic
6436,Squamous Differentiation,Stage IIB Lung Large Cell Carcinoma AJCC v7
6437,Intermediate Filaments Present,Fusion-Positive Alveolar Rhabdomyosarcoma
6438,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Mucinous Cystic Tumor with Mural Nodules
6439,Indolent Clinical Course,Ovarian Angiosarcoma
6440,Single Type of Tissue Derived from One Embryonic Layer Present,Childhood Ovarian Immature Teratoma
6441,Seminomatous Component Present,Childhood Ovarian Immature Teratoma
6442,Indolent Clinical Course,Stage I Bone Sarcoma AJCC v7
6443,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated Epithelioid Sarcoma
6444,Intermediate Filaments Present,"Undifferentiated Sarcoma, Not Otherwise Specified"
6445,Mixed Neoplastic Glandular and Squamous Cell Population,Ductal Eccrine Carcinoma with Squamous Metaplasia
6446,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
6447,Solid Growth Pattern,DDIT4L Acute Lymphoblastic Leukemia
6448,Benign Cellular Infiltrate,Primary Malignant Liver Neoplasm
6449,Mixed Epithelial Cell Population,Exophytic Schneiderian Papilloma
6450,Favorable Clinical Outcome,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
6451,High Grade Lesion,Endovascular papillary angioendothelioma
6452,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Bile Duct Carcinoma
6453,Intracytoplasmic Eosinophilic Inclusion,sarcoma of vagina
6454,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
6455,Well-Circumscribed Lesion,Diffuse neurofibroma
6456,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Papillary Clear Cell Adenocarcinoma
6457,Intermediate Filaments Present,leiomyosarcoma of appendix
6458,Papillary Pattern,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
6459,Mixed Neoplastic Glandular and Squamous Cell Population,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
6460,Intracytoplasmic Eosinophilic Inclusion,Sclerosing liposarcoma
6461,Solid Growth Pattern,Childhood Acute Monoblastic and Monocytic Leukemia
6462,Benign Cellular Infiltrate,"Pancreatic carcinoma, familial"
6463,Aggressive Clinical Course,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
6464,Mixed Neoplastic Glandular and Squamous Cell Population,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
6465,Chronic Clinical Course,Childhood Burkitt Leukemia
6466,Solid Growth Pattern,Acute Myeloid Leukemia with t(5;17)(q35;q21)
6467,Necrotic changes (finding),Thymic Typical Carcinoid Tumor
6468,Histiocytosis,"Malignant lymphoma centroblastic, diffuse"
6469,Solid Growth Pattern,"Leukemia, Myelocytic, Acute"
6470,Precise Histogenesis Unknown,Astrocytoma of brain
6471,Benign Cellular Infiltrate,PRETEXT Stage 3 Hepatoblastoma
6472,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Signet Ring Cell Adenocarcinoma
6473,Borderline Lesion,Respiratory papilloma
6474,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Endometrioid Adenocarcinoma
6475,Mucoid Stroma Formation,Inverted papilloma of urinary bladder
6476,Borderline Lesion,Breast Apocrine Adenoma
6477,Benign Cellular Infiltrate,malignant neoplasm of large intestine stage IV
6478,Papillary Pattern,Bladder Urothelial Carcinoma in Situ
6479,Intracytoplasmic Eosinophilic Inclusion,rhabdomyosarcoma of mediastinum
6480,Dysplasia,Skin Papilloma
6481,Intermediate Filaments Present,Mediastinal Synovial Sarcoma
6482,Mixed Neoplastic Glandular and Squamous Cell Population,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
6483,Recurrent Genetic Abnormalities Present,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified"
6484,Indolent Clinical Course,"Liposarcoma, well differentiated"
6485,Precise Histogenesis Unknown,Adult Brain Stem Glioma
6486,Benign Cellular Infiltrate,Esophageal Large Cell Neuroendocrine Carcinoma
6487,Intermediate Grade Lesion,Pancreatic Endocrine Carcinoma
6488,Mucoid Stroma Formation,Nonencapsulated sclerosing tumor
6489,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
6490,Intermediate Filaments Present,Leiomyosarcoma of stomach
6491,Indolent Clinical Course,Metastatic Bone Ewing Sarcoma
6492,Severe cytologic atypia,Small Intestinal Neuroendocrine Tumor
6493,Benign Cellular Infiltrate,Esophageal Synovial Sarcoma
6494,Precise Histogenesis Unknown,Recurrent Childhood Visual Pathway Astrocytoma
6495,Intermediate Filaments Present,Localized Bone Ewing Sarcoma
6496,Seminomatous Component Present,Vaginal Dermoid Cyst
6497,Precise Histogenesis Unknown,Adult Anaplastic Astrocytoma
6498,Multilayered Rosette Formation,Medulloblastoma with extensive nodularity
6499,Intermediate Filaments Present,Post-Radiotherapy Breast Angiosarcoma
6500,Seminomatous Component Present,Testicular choriocarcinoma stage III
6501,Favorable Clinical Outcome,Skin Basal Cell Carcinoma with Adnexal Differentiation
6502,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Uterine Sarcoma AJCC v7
6503,Locally Aggressive Lesion,Myofibroblastoma
6504,Intracytoplasmic Eosinophilic Inclusion,Epithelioid sarcoma non-metastatic
6505,Mixed Neoplastic Glandular and Squamous Cell Population,Biliary Intraepithelial Neoplasia-3
6506,Intermediate Filaments Present,Extra-osseous Ewing's sarcoma metastatic
6507,Indolent Clinical Course,"Synovial sarcoma, epithelioid cell"
6508,Invasive Lesion,Pilomatrixoma
6509,Locally Aggressive Lesion,Breast Myofibroblastoma
6510,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Papillary serous endometrial carcinoma
6511,Indolent Clinical Course,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
6512,Absence of a Hormonal Syndrome,malignant gastrinoma of pancreas
6513,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Pericanalicular fibroadenoma
6514,Precise Histogenesis Unknown,Pilocytic astrocytoma of cerebellum
6515,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Phyllodes tumor, benign"
6516,Benign Cellular Infiltrate,Stage IA Esophageal Cancer AJCC v7
6517,Nuclear pleomorphism,Low-grade fibromyxoid sarcoma
6518,Favorable Clinical Outcome,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
6519,Benign Cellular Infiltrate,Mixed Hepatoblastoma with Teratoid Features
6520,Benign Cellular Infiltrate,Gallbladder squamous cell carcinoma
6521,Benign Cellular Infiltrate,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
6522,Indolent Clinical Course,Dedifferentiated chondrosarcoma
6523,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of lip
6524,Carcinomatous Component Present,Salivary Gland Pleomorphic Adenoma
6525,Mixed Cellular Population,Squamous Papilloma of the Nasopharynx
6526,Indolent Clinical Course,Grade III Childhood Astrocytoma
6527,Grade 4 Lesion,Grade III Childhood Astrocytoma
6528,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,clear cell adenocarcinofibroma of ovary
6529,Necrotic changes (finding),Benign Esophageal Schwannoma
6530,Grade 4 Lesion,Childhood Brain Stem Astrocytoma
6531,Precise Histogenesis Unknown,Adult Anaplastic Oligodendroglioma
6532,Intracytoplasmic Eosinophilic Inclusion,Cardiac Leiomyosarcoma
6533,Invasive Lesion,Vulvar Seborrheic Keratosis
6534,Borderline Lesion,Vestibular Papilloma
6535,Indolent Clinical Course,AJCC Grade 2 Sarcoma
6536,Benign Cellular Infiltrate,Rectosigmoid Adenocarcinoma
6537,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of tongue
6538,Severe cytologic atypia,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
6539,Benign Cellular Infiltrate,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
6540,Malignant Germinomatous Cellular Infiltrate,Vulvar Yolk Sac Tumor
6541,Encapsulated Mass,Perineurioma
6542,Indolent Clinical Course,Medullomyoblastoma
6543,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
6544,Chronic Clinical Course,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7
6545,Mixture of Germ Cell Neoplastic Components Present,Gestational Trophoblastic Neoplasms
6546,Precise Histogenesis Unknown,Adult Pilocytic Astrocytoma
6547,Tubular Structures Present,Hilus cell tumor of ovary
6548,Diffuse Lesion,Pyogenic granuloma
6549,Mitotic Activity,Benign Uterine Corpus PEComa
6550,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Endometrial Mucinous Adenocarcinoma
6551,Benign Cellular Infiltrate,small cell carcinoma of gallbladder
6552,Intermediate Filaments Present,Parosteal Osteosarcoma
6553,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Pleomorphic Hepatocellular Carcinoma
6554,Well-Circumscribed Lesion,Nuchal-type fibroma
6555,Indolent Clinical Course,Cerebral Lymphoma in Immunocompetent Host
6556,Junctional Proliferation,Neuronevus
6557,Papillary Pattern,Intraductal Proliferative Lesion of the Breast
6558,Diffuse Lesion,Congenital hemangioma
6559,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
6560,Mixed Neoplastic Glandular and Squamous Cell Population,Breast Mucinous Cystadenocarcinoma
6561,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
6562,Indolent Clinical Course,Epithelioid sarcoma recurrent
6563,Premalignant Lesion,Stage III Lung Cancer AJCC v6
6564,Prominent Schwannian Stroma Present,Stage 2A Neuroblastoma
6565,Severe cytologic atypia,Intestinal Neuroendocrine Tumor G2
6566,Solid Growth Pattern,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
6567,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
6568,Mixture of Germ Cell Neoplastic Components Present,Testicular yolk sac tumor
6569,Solid Growth Pattern,Childhood Acute Myeloid Leukemia Not Otherwise Specified
6570,Papillary Pattern,Usual ductal hyperplasia of breast
6571,Well-Circumscribed Lesion,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
6572,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Low Grade Intraepithelial Neoplasia
6573,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Cystadenoma
6574,Necrotic changes (finding),Plexiform Schwannoma
6575,Mixed Neoplastic Glandular and Squamous Cell Population,Type I Endometrial Adenocarcinoma
6576,CD30-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
6577,Metastatic Lesion,Mixed Somatotroph and Lactotroph Adenoma
6578,Malignant Germinomatous Cellular Infiltrate,Extragonadal primary embryonal carcinoma
6579,Dystrophic calcification,Papillary craniopharyngioma
6580,Mixed Neoplastic Glandular and Squamous Cell Population,Rectosigmoid Signet Ring Cell Carcinoma
6581,Intermediate Filaments Present,sarcoma of small intestine
6582,Cytologic atypia,Colorectal Goblet Cell Rich Hyperplastic Polyp
6583,Mixed Neoplastic Glandular and Squamous Cell Population,Small intestine adenocarcinoma metastatic NOS
6584,Diffuse Lesion,Bladder Squamous Papilloma
6585,Mixed Neoplastic Glandular and Squamous Cell Population,Barrett's Adenocarcinoma
6586,Invasive Lesion,Sebaceoma
6587,Benign Cellular Infiltrate,Pancreatic sarcoma
6588,Intracytoplasmic Eosinophilic Inclusion,Poorly Differentiated Fibrosarcoma
6589,Indolent Clinical Course,Recurrent Rhabdomyosarcoma
6590,Indolent Clinical Course,Synovial sarcoma metastatic
6591,Indolent Clinical Course,Gliomatosis Cerebri Type II
6592,Intracytoplasmic Eosinophilic Inclusion,Radiation-Related Sarcoma
6593,Nuclear Clearing,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
6594,Benign Cellular Infiltrate,Pancreatic Foamy Gland Adenocarcinoma
6595,Benign Cellular Infiltrate,Squamous cell carcinoma of rectum
6596,Intermediate Filaments Present,Fascial fibrosarcoma
6597,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
6598,Mixed Neoplastic Glandular and Squamous Cell Population,Benign oncocytoma of salivary gland
6599,Dysplasia,Gastric hyperplastic polyp
6600,Indolent Clinical Course,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
6601,Mixed Neoplastic Glandular and Squamous Cell Population,ENSAT Stage II Adrenal Cortex Carcinoma
6602,Lobular Pattern,Malignant Proliferating Pilar Tumor
6603,Dysplasia,Syringocystadenoma Papilliferum
6604,Mixed Neoplastic Glandular and Squamous Cell Population,Adenoma of ampulla of Vater
6605,Benign Cellular Infiltrate,Intrahepatic Cholangiocarcinoma
6606,Mucoid Stroma Formation,"Papilloma, Squamous Cell"
6607,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of cecum
6608,Solid Growth Pattern,Adult Burkitt Leukemia
6609,High Mitotic Activity,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
6610,Regional Disease,Distantly Metastatic Malignant Neoplasm
6611,High Mitotic Activity,Gastric Neuroendocrine Tumor
6612,Benign Cellular Infiltrate,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
6613,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
6614,Precise Histogenesis Unknown,Glioblastoma with Primitive Neuronal Component
6615,Intermediate Filaments Present,Mixed Liposarcoma
6616,Favorable Clinical Outcome,Stage III Acral Lentiginous Melanoma AJCC v7
6617,Mucoid Stroma Formation,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
6618,Benign Cellular Infiltrate,Gallbladder Melanoma
6619,Indolent Clinical Course,Desmoplastic Small Round Cell Tumor
6620,Invasive Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
6621,Low Grade Lesion,Adrenal Gland Angiosarcoma
6622,Intracytoplasmic Eosinophilic Inclusion,Anaplastic Embryonal Rhabdomyosarcoma
6623,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Megakaryoblastic Leukemia
6624,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, Clear Cell"
6625,Precise Histogenesis Unknown,Adult Giant Cell Glioblastoma
6626,Precise Histogenesis Unknown,Recurrent Childhood Gemistocytic Astrocytoma
6627,Mucoid Stroma Formation,Peripheral Breast Papilloma
6628,Localized Lesion,ISS Stage I Plasma Cell Myeloma
6629,Indolent Clinical Course,Mediastinal Synovial Sarcoma
6630,Premalignant Lesion,Stage IIIA Lung Small Cell Carcinoma AJCC v7
6631,Intermediate Filaments Present,Meningothelial sarcoma
6632,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in tubulovillous adenoma
6633,Seminomatous Component Present,Testicular choriocarcinoma stage I
6634,Neuroectodermal Differentiation,Metastatic Bone Ewing Sarcoma
6635,Mucoid Stroma Formation,Infiltrating papillary adenocarcinoma
6636,Favorable Clinical Outcome,Basal cell carcinoma - follicular
6637,Mixed Epithelial Cell Population,Lung Squamous Cell Papilloma
6638,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Inverted Schneiderian Papilloma
6639,Favorable Clinical Outcome,Cutaneous Radiation-Related Angiosarcoma
6640,Indolent Clinical Course,leiomyosarcoma of extrahepatic bile duct
6641,Severe cytologic atypia,Small Intestinal Gangliocytic Paraganglioma
6642,Indolent Clinical Course,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
6643,Severe cytologic atypia,Carcinoid tumor of the cecum
6644,High Mitotic Activity,Urethral Leiomyoma
6645,Benign Cellular Infiltrate,signet ring cell carcinoma of gallbladder
6646,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Tubular Adenocarcinoma
6647,Intermediate Filaments Present,Childhood Rhabdomyosarcoma
6648,Premalignant Lesion,Lung Basaloid Squamous Cell Carcinoma
6649,Severe cytologic atypia,Anal Canal Neuroendocrine Tumor
6650,Tumor Vascular Invasion,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
6651,Well-Circumscribed Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
6652,Intermediate Filaments Present,Cervical Alveolar Soft Part Sarcoma
6653,Necrotic changes (finding),Childhood Brain Anaplastic Astrocytoma
6654,Indolent Clinical Course,Recurrent Olfactory Neuroblastoma
6655,Borderline Lesion,Water-clear cell adenoma
6656,Malignant Germinomatous Cellular Infiltrate,Mature Gastric Teratoma
6657,atypia morphology,Atrial myxoma
6658,Mixed Neoplastic Glandular and Squamous Cell Population,Grade II Prostatic Intraepithelial Neoplasia
6659,Local disease,Leiomyomatosis peritonealis disseminata
6660,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Aleukemic Monocytic Leukemia Cutis
6661,Indolent Clinical Course,Spindle cell rhabdomyosarcoma
6662,Intermediate Filaments Present,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
6663,Benign Cellular Infiltrate,Stage III Colon Cancer
6664,Benign Cellular Infiltrate,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
6665,Ineffective hematopoiesis,"Myeloproliferative Neoplasm, Unclassifiable"
6666,Intermediate Filaments Present,Cardiac Malignant Peripheral Nerve Sheath Tumor
6667,Precise Histogenesis Unknown,Extraventricular neurocytoma
6668,Invasive Lesion,Cervical intraepithelial neoplasia grade 2
6669,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
6670,Favorable Clinical Outcome,Recurrent Childhood Hepatocellular Carcinoma
6671,Precise Histogenesis Unknown,Gliofibroma
6672,Intraductal Lesion,Periductal Breast Myoepitheliosis
6673,Low Grade Lesion,Conventional Angiosarcoma
6674,Local disease,Leiomyomatosis
6675,Mixed Neoplastic Glandular and Squamous Cell Population,Well Differentiated Adrenal Cortex Carcinoma
6676,Precise Histogenesis Unknown,Neural Glioblastoma
6677,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of skin
6678,Mixture of Germ Cell Neoplastic Components Present,Gestational choriocarcinoma
6679,Intermediate Filaments Present,Leiomyosarcoma NCI Grade 3
6680,Aggressive Clinical Course,Marginal zone lymphoma recurrent
6681,Necrotic changes (finding),"Anaplastic Astrocytoma, IDH-Wildtype"
6682,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
6683,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Choriocarcinoma
6684,Chronic Clinical Course,Adult Acute Promyelocytic Leukemia with PML-RARA
6685,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Hepatoid Adenocarcinoma
6686,Glandular Differentiation,"Lung Large Cell Carcinoma, Clear Cell Variant"
6687,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Endometrioid Adenocarcinoma
6688,Mixed Neoplastic Glandular and Squamous Cell Population,"Paget's Disease, Mammary"
6689,Neuroendocrine Differentiation,Stage I Skin Cancer
6690,High Mitotic Activity,Cellular Ependymoma
6691,Benign Cellular Infiltrate,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
6692,Indolent Clinical Course,Pineal germinoma
6693,Premalignant Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
6694,Favorable Clinical Outcome,Plantar Verrucous Skin Carcinoma
6695,Indolent Clinical Course,Salivary Gland Myoepithelial Carcinoma
6696,Indolent Clinical Course,Vertebral chordoma
6697,Indolent Clinical Course,Malignant Uterine Corpus PEComa
6698,Mixed Neoplastic Glandular and Squamous Cell Population,Serous Endometrial Intraepithelial Carcinoma
6699,Well-Circumscribed Lesion,"Fibromatosis, Aggressive"
6700,Necrotic changes (finding),Jugular Foramen Schwannoma
6701,Anaplasia,Adult Ganglioglioma
6702,Benign Cellular Infiltrate,Adult Fibrolamellar Carcinoma
6703,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of orbit
6704,Mucoid Stroma Formation,Hereditary Papillary Renal Carcinoma
6705,Benign Cellular Infiltrate,Hepatosplenic T-cell lymphoma
6706,Intracytoplasmic Eosinophilic Inclusion,Kaposi Sarcoma Related to Immunosuppressive Treatment
6707,Indolent Clinical Course,Recurrent Childhood Anaplastic Oligoastrocytoma
6708,Mixed Neoplastic Glandular and Squamous Cell Population,Localized Unresectable Adult Hepatocellular Carcinoma
6709,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
6710,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
6711,Nuclear Grooves,Childhood Thyroid Gland Follicular Carcinoma
6712,Intracytoplasmic Eosinophilic Inclusion,Malignant Fibrous Histiocytoma
6713,Ineffective hematopoiesis,Philadelphia chromosome positive chronic myelogenous leukemia
6714,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Adenofibroma
6715,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Adenofibroma
6716,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Intraepithelial Neoplasia
6717,Seminomatous Component Present,Testicular yolk sac tumor
6718,Seminomatous Component Present,Mature Pericardial Teratoma
6719,Favorable Clinical Outcome,Clear Cell Hepatocellular Carcinoma
6720,Borderline Lesion,Thyroid Gland Oncocytic Adenoma
6721,Low Grade Lesion,Pulmonary Artery Angiosarcoma
6722,Squamous Differentiation,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
6723,HMB-45-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
6724,Low Grade Lesion,Metastatic angiosarcoma
6725,Indolent Clinical Course,Peripheral Primitive Neuroectodermal Tumor of the Kidney
6726,Indolent Clinical Course,Ewings sarcoma-primitive neuroectodermal tumor (PNET)
6727,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Hepatocellular Carcinoma AJCC v7
6728,Nuclear Grooves,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
6729,Severe cytologic atypia,Appendix Neuroendocrine Tumor G2
6730,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Squamous Cell Carcinoma
6731,Mild dysplasia,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
6732,Severe dysplasia,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
6733,Solid Growth Pattern,Mixed phenotype acute leukemia
6734,Intracytoplasmic Eosinophilic Inclusion,Stage IC Uterine Sarcoma AJCC v7
6735,Benign Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v6 and v7
6736,Capsular Invasion,Oxyphilic Adenoma
6737,Mitotic Activity,Pineocytoma
6738,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Acinar Cell Cystadenoma
6739,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Mucinous Adenofibroma
6740,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Low Grade Broad Ligament Serous Adenocarcinoma
6741,Intermediate Filaments Present,Fusion-Negative Alveolar Rhabdomyosarcoma
6742,Squamous Differentiation,Stage IIIB Lung Large Cell Carcinoma AJCC v7
6743,CD21-Positive Neoplastic Cells Present,Letterer-Siwe Disease
6744,Mixed Neoplastic Glandular and Squamous Cell Population,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
6745,Indolent Clinical Course,Ovarian Myxoid Liposarcoma
6746,Mixed Neoplastic Glandular and Squamous Cell Population,Ductal Eccrine Carcinoma with Spindle Cell Elements
6747,Invasive Lesion,Anogenital papillomaviral intraepithelial neoplasia
6748,Intracytoplasmic Eosinophilic Inclusion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
6749,Mixed Cellular Population,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
6750,Mucoid Stroma Formation,Lung Micropapillary Adenocarcinoma
6751,Seminomatous Component Present,Ovarian Fetiform Teratoma
6752,Invasive Lesion,Benign tumor of salivary gland
6753,Premalignant Lesion,Secondary malignant neoplasm of lung
6754,Auer Rods Present,"Acute myeloid leukemia, minimal differentiation"
6755,Dysplasia,Subcutaneous Nodular Fasciitis
6756,Superficial Lesion,Sclerosing liposarcoma
6757,Intracytoplasmic Eosinophilic Inclusion,Sclerosing Epithelioid Fibrosarcoma
6758,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatitis C Virus-Related Hepatocellular Carcinoma
6759,CD15-Positive Neoplastic Cells Present,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
6760,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Tumor
6761,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
6762,Benign Cellular Infiltrate,Malignant neoplasm of middle third of esophagus
6763,atypia morphology,Ovarian Adenomatoid Tumor
6764,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
6765,Premalignant Lesion,Non-Hodgkin's lymphoma of lung
6766,Necrotic changes (finding),Benign Cardiac Schwannoma
6767,Indolent Clinical Course,Chordoma
6768,Premalignant Lesion,Stage IA Lung Squamous Cell Carcinoma AJCC v7
6769,Premalignant Lesion,Large cell carcinoma with rhabdoid phenotype
6770,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous adenocarcinoma gastric
6771,Glandular Differentiation,Undifferentiated Carcinoma of Unknown Primary
6772,Absence of a Hormonal Syndrome,insulinoma
6773,High Mitotic Activity,Glucagonoma
6774,Mixed Neoplastic Glandular and Squamous Cell Population,Klatskin Tumor
6775,Necrotic changes (finding),Recurrent Childhood Diffuse Astrocytoma
6776,Mixed Neoplastic Glandular and Squamous Cell Population,Colon Micropapillary Adenocarcinoma
6777,Dysplasia,Benign neoplasm of sebaceous gland
6778,Borderline Lesion,Central Breast Papilloma
6779,Grade 4 Lesion,Recurrent Childhood Optic Nerve Astrocytoma
6780,Benign Cellular Infiltrate,Bile duct carcinoma
6781,Locally Aggressive Lesion,Osteoid osteoma
6782,Favorable Clinical Outcome,Adenoid cystic eccrine carcinoma
6783,High Mitotic Activity,Carcinoid tumor of intestine
6784,Borderline Lesion,Serous cystadenoma of ovary
6785,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma stage III
6786,Indolent Clinical Course,High Grade Sarcoma
6787,Intracytoplasmic Eosinophilic Inclusion,Grade II Chondrosarcoma
6788,Favorable Clinical Outcome,Cutaneous Mature B-Cell Neoplasm
6789,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary Renal Cell Carcinoma
6790,Intracytoplasmic Eosinophilic Inclusion,liposarcoma of mediastinum
6791,Indolent Clinical Course,Poorly Differentiated Angiosarcoma
6792,Mucoid Stroma Formation,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
6793,Intermediate Filaments Present,FNCLCC Sarcoma Grade 1
6794,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor
6795,Villous Pattern,Tubular adenoma of colon
6796,Seminomatous Component Present,Pancreatic Teratoma
6797,Scattered Collections of Differentiating Neuroblasts Present,ganglioneuroblastoma of mediastinum
6798,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Esophageal Glandular Intraepithelial Neoplasia
6799,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous adenocarcinoma of colon
6800,Epidermotropic Lymphocytic Infiltrate,Follicular mycosis fungoides
6801,Intermediate Filaments Present,Stage II Uterine Sarcoma AJCC v7
6802,Precise Histogenesis Unknown,Diffuse Glioma
6803,Intermediate Filaments Present,leiomyosarcoma of bone
6804,High Mitotic Activity,Uterine Corpus Diffuse Leiomyomatosis
6805,Extensive Necrosis,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
6806,Invasive Lesion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
6807,Nuclear Clearing,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
6808,Papillary Pattern,Hard Palate Monomorphic Adenoma
6809,Biphasic Pattern,Recurrent Childhood Pilomyxoid Astrocytoma
6810,Indolent Clinical Course,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
6811,Intermediate Filaments Present,Childhood Periosteal Osteosarcoma
6812,Intracytoplasmic Eosinophilic Inclusion,Childhood Periosteal Osteosarcoma
6813,Borderline Lesion,Anal Canal Squamous Papilloma
6814,Chronic Clinical Course,recurrent adult acute myeloid leukemia
6815,Premalignant Lesion,Lung Acinar Adenocarcinoma
6816,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Cancer by AJCC v6 Stage
6817,atypia morphology,Epithelioid and spindle cell nevus
6818,Invasive Lesion,Dartoic myoma
6819,Mixed Neoplastic Glandular and Squamous Cell Population,ACTH-Producing Pituitary Gland Carcinoma
6820,Tumor Vascular Invasion,Adrenal Cortex Oncocytic Adenoma
6821,High Grade Lesion,Hemangioendothelioma of skin
6822,CD30-Positive Neoplastic Cells Present,Eosinophilic Granuloma
6823,Sclerotic Pattern,Spindle cell rhabdomyosarcoma
6824,Intracytoplasmic Eosinophilic Inclusion,Low-grade fibromyxoid sarcoma
6825,Benign Cellular Infiltrate,Extrarenal Rhabdoid Tumor of the Liver
6826,Intracytoplasmic Eosinophilic Inclusion,Pleural Biphasic Synovial Sarcoma
6827,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with squamous metaplasia
6828,Solid Growth Pattern,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
6829,atypia morphology,Regressing nevus
6830,Intracytoplasmic Eosinophilic Inclusion,Gastric Kaposi's Sarcoma
6831,Indolent Clinical Course,Multifocal osteosarcoma
6832,Mixed Neoplastic Glandular and Squamous Cell Population,Hard Palate Squamous Cell Carcinoma
6833,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of ovary
6834,Intermediate Filaments Present,Liposarcoma recurrent
6835,Indolent Clinical Course,Childhood Central Nervous System Ganglioneuroblastoma
6836,Perineural spread,Chief cell adenoma
6837,Benign Cellular Infiltrate,Esophageal Cancer by AJCC v6 Stage
6838,Premalignant Lesion,Adenosquamous cell lung cancer stage III
6839,Indolent Clinical Course,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
6840,Benign Cellular Infiltrate,Duodenal Extraskeletal Osteosarcoma
6841,Indolent Clinical Course,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
6842,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Esophageal Adenocarcinoma AJCC v7
6843,Seminomatous Component Present,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
6844,Benign Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
6845,Benign Cellular Infiltrate,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
6846,Borderline Lesion,Bartholin Gland Adenoma
6847,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
6848,Anaplasia,Childhood Choroid Plexus Papilloma
6849,Mixed Neoplastic Glandular and Squamous Cell Population,Broad Ligament Serous Adenofibroma
6850,Low Mitotic Activity,Small cell carcinoma of esophagus
6851,Skin nodule,"Basal cell carcinoma, micronodular"
6852,Borderline Lesion,Inverting papilloma of the nasal cavity
6853,Invasive Lesion,Low Grade Conjunctival Intraepithelial Neoplasia
6854,Mixed Neoplastic Glandular and Squamous Cell Population,Anaplastic adrenocortical carcinoma
6855,High Mitotic Activity,Vipoma
6856,Benign Cellular Infiltrate,Gastric Choriocarcinoma
6857,Necrotic changes (finding),Choroid Plexus Papilloma
6858,Microvascular Proliferation,Recurrent Childhood Anaplastic Astrocytoma
6859,CD4-Positive Neoplastic Cells Present,Subcutaneous panniculitis-like T-cell lymphoma
6860,Metaplasia of Malignant Cells Present,Metaplastic carcinoma
6861,Diffuse Lesion,Intra-Abdominal Lymphangioma
6862,Chronic Clinical Course,Hypodiploid B Acute Lymphoblastic Leukemia
6863,Squamous Differentiation,Lymphoepithelial carcinoma
6864,Mixed Neoplastic Glandular and Squamous Cell Population,Verrucous carcinoma of penis
6865,Intermediate Filaments Present,Aortic Angiosarcoma
6866,Indolent Clinical Course,Stage IA Bone Cancer AJCC v7
6867,Glandular Differentiation,Undifferentiated carcinoma of ovary
6868,Collagenous Stroma Formation,Odontogenic myxoma
6869,Histiocytosis,Immunoblastic lymphoma associated with AIDS
6870,Invasive Lesion,Cervical Squamous Intraepithelial Neoplasia
6871,Seminomatous Component Present,Monodermal Testicular Teratoma
6872,Well-Circumscribed Lesion,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
6873,Intermediate Filaments Present,Childhood Soft Tissue Sarcoma
6874,Intermediate Filaments Present,undifferentiated sarcoma of soft tissue
6875,Precise Histogenesis Unknown,Diencephalic Glioblastoma
6876,Indolent Clinical Course,leiomyosarcoma of retroperitoneum
6877,High Mitotic Activity,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
6878,Precise Histogenesis Unknown,Oligodendroglial Neoplasm
6879,Intracytoplasmic Eosinophilic Inclusion,Intracortical osteosarcoma
6880,Tumor Vascular Invasion,Glomerulosa Cell Adrenal Cortical Adenoma
6881,Glandular Differentiation,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
6882,Capsular Invasion,Thyroid Gland Mucinous Follicular Adenoma
6883,Nuclear Pseudoinclusion,Thyroid Gland Mucinous Follicular Adenoma
6884,Invasive Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant"
6885,Mucoid Stroma Formation,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
6886,Metaplasia of Malignant Cells Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
6887,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Mucinous Cystic Tumor with Mural Nodules
6888,Nuclear Grooves,Thyroid Gland Lipoadenoma
6889,Mucoid Stroma Formation,Intraductal papilloma of breast
6890,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Enteric Type Adenocarcinoma
6891,Well-Circumscribed Lesion,Dermatofibrosarcoma Protuberans
6892,Malignant Germinomatous Cellular Infiltrate,Ovarian Biphasic or Triphasic Teratoma
6893,Nuclear Clearing,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
6894,Nuclear Grooves,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
6895,Benign Cellular Infiltrate,Secondary malignant neoplasm of small intestine
6896,Indolent Clinical Course,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
6897,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Angiosarcoma
6898,Indolent Clinical Course,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
6899,Mixed Neoplastic Glandular and Squamous Cell Population,Extraocular Cutaneous Sebaceous Carcinoma
6900,Indolent Clinical Course,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
6901,Acute Clinical Course,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta
6902,Glandular Differentiation,Vaginal Undifferentiated Carcinoma
6903,Squamous Differentiation,Thymic Undifferentiated Carcinoma
6904,Intermediate Filaments Present,Stage IIB Bone Sarcoma AJCC v7
6905,Indolent Clinical Course,Metastatic malignant neoplasm to brain
6906,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Pure Erythroid Leukemia
6907,Favorable Clinical Outcome,Hepatitis C Virus-Related Hepatocellular Carcinoma
6908,Favorable Clinical Outcome,Old Burn Scar-Related Skin Squamous Cell Carcinoma
6909,Indolent Clinical Course,Adult Central Nervous System Germinoma
6910,Borderline Lesion,Sebaceous adenoma
6911,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of lung
6912,Benign Cellular Infiltrate,Stage I Colon Cancer AJCC v6 and v7
6913,Mucoid Stroma Formation,Bronchial adenoma
6914,Indolent Clinical Course,Childhood Mesenchymal Chondrosarcoma
6915,Malignant Germinomatous Cellular Infiltrate,"Struma ovarii, malignant"
6916,Mixed Neoplastic Glandular and Squamous Cell Population,"Papillary mucinous cystadenoma, borderline malignancy"
6917,Indolent Clinical Course,Childhood Myxoid Chondrosarcoma
6918,Superficial Lesion,Lumbosacral Lipoma
6919,Benign Cellular Infiltrate,Serous cystadenocarcinoma of pancreas
6920,Increased Cellularity Present,Ureter Urothelial Papilloma
6921,Borderline Lesion,Parotid Gland Warthin Tumor
6922,Benign Cellular Infiltrate,Esophageal Lymphoma
6923,Favorable Clinical Outcome,Solar Radiation-Related Skin Squamous Cell Carcinoma
6924,Invasive Lesion,Intestinal Intraepithelial Neoplasia
6925,Benign Cellular Infiltrate,Grade 2 Colon Adenocarcinoma
6926,Microvascular Proliferation,Recurrent Childhood Gemistocytic Astrocytoma
6927,Aggressive Clinical Course,Familial Waldenstrom's Macroglobulinaemia
6928,Severe cytologic atypia,Regional Digestive System Neuroendocrine Tumor G1
6929,Indolent Clinical Course,leiomyosarcoma of mediastinum
6930,Indolent Clinical Course,Recurrent Childhood Gliosarcoma
6931,Dysplasia,Ancell-Spiegler cylindromas
6932,Premalignant Lesion,Occult Lung Small Cell Carcinoma
6933,Invasive Lesion,Cervical Intraepithelial Neoplasia Grade 2/3
6934,atypia morphology,Solitary Osteochondroma
6935,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Clear Cell Renal Cell Carcinoma
6936,Borderline Lesion,intraductal papilloma of salivary gland
6937,Intracytoplasmic Eosinophilic Inclusion,Glandular malignant peripheral nerve sheath tumor
6938,Indolent Clinical Course,Transplant-Related Kaposi Sarcoma
6939,Keratin pearl formation,Vulvar Non-Keratinizing Squamous Cell Carcinoma
6940,Benign Cellular Infiltrate,Cecum Lymphoma
6941,Severe cytologic atypia,Carcinoid tumor of the duodenum
6942,Borderline Lesion,Cystadenoma of pancreas
6943,Indolent Clinical Course,Well Differentiated Fibrosarcoma
6944,"Undifferentiated ""Fetal-Type"" Tissues Present",benign mature teratoma of pancreas
6945,Ineffective hematopoiesis,Polycythemia Vera
6946,Invasive Lesion,High Grade Esophageal Glandular Intraepithelial Neoplasia
6947,Indolent Clinical Course,Malignant Gastric Soft Tissue Neoplasm
6948,Benign Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma
6949,Mixed Epithelial Cell Population,Inverted Squamous Cell Papilloma
6950,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma of the breast
6951,Necrotic changes (finding),Mediastinal Schwannoma
6952,Intermediate Filaments Present,Epithelioid sarcoma non-metastatic
6953,Mucoid Stroma Formation,verrucous carcinoma of esophagus
6954,Borderline Lesion,Sphenoid Sinus Inverted Papilloma
6955,Mixed Neoplastic Glandular and Squamous Cell Population,Undifferentiated carcinoma of esophagus
6956,Benign Cellular Infiltrate,Malignant tumor of colon
6957,Intermediate Filaments Present,Extra-osseous Ewing's sarcoma recurrent
6958,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Intraosseous Squamous Cell Carcinoma
6959,Dilated Thin-Walled Vascular Space Formation,Vulvar Superficial Myofibroblastoma
6960,Diffuse Lesion,"Hemangioma, Cavernous"
6961,Indolent Clinical Course,Growth Hormone-Producing Pituitary Gland Carcinoma
6962,Aggressive Clinical Course,Grade 1 Cutaneous Follicular Lymphoma
6963,Indolent Clinical Course,TSH-Producing Pituitary Gland Carcinoma
6964,Tumor Vascular Invasion,estrogen-producing adrenal cortical adenoma
6965,Low Grade Lesion,hemangioendothelial sarcoma of bone
6966,Mucoid Stroma Formation,Intraductal papillomatosis
6967,Severe cytologic atypia,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
6968,Diffuse Lesion,Renal Pelvis Urothelial Papilloma
6969,Benign Cellular Infiltrate,Stage IIIA Esophageal Cancer AJCC v7
6970,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with spindle cell metaplasia
6971,Indolent Clinical Course,Extrarenal rhabdoid tumor
6972,Indolent Clinical Course,Asynchronous Multifocal Osteosarcoma
6973,Indolent Clinical Course,Liposarcoma recurrent
6974,High Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor
6975,Diffuse Lesion,Cavernous lymphangioma
6976,Scattered Collections of Differentiating Neuroblasts Present,"Childhood Ganglioneuroblastoma, Intermixed"
6977,Extraocular Dissemination of Disease,Pediatric Intraocular Retinoblastoma
6978,Indolent Clinical Course,"Sarcoma, Small Cell"
6979,Microvascular Proliferation,"Gemistocytic Astrocytoma, IDH-Mutant"
6980,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma in situ with questionable stromal invasion
6981,Favorable Clinical Outcome,Squamous cell carcinoma of skin
6982,Invasive Lesion,Salivary Gland Pleomorphic Adenoma
6983,Infiltrative Growth Pattern,Esophageal Fibroma
6984,Intracytoplasmic Eosinophilic Inclusion,Stage III Adult Soft Tissue Sarcoma AJCC v7
6985,Mixed Neoplastic Glandular and Squamous Cell Population,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
6986,Benign Cellular Infiltrate,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
6987,Neuroendocrine Differentiation,Stage III Skin Cancer
6988,Mitotic Activity,Diffuse Astrocytoma
6989,Glandular Differentiation,Cervical Lymphoepithelioma-Like Carcinoma
6990,Intermediate Filaments Present,Primary leiomyosarcoma
6991,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Variant Thyroid Gland Follicular Carcinoma
6992,Benign Cellular Infiltrate,Hepatic cancer stage IVA
6993,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Hepatocellular Carcinoma
6994,Anaplasia,Benign Childhood Supratentorial Neoplasm
6995,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
6996,Mixed Neoplastic Glandular and Squamous Cell Population,Oxyphilic Endometrial Endometrioid Adenocarcinoma
6997,Intracytoplasmic Eosinophilic Inclusion,Ewings sarcoma
6998,Precise Histogenesis Unknown,Childhood Cerebral Diffuse Astrocytoma
6999,Mixed Neoplastic Glandular and Squamous Cell Population,Salivary Gland Oncocytic Carcinoma
7000,Indolent Clinical Course,Askin's tumor
7001,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of gallbladder with squamous metaplasia
7002,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatoid adenocarcinoma
7003,Intermediate Filaments Present,Osteoblastic Osteosarcoma
7004,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Adenocarcinoma
7005,Intracytoplasmic Eosinophilic Inclusion,Superior Vena Cava Angiosarcoma
7006,Glandular Differentiation,Undifferentiated carcinoma
7007,Metastatic Lesion,Meningeal Lymphoma
7008,Mixed Neoplastic Glandular and Squamous Cell Population,Skin Pseudovascular Squamous Cell Carcinoma
7009,Aggressive Clinical Course,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
7010,Premalignant Lesion,Lung Cancer by AJCC v7 Stage
7011,Malignant Cellular Infiltrate,"Phosphaturic mesenchymal tumor, benign"
7012,Favorable Clinical Outcome,Subcutaneous panniculitis-like T-cell lymphoma
7013,Indolent Clinical Course,Pulmonary Artery Leiomyosarcoma
7014,Mixed Neoplastic Glandular and Squamous Cell Population,Acantholytic squamous cell carcinoma
7015,Mucoid Stroma Formation,Childhood Thyroid Gland Papillary Carcinoma
7016,Locally Aggressive Lesion,Angiofibroma
7017,Indolent Clinical Course,Central Nervous System Carcinoma
7018,Indolent Clinical Course,Vulvar Proximal-Type Epithelioid Sarcoma
7019,Indolent Clinical Course,Angiosarcoma recurrent
7020,Mixed Neoplastic Glandular and Squamous Cell Population,Cystadenocarcinoma
7021,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease of the Anus
7022,Intermediate Filaments Present,Myxoid/Round Cell Liposarcoma
7023,Favorable Clinical Outcome,Stage IIB Merkel Cell Carcinoma AJCC v7
7024,Indolent Clinical Course,Central Nervous System Embryonal Carcinoma
7025,Borderline Lesion,Mixed Cell Adrenal Cortical Adenoma
7026,Intermediate Filaments Present,sarcoma of trachea
7027,Severe cytologic atypia,Gallbladder Neuroendocrine Tumor G1
7028,Mixed Neoplastic Glandular and Squamous Cell Population,Lower Gingival Verrucous Carcinoma
7029,Favorable Clinical Outcome,Sebaceous Adenocarcinoma
7030,Superficial Lesion,Infiltrating Intramuscular Lipoma
7031,Anaplasia,Benign Childhood Central Nervous System Neoplasm
7032,Indolent Clinical Course,Localized Peripheral Primitive Neuroectodermal Tumor
7033,Intermediate Filaments Present,Stage IV Uterine Sarcoma AJCC v7
7034,Indolent Clinical Course,Recurrent Childhood Medulloblastoma
7035,Benign Cellular Infiltrate,rhabdomyosarcoma of liver
7036,Benign Cellular Infiltrate,Pancreatic carcinoma
7037,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Adenocarcinoma
7038,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei
7039,Pregnancy Complications,Non-Gestational Ovarian Choriocarcinoma
7040,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Squamous Cell Carcinoma
7041,Benign Cellular Infiltrate,Stage IIB Small Intestinal Cancer AJCC v7
7042,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,M5b Acute differentiated monocytic leukemia
7043,Chronic Clinical Course,Ph-Like Acute Lymphoblastic Leukemia
7044,Dysplasia,Scrotal Hemangioma
7045,Indolent Clinical Course,Transplant-Related Malignant Neoplasm
7046,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hepatocellular Carcinoma AJCC v7
7047,Favorable Clinical Outcome,Desmoplastic melanoma
7048,Intermediate Filaments Present,Stage IA Osteosarcoma AJCC v7
7049,Papillary Pattern,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
7050,Indolent Clinical Course,Stage IB Osteosarcoma AJCC v7
7051,Benign Cellular Infiltrate,Esophageal Basaloid Carcinoma
7052,Benign Cellular Infiltrate,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified"
7053,Mixed Neoplastic Glandular and Squamous Cell Population,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
7054,High Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Vagina
7055,Mitotic Activity,Peritoneal Well Differentiated Papillary Mesothelioma
7056,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraepithelial Neoplasia-3
7057,Favorable Clinical Outcome,Stage I Lip Basal Cell Carcinoma
7058,Dysplasia,Verrucous keratotic hemangioma
7059,Villous Pattern,tubular adenoma of stomach
7060,Indolent Clinical Course,Radiation-Related Angiosarcoma
7061,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
7062,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
7063,Precise Histogenesis Unknown,"Diffuse midline glioma, point mutation K27M in histone H3"
7064,Metaplasia of Malignant Cells Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
7065,Glandular Differentiation,Endometrial Large Cell Neuroendocrine Carcinoma
7066,Borderline Lesion,Bronchial adenoma
7067,Mixed Neoplastic Glandular and Squamous Cell Population,Urethral Condyloma Acuminatum
7068,Seminomatous Component Present,Adult Teratoma
7069,Borderline Lesion,Benign Ovarian Serous Tumor
7070,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Proliferating Brenner Tumor
7071,High Mitotic Activity,Carcinoid tumor of rectum
7072,Benign Cellular Infiltrate,Anal canal squamous cell carcinoma
7073,Favorable Clinical Outcome,Aflatoxins-Related Hepatocellular Carcinoma
7074,Benign Cellular Infiltrate,undifferentiated carcinoma of appendix
7075,Indolent Clinical Course,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
7076,Intermediate Filaments Present,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
7077,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Choriocarcinoma
7078,Intermediate Filaments Present,leiomyosarcoma of mediastinum
7079,Mucoid Stroma Formation,intraductal papilloma of salivary gland
7080,Intracytoplasmic Eosinophilic Inclusion,Inflammatory Leiomyosarcoma
7081,Benign Cellular Infiltrate,Localized Resectable Adult Liver Carcinoma
7082,Low Mitotic Activity,Esophageal Large Cell Neuroendocrine Carcinoma
7083,High Mitotic Activity,Colorectal Leiomyoma
7084,Nuclear Atypia,Glomangiomatosis
7085,Geographic Necrosis,Benign germ cell tumor of ovary
7086,Indolent Clinical Course,Stage III Osteosarcoma AJCC v7
7087,Absence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor G2
7088,Benign Cellular Infiltrate,Small Intestinal Angiosarcoma
7089,Mixed Neoplastic Glandular and Squamous Cell Population,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
7090,Mixed Epithelial Cell Population,Paranasal Sinus Schneiderian Papilloma
7091,Intracytoplasmic Eosinophilic Inclusion,Localized Bone Ewing Sarcoma
7092,Precise Histogenesis Unknown,Juvenile astrocytoma
7093,Invasive Lesion,Intraductal carcinoma and lobular carcinoma in situ
7094,Indolent Clinical Course,Uterine Corpus Myxoid Leiomyosarcoma
7095,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Melanocytic Nevus
7096,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Esophageal Squamous Intraepithelial Neoplasia
7097,Aggressive Clinical Course,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma
7098,Intermediate Filaments Present,Uterine Corpus Endometrial Stromal Sarcoma
7099,Benign Cellular Infiltrate,Stage IIIB Gastric Carcinoma
7100,Intermediate Filaments Present,Intimal sarcoma
7101,Biphasic Pattern,Intimal sarcoma
7102,Mixed Neoplastic Glandular and Squamous Cell Population,Inverted Squamous Cell Papilloma
7103,Indolent Clinical Course,Gallbladder Angiosarcoma
7104,Mixed Neoplastic Glandular and Squamous Cell Population,Thymic Papillary Adenocarcinoma
7105,Glial Differentiation,Cerebellar Liponeurocytoma
7106,Severe cytologic atypia,Minimal Deviation Melanoma
7107,Indolent Clinical Course,Secondary Central Nervous System Hodgkin Lymphoma
7108,Premalignant Lesion,Stage IA Lung Cancer AJCC v7
7109,Intracytoplasmic Eosinophilic Inclusion,Childhood Osteosarcoma
7110,Borderline Lesion,Benign Breast Adenomyoepithelioma
7111,Mixed Neoplastic Glandular and Squamous Cell Population,Lung squamous cell carcinoma stage III
7112,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical high grade squamous intraepithelial lesion
7113,Indolent Clinical Course,Sarcoma of ovary
7114,Dysplasia,"Atypical Melanocytic Nevus, Genital Type"
7115,atypia morphology,Fallopian Tube Adenomatoid Tumor
7116,Indolent Clinical Course,Adult Liposarcoma
7117,Pushing Tumor Margin,Endometrial Stromal Sarcoma
7118,Premalignant Lesion,Adenosquamous cell lung cancer stage IV
7119,Chronic Clinical Course,Acute myeloid leukemia with recurrent genetic abnormality
7120,Intracytoplasmic Eosinophilic Inclusion,Recurrent Uterine Corpus Sarcoma
7121,Mixed Cellular Population,Vestibular Papilloma
7122,Seminomatous Component Present,Childhood Testicular Yolk Sac Tumor
7123,Mixed Neoplastic Glandular and Squamous Cell Population,Serous Tubal Intraepithelial Carcinoma
7124,Well-Circumscribed Lesion,Fibromatosis colli
7125,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Low Grade Ovarian Serous Adenocarcinoma
7126,Increased Cellularity Present,Bladder papilloma
7127,Benign Cellular Infiltrate,Colorectal Squamous Cell Carcinoma
7128,Precise Histogenesis Unknown,Pleomorphic Xanthoastrocytoma
7129,Indolent Clinical Course,"Glioblastoma, IDH-Wildtype"
7130,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma
7131,Premalignant Lesion,Stage IA Lung Non-Small Cell Carcinoma AJCC v7
7132,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Craniopharyngioma
7133,Intracytoplasmic Eosinophilic Inclusion,sarcoma of spinal cord
7134,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
7135,Acute Clinical Course,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation
7136,Indolent Clinical Course,lymphangiosarcoma
7137,Precise Histogenesis Unknown,Adult Brain Stem Astrocytoma
7138,Favorable Clinical Outcome,Adult Pleomorphic Hepatocellular Carcinoma
7139,Benign Cellular Infiltrate,Gastric Carcinoma with Lymphoid Stroma
7140,Glandular Differentiation,large cell neuroendocrine carcinoma of breast
7141,Dysplasia,Trichoadenoma
7142,Diffuse Lesion,Cavernous hemangioma of orbit
7143,Borderline Lesion,Ovarian Microcystic Stromal Tumor
7144,Malignant Germinomatous Cellular Infiltrate,Teratoma
7145,Intermediate Filaments Present,Sarcomatosis
7146,Encapsulated Mass,Plexiform Neurofibroma
7147,Dysplasia,Lymphangioma of skin
7148,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Thyroid Gland Follicular Carcinoma
7149,Benign Cellular Infiltrate,leiomyosarcoma of anus
7150,Favorable Clinical Outcome,Stage IIIA Merkel Cell Carcinoma AJCC v7
7151,Invasive Lesion,Cervical Squamous Cell Carcinoma In Situ
7152,Mucoid Stroma Formation,Solid Papillary Breast Carcinoma
7153,Intermediate Filaments Present,Renal Vein Leiomyosarcoma
7154,Mucoid Stroma Formation,"Cystadenoma, Papillary"
7155,Mixed Neoplastic Glandular and Squamous Cell Population,Vulval intraepithelial neoplasia grade 2
7156,Precise Histogenesis Unknown,Anaplastic Diencephalic Astrocytoma
7157,Seminomatous Component Present,teratocarcinoma of mediastinum
7158,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of liver
7159,Borderline Lesion,Vulvar Nodular Hidradenoma
7160,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Low Grade Intraepithelial Neoplasia
7161,Borderline Lesion,Epithelioid hemangioendothelioma
7162,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal High Grade Intraepithelial Neoplasia
7163,Mixed Neoplastic Glandular and Squamous Cell Population,Submucosal Invasive Colon Adenocarcinoma
7164,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Appendix Mucinous Adenocarcinoma
7165,Favorable Clinical Outcome,Stage IV Hepatocellular Carcinoma AJCC v7
7166,Intermediate Filaments Present,Rhabdomyosarcoma of cervix uteri
7167,Precise Histogenesis Unknown,Recurrent Childhood Astrocytic Tumor
7168,Generalized illness,Early Favorable Non-Hodgkin Lymphoma
7169,Borderline Lesion,"Adenoma, Sweat Gland"
7170,Borderline Lesion,Compact Cell Adrenal Cortical Adenoma
7171,Intermediate Filaments Present,Intracranial Liposarcoma
7172,Squamous Differentiation,Stage IA Lung Large Cell Carcinoma AJCC v7
7173,Indolent Clinical Course,Metastatic Childhood Soft Tissue Sarcoma
7174,Intracytoplasmic Eosinophilic Inclusion,Colon Sarcoma
7175,Benign Cellular Infiltrate,Gastroesophageal Junction Neuroendocrine Carcinoma
7176,Severe cytologic atypia,Colon Neuroendocrine Tumor G1
7177,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Osteosarcoma AJCC v7
7178,Benign Cellular Infiltrate,Colon Carcinoma Metastatic in the Lung
7179,Benign Cellular Infiltrate,Stage II Rectal Cancer
7180,Premalignant Lesion,Stage IIA Lung Large Cell Carcinoma AJCC v7
7181,Aggressive Clinical Course,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma
7182,Glandular Differentiation,Laryngeal Lymphoepithelial Carcinoma
7183,Favorable Clinical Outcome,Ductal Eccrine Carcinoma with Squamous Metaplasia
7184,Intermediate Filaments Present,Stage IVB Bone Sarcoma AJCC v7
7185,High Mitotic Activity,Small Intestinal VIP-Producing Neuroendocrine Tumor
7186,Low Mitotic Activity,Gallbladder Neuroendocrine Carcinoma
7187,Mixed Epithelial Cell Population,Oncocytic Schneiderian papilloma
7188,Aggressive Clinical Course,Stage I Indolent Adult Non-Hodgkin Lymphoma
7189,Intracytoplasmic Eosinophilic Inclusion,fibrosarcoma of kidney
7190,Mixed Neoplastic Glandular and Squamous Cell Population,"Lung Squamous Cell Carcinoma, Papillary Variant"
7191,Benign Cellular Infiltrate,Liver Mucosa-Associated Lymphoid Tissue Lymphoma
7192,Chronic Clinical Course,"Acute myeloid leukemia, inv(16)(p13q22)"
7193,Intracytoplasmic Eosinophilic Inclusion,Undifferentiated (Embryonal) Sarcoma
7194,Low Grade Lesion,Radiation-Related Angiosarcoma
7195,High Mitotic Activity,Childhood Oligoastrocytoma
7196,Intermediate Filaments Present,Stage IIA Bone Sarcoma AJCC v7
7197,Invasive Lesion,Desmoplastic trichoepithelioma
7198,Mucoid Stroma Formation,Papillary carcinoma of the breast
7199,Mixed Neoplastic Glandular and Squamous Cell Population,Old Burn Scar-Related Skin Squamous Cell Carcinoma
7200,High Mitotic Activity,Uterine Corpus Cellular Leiomyoma
7201,Indolent Clinical Course,Virus-Related Sarcoma
7202,Solid Growth Pattern,Childhood T Acute Lymphoblastic Leukemia
7203,Mixed Cellular Population,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
7204,High Mitotic Activity,Uterine Corpus Hydropic Leiomyoma
7205,Intermediate Filaments Present,Stage IIA Soft Tissue Sarcoma AJCC v7
7206,Mixed Neoplastic Glandular and Squamous Cell Population,Anal canal squamous cell carcinoma
7207,atypia morphology,Ovarian Myxoma
7208,Dysplasia,Syringoma
7209,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Myelomonocytic Leukemia
7210,Intermediate Filaments Present,undifferentiated sarcoma of ovary
7211,Borderline Lesion,Bladder Urothelial Papilloma
7212,Severe cytologic atypia,Pancreatic ACTH-Producing Neuroendocrine Tumor
7213,Indolent Clinical Course,Childhood Cerebellar Anaplastic Astrocytoma
7214,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Myeloid Leukemia with Minimal Differentiation
7215,Precise Histogenesis Unknown,Childhood Cerebral Anaplastic Astrocytoma
7216,Intracytoplasmic Eosinophilic Inclusion,Childhood Undifferentiated Pleomorphic Sarcoma
7217,Seminomatous Component Present,Dermoid cyst of skin
7218,Benign Cellular Infiltrate,Anal Verrucous Carcinoma
7219,Intermediate Filaments Present,Low Grade Malignant Peripheral Nerve Sheath Tumor
7220,Invasive Lesion,Perifollicular fibroma
7221,Premalignant Lesion,mucinous adenocarcinoma of lung
7222,Intermediate Filaments Present,CIC-DUX Sarcoma
7223,Glandular Differentiation,"Carcinoma, Giant Cell"
7224,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in situ in tubulovillous adenoma
7225,Mixed Neoplastic Glandular and Squamous Cell Population,Submandibular Gland Squamous Cell Carcinoma
7226,Intracytoplasmic Eosinophilic Inclusion,Intracranial Extraskeletal Myxoid Chondrosarcoma
7227,Intermediate Filaments Present,FNCLCC Sarcoma Grade 3
7228,Dysplasia,Dermal Duct Tumor
7229,Favorable Clinical Outcome,Digital papillary eccrine carcinoma of skin
7230,Glandular Differentiation,Esophageal Large Cell Neuroendocrine Carcinoma
7231,Intracytoplasmic Eosinophilic Inclusion,High Grade Malignant Peripheral Nerve Sheath Tumor
7232,Grade 4 Lesion,Recurrent Childhood Visual Pathway Astrocytoma
7233,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion
7234,Indolent Clinical Course,Cutaneous Radiation-Related Angiosarcoma
7235,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Sebaceous Carcinoma
7236,Mixed Neoplastic Glandular and Squamous Cell Population,basaloid carcinoma of anus
7237,Invasive Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
7238,Metastatic Lesion,Extraskeletal osteosarcoma non-metastatic
7239,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
7240,Invasive Lesion,Low Grade Penile Intraepithelial Neoplasia
7241,Intracytoplasmic Eosinophilic Inclusion,Childhood Malignant Peripheral Nerve Sheath Tumor
7242,Indolent Clinical Course,Kaposi's sarcoma of cornea
7243,Indolent Clinical Course,Malignant Gastric Gastrointestinal Stromal Tumor
7244,Invasive Lesion,Intracystic papillary adenoma
7245,Nuclear Clearing,Thyroid Gland Hyperfunctioning Adenoma
7246,Well-Circumscribed Lesion,Recurrent Childhood Pineoblastoma
7247,Diffuse Lesion,Hemangioma
7248,Indolent Clinical Course,Lung Carcinoma Metastatic in the Brain
7249,Indolent Clinical Course,Hemangiosarcoma
7250,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Glandular Intraepithelial Neoplasia
7251,Invasive Lesion,High Grade Glandular Intraepithelial Neoplasia
7252,Favorable Clinical Outcome,Mucin-Producing Intrahepatic Cholangiocarcinoma
7253,Invasive Lesion,Grade II Prostatic Intraepithelial Neoplasia
7254,Indolent Clinical Course,ACTH-Producing Pituitary Gland Carcinoma
7255,Indolent Clinical Course,Sarcoma of kidney
7256,Favorable Clinical Outcome,Stage III Cutaneous Melanoma AJCC v7
7257,Favorable Clinical Outcome,Apocrine Breast Carcinoma In Situ
7258,Intermediate Filaments Present,Childhood Small Intestinal Leiomyosarcoma
7259,High Mitotic Activity,Recurrent Childhood Oligoastrocytoma
7260,Koilocytotic atypia,Vaginal Papillary Carcinoma
7261,Glandular Differentiation,large cell neuroendocrine carcinoma of anal canal
7262,Benign Cellular Infiltrate,Colorectal Diffuse Large B-Cell Lymphoma
7263,Favorable Clinical Outcome,Skin Lymphangiosarcoma
7264,Indolent Clinical Course,Cardiac Malignant Fibrous Histiocytoma
7265,Necrotic changes (finding),"Diffuse Astrocytoma, IDH-Mutant"
7266,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Clear Cell Cystadenocarcinoma
7267,Intermediate Filaments Present,Conventional Leiomyosarcoma
7268,Indolent Clinical Course,Proneural Glioblastoma
7269,Indolent Clinical Course,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
7270,Borderline Lesion,Cardiac Epithelioid Hemangioendothelioma
7271,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,"Acute Myeloid Leukemia, M1"
7272,Premalignant Lesion,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
7273,Chronic Clinical Course,Acute myeloid leukemia with mutated CEBPA
7274,Benign Cellular Infiltrate,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
7275,Precise Histogenesis Unknown,Cellular Ependymoma
7276,Favorable Clinical Outcome,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
7277,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Endometrial Mucinous Adenocarcinoma
7278,Metastatic Lesion,anaplastic large cell lymphoma of central nervous system
7279,Malignant Germinomatous Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern"
7280,Invasive Lesion,Squamous Cell Carcinoma In Situ of the Nipple
7281,Favorable Clinical Outcome,Adult Fibrolamellar Carcinoma
7282,Benign Cellular Infiltrate,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
7283,Indolent Clinical Course,Malignant tenosynovial giant cell tumor
7284,Mixed Neoplastic Glandular and Squamous Cell Population,Lip and Oral Cavity Squamous Cell Carcinoma
7285,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian serous cystadenofibroma
7286,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
7287,Mixture of Germ Cell Neoplastic Components Present,Trophoblastic Neoplasms
7288,Mixture of Germ Cell Neoplastic Components Present,"Testicular Seminoma, Tubular Variant"
7289,Intermediate Filaments Present,Inferior Vena Cava Leiomyosarcoma
7290,Histiocytosis,Centroblastic lymphoma stage III
7291,Composite Lesion,"Thymoma, type B3"
7292,Invasive Lesion,Benign fibrohistiocytic neoplasm of skin
7293,Well Differentiated Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
7294,Nuclear Clearing,Childhood Thyroid Gland Follicular Carcinoma
7295,Indolent Clinical Course,Aortic Angiosarcoma
7296,Mitotic Activity,Benign Childhood Germ Cell Tumor
7297,High Mitotic Activity,Liver Leiomyoma
7298,Invasive Lesion,High grade cervical glandular intraepithelial neoplasia
7299,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Benign Ovarian Clear Cell Tumor
7300,Mucoid Stroma Formation,Buccal Mucosa Verrucous Carcinoma
7301,Benign Cellular Infiltrate,Carcinoma of the Appendix
7302,Solid Growth Pattern,Blast Phase
7303,Carcinomatous Component Present,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
7304,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, Oxyphilic"
7305,Invasive Lesion,Vulvar Trichoepithelioma
7306,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
7307,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of vulva
7308,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Acidophil Stem Cell Pituitary Gland Adenoma
7309,Benign Cellular Infiltrate,Rectosigmoid Mucinous Adenocarcinoma
7310,Mixed Cellular Population,Squamous Papilloma of the Larynx
7311,Therapy-Related Toxicity,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
7312,Diffuse Lesion,Chorioangioma
7313,Favorable Clinical Outcome,Breast Carcinoma Metastatic in the Skin
7314,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
7315,Indolent Clinical Course,Intracranial Liposarcoma
7316,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
7317,Invasive Lesion,Noninfiltrating Intraductal Carcinoma
7318,Squamous Differentiation,Stage IIA Lung Large Cell Carcinoma AJCC v7
7319,Solid Growth Pattern,M5b Acute differentiated monocytic leukemia
7320,Intracytoplasmic Eosinophilic Inclusion,Ovarian Myxoid Liposarcoma
7321,Mixed Neoplastic Glandular and Squamous Cell Population,ENSAT Stage IV Adrenal Cortex Carcinoma
7322,Nuclear Grooves,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
7323,Low Grade Lesion,Angiosarcoma non-metastatic
7324,Dysplasia,Large cell acanthoma
7325,Benign Cellular Infiltrate,Small intestine carcinoma resectable
7326,Premalignant Lesion,combined small cell carcinoma of lung
7327,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of Accessory Sinus
7328,Intermediate Filaments Present,Fibrosarcoma non-metastatic
7329,Mixed Neoplastic Glandular and Squamous Cell Population,Glandular Cell Intraepithelial Neoplasia
7330,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Basaloid Carcinoma
7331,Mixed Neoplastic Glandular and Squamous Cell Population,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant"
7332,Intermediate Filaments Present,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
7333,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraepithelial Neoplasia-1B
7334,Histiocytosis,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
7335,Mixed Neoplastic Glandular and Squamous Cell Population,Adrenal Cortex Carcinoma by ENSAT Stage
7336,Precise Histogenesis Unknown,Ganglioneuroma
7337,Invasive Lesion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
7338,Intracytoplasmic Eosinophilic Inclusion,Metachronous Osteosarcoma
7339,Benign Cellular Infiltrate,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
7340,Borderline Lesion,"Papilloma, Squamous Cell"
7341,Indolent Clinical Course,Adult Epithelioid Sarcoma
7342,Intermediate Filaments Present,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
7343,Solid Growth Pattern,"Leukemia, Myelocytic, Acute"
7344,Intermediate Filaments Present,Vulvar Alveolar Soft Part Sarcoma
7345,Intermediate Filaments Present,Laryngeal Leiomyosarcoma
7346,Favorable Clinical Outcome,Solar Radiation-Related Cutaneous Melanoma
7347,Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
7348,Solid Growth Pattern,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
7349,Indolent Clinical Course,Leiomyosarcoma of uterus
7350,Mucoid Stroma Formation,Respiratory papilloma
7351,Mixed Neoplastic Glandular and Squamous Cell Population,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
7352,Solid Growth Pattern,ROSE Cluster 8
7353,Well-Circumscribed Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
7354,Mixture of Germ Cell Neoplastic Components Present,Childhood Central Nervous System Choriocarcinoma
7355,Precise Histogenesis Unknown,Visual Pathway Astrocytoma
7356,Borderline Lesion,Skin Papilloma
7357,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar Cell Carcinoma
7358,Severe cytologic atypia,Localized Digestive System Neuroendocrine Tumor G1
7359,Metastatic Lesion,Benign Sertoli Cell Tumor
7360,High Mitotic Activity,Gastric Carcinoid Tumor
7361,Ineffective hematopoiesis,Chronic myeloproliferative disorder
7362,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma
7363,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma
7364,Invasive Lesion,Bladder squamous cell carcinoma stage 0
7365,Metastatic Lesion,Non-Functioning Pituitary Gland Neoplasm
7366,Indolent Clinical Course,Malignant Chest Wall Bone Neoplasm
7367,Anaplasia,Recurrent Childhood Ependymoma
7368,Favorable Clinical Outcome,Cystic basal cell carcinoma
7369,Squamous Differentiation,Cervical Large Cell Neuroendocrine Carcinoma
7370,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Epithelioid Leiomyosarcoma
7371,Borderline Lesion,Ethmoid Sinus Schneiderian Papilloma
7372,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Melanocytic Nevus
7373,Locally Aggressive Lesion,Cartilaginous exostosis
7374,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma NCI Grade 2
7375,Benign Cellular Infiltrate,neuroendocrine carcinoma of anal canal
7376,Precise Histogenesis Unknown,Intradural Extramedullary Cauda Equina Astrocytoma
7377,Benign Cellular Infiltrate,Malignant tumor of exocrine pancreas
7378,Well-Circumscribed Lesion,Childhood Pineoblastoma
7379,Indolent Clinical Course,leiomyosarcoma of bone
7380,Indolent Clinical Course,Angiosarcoma of the breast
7381,Indolent Clinical Course,Primary chondrosarcoma of bone
7382,Premalignant Lesion,Fetal Lung Adenocarcinoma
7383,Benign Cellular Infiltrate,verrucous carcinoma of esophagus
7384,Indolent Clinical Course,Gastric Synovial Sarcoma
7385,Diffuse Lesion,"Papilloma, Intraductal"
7386,Invasive Lesion,Cutaneous myxoma
7387,Intracytoplasmic Eosinophilic Inclusion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
7388,Microvascular Proliferation,Recurrent Childhood Protoplasmic Astrocytoma
7389,Borderline Lesion,Benign Epithelioma
7390,High Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G2
7391,Necrotic changes (finding),Anaplastic astrocytoma
7392,Benign Cellular Infiltrate,Gallbladder papillary adenocarcinoma
7393,Precise Histogenesis Unknown,Anaplastic Oligodendroglioma
7394,Indolent Clinical Course,Adult Extraskeletal Myxoid Chondrosarcoma
7395,Intracytoplasmic Eosinophilic Inclusion,Myxoid chondrosarcoma
7396,"Undifferentiated ""Fetal-Type"" Tissues Present",Testicular Dermoid Cyst
7397,Benign Cellular Infiltrate,Stage IVA Rectal Cancer AJCC v7
7398,Mixed Neoplastic Glandular and Squamous Cell Population,Lung adenocarcinoma recurrent
7399,Benign Cellular Infiltrate,Kaposi's sarcoma of extrahepatic bile duct
7400,Mucoid Stroma Formation,Type 1 Papillary Renal Cell Carcinoma
7401,Solid Growth Pattern,Childhood Acute Myeloid Leukemia
7402,Precise Histogenesis Unknown,Papillary glioneuronal tumor
7403,Diffuse Lesion,Airway Hemangioma
7404,Nuclear Grooves,Thyroid Gland Follicular Adenoma
7405,Aggressive Clinical Course,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma
7406,Intermediate Filaments Present,Cardiac Biphasic Synovial Sarcoma
7407,High Mitotic Activity,Mixed Oligodendroglioma-Astrocytoma
7408,Indolent Clinical Course,High Grade Paranasal Sinus Sarcoma
7409,Intermediate Filaments Present,Endometrial Stromal Sarcoma
7410,Borderline Lesion,malignant epithelioid hemangioendothelioma of liver
7411,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
7412,High Mitotic Activity,Vaginal Leiomyoma
7413,Indolent Clinical Course,Kadish Stage A Olfactory Neuroblastoma
7414,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with FLT3/ITD Mutation
7415,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Renal Cell Cancer
7416,Precise Histogenesis Unknown,Adult Subependymal Giant Cell Astrocytoma
7417,Indolent Clinical Course,Leiomyosarcoma NCI Grade 3
7418,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Microcystic Pattern"
7419,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
7420,Precise Histogenesis Unknown,"Anaplastic Astrocytoma, IDH-Wildtype"
7421,Grade 4 Lesion,Anaplastic astrocytoma
7422,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Papillary Pattern"
7423,Mixed Neoplastic Glandular and Squamous Cell Population,Villoglandular Endometrial Endometrioid Adenocarcinoma
7424,Intracytoplasmic Eosinophilic Inclusion,Breast Rhabdomyosarcoma
7425,Severe cytologic atypia,insulinoma
7426,Neoplastic Plasma Cells Present in Bone Marrow,Extramedullary Plasmacytoma
7427,CD1a-Positive Neoplastic Cells Present,Histiocytic sarcoma
7428,Absence of a Hormonal Syndrome,Malignant Pancreatic Vipoma
7429,Indolent Clinical Course,Angiosarcoma of liver
7430,Seminomatous Component Present,Adult Central Nervous System Immature Teratoma
7431,Acute Clinical Course,Chronic leukemia (category)
7432,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Glandular Neoplasm
7433,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Vulvar Ectopic Fibroadenoma
7434,Dysplasia,Angioma serpiginosum
7435,Mixed Neoplastic Glandular and Squamous Cell Population,Bartholin Gland Adenocarcinoma
7436,Favorable Clinical Outcome,Kaposi's sarcoma classical type
7437,Intermediate Filaments Present,Metastatic osteosarcoma
7438,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Papillary Mucinous Neoplasm
7439,Mixed Neoplastic Glandular and Squamous Cell Population,basaloid carcinoma of penis
7440,Pushing Tumor Margin,Condylomata Acuminata
7441,Nuclear Clearing,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
7442,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
7443,Favorable Clinical Outcome,Cutaneous Liposarcoma
7444,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Cystadenofibroma
7445,Scattered Collections of Differentiating Neuroblasts Present,Ganglioneuroblastoma
7446,Squamous Differentiation,Tonsillar Undifferentiated Carcinoma
7447,Indolent Clinical Course,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
7448,Mixed Neoplastic Glandular and Squamous Cell Population,Subglottic Squamous Cell Carcinoma
7449,Squamous Differentiation,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
7450,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
7451,Intracytoplasmic Eosinophilic Inclusion,Cervical Angiosarcoma
7452,Benign Cellular Infiltrate,Unresectable Gallbladder Carcinoma
7453,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of renal pelvis
7454,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Tumor with Microinvasion
7455,Seminomatous Component Present,Ovarian Solid Teratoma
7456,Local disease,Advanced Unfavorable Non-Hodgkin Lymphoma
7457,Benign Cellular Infiltrate,Rectal Adenosquamous Carcinoma
7458,Malignant Germinomatous Cellular Infiltrate,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
7459,Intracytoplasmic Eosinophilic Inclusion,Secondary osteosarcoma
7460,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7
7461,Mixed Neoplastic Glandular and Squamous Cell Population,Seminal Vesicle Adenocarcinoma
7462,Mixed Neoplastic Glandular and Squamous Cell Population,"Glycogen-Rich, Clear Cell Breast Carcinoma"
7463,Intracytoplasmic Eosinophilic Inclusion,Stage IV Bone Sarcoma AJCC v7
7464,Indolent Clinical Course,Malignant neoplasm of pineal gland
7465,Intracytoplasmic Eosinophilic Inclusion,liposarcoma of kidney
7466,Invasive Lesion,Parotid Gland Lymphangioma
7467,Mucoid Stroma Formation,Renal Pelvis Inverted Papilloma
7468,atypia morphology,Benign neoplasm of mesothelial tissue of peritoneum
7469,Prominent Schwannian Stroma Present,Olfactory Neuroblastoma
7470,Solid Growth Pattern,testicular leukemia
7471,Bilateral Disease,Unilateral Breast Carcinoma
7472,Premalignant Lesion,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
7473,Mixed Neoplastic Glandular and Squamous Cell Population,Intraductal Non-Comedo Breast Adenocarcinoma
7474,Favorable Clinical Outcome,Basal cell carcinoma of vulva
7475,Indolent Clinical Course,sarcoma of vagina
7476,Indolent Clinical Course,Angiosarcoma Associated with Lymphedema
7477,Focal dysplasia,Traditional Serrated Adenoma
7478,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Serous Neoplasm
7479,Intermediate Filaments Present,embryonal rhabdomyosarcoma of orbit
7480,Glandular Differentiation,Anaplastic thyroid carcinoma
7481,Intermediate Filaments Present,Stage III Bone Sarcoma AJCC v7
7482,Intracytoplasmic Eosinophilic Inclusion,Gastrointestinal Stromal Sarcoma
7483,Indolent Clinical Course,Adult Desmoplastic Small Round Cell Tumor
7484,Invasive Lesion,Parotid Gland Lipoma
7485,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Esophageal Adenocarcinoma AJCC v7
7486,Intracytoplasmic Eosinophilic Inclusion,Childhood Mesenchymal Chondrosarcoma
7487,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Teratoma
7488,Indolent Clinical Course,Adult Mesenchymal Chondrosarcoma
7489,Aggressive Clinical Course,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
7490,Malignant Germinomatous Cellular Infiltrate,Yolk Sac Tumor
7491,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of salivary gland
7492,Acinar Cell Differentiation,undifferentiated carcinoma of pancreas
7493,Geographic Necrosis,Benign Cardiac Germ Cell Tumor
7494,Indolent Clinical Course,Stage IV Bone Cancer AJCC v7
7495,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute monocytic/monoblastic leukemia
7496,Diffuse Lesion,"Transitional cell papilloma, benign"
7497,Intracytoplasmic Eosinophilic Inclusion,Chondrosarcoma
7498,Favorable Clinical Outcome,Stage I Lentigo Maligna Melanoma AJCC v7
7499,Encapsulated Mass,Mediastinal Neurofibroma
7500,Benign Cellular Infiltrate,Carcinoma in situ of small intestine
7501,Solid Growth Pattern,Acute promyelocytic leukemia - hypogranular variant
7502,Low Mitotic Activity,Intestinal Neuroendocrine Carcinoma
7503,Benign Cellular Infiltrate,Esophageal Neuroendocrine Carcinoma
7504,Intracytoplasmic Eosinophilic Inclusion,Sclerosing rhabdomyosarcoma
7505,Pain,Osteoma
7506,Anaplasia,Well Differentiated Oligodendroglioma
7507,Favorable Clinical Outcome,Anal margin basal cell carcinoma
7508,Indolent Clinical Course,Malignant fibrous histiocytoma of skin
7509,Mucoid Stroma Formation,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
7510,Mixed Neoplastic Glandular and Squamous Cell Population,Signet-ring cell adenocarcinoma gastric
7511,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian mucinous tumor
7512,High Mitotic Activity,Adult Ependymoma
7513,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Polyembryoma AJCC v6 and v7
7514,Diffuse Lesion,Hemangioma of gingiva
7515,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Squamous Cell Papilloma
7516,Seminomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma
7517,Seminomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Adenoma
7518,Premalignant Lesion,Malignant Lung Hilum Neoplasm
7519,Intermediate Filaments Present,Childhood Liposarcoma
7520,Metastatic Lesion,Pituitary Gland Oncocytic Adenoma
7521,Intermediate Filaments Present,Childhood Alveolar Soft Part Sarcoma
7522,Indolent Clinical Course,Malignant neoplasm of cerebrum
7523,Indolent Clinical Course,Alveolar soft part sarcoma non-metastatic
7524,Intracytoplasmic Eosinophilic Inclusion,Leptomeningeal sarcoma
7525,Indolent Clinical Course,Extra-osseous Ewing's sarcoma metastatic
7526,Metastatic Lesion,Extra-osseous Ewing's sarcoma non-metastatic
7527,Neoplastic Growth or Spread,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
7528,Invasive Lesion,Hard Palate Monomorphic Adenoma
7529,Mixed Neoplastic Glandular and Squamous Cell Population,Parathyroid Gland Oncocytic Adenoma
7530,Intermediate Filaments Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix
7531,Invasive Lesion,Benign neoplasm of scrotum
7532,Mixed Neoplastic Glandular and Squamous Cell Population,Intramucosal Adenocarcinoma
7533,Indolent Clinical Course,Spindle cell liposarcoma
7534,Indolent Clinical Course,Lung Carcinoma Metastatic in the Bone
7535,Chronic Clinical Course,Adult T Acute Lymphoblastic Leukemia
7536,"Undifferentiated ""Fetal-Type"" Tissues Present",Dermoid Cyst of the Spinal Cord
7537,Localized Lesion,Indolent multiple myeloma
7538,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,serous surface papillary carcinoma of ovary
7539,Invasive Lesion,Intraductal papillary breast neoplasm
7540,Intermediate Filaments Present,Colorectal Sarcoma
7541,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiocarcinoma recurrent
7542,Intermediate Filaments Present,hemangioendothelial sarcoma of bone
7543,Tumor Vascular Invasion,Non-Functioning Adrenal Cortex Adenoma
7544,Benign Cellular Infiltrate,MALT lymphoma of stomach
7545,Aggressive Clinical Course,MALT lymphoma of stomach
7546,Indolent Clinical Course,Adult Malignant Peripheral Nerve Sheath Tumor
7547,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia
7548,Malignant Germinomatous Cellular Infiltrate,Mature Mediastinal Teratoma
7549,Favorable Clinical Outcome,Lymphoepithelioma-Like Hepatocellular Carcinoma
7550,Blasts Expressing CD56 and Immature T-Cell Markers Present,Mixed phenotype acute leukemia B/myeloid
7551,Solid Growth Pattern,"Leukemia, Plasma Cell"
7552,High Mitotic Activity,Central Nervous System Leiomyoma
7553,Hemorrhagic Neuroblastic Nodules Present,"Childhood Ganglioneuroblastoma, Intermixed"
7554,Intermediate Filaments Present,Telangiectatic osteosarcoma
7555,Benign Cellular Infiltrate,Stage IIIB Esophageal Cancer AJCC v7
7556,Indolent Clinical Course,embryonal rhabdomyosarcoma of prostate
7557,Favorable Clinical Outcome,Malignant neoplasm of scrotum
7558,Indolent Clinical Course,Malignant Pericytic Neoplasm
7559,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Lymphoepithelioma-Like Carcinoma
7560,Mixture of Germ Cell Neoplastic Components Present,Testicular Spermatocytic Seminoma with Sarcoma
7561,Mixed Neoplastic Glandular and Squamous Cell Population,Renal cell carcinoma recurrent
7562,Grade 4 Lesion,Glioneuronal Tumor with Neuropil-Like Islands
7563,Favorable Clinical Outcome,Malignant neoplasm of sweat gland
7564,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Ovarian Serous Adenocarcinoma
7565,Severe cytologic atypia,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
7566,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
7567,Anaplasia,Brain Oligodendroglioma
7568,Precise Histogenesis Unknown,Cerebral Glioblastoma
7569,Precise Histogenesis Unknown,Cellular Ependymoma
7570,Favorable Clinical Outcome,BCLC Stage 0 Adult Hepatocellular Carcinoma
7571,Intracytoplasmic Eosinophilic Inclusion,Rhabdomyosarcoma with ganglionic differentiation
7572,Benign Cellular Infiltrate,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
7573,Indolent Clinical Course,Chondrosarcoma metastatic
7574,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrioid carcinoma of prostate
7575,Squamous Differentiation,Nasopharyngeal lymphoepithelioma stage I
7576,CD30-Positive Neoplastic Cells Present,Central Nervous System Histiocytic and Dendritic Cell Neoplasm
7577,Acute Clinical Course,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
7578,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of salivary gland
7579,Intracytoplasmic Eosinophilic Inclusion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
7580,Severe cytologic atypia,Transverse Colon Neuroendocrine Tumor G1
7581,Junctional Proliferation,"Nevus, Intradermal"
7582,Low Grade Lesion,Angiosarcoma recurrent
7583,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
7584,Precise Histogenesis Unknown,Low Grade Astrocytic Tumor
7585,Severe cytologic atypia,Carcinoid tumor of pancreas
7586,Mixed Neoplastic Glandular and Squamous Cell Population,Low grade cervical glandular intraepithelial neoplasia
7587,Nodular lesions,"Ganglioneuroblastoma, Intermixed"
7588,Indolent Clinical Course,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
7589,Intracytoplasmic Eosinophilic Inclusion,Thyroid Angiosarcoma
7590,atypia morphology,"Nevus, Spindle Cell"
7591,Benign Cellular Infiltrate,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
7592,Mixed Neoplastic Glandular and Squamous Cell Population,Sebaceous Adenocarcinoma
7593,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Serous Adenocarcinoma
7594,Dysplasia,"Adenoma, Sweat Gland"
7595,Squamous Differentiation,Oropharyngeal lymphoepithelioma stage I
7596,Capsular Invasion,Microfollicular adenoma
7597,Ground Glass Nuclear Inclusion,Microfollicular adenoma
7598,Favorable Clinical Outcome,Acral Lentiginous Malignant Melanoma
7599,Seminomatous Component Present,Testicular choriocarcinoma stage II
7600,Favorable Clinical Outcome,Malignant Sebaceous Neoplasm
7601,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of appendix
7602,Intracytoplasmic Eosinophilic Inclusion,Small cell osteosarcoma
7603,Premalignant Lesion,Sarcomatoid carcinoma of the lung
7604,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Serous Tumor
7605,Solid Growth Pattern,Acute lymphocytic leukemia
7606,Intermediate Filaments Present,Liver Fibrosarcoma
7607,Indolent Clinical Course,Radiation-Related Osteosarcoma
7608,Mixed Neoplastic Glandular and Squamous Cell Population,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant"
7609,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
7610,Malignant Germinomatous Cellular Infiltrate,polyembryoma of ovary
7611,Intestinal metaplasia,Metastatic signet ring cell carcinoma
7612,Indolent Clinical Course,Pancreatic sarcoma
7613,Nuclear Pseudoinclusion,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
7614,Mixed Neoplastic Glandular and Squamous Cell Population,papillary squamous cell carcinoma of larynx
7615,Intermediate Filaments Present,Synovial sarcoma recurrent
7616,Indolent Clinical Course,Transplant-Related Bladder Urothelial Carcinoma
7617,Invasive Lesion,Glandular Cell Intraepithelial Neoplasia
7618,Favorable Clinical Outcome,Transplant-Related Skin Squamous Cell Carcinoma
7619,Acinar Cell Differentiation,Pancreatic Foamy Gland Adenocarcinoma
7620,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Intraepithelial Neoplasia
7621,Multilayered Rosette Formation,Medulloblastoma with Leptomeningeal Spread
7622,Malignant Germinomatous Cellular Infiltrate,Mature Teratoma
7623,Borderline Lesion,Benign oncocytoma of salivary gland
7624,atypia morphology,Uterine Corpus Adenomatoid Tumor
7625,Keratin pearl formation,Undifferentiated carcinoma of nasopharynx
7626,Borderline Lesion,Eccrine dermal cylindroma
7627,Indolent Clinical Course,Malignant Pineal Region Germ Cell Tumor
7628,High Grade Lesion,Retiform hemangioendothelioma
7629,Mixed Neoplastic Glandular and Squamous Cell Population,Ethmoid Sinus Squamous Cell Carcinoma
7630,Benign Cellular Infiltrate,small cell carcinoma of appendix
7631,Microvascular Proliferation,Childhood Diffuse Astrocytoma
7632,Indolent Clinical Course,Sclerosing Epithelioid Fibrosarcoma
7633,Favorable Clinical Outcome,Cutaneous Precursor Lymphoid Neoplasm
7634,Favorable Clinical Outcome,Primary cutaneous gamma-delta T-cell lymphoma
7635,Benign Cellular Infiltrate,Adenoma of the Colon with Intramucosal Adenocarcinoma
7636,Polymorphic Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
7637,Borderline Lesion,sebaceous adenoma of salivary gland
7638,Severe cytologic atypia,Gastric Neuroendocrine Tumor
7639,Intermediate Filaments Present,Stage IB Soft Tissue Sarcoma AJCC v7
7640,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Megakaryocytic Leukemias
7641,Chronic Clinical Course,Precursor B-cell lymphoblastic leukemia
7642,Indolent Clinical Course,Stage IVA Bone Cancer AJCC v7
7643,High Mitotic Activity,Ovarian Low Grade Endometrioid Stromal Sarcoma
7644,Indolent Clinical Course,Stage IB Bone Sarcoma AJCC v7
7645,Benign Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v6
7646,Intestinal metaplasia,"Carcinoma, Signet Ring Cell"
7647,Benign Cellular Infiltrate,Secondary malignant neoplasm of anus
7648,Glandular Differentiation,Anaplastic Carcinoma of the Rectum
7649,Squamous Differentiation,Anaplastic Carcinoma of the Rectum
7650,Indolent Clinical Course,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
7651,Intermediate Filaments Present,Rectal Rhabdomyosarcoma
7652,Indolent Clinical Course,Ewing's sarcoma of bone
7653,Invasive Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
7654,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in multiple adenomatous polyps
7655,Metaplasia of Malignant Cells Present,Bladder squamous cell carcinoma stage 0
7656,Diffuse Lesion,intraductal papilloma of salivary gland
7657,Mucoid Stroma Formation,sialadenoma papilliferum of salivary gland
7658,Intracytoplasmic Eosinophilic Inclusion,Gallbladder Kaposi's Sarcoma
7659,Indolent Clinical Course,Stage IVB Uterine Sarcoma AJCC v7
7660,Mucoid Stroma Formation,Cervical Mullerian Papilloma
7661,Benign Cellular Infiltrate,leiomyosarcoma of extrahepatic bile duct
7662,Invasive Lesion,High Grade Esophageal Squamous Intraepithelial Neoplasia
7663,Intermediate Filaments Present,Mesenchymal Chondrosarcoma
7664,Intracytoplasmic Eosinophilic Inclusion,Childhood Leiomyosarcoma
7665,Indolent Clinical Course,AIDS-Related Cervical Kaposi Sarcoma
7666,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Adenocarcinoma
7667,Aggressive Clinical Course,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor
7668,Severe cytologic atypia,Anal Canal Neuroendocrine Tumor G2
7669,Indolent Clinical Course,Childhood Brain Anaplastic Astrocytoma
7670,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Canal Squamous Papilloma
7671,Premalignant Lesion,Lung Carcinoma Metastatic in the Brain
7672,Benign Cellular Infiltrate,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
7673,Intestinal metaplasia,Signet Ring Cell Intrahepatic Cholangiocarcinoma
7674,Local disease,Lipomatosis of Nerve
7675,Diffuse Lesion,Cerebral hemangioma
7676,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Cribriform Breast Carcinoma
7677,Indolent Clinical Course,Recurrent Childhood Rhabdomyosarcoma
7678,Borderline Lesion,Benign Eccrine Neoplasm
7679,Premalignant Lesion,Lung squamous cell carcinoma stage II
7680,Low Grade Lesion,Soft Tissue Angiosarcoma
7681,Striated Muscle Component Present,Mixed epithelial-mesenchymal hepatoblastoma
7682,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Benign neoplasm of placenta
7683,Benign Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7
7684,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma of lung, stage I"
7685,Benign Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma
7686,Invasive Lesion,Cervical Adenocarcinoma In Situ
7687,Borderline Lesion,Rete Ovarii Cystadenoma
7688,Solid Growth Pattern,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7689,Chronic Clinical Course,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7690,High Mitotic Activity,Breast Leiomyoma
7691,Indolent Clinical Course,"Ossifying fibromyxoid tumor, malignant"
7692,No Evidence of Radiologic Finding,Occult Lung Adenocarcinoma
7693,Intermediate Filaments Present,"Endometrial stromal sarcoma, high grade"
7694,Indolent Clinical Course,Liver Synovial Sarcoma
7695,Indolent Clinical Course,Prostate Stromal Sarcoma
7696,Necrotic changes (finding),"Diffuse Astrocytoma, IDH-Wildtype"
7697,Aggressive Clinical Course,Mycosis Fungoides
7698,Intracytoplasmic Eosinophilic Inclusion,Extraskeletal Osteosarcoma
7699,Intermediate Filaments Present,Stage III Adult Soft Tissue Sarcoma AJCC v7
7700,Intracytoplasmic Eosinophilic Inclusion,Low Grade Paranasal Sinus Sarcoma
7701,Indolent Clinical Course,Low Grade Paranasal Sinus Sarcoma
7702,Mucoid Stroma Formation,Oropharyngeal squamous papilloma
7703,Mucoid Stroma Formation,Cervical Papillary Squamous Cell Carcinoma
7704,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline serous tumor of ovary
7705,High Grade Lesion,Childhood Epithelioid Hemangioendothelioma
7706,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma NCI Grade 2
7707,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma
7708,Invasive Lesion,External Auditory Canal Ceruminous Adenoma
7709,Tumor Vascular Invasion,Adrenal Cortical Adenoma
7710,Metastatic Lesion,Soft Palate Pleomorphic Adenoma
7711,Metaplasia of Malignant Cells Present,Gastric Intestinal-Type Adenocarcinoma
7712,Precise Histogenesis Unknown,Anaplastic Oligodendroglioma
7713,Premalignant Lesion,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
7714,Indolent Clinical Course,Malignant Central Nervous System Germ Cell Tumor
7715,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma of liver
7716,Borderline Lesion,Vulvar Inverted Follicular Keratosis
7717,Nuclear Pseudoinclusion,Follicular thyroid carcinoma
7718,Indolent Clinical Course,Meningeal Lymphoma
7719,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in adenomatous polyp
7720,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Vulvar Cancer
7721,Benign Cellular Infiltrate,Liver Yolk Sac Tumor
7722,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatocellular Carcinoma by BCLC Stage
7723,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 1 Colorectal Adenocarcinoma
7724,Precise Histogenesis Unknown,Adult Brain Oligodendroglioma
7725,Indolent Clinical Course,Uterine Corpus Sarcoma
7726,Borderline Lesion,Pedunculated conjunctival papilloma
7727,Borderline Lesion,Trichoadenoma
7728,Intermediate Filaments Present,Myxoinflammatory fibroblastic sarcoma
7729,Favorable Clinical Outcome,Localized Resectable Adult Hepatocellular Carcinoma
7730,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells
7731,Severe cytologic atypia,Ascending Colon Neuroendocrine Tumor G1
7732,Indolent Clinical Course,Peripheral primitive neuroectodermal bone tumor
7733,Indolent Clinical Course,Malignant Fibrous Histiocytoma
7734,Invasive Lesion,Vulval intraepithelial neoplasia grade 2
7735,Encapsulated Mass,Epithelioid neurofibroma
7736,Mixed Neoplastic Glandular and Squamous Cell Population,Acinic cell carcinoma of salivary gland
7737,Composite Lesion,Widely Invasive Thymoma
7738,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Serous Adenocarcinoma
7739,Intramucosal Lesion,Submucosal Invasive Colon Adenocarcinoma
7740,Dysplasia,Vulvar Trichoepithelioma
7741,Locally Aggressive Lesion,Angiomyofibroblastoma
7742,Dysplasia,Benign Germinative Follicular Epithelium Neoplasm
7743,Intracytoplasmic Eosinophilic Inclusion,Epithelioid Sarcoma NCI Grade 2
7744,Benign Cellular Infiltrate,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
7745,Indolent Clinical Course,Intracortical osteosarcoma
7746,Mixture of Germ Cell Neoplastic Components Present,Testicular yolk sac tumor stage III
7747,Intracytoplasmic Eosinophilic Inclusion,sarcoma of esophagus
7748,Intracytoplasmic Eosinophilic Inclusion,Stage IIIC Uterine Sarcoma AJCC v7
7749,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma stage I
7750,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal verrucous carcinoma stage IV
7751,Intermediate Filaments Present,Radiation-Related Osteosarcoma
7752,Indolent Clinical Course,Stage IV Osteosarcoma AJCC v7
7753,Intermediate Filaments Present,sarcoma of lung
7754,Indolent Clinical Course,leiomyosarcoma of kidney
7755,Intracytoplasmic Eosinophilic Inclusion,Thymoliposarcoma
7756,Indolent Clinical Course,Fibroblastic osteosarcoma
7757,Benign Cellular Infiltrate,Stage 0 Anal Canal Cancer AJCC v6 and v7
7758,Favorable Clinical Outcome,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
7759,Indolent Clinical Course,Stage IVB Bone Sarcoma AJCC v7
7760,High Mitotic Activity,Tubular breast carcinoma
7761,Glandular Differentiation,large cell neuroendocrine carcinoma of ovary
7762,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Mucinous-Cystic Neoplasm
7763,Indolent Clinical Course,Transplant-Related Skin Squamous Cell Carcinoma
7764,Mucoid Stroma Formation,Papillary transitional cell carcinoma
7765,Benign Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v7
7766,Intracytoplasmic Eosinophilic Inclusion,Adult Undifferentiated Pleomorphic Sarcoma
7767,High Mitotic Activity,Appendix Tubular Carcinoid
7768,Fibrovascular Stalks Present,Gallbladder Flat Biliary Intraepithelial Neoplasia
7769,Benign Cellular Infiltrate,Malignant neoplasm of stomach recurrent
7770,Invasive Lesion,Hidradenoma Papilliferum
7771,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous intraepithelial neoplasia grade 2
7772,Acute Clinical Course,Progressive Hairy Cell Leukemia Initial Treatment
7773,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Esophageal Adenocarcinoma AJCC v7
7774,Locally Aggressive Lesion,Benign Fibroblastic Neoplasm
7775,Benign Cellular Infiltrate,Alcohol-Related Esophageal Squamous Cell Carcinoma
7776,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease of the Breast with Invasive Ductal Carcinoma
7777,Seminomatous Component Present,Adult cystic teratoma
7778,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Clear Cell Adenocarcinoma
7779,High Mitotic Activity,Uterine Corpus Apoplectic Leiomyoma
7780,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
7781,Premalignant Lesion,Primary Pulmonary Diffuse Large B-Cell Lymphoma
7782,Indolent Clinical Course,Adult Myxoid Chondrosarcoma
7783,Intermediate Filaments Present,"Sarcoma, Epithelioid"
7784,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Hepatocellular Carcinoma
7785,Glandular Differentiation,Ampulla of Vater Undifferentiated Carcinoma
7786,Indolent Clinical Course,Childhood Embryonal Rhabdomyosarcoma
7787,Indolent Clinical Course,Ovarian Low Grade Endometrioid Stromal Sarcoma
7788,Intracytoplasmic Eosinophilic Inclusion,Laryngeal Leiomyosarcoma
7789,Benign Cellular Infiltrate,Duodenal carcinoma recurrent
7790,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Papilloma
7791,Severe cytologic atypia,Pancreatic Somatostatinoma
7792,Lytic lesion,Indolent Systemic Mastocytosis
7793,Acinar Cell Differentiation,Mixed Ductal-Endocrine Carcinoma
7794,Mucoid Stroma Formation,Serous surface papillary carcinoma
7795,Indolent Clinical Course,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
7796,Borderline Lesion,Peripheral Breast Papilloma
7797,Indolent Clinical Course,Sclerosing rhabdomyosarcoma
7798,Locally Aggressive Lesion,Osteoma
7799,Premalignant Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7
7800,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of colon
7801,Precise Histogenesis Unknown,Small cell glioblastoma
7802,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma stage III
7803,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Nephrogenic adenofibroma
7804,Extensive Necrosis,oligodendroglioma
7805,Aggressive Clinical Course,Mycosis fungoides stage IV
7806,High Grade Lesion,Grade II Chondrosarcoma
7807,Benign Cellular Infiltrate,Leiomyosarcoma of stomach
7808,Intracytoplasmic Eosinophilic Inclusion,Grade III Chondrosarcoma
7809,Mucoid Stroma Formation,Paranasal Sinus Schneiderian Papilloma
7810,Intracytoplasmic Eosinophilic Inclusion,Well Differentiated Fibrosarcoma
7811,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Keratinizing Squamous Cell Carcinoma
7812,Intracytoplasmic Eosinophilic Inclusion,Extraskeletal osteosarcoma metastatic
7813,High Mitotic Activity,Adult Spinal Cord Ependymoma
7814,Aggressive Clinical Course,Follicular mycosis fungoides
7815,Indolent Clinical Course,Malignant neoplasm of thalamus
7816,Indolent Clinical Course,Central Nervous System Extraskeletal Osteosarcoma
7817,Mixed Neoplastic Glandular and Squamous Cell Population,clear cell adenocarcinoma of urethra
7818,Intermediate Filaments Present,Low Grade Sarcoma
7819,CD30-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
7820,Invasive Lesion,High Grade Penile Intraepithelial Neoplasia
7821,Invasive Lesion,High Grade Conjunctival Intraepithelial Neoplasia
7822,Favorable Clinical Outcome,Leukemic infiltration of skin
7823,Borderline Lesion,Frontal Sinus Inverted Papilloma
7824,Indolent Clinical Course,Cerebellar Vermis Medulloblastoma
7825,Intermediate Filaments Present,Kaposi's sarcoma of skin
7826,Borderline Lesion,"Acanthoma, Pilar Sheath"
7827,Borderline Lesion,Tumor of follicular infundibulum
7828,Generalized illness,Early Unfavorable Hodgkin Lymphoma
7829,Precise Histogenesis Unknown,Recurrent Childhood Pilomyxoid Astrocytoma
7830,Precise Histogenesis Unknown,Ganglioglioma
7831,Mixed Neoplastic Glandular and Squamous Cell Population,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
7832,Benign Cellular Infiltrate,Distal Bile Duct Carcinoma
7833,Mixed Neoplastic Glandular and Squamous Cell Population,Periampullary Adenocarcinoma
7834,Chronic Clinical Course,Adult B Acute Lymphoblastic Leukemia
7835,atypia morphology,Cockade nevus
7836,Solid Growth Pattern,Aleukemic Monocytic Leukemia Cutis
7837,Borderline Lesion,Papilloma of nasal vestibule
7838,Mixture of Germ Cell Neoplastic Components Present,Testicular Dermoid Cyst
7839,Capsular Invasion,Non-Functioning Adrenal Cortex Adenoma
7840,Intracytoplasmic Eosinophilic Inclusion,Classical Low Grade Fibromyxoid Sarcoma
7841,Precise Histogenesis Unknown,Ependymoma
7842,Mixed Neoplastic Glandular and Squamous Cell Population,Apocrine Breast Carcinoma In Situ
7843,Mucoid Stroma Formation,Renal Pelvis Urothelial Papilloma
7844,Benign Cellular Infiltrate,Macrotrabecular Hepatoblastoma
7845,Intracytoplasmic Eosinophilic Inclusion,Soft Tissue Angiosarcoma
7846,New bone formation (morphologic abnormality),Mixed epithelial-mesenchymal hepatoblastoma
7847,Mixed Neoplastic Glandular and Squamous Cell Population,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
7848,Benign Cellular Infiltrate,Colorectal Mantle Cell Lymphoma
7849,Invasive Lesion,Skin appendage adenoma
7850,Invasive Lesion,Benign myoepithelioma
7851,Borderline Lesion,"Adenoma, Monomorphic"
7852,Diffuse Lesion,Spindle cell hemangioma
7853,Mitotic Activity,"Diffuse Astrocytoma, IDH-Wildtype"
7854,Benign Cellular Infiltrate,malignant epithelioid hemangioendothelioma of liver
7855,Indolent Clinical Course,Stage III Adult Soft Tissue Sarcoma AJCC v7
7856,Mixture of Germ Cell Neoplastic Components Present,Stage IIA Gestational Trophoblastic Tumor AJCC v7
7857,Favorable Clinical Outcome,Stage IV Liver Cancer
7858,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of anus
7859,Benign Cellular Infiltrate,hepatoid adenocarcinoma of gallbladder
7860,Infiltrative Growth Pattern,fibroma
7861,Favorable Clinical Outcome,Lentigo maligna melanoma
7862,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Mature Teratoma
7863,High Mitotic Activity,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
7864,Aggressive Clinical Course,Indolent Non-Hodgkin Lymphoma
7865,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal Basaloid Squamous Cell Carcinoma
7866,Diffuse Lesion,Bladder papilloma
7867,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Mucinous Adenocarcinoma
7868,Prominent Schwannian Stroma Present,Peripheral neuroblastoma
7869,Aggressive Clinical Course,Tubulocystic renal cell carcinoma
7870,HMB-45-Positive Neoplastic Cells Present,Histiocytic sarcoma
7871,Encapsulated Mass,Pacinian tumor
7872,Benign Cellular Infiltrate,adenocarcinoma of gallbladder with squamous metaplasia
7873,Indolent Clinical Course,Brain sarcoma
7874,Grade 4 Lesion,Adult Pilocytic Astrocytoma
7875,Ineffective hematopoiesis,"Thrombocythemia, Essential"
7876,Indolent Clinical Course,Childhood Central Nervous System Embryonal Carcinoma
7877,Mixture of Germ Cell Neoplastic Components Present,Testicular embryonal carcinoma stage III
7878,Benign Cellular Infiltrate,Stage 0 Gastric Cancer AJCC v6 and v7
7879,Tubular Structures Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified"
7880,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar cell carcinoma of pancreas
7881,Favorable Clinical Outcome,"Basal cell carcinoma, infundibulocystic"
7882,Local disease,"Lipomatosis, Multiple Symmetrical"
7883,Mucoid Stroma Formation,Ovarian Surface Papilloma
7884,Favorable Clinical Outcome,Hepatocellular Carcinoma by BCLC Stage
7885,Solid Growth Pattern,Lymphoid leukemia
7886,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma in situ in adenomatous polyp
7887,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Teratoma with Malignant Transformation
7888,Anaplasia,Adult Brain Oligodendroglioma
7889,Benign Cellular Infiltrate,BCLC Stage C Hepatocellular Carcinoma
7890,Indolent Clinical Course,Malignant neoplasm of olfactory nerve
7891,Cytologic atypia,Appendix Hyperplastic Polyp
7892,Mixed Neoplastic Glandular and Squamous Cell Population,Gingival Spindle Cell Carcinoma
7893,Intermediate Filaments Present,Malignant Fibrous Histiocytoma
7894,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
7895,Malignant Germinomatous Cellular Infiltrate,Testicular yolk sac tumor
7896,Intermediate Filaments Present,Cutaneous Liposarcoma
7897,atypia morphology,Epithelioid cell nevus
7898,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Mature Teratoma
7899,Benign Cellular Infiltrate,Gallbladder Rhabdomyosarcoma
7900,High Mitotic Activity,Gallbladder Neuroendocrine Tumor G2
7901,Mild dysplasia,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
7902,Invasive Lesion,Benign Outer Hair Sheath and Infundibulum Neoplasm
7903,Malignant Germinomatous Cellular Infiltrate,Pineal Region Choriocarcinoma
7904,High Mitotic Activity,Appendix Neuroendocrine Tumor G2
7905,Metastatic Lesion,Densely Granulated Somatotroph Adenoma
7906,Indolent Clinical Course,Adult Meningeal Melanoma
7907,Favorable Clinical Outcome,Sarcomatoid Intrahepatic Cholangiocarcinoma
7908,Squamous Differentiation,undifferentiated carcinoma of extrahepatic bile duct
7909,Benign Cellular Infiltrate,Gastric Non-Hodgkin's Lymphoma
7910,Premalignant Lesion,Lung Spindle Cell Carcinoma
7911,Mixture of Germ Cell Neoplastic Components Present,"Trophoblastic Tumor, Placental Site"
7912,Indolent Clinical Course,Colon Leiomyosarcoma
7913,Squamous Differentiation,Stage IIIA Lung Large Cell Carcinoma AJCC v7
7914,Intracytoplasmic Eosinophilic Inclusion,Stage I Bone Sarcoma AJCC v7
7915,Intracytoplasmic Eosinophilic Inclusion,Recurrent Malignant Peripheral Nerve Sheath Tumor
7916,Mixed Neoplastic Glandular and Squamous Cell Population,Pyriform Fossa Squamous Cell Carcinoma
7917,Rosette formation,Esthesioneurocytoma
7918,High Mitotic Activity,Uterine Fibroids
7919,Single Type of Tissue Derived from One Embryonic Layer Present,Malignant Ovarian Teratoma
7920,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Renal Cell Cancer AJCC v7
7921,Encapsulated Mass,Nodular fasciitis
7922,Intermediate Filaments Present,Fibrosarcoma of bone
7923,Mixed Neoplastic Glandular and Squamous Cell Population,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
7924,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Serous Neoplasm
7925,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraductal Papillary-Mucinous Adenoma
7926,Mixed Neoplastic Glandular and Squamous Cell Population,cystic mucinous tumor of pancreas with moderate dysplasia
7927,Metastatic Lesion,Benign oncocytoma of salivary gland
7928,Dysplasia,Eccrine dermal cylindroma
7929,Aggressive Clinical Course,Ann Arbor Stage III Grade 2 Follicular Lymphoma
7930,Intestinal metaplasia,signet ring cell carcinoma of appendix
7931,Papillary Pattern,Intraductal Non-Comedo Breast Adenocarcinoma
7932,Indolent Clinical Course,Malignant Central Nervous System Neoplasm
7933,Composite Lesion,Thymoma malignant noninvasive
7934,Intracytoplasmic Eosinophilic Inclusion,Childhood Pleomorphic Rhabdomyosarcoma
7935,Benign Cellular Infiltrate,Squamous Cell Carcinoma of Anal Margin
7936,Precise Histogenesis Unknown,Childhood Oligoastrocytoma
7937,Precise Histogenesis Unknown,Visual Pathway Glioma
7938,High Grade Lesion,Inflammatory liposarcoma
7939,Mucoid Stroma Formation,Serous papillary cystic tumor of borderline malignancy
7940,atypia morphology,Lung Glandular Papilloma
7941,Endobronchial Lesion,Lung Pleomorphic Adenoma
7942,Borderline Lesion,Ovarian Adenomatoid Tumor
7943,Indolent Clinical Course,Leiomyosarcoma of small intestine
7944,High Mitotic Activity,Uterine Corpus Myxoid Leiomyoma
7945,Borderline Lesion,Squamous cell papilloma of eyelid
7946,Chronic Clinical Course,Acute myelomonocytic leukemia
7947,Benign Cellular Infiltrate,BCLC Stage C Adult Hepatocellular Carcinoma
7948,Mucoid Stroma Formation,Papillomatosis
7949,Solid Growth Pattern,Acute Myeloid Leukemia with t(11;17)(q13;q21)
7950,Mixed Cellular Population,sebaceous adenoma of salivary gland
7951,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Adenocarcinoma within Anorectal Fistula
7952,Chronic Clinical Course,Acute monocytic/monoblastic leukemia
7953,Necrotic changes (finding),Neurilemmoma
7954,Intracytoplasmic Eosinophilic Inclusion,Stage IA Soft Tissue Sarcoma AJCC v7
7955,Mixture of Germ Cell Neoplastic Components Present,Choriocarcinoma
7956,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar cell cystadenocarcinoma
7957,Mixture of Germ Cell Neoplastic Components Present,Teratoma of testis
7958,Villous Pattern,Vaginal Tubular Adenoma
7959,High Mitotic Activity,Pancreatic ACTH-Producing Neuroendocrine Tumor
7960,Borderline Lesion,Breast adenoma
7961,Favorable Clinical Outcome,Alcohol-Related Hepatocellular Carcinoma
7962,High Mitotic Activity,Laryngeal Leiomyoma
7963,Solid Growth Pattern,Acute myeloid leukemia with multilineage dysplasia
7964,Indolent Clinical Course,Recurrent Childhood Glioblastoma
7965,Argentaffin Positive Neoplastic Cells Present,Gastric Carcinoid Tumor
7966,Indolent Clinical Course,FNCLCC Sarcoma Grade 2
7967,Aggressive Clinical Course,Granulomatous slack skin disease
7968,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder squamous cell carcinoma stage 0
7969,Borderline Lesion,cystadenoma of salivary gland
7970,Indolent Clinical Course,Central Nervous System Fibrosarcoma
7971,Intracytoplasmic Eosinophilic Inclusion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
7972,Aggressive Clinical Course,Nodal marginal zone B-cell lymphoma stage IV
7973,High Mitotic Activity,Gallbladder Tubular Carcinoid
7974,Locally Aggressive Lesion,Osteoblastoma
7975,Solid Growth Pattern,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
7976,Low Grade Lesion,Post-Radiotherapy Breast Angiosarcoma
7977,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
7978,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Densely Granulated Lactotroph Adenoma
7979,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Esophageal Glandular Intraepithelial Neoplasia
7980,Tumor Vascular Invasion,Pituitary Gland Oncocytic Adenoma
7981,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Squamous Cell Carcinoma
7982,Invasive Lesion,Carcinoma in situ of vagina
7983,Mixed Neoplastic Glandular and Squamous Cell Population,Conventional (Clear Cell) Renal Cell Carcinoma
7984,Diffuse Lesion,Breast Capillary Hemangioma
7985,Mucoid Stroma Formation,Intracystic papillary adenoma
7986,Seminomatous Component Present,Malignant teratoma of testis
7987,Malignant Germinomatous Cellular Infiltrate,Malignant teratoma of testis
7988,Premalignant Lesion,Lepidic Predominant Adenocarcinoma
7989,Indolent Clinical Course,Large cell medulloblastoma
7990,HMB-45-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
7991,Intracytoplasmic Eosinophilic Inclusion,Spindle cell liposarcoma
7992,Locally Aggressive Lesion,Juxtacortical chondroma
7993,Benign Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
7994,Mucoid Stroma Formation,Papilloma of nasal vestibule
7995,Solid Growth Pattern,Aleukemic Acute Lymphoblastic Leukemia Cutis
7996,Mixed Neoplastic Glandular and Squamous Cell Population,Verrucous carcinoma
7997,Diffuse Lesion,Intracranial cavernous hemangioma
7998,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7
7999,Benign Cellular Infiltrate,Colon Cancer by AJCC v7 Stage
8000,Benign Cellular Infiltrate,Kaposi's sarcoma of esophagus
8001,Indolent Clinical Course,Mesenchymal Glioblastoma
8002,Benign Cellular Infiltrate,Extrahepatic Bile Duct Lymphoma
8003,Confluent Sheets of Neoplastic B-Lymphocytes Present,Primary Cutaneous Plasmablastic Lymphoma
8004,Intracytoplasmic Eosinophilic Inclusion,Synchronous Multifocal Osteosarcoma
8005,Benign Cellular Infiltrate,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified"
8006,Mixed Neoplastic Glandular and Squamous Cell Population,Lymphoepithelioma-Like Hepatocellular Carcinoma
8007,Indolent Clinical Course,Malignant Smooth Muscle Neoplasm
8008,Benign Cellular Infiltrate,Stage I Esophageal Cancer
8009,Intermediate Filaments Present,Intraosseous well differentiated osteosarcoma
8010,Indolent Clinical Course,Malignant neoplasm of cerebellum
8011,Malignant Germinomatous Cellular Infiltrate,Childhood Teratoma
8012,Mixed Neoplastic Glandular and Squamous Cell Population,Occult Lung Adenocarcinoma
8013,Mixture of Germ Cell Neoplastic Components Present,Stage IB Gestational Trophoblastic Tumor AJCC v7
8014,Intracytoplasmic Eosinophilic Inclusion,High Grade Paranasal Sinus Sarcoma
8015,High Grade Lesion,malignant epithelioid hemangioendothelioma of liver
8016,Indolent Clinical Course,Lung Monophasic Synovial Sarcoma
8017,High Grade Lesion,Adult Epithelioid Hemangioendothelioma
8018,Nuclear Pseudoinclusion,Clear Cell Variant Thyroid Gland Follicular Carcinoma
8019,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamotransitional Carcinoma
8020,Intermediate Filaments Present,Duodenal Extraskeletal Osteosarcoma
8021,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with mutated NPM1
8022,Heterologous Elements Present,"Uterine Carcinosarcoma, Homologous Type"
8023,Favorable Clinical Outcome,Sarcomatoid Hepatocellular Carcinoma
8024,Mitotic Activity,Gemistocytic astrocytoma
8025,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Monoblastic Leukemia
8026,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Mucinous Adenocarcinoma
8027,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Endometrioid Adenocarcinoma
8028,Solid Growth Pattern,Childhood Acute Myeloid Leukemia without Maturation
8029,Indolent Clinical Course,Anaplastic Oligodendroglioma
8030,Invasive Lesion,Adenolymphoma
8031,High Mitotic Activity,Esophageal Neuroendocrine Tumor G1
8032,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of oropharynx
8033,atypia morphology,Meyerson Nevus
8034,Mixed Neoplastic Glandular and Squamous Cell Population,Broad Ligament Serous Adenocarcinoma
8035,CD30-Positive Neoplastic Cells Present,Fibroblastic reticular cell tumor
8036,Intracytoplasmic Eosinophilic Inclusion,Chondrosarcoma metastatic
8037,Precise Histogenesis Unknown,Childhood Ganglioglioma
8038,Indolent Clinical Course,"Leiomyosarcoma, Myxoid"
8039,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx stage II
8040,Diffuse Lesion,Synovial Hemangioma
8041,Carcinomatous Component Present,Pleomorphic adenoma of lacrimal gland
8042,Invasive Lesion,Benign Pilar-Associated Mesenchyme Neoplasm
8043,Capsular Invasion,Parathyroid transitional clear cell adenoma
8044,Mixed Cellular Population,Common wart
8045,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Ovarian Mucinous Tumor
8046,Borderline Lesion,Parathyroid mixed cell type adenoma
8047,Borderline Lesion,Endocervical polyp
8048,Mixed Neoplastic Glandular and Squamous Cell Population,Ethmoid Sinus Adenocarcinoma
8049,Severe cytologic atypia,Malignant Pancreatic Somatostatinoma
8050,Secondary Lesion,Primary ameloblastic carcinoma
8051,Severe cytologic atypia,Digestive System Neuroendocrine Tumor G2
8052,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
8053,Tubular Pattern,Urethral Villous Adenoma
8054,Capsular Invasion,Mixed Cell Adrenal Cortical Adenoma
8055,Mixed Neoplastic Glandular and Squamous Cell Population,Retromolar Trigone Squamous Cell Carcinoma
8056,Mixed Neoplastic Glandular and Squamous Cell Population,Solid Papillary Breast Carcinoma
8057,Indolent Clinical Course,Secondary malignant neoplasm of bone
8058,Indolent Clinical Course,"Perivascular epithelioid tumor, malignant"
8059,Encapsulated Mass,Soft tissue perineurioma
8060,Benign Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v6 Stage
8061,Mixed Neoplastic Glandular and Squamous Cell Population,Appendix High Grade Intraepithelial Neoplasia
8062,Favorable Clinical Outcome,eccrine adenocarcinoma of vulva
8063,Benign Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v7
8064,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
8065,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary craniopharyngioma
8066,Intermediate Filaments Present,Sarcoma of vulva
8067,Benign Cellular Infiltrate,Anal Rhabdomyosarcoma
8068,Mucoid Stroma Formation,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
8069,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Cystadenofibroma
8070,Intermediate Filaments Present,Liver Extraskeletal Osteosarcoma
8071,Multilayered Rosette Formation,Recurrent Childhood Medulloblastoma
8072,Prominent Schwannian Stroma Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System
8073,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Macrocystic Serous Cystadenoma
8074,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7
8075,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder adenocarcinoma stage 0
8076,Intermediate Filaments Present,Endemic African Kaposi Sarcoma
8077,Solid Growth Pattern,Splenic Manifestation of T-Cell Prolymphocytic Leukemia
8078,Borderline Lesion,Apocrine cystadenoma
8079,Premalignant Lesion,Stage IIIB Lung Large Cell Carcinoma AJCC v7
8080,Mixed Epithelial Cell Population,Bladder Squamous Papilloma
8081,Intermediate Filaments Present,Thymoliposarcoma
8082,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Non-Keratinizing Squamous Cell Carcinoma
8083,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
8084,Polymorphic Cellular Infiltrate,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
8085,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Esophageal Adenocarcinoma AJCC v7
8086,Tumor Vascular Invasion,Thyroid Gland Signet Ring Cell Follicular Adenoma
8087,Aggressive Clinical Course,Mycosis fungoides refractory
8088,Large Pineocytomatous Rosette Formation,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation
8089,Indolent Clinical Course,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
8090,Mixed Neoplastic Glandular and Squamous Cell Population,Maxillary Sinus Squamous Cell Carcinoma
8091,Chronic Clinical Course,Acute bilineal leukemia
8092,Mucoid Stroma Formation,Papillary Thyroid Microcarcinoma
8093,Indolent Clinical Course,Stage IIB Bone Sarcoma AJCC v7
8094,Benign Cellular Infiltrate,Esophageal Malignant Peripheral Nerve Sheath Tumor
8095,Non-Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
8096,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Erythroleukemia
8097,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
8098,Invasive Lesion,Hemangioma of skin
8099,High Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G2
8100,Mixed Neoplastic Glandular and Squamous Cell Population,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
8101,Intracytoplasmic Eosinophilic Inclusion,Adult Epithelioid Sarcoma
8102,Dysplasia,Colorectal hyperplastic polyp
8103,Solid Growth Pattern,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
8104,Benign Cellular Infiltrate,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
8105,High Mitotic Activity,Ureter Leiomyoma
8106,Solid Growth Pattern,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
8107,Intermediate Filaments Present,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
8108,Intracytoplasmic Eosinophilic Inclusion,Adult Clear Cell Sarcoma of Soft Parts
8109,Diffuse Lesion,Vaginal Mullerian Papilloma
8110,Intracytoplasmic Eosinophilic Inclusion,Adult Angiosarcoma
8111,Favorable Clinical Outcome,Melanoma recurrent
8112,Malabsorption Syndrome,Indolent Systemic Mastocytosis
8113,Absence of a Hormonal Syndrome,Glucagonoma
8114,Benign Cellular Infiltrate,BCLC Stage A Adult Hepatocellular Carcinoma
8115,Favorable Clinical Outcome,Amelanotic Skin Melanoma
8116,Mucoid Stroma Formation,"Cystadenocarcinoma, Papillary"
8117,Mixed Cellular Population,Sclerosing rhabdomyosarcoma
8118,Benign Cellular Infiltrate,Carcinoma of anal margin
8119,Indolent Clinical Course,Parotid Gland Kaposi Sarcoma
8120,Borderline Lesion,Classical Poroma
8121,Acute Clinical Course,Chronic lymphocytic leukemia stage 1
8122,Diffuse Lesion,Inverted urothelial papilloma
8123,Indolent Clinical Course,Gallbladder Kaposi's Sarcoma
8124,Benign Cellular Infiltrate,Undifferentiated carcinoma of stomach
8125,Intermediate Filaments Present,Metastatic Bone Ewing Sarcoma
8126,Benign Cellular Infiltrate,Mixed Acinar-Ductal Carcinoma of the Pancreas
8127,Malignant Germinomatous Cellular Infiltrate,Vaginal Dermoid Cyst
8128,CD15-Positive Neoplastic Cells Present,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma
8129,Borderline Lesion,Alveolar adenoma
8130,Indolent Clinical Course,Metastatic Ewing's Sarcoma
8131,Intracytoplasmic Eosinophilic Inclusion,Ewing's sarcoma recurrent
8132,Intermediate Filaments Present,Stage IB Adult Soft Tissue Sarcoma AJCC v7
8133,Diffuse Lesion,Colon Lymphangioma
8134,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Sparsely Granulated Lactotroph Adenoma
8135,Indolent Clinical Course,Mesenchymal Chondrosarcoma
8136,Intracytoplasmic Eosinophilic Inclusion,Gallbladder Angiosarcoma
8137,Mixed Neoplastic Glandular and Squamous Cell Population,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
8138,Diffuse Lesion,Maxillary Sinus Inverted Papilloma
8139,Ependymal Rosette Formation,Tanycytic ependymoma
8140,Invasive Lesion,Biliary Intraepithelial Neoplasia-3
8141,Mucoid Stroma Formation,Thymic Papillary Adenocarcinoma
8142,Mixed Neoplastic Glandular and Squamous Cell Population,Breast adenocarcinoma
8143,Capsular Invasion,Parathyroid Gland Oncocytic Adenoma
8144,Precise Histogenesis Unknown,Recurrent Childhood Pleomorphic Xanthoastrocytoma
8145,Borderline Lesion,Trichoepithelioma
8146,Invasive Lesion,Cutaneous leiomyoma
8147,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Serous Adenofibroma
8148,Benign Cellular Infiltrate,Malignant Gastric Germ Cell Tumor
8149,Indolent Clinical Course,Pleural Monophasic Synovial Sarcoma
8150,Benign Cellular Infiltrate,Gastric Cardia Carcinoma
8151,Favorable Clinical Outcome,Stage I Cutaneous Melanoma AJCC v7
8152,Low Grade Lesion,Skin Angiosarcoma
8153,Intracytoplasmic Eosinophilic Inclusion,Childhood Small Intestinal Leiomyosarcoma
8154,Diffuse Lesion,Hemangioma of spleen
8155,Precise Histogenesis Unknown,Pilocytic Astrocytoma
8156,Indolent Clinical Course,Ependymoblastoma
8157,Mixed Neoplastic Glandular and Squamous Cell Population,Type 1 Papillary Renal Cell Carcinoma
8158,Benign Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v7
8159,Precise Histogenesis Unknown,Childhood Supratentorial Ependymoma
8160,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma recurrent
8161,Diffuse Lesion,Gastric Hemangioma
8162,Low Grade Lesion,Childhood Angiosarcoma
8163,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Seromucinous Cystadenoma
8164,Invasive Lesion,Benign Breast Eccrine Spiradenoma
8165,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
8166,Indolent Clinical Course,Adult Leiomyosarcoma
8167,Benign Cellular Infiltrate,Stomach Carcinoma
8168,Indolent Clinical Course,rhabdomyosarcoma of extrahepatic bile duct
8169,Microvascular Proliferation,"Diffuse Astrocytoma, IDH-Wildtype"
8170,High Mitotic Activity,Childhood Oligodendroglioma
8171,CD15-Positive Neoplastic Cells Present,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
8172,Solid Growth Pattern,Aleukemic Chronic Lymphocytic Leukemia
8173,Malignant Germinomatous Cellular Infiltrate,Dermoid cyst with secondary tumor
8174,Benign Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v7
8175,Multilayered Rosette Formation,Recurrent Medulloblastoma
8176,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, large cell, nonkeratinizing"
8177,Keratin Present,"Squamous cell carcinoma, large cell, nonkeratinizing"
8178,Indolent Clinical Course,Malignant Leptomeningeal Neoplasm
8179,Mixed Neoplastic Glandular and Squamous Cell Population,"Gallbladder Adenocarcinoma, Biliary Type"
8180,Premalignant Lesion,Large cell carcinoma of lung
8181,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
8182,Invasive Lesion,Melanoacanthoma
8183,Benign Cellular Infiltrate,Malignant melanoma of rectum
8184,Acute Clinical Course,Hairy cell leukemia variant
8185,Glandular Differentiation,Giant cell carcinoma of lung
8186,"Undifferentiated ""Fetal-Type"" Tissues Present",Dermoid cyst of orbit
8187,High Mitotic Activity,"Leydig cell tumor, benign"
8188,Mixed Neoplastic Glandular and Squamous Cell Population,Medullary carcinoma of breast
8189,Benign Cellular Infiltrate,Angiosarcoma of liver
8190,Indolent Clinical Course,Malignant Bone Neoplasm
8191,Malignant Germinomatous Cellular Infiltrate,Childhood Testicular Immature Teratoma
8192,Benign Cellular Infiltrate,Stage III Liver Cancer
8193,Locally Aggressive Lesion,Fibroma of tendon sheath
8194,Malignant Germinomatous Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7
8195,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Immature Teratoma
8196,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage 0 Hepatocellular Carcinoma
8197,Intermediate Filaments Present,Non-Metastatic Childhood Soft Tissue Sarcoma
8198,Indolent Clinical Course,Sarcoma by NCI Grade
8199,Mixed Neoplastic Glandular and Squamous Cell Population,Primary solid type intraosseous squamous cell carcinoma
8200,Indolent Clinical Course,Malignant fibrous histiocytoma metastatic
8201,Indolent Clinical Course,Sarcoma of liver
8202,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
8203,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Hepatoid Adenocarcinoma
8204,Solid Growth Pattern,Refractory Childhood Acute Lymphoblastic Leukemia
8205,Borderline Lesion,Ovarian Cystadenoma
8206,Mucoid Stroma Formation,Lower Gingival Verrucous Carcinoma
8207,Intermediate Filaments Present,Metastatic angiosarcoma
8208,Invasive Lesion,Pleomorphic adenoma of parotid gland
8209,Benign Cellular Infiltrate,Malignant neoplasm of appendix
8210,Favorable Clinical Outcome,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
8211,Favorable Clinical Outcome,Stage IB Cutaneous Melanoma AJCC v7
8212,Blasts Expressing CD56 and Immature T-Cell Markers Present,Mixed phenotype acute leukemia
8213,Indolent Clinical Course,Non-Hodgkin's lymphoma of central nervous system
8214,Mixture of Germ Cell Neoplastic Components Present,Testicular choriocarcinoma stage II
8215,Homer Wright Rosette Formation,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
8216,Cutaneous Involvement,Mast-Cell Sarcoma
8217,Capsular Invasion,Glomerulosa Cell Adrenal Cortical Adenoma
8218,Favorable Clinical Outcome,Paget's disease of vulva
8219,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
8220,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary Renal Cell Carcinoma
8221,Glandular Differentiation,Stage IIB Lung Large Cell Carcinoma AJCC v7
8222,Benign Cellular Infiltrate,Moderately Differentiated Hepatocellular Carcinoma
8223,Benign Cellular Infiltrate,Stage I Rectal Cancer AJCC v6 and v7
8224,Favorable Clinical Outcome,Stage IIB Cutaneous Melanoma AJCC v6 and v7
8225,Nuclear Grooves,Thyroid Gland Clear Cell Follicular Adenoma
8226,Intracytoplasmic Eosinophilic Inclusion,Stage I Osteosarcoma AJCC v7
8227,Solid Growth Pattern,Ph-Like Acute Lymphoblastic Leukemia
8228,Premalignant Lesion,Adenosquamous cell lung cancer stage IIIA
8229,Diffuse Lesion,Renal Pelvis Inverted Papilloma
8230,Mucoid Stroma Formation,"Papillary transitional cell carcinoma, non-invasive"
8231,Favorable Clinical Outcome,Transplant-Related Hepatocellular Carcinoma
8232,Necrotic changes (finding),Acoustic Neuroma
8233,Prominent Schwannian Stroma Present,Neuroblastoma of brain
8234,Mixed Neoplastic Glandular and Squamous Cell Population,Maxillary Sinus Adenocarcinoma
8235,Mixed Neoplastic Glandular and Squamous Cell Population,Ocular Sebaceous Carcinoma
8236,Premalignant Lesion,"Lung Squamous Cell Carcinoma, Small Cell Variant"
8237,Intermediate Filaments Present,Proximal-Type Epithelioid Sarcoma
8238,Premalignant Lesion,Stage I Lung Cancer AJCC v7
8239,Solid Growth Pattern,"Leukemia, Myeloid, Chronic-Phase"
8240,Favorable Clinical Outcome,Invasive Apocrine Breast Carcinoma
8241,Indolent Clinical Course,Major Salivary Gland Sarcoma
8242,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Tumor G1
8243,Benign Cellular Infiltrate,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
8244,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Mucinous Cystadenoma
8245,Cystic Change,Colloid Carcinoma of the Pancreas
8246,Premalignant Lesion,Occult Lung Adenosquamous Carcinoma
8247,Dermal Involvement,Hidroacanthoma simplex
8248,Seminomatous Component Present,Struma Ovarii
8249,Grade 4 Lesion,Astrocytoma
8250,Intracytoplasmic Eosinophilic Inclusion,Ovarian Low Grade Endometrioid Stromal Sarcoma
8251,Intermediate Filaments Present,Chondrosarcoma
8252,High Mitotic Activity,Cellular leiomyoma
8253,Mixture of Germ Cell Neoplastic Components Present,Testicular embryonal carcinoma
8254,Mixed Neoplastic Glandular and Squamous Cell Population,Aflatoxins-Related Hepatocellular Carcinoma
8255,Plexiform Vasculature Present,undifferentiated sarcoma of ovary
8256,Mucoid Stroma Formation,Cervical Squamous Papilloma
8257,Benign Cellular Infiltrate,Mucinous adenocarcinoma of appendix
8258,High Mitotic Activity,insulinoma
8259,Severe cytologic atypia,Glucagonoma
8260,Chronic Clinical Course,ROSE Cluster 8
8261,Favorable Clinical Outcome,BCLC Stage A Adult Hepatocellular Carcinoma
8262,Benign Cellular Infiltrate,Rectal Rhabdomyosarcoma
8263,Diffuse Lesion,Skin Papilloma
8264,Invasive Lesion,Skin Papilloma
8265,Epidermal Involvement,Dermal Duct Tumor
8266,Mixed Neoplastic Glandular and Squamous Cell Population,adenosquamous carcinoma of ovary
8267,Mixed Neoplastic Glandular and Squamous Cell Population,Chromophobe Renal Cell Carcinoma
8268,Indolent Clinical Course,Small cell glioblastoma
8269,Atypical Mitotic Figures,Glomangiomatosis
8270,atypia morphology,Left atrial myxoma
8271,High Mitotic Activity,Uterine Corpus Dissecting Leiomyoma
8272,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Teratoma AJCC v6 and v7
8273,Mixed Neoplastic Glandular and Squamous Cell Population,keratinizing squamous cell carcinoma of nasal cavity
8274,Favorable Clinical Outcome,Infiltrating basal cell carcinoma
8275,Borderline Lesion,Frontal Sinus Schneiderian Papilloma
8276,Pain,Ivory Exostosis
8277,Glandular Differentiation,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
8278,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar cell tumor
8279,Premalignant Lesion,Large cell lung cancer stage III
8280,Benign Cellular Infiltrate,Colon Serrated Adenocarcinoma
8281,Intermediate Filaments Present,Sarcoma NCI Grade 3
8282,Aggressive Clinical Course,Marginal zone lymphoma stage II
8283,Premalignant Lesion,Papillary Lung Adenocarcinoma
8284,Solid Growth Pattern,Erythroleukemia (Erythroid/Myeloid)
8285,Aggressive Clinical Course,Mycosis Fungoides Variant
8286,Indolent Clinical Course,Childhood Leiomyosarcoma
8287,Benign Cellular Infiltrate,Childhood Malignant Liver Neoplasm
8288,Single Type of Tissue Derived from One Embryonic Layer Present,Mature Ovarian Teratoma
8289,Precise Histogenesis Unknown,Papillary ependymoma
8290,Solid Growth Pattern,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
8291,Prominent Schwannian Stroma Present,Recurrent Olfactory Neuroblastoma
8292,Invasive Lesion,Gastric dysplasia
8293,Low Mitotic Activity,large cell neuroendocrine carcinoma of extrahepatic bile duct
8294,Precise Histogenesis Unknown,Childhood Brain Stem Mixed Glioma
8295,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary squamous cell carcinoma
8296,Benign Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v7
8297,Mixed Neoplastic Glandular and Squamous Cell Population,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
8298,Benign Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v7
8299,Precise Histogenesis Unknown,Recurrent Childhood Oligodendroglioma
8300,Premalignant Lesion,Lung adenocarcinoma recurrent
8301,Indolent Clinical Course,AJCC Grade 4 Sarcoma
8302,Intermediate Filaments Present,"Chondrosarcoma, Clear Cell"
8303,Locally Aggressive Lesion,Hemangioma of bone
8304,Premalignant Lesion,Adenosquamous cell lung cancer stage II
8305,Intermediate Filaments Present,Adult Leiomyosarcoma
8306,Intracytoplasmic Eosinophilic Inclusion,Lung Biphasic Synovial Sarcoma
8307,Indolent Clinical Course,Stage IV Adult Soft Tissue Sarcoma AJCC v7
8308,Prominent Schwannian Stroma Present,Kadish Stage A Olfactory Neuroblastoma
8309,Microvascular Proliferation,Diffuse Astrocytoma
8310,Necrotic changes (finding),Diffuse Astrocytoma
8311,Intracytoplasmic Eosinophilic Inclusion,Primary leiomyosarcoma
8312,Premalignant Lesion,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
8313,Severe cytologic atypia,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
8314,Intermediate Filaments Present,Leiomyosarcoma recurrent
8315,Invasive Lesion,Borderline serous tumor of ovary
8316,Indolent Clinical Course,Leiomyosarcoma NCI Grade 2
8317,Intracytoplasmic Eosinophilic Inclusion,High grade surface osteosarcoma
8318,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease Extramammary
8319,Benign Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v7
8320,Precise Histogenesis Unknown,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor
8321,Chronic Clinical Course,Acute monoblastic leukemia
8322,Keratin pearl formation,Nasopharyngeal Nonkeratinizing Carcinoma
8323,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Ligament Adenocarcinoma
8324,Borderline Lesion,inverted follicular keratosis
8325,Favorable Clinical Outcome,Stage I Skin Cancer
8326,Mixed Neoplastic Glandular and Squamous Cell Population,Low grade appendiceal mucinous neoplasm
8327,Benign Cellular Infiltrate,undifferentiated carcinoma of gallbladder
8328,Seminomatous Component Present,Dermoid cyst of orbit
8329,Benign Cellular Infiltrate,Stage III Anal Canal Cancer AJCC v6 and v7
8330,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of scrotum
8331,Aggressive Clinical Course,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
8332,Locally Aggressive Lesion,Dermal Fibroma
8333,Favorable Clinical Outcome,Stage III Liver Cancer
8334,Favorable Clinical Outcome,"Basal cell carcinoma, micronodular"
8335,Intermediate Filaments Present,Stage IIB Uterine Sarcoma AJCC v7
8336,Invasive Lesion,Intraductal Proliferative Lesion of the Breast
8337,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of rectum
8338,Dysplasia,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
8339,Indolent Clinical Course,synovial sarcoma
8340,Generalized Dysplasia,Colon Sessile Serrated Adenoma/Polyp
8341,CD8-Positive Neoplastic Cells Present,Hepatosplenic T-cell lymphoma
8342,Intracytoplasmic Eosinophilic Inclusion,Sarcoma by NCI Grade
8343,Indolent Clinical Course,Undifferentiated round cell sarcoma
8344,Papillary Pattern,Pancreatic Intraepithelial Neoplasia-1A
8345,Intermediate Grade Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
8346,Indolent Clinical Course,AIDS-Related Primary Central Nervous System Lymphoma
8347,Intracytoplasmic Eosinophilic Inclusion,Myxoid/Round Cell Liposarcoma
8348,Mixture of Germ Cell Neoplastic Components Present,Testicular Monophasic Choriocarcinoma
8349,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenoma, Mucinous"
8350,Mixed Neoplastic Glandular and Squamous Cell Population,Urethral Verrucous Carcinoma
8351,Malignant Germinomatous Cellular Infiltrate,Pineal Region Teratoma
8352,Mucoid Stroma Formation,Papilloma of buccal mucosa
8353,Grade 4 Lesion,Juvenile Pilocytic Astrocytoma
8354,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Squamous Cell Tumor
8355,Malignant Germinomatous Cellular Infiltrate,teratocarcinoma of mediastinum
8356,Malignant Germinomatous Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
8357,Histiocytosis,Centroblastic lymphoma stage I
8358,CD1a-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Follicular"
8359,Benign Cellular Infiltrate,Gastric Fundus Carcinoma
8360,Polymorphic Cellular Infiltrate,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
8361,Diffuse Lesion,Squamous cell papilloma of skin
8362,Biphasic Pattern,Pilomyxoid astrocytoma
8363,Seminomatous Component Present,Testicular yolk sac tumor stage I
8364,Mixed Neoplastic Glandular and Squamous Cell Population,Rectosigmoid Mucinous Adenocarcinoma
8365,Mixed Neoplastic Glandular and Squamous Cell Population,signet ring cell carcinoma of breast
8366,Benign Cellular Infiltrate,Recurrent Extrahepatic Bile Duct Carcinoma
8367,Intermediate Filaments Present,sarcoma of esophagus
8368,Acute Clinical Course,Splenic Manifestation of Hairy Cell Leukemia
8369,Intracytoplasmic Eosinophilic Inclusion,Iatrogenic Kaposi Sarcoma
8370,Mixed Neoplastic Glandular and Squamous Cell Population,Oxyphilic Adenoma
8371,Benign Cellular Infiltrate,Colon Leiomyosarcoma
8372,Squamous Differentiation,Stage IB Lung Large Cell Carcinoma AJCC v7
8373,Invasive Lesion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
8374,Invasive Lesion,Stage 0 Esophageal Cancer AJCC v7
8375,Indolent Clinical Course,Recurrent Childhood Soft Tissue Sarcoma
8376,Dysplasia,Colorectal Mucin Poor Hyperplastic Polyp
8377,Premalignant Lesion,Bronchogenic Carcinoma
8378,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Esophageal Adenocarcinoma AJCC v7
8379,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of penis
8380,Mixed Neoplastic Glandular and Squamous Cell Population,Oncocytic Breast Carcinoma
8381,Chronic Clinical Course,M5b Acute differentiated monocytic leukemia
8382,Intracytoplasmic Eosinophilic Inclusion,Fibroblastic osteosarcoma
8383,Glandular Differentiation,Small Intestinal Undifferentiated Carcinoma
8384,Indolent Clinical Course,Kaposi Sarcoma
8385,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Mucinous Neoplasm
8386,Intracytoplasmic Eosinophilic Inclusion,Fibrosarcoma of bone
8387,Mucoid Stroma Formation,Exophytic Schneiderian Papilloma
8388,Benign Cellular Infiltrate,Gastric Intramucosal Adenocarcinoma
8389,Benign Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v7
8390,Aggressive Clinical Course,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
8391,Mucoid Stroma Formation,Intraductal papillary neoplasm with high grade intraepithelial neoplasia
8392,HMB-45-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
8393,Benign Cellular Infiltrate,Advanced Adult Hepatocellular Carcinoma
8394,Mixed Neoplastic Glandular and Squamous Cell Population,Minor Salivary Gland Acinic Cell Carcinoma
8395,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Adenocarcinoma
8396,Favorable Clinical Outcome,Liver Adenosquamous Carcinoma
8397,Invasive Lesion,Squamous intraepithelial neoplasia grade 2
8398,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Pancreatic Cancer AJCC v6 and v7
8399,Benign Cellular Infiltrate,Stage IIB Colon Cancer AJCC v7
8400,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Childhood Acute Monoblastic and Monocytic Leukemia
8401,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Prostate Phyllodes Tumor
8402,Indolent Clinical Course,Stage IA Adult Soft Tissue Sarcoma AJCC v7
8403,atypia morphology,Deep Penetrating Nevus
8404,Intestinal metaplasia,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
8405,Endophytic Tumor Growth,Urethral Condyloma Acuminatum
8406,Dysplasia,Benign neoplasm of sweat gland
8407,Benign Cellular Infiltrate,Anal Extramucosal (Perianal) Adenocarcinoma
8408,Favorable Clinical Outcome,Stage I Acral Lentiginous Melanoma AJCC v7
8409,Favorable Clinical Outcome,Stage II Acral Lentiginous Melanoma AJCC v6 and v7
8410,Solid Growth Pattern,Infant Leukemia
8411,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
8412,High Mitotic Activity,Gastric Leiomyoma
8413,Invasive Lesion,Eccrine spiradenoma
8414,Chronic Clinical Course,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement
8415,atypia morphology,Adenomatoid Tumor
8416,Benign Cellular Infiltrate,Aflatoxins-Related Hepatocellular Carcinoma
8417,Chronic Clinical Course,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
8418,Grade 4 Lesion,Recurrent Childhood Diffuse Astrocytoma
8419,Invasive Lesion,Flat Ductal Epithelial Atypia of the Breast
8420,Grade 4 Lesion,Recurrent Childhood Fibrillary Astrocytoma
8421,Benign Cellular Infiltrate,Childhood Malignant Small Intestinal Neoplasm
8422,Precise Histogenesis Unknown,Recurrent Childhood Gliosarcoma
8423,Favorable Clinical Outcome,Granulomatous slack skin disease
8424,Dysplasia,Eccrine Poroma
8425,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7
8426,Indolent Clinical Course,High Grade Malignant Peripheral Nerve Sheath Tumor
8427,Indolent Clinical Course,Secondary Central Chondrosarcoma
8428,Dense Collagenized Tissue Present,Infiltrating basal cell carcinoma
8429,Low Grade Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
8430,Borderline Lesion,Parotid monomorphic adenoma
8431,Benign Cellular Infiltrate,Hepatoblastoma
8432,Intermediate Filaments Present,Extraskeletal osteosarcoma non-metastatic
8433,Dysplasia,Warty dyskeratoma
8434,Benign Cellular Infiltrate,Mucinous cystadenocarcinoma appendix
8435,Benign Cellular Infiltrate,Pancreatoblastoma
8436,Premalignant Lesion,Pancoast Tumor
8437,Diffuse Lesion,Inverted Squamous Cell Papilloma
8438,Invasive Lesion,Biliary Intraepithelial Neoplasia-1
8439,Diffuse Lesion,Sphenoid Sinus Inverted Papilloma
8440,Benign Cellular Infiltrate,adenosquamous carcinoma of esophagus
8441,Premalignant Lesion,Kaposi's sarcoma of lung
8442,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
8443,Nuclear Pseudoinclusion,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
8444,Low Mitotic Activity,Anal Canal Small Cell Neuroendocrine Carcinoma
8445,Well-Circumscribed Lesion,Fibrous Hamartoma of Infancy
8446,Locally Aggressive Lesion,Vulvar Superficial Myofibroblastoma
8447,Mixed Neoplastic Glandular and Squamous Cell Population,Colon Medullary Carcinoma
8448,High Mitotic Activity,Cutaneous leiomyoma
8449,Grade 4 Lesion,Anaplastic astrocytoma
8450,Well-Circumscribed Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
8451,Mixed Neoplastic Glandular and Squamous Cell Population,Cystadenofibroma of fallopian tube
8452,Solid Growth Pattern,Adult B Acute Lymphoblastic Leukemia
8453,Mixed Neoplastic Glandular and Squamous Cell Population,Signet Ring Cell Intrahepatic Cholangiocarcinoma
8454,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of gallbladder
8455,Solid Growth Pattern,Chronic lymphocytic leukemia refractory
8456,Microvascular Proliferation,Anaplastic Brain Stem Astrocytoma
8457,Mixed Cellular Population,Spindle cell rhabdomyosarcoma
8458,Invasive Lesion,Apocrine Breast Carcinoma In Situ
8459,Aggressive Clinical Course,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
8460,Benign Cellular Infiltrate,Gastric Pylorus Carcinoma
8461,Premalignant Lesion,Stage IB Lung Cancer AJCC v7
8462,Intermediate Filaments Present,Kaposi's sarcoma of esophagus
8463,Invasive Lesion,Sclerosing Polycystic Adenosis
8464,Encapsulated Mass,adenoma of intrahepatic bile duct
8465,Blasts Expressing B-Lymphoid and Myeloid Markers Present,NK-lymphoblastic leukemia/lymphoma
8466,Well-Circumscribed Lesion,Alveolar rhabdomyosarcoma
8467,Precise Histogenesis Unknown,Grade III Childhood Astrocytoma
8468,Benign Cellular Infiltrate,mantle cell lymphoma of small intestine
8469,Well-Circumscribed Lesion,"Fibromatosis, Abdominal"
8470,Grade 4 Lesion,Pineal Gland Astrocytoma
8471,Aggressive Clinical Course,Splenic marginal zone lymphoma refractory
8472,Anaplasia,Ependymoma of brain stem
8473,Benign Cellular Infiltrate,Pancreatic Hepatoid Adenocarcinoma
8474,Aggressive Clinical Course,Pagetoid reticulosis
8475,Indolent Clinical Course,Osteoblastic Osteosarcoma
8476,Benign Cellular Infiltrate,Peripheral Intrahepatic Cholangiocarcinoma
8477,Severe cytologic atypia,Esophageal Neuroendocrine Tumor G1
8478,Low Grade Lesion,Peripheral Intraneural Angiosarcoma
8479,Benign Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
8480,Malignant Germinomatous Cellular Infiltrate,Testicular embryonal carcinoma stage III
8481,Solid Growth Pattern,Refractory Adult Acute Lymphoblastic Leukemia
8482,Benign Cellular Infiltrate,Stage 0 Gallbladder Cancer AJCC v6 and v7
8483,Ground Glass Nuclear Inclusion,Follicular thyroid carcinoma
8484,Mixed Neoplastic Glandular and Squamous Cell Population,Pleomorphic Hepatocellular Carcinoma
8485,Anaplasia,Adult Brain Ependymoma
8486,Invasive Lesion,Nuchal-type fibroma
8487,Favorable Clinical Outcome,Clear Cell Intrahepatic Cholangiocarcinoma
8488,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma
8489,Solid Growth Pattern,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
8490,High Mitotic Activity,Colorectal Neuroendocrine Tumor G1
8491,Intracytoplasmic Eosinophilic Inclusion,Epithelioid sarcoma recurrent
8492,Intracytoplasmic Eosinophilic Inclusion,Inferior Vena Cava Leiomyosarcoma
8493,Acinar Cell Differentiation,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
8494,Intracytoplasmic Eosinophilic Inclusion,Vulvar Proximal-Type Epithelioid Sarcoma
8495,Mucoid Stroma Formation,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
8496,Prominent Schwannian Stroma Present,Undifferentiated Neuroblastoma
8497,Indolent Clinical Course,mesenchymal chondrosarcoma of bone
8498,Favorable Clinical Outcome,Stage IIA Merkel Cell Carcinoma AJCC v7
8499,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
8500,Scattered Collections of Differentiating Neuroblasts Present,"Ganglioneuroblastoma, Intermixed"
8501,Diffuse Lesion,Papilloma of buccal mucosa
8502,Indolent Clinical Course,Pulmonary Artery Angiosarcoma
8503,Mixture of Germ Cell Neoplastic Components Present,Non-Metastatic Gestational Trophoblastic Tumor
8504,Benign Cellular Infiltrate,Primary Peritoneal Serous Adenocarcinoma
8505,Metastatic Lesion,Non-Hodgkin's lymphoma of central nervous system
8506,Benign Cellular Infiltrate,Small intestine carcinoma stage IV
8507,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
8508,High Grade Lesion,Benign Mastocytoma
8509,Aggressive Clinical Course,Skin-associated lymphoid tissue lymphoma
8510,Chronic Clinical Course,Cytogenetically normal acute myeloid leukemia
8511,Solid Growth Pattern,Splenic Manifestation of Leukemia
8512,Indolent Clinical Course,sarcoma of small intestine
8513,Benign Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma
8514,Dysplasia,Colorectal Goblet Cell Rich Hyperplastic Polyp
8515,Favorable Clinical Outcome,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
8516,High Mitotic Activity,"Glucagonoma, malignant"
8517,Mixed Neoplastic Glandular and Squamous Cell Population,Noninfiltrating Intraductal Carcinoma
8518,Benign Cellular Infiltrate,Colorectal cancer recurrent
8519,Intracytoplasmic Eosinophilic Inclusion,fibrosarcoma of ovary
8520,Benign Cellular Infiltrate,Rectosigmoid cancer recurrent
8521,Indolent Clinical Course,Undifferentiated Epithelioid Sarcoma
8522,High Mitotic Activity,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
8523,Mucoid Stroma Formation,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
8524,Intermediate Filaments Present,Ovarian Rhabdomyosarcoma
8525,Indolent Clinical Course,Central Nervous System Embryonal Neoplasm
8526,Invasive Lesion,Large cell acanthoma
8527,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Myelomonocytic Leukemia
8528,High Mitotic Activity,Rectal Leiomyoma
8529,Indolent Clinical Course,fibrosarcoma of soft tissue
8530,Indolent Clinical Course,Tibial adamantinoma
8531,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Intramucosal Adenocarcinoma
8532,Indolent Clinical Course,Juxtacortical chondrosarcoma
8533,Intermediate Filaments Present,Juxtacortical chondrosarcoma
8534,Mixed Neoplastic Glandular and Squamous Cell Population,Glandular papilloma
8535,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma
8536,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with cartilaginous metaplasia
8537,Indolent Clinical Course,Neuroblastoma of brain
8538,Benign Cellular Infiltrate,Bile duct signet-ring cell carcinoma
8539,Mixed Neoplastic Glandular and Squamous Cell Population,intraductal micropapillary carcinoma of breast
8540,Borderline Lesion,Lung Mucous Gland Adenoma
8541,Precise Histogenesis Unknown,Adult Oligodendroglial Tumor
8542,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Tumor G1
8543,Intermediate Filaments Present,Inflammatory liposarcoma
8544,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Ovarian Mucinous Tumor
8545,atypia morphology,Benign Notochordal Cell Tumor
8546,Locally Aggressive Lesion,Cranial Nodular Fasciitis
8547,Benign Cellular Infiltrate,adenosquamous carcinoma of pancreas
8548,High Mitotic Activity,Intravenous leiomyomatosis
8549,Indolent Clinical Course,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8550,Premalignant Lesion,Occult Lung Large Cell Carcinoma
8551,Increased Cellularity Present,"Transitional cell papilloma, benign"
8552,Invasive Lesion,Benign neoplasm of submaxillary gland
8553,Invasive Lesion,Syringoma
8554,Increased Cellularity Present,"Transitional cell papilloma, inverted"
8555,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous adenocarcinoma of appendix
8556,Cytopenia,Indolent Systemic Mastocytosis
8557,Solid Growth Pattern,Childhood Acute Myeloid Leukemia with Minimal Differentiation
8558,Mixed Neoplastic Glandular and Squamous Cell Population,Parietal cell carcinoma
8559,Favorable Clinical Outcome,Secondary malignant neoplasm of skin
8560,Indolent Clinical Course,Stage IIB Bone Cancer AJCC v7
8561,Junctional Proliferation,Vaginal Blue Nevus
8562,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Ductal and Invasive Lobular Breast Carcinoma
8563,Dysplasia,Hidrocystoma
8564,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Non-Keratinizing Squamous Cell Carcinoma
8565,Dilated Vascular Space Formation,Glomangiomatosis
8566,Indolent Clinical Course,Small Intestinal Angiosarcoma
8567,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion
8568,Intermediate Filaments Present,Secondary Central Chondrosarcoma
8569,Diffuse Lesion,Sphenoid Sinus Schneiderian Papilloma
8570,Aggressive Clinical Course,Ann Arbor Stage II Grade 1 Follicular Lymphoma
8571,atypia morphology,Cartilaginous exostosis
8572,Mixed Neoplastic Glandular and Squamous Cell Population,Inflammatory carcinoma of breast stage III
8573,Mucoid Stroma Formation,papillary adenoma of extrahepatic bile duct
8574,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Adult Acute Megakaryoblastic Leukemia
8575,Chronic Clinical Course,Adult Acute Megakaryoblastic Leukemia
8576,Necrotic changes (finding),Adult Anaplastic Astrocytoma
8577,Intracytoplasmic Eosinophilic Inclusion,Stage I Uterine Sarcoma AJCC v7
8578,In Situ Lesion,"Carcinoma bladder stage I, without cancer in situ"
8579,Locally Aggressive Lesion,Non-Ossifying Fibroma
8580,Intracytoplasmic Eosinophilic Inclusion,Conventional Alveolar Rhabdomyosarcoma
8581,Precise Histogenesis Unknown,Mixed Oligodendroglioma-Astrocytoma
8582,Intracytoplasmic Eosinophilic Inclusion,Intimal sarcoma
8583,Mucoid Stroma Formation,Maxillary Sinus Inverted Papilloma
8584,Intermediate Filaments Present,Primary chondrosarcoma of bone
8585,Invasive Lesion,High Grade Corneal Intraepithelial Neoplasia
8586,Aggressive Clinical Course,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
8587,Intracytoplasmic Eosinophilic Inclusion,sarcoma of oral cavity
8588,Indolent Clinical Course,malignant myoepithelioma of breast
8589,High Mitotic Activity,Papillary ependymoma
8590,Benign Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v7
8591,Indolent Clinical Course,Cervical Alveolar Soft Part Sarcoma
8592,atypia morphology,Intramuscular Myxoma
8593,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary Leiomyomatosis and Renal Cell Cancer
8594,Benign Cellular Infiltrate,Malignant tumor of extrahepatic bile duct
8595,Cytologic atypia,Hyperplastic Polyp
8596,Benign Cellular Infiltrate,Stage IVA Gallbladder Carcinoma
8597,Tumor Vascular Invasion,Water-clear cell adenoma
8598,Indolent Clinical Course,Ovarian Liposarcoma
8599,Necrotic changes (finding),Conventional Schwannoma
8600,Mucoid Stroma Formation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
8601,Indolent Clinical Course,Malignant Giant Cell Tumor of Bone
8602,Mixed Cellular Population,Papilloma of nasal vestibule
8603,Squamous Differentiation,"Carcinoma, Large Cell"
8604,Histiocytosis,Immunoblastic Large-Cell Lymphoma
8605,Benign Cellular Infiltrate,Secondary malignant neoplasm of extrahepatic bile ducts
8606,Encapsulated Mass,Intrahepatic Bile Duct Microcystic Adenoma
8607,Premalignant Lesion,Adenocarcinoma of lung (disorder)
8608,Solid Growth Pattern,"Leukemia, Prolymphocytic, B-Cell"
8609,Indolent Clinical Course,rhabdomyosarcoma of prostate
8610,Mitotic Activity,"Gemistocytic Astrocytoma, IDH-Mutant"
8611,Mixed Epithelial Cell Population,Oropharyngeal squamous papilloma
8612,Intermediate Filaments Present,Recurrent Adult Soft Tissue Sarcoma
8613,Mucoid Stroma Formation,Papillary transitional cell neoplasm of low malignant potential
8614,Neuroendocrine Differentiation,Stage IV Skin Cancer
8615,Precise Histogenesis Unknown,Glioneuronal Tumor with Neuropil-Like Islands
8616,Indolent Clinical Course,AJCC Grade 3 Sarcoma
8617,Grade 4 Lesion,"Anaplastic Astrocytoma, IDH-Wildtype"
8618,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Lung Adenocarcinoma AJCC v7
8619,Malignant Germinomatous Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
8620,Diffuse Lesion,Skin Cavernous Hemangioma
8621,Malignant Germinomatous Cellular Infiltrate,Stage II Immature Testicular Teratoma AJCC v6 and v7
8622,Seminomatous Component Present,Intramedullary Spinal Cord Teratoma
8623,Benign Cellular Infiltrate,Small intestine carcinoma stage III
8624,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal squamous cell carcinoma stage III
8625,Mitotic Activity,Fibrillary Astrocytoma
8626,Indolent Clinical Course,leiomyosarcoma of fallopian tube
8627,High Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v7
8628,Mitotic Activity,Adult Diffuse Astrocytoma
8629,Benign Cellular Infiltrate,Perihilar Intrahepatic Cholangiocarcinoma
8630,Locally Aggressive Lesion,Periosteal fibroma
8631,Blasts of Mixed Phenotype Present,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
8632,Indolent Clinical Course,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8633,Mixed Neoplastic Glandular and Squamous Cell Population,Follicular thyroid carcinoma
8634,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx stage I
8635,Multilayered Rosette Formation,Adult Brain Medulloblastoma
8636,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Surface Papilloma
8637,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
8638,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage B Hepatocellular Carcinoma
8639,Seminomatous Component Present,Teratoma
8640,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1
8641,Borderline Lesion,Benign epithelial neoplasm of skin
8642,Favorable Clinical Outcome,Stage IIC Cutaneous Melanoma AJCC v6 and v7
8643,Mixed Neoplastic Glandular and Squamous Cell Population,Appendix Low Grade Intraepithelial Neoplasia
8644,Low Grade Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
8645,Benign Cellular Infiltrate,Paget Disease of the Anus
8646,Indolent Clinical Course,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified"
8647,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
8648,Mixture of Germ Cell Neoplastic Components Present,Monodermal Testicular Teratoma
8649,Benign Cellular Infiltrate,Ampulla of Vater Hepatoid Adenocarcinoma
8650,Indolent Clinical Course,sarcoma of trachea
8651,Indolent Clinical Course,Malignant Intracranial Neoplasm
8652,Indolent Clinical Course,Bladder Sarcoma
8653,Intermediate Filaments Present,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8654,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma of apocrine gland
8655,Favorable Clinical Outcome,Carcinoma of apocrine gland
8656,Indolent Clinical Course,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
8657,Aggressive Clinical Course,Spindle Cell Oncocytoma of the Adenohypophysis
8658,Mixed Neoplastic Glandular and Squamous Cell Population,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma
8659,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Intraepithelial Neoplasia
8660,Aggressive Clinical Course,Colon Mucosa-Associated Lymphoid Tissue Lymphoma
8661,Mixed Neoplastic Glandular and Squamous Cell Population,Krukenberg Tumor
8662,Invasive Lesion,"Adenoma, Sweat Gland"
8663,Nuclear Grooves,Microfollicular adenoma
8664,Composite Lesion,Micronodular thymoma with lymphoid stroma
8665,Dysplasia,"Adenoma, Sweat Gland"
8666,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell choriocarcinoma stage II
8667,Indolent Clinical Course,Malignant neoplasm of soft tissue
8668,Intermediate Filaments Present,Stage IIIA Uterine Sarcoma AJCC v7
8669,Intermediate Filaments Present,Rhabdomyosarcoma
8670,Aggressive Clinical Course,Splenic Lymphoplasmacytic Lymphoma
8671,Low Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma
8672,Intracytoplasmic Eosinophilic Inclusion,Sarcoma NCI Grade 2
8673,Glandular Differentiation,Stage IIIB Lung Large Cell Carcinoma AJCC v7
8674,Benign Cellular Infiltrate,Esophageal squamous cell carcinoma recurrent
8675,Indolent Clinical Course,"Cranial Nerve Neoplasms, Malignant"
8676,Nuclear Clearing,Thyroid Gland Clear Cell Follicular Adenoma
8677,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Biphasic or Triphasic Teratoma
8678,Mixed Neoplastic Glandular and Squamous Cell Population,Eccrine carcinoma of skin
8679,Intracytoplasmic Eosinophilic Inclusion,Angiosarcoma non-metastatic
8680,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Fetiform Teratoma
8681,Intracytoplasmic Eosinophilic Inclusion,Kaposi Sarcoma
8682,Premalignant Lesion,Adenosquamous cell lung cancer stage IIIB
8683,Locally Aggressive Lesion,Subcutaneous Nodular Fasciitis
8684,Premalignant Lesion,Stage II Lung Cancer AJCC v6
8685,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Teratoma
8686,Benign Cellular Infiltrate,Primary serous papillary carcinoma of peritoneum
8687,Intermediate Filaments Present,Meningeal sarcomatosis
8688,Nuclear Pseudoinclusion,Thyroid Gland Signet Ring Cell Follicular Adenoma
8689,Cytologic atypia,Gastric hyperplastic polyp
8690,Intermediate Filaments Present,sarcoma of vagina
8691,Local disease,Pulmonary lymphangioleiomyomatosis
8692,Intracytoplasmic Eosinophilic Inclusion,Intraocular Malignant Peripheral Nerve Sheath Tumor
8693,Indolent Clinical Course,leiomyosarcoma of lung
8694,High Grade Lesion,Sclerosing liposarcoma
8695,Solid Growth Pattern,Philadelphia-Positive Myelogenous Leukemia
8696,Intermediate Filaments Present,Gastrointestinal Stromal Sarcoma
8697,Mucoid Stroma Formation,Follicular Variant Thyroid Gland Papillary Carcinoma
8698,Seminomatous Component Present,Dermoid Cyst
8699,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Carcinoma
8700,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Intestinal-Type Adenocarcinoma
8701,Mixed Neoplastic Glandular and Squamous Cell Population,Colloid Carcinoma of the Pancreas
8702,Squamous Differentiation,large cell neuroendocrine carcinoma of thymus
8703,Mixed Neoplastic Glandular and Squamous Cell Population,carcinoma of pancreas with osteoclast-like giant cells
8704,Intracytoplasmic Eosinophilic Inclusion,Vulvar Alveolar Soft Part Sarcoma
8705,Mixed Neoplastic Glandular and Squamous Cell Population,Intestinal-Type Sinonasal Adenocarcinoma
8706,Intermediate Filaments Present,Stage IB Bone Sarcoma AJCC v7
8707,Intracytoplasmic Eosinophilic Inclusion,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
8708,Squamous Differentiation,Gastric Large Cell Neuroendocrine Carcinoma
8709,High Mitotic Activity,Bizarre leiomyoma
8710,Indolent Clinical Course,Adult Angiosarcoma
8711,Low Grade Lesion,Adult Angiosarcoma
8712,Benign Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v6
8713,Indolent Clinical Course,AIDS-Related Gastric Kaposi Sarcoma
8714,Borderline Lesion,Benign neoplasm of sebaceous gland
8715,High Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor
8716,Precise Histogenesis Unknown,Recurrent Childhood Fibrillary Astrocytoma
8717,Favorable Clinical Outcome,Fibrolamellar Hepatocellular Carcinoma
8718,Mucoid Stroma Formation,Anal Verrucous Carcinoma
8719,Intermediate Filaments Present,Sclerosing rhabdomyosarcoma
8720,Indolent Clinical Course,Stage II Bone Cancer AJCC v7
8721,Papillary Pattern,Low Grade Ductal Breast Carcinoma In Situ
8722,Intermediate Filaments Present,Parotid Gland Kaposi Sarcoma
8723,Indolent Clinical Course,Malignant Intracranial Neoplasms By Morphology
8724,atypia morphology,Myxoma of the Endocardium
8725,Diffuse Lesion,inverted ductal papilloma of salivary gland
8726,Aggressive Clinical Course,Extranodal marginal zone B-cell lymphoma (MALT type) stage III
8727,Mixed Neoplastic Glandular and Squamous Cell Population,keratinizing squamous cell carcinoma of vulva
8728,Mixture of Germ Cell Neoplastic Components Present,Choriocarcinoma of ovary
8729,Favorable Clinical Outcome,Stage III Cutaneous Melanoma AJCC v6
8730,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Dermoid Cyst
8731,Intermediate Filaments Present,liposarcoma of breast
8732,Indolent Clinical Course,Bone Sarcoma
8733,Favorable Clinical Outcome,Early Hepatocellular Carcinoma
8734,Benign Cellular Infiltrate,small cell carcinoma of extrahepatic bile duct
8735,Favorable Clinical Outcome,Vulvar Adenocarcinoma of Sweat Gland Type
8736,Intracytoplasmic Eosinophilic Inclusion,Secondary Central Chondrosarcoma
8737,Mixed Cellular Population,Lung Squamous Cell Papilloma
8738,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor
8739,Intracytoplasmic Eosinophilic Inclusion,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
8740,Benign Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma
8741,Premalignant Lesion,Combined Lung Large Cell Neuroendocrine Carcinoma
8742,Mixed Neoplastic Glandular and Squamous Cell Population,Major Salivary Gland Acinic Cell Carcinoma
8743,Mixed Neoplastic Glandular and Squamous Cell Population,Appendix Villous Adenoma
8744,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus High Grade Endometrial Stromal Sarcoma
8745,Mucoid Stroma Formation,Papillary tumor of renal pelvis
8746,Intermediate Filaments Present,Gastric Synovial Sarcoma
8747,Borderline Lesion,Thyroid Gland Hyperfunctioning Adenoma
8748,"Undifferentiated ""Fetal-Type"" Tissues Present",Mature Testicular Teratoma
8749,Mixed Neoplastic Glandular and Squamous Cell Population,"Glandular intraepithelial neoplasia, low grade"
8750,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Peritoneal High Grade Serous Adenocarcinoma
8751,Intermediate Filaments Present,Hemangiosarcoma
8752,Borderline Lesion,Ovarian Fibromata
8753,Locally Aggressive Lesion,Osteochondromyxoma
8754,HMB-45-Positive Neoplastic Cells Present,Eosinophilic Granuloma
8755,Intermediate Filaments Present,Gastric Liposarcoma
8756,Premalignant Lesion,Breast Carcinoma Metastatic in the Lung
8757,Favorable Clinical Outcome,Malignant Apocrine Neoplasm
8758,Dysplasia,Benign Apocrine Neoplasm
8759,Benign Cellular Infiltrate,Lymphoepithelioma-Like Hepatocellular Carcinoma
8760,Precise Histogenesis Unknown,Adult Anaplastic Ependymoma
8761,Mixed Neoplastic Glandular and Squamous Cell Population,Benign squamous cell tumor
8762,Mixed Neoplastic Glandular and Squamous Cell Population,Microcystic adnexal carcinoma
8763,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal adenocarcinoma
8764,Premalignant Lesion,Lung Biphasic Synovial Sarcoma
8765,Invasive Lesion,Transitional Cell Intraepithelial Neoplasia
8766,Indolent Clinical Course,Melanotic malignant nerve sheath tumor
8767,Intermediate Filaments Present,Cardiac Fibrosarcoma
8768,Indolent Clinical Course,Chordoma of clivus
8769,Diffuse Lesion,ductal papilloma of salivary gland
8770,Benign Cellular Infiltrate,Stage IIIB Anal Canal Cancer AJCC v6 and v7
8771,High Mitotic Activity,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
8772,Aggressive Clinical Course,Marginal zone lymphoma stage IV
8773,Diffuse Lesion,Vestibular Papilloma
8774,Chronic Clinical Course,Acute myeloid leukemia with mutated NPM1
8775,Intracytoplasmic Eosinophilic Inclusion,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
8776,Benign Cellular Infiltrate,Recurrent Hepatocellular Carcinoma
8777,Necrotic changes (finding),"Anaplastic Astrocytoma, IDH-Mutant"
8778,Intracytoplasmic Eosinophilic Inclusion,Liposarcoma non-metastatic
8779,Severe cytologic atypia,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
8780,High Grade Lesion,Clivus Chondroid Chordoma
8781,Prominent Schwannian Stroma Present,Retinoblastoma
8782,Intermediate Filaments Present,Periosteal Osteosarcoma
8783,Benign Cellular Infiltrate,Colorectal Adenosquamous Carcinoma
8784,Anaplasia,Pleomorphic Xanthoastrocytoma
8785,Grade 4 Lesion,Childhood Cerebral Diffuse Astrocytoma
8786,Seminomatous Component Present,Central Nervous System Teratoma
8787,Precise Histogenesis Unknown,Adult Diffuse Astrocytoma
8788,Mucoid Stroma Formation,Papillary adenocarcinoma
8789,Neuroendocrine Differentiation,Stage II Skin Cancer
8790,Indolent Clinical Course,liposarcoma of bone
8791,Benign Cellular Infiltrate,Rectal Signet Ring Cell Adenocarcinoma
8792,Well-Circumscribed Lesion,Dupuytren Contracture
8793,CD35-Positive Neoplastic Cells Present,Histiocytic sarcoma
8794,Benign Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v7
8795,Precise Histogenesis Unknown,Pituitary Gland Gangliocytoma
8796,bone marrow fibrosis,"Thrombocythemia, Essential"
8797,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of extrahepatic bile duct
8798,Tubular Structures Present,Lipid cell tumor of ovary
8799,Solid Growth Pattern,Meningeal Leukemia
8800,Keratin pearl formation,Nasopharyngeal lymphoepithelioma recurrent
8801,Keratin pearl formation,Nasopharyngeal lymphoepithelioma stage I
8802,Mixed Neoplastic Glandular and Squamous Cell Population,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
8803,Seminomatous Component Present,Liver Teratoma
8804,Infiltrative Growth Pattern,Nuchal-type fibroma
8805,Intermediate Filaments Present,"Leiomyosarcoma, Myxoid"
8806,Malignant Germinomatous Cellular Infiltrate,Adult Yolk Sac Tumor
8807,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of nasopharynx
8808,Borderline Lesion,Anal Papillary Hidradenoma
8809,Benign Cellular Infiltrate,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
8810,Intracytoplasmic Eosinophilic Inclusion,Stage II Soft Tissue Sarcoma AJCC v7
8811,CD56-Positive Neoplastic Cells Present,Subcutaneous panniculitis-like T-cell lymphoma
8812,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline cystadenoma
8813,Favorable Clinical Outcome,Vulvar Clear Cell Hidradenocarcinoma
8814,Mixed Neoplastic Glandular and Squamous Cell Population,Glandular cell neoplasm
8815,Metastatic Lesion,AIDS-Related Primary Central Nervous System Lymphoma
8816,Seminomatous Component Present,Testicular Monophasic Choriocarcinoma
8817,Squamous Differentiation,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
8818,Premalignant Lesion,mucoepidermoid carcinoma of lung
8819,Nuclear Clearing,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
8820,Intracytoplasmic Eosinophilic Inclusion,Recurrent Kaposi Sarcoma
8821,Diffuse Lesion,"Schneiderian papilloma, inverted"
8822,Benign Cellular Infiltrate,Malignant neoplasm of stomach stage I
8823,Indolent Clinical Course,Childhood Soft Tissue Sarcoma
8824,Solid Growth Pattern,Aleukemic Leukemia Cutis
8825,Favorable Clinical Outcome,Malignant eccrine spiradenoma
8826,Seminomatous Component Present,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
8827,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 2 Endometrial Endometrioid Adenocarcinoma
8828,Indolent Clinical Course,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
8829,Benign Cellular Infiltrate,High Grade Appendix Mucinous Adenocarcinoma
8830,High Mitotic Activity,Leiomyoma of esophagus
8831,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma recurrent
8832,Invasive Lesion,"Adenoma, Sweat Gland"
8833,Benign Cellular Infiltrate,Pancreatic Large Cell Neuroendocrine Carcinoma
8834,Intracytoplasmic Eosinophilic Inclusion,Anal Rhabdomyosarcoma
8835,Mixture of Germ Cell Neoplastic Components Present,"Testicular Yolk Sac Tumor, Enteric Pattern"
8836,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma
8837,Mixed Neoplastic Glandular and Squamous Cell Population,Paget Disease
8838,Benign Cellular Infiltrate,sarcoma of esophagus
8839,Well-Circumscribed Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
8840,Indolent Clinical Course,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone
8841,Invasive Lesion,Piloleiomyoma
8842,Ineffective hematopoiesis,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
8843,Dysplasia,Apocrine cystadenoma
8844,Glandular Differentiation,Stage IIIA Lung Large Cell Carcinoma AJCC v7
8845,Premalignant Lesion,Stage IIA Lung Adenosquamous Carcinoma AJCC v7
8846,Benign Cellular Infiltrate,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
8847,Seminomatous Component Present,Grade 1 Ovarian Teratoma
8848,Precise Histogenesis Unknown,Gliomatosis Cerebri Type II
8849,Nuclear Clearing,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
8850,Nuclear Pseudoinclusion,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
8851,Benign Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v6
8852,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
8853,Ground Glass Nuclear Inclusion,Thyroid Hurthle Cell Carcinoma
8854,Nuclear Pseudoinclusion,Thyroid Hurthle Cell Carcinoma
8855,Necrotic changes (finding),Sternal Intraosseous Schwannoma
8856,Malignant Germinomatous Cellular Infiltrate,Ovarian Cystic Teratoma
8857,Endophytic Tumor Growth,Condyloma acuminata of vagina
8858,Intermediate Filaments Present,Cardiac Sarcoma
8859,Localized Lesion,DS Stage I Plasma Cell Myeloma
8860,Invasive Lesion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
8861,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
8862,Indolent Clinical Course,Central Nervous System Angiosarcoma
8863,Locally Aggressive Lesion,Cellular fibroma
8864,Indolent Clinical Course,Childhood Glioblastoma
8865,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of vagina
8866,Benign Cellular Infiltrate,Squamous Cell Bile Duct Carcinoma
8867,Mitotic Activity,Pleural Well Differentiated Papillary Mesothelioma
8868,Intracytoplasmic Eosinophilic Inclusion,Distal-Type Epithelioid Sarcoma
8869,Solid Growth Pattern,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta
8870,Gastric-Type Epithelial Differentiation,tubular adenoma of stomach
8871,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Clear Cell Adenocarcinoma
8872,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Signet Ring Cell Carcinoma
8873,Well-Circumscribed Lesion,alveolar rhabdomyosarcoma of orbit
8874,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
8875,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Tubular Adenoma
8876,Mixed Neoplastic Glandular and Squamous Cell Population,Follicular Variant Thyroid Gland Papillary Carcinoma
8877,Ineffective hematopoiesis,Chronic Neutrophilic Leukemia
8878,Intermediate Filaments Present,Virus-Related Sarcoma
8879,Seminomatous Component Present,"Struma ovarii, malignant"
8880,Metastatic Lesion,ACTH-Secreting Pituitary Adenoma
8881,Solid Growth Pattern,Acute myelomonocytic leukemia
8882,Chronic Clinical Course,Infant T Acute Lymphoblastic Leukemia
8883,Acinar Cell Differentiation,Colloid Carcinoma of the Pancreas
8884,Mixed Neoplastic Glandular and Squamous Cell Population,Mucinous Adenocarcinoma
8885,Indolent Clinical Course,Vulvar Alveolar Soft Part Sarcoma
8886,Grade 4 Lesion,Astrocytoma of brain
8887,Anaplasia,Childhood Pleomorphic Xanthoastrocytoma
8888,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of the prostate stage III
8889,Intermediate Filaments Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
8890,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Teratoma
8891,Mitotic Activity,Recurrent Childhood Diffuse Astrocytoma
8892,Diffuse Lesion,Peripheral Breast Papilloma
8893,Grade 4 Lesion,Visual Pathway Astrocytoma
8894,Mixed Neoplastic Glandular and Squamous Cell Population,Submandibular Gland Adenocarcinoma
8895,Invasive Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ
8896,Poorly Differentiated Lesion,Gastric Carcinoid Tumor
8897,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
8898,Mixed Neoplastic Glandular and Squamous Cell Population,Moderate pancreatic duct dysplasia
8899,Aggressive Clinical Course,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma
8900,Aggressive Clinical Course,mucosa-associated lymphoid tissue (MALT) lymphoma of breast
8901,Mitotic Activity,Solitary Osteochondroma
8902,Favorable Clinical Outcome,Stage I Cutaneous Melanoma AJCC v6
8903,Severe cytologic atypia,Functioning Pancreatic Neuroendocrine Tumor G2
8904,High Mitotic Activity,Myxoid leiomyoma
8905,Intracytoplasmic Eosinophilic Inclusion,Leiomyosarcoma of stomach
8906,Benign Cellular Infiltrate,Immunoproliferative Small Intestinal Disease
8907,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Teratoma AJCC v6 and v7
8908,Mixed Neoplastic Glandular and Squamous Cell Population,Intraductal papillary adenocarcinoma with invasion
8909,Intracytoplasmic Eosinophilic Inclusion,Breast Extraskeletal Osteosarcoma
8910,Increased Cellularity Present,Cartilaginous exostosis
8911,Intermediate Filaments Present,Well Differentiated Fibrosarcoma
8912,Indolent Clinical Course,Post-Radiotherapy Breast Angiosarcoma
8913,Benign Cellular Infiltrate,Colorectal Serrated Adenocarcinoma
8914,Aggressive Clinical Course,Diffuse follicle center lymphoma
8915,Intermediate Filaments Present,Stage IVA Uterine Sarcoma AJCC v7
8916,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Papillary Cystadenoma
8917,Chronic Clinical Course,Infant Acute Lymphoblastic Leukemia
8918,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary mucinous cystadenocarcinoma
8919,Mucoid Stroma Formation,"Papilloma, Intraductal"
8920,Precise Histogenesis Unknown,Recurrent Childhood Pilocytic Astrocytoma
8921,Dysplasia,Trichoepithelioma
8922,Favorable Clinical Outcome,Superficial basal cell carcinoma
8923,Indolent Clinical Course,malignant neurologic neoplasms
8924,Mucoid Stroma Formation,serous surface papillary carcinoma of ovary
8925,Indolent Clinical Course,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
8926,Indolent Clinical Course,Gastric Liposarcoma
8927,Invasive Lesion,Cervical Intraepithelial Neoplasia
8928,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Fallopian Tube Serous Adenocarcinoma
8929,Mixed Neoplastic Glandular and Squamous Cell Population,Hereditary clear cell renal cell carcinoma
8930,CD15-Positive Neoplastic Cells Present,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma
8931,Indolent Clinical Course,Kaposi's sarcoma of extrahepatic bile duct
8932,Benign Cellular Infiltrate,Colorectal Hodgkin Lymphoma
8933,Indolent Clinical Course,Adult Synovial Sarcoma
8934,Seminomatous Component Present,Mature Mediastinal Teratoma
8935,Benign Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v7
8936,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder squamous cell carcinoma
8937,Borderline Lesion,Ovarian Endometrioid Cystadenoma
8938,Benign Cellular Infiltrate,Adenocarcinoma of anal glands
8939,Benign Cellular Infiltrate,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
8940,Encapsulated Mass,Melanotic neurofibroma
8941,Endophytic Tumor Growth,Plantar wart
8942,Diffuse Lesion,Squamous Papilloma of the Nasopharynx
8943,Pushing Tumor Margin,Condyloma anal
8944,Intracytoplasmic Eosinophilic Inclusion,Extraskeletal osteosarcoma recurrent
8945,Favorable Clinical Outcome,Localized Non-Resectable Adult Liver Carcinoma
8946,Severe cytologic atypia,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
8947,Mixed Neoplastic Glandular and Squamous Cell Population,squamous cell carcinoma of middle ear
8948,Locally Aggressive Lesion,Fibromatosis colli
8949,Benign Cellular Infiltrate,Small intestine carcinoma stage II
8950,Favorable Clinical Outcome,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
8951,Histiocytosis,Recurrent Adult Immunoblastic Lymphoma
8952,Benign Cellular Infiltrate,Colorectal Small Cell Neuroendocrine Carcinoma
8953,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx recurrent
8954,Solid Growth Pattern,Burkitt Leukemia
8955,Mitotic Activity,Adult Pineocytoma
8956,Mixed Neoplastic Glandular and Squamous Cell Population,Buschke-Lowenstein Tumor
8957,Intestinal metaplasia,Rectal Signet Ring Cell Adenocarcinoma
8958,Intracytoplasmic Eosinophilic Inclusion,sarcoma of central nervous system
8959,Benign Cellular Infiltrate,Gastric Adenocarcinoma
8960,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, endocervical type"
8961,Benign Cellular Infiltrate,Colon Small Cell Neuroendocrine Carcinoma
8962,Pleural effusion disorder,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
8963,Infiltrative Growth Pattern,Fibroma of lung
8964,Low Mitotic Activity,Gastric Small Cell Carcinoma
8965,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial Mixed Cell Adenocarcinoma
8966,Mixed Neoplastic Glandular and Squamous Cell Population,Skin Basaloid Carcinoma
8967,Metastatic Lesion,Cerebral Lymphoma in Immunocompetent Host
8968,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx stage III
8969,Indolent Clinical Course,Fibromyxosarcoma
8970,Mixed Cellular Population,Pedunculated conjunctival papilloma
8971,Indolent Clinical Course,Central Nervous System Mixed Germ Cell Tumor
8972,Diffuse Lesion,"Hemangioma, Intramuscular"
8973,Precise Histogenesis Unknown,Recurrent Childhood Anaplastic Oligoastrocytoma
8974,Endophytic Tumor Growth,Condyloma acuminata of vulva
8975,Invasive Lesion,Benign epithelial neoplasm of skin
8976,Squamous Differentiation,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
8977,Intermediate Filaments Present,Bone Surface (Peripheral) Osteosarcoma
8978,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
8979,Favorable Clinical Outcome,Liver carcinoma
8980,Chronic Clinical Course,Childhood Acute Myeloid Leukemia Not Otherwise Specified
8981,Indolent Clinical Course,Secondary Central Nervous System Non-Hodgkin Lymphoma
8982,Dysplasia,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
8983,Benign Cellular Infiltrate,Malignant neoplasm of stomach stage II
8984,Metastatic Lesion,canalicular adenoma of salivary gland
8985,Stromal Invasion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
8986,Mixed Neoplastic Glandular and Squamous Cell Population,basal cell adenocarcinoma of salivary gland
8987,Intestinal metaplasia,Krukenberg Tumor
8988,Premalignant Lesion,Lung squamous cell carcinoma recurrent
8989,Tumor Vascular Invasion,Microfollicular adenoma
8990,Indolent Clinical Course,sarcoma of penis
8991,Tumor Vascular Invasion,Compact Cell Adrenal Cortical Adenoma
8992,Intermediate Filaments Present,Stage IB Uterine Sarcoma AJCC v7
8993,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
8994,Multilayered Rosette Formation,Familial Adenomatous Polyposis Associated Medulloblastoma
8995,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell choriocarcinoma stage IV
8996,Intermediate Filaments Present,rhabdomyosarcoma of liver
8997,Mucoid Stroma Formation,Tall Cell Variant Thyroid Gland Papillary Carcinoma
8998,Intracytoplasmic Eosinophilic Inclusion,Recurrent Childhood Soft Tissue Sarcoma
8999,Borderline Lesion,Seminal Vesicle Cystadenoma
9000,Borderline Lesion,Sebaceoma
9001,Gastric-Type Epithelial Differentiation,villous adenoma of stomach
9002,Intermediate Filaments Present,liposarcoma of kidney
9003,Mixed Neoplastic Glandular and Squamous Cell Population,Laryngeal Acantholytic Squamous Cell Carcinoma
9004,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
9005,Borderline Lesion,Ovarian Cellular Fibroma
9006,Borderline Lesion,Adenoma of lung
9007,Favorable Clinical Outcome,Stage IIIB Hepatocellular Carcinoma AJCC v7
9008,Nuclear Grooves,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
9009,Severe dysplasia,Pancreatic Intraductal Papillary-Mucinous Adenoma
9010,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Spindle Cell Carcinoma
9011,Fatty degeneration,Beta-Catenin-Activated Hepatocellular Adenoma
9012,Intracytoplasmic Eosinophilic Inclusion,Stage IB Osteosarcoma AJCC v7
9013,Invasive Lesion,Intraductal Cribriform Breast Adenocarcinoma
9014,Indolent Clinical Course,Adult Rhabdomyosarcoma
9015,Intermediate Filaments Present,Secondary Chondrosarcoma
9016,Locally Aggressive Lesion,Benign Bone Schwannoma
9017,Favorable Clinical Outcome,Stage III Lip Basal Cell Carcinoma
9018,Tubular Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
9019,Infiltrative Growth Pattern,fibroma of testis
9020,Locally Aggressive Lesion,Benign Notochordal Cell Tumor
9021,Benign Cellular Infiltrate,Recurrent Adult Hepatocellular Carcinoma
9022,Indolent Clinical Course,Plasma Cell Post-Transplant Lymphoproliferative Disorder
9023,Borderline Lesion,Lung Mixed Squamous Cell and Glandular Papilloma
9024,Dysplasia,Lipoma of skin
9025,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Proliferating Brenner Tumor
9026,Precise Histogenesis Unknown,WHO Grade III Glioma
9027,Squamous Differentiation,Large cell neuroendocrine carcinoma
9028,Mixed Neoplastic Glandular and Squamous Cell Population,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
9029,Diffuse Lesion,Schneiderian papilloma
9030,Mixed Neoplastic Glandular and Squamous Cell Population,High Grade Anal Canal Squamous Intraepithelial Neoplasia
9031,Chronic Clinical Course,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
9032,Aggressive Clinical Course,Recurrent Grade 1 Follicular Lymphoma
9033,Papillary Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma
9034,Benign Cellular Infiltrate,Postsurgical Stage II Hepatoblastoma
9035,Auer Rods Present,Childhood Acute Myeloid Leukemia with Minimal Differentiation
9036,Favorable Clinical Outcome,Grade 2 Cutaneous Follicular Lymphoma
9037,Indolent Clinical Course,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
9038,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
9039,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenocarcinoma, Mucinous"
9040,Dysplasia,Perifollicular fibroma
9041,Composite Lesion,Thymoma malignant invasive
9042,Intermediate Filaments Present,Adult Pleomorphic Rhabdomyosarcoma
9043,Benign Cellular Infiltrate,Malignant melanoma of anus
9044,Acute Clinical Course,Chronic lymphocytic leukemia stage 3
9045,Benign Cellular Infiltrate,Gastric Diffuse Large B-Cell Lymphoma
9046,Mixed Neoplastic Glandular and Squamous Cell Population,Digital papillary eccrine carcinoma of skin
9047,Indolent Clinical Course,Stage IIB Osteosarcoma AJCC v7
9048,Indolent Clinical Course,Uterine Corpus Epithelioid Leiomyosarcoma
9049,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Teratoma AJCC v6 and v7
9050,Intermediate Filaments Present,Secondary Peripheral Chondrosarcoma
9051,Mixed Neoplastic Glandular and Squamous Cell Population,Acinar cell adenoma
9052,Indolent Clinical Course,Adult Fibrosarcoma
9053,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor
9054,Invasive Lesion,Low Grade Esophageal Squamous Intraepithelial Neoplasia
9055,Intermediate Filaments Present,Stage I Uterine Sarcoma AJCC v7
9056,Mixed Neoplastic Glandular and Squamous Cell Population,Appendix Mucinous Cystadenoma
9057,Indolent Clinical Course,Kaposi's sarcoma of conjunctiva
9058,Mixed Neoplastic Glandular and Squamous Cell Population,Solid Lung Adenocarcinoma
9059,Multilayered Rosette Formation,Desmoplastic Medulloblastoma
9060,Carcinomatous Component Present,Mixed Salivary Gland Tumor
9061,Papillary Pattern,Salivary duct carcinoma
9062,Intermediate Filaments Present,Central Nervous System Kaposi Sarcoma
9063,Intracytoplasmic Eosinophilic Inclusion,leiomyosarcoma of breast
9064,Indolent Clinical Course,Vaginal Rhabdomyosarcoma
9065,Capsular Invasion,Thyroid Gland Hyperfunctioning Adenoma
9066,Borderline Lesion,Pilomatrixoma
9067,Acute Clinical Course,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA
9068,Intracytoplasmic Eosinophilic Inclusion,Vulvar Alveolar Rhabdomyosarcoma
9069,Indolent Clinical Course,Vulvar Alveolar Rhabdomyosarcoma
9070,Tumor Vascular Invasion,Cortisol-Producing Adrenal Cortex Adenoma
9071,Dysplasia,Tufted angioma of skin
9072,Seminomatous Component Present,Testicular Dermoid Cyst
9073,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Cystosarcoma Phyllodes
9074,Indolent Clinical Course,Secondary Central Nervous System Lymphoma
9075,Mixed Neoplastic Glandular and Squamous Cell Population,Non-Hereditary Clear Cell Renal Cell Carcinoma
9076,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of renal pelvis
9077,Indolent Clinical Course,Childhood Fibrosarcoma
9078,High Mitotic Activity,Childhood Supratentorial Ependymoma
9079,Dysplasia,Cutaneous Fibrous Histiocytoma
9080,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Serous Tumor
9081,Intermediate Filaments Present,Osteosarcoma recurrent
9082,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
9083,Mucoid Stroma Formation,Papillary Breast Neoplasm
9084,Junctional Proliferation,Vulvar Blue Nevus
9085,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma of lung stage IIIB
9086,Benign Cellular Infiltrate,Cecum Non-Hodgkin Lymphoma
9087,Premalignant Lesion,Small cell lung cancer extensive stage
9088,Intracytoplasmic Eosinophilic Inclusion,Alveolar rhabdomyosarcoma
9089,Intermediate Filaments Present,Lung Synovial Sarcoma
9090,Benign Cellular Infiltrate,rhabdomyosarcoma of extrahepatic bile duct
9091,Mixed Neoplastic Glandular and Squamous Cell Population,Plantar wart
9092,Mixed Neoplastic Glandular and Squamous Cell Population,Anterior Tongue Squamous Cell Carcinoma
9093,Intracytoplasmic Eosinophilic Inclusion,"Perineurioma, malignant"
9094,Grade 4 Lesion,Diffuse Astrocytoma
9095,Solid Growth Pattern,Acute Myeloid Leukemia with FLT3/ITD Mutation
9096,Intermediate Filaments Present,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
9097,Intracytoplasmic Eosinophilic Inclusion,AJCC Grade 2 Sarcoma
9098,Microvascular Proliferation,Secondary Supratentorial Anaplastic Astrocytoma
9099,Intracytoplasmic Eosinophilic Inclusion,rhabdomyosarcoma of testis
9100,High Mitotic Activity,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
9101,Aggressive Clinical Course,Lymphoplasmacytoid lymphoma/immunocytoma stage III
9102,Intermediate Filaments Present,Breast Rhabdomyosarcoma
9103,Mucoid Stroma Formation,Fallopian Tube Papillary Adenocarcinoma
9104,High Mitotic Activity,insulinoma
9105,Dysplasia,Seborrheic keratosis
9106,Indolent Clinical Course,Well Differentiated Leiomyosarcoma
9107,Solid Growth Pattern,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant"
9108,Multilayered Rosette Formation,Adult Medulloblastoma
9109,Solid Growth Pattern,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation
9110,Intermediate Filaments Present,Chondrosarcoma localised
9111,Mixed Cellular Population,Vestibular Micropapillomatosis
9112,Indolent Clinical Course,CNS metastases
9113,Malignant Germinomatous Cellular Infiltrate,Childhood Immature Teratoma
9114,Mixed Neoplastic Glandular and Squamous Cell Population,Vulvar Inverted Follicular Keratosis
9115,Benign Cellular Infiltrate,Pleomorphic Hepatocellular Carcinoma
9116,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Papillary Cystadenoma
9117,Severe cytologic atypia,Vipoma
9118,Precise Histogenesis Unknown,Myxopapillary ependymoma
9119,Severe cytologic atypia,Stage III Appendix Neuroendocrine Tumor AJCC v7
9120,Intermediate Filaments Present,Sarcoma of breast
9121,Borderline Lesion,Ovarian serous cystadenofibroma
9122,Borderline Lesion,Parathyroid transitional clear cell adenoma
9123,Intermediate Filaments Present,Kaposi's sarcoma classical type
9124,Indolent Clinical Course,Kaposi's sarcoma classical type
9125,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Serous Adenocarcinoma
9126,Indolent Clinical Course,Recurrent Childhood Anaplastic Oligodendroglioma
9127,Intermediate Filaments Present,Undifferentiated round cell sarcoma
9128,Intracytoplasmic Eosinophilic Inclusion,Pulmonary Vein Leiomyosarcoma
9129,Indolent Clinical Course,Pulmonary Vein Leiomyosarcoma
9130,Indolent Clinical Course,Anaplastic (Malignant) Intracranial Meningioma
9131,Invasive Lesion,Low Grade Prostatic Intraepithelial Neoplasia
9132,Nuclear Pseudoinclusion,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
9133,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
9134,Intracytoplasmic Eosinophilic Inclusion,Thyroid Sarcoma
9135,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Yolk Sac Tumor
9136,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Clear Cell Cystadenofibroma
9137,Polymorphic Cellular Infiltrate,Monomorphic Post-Transplant Lymphoproliferative Disorder
9138,Borderline Lesion,Vulvar Syringoma
9139,Acinar Cell Differentiation,Pancreatic Ductal Adenocarcinoma
9140,Dysplasia,Squamous cell papilloma of skin
9141,Polymorphic Cellular Infiltrate,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
9142,Mixture of Germ Cell Neoplastic Components Present,Poor Prognosis Metastatic Gestational Trophoblastic Tumor
9143,Intermediate Filaments Present,leiomyosarcoma of retroperitoneum
9144,Precise Histogenesis Unknown,Pilomyxoid astrocytoma
9145,Severe cytologic atypia,Appendix Neuroendocrine Tumor
9146,Mixed Neoplastic Glandular and Squamous Cell Population,Sarcomatoid Intrahepatic Cholangiocarcinoma
9147,Solid Growth Pattern,Childhood Leukemia
9148,Invasive Lesion,Benign Germinative Follicular Epithelium Neoplasm
9149,Indolent Clinical Course,Epithelioid Sarcoma NCI Grade 2
9150,Malignant Germinomatous Cellular Infiltrate,Ovarian Dermoid Cyst with Secondary Tumor
9151,Indolent Clinical Course,sarcoma of anus
9152,Indolent Clinical Course,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
9153,Superficial Lesion,Intramuscular lipoma
9154,atypia morphology,"Retinoblastoma, spontaneously regressed"
9155,Benign Cellular Infiltrate,Liver Extraskeletal Osteosarcoma
9156,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
9157,Intracytoplasmic Eosinophilic Inclusion,Ovarian Angiosarcoma
9158,Favorable Clinical Outcome,Papillary Eccrine Carcinoma
9159,Indolent Clinical Course,Secondary malignant neoplasm of vertebral column
9160,Premalignant Lesion,Recurrent Lung Carcinoma Cell Type Unspecified
9161,Intracytoplasmic Eosinophilic Inclusion,Fibrosarcoma non-metastatic
9162,Benign Cellular Infiltrate,Resectable Malignant Liver Neoplasm
9163,Benign Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v7
9164,Mucoid Stroma Formation,Papillary cystic tumor
9165,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial adenocarcinoma
9166,Mixed Neoplastic Glandular and Squamous Cell Population,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
9167,Severe cytologic atypia,Ampulla of Vater Gangliocytic Paraganglioma
9168,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Rhabdomyosarcoma
9169,Invasive Lesion,"Acanthoma, Clear Cell"
9170,Intermediate Filaments Present,Childhood Mesenchymal Chondrosarcoma
9171,Polymorphic Cellular Infiltrate,Plasma Cell Post-Transplant Lymphoproliferative Disorder
9172,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Esophageal Adenocarcinoma AJCC v7
9173,Intermediate Filaments Present,Adult Alveolar Soft Part Sarcoma
9174,Diffuse Lesion,Lung Glandular Papilloma
9175,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the oral cavity recurrent
9176,Mixed Neoplastic Glandular and Squamous Cell Population,BCLC Stage C Adult Hepatocellular Carcinoma
9177,Invasive Lesion,Lipoma of skin
9178,Malignant Germinomatous Cellular Infiltrate,Endodermal sinus tumor of ovary
9179,Villous Pattern,tubular adenoma of gallbladder
9180,Endophytic Tumor Growth,Condyloma acuminata of cervix
9181,Severe cytologic atypia,Ovarian Low Grade Endometrioid Stromal Sarcoma
9182,Indolent Clinical Course,Stage IV Soft Tissue Sarcoma AJCC v7
9183,Mixed Neoplastic Glandular and Squamous Cell Population,Alcohol-Related Hepatocellular Carcinoma
9184,Aggressive Clinical Course,Primary Cutaneous Follicle Center Lymphoma
9185,Malignant Germinomatous Cellular Infiltrate,Testicular Non-Seminomatous Germ Cell Tumor
9186,Mixed Neoplastic Glandular and Squamous Cell Population,"Vulvar Adenocarcinoma, Intestinal-Type"
9187,Ground Glass Nuclear Inclusion,minimally invasive follicular carcinoma of the thyroid gland
9188,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Colon Adenocarcinoma
9189,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Verrucous Carcinoma
9190,Mixed Neoplastic Glandular and Squamous Cell Population,Mesonephroma
9191,Benign Cellular Infiltrate,Hepatoblastoma non-resectable
9192,Benign Cellular Infiltrate,Stage I Esophageal Cancer AJCC v7
9193,Premalignant Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma
9194,atypia morphology,Osteochondromatosis
9195,Borderline Lesion,sialadenoma papilliferum of salivary gland
9196,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Moderately Differentiated Squamous Cell Carcinoma
9197,Intracytoplasmic Eosinophilic Inclusion,Stage IIA Osteosarcoma AJCC v7
9198,Invasive Lesion,Intraductal breast neoplasm
9199,Mucoid Stroma Formation,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
9200,Intermediate Filaments Present,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
9201,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
9202,Intracytoplasmic Eosinophilic Inclusion,Extraskeletal osteosarcoma non-metastatic
9203,Intracytoplasmic Eosinophilic Inclusion,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
9204,Benign Cellular Infiltrate,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
9205,Mixed Neoplastic Glandular and Squamous Cell Population,Biliary Intraepithelial Neoplasia-1
9206,Mucoid Stroma Formation,Sphenoid Sinus Inverted Papilloma
9207,Malignant Germinomatous Cellular Infiltrate,Mature Testicular Teratoma
9208,Indolent Clinical Course,Extra-osseous Ewing's sarcoma recurrent
9209,Malignant Germinomatous Cellular Infiltrate,Thyroid Gland Teratoma
9210,Indolent Clinical Course,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
9211,Benign Cellular Infiltrate,Extrahepatic Bile Duct Neuroendocrine Carcinoma
9212,Borderline Lesion,Prostatic Adenoma
9213,Pushing Tumor Margin,Low Grade Endometrial Stromal Sarcoma
9214,Acute Clinical Course,Chronic lymphocytic leukemia refractory
9215,Indolent Clinical Course,Colorectal Leiomyosarcoma
9216,Indolent Clinical Course,Extrarenal Rhabdoid Tumor of the Liver
9217,Chronic Clinical Course,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
9218,Intermediate Filaments Present,Adult Synovial Sarcoma
9219,Benign Cellular Infiltrate,Primary hepatic neuroendocrine carcinoma
9220,Diffuse Lesion,Cardiac Intramuscular Hemangioma
9221,Acute Clinical Course,Prolymphocytic Leukemia
9222,Necrotic changes (finding),Deep Leiomyoma
9223,Papillary Pattern,Atypical Ductal Breast Hyperplasia
9224,Borderline Lesion,Ovarian Seromucinous Adenofibroma
9225,Indolent Clinical Course,Malignant tumor of choroid plexus
9226,Invasive Lesion,Plantar wart
9227,Well-Circumscribed Lesion,embryonal rhabdomyosarcoma of prostate
9228,Mixed Neoplastic Glandular and Squamous Cell Population,Diffuse Gastric Adenocarcinoma
9229,Benign Cellular Infiltrate,Stage IIIA Anal Canal Cancer AJCC v6 and v7
9230,High Grade Lesion,Cardiac Epithelioid Hemangioendothelioma
9231,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of breast with spindle cell metaplasia
9232,Premalignant Lesion,Stage IB Lung Squamous Cell Carcinoma AJCC v7
9233,Precise Histogenesis Unknown,Anaplastic astrocytoma
9234,Intracytoplasmic Eosinophilic Inclusion,Periosteal Osteosarcoma
9235,Indolent Clinical Course,"Liposarcoma, Pleomorphic"
9236,Extracutaneous Dissemination of Disease,Pagetoid reticulosis
9237,Diffuse Lesion,Cardiac hemangioma
9238,Metastatic Lesion,Benign Ameloblastoma
9239,Anaplasia,Cellular Ependymoma
9240,Prominent Schwannian Stroma Present,neuroblastoma of spinal cord
9241,Favorable Clinical Outcome,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
9242,Anaplasia,Adult Oligodendroglioma
9243,Neuroectodermal Differentiation,Extra-osseous Ewing's sarcoma
9244,Favorable Clinical Outcome,Stage I Liver Carcinoma
9245,Precise Histogenesis Unknown,Adult Brain Stem Gliosarcoma
9246,Malignant Germinomatous Cellular Infiltrate,Childhood Choriocarcinoma
9247,Seminomatous Component Present,Childhood Central Nervous System Mature Teratoma
9248,Metastatic Lesion,Cerebral Hodgkin Lymphoma
9249,Intermediate Filaments Present,Stage I Soft Tissue Sarcoma AJCC v7
9250,Mixed Neoplastic Glandular and Squamous Cell Population,Grade 3 Rectal Adenocarcinoma
9251,Indolent Clinical Course,Inferior Vena Cava Leiomyosarcoma
9252,Tubular Structures Present,Luteoma
9253,Intermediate Filaments Present,Pulmonary Artery Leiomyosarcoma
9254,Infiltrative Growth Pattern,Angiofibroma
9255,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Intraepithelial Neoplasia-1A
9256,Ground Glass Nuclear Inclusion,Childhood Thyroid Gland Follicular Carcinoma
9257,Intracytoplasmic Eosinophilic Inclusion,Uterine Angiosarcoma
9258,Intermediate Filaments Present,leiomyosarcoma of anus
9259,Metastatic Lesion,Pituitary Gland Microadenoma
9260,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Clear Cell Adenofibroma
9261,Benign Cellular Infiltrate,Small Intestinal Lymphoma
9262,Benign Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma
9263,Glandular Differentiation,Tonsillar Undifferentiated Carcinoma
9264,Indolent Clinical Course,Meningeal melanoma
9265,Nodules of Compact Keratin Present,Papillary craniopharyngioma
9266,Indolent Clinical Course,leiomyosarcoma of vulva
9267,Benign Cellular Infiltrate,Pancreatic carcinoma non-resectable
9268,Precise Histogenesis Unknown,Lhermitte-Duclos disease
9269,Benign Cellular Infiltrate,Squamous cell carcinoma of colon
9270,Benign Cellular Infiltrate,Colon Adenosquamous Carcinoma
9271,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell breast carcinoma
9272,Low Mitotic Activity,Colorectal Large Cell Neuroendocrine Carcinoma
9273,Solid Growth Pattern,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia
9274,Borderline Lesion,Pancreatic Acinar Cell Cystadenoma
9275,Mixed Neoplastic Glandular and Squamous Cell Population,Serous cystadenoma of pancreas
9276,Well-Circumscribed Lesion,"Fibromatosis, Plantar"
9277,Nuclear Pseudoinclusion,Thyroid Gland Lipoadenoma
9278,Favorable Clinical Outcome,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
9279,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Choriocarcinoma
9280,Mixed Neoplastic Glandular and Squamous Cell Population,Non-Small Cell Adenocarcinoma
9281,Benign Cellular Infiltrate,Rectal Kaposi Sarcoma
9282,Benign Cellular Infiltrate,Rectal Small Cell Neuroendocrine Carcinoma
9283,Malignant Cellular Infiltrate,Actinic keratosis
9284,Benign Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v7
9285,Mixed Neoplastic Glandular and Squamous Cell Population,Disseminated squamous cell carcinoma
9286,Metaplasia of Malignant Cells Present,"Adenocarcinoma, intestinal type"
9287,Endophytic Tumor Growth,Condyloma Acuminatum with Dysplasia
9288,Intermediate Filaments Present,Distal-Type Epithelioid Sarcoma
9289,Mixed Neoplastic Glandular and Squamous Cell Population,Intraductal Cribriform Breast Adenocarcinoma
9290,Benign Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma
9291,Precise Histogenesis Unknown,Optic Nerve Astrocytoma
9292,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
9293,Perineural spread,Parathyroid Gland Lipoadenoma
9294,Multilayered Rosette Formation,Melanotic medulloblastoma
9295,Mucoid Stroma Formation,Papillary mucinous cystadenoma
9296,Benign Cellular Infiltrate,Malignant neoplasm of upper third of esophagus
9297,Favorable Clinical Outcome,Ceruminous adenocarcinoma
9298,Mucoid Stroma Formation,Lung Glandular Papilloma
9299,Malignant Germinomatous Cellular Infiltrate,Adult Teratoma
9300,Squamous Differentiation,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
9301,Chronic Clinical Course,Childhood T Acute Lymphoblastic Leukemia
9302,High Mitotic Activity,Prostate Leiomyoma
9303,Benign Cellular Infiltrate,Ampulla of Vater Squamous Cell Carcinoma
9304,Metastatic Lesion,sebaceous adenoma of salivary gland
9305,Favorable Clinical Outcome,Anal margin Paget's disease
9306,Indolent Clinical Course,Mixed Liposarcoma
9307,Tissues Derived from Two or Three Embryonic Layers Present,Struma Ovarii
9308,Low Mitotic Activity,Gastric Large Cell Neuroendocrine Carcinoma
9309,Borderline Lesion,Schneiderian papilloma
9310,Indolent Clinical Course,Peripheral neuroepithelioma of bone metastatic
9311,Diffuse Lesion,"Transitional cell papilloma, inverted"
9312,Mixed Neoplastic Glandular and Squamous Cell Population,Ampulla of Vater Tubulovillous Adenoma
9313,Exophytic Polypoid Lesion,Flat adenoma
9314,Invasive Lesion,Central Breast Papilloma
9315,Intermediate Filaments Present,Primary Bone Osteosarcoma
9316,Mucoid Stroma Formation,Skin Papilloma
9317,Indolent Clinical Course,Recurrent Childhood Gliomatosis Cerebri
9318,Severe cytologic atypia,Recurrent Digestive System Neuroendocrine Tumor G1
9319,Invasive Lesion,Ancell-Spiegler cylindromas
9320,Squamous Differentiation,Minor Salivary Gland Undifferentiated Carcinoma
9321,Squamous Differentiation,Parotid Gland Undifferentiated Carcinoma
9322,Glandular Differentiation,NUT midline carcinoma
9323,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
9324,Intracytoplasmic Eosinophilic Inclusion,Stage IIB Osteosarcoma AJCC v7
9325,Indolent Clinical Course,Leiomyosarcoma of stomach
9326,Invasive Lesion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
9327,Intermediate Filaments Present,Retroperitoneal sarcoma
9328,Benign Cellular Infiltrate,Bile duct mucinous adenocarcinoma
9329,Seminomatous Component Present,Stage IV Ovarian Teratoma AJCC v6 and v7
9330,Diffuse Lesion,Lung Squamous Cell Papilloma
9331,Borderline Lesion,Lung Squamous Cell Papilloma
9332,Intracytoplasmic Eosinophilic Inclusion,sarcoma of testis
9333,Favorable Clinical Outcome,Basal cell carcinoma - keratotic
9334,Mixed Neoplastic Glandular and Squamous Cell Population,adenocarcinoma of middle ear
9335,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Endometrial Stromal Sarcoma
9336,Grade 4 Lesion,Protoplasmic astrocytoma
9337,Indolent Clinical Course,Central Nervous System T-Cell Non-Hodgkin Lymphoma
9338,Giant Mitochondria Present,Sparsely Granulated Lactotroph Adenoma
9339,Indolent Clinical Course,Medulloblastoma
9340,Intracytoplasmic Eosinophilic Inclusion,Small Intestinal Kaposi Sarcoma
9341,Superficial Lesion,Pelvic Fibromatosis
9342,Precise Histogenesis Unknown,Recurrent Childhood Visual Pathway Glioma
9343,Diffuse Lesion,Central Nervous System Hemangioma
9344,Mixed Neoplastic Glandular and Squamous Cell Population,verrucous carcinoma of esophagus
9345,Mixed Neoplastic Glandular and Squamous Cell Population,Lepidic Predominant Adenocarcinoma
9346,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Kaposi Sarcoma
9347,Favorable Clinical Outcome,Kaposi's sarcoma of skin
9348,Invasive Lesion,Dysplasia of anus
9349,Mixed Epithelial Cell Population,Anal Canal Squamous Papilloma
9350,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Type II Endometrial Adenocarcinoma
9351,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Brenner Tumor
9352,Scattered Collections of Differentiating Neuroblasts Present,"Childhood Ganglioneuroblastoma, Nodular"
9353,High Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor G2
9354,Mucoid Stroma Formation,Fallopian Tube Papilloma
9355,Grade 4 Lesion,Childhood Astrocytoma
9356,Malignant Germinomatous Cellular Infiltrate,Dermoid Cyst of the Spinal Cord
9357,Intermediate Filaments Present,Adult Extraskeletal Myxoid Chondrosarcoma
9358,Indolent Clinical Course,Primary malignant neoplasm of brain
9359,Borderline Lesion,Pleural Epithelioid Hemangioendothelioma
9360,Indolent Clinical Course,Anaplastic Brain Stem Glioma
9361,Metastatic Lesion,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
9362,Invasive Lesion,Stage 0is Ureter Cancer AJCC v7
9363,atypia morphology,Benign neoplasm of mesothelial tissue of pleura
9364,Mixed Cellular Population,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
9365,Indolent Clinical Course,Kaposi's sarcoma of esophagus
9366,Intermediate Filaments Present,Stage I Adult Soft Tissue Sarcoma AJCC v7
9367,Mixed Neoplastic Glandular and Squamous Cell Population,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
9368,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
9369,atypia morphology,Compound nevus of skin
9370,Capsular Invasion,Sex Hormone-Producing Adrenal Cortex Adenoma
9371,Squamous Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma
9372,Benign Cellular Infiltrate,Stage IV Esophagus Carcinoma
9373,Intermediate Filaments Present,Cardiac Malignant Fibrous Histiocytoma
9374,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
9375,Intermediate Filaments Present,Kaposi's sarcoma of liver
9376,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma with horn formation
9377,Invasive Lesion,Vaginal intraepithelial neoplasia grade 1
9378,Indolent Clinical Course,Sarcoma of skin
9379,Indolent Clinical Course,Secondary Supratentorial Anaplastic Astrocytoma
9380,Borderline Lesion,benign endometrioid tumor of ovary
9381,Indolent Clinical Course,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
9382,Necrotic changes (finding),Fibrillary Astrocytoma
9383,Grade 4 Lesion,Pleomorphic Xanthoastrocytoma
9384,Poikilocytosis,"Polycythemia Vera, Polycythemic Phase"
9385,Grade 4 Lesion,Astrocytoma of spinal cord
9386,Borderline Lesion,Epithelioid hemangioendothelioma of lung
9387,Scattered Collections of Differentiating Neuroblasts Present,Peripheral Ganglioneuroblastoma
9388,Benign Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v6 and v7
9389,Solid Growth Pattern,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q
9390,Indolent Clinical Course,neuroblastoma of spinal cord
9391,High Mitotic Activity,Mediastinal Leiomyoma
9392,Squamous Differentiation,Undifferentiated carcinoma
9393,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the nasal cavity
9394,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Immature Teratoma
9395,Favorable Clinical Outcome,Balloon cell malignant melanoma
9396,Mixed Neoplastic Glandular and Squamous Cell Population,Ovarian Surface Papilloma
9397,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Conjunctival Intraepithelial Neoplasia
9398,Intermediate Filaments Present,Rhabdomyosarcoma of the orbit
9399,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Serous Adenofibroma
9400,Diffuse Lesion,Choroid Plexus Papilloma
9401,Indolent Clinical Course,Low grade myofibroblastic sarcoma
9402,Severe cytologic atypia,Colorectal Neuroendocrine Tumor G1
9403,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial intraepithelial neoplasia
9404,Benign Cellular Infiltrate,Gallbladder Cancer by AJCC v6 Stage
9405,Acinar Cell Differentiation,Pancreatic Well Differentiated Ductal Adenocarcinoma
9406,Intermediate Filaments Present,Malignant Peripheral Nerve Sheath Tumor
9407,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
9408,Mixed Neoplastic Glandular and Squamous Cell Population,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
9409,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma with neuroendocrine differentiation
9410,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrial adenocarcinoma metastatic
9411,Prominent Schwannian Stroma Present,Neuroblastoma recurrent
9412,Malignant Germinomatous Cellular Infiltrate,Mediastinal Immature Teratoma
9413,Invasive Lesion,Apocrine adenoma
9414,Indolent Clinical Course,Monomorphic Post-Transplant Lymphoproliferative Disorder
9415,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Thyrotroph adenoma
9416,Necrotic changes (finding),Schwannomatosis
9417,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,squamous cell carcinoma of ovary
9418,Invasive Lesion,benign myoepithelioma of salivary gland
9419,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant eccrine spiradenoma
9420,Favorable Clinical Outcome,Malignant Vulvar Sweat Gland Neoplasm
9421,Borderline Lesion,Benign Outer Hair Sheath and Infundibulum Neoplasm
9422,Mixed Neoplastic Glandular and Squamous Cell Population,Adamantinous Craniopharyngioma
9423,Malignant Germinomatous Cellular Infiltrate,Monodermal teratoma
9424,Mucoid Stroma Formation,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
9425,Favorable Clinical Outcome,Invasive Cutaneous Melanoma
9426,Metaplasia of Malignant Cells Present,verrucous carcinoma of bladder
9427,Intracytoplasmic Eosinophilic Inclusion,Fusion-Negative Alveolar Rhabdomyosarcoma
9428,Benign Cellular Infiltrate,malignant lymphoma of pancreatic lymph nodes
9429,Mixed Neoplastic Glandular and Squamous Cell Population,Papillary Eccrine Carcinoma
9430,Intracytoplasmic Eosinophilic Inclusion,Recurrent Rhabdomyosarcoma
9431,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
9432,Premalignant Lesion,Tracheal Lymphoma
9433,Capsular Invasion,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
9434,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Villous Adenoma
9435,Intermediate Filaments Present,Sarcoma of soft tissue
9436,Mucoid Stroma Formation,Primary serous papillary carcinoma of peritoneum
9437,Favorable Clinical Outcome,Mycosis fungoides recurrent
9438,Nuclear Grooves,Thyroid Gland Signet Ring Cell Follicular Adenoma
9439,Premalignant Lesion,High Grade Lung Neuroendocrine Neoplasm
9440,Metaplasia of Malignant Cells Present,intestinal type adenocarcinoma of gallbladder
9441,Solid Growth Pattern,"Acute myeloid leukemia, t(16;16)(p13;q22)"
9442,Polymorphic Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
9443,Intracytoplasmic Eosinophilic Inclusion,sarcoma of extrahepatic bile duct
9444,Dysplasia,Sebaceous adenoma
9445,Lobulated Growth Pattern,Benign Notochordal Cell Tumor
9446,Benign Cellular Infiltrate,Hepatoma resectable
9447,Malignant Germinomatous Cellular Infiltrate,Adult cystic teratoma
9448,Benign Cellular Infiltrate,Stage IIIC Esophageal Adenocarcinoma AJCC v7
9449,Benign Cellular Infiltrate,Leiomyosarcoma of small intestine
9450,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Villoglandular Adenocarcinoma
9451,Severe cytologic atypia,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
9452,Favorable Clinical Outcome,Stage 0 Cutaneous Melanoma AJCC v6 and v7
9453,Solid Growth Pattern,Myeloid Leukemia
9454,Composite Lesion,"Thymoma, type AB, malignant"
9455,Composite Lesion,"Thymoma, type B1"
9456,Precise Histogenesis Unknown,Meningeal Gliomatosis
9457,Portal Hypertension,Indolent Systemic Mastocytosis
9458,Benign Cellular Infiltrate,Postsurgical Stage I Hepatoblastoma
9459,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive papillary breast carcinoma
9460,Precise Histogenesis Unknown,Recurrent Childhood Diffuse Astrocytoma
9461,Aggressive Clinical Course,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma
9462,Invasive Lesion,Benign neoplasm of minor salivary gland
9463,Benign Cellular Infiltrate,Hepatoblastoma resectable
9464,High Mitotic Activity,Small Intestinal Carcinoid Tumor
9465,Intracytoplasmic Eosinophilic Inclusion,Transplant-Related Kaposi Sarcoma
9466,Locally Aggressive Lesion,Cardiac fibroma
9467,Mixed Neoplastic Glandular and Squamous Cell Population,Intraductal carcinoma and lobular carcinoma in situ
9468,Intermediate Filaments Present,Epithelioid Sarcoma NCI Grade 3
9469,Glandular Differentiation,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
9470,Seminomatous Component Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor
9471,Indolent Clinical Course,Medulloblastoma with extensive nodularity
9472,Invasive Lesion,High Grade Gastric Intraepithelial Neoplasia
9473,Intracytoplasmic Eosinophilic Inclusion,Stage II Uterine Sarcoma AJCC v7
9474,Malignant Cellular Infiltrate,Benign neurologic neoplasms
9475,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Extraskeletal Osteosarcoma
9476,Indolent Clinical Course,Adult Soft Tissue Sarcoma
9477,Mixed Neoplastic Glandular and Squamous Cell Population,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
9478,Borderline Lesion,Oral Cavity Adenoma
9479,Favorable Clinical Outcome,Minimal Deviation Melanoma
9480,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Monodermal and Highly Specialized Teratoma
9481,Invasive Lesion,Senile hemangioma of lip
9482,Mixed Cellular Population,Childhood Spindle Cell Rhabdomyosarcoma
9483,High Grade Lesion,Spindle cell liposarcoma
9484,Metastatic Lesion,FSH-Producing Gonadotroph Adenoma
9485,Aggressive Clinical Course,Marginal zone lymphoma stage I
9486,Severe cytologic atypia,Low Grade Endometrial Stromal Sarcoma
9487,Benign Cellular Infiltrate,Duodenal Cancer
9488,Benign Cellular Infiltrate,mucinous adenocarcinoma of gallbladder
9489,Mixed Neoplastic Glandular and Squamous Cell Population,Oropharyngeal squamous cell carcinoma stage II
9490,High Mitotic Activity,Oligodendroglioma of spinal cord
9491,Indolent Clinical Course,Skin Angiosarcoma
9492,Premalignant Lesion,Large cell lung cancer stage I
9493,Indolent Clinical Course,Prostate Angiosarcoma
9494,Prominent Schwannian Stroma Present,olfactory neuroblastoma of nasal cavity
9495,Local disease,HIV lipodystrophy
9496,Premalignant Lesion,Lung squamous cell carcinoma stage III
9497,Benign Cellular Infiltrate,Well Differentiated Hepatocellular Carcinoma
9498,Favorable Clinical Outcome,Grade 3 Cutaneous Follicular Lymphoma
9499,Intracytoplasmic Eosinophilic Inclusion,Clear Cell Sarcoma of Soft Tissue
9500,Glandular Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma
9501,Villous Pattern,tubular adenoma of extrahepatic bile duct
9502,Glandular Differentiation,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
9503,Intermediate Filaments Present,Adult Liposarcoma
9504,Premalignant Lesion,Non-small cell lung cancer stage IIIA
9505,Mixed Neoplastic Glandular and Squamous Cell Population,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
9506,Borderline Lesion,Vulvar Seborrheic Keratosis
9507,CD8-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
9508,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with mutated CEBPA
9509,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,High Grade Ovarian Serous Adenocarcinoma
9510,Dysplasia,Skin Cavernous Hemangioma
9511,Indolent Clinical Course,Breast Rhabdomyosarcoma
9512,Benign Cellular Infiltrate,mucinous adenocarcinoma of anus
9513,Benign Cellular Infiltrate,Stage II Gastric Carcinoma
9514,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Intestinal-Type Adenocarcinoma
9515,Solid Growth Pattern,Neonatal leukemia
9516,Necrotic changes (finding),Adult Diffuse Astrocytoma
9517,Solid Growth Pattern,"T-Cell Prolymphocytic Leukemia, Small Cell Variant"
9518,Mixed Neoplastic Glandular and Squamous Cell Population,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
9519,Aggressive Clinical Course,Indolent Adult Non-Hodgkin Lymphoma
9520,Indolent Clinical Course,sarcoma of central nervous system
9521,Mixed Neoplastic Glandular and Squamous Cell Population,Carcinoma in situ of penis
9522,Malignant Germinomatous Cellular Infiltrate,Pineal Region Yolk Sac Tumor
9523,Mixed Neoplastic Glandular and Squamous Cell Population,Plantar Verrucous Skin Carcinoma
9524,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Broad Ligament Serous Adenocarcinoma
9525,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Corneal Intraepithelial Neoplasia
9526,Glandular Differentiation,Nasopharyngeal lymphoepithelioma stage I
9527,Diffuse Lesion,Giant Hemangioma
9528,Intracytoplasmic Eosinophilic Inclusion,Fibromyxosarcoma
9529,Aggressive Clinical Course,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma
9530,Invasive Lesion,Sclerosing Breast Papilloma
9531,Tumor Vascular Invasion,Parathyroid transitional clear cell adenoma
9532,Low Mitotic Activity,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
9533,Immunologic Deficiency Syndromes,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly
9534,Pseudogranulomatous Pattern,Vulvar Proximal-Type Epithelioid Sarcoma
9535,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
9536,Malignant Germinomatous Cellular Infiltrate,Testicular Trophoblastic Tumor
9537,Mixed Neoplastic Glandular and Squamous Cell Population,Cystadenoma
9538,Premalignant Lesion,epithelial-myoepithelial carcinoma of lung
9539,Composite Lesion,"Ganglioneuroblastoma, Intermixed"
9540,Malignant Germinomatous Cellular Infiltrate,Mature Pericardial Teratoma
9541,Intracytoplasmic Eosinophilic Inclusion,Cutaneous Liposarcoma
9542,Precise Histogenesis Unknown,Anaplastic Hemispheric Astrocytoma
9543,Mixed Neoplastic Glandular and Squamous Cell Population,"Schneiderian papilloma, inverted"
9544,Intermediate Filaments Present,Superior Vena Cava Leiomyosarcoma
9545,Low Grade Lesion,Thyroid Angiosarcoma
9546,Mitotic Activity,Benign Glomus Tumor
9547,Prominent Schwannian Stroma Present,Childhood Central Nervous System Neuroblastoma
9548,Mucoid Stroma Formation,Inverted Papilloma
9549,Mixed Neoplastic Glandular and Squamous Cell Population,mucinous adenocarcinoma of bladder
9550,Diffuse Lesion,Meningeal melanocytoma
9551,Glandular Differentiation,Oropharyngeal lymphoepithelioma stage III
9552,Well Differentiated Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
9553,Indolent Clinical Course,Anal Rhabdomyosarcoma
9554,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hilar Cholangiocarcinoma AJCC v7
9555,Borderline Lesion,Clear Cell Adrenal Cortical Adenoma
9556,Benign Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7
9557,Mixed Cellular Population,Esophageal squamous papilloma
9558,Mixed Epithelial Cell Population,Esophageal squamous papilloma
9559,Squamous Differentiation,large cell neuroendocrine carcinoma of lung
9560,Borderline Lesion,Ovarian Mucinous Adenofibroma
9561,Mixed Neoplastic Glandular and Squamous Cell Population,Low Grade Broad Ligament Serous Adenocarcinoma
9562,Precise Histogenesis Unknown,Ependymoma of brain
9563,Borderline Lesion,Breast Papillomatosis
9564,Intermediate Filaments Present,Ovarian Angiosarcoma
9565,Benign Cellular Infiltrate,Poorly Differentiated Hepatocellular Carcinoma
9566,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
9567,Mixed Neoplastic Glandular and Squamous Cell Population,Eccrine ductal carcinoma
9568,Intermediate Filaments Present,Poorly Differentiated Fibrosarcoma
9569,Mixed Neoplastic Glandular and Squamous Cell Population,villous adenoma of stomach
9570,Intermediate Filaments Present,Fibroblastic osteosarcoma
9571,Indolent Clinical Course,Angiosarcoma non-metastatic
9572,Invasive Lesion,Bladder transitional cell carcinoma stage 0
9573,Moderate dysplasia,Pancreatic Intraductal Papillary-Mucinous Adenoma
9574,Favorable Clinical Outcome,Extraocular Cutaneous Sebaceous Carcinoma
9575,Neuroendocrine Differentiation,Stage II Lip Basal Cell Carcinoma
9576,Mixed Neoplastic Glandular and Squamous Cell Population,"Prostate Ductal Adenocarcinoma, Solid Pattern"
9577,Intermediate Filaments Present,Undifferentiated (Embryonal) Sarcoma
9578,Benign Cellular Infiltrate,clear cell adenocarcinoma of gallbladder
9579,Mixed Neoplastic Glandular and Squamous Cell Population,Soft Palate Squamous Cell Carcinoma
9580,Squamous Differentiation,Vaginal Undifferentiated Carcinoma
9581,Mixed Neoplastic Glandular and Squamous Cell Population,"Cystadenocarcinoma, Serous"
9582,Precise Histogenesis Unknown,Lumbosacral Spinal Cord Ependymal Tumor
9583,Solid Growth Pattern,Acute myeloid leukemia with mutated RUNX1
9584,Chronic Clinical Course,Acute myeloid leukemia with mutated RUNX1
9585,Aggressive Clinical Course,Ureter Schwannoma
9586,Chronic Clinical Course,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
9587,Aggressive Clinical Course,Stage IB Mycosis Fungoides AJCC v7
9588,Chronic Clinical Course,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A
9589,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Head and Neck Squamous Cell Carcinoma
9590,Chronic Clinical Course,Acute Megakaryoblastic Leukemia with NUP98-KDM5A
9591,Multilayered Rosette Formation,Large Cell/Anaplastic Medulloblastoma
9592,Indolent Clinical Course,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
9593,CD21-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
9594,CD35-Positive Neoplastic Cells Present,histiocytic sarcoma of central nervous system
9595,Indolent Clinical Course,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
9596,Neuroectodermal Differentiation,Unresectable Ewing Sarcoma
9597,Intracytoplasmic Eosinophilic Inclusion,Unresectable Ewing Sarcoma
9598,Intermediate Filaments Present,Unresectable Ewing Sarcoma
9599,C19MC Amplification,Medulloepithelioma
9600,Human Papillomavirus Positive,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9601,Precise Histogenesis Unknown,Ventricular and Brain Stem Ependymal Tumor
9602,Genetic finding,Cerebral Primitive Neuroectodermal Tumor
9603,Indolent Clinical Course,"Medulloblastoma, WNT-Activated"
9604,Multilayered Rosette Formation,"Medulloblastoma, SHH-Activated"
9605,Benign Cellular Infiltrate,Unresectable Digestive System Adenocarcinoma
9606,Genetic finding,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified"
9607,Intermediate Filaments Present,Unresectable Liposarcoma
9608,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory cytopenia with unilineage dysplasia
9609,Chronic Clinical Course,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
9610,Genetic finding,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
9611,Favorable Clinical Outcome,Stage IA Mycosis Fungoides AJCC v7
9612,Precise Histogenesis Unknown,Fourth Ventricle Ependymal Tumor
9613,Indolent Clinical Course,Central Nervous System Undifferentiated Pleomorphic Sarcoma
9614,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Undifferentiated Pleomorphic Sarcoma
9615,Pain,Osteoma of skull
9616,Precise Histogenesis Unknown,Thoracic Spinal Cord Ependymal Tumor
9617,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
9618,Solid Growth Pattern,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
9619,Precise Histogenesis Unknown,Cervical and Thoracic Spinal Cord Ependymal Tumor
9620,Multifocal Lesion,Cervical and Thoracic Spinal Cord Ependymal Tumor
9621,Solid Growth Pattern,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
9622,Solid Growth Pattern,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A
9623,Precise Histogenesis Unknown,WHO Grade II Glioma
9624,Epstein-Barr Virus Positive,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9625,Epstein-Barr Virus Positive,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9626,Aggressive Clinical Course,Benign Dermal Schwannoma
9627,Aggressive Clinical Course,Mediastinal Schwannoma
9628,Invasive Lesion,Fibrous Hamartoma of Infancy
9629,Precise Histogenesis Unknown,Low grade glioma
9630,Birbeck Granules Present,histiocytic sarcoma of central nervous system
9631,Genetic finding,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
9632,Indolent Clinical Course,"Medulloblastoma, Not Otherwise Specified"
9633,Aggressive Clinical Course,Jugular Foramen Schwannoma
9634,Solid Growth Pattern,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
9635,Solid Growth Pattern,Early T Acute Lymphoblastic Leukemia
9636,Chronic Clinical Course,Early T Acute Lymphoblastic Leukemia
9637,Ventricular Involvement Only,Cerebellar and Fourth Ventricle Ependymal Tumor
9638,Chronic Clinical Course,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4
9639,Precise Histogenesis Unknown,Ependymal Tumor of Brain and Spinal Cord
9640,Precise Histogenesis Unknown,Lateral Ventricle Ependymal Tumor
9641,Aggressive Clinical Course,Cellular Schwannoma
9642,Chronic Clinical Course,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10
9643,Aggressive Clinical Course,Acoustic Neuroma
9644,Intermediate Filaments Present,Central Nervous System Undifferentiated Pleomorphic Sarcoma
9645,Precise Histogenesis Unknown,Cervical Spinal Cord Ependymal Tumor
9646,Precise Histogenesis Unknown,Thoracic and Lumbosacral Spinal Cord Ependymal Tumor
9647,Multifocal Lesion,Cervical and Lumbosacral Spinal Cord Ependymal Tumor
9648,Chronic Clinical Course,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
9649,Genetic finding,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
9650,Favorable Clinical Outcome,Stage IB Mycosis Fungoides AJCC v7
9651,Primary Lesion,Recurrent Subsequent Malignant Neoplasm
9652,Solid Growth Pattern,Acute Megakaryoblastic Leukemia with NUP98-KDM5A
9653,Genetic finding,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
9654,Indolent Clinical Course,Recurrent Gliosarcoma
9655,Superficial Lesion,Central Nervous System Desmoid-Type Fibromatosis
9656,Precise Histogenesis Unknown,Infratentorial and Spinal Cord Ependymal Tumor
9657,Indolent Clinical Course,Large Cell/Anaplastic Medulloblastoma
9658,Metastatic Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
9659,Indolent Clinical Course,Central Nervous System Intravascular Large B-Cell Lymphoma
9660,Metastatic Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma
9661,Indolent Clinical Course,Unresectable Osteosarcoma
9662,Indolent Clinical Course,Central Nervous System Embryonal Tumor with Rhabdoid Features
9663,Precise Histogenesis Unknown,Rosette-forming glioneuronal neoplasm
9664,Aggressive Clinical Course,Benign Esophageal Schwannoma
9665,Thrombocytosis,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
9666,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH"
9667,Indolent Clinical Course,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
9668,WNT Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
9669,Locally Aggressive Lesion,Central Nervous System Myofibroblastoma
9670,Indolent Clinical Course,"Medulloblastoma, SHH-Activated, TP53-Wildtype"
9671,Multilayered Rosette Formation,"Medulloblastoma, SHH-Activated, TP53-Wildtype"
9672,Intermediate Filaments Present,Unresectable Leiomyosarcoma
9673,Genetic finding,"Intracranial Embryonal Tumor, Not Otherwise Specified"
9674,Aggressive Clinical Course,Plexiform Schwannoma
9675,Ventricular Involvement Only,Fourth Ventricle and Brain Stem Ependymal Tumor
9676,Chronic Clinical Course,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2
9677,Precise Histogenesis Unknown,"Cerebellar, Brain Stem, and Cervical Spinal Cord Ependymal Tumor"
9678,Genetic finding,"Central Nervous System Embryonal Tumor, Not Otherwise Specified"
9679,Aggressive Clinical Course,Benign Bone Schwannoma
9680,Chronic Clinical Course,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
9681,C19MC Amplification,Malignant medulloepithelioma of ciliary body
9682,Epstein-Barr Virus Positive,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9683,Dysplasia,Fibrous Hamartoma of Infancy
9684,Aggressive Clinical Course,Conventional Schwannoma
9685,Intermediate Filaments Present,Central Nervous System Mesenchymal Chondrosarcoma
9686,High Grade Lesion,Central Nervous System Epithelioid Hemangioendothelioma
9687,Borderline Lesion,Central Nervous System Epithelioid Hemangioendothelioma
9688,Multilayered Rosette Formation,"Medulloblastoma, Genetically Defined"
9689,Loss of INI 1 Protein Expression,Central Nervous System Embryonal Tumor with Rhabdoid Features
9690,CD30-Positive Neoplastic Cells Present,histiocytic sarcoma of central nervous system
9691,Mixed Neoplastic Glandular and Squamous Cell Population,Localized Non-Resectable Adult Liver Carcinoma
9692,Indolent Clinical Course,Unresectable Ewing Sarcoma
9693,Ventricular Involvement Only,Ventricular and Brain Stem Ependymal Tumor
9694,Multifocal Lesion,Cerebellar and Brain Stem Ependymal Tumor
9695,Multifocal Lesion,Cerebellar and Fourth Ventricle Ependymal Tumor
9696,Precise Histogenesis Unknown,Cerebellar and Ventricular Ependymal Tumor
9697,Multifocal Lesion,Thoracic and Lumbosacral Spinal Cord Ependymal Tumor
9698,Solid Growth Pattern,Acute myeloid leukemia with BCR-ABL1
9699,Solid Growth Pattern,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
9700,Human Papillomavirus Positive,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9701,Aggressive Clinical Course,Peripheral Nerve Schwannoma
9702,Genetic finding,primitive neuroectodermal tumor (PNET) of spinal cord
9703,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory cytopenia with multilineage dysplasia
9704,Indolent Clinical Course,Central Nervous System Mesenchymal Chondrosarcoma
9705,Genetic finding,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
9706,Intermediate Filaments Present,Unresectable Osteosarcoma
9707,Indolent Clinical Course,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
9708,Aggressive Clinical Course,Cerebellopontine Angle Schwannoma
9709,Multilayered Rosette Formation,"Medulloblastoma, Non-WNT/Non-SHH"
9710,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
9711,Epstein-Barr Virus Positive,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9712,Multilayered Rosette Formation,"Medulloblastoma, Not Otherwise Specified"
9713,Multifocal Lesion,Ventricular and Brain Stem Ependymal Tumor
9714,Indolent Clinical Course,"Medulloblastoma, SHH-Activated, TP53-Mutant"
9715,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Digestive System Adenocarcinoma
9716,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Serous Adenocarcinoma
9717,Intracytoplasmic Eosinophilic Inclusion,Unresectable Liposarcoma
9718,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory Neutropenia
9719,Multifocal Lesion,Fourth Ventricle and Brain Stem Ependymal Tumor
9720,Aggressive Clinical Course,Trigeminal schwannoma
9721,Precise Histogenesis Unknown,Cerebellar and Fourth Ventricle Ependymal Tumor
9722,Aggressive Clinical Course,Stage IA Mycosis Fungoides AJCC v7
9723,Ventricular Involvement Only,Cerebellar and Ventricular Ependymal Tumor
9724,Locally Aggressive Lesion,Osteoma of skull
9725,Precise Histogenesis Unknown,Diffuse leptomeningeal glioneuronal neoplasm
9726,Chronic Clinical Course,Acute myeloid leukemia with BCR-ABL1
9727,Bone Marrow Dysplasia Present,Acute myeloid leukemia with mutated RUNX1
9728,Precise Histogenesis Unknown,Cervical and Lumbosacral Spinal Cord Ependymal Tumor
9729,Aggressive Clinical Course,Benign Intraocular Schwannoma
9730,Aggressive Clinical Course,Neurilemmoma
9731,Indolent Clinical Course,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
9732,Diffuse Lesion,Anastomosing Hemangioma
9733,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
9734,Epstein-Barr Virus Positive,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
9735,Human Papillomavirus Positive,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9736,Aggressive Clinical Course,Sympathetic Schwannoma
9737,Aggressive Clinical Course,Pleural Schwannoma
9738,Metastatic Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
9739,Metastatic Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
9740,CD1a-Positive Neoplastic Cells Present,histiocytic sarcoma of central nervous system
9741,HMB-45-Positive Neoplastic Cells Present,histiocytic sarcoma of central nervous system
9742,C19MC Amplification,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
9743,WNT Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
9744,Multilayered Rosette Formation,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
9745,Indolent Clinical Course,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
9746,Precise Histogenesis Unknown,Ventricular Ependymal Tumor
9747,Indolent Clinical Course,Unresectable Leiomyosarcoma
9748,Indolent Clinical Course,Unresectable Liposarcoma
9749,Aggressive Clinical Course,Degenerated Schwannoma
9750,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory Thrombocytopenia
9751,Genetic finding,"Supratentorial Embryonal Tumor, Not Otherwise Specified"
9752,Solid Growth Pattern,Recurrent Childhood T Acute Lymphoblastic Leukemia
9753,Chronic Clinical Course,Recurrent Childhood T Acute Lymphoblastic Leukemia
9754,Precise Histogenesis Unknown,Frontal Lobe and Parietal Lobe Ependymal Tumor
9755,Precise Histogenesis Unknown,Cerebellar and Brain Stem Ependymal Tumor
9756,Precise Histogenesis Unknown,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor"
9757,Indolent Clinical Course,Sacral Chordoma
9758,Precise Histogenesis Unknown,MGMT-Unmethylated Glioblastoma
9759,Solid Growth Pattern,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2
9760,Multifocal Lesion,Cerebellar and Ventricular Ependymal Tumor
9761,Aggressive Clinical Course,Benign Cardiac Schwannoma
9762,Solid Growth Pattern,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
9763,Precise Histogenesis Unknown,Recurrent Glioma
9764,Human Papillomavirus Positive,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
9765,Precise Histogenesis Unknown,Recurrent Gliosarcoma
9766,Precise Histogenesis Unknown,Ependymal Tumor of Spinal Cord
9767,Well-Circumscribed Lesion,Central Nervous System Desmoid-Type Fibromatosis
9768,Genetic finding,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
9769,Indolent Clinical Course,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
9770,CD30-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
9771,HMB-45-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
9772,CD21-Positive Neoplastic Cells Present,histiocytic sarcoma of central nervous system
9773,Precise Histogenesis Unknown,Temporal Lobe Ependymal Tumor
9774,Indolent Clinical Course,"Medulloblastoma, Non-WNT/Non-SHH"
9775,WNT Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH"
9776,Precise Histogenesis Unknown,Parietal Lobe Ependymal Tumor
9777,Precise Histogenesis Unknown,Cerebellar Ependymal Tumor
9778,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
9779,Aggressive Clinical Course,Microcystic/Reticular Schwannoma
9780,Multilayered Rosette Formation,"Medulloblastoma, WNT-Activated"
9781,Indolent Clinical Course,"Medulloblastoma, SHH-Activated"
9782,Multilayered Rosette Formation,"Medulloblastoma, SHH-Activated, TP53-Mutant"
9783,Thrombocytosis,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
9784,Aggressive Clinical Course,Schwannoma of the Twelfth Cranial Nerve
9785,Metastatic Lesion,Atypical Pituitary Gland Adenoma
9786,Aggressive Clinical Course,Schwannomatosis
9787,Mixed Neoplastic Glandular and Squamous Cell Population,basaloid squamous cell carcinoma of floor of mouth
9788,Ventricular Involvement Only,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor"
9789,Precise Histogenesis Unknown,Fourth Ventricle and Brain Stem Ependymal Tumor
9790,Precise Histogenesis Unknown,"Temporal Lobe, Parietal Lobe, and Lateral Ventricle Ependymal Tumor"
9791,Ventricular Involvement Only,"Temporal Lobe, Parietal Lobe, and Lateral Ventricle Ependymal Tumor"
9792,Indolent Clinical Course,MGMT-Unmethylated Glioblastoma
9793,Solid Growth Pattern,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4
9794,Precise Histogenesis Unknown,Supratentorial Ependymal Tumor
9795,Precise Histogenesis Unknown,Third Ventricle Ependymal Tumor
9796,Solid Growth Pattern,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10
9797,Benign Cellular Infiltrate,Small Intestinal Myeloid Sarcoma
9798,Precise Histogenesis Unknown,"Cervical, Thoracic, and Lumbosacral Spinal Cord Ependymal Tumor"
9799,Chronic Clinical Course,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
9800,Mixed Neoplastic Glandular and Squamous Cell Population,Gingival Squamous Cell Carcinoma
9801,Human Papillomavirus Positive,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
9802,Indolent Clinical Course,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
9803,Nuclear pleomorphism,Large cell medulloblastoma
9804,Intracytoplasmic Eosinophilic Inclusion,Central Nervous System Mesenchymal Chondrosarcoma
9805,Indolent Clinical Course,Central Nervous System Epithelioid Hemangioendothelioma
9806,Precise Histogenesis Unknown,Recurrent Ependymal Tumor
9807,Aggressive Clinical Course,Benign Mediastinal Psammomatous Schwannoma
9808,Indolent Clinical Course,"Medulloblastoma, Genetically Defined"
9809,Aggressive Clinical Course,Colorectal Schwannoma
9810,Intracytoplasmic Eosinophilic Inclusion,Unresectable Osteosarcoma
9811,Loss of BRG1 Protein Expression,Central Nervous System Embryonal Tumor with Rhabdoid Features
9812,CD35-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
9813,Homer Wright Rosette Formation,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
9814,Precise Histogenesis Unknown,Frontal Lobe Ependymal Tumor
9815,Multilayered Rosette Formation,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
9816,Mixed Neoplastic Glandular and Squamous Cell Population,Small Cell Adenocarcinoma
9817,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Endometrial Serous Adenocarcinoma
9818,Intracytoplasmic Eosinophilic Inclusion,Unresectable Leiomyosarcoma
9819,Precise Histogenesis Unknown,Posterior Cranial Fossa Ependymal Tumor
9820,Precise Histogenesis Unknown,"Occipital Lobe, Parietal Lobe, and Ventricular Ependymal Tumor"
9821,Ventricular Involvement Only,"Occipital Lobe, Parietal Lobe, and Ventricular Ependymal Tumor"
9822,Aggressive Clinical Course,Gastric Schwannoma
9823,Precise Histogenesis Unknown,Parietal Lobe and Occipital Lobe Ependymal Tumor
9824,Precise Histogenesis Unknown,Temporal Lobe and Parietal Lobe Ependymal Tumor
9825,Precise Histogenesis Unknown,Infratentorial Ependymal Tumor
9826,Aggressive Clinical Course,Sternal Intraosseous Schwannoma
9827,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous non-small cell lung cancer
9828,Favorable Clinical Outcome,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
9829,Benign Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage
9830,Benign Cellular Infiltrate,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
9831,Benign Cellular Infiltrate,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
9832,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
9833,Benign Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
9834,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
9835,Benign Cellular Infiltrate,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
9836,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
9837,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
9838,Benign Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
9839,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
9840,Benign Cellular Infiltrate,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
9841,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
9842,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
9843,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
9844,Indolent Clinical Course,Breast Carcinoma Metastatic in the Central Nervous System
9845,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
9846,Benign Cellular Infiltrate,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
9847,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
9848,Mixed Neoplastic Glandular and Squamous Cell Population,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
9849,Mixed Neoplastic Glandular and Squamous Cell Population,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
9850,Benign Cellular Infiltrate,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
9851,Benign Cellular Infiltrate,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
9852,Benign Cellular Infiltrate,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
9853,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
9854,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
9855,Benign Cellular Infiltrate,Gastric Cancer by AJCC v8 Clinical Stage
9856,Benign Cellular Infiltrate,Clinical Stage I Gastric Cancer AJCC v8
9857,Benign Cellular Infiltrate,Clinical Stage II Gastric Cancer AJCC v8
9858,Benign Cellular Infiltrate,Clinical Stage IV Gastric Cancer AJCC v8
9859,Benign Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8
9860,Benign Cellular Infiltrate,Pathologic Stage II Gastric Cancer AJCC v8
9861,Benign Cellular Infiltrate,Pathologic Stage IIIA Gastric Cancer AJCC v8
9862,Benign Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8
9863,Benign Cellular Infiltrate,Stage IIB Anal Cancer AJCC v8
9864,Benign Cellular Infiltrate,Metastatic Digestive System Carcinoma
9865,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Small Intestinal Adenocarcinoma AJCC v8
9866,Benign Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v8
9867,Benign Cellular Infiltrate,Stage II Appendix Carcinoma AJCC v8
9868,Benign Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v8
9869,Benign Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v8
9870,Benign Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v8
9871,HMB-45-Positive Neoplastic Cells Present,Refractory Histiocytic and Dendritic Cell Neoplasm
9872,CD30-Positive Neoplastic Cells Present,Recurrent Histiocytic and Dendritic Cell Neoplasm
9873,CD30-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
9874,Benign Cellular Infiltrate,Stage III Colorectal Cancer AJCC v8
9875,Benign Cellular Infiltrate,Stage IVC Colorectal Cancer AJCC v8
9876,Benign Cellular Infiltrate,Colon Cancer by AJCC v8 Stage
9877,Benign Cellular Infiltrate,Stage III Colon Cancer AJCC v8
9878,Benign Cellular Infiltrate,Stage I Rectal Cancer AJCC v8
9879,Benign Cellular Infiltrate,Stage IIA Rectal Cancer AJCC v8
9880,Benign Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v8
9881,Chronic Clinical Course,Acute myeloid leukemia refractory
9882,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Hepatocellular Carcinoma AJCC v8
9883,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Hepatocellular Carcinoma AJCC v8
9884,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Hepatocellular Carcinoma AJCC v8
9885,Favorable Clinical Outcome,Stage IIIB Hepatocellular Carcinoma AJCC v8
9886,Benign Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v8
9887,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hepatocellular Carcinoma AJCC v8
9888,Favorable Clinical Outcome,Stage I Intrahepatic Bile Duct Cancer AJCC v8
9889,Benign Cellular Infiltrate,Stage 0 Gallbladder Cancer AJCC v8
9890,Benign Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v8
9891,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
9892,Benign Cellular Infiltrate,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
9893,Benign Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v8
9894,High Mitotic Activity,Gastric Neuroendocrine Tumor by AJCC v8 Stage
9895,High Mitotic Activity,Stage III Gastric Neuroendocrine Tumor AJCC v8
9896,High Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8
9897,Severe cytologic atypia,Stage III Duodenal Neuroendocrine Tumor AJCC v8
9898,Severe cytologic atypia,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
9899,Severe cytologic atypia,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
9900,Severe cytologic atypia,Ileal Neuroendocrine Tumor
9901,High Mitotic Activity,Ileal Neuroendocrine Tumor by AJCC v8 Stage
9902,High Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v8 Stage
9903,Severe cytologic atypia,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
9904,Severe cytologic atypia,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
9905,Severe cytologic atypia,Stage IV Colon Neuroendocrine Tumor AJCC v8
9906,Severe cytologic atypia,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
9907,Composite Lesion,Stage II Thymoma AJCC v8
9908,Composite Lesion,Stage IIIA Thymoma AJCC v8
9909,Premalignant Lesion,Occult Lung Cancer AJCC v8
9910,Premalignant Lesion,Stage IB Lung Cancer AJCC v8
9911,Premalignant Lesion,Stage III Lung Cancer AJCC v8
9912,Premalignant Lesion,Stage IVA Lung Cancer AJCC v8
9913,Premalignant Lesion,Lung Adenocarcinoma In Situ
9914,HMB-45-Positive Neoplastic Cells Present,Refractory Erdheim-Chester Disease
9915,Microvascular Proliferation,Recurrent Anaplastic Astrocytoma
9916,Precise Histogenesis Unknown,Refractory Diffuse Intrinsic Pontine Glioma
9917,Indolent Clinical Course,Stage IB Bone Cancer AJCC v8
9918,Indolent Clinical Course,Stage II Bone Cancer AJCC v8
9919,Indolent Clinical Course,Stage IIB Bone Cancer AJCC v8
9920,Indolent Clinical Course,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
9921,Indolent Clinical Course,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
9922,Intracytoplasmic Eosinophilic Inclusion,Soft Tissue Sarcoma by AJCC v7 Stage
9923,Minimally Invasive Lesion,Invasive Mucinous Lung Adenocarcinoma
9924,Keratin pearl formation,Lung Non-Keratinizing Squamous Cell Carcinoma
9925,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Non-Keratinizing Squamous Cell Carcinoma
9926,Intracytoplasmic Eosinophilic Inclusion,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
9927,Intermediate Filaments Present,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
9928,Indolent Clinical Course,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
9929,Intermediate Filaments Present,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
9930,Indolent Clinical Course,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
9931,Intermediate Filaments Present,Stage I Retroperitoneal Sarcoma AJCC v8
9932,Intermediate Filaments Present,Stage IA Retroperitoneal Sarcoma AJCC v8
9933,Intermediate Filaments Present,Stage IB Retroperitoneal Sarcoma AJCC v8
9934,Intermediate Filaments Present,Stage II Retroperitoneal Sarcoma AJCC v8
9935,Intermediate Filaments Present,Stage IIIA Retroperitoneal Sarcoma AJCC v8
9936,Intracytoplasmic Eosinophilic Inclusion,Stage IV Retroperitoneal Sarcoma AJCC v8
9937,Favorable Clinical Outcome,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
9938,Favorable Clinical Outcome,Clinical Stage IV Cutaneous Melanoma AJCC v8
9939,Favorable Clinical Outcome,Pathologic Stage I Cutaneous Melanoma AJCC v8
9940,Favorable Clinical Outcome,Pathologic Stage IIID Cutaneous Melanoma AJCC v8
9941,Favorable Clinical Outcome,Pathologic Stage IV Cutaneous Melanoma AJCC v8
9942,Low Mitotic Activity,Refractory Pancreatic Neuroendocrine Carcinoma
9943,Intermediate Filaments Present,Recurrent Soft Tissue Sarcoma
9944,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Perineal Ectopic Fibroadenoma
9945,Histiocytosis,Activated B-cell type diffuse large B-cell lymphoma
9946,HMB-45-Positive Neoplastic Cells Present,Erdheim-Chester Disease
9947,Epidermotropic Lymphocytic Infiltrate,Subcutaneous panniculitis-like T-cell lymphoma
9948,Dermal Involvement,Subcutaneous panniculitis-like T-cell lymphoma
9949,Hypercalcemia,Indolent multiple myeloma
9950,Bone pain,Indolent multiple myeloma
9951,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,"Bronchiolo-alveolar carcinoma, non-mucinous"
9952,Extensive Stage Lesion,Locally Advanced Malignant Neoplasm
9953,Severe cytologic atypia,Stage I Digestive System Neuroendocrine Tumor AJCC v7
9954,High Mitotic Activity,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
9955,Favorable Clinical Outcome,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
9956,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
9957,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
9958,Favorable Clinical Outcome,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
9959,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
9960,Benign Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v7 Stage
9961,Benign Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
9962,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
9963,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
9964,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
9965,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
9966,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
9967,Benign Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
9968,Benign Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
9969,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
9970,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
9971,Benign Cellular Infiltrate,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
9972,Benign Cellular Infiltrate,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
9973,Benign Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
9974,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
9975,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
9976,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
9977,Mixed Neoplastic Glandular and Squamous Cell Population,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
9978,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
9979,Benign Cellular Infiltrate,Pathologic Stage IIIB Gastric Cancer AJCC v8
9980,Benign Cellular Infiltrate,Stage II Anal Cancer AJCC v8
9981,Benign Cellular Infiltrate,Stage I Small Intestinal Adenocarcinoma AJCC v8
9982,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Small Intestinal Adenocarcinoma AJCC v8
9983,Benign Cellular Infiltrate,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
9984,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
9985,HMB-45-Positive Neoplastic Cells Present,Recurrent Histiocytic and Dendritic Cell Neoplasm
9986,HMB-45-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
9987,CD21-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
9988,Benign Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v8
9989,Benign Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v8
9990,Benign Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v8
9991,Benign Cellular Infiltrate,Stage III Rectal Cancer AJCC v8
9992,Benign Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v8
9993,Benign Cellular Infiltrate,Stage IV Rectal Cancer AJCC v8
9994,Benign Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v8
9995,Benign Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v8 Stage
9996,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Hepatocellular Carcinoma AJCC v8
9997,Favorable Clinical Outcome,Stage IIIA Hepatocellular Carcinoma AJCC v8
9998,Benign Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v8
9999,Benign Cellular Infiltrate,Stage II Intrahepatic Bile Duct Cancer AJCC v8
10000,Favorable Clinical Outcome,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
10001,Benign Cellular Infiltrate,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
10002,Benign Cellular Infiltrate,Stage IIA Gallbladder Cancer AJCC v8
10003,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hilar Cholangiocarcinoma AJCC v8
10004,Benign Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
10005,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
10006,Favorable Clinical Outcome,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
10007,Favorable Clinical Outcome,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
10008,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
10009,Benign Cellular Infiltrate,Stage I Distal Bile Duct Cancer AJCC v8
10010,Chronic Clinical Course,Recurrent Ph-Like Acute Lymphoblastic Leukemia
10011,Solid Growth Pattern,Recurrent Ph-Like Acute Lymphoblastic Leukemia
10012,Benign Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v8
10013,Benign Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v8
10014,Benign Cellular Infiltrate,Pancreatic Cancer by AJCC v8 Stage
10015,High Mitotic Activity,Stage I Gastric Neuroendocrine Tumor AJCC v8
10016,Severe cytologic atypia,Stage IV Gastric Neuroendocrine Tumor AJCC v8
10017,High Mitotic Activity,Stage III Jejunal Neuroendocrine Tumor AJCC v8
10018,High Mitotic Activity,Stage II Ileal Neuroendocrine Tumor AJCC v8
10019,Severe cytologic atypia,Colon Neuroendocrine Tumor by AJCC v8 Stage
10020,High Mitotic Activity,Rectal Neuroendocrine Tumor by AJCC v8 Stage
10021,Severe cytologic atypia,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
10022,High Mitotic Activity,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
10023,Composite Lesion,Stage I Thymoma AJCC v8
10024,Composite Lesion,Stage IV Thymoma AJCC v8
10025,No Evidence of Radiologic Finding,Occult Lung Cancer AJCC v8
10026,Premalignant Lesion,Stage I Lung Cancer AJCC v8
10027,Premalignant Lesion,Stage IIIB Lung Cancer AJCC v8
10028,Premalignant Lesion,Stage IV Lung Cancer AJCC v8
10029,Solid Growth Pattern,Refractory Acute Lymphoblastic Leukemia
10030,CD30-Positive Neoplastic Cells Present,Refractory Erdheim-Chester Disease
10031,Premalignant Lesion,Lung Adenocarcinoma by AJCC v7 Stage
10032,Premalignant Lesion,Lung Adenosquamous Carcinoma by AJCC v7 Stage
10033,Indolent Clinical Course,Recurrent Anaplastic Astrocytoma
10034,Indolent Clinical Course,Bone Cancer by AJCC v8 Stage
10035,Indolent Clinical Course,Stage IA Bone Cancer AJCC v8
10036,Indolent Clinical Course,Stage III Bone Cancer AJCC v8
10037,Indolent Clinical Course,Osteosarcoma by AJCC v7 Stage
10038,Intermediate Filaments Present,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10039,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10040,Intracytoplasmic Eosinophilic Inclusion,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10041,Premalignant Lesion,Invasive Mucinous Lung Adenocarcinoma
10042,Premalignant Lesion,keratinizing squamous cell carcinoma of lung
10043,Prominent Keratin Formation,Lung Non-Keratinizing Squamous Cell Carcinoma
10044,Intracytoplasmic Eosinophilic Inclusion,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
10045,Indolent Clinical Course,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10046,Indolent Clinical Course,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10047,Intermediate Filaments Present,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10048,Intracytoplasmic Eosinophilic Inclusion,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10049,Intracytoplasmic Eosinophilic Inclusion,Stage I Retroperitoneal Sarcoma AJCC v8
10050,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Retroperitoneal Sarcoma AJCC v8
10051,Favorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
10052,Favorable Clinical Outcome,Clinical Stage II Merkel Cell Carcinoma AJCC v8
10053,Favorable Clinical Outcome,Cutaneous Melanoma by AJCC v8 Clinical Stage
10054,Favorable Clinical Outcome,Clinical Stage IB Cutaneous Melanoma AJCC v8
10055,Favorable Clinical Outcome,Clinical Stage II Cutaneous Melanoma AJCC v8
10056,Favorable Clinical Outcome,Pathologic Stage IA Cutaneous Melanoma AJCC v8
10057,Metastatic Lesion,Refractory Central Nervous System Lymphoma
10058,Solid Growth Pattern,Leukemic Nonnodal Mantle Cell Lymphoma
10059,Histiocytosis,Double expressor lymphoma
10060,Lymphoepithelial Lesion,Follicular Bronchitis/Bronchiolitis
10061,Monomorphic Cellular Infiltrate,Small Intestinal Enteropathy-Associated T-Cell Lymphoma
10062,Pathological fracture,Indolent multiple myeloma
10063,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma stage IV
10064,Severe cytologic atypia,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
10065,High Mitotic Activity,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
10066,Low Grade Lesion,Recurrent Breast Angiosarcoma
10067,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
10068,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
10069,Benign Cellular Infiltrate,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
10070,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Adenocarcinoma by AJCC v7 Stage
10071,Benign Cellular Infiltrate,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
10072,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
10073,Benign Cellular Infiltrate,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
10074,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
10075,Benign Cellular Infiltrate,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
10076,Benign Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
10077,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
10078,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
10079,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
10080,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10081,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
10082,Benign Cellular Infiltrate,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
10083,Benign Cellular Infiltrate,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
10084,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10085,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
10086,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
10087,Benign Cellular Infiltrate,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
10088,Benign Cellular Infiltrate,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
10089,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
10090,Benign Cellular Infiltrate,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10091,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10092,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
10093,Benign Cellular Infiltrate,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10094,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
10095,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10096,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
10097,Benign Cellular Infiltrate,Clinical Stage III Gastric Cancer AJCC v8
10098,Benign Cellular Infiltrate,Clinical Stage IVB Gastric Cancer AJCC v8
10099,Benign Cellular Infiltrate,Pathologic Stage I Gastric Cancer AJCC v8
10100,Benign Cellular Infiltrate,Pathologic Stage III Gastric Cancer AJCC v8
10101,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
10102,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Head and Neck Squamous Cell Carcinoma
10103,Extensive Stage Lesion,Locally Advanced Paraganglioma
10104,Benign Cellular Infiltrate,Stage I Anal Cancer AJCC v8
10105,Benign Cellular Infiltrate,Small Intestinal Adenocarcinoma by AJCC v8 Stage
10106,Mixed Neoplastic Glandular and Squamous Cell Population,Small Intestinal Adenocarcinoma by AJCC v8 Stage
10107,Benign Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v8
10108,Benign Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v8
10109,Benign Cellular Infiltrate,Stage IVB Colon Cancer AJCC v8
10110,Solid Growth Pattern,Acute myeloid leukemia refractory
10111,Favorable Clinical Outcome,Hepatocellular Carcinoma by AJCC v8 Stage
10112,Mixed Neoplastic Glandular and Squamous Cell Population,Hepatocellular Carcinoma by AJCC v8 Stage
10113,Benign Cellular Infiltrate,Stage IA Hepatocellular Carcinoma AJCC v8
10114,Favorable Clinical Outcome,Stage II Hepatocellular Carcinoma AJCC v8
10115,Benign Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v8
10116,Favorable Clinical Outcome,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
10117,Benign Cellular Infiltrate,Stage IIIB Gallbladder Cancer AJCC v8
10118,Benign Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v8 Stage
10119,Benign Cellular Infiltrate,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
10120,Benign Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
10121,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
10122,Benign Cellular Infiltrate,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
10123,Benign Cellular Infiltrate,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
10124,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
10125,Benign Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v7 Stage
10126,Benign Cellular Infiltrate,Stage II Distal Bile Duct Cancer AJCC v8
10127,Mixed Neoplastic Glandular and Squamous Cell Population,Eyelid Sebaceous Gland Carcinoma
10128,Benign Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v7 Stage
10129,Benign Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v8
10130,Benign Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v8
10131,Severe cytologic atypia,Stage III Gastric Neuroendocrine Tumor AJCC v8
10132,Severe cytologic atypia,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
10133,Severe cytologic atypia,Stage I Duodenal Neuroendocrine Tumor AJCC v8
10134,High Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
10135,High Mitotic Activity,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
10136,Severe cytologic atypia,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
10137,Severe cytologic atypia,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
10138,Severe cytologic atypia,Stage II Ileal Neuroendocrine Tumor AJCC v8
10139,Severe cytologic atypia,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
10140,Severe cytologic atypia,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
10141,Severe cytologic atypia,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
10142,High Mitotic Activity,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
10143,High Mitotic Activity,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
10144,High Mitotic Activity,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
10145,Composite Lesion,Stage IVB Thymoma AJCC v8
10146,Premalignant Lesion,Stage IA1 Lung Cancer AJCC v8
10147,Premalignant Lesion,Stage IA2 Lung Cancer AJCC v8
10148,Premalignant Lesion,Stage II Lung Cancer AJCC v8
10149,Premalignant Lesion,Stage IVB Lung Cancer AJCC v8
10150,Premalignant Lesion,Lung Large Cell Carcinoma by AJCC v7 Stage
10151,Precise Histogenesis Unknown,Recurrent Diffuse Intrinsic Pontine Glioma
10152,Indolent Clinical Course,Stage IV Bone Cancer AJCC v8
10153,Mixed Neoplastic Glandular and Squamous Cell Population,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
10154,Indolent Clinical Course,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage
10155,Intracytoplasmic Eosinophilic Inclusion,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10156,Indolent Clinical Course,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10157,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10158,Indolent Clinical Course,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10159,Indolent Clinical Course,Uterine Corpus Sarcoma by AJCC v7 Stage
10160,Metaplasia of Malignant Cells Present,Lung Enteric Adenocarcinoma
10161,Indolent Clinical Course,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10162,Intermediate Filaments Present,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10163,Intracytoplasmic Eosinophilic Inclusion,Stage IB Retroperitoneal Sarcoma AJCC v8
10164,Intermediate Filaments Present,Stage IV Retroperitoneal Sarcoma AJCC v8
10165,Favorable Clinical Outcome,Pathologic Stage IIA Cutaneous Melanoma AJCC v8
10166,Favorable Clinical Outcome,Pathologic Stage IIB Cutaneous Melanoma AJCC v8
10167,Mixed Neoplastic Glandular and Squamous Cell Population,Pleomorphic lobular carcinoma in situ of breast
10168,Intermediate Grade Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
10169,Indolent Clinical Course,Recurrent Central Nervous System Lymphoma
10170,Metastatic Lesion,Recurrent Central Nervous System Lymphoma
10171,Indolent Clinical Course,Recurrent Soft Tissue Sarcoma
10172,Localized Lesion,Plasma Cell Myeloma by DS Stage
10173,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Head and Neck Squamous Cell Carcinoma
10174,Monomorphic Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma
10175,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma stage I
10176,Poorly Differentiated Lesion,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
10177,Favorable Clinical Outcome,Cutaneous Squamous Cell Carcinoma of the Head and Neck
10178,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
10179,Premalignant Lesion,Squamous non-small cell lung cancer
10180,Favorable Clinical Outcome,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10181,Invasive Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
10182,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
10183,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
10184,Invasive Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
10185,Benign Cellular Infiltrate,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
10186,Benign Cellular Infiltrate,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
10187,Benign Cellular Infiltrate,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
10188,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
10189,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
10190,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
10191,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
10192,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
10193,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
10194,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
10195,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10196,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
10197,Benign Cellular Infiltrate,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
10198,Benign Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
10199,Benign Cellular Infiltrate,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10200,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10201,Benign Cellular Infiltrate,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
10202,Benign Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
10203,Mixed Neoplastic Glandular and Squamous Cell Population,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
10204,Benign Cellular Infiltrate,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10205,Benign Cellular Infiltrate,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10206,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10207,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
10208,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10209,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
10210,Benign Cellular Infiltrate,Pathologic Stage 0 Gastric Cancer AJCC v8
10211,Benign Cellular Infiltrate,Stage II Small Intestinal Adenocarcinoma AJCC v8
10212,Benign Cellular Infiltrate,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
10213,Benign Cellular Infiltrate,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
10214,Benign Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v8
10215,Benign Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v8
10216,CD21-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
10217,CD35-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
10218,Benign Cellular Infiltrate,Stage IIB Colorectal Cancer AJCC v8
10219,Benign Cellular Infiltrate,Stage IVA Colon Cancer AJCC v8
10220,Benign Cellular Infiltrate,Stage IVC Colon Cancer AJCC v8
10221,Benign Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v8
10222,Favorable Clinical Outcome,Stage IA Hepatocellular Carcinoma AJCC v8
10223,Favorable Clinical Outcome,Stage IB Hepatocellular Carcinoma AJCC v8
10224,Benign Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v8
10225,Favorable Clinical Outcome,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
10226,Mixed Neoplastic Glandular and Squamous Cell Population,Hilar Cholangiocarcinoma by AJCC v7 Stage
10227,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Hilar Cholangiocarcinoma AJCC v8
10228,Benign Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
10229,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
10230,Favorable Clinical Outcome,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
10231,Favorable Clinical Outcome,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
10232,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
10233,Benign Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
10234,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
10235,Favorable Clinical Outcome,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
10236,Benign Cellular Infiltrate,Pancreatic Cancer by AJCC v6 and v7 Stage
10237,Benign Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v8
10238,Benign Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v8
10239,Poorly Differentiated Lesion,Non-squamous non-small cell lung cancer
10240,High Mitotic Activity,Stage II Gastric Neuroendocrine Tumor AJCC v8
10241,High Mitotic Activity,Stage IV Gastric Neuroendocrine Tumor AJCC v8
10242,High Mitotic Activity,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
10243,High Mitotic Activity,Stage II Duodenal Neuroendocrine Tumor AJCC v8
10244,High Mitotic Activity,Stage III Duodenal Neuroendocrine Tumor AJCC v8
10245,High Mitotic Activity,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
10246,Severe cytologic atypia,Duodenal Neuroendocrine Tumor
10247,High Mitotic Activity,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
10248,High Mitotic Activity,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
10249,Severe cytologic atypia,Appendix Neuroendocrine Tumor by AJCC v8 Stage
10250,Severe cytologic atypia,Stage I Appendix Neuroendocrine Tumor AJCC v8
10251,Severe cytologic atypia,Colon Neuroendocrine Tumor
10252,Severe cytologic atypia,Stage I Rectal Neuroendocrine Tumor AJCC v8
10253,Severe cytologic atypia,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
10254,Premalignant Lesion,Stage IIA Lung Cancer AJCC v8
10255,Precise Histogenesis Unknown,Recurrent Anaplastic Astrocytoma
10256,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Cervical Adenocarcinoma
10257,Intracytoplasmic Eosinophilic Inclusion,Soft Tissue Sarcoma by AJCC v8 Stage
10258,Intracytoplasmic Eosinophilic Inclusion,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage
10259,Indolent Clinical Course,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10260,Intermediate Filaments Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10261,Intermediate Filaments Present,Uterine Corpus Sarcoma by AJCC v7 Stage
10262,Indolent Clinical Course,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
10263,Intracytoplasmic Eosinophilic Inclusion,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10264,Indolent Clinical Course,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10265,Intracytoplasmic Eosinophilic Inclusion,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10266,Indolent Clinical Course,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10267,Intracytoplasmic Eosinophilic Inclusion,Retroperitoneal Sarcoma by AJCC v8 Stage
10268,Intracytoplasmic Eosinophilic Inclusion,Stage IA Retroperitoneal Sarcoma AJCC v8
10269,Indolent Clinical Course,Stage II Retroperitoneal Sarcoma AJCC v8
10270,Indolent Clinical Course,Stage III Retroperitoneal Sarcoma AJCC v8
10271,Intermediate Filaments Present,Stage III Retroperitoneal Sarcoma AJCC v8
10272,Intracytoplasmic Eosinophilic Inclusion,Stage III Retroperitoneal Sarcoma AJCC v8
10273,Indolent Clinical Course,Stage IIIB Retroperitoneal Sarcoma AJCC v8
10274,Intermediate Filaments Present,Stage IIIB Retroperitoneal Sarcoma AJCC v8
10275,Favorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v7 Stage
10276,Favorable Clinical Outcome,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
10277,Favorable Clinical Outcome,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
10278,Favorable Clinical Outcome,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
10279,Favorable Clinical Outcome,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
10280,Neuroendocrine Differentiation,Intermediate Atypical Prostate Carcinoma
10281,Favorable Clinical Outcome,Clinical Stage 0 Cutaneous Melanoma AJCC v8
10282,Favorable Clinical Outcome,Clinical Stage IIC Cutaneous Melanoma AJCC v8
10283,Favorable Clinical Outcome,Pathologic Stage IB Cutaneous Melanoma AJCC v8
10284,Favorable Clinical Outcome,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
10285,Mass in breast,Pleomorphic lobular carcinoma in situ of breast
10286,Intracytoplasmic Eosinophilic Inclusion,Refractory Soft Tissue Sarcoma
10287,Localized Lesion,Plasma Cell Myeloma by ISS Stage
10288,Histiocytosis,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
10289,Pathological fracture,Smoldering myeloma
10290,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Minimally Invasive Mucinous Lung Adenocarcinoma
10291,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma recurrent
10292,High Mitotic Activity,Stage I Digestive System Neuroendocrine Tumor AJCC v7
10293,High Mitotic Activity,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
10294,High Mitotic Activity,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
10295,Indolent Clinical Course,Recurrent Breast Angiosarcoma
10296,Intracytoplasmic Eosinophilic Inclusion,Recurrent Breast Angiosarcoma
10297,Extensive Stage Lesion,Locally Advanced Malignant Solid Neoplasm
10298,Invasive Lesion,Oral Intraepithelial Neoplasia
10299,Favorable Clinical Outcome,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
10300,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
10301,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
10302,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
10303,Benign Cellular Infiltrate,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
10304,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
10305,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
10306,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
10307,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
10308,Benign Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
10309,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
10310,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
10311,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
10312,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
10313,Benign Cellular Infiltrate,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
10314,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
10315,Benign Cellular Infiltrate,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10316,Benign Cellular Infiltrate,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
10317,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
10318,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
10319,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10320,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
10321,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
10322,Benign Cellular Infiltrate,Clinical Stage IIA Gastric Cancer AJCC v8
10323,Benign Cellular Infiltrate,Clinical Stage IIB Gastric Cancer AJCC v8
10324,Benign Cellular Infiltrate,Appendix Carcinoma by AJCC v7 Stage
10325,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
10326,Benign Cellular Infiltrate,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
10327,Benign Cellular Infiltrate,Stage III Small Intestinal Adenocarcinoma AJCC v8
10328,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
10329,Benign Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage
10330,Benign Cellular Infiltrate,Stage IVA Appendix Carcinoma AJCC v8
10331,Prominent Schwannian Stroma Present,Refractory Neuroblastoma
10332,Benign Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v8
10333,Benign Cellular Infiltrate,Stage I Colon Cancer AJCC v8
10334,Benign Cellular Infiltrate,Stage II Colon Cancer AJCC v8
10335,Benign Cellular Infiltrate,Stage IIB Colon Cancer AJCC v8
10336,Benign Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
10337,Mixed Neoplastic Glandular and Squamous Cell Population,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
10338,Benign Cellular Infiltrate,Stage IB Hepatocellular Carcinoma AJCC v8
10339,Favorable Clinical Outcome,Stage III Hepatocellular Carcinoma AJCC v8
10340,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Hepatocellular Carcinoma AJCC v8
10341,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Hepatocellular Carcinoma AJCC v8
10342,Benign Cellular Infiltrate,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
10343,Benign Cellular Infiltrate,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
10344,Favorable Clinical Outcome,Stage II Intrahepatic Bile Duct Cancer AJCC v8
10345,Benign Cellular Infiltrate,Stage III Intrahepatic Bile Duct Cancer AJCC v8
10346,Favorable Clinical Outcome,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
10347,Benign Cellular Infiltrate,Gallbladder Cancer by AJCC v8 Stage
10348,Benign Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v8
10349,Benign Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v8
10350,Benign Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v7 Stage
10351,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Hilar Cholangiocarcinoma AJCC v8
10352,Benign Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
10353,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hilar Cholangiocarcinoma AJCC v8
10354,Benign Cellular Infiltrate,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
10355,Favorable Clinical Outcome,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
10356,Favorable Clinical Outcome,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
10357,Benign Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v8
10358,Favorable Clinical Outcome,Eyelid Sebaceous Gland Carcinoma
10359,Chronic Clinical Course,Refractory Ph-Like Acute Lymphoblastic Leukemia
10360,Benign Cellular Infiltrate,Stage II Ampulla of Vater Cancer AJCC v8
10361,Benign Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8
10362,Benign Cellular Infiltrate,Stage IIIA Ampulla of Vater Cancer AJCC v8
10363,Benign Cellular Infiltrate,Stage IIIB Ampulla of Vater Cancer AJCC v8
10364,Benign Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v8
10365,Benign Cellular Infiltrate,Stage IIA Pancreatic Cancer AJCC v8
10366,Severe cytologic atypia,Stage I Gastric Neuroendocrine Tumor AJCC v8
10367,Severe cytologic atypia,Stage II Gastric Neuroendocrine Tumor AJCC v8
10368,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
10369,Severe cytologic atypia,Jejunal Neuroendocrine Tumor
10370,High Mitotic Activity,Stage II Jejunal Neuroendocrine Tumor AJCC v8
10371,Severe cytologic atypia,Stage II Jejunal Neuroendocrine Tumor AJCC v8
10372,Severe cytologic atypia,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
10373,Severe cytologic atypia,Stage I Ileal Neuroendocrine Tumor AJCC v8
10374,Severe cytologic atypia,Stage III Ileal Neuroendocrine Tumor AJCC v8
10375,High Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage
10376,Severe cytologic atypia,Appendix Neuroendocrine Tumor by AJCC v7 Stage
10377,High Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v8
10378,Severe cytologic atypia,Stage IV Appendix Neuroendocrine Tumor AJCC v8
10379,High Mitotic Activity,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
10380,High Mitotic Activity,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
10381,High Mitotic Activity,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
10382,Severe cytologic atypia,Stage I Colon Neuroendocrine Tumor AJCC v8
10383,Severe cytologic atypia,Stage IIA Colon Neuroendocrine Tumor AJCC v8
10384,High Mitotic Activity,Stage IIB Colon Neuroendocrine Tumor AJCC v8
10385,Severe cytologic atypia,Stage IIB Colon Neuroendocrine Tumor AJCC v8
10386,High Mitotic Activity,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
10387,Severe cytologic atypia,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
10388,High Mitotic Activity,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
10389,High Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
10390,Composite Lesion,Stage III Thymoma AJCC v8
10391,Favorable Clinical Outcome,Unresectable Head and Neck Squamous Cell Carcinoma
10392,Premalignant Lesion,Lung Cancer by AJCC v8 Stage
10393,Premalignant Lesion,Stage IIIC Lung Cancer AJCC v8
10394,Stromal Invasion,Lung Adenocarcinoma In Situ
10395,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Adenocarcinoma In Situ
10396,Grade 4 Lesion,Recurrent Anaplastic Astrocytoma
10397,Indolent Clinical Course,Bone Cancer by AJCC v7 Stage
10398,Intermediate Filaments Present,Bone Sarcoma by AJCC v7 Stage
10399,Intermediate Filaments Present,Soft Tissue Sarcoma by AJCC v8 Stage
10400,Intermediate Filaments Present,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10401,Intermediate Filaments Present,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10402,Intermediate Filaments Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10403,Intermediate Filaments Present,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10404,Indolent Clinical Course,Soft Tissue Sarcoma by AJCC v7 Stage
10405,Premalignant Lesion,Lung Enteric Adenocarcinoma
10406,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Enteric Adenocarcinoma
10407,Stromal Invasion,Lung Mucinous Adenocarcinoma In Situ
10408,Invasive Lesion,Lung Squamous Cell Carcinoma In Situ
10409,Intracytoplasmic Eosinophilic Inclusion,Gastrointestinal Stromal Tumor by AJCC v8 Stage
10410,Indolent Clinical Course,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10411,Intermediate Filaments Present,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10412,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10413,Intermediate Filaments Present,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10414,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10415,Indolent Clinical Course,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10416,Intracytoplasmic Eosinophilic Inclusion,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10417,Indolent Clinical Course,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10418,Intracytoplasmic Eosinophilic Inclusion,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10419,Indolent Clinical Course,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10420,Intracytoplasmic Eosinophilic Inclusion,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10421,Indolent Clinical Course,Stage IIIA Retroperitoneal Sarcoma AJCC v8
10422,Indolent Clinical Course,Stage IV Retroperitoneal Sarcoma AJCC v8
10423,Favorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v8 Stage
10424,Favorable Clinical Outcome,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
10425,Favorable Clinical Outcome,Clinical Stage III Merkel Cell Carcinoma AJCC v8
10426,Favorable Clinical Outcome,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
10427,Favorable Clinical Outcome,Clinical Stage IIA Cutaneous Melanoma AJCC v8
10428,Favorable Clinical Outcome,Pathologic Stage II Cutaneous Melanoma AJCC v8
10429,Favorable Clinical Outcome,Pathologic Stage III Cutaneous Melanoma AJCC v8
10430,Favorable Clinical Outcome,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
10431,Indolent Clinical Course,Refractory Soft Tissue Sarcoma
10432,Intracytoplasmic Eosinophilic Inclusion,Recurrent Soft Tissue Sarcoma
10433,Histiocytosis,"Diffuse large B-cell lymphoma, unclassifiable, NOS"
10434,Hypercalcemia,Smoldering myeloma
10435,Severe cytologic atypia,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
10436,Severe cytologic atypia,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
10437,Severe cytologic atypia,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
10438,Pathological fracture,DS Stage I Plasma Cell Myeloma
10439,Intermediate Filaments Present,Recurrent Breast Angiosarcoma
10440,Favorable Clinical Outcome,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10441,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10442,Benign Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Stage
10443,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Adenocarcinoma by AJCC v8 Stage
10444,Benign Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
10445,Benign Cellular Infiltrate,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
10446,Benign Cellular Infiltrate,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
10447,Benign Cellular Infiltrate,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
10448,Benign Cellular Infiltrate,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
10449,Benign Cellular Infiltrate,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
10450,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
10451,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
10452,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
10453,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
10454,Benign Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10455,Benign Cellular Infiltrate,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10456,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
10457,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
10458,Indolent Clinical Course,Recurrent Atypical Teratoid/Rhabdoid Tumor
10459,Indolent Clinical Course,Lung Carcinoma Metastatic in the Central Nervous System
10460,Indolent Clinical Course,Melanoma Metastatic in the Central Nervous System
10461,Benign Cellular Infiltrate,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
10462,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
10463,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
10464,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
10465,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
10466,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10467,Benign Cellular Infiltrate,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
10468,Invasive Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10469,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
10470,Benign Cellular Infiltrate,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10471,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10472,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10473,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10474,Benign Cellular Infiltrate,Clinical Stage 0 Gastric Cancer AJCC v8
10475,Benign Cellular Infiltrate,Pathologic Stage IA Gastric Cancer AJCC v8
10476,Benign Cellular Infiltrate,Pathologic Stage IV Gastric Cancer AJCC v8
10477,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
10478,Benign Cellular Infiltrate,Anal Canal Cancer by AJCC v6 and v7 Stage
10479,Benign Cellular Infiltrate,Stage 0 Anal Cancer AJCC v8
10480,Benign Cellular Infiltrate,Stage IIA Anal Cancer AJCC v8
10481,Benign Cellular Infiltrate,Stage IIIA Anal Cancer AJCC v8
10482,Benign Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8
10483,Benign Cellular Infiltrate,Stage IIIC Anal Cancer AJCC v8
10484,Benign Cellular Infiltrate,Stage IV Anal Cancer AJCC v8
10485,Benign Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v8
10486,CD30-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
10487,Benign Cellular Infiltrate,Stage II Colorectal Cancer AJCC v8
10488,Benign Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v8
10489,Benign Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v8
10490,Benign Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v8
10491,Benign Cellular Infiltrate,Rectal Cancer by AJCC v8 Stage
10492,Benign Cellular Infiltrate,Stage IIA Colon Cancer AJCC v8
10493,Benign Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v8
10494,Benign Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v8
10495,Benign Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v8
10496,Benign Cellular Infiltrate,Stage IVA Rectal Cancer AJCC v8
10497,Favorable Clinical Outcome,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
10498,Benign Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8
10499,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Hepatocellular Carcinoma AJCC v8
10500,Favorable Clinical Outcome,Stage IVB Hepatocellular Carcinoma AJCC v8
10501,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hepatocellular Carcinoma AJCC v8
10502,Favorable Clinical Outcome,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
10503,Benign Cellular Infiltrate,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
10504,Benign Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8
10505,Benign Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v8
10506,Benign Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8
10507,Mixed Neoplastic Glandular and Squamous Cell Population,Hilar Cholangiocarcinoma by AJCC v8 Stage
10508,Benign Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v8
10509,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Hilar Cholangiocarcinoma AJCC v8
10510,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Hilar Cholangiocarcinoma AJCC v8
10511,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
10512,Benign Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v8
10513,Benign Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v8
10514,Solid Growth Pattern,Refractory Ph-Like Acute Lymphoblastic Leukemia
10515,Benign Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v8
10516,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Pancreatic Cancer AJCC v8
10517,Benign Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v8
10518,Premalignant Lesion,Non-squamous non-small cell lung cancer
10519,Severe cytologic atypia,Stage II Duodenal Neuroendocrine Tumor AJCC v8
10520,High Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
10521,Severe cytologic atypia,Stage III Jejunal Neuroendocrine Tumor AJCC v8
10522,Severe cytologic atypia,Stage IV Ileal Neuroendocrine Tumor AJCC v8
10523,Severe cytologic atypia,Stage II Appendix Neuroendocrine Tumor AJCC v8
10524,Severe cytologic atypia,Stage I Colorectal Neuroendocrine Tumor AJCC v8
10525,High Mitotic Activity,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
10526,Severe cytologic atypia,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
10527,Severe cytologic atypia,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
10528,High Mitotic Activity,Stage IV Colon Neuroendocrine Tumor AJCC v8
10529,Severe cytologic atypia,Rectal Neuroendocrine Tumor by AJCC v8 Stage
10530,High Mitotic Activity,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
10531,High Mitotic Activity,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
10532,Composite Lesion,Stage IVA Thymoma AJCC v8
10533,Premalignant Lesion,Stage 0 Lung Cancer AJCC v8
10534,Premalignant Lesion,Stage IA3 Lung Cancer AJCC v8
10535,Premalignant Lesion,Stage IIIA Lung Cancer AJCC v8
10536,Squamous Differentiation,Lung Large Cell Carcinoma by AJCC v7 Stage
10537,Premalignant Lesion,Lung Squamous Cell Carcinoma by AJCC v7 Stage
10538,Premalignant Lesion,Lung Small Cell Carcinoma by AJCC v7 Stage
10539,Necrotic changes (finding),Recurrent Anaplastic Astrocytoma
10540,Indolent Clinical Course,Stage I Bone Cancer AJCC v8
10541,Indolent Clinical Course,Stage IVA Bone Cancer AJCC v8
10542,Intermediate Filaments Present,Osteosarcoma by AJCC v7 Stage
10543,Intracytoplasmic Eosinophilic Inclusion,Osteosarcoma by AJCC v7 Stage
10544,Intermediate Filaments Present,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10545,Intermediate Filaments Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10546,Mixed Neoplastic Glandular and Squamous Cell Population,keratinizing squamous cell carcinoma of lung
10547,Intercellular Bridges Present,Lung Non-Keratinizing Squamous Cell Carcinoma
10548,Premalignant Lesion,Lung Non-Keratinizing Squamous Cell Carcinoma
10549,Stromal Invasion,Lung Non-Mucinous Adenocarcinoma In Situ
10550,Premalignant Lesion,Lung Squamous Cell Carcinoma In Situ
10551,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Squamous Cell Carcinoma In Situ
10552,Intermediate Filaments Present,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
10553,Intracytoplasmic Eosinophilic Inclusion,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10554,Indolent Clinical Course,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10555,Intermediate Filaments Present,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10556,Intracytoplasmic Eosinophilic Inclusion,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10557,Intermediate Filaments Present,Retroperitoneal Sarcoma by AJCC v8 Stage
10558,Indolent Clinical Course,Stage I Retroperitoneal Sarcoma AJCC v8
10559,Indolent Clinical Course,Stage IB Retroperitoneal Sarcoma AJCC v8
10560,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Retroperitoneal Sarcoma AJCC v8
10561,Favorable Clinical Outcome,Clinical Stage I Merkel Cell Carcinoma AJCC v8
10562,Favorable Clinical Outcome,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
10563,Favorable Clinical Outcome,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
10564,Favorable Clinical Outcome,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
10565,Favorable Clinical Outcome,Cutaneous Melanoma by AJCC v8 Stage
10566,Favorable Clinical Outcome,Clinical Stage I Cutaneous Melanoma AJCC v8
10567,Favorable Clinical Outcome,Clinical Stage IA Cutaneous Melanoma AJCC v8
10568,Favorable Clinical Outcome,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
10569,Invasive Lesion,Pleomorphic lobular carcinoma in situ of breast
10570,Benign Cellular Infiltrate,Refractory Anal Carcinoma
10571,Well Differentiated Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
10572,Favorable Clinical Outcome,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
10573,Morphologic Overlap,Double expressor lymphoma
10574,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Anal Ectopic Fibroadenoma
10575,Lymphoepithelial Lesion,Pulmonary nodular lymphoid hyperplasia
10576,Peribronchial and Lobular Septal Involvement Only,Pulmonary nodular lymphoid hyperplasia
10577,Papillary Pattern,Solid Lung Adenocarcinoma
10578,Acinar Pattern,Solid Lung Adenocarcinoma
10579,Lepidic Growth Pattern,Solid Lung Adenocarcinoma
10580,Osteolytic lesion,Smoldering myeloma
10581,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma stage III
10582,High Mitotic Activity,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
10583,Severe cytologic atypia,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
10584,CD30-Positive Neoplastic Cells Present,Central Nervous System Erdheim-Chester Disease
10585,HMB-45-Positive Neoplastic Cells Present,Central Nervous System Erdheim-Chester Disease
10586,Benign Cellular Infiltrate,AIDS-Related Anal Canal Carcinoma
10587,Invasive Lesion,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10588,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10589,Benign Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
10590,Benign Cellular Infiltrate,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
10591,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
10592,Benign Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
10593,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
10594,Benign Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
10595,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
10596,Invasive Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10597,Benign Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
10598,Benign Cellular Infiltrate,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
10599,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
10600,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
10601,Premalignant Lesion,Lung Carcinoma Metastatic in the Central Nervous System
10602,Benign Cellular Infiltrate,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10603,Benign Cellular Infiltrate,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
10604,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
10605,Invasive Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10606,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10607,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
10608,Benign Cellular Infiltrate,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10609,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10610,Benign Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
10611,Benign Cellular Infiltrate,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10612,Benign Cellular Infiltrate,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
10613,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
10614,Benign Cellular Infiltrate,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10615,Benign Cellular Infiltrate,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
10616,Benign Cellular Infiltrate,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10617,Benign Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
10618,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10619,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
10620,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10621,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10622,Benign Cellular Infiltrate,Gastric Cancer by AJCC v8 Stage
10623,Benign Cellular Infiltrate,Gastric Cancer by AJCC v8 Pathologic Stage
10624,Benign Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
10625,Benign Cellular Infiltrate,Pathologic Stage IIA Gastric Cancer AJCC v8
10626,Benign Cellular Infiltrate,Pathologic Stage IIB Gastric Cancer AJCC v8
10627,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
10628,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
10629,Benign Cellular Infiltrate,Small Intestinal Cancer by AJCC v7 Stage
10630,Benign Cellular Infiltrate,Anal Cancer by AJCC v8 Stage
10631,Benign Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
10632,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
10633,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Small Intestinal Adenocarcinoma AJCC v8
10634,Benign Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8
10635,Benign Cellular Infiltrate,Stage IV Appendix Carcinoma AJCC v8
10636,Benign Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v8
10637,HMB-45-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
10638,CD35-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
10639,Benign Cellular Infiltrate,Stage I Colorectal Cancer AJCC v8
10640,Benign Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v8
10641,Benign Cellular Infiltrate,Stage IIC Colon Cancer AJCC v8
10642,Benign Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v8
10643,Benign Cellular Infiltrate,Stage IV Colon Cancer AJCC v8
10644,Benign Cellular Infiltrate,Stage II Rectal Cancer AJCC v8
10645,Benign Cellular Infiltrate,Stage IVC Rectal Cancer AJCC v8
10646,Favorable Clinical Outcome,Stage I Hepatocellular Carcinoma AJCC v8
10647,Benign Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v8
10648,Benign Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v8
10649,Favorable Clinical Outcome,Stage IV Hepatocellular Carcinoma AJCC v8
10650,Favorable Clinical Outcome,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
10651,Favorable Clinical Outcome,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
10652,Favorable Clinical Outcome,Stage III Intrahepatic Bile Duct Cancer AJCC v8
10653,Benign Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v8
10654,Benign Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v8
10655,Benign Cellular Infiltrate,Stage III Hilar Cholangiocarcinoma AJCC v8
10656,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Hilar Cholangiocarcinoma AJCC v8
10657,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
10658,Benign Cellular Infiltrate,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
10659,Benign Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v8 Stage
10660,Benign Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v8
10661,Benign Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v8
10662,Benign Cellular Infiltrate,Stage 0 Ampulla of Vater Cancer AJCC v8
10663,Benign Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v8
10664,Benign Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v8
10665,Squamous Differentiation,Non-squamous non-small cell lung cancer
10666,Severe cytologic atypia,Gastric Neuroendocrine Tumor by AJCC v8 Stage
10667,High Mitotic Activity,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
10668,High Mitotic Activity,Jejunal Neuroendocrine Tumor
10669,High Mitotic Activity,Ileal Neuroendocrine Tumor
10670,Severe cytologic atypia,Stage I Jejunal Neuroendocrine Tumor AJCC v8
10671,High Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
10672,High Mitotic Activity,Stage III Ileal Neuroendocrine Tumor AJCC v8
10673,Severe cytologic atypia,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
10674,High Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v8
10675,High Mitotic Activity,Stage I Colorectal Neuroendocrine Tumor AJCC v8
10676,High Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
10677,Severe cytologic atypia,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
10678,High Mitotic Activity,Rectal Neuroendocrine Tumor
10679,Severe cytologic atypia,Rectal Neuroendocrine Tumor
10680,High Mitotic Activity,Stage IIA Colon Neuroendocrine Tumor AJCC v8
10681,High Mitotic Activity,Stage I Rectal Neuroendocrine Tumor AJCC v8
10682,High Mitotic Activity,Stage IV Rectal Neuroendocrine Tumor AJCC v8
10683,Severe cytologic atypia,Stage IV Rectal Neuroendocrine Tumor AJCC v8
10684,Severe cytologic atypia,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
10685,Benign Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver
10686,Composite Lesion,Stage IIIB Thymoma AJCC v8
10687,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Head and Neck Squamous Cell Carcinoma
10688,Premalignant Lesion,Stage IIB Lung Cancer AJCC v8
10689,Premalignant Lesion,Lung Non-Small Cell Cancer by AJCC v7 Stage
10690,Glandular Differentiation,Lung Large Cell Carcinoma by AJCC v7 Stage
10691,Indolent Clinical Course,Stage IIA Bone Cancer AJCC v8
10692,Indolent Clinical Course,Bone Sarcoma by AJCC v7 Stage
10693,Intracytoplasmic Eosinophilic Inclusion,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10694,Indolent Clinical Course,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10695,Intracytoplasmic Eosinophilic Inclusion,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10696,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Mucinous Adenocarcinoma In Situ
10697,Indolent Clinical Course,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
10698,Intermediate Filaments Present,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10699,Intracytoplasmic Eosinophilic Inclusion,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10700,Intracytoplasmic Eosinophilic Inclusion,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10701,Indolent Clinical Course,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10702,Intermediate Filaments Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10703,Indolent Clinical Course,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10704,Intermediate Filaments Present,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10705,Intermediate Filaments Present,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10706,Intracytoplasmic Eosinophilic Inclusion,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10707,Favorable Clinical Outcome,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
10708,Favorable Clinical Outcome,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
10709,Glandular Differentiation,Intermediate Atypical Prostate Carcinoma
10710,Favorable Clinical Outcome,Clinical Stage IIB Cutaneous Melanoma AJCC v8
10711,Favorable Clinical Outcome,Clinical Stage III Cutaneous Melanoma AJCC v8
10712,Favorable Clinical Outcome,Pathologic Stage 0 Cutaneous Melanoma AJCC v8
10713,Favorable Clinical Outcome,Pathologic Stage IIC Cutaneous Melanoma AJCC v8
10714,Favorable Clinical Outcome,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
10715,Mixed Cellular Population,Pleomorphic lobular carcinoma in situ of breast
10716,Favorable Clinical Outcome,Primary cutaneous acral CD8 positive T-cell lymphoma
10717,CD30-Positive Neoplastic Cells Present,Primary cutaneous acral CD8 positive T-cell lymphoma
10718,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Bronchioloalveolar Adenocarcinoma
10719,CD30-Positive Neoplastic Cells Present,Erdheim-Chester Disease
10720,Hypercalcemia,DS Stage I Plasma Cell Myeloma
10721,Poorly Differentiated Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
10722,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck
10723,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
10724,Benign Cellular Infiltrate,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
10725,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
10726,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
10727,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
10728,Benign Cellular Infiltrate,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
10729,Benign Cellular Infiltrate,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
10730,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
10731,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
10732,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
10733,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10734,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
10735,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10736,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
10737,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
10738,Invasive Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
10739,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
10740,Benign Cellular Infiltrate,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
10741,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
10742,Benign Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
10743,Benign Cellular Infiltrate,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
10744,Benign Cellular Infiltrate,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
10745,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10746,Benign Cellular Infiltrate,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
10747,Benign Cellular Infiltrate,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
10748,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
10749,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
10750,Benign Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
10751,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
10752,Benign Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8
10753,Benign Cellular Infiltrate,Stage III Anal Cancer AJCC v8
10754,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
10755,Benign Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
10756,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Small Intestinal Adenocarcinoma AJCC v8
10757,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
10758,Benign Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v8
10759,Benign Cellular Infiltrate,Stage III Appendix Carcinoma AJCC v8
10760,Benign Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v8
10761,CD30-Positive Neoplastic Cells Present,Refractory Histiocytic and Dendritic Cell Neoplasm
10762,Benign Cellular Infiltrate,Colorectal Cancer by AJCC v8 Stage
10763,Benign Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v8
10764,Benign Cellular Infiltrate,Stage 0 Colon Cancer AJCC v8
10765,Benign Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v8
10766,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Hepatocellular Carcinoma AJCC v8
10767,Favorable Clinical Outcome,Stage IVA Hepatocellular Carcinoma AJCC v8
10768,Benign Cellular Infiltrate,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
10769,Benign Cellular Infiltrate,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
10770,Benign Cellular Infiltrate,Stage I Intrahepatic Bile Duct Cancer AJCC v8
10771,Benign Cellular Infiltrate,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
10772,Benign Cellular Infiltrate,Stage IVA Gallbladder Cancer AJCC v8
10773,Benign Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v8
10774,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
10775,Benign Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8
10776,Benign Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v8
10777,Favorable Clinical Outcome,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
10778,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
10779,Benign Cellular Infiltrate,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
10780,Favorable Clinical Outcome,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
10781,Benign Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
10782,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
10783,Favorable Clinical Outcome,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
10784,Benign Cellular Infiltrate,Stage IIA Distal Bile Duct Cancer AJCC v8
10785,Benign Cellular Infiltrate,Stage IIIA Distal Bile Duct Cancer AJCC v8
10786,Benign Cellular Infiltrate,Stage IIIB Distal Bile Duct Cancer AJCC v8
10787,Benign Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage
10788,Benign Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v8
10789,Benign Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v8
10790,High Mitotic Activity,Duodenal Neuroendocrine Tumor
10791,High Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
10792,Severe cytologic atypia,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
10793,Severe cytologic atypia,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
10794,High Mitotic Activity,Stage I Jejunal Neuroendocrine Tumor AJCC v8
10795,Severe cytologic atypia,Ileal Neuroendocrine Tumor by AJCC v8 Stage
10796,High Mitotic Activity,Stage I Ileal Neuroendocrine Tumor AJCC v8
10797,High Mitotic Activity,Stage IV Ileal Neuroendocrine Tumor AJCC v8
10798,High Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v8
10799,High Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v8
10800,Severe cytologic atypia,Stage III Appendix Neuroendocrine Tumor AJCC v8
10801,High Mitotic Activity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
10802,High Mitotic Activity,Colon Neuroendocrine Tumor
10803,High Mitotic Activity,Colon Neuroendocrine Tumor by AJCC v8 Stage
10804,High Mitotic Activity,Stage I Colon Neuroendocrine Tumor AJCC v8
10805,High Mitotic Activity,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
10806,Severe cytologic atypia,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
10807,High Mitotic Activity,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
10808,Severe cytologic atypia,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
10809,Severe cytologic atypia,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
10810,Severe cytologic atypia,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
10811,Composite Lesion,Thymoma by AJCC v8 Stage
10812,Chronic Clinical Course,Refractory Acute Lymphoblastic Leukemia
10813,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Adenocarcinoma by AJCC v7 Stage
10814,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Squamous Cell Carcinoma by AJCC v7 Stage
10815,Indolent Clinical Course,Stage IVB Bone Cancer AJCC v8
10816,Intracytoplasmic Eosinophilic Inclusion,Bone Sarcoma by AJCC v7 Stage
10817,Indolent Clinical Course,Soft Tissue Sarcoma by AJCC v8 Stage
10818,Intermediate Filaments Present,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage
10819,Indolent Clinical Course,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10820,Intracytoplasmic Eosinophilic Inclusion,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10821,Indolent Clinical Course,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10822,Intracytoplasmic Eosinophilic Inclusion,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
10823,Intermediate Filaments Present,Soft Tissue Sarcoma by AJCC v7 Stage
10824,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Sarcoma by AJCC v7 Stage
10825,Mixed Neoplastic Glandular and Squamous Cell Population,Invasive Mucinous Lung Adenocarcinoma
10826,Premalignant Lesion,Lung Non-Mucinous Adenocarcinoma In Situ
10827,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Non-Mucinous Adenocarcinoma In Situ
10828,Premalignant Lesion,Lung Mucinous Adenocarcinoma In Situ
10829,Indolent Clinical Course,Gastrointestinal Stromal Tumor by AJCC v8 Stage
10830,Intermediate Filaments Present,Gastrointestinal Stromal Tumor by AJCC v8 Stage
10831,Intermediate Filaments Present,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
10832,Intermediate Filaments Present,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10833,Intermediate Filaments Present,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
10834,Intermediate Filaments Present,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10835,Intracytoplasmic Eosinophilic Inclusion,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
10836,Indolent Clinical Course,Retroperitoneal Sarcoma by AJCC v8 Stage
10837,Indolent Clinical Course,Stage IA Retroperitoneal Sarcoma AJCC v8
10838,Intracytoplasmic Eosinophilic Inclusion,Stage II Retroperitoneal Sarcoma AJCC v8
10839,Favorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
10840,Favorable Clinical Outcome,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
10841,Favorable Clinical Outcome,Cutaneous Melanoma by AJCC v8 Pathologic Stage
10842,Benign Cellular Infiltrate,Refractory Pancreatic Neuroendocrine Carcinoma
10843,Low Grade Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
10844,Indolent Clinical Course,Refractory Central Nervous System Lymphoma
10845,Intermediate Filaments Present,Refractory Soft Tissue Sarcoma
10846,Lymphoepithelial Lesion,Lymphoid interstitial pneumonia
10847,Peribronchial and Lobular Septal Involvement Only,Lymphoid interstitial pneumonia
10848,Histiocytosis,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile"
10849,Bone pain,Smoldering myeloma
10850,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma refractory
10851,Monomorphic Cellular Infiltrate,Intestinal T-cell lymphoma stage II
10852,High Mitotic Activity,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
10853,Severe cytologic atypia,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
10854,Composite Lesion,Masaoka-Koga Stage IVa
10855,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Sarcoma by AJCC v8 Stage
10856,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Leiomyosarcoma by AJCC v8 Stage
10857,Intermediate Filaments Present,Stage II Uterine Corpus Leiomyosarcoma AJCC v8
10858,Intermediate Filaments Present,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8
10859,Intermediate Filaments Present,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8
10860,Intermediate Filaments Present,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
10861,Pushing Tumor Margin,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10862,Intermediate Filaments Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10863,Intracytoplasmic Eosinophilic Inclusion,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10864,Intermediate Filaments Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10865,Pushing Tumor Margin,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10866,Indolent Clinical Course,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10867,Pushing Tumor Margin,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10868,Intermediate Filaments Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10869,Indolent Clinical Course,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10870,Indolent Clinical Course,Uterine Corpus Adenosarcoma by AJCC v8 Stage
10871,Intermediate Filaments Present,Uterine Corpus Adenosarcoma by AJCC v8 Stage
10872,Intracytoplasmic Eosinophilic Inclusion,Stage I Uterine Corpus Adenosarcoma AJCC v8
10873,Intracytoplasmic Eosinophilic Inclusion,Stage IB Uterine Corpus Adenosarcoma AJCC v8
10874,Indolent Clinical Course,Stage IC Uterine Corpus Adenosarcoma AJCC v8
10875,Indolent Clinical Course,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
10876,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Renal Cell Cancer AJCC v8
10877,Mucoid Stroma Formation,Stage 0a Renal Pelvis Cancer AJCC v8
10878,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
10879,Mucoid Stroma Formation,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
10880,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
10881,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
10882,Nuclear Grooves,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
10883,Nuclear Clearing,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
10884,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
10885,Glandular Differentiation,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
10886,Acute Clinical Course,Stage C Chronic Lymphocytic Leukemia
10887,Aggressive Clinical Course,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage
10888,Aggressive Clinical Course,Nodal Marginal Zone Lymphoma by Ann Arbor Stage
10889,Monomorphic Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage
10890,Intermediate Filaments Present,Pulmonary Artery Intimal Sarcoma
10891,Invasive Lesion,Lung Myoepithelioma
10892,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdomyosarcoma
10893,Benign Cellular Infiltrate,Advanced Microsatellite Stable Colorectal Carcinoma
10894,Intracytoplasmic Eosinophilic Inclusion,Refractory Alveolar Rhabdomyosarcoma
10895,Solid Growth Pattern,Recurrent Hairy Cell Leukemia
10896,Composite Lesion,Atypical Type A Thymoma
10897,Indolent Clinical Course,Locally Advanced Angiosarcoma
10898,Metastatic Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma
10899,Intracytoplasmic Eosinophilic Inclusion,Cardiac Myxofibrosarcoma
10900,Indolent Clinical Course,Pericardial Sarcoma
10901,Precise Histogenesis Unknown,Refractory Glioma
10902,Multilayered Rosette Formation,"Refractory Medulloblastoma, SHH-Activated"
10903,Poorly Differentiated Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
10904,Neuroendocrine Differentiation,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
10905,Mixed Cellular Population,chondroma of lung
10906,Mixed Cellular Population,Breast Extraskeletal Osteosarcoma
10907,Mixed Cellular Population,Liver Extraskeletal Osteosarcoma
10908,Intracytoplasmic Eosinophilic Inclusion,Adenosarcoma
10909,Intermediate Filaments Present,Uterine Ligament Adenosarcoma
10910,Composite Lesion,Masaoka-Koga Stage IIb
10911,Composite Lesion,Masaoka-Koga Stage IVb
10912,Indolent Clinical Course,Stage I Uterine Corpus Leiomyosarcoma AJCC v8
10913,Indolent Clinical Course,Stage II Uterine Corpus Leiomyosarcoma AJCC v8
10914,Intermediate Filaments Present,Stage III Uterine Corpus Leiomyosarcoma AJCC v8
10915,Intermediate Filaments Present,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8
10916,Indolent Clinical Course,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8
10917,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8
10918,Intermediate Filaments Present,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8
10919,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8
10920,Indolent Clinical Course,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10921,Intermediate Filaments Present,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10922,Intracytoplasmic Eosinophilic Inclusion,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10923,Pushing Tumor Margin,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10924,Pushing Tumor Margin,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10925,Intermediate Filaments Present,Stage IC Uterine Corpus Adenosarcoma AJCC v8
10926,Indolent Clinical Course,Stage II Uterine Corpus Adenosarcoma AJCC v8
10927,Intermediate Filaments Present,Stage III Uterine Corpus Adenosarcoma AJCC v8
10928,Intermediate Filaments Present,Stage IV Uterine Corpus Adenosarcoma AJCC v8
10929,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
10930,Mucoid Stroma Formation,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
10931,Nuclear Grooves,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
10932,Mixed Neoplastic Glandular and Squamous Cell Population,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
10933,Mixed Neoplastic Glandular and Squamous Cell Population,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
10934,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
10935,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
10936,Mucoid Stroma Formation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
10937,Nuclear Clearing,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
10938,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
10939,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
10940,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
10941,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
10942,Nuclear Clearing,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
10943,Nuclear Grooves,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
10944,Nuclear Clearing,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
10945,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Adrenal Cortex Carcinoma AJCC v8
10946,Solid Growth Pattern,Chronic Lymphocytic Leukemia- Modified Rai Staging System
10947,Acute Clinical Course,Stage A Chronic Lymphocytic Leukemia
10948,Solid Growth Pattern,Stage A Chronic Lymphocytic Leukemia
10949,Blasts Expressing CD56 and Immature T-Cell Markers Present,acute biphenotypic leukemia in relapse
10950,Solid Growth Pattern,Acute lymphoblastic leukemia recurrent
10951,Chronic Clinical Course,Refractory B Acute Lymphoblastic Leukemia
10952,Indolent Clinical Course,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
10953,Indolent Clinical Course,Recurrent Malignant Glioma
10954,Multilayered Rosette Formation,Refractory Medulloblastoma
10955,Precise Histogenesis Unknown,Recurrent Anaplastic Oligoastrocytoma
10956,Indolent Clinical Course,Refractory Alveolar Rhabdomyosarcoma
10957,Acute Clinical Course,Recurrent Hairy Cell Leukemia
10958,Mixed Neoplastic Glandular and Squamous Cell Population,Skin squamous cell carcinoma metastatic
10959,Chronic lymphocytic inflammation,Atypical Type A Thymoma
10960,Low Grade Lesion,Locally Advanced Angiosarcoma
10961,Indolent Clinical Course,Pericardial Angiosarcoma
10962,Intracytoplasmic Eosinophilic Inclusion,Pericardial Angiosarcoma
10963,Mitotic Activity,Benign Pericardial Germ Cell Tumor
10964,Geographic Necrosis,Benign Pericardial Germ Cell Tumor
10965,Anaplasia,Refractory Ependymoma
10966,Precise Histogenesis Unknown,Refractory Ependymoma
10967,Precise Histogenesis Unknown,Recurrent WHO Grade II Glioma
10968,Borderline Lesion,Pulmonary Sclerosing Hemangioma
10969,Mixed Cellular Population,Benign Extraskeletal Cartilaginous and Osseous Neoplasm
10970,Neuroendocrine Differentiation,Stage IIIB Lung Large Cell Carcinoma AJCC v7
10971,Neuroendocrine Differentiation,Stage IIIA Lung Large Cell Carcinoma AJCC v7
10972,Intermediate Filaments Present,Adenosarcoma
10973,Composite Lesion,Masaoka-Koga Stage IIa
10974,Composite Lesion,Masaoka-Koga Stage II
10975,Composite Lesion,Masaoka-Koga Stage IV
10976,Intermediate Filaments Present,Uterine Corpus Sarcoma by AJCC v8 Stage
10977,Indolent Clinical Course,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
10978,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
10979,Indolent Clinical Course,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10980,Indolent Clinical Course,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10981,Intracytoplasmic Eosinophilic Inclusion,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10982,Intracytoplasmic Eosinophilic Inclusion,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10983,Intracytoplasmic Eosinophilic Inclusion,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10984,Pushing Tumor Margin,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10985,Indolent Clinical Course,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
10986,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Adenosarcoma by AJCC v8 Stage
10987,Intermediate Filaments Present,Stage II Uterine Corpus Adenosarcoma AJCC v8
10988,Intracytoplasmic Eosinophilic Inclusion,Stage II Uterine Corpus Adenosarcoma AJCC v8
10989,Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v8
10990,Mucoid Stroma Formation,Stage 0a Ureter Cancer AJCC v8
10991,Invasive Lesion,Stage 0is Ureter Cancer AJCC v8
10992,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
10993,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
10994,Mucoid Stroma Formation,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
10995,Mucoid Stroma Formation,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
10996,Nuclear Grooves,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
10997,Nuclear Clearing,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
10998,Nuclear Pseudoinclusion,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
10999,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11000,Nuclear Pseudoinclusion,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11001,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11002,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
11003,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
11004,Nuclear Grooves,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
11005,Glandular Differentiation,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
11006,Squamous Differentiation,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
11007,Squamous Differentiation,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
11008,Squamous Differentiation,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
11009,Premalignant Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma
11010,Premalignant Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma
11011,Acute Clinical Course,Stage B Chronic Lymphocytic Leukemia
11012,CD15-Positive Neoplastic Cells Present,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage
11013,Aggressive Clinical Course,Waldenstrom's macroglobulinemia refractory
11014,Indolent Clinical Course,Malignant Lung PEComa
11015,Solid Growth Pattern,Recurrent B Acute Lymphoblastic Leukemia
11016,Indolent Clinical Course,Pulmonary Artery Intimal Sarcoma
11017,Intracytoplasmic Eosinophilic Inclusion,Pulmonary Artery Intimal Sarcoma
11018,Premalignant Lesion,Primary myoepithelial carcinoma of lung
11019,CD21-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
11020,Precise Histogenesis Unknown,Refractory Malignant Glioma
11021,Precise Histogenesis Unknown,Recurrent Anaplastic Oligodendroglioma
11022,Benign Cellular Infiltrate,Metastatic Bile Duct Carcinoma
11023,Intermediate Filaments Present,Refractory Alveolar Rhabdomyosarcoma
11024,Glandular Differentiation,Mediastinal/Thymic NUT Carcinoma
11025,Mixed Neoplastic Glandular and Squamous Cell Population,Thymic Hepatoid Adenocarcinoma
11026,Borderline Lesion,Metastatic Epithelioid Hemangioendothelioma
11027,Borderline Lesion,Mediastinal Epithelioid Hemangioendothelioma
11028,Indolent Clinical Course,Hemangiosarcoma of heart
11029,Indolent Clinical Course,Pericardial Synovial Sarcoma
11030,Indolent Clinical Course,"Recurrent Medulloblastoma, SHH-Activated"
11031,Indolent Clinical Course,"Refractory Medulloblastoma, SHH-Activated"
11032,Squamous Differentiation,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11033,Mixed Cellular Population,Childhood Extraskeletal Osteosarcoma
11034,Intermediate Filaments Present,Vaginal Adenosarcoma
11035,Endobronchial Lesion,Pulmonary Sclerosing Hemangioma
11036,Mixed Cellular Population,Malignant Extraskeletal Cartilaginous and Osseous Neoplasm
11037,Neuroendocrine Differentiation,Large cell lung cancer stage II
11038,Neuroendocrine Differentiation,Stage IA Lung Large Cell Carcinoma AJCC v7
11039,Mitotic Activity,Mature Pericardial Teratoma
11040,Indolent Clinical Course,Ovarian Adenosarcoma
11041,Intracytoplasmic Eosinophilic Inclusion,Ovarian Adenosarcoma
11042,Mixed Cellular Population,Extraskeletal osteosarcoma non-metastatic
11043,Mixed Cellular Population,Extraskeletal osteosarcoma recurrent
11044,Neuroendocrine Differentiation,Large cell lung cancer stage III
11045,Intracytoplasmic Eosinophilic Inclusion,Uterine Ligament Adenosarcoma
11046,Indolent Clinical Course,Uterine Corpus Leiomyosarcoma by AJCC v8 Stage
11047,Intracytoplasmic Eosinophilic Inclusion,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8
11048,Intracytoplasmic Eosinophilic Inclusion,Stage II Uterine Corpus Leiomyosarcoma AJCC v8
11049,Indolent Clinical Course,Stage III Uterine Corpus Leiomyosarcoma AJCC v8
11050,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8
11051,Indolent Clinical Course,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8
11052,Indolent Clinical Course,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8
11053,Intermediate Filaments Present,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11054,Intracytoplasmic Eosinophilic Inclusion,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11055,Pushing Tumor Margin,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11056,Indolent Clinical Course,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11057,Intermediate Filaments Present,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11058,Indolent Clinical Course,Stage IA Uterine Corpus Adenosarcoma AJCC v8
11059,Indolent Clinical Course,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
11060,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
11061,Invasive Lesion,Stage 0a Ureter Cancer AJCC v8
11062,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
11063,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
11064,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
11065,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
11066,Mucoid Stroma Formation,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
11067,Mucoid Stroma Formation,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
11068,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
11069,Mucoid Stroma Formation,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
11070,Nuclear Pseudoinclusion,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
11071,Nuclear Pseudoinclusion,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
11072,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11073,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
11074,Nuclear Clearing,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11075,Nuclear Clearing,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
11076,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
11077,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
11078,Glandular Differentiation,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
11079,Mixed Neoplastic Glandular and Squamous Cell Population,Adrenal Cortex Carcinoma by AJCC v7 Stage
11080,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Adrenal Cortex Carcinoma AJCC v8
11081,Aggressive Clinical Course,Mycosis Fungoides by AJCC v7 Stage
11082,Solid Growth Pattern,Stage B Chronic Lymphocytic Leukemia
11083,Premalignant Lesion,Pulmonary Artery Intimal Sarcoma
11084,Intermediate Filaments Present,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
11085,Indolent Clinical Course,Refractory Malignant Glioma
11086,Indolent Clinical Course,Recurrent Anaplastic Oligoastrocytoma
11087,Well-Circumscribed Lesion,Recurrent Alveolar Rhabdomyosarcoma
11088,Favorable Clinical Outcome,Skin squamous cell carcinoma recurrent
11089,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Angiosarcoma
11090,Malignant Germinomatous Cellular Infiltrate,Cardiac Yolk Sac Tumor
11091,Seminomatous Component Present,Cardiac teratoma
11092,Low Grade Lesion,Hemangiosarcoma of heart
11093,Intracytoplasmic Eosinophilic Inclusion,Pericardial Sarcoma
11094,Premalignant Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11095,Benign Cellular Infiltrate,Refractory Colorectal Carcinoma
11096,Composite Lesion,Refractory Malignant Thymoma
11097,Cellular Pleomorphism,Lung Clear Cell Tumor
11098,Intermediate Filaments Present,Fallopian Tube Adenosarcoma
11099,Intracytoplasmic Eosinophilic Inclusion,Fallopian Tube Adenosarcoma
11100,Indolent Clinical Course,Vaginal Adenosarcoma
11101,Neuroendocrine Differentiation,Large cell carcinoma of lung
11102,Neuroendocrine Differentiation,"Lung Large Cell Carcinoma, Clear Cell Variant"
11103,Neuroendocrine Differentiation,Stage IB Lung Large Cell Carcinoma AJCC v7
11104,Geographic Necrosis,Mature Pericardial Teratoma
11105,Mixed Cellular Population,Adult Extraskeletal Osteosarcoma
11106,Indolent Clinical Course,Adenosarcoma
11107,Mixed Cellular Population,Soft tissue chondroma
11108,Composite Lesion,Masaoka-Koga Stage I
11109,Intermediate Filaments Present,Stage I Uterine Corpus Leiomyosarcoma AJCC v8
11110,Intermediate Filaments Present,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8
11111,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8
11112,Intracytoplasmic Eosinophilic Inclusion,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8
11113,Intermediate Filaments Present,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
11114,Indolent Clinical Course,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11115,Pushing Tumor Margin,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11116,Intracytoplasmic Eosinophilic Inclusion,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11117,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11118,Intermediate Filaments Present,Stage I Uterine Corpus Adenosarcoma AJCC v8
11119,Intermediate Filaments Present,Stage IA Uterine Corpus Adenosarcoma AJCC v8
11120,Intermediate Filaments Present,Stage IB Uterine Corpus Adenosarcoma AJCC v8
11121,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
11122,Intermediate Filaments Present,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
11123,Intracytoplasmic Eosinophilic Inclusion,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
11124,Mixture of Germ Cell Neoplastic Components Present,Gestational Trophoblastic Tumor by AJCC v7 Stage
11125,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Cancer by AJCC v8 Stage
11126,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Renal Cell Cancer AJCC v8
11127,Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
11128,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
11129,Nuclear Pseudoinclusion,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
11130,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
11131,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
11132,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
11133,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
11134,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
11135,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
11136,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
11137,Nuclear Grooves,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11138,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11139,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11140,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
11141,Nuclear Grooves,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
11142,Nuclear Grooves,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
11143,Squamous Differentiation,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
11144,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Adrenal Cortex Carcinoma AJCC v8
11145,Favorable Clinical Outcome,Mycosis Fungoides by AJCC v7 Stage
11146,Solid Growth Pattern,Stage C Chronic Lymphocytic Leukemia
11147,Localized Lesion,RISS Stage I Plasma Cell Myeloma
11148,Squamous Differentiation,Thoracic NUT Carcinoma
11149,Glandular Differentiation,Thoracic NUT Carcinoma
11150,Premalignant Lesion,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
11151,Indolent Clinical Course,Primary myoepithelial carcinoma of lung
11152,HMB-45-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
11153,Indolent Clinical Course,Refractory Peripheral Primitive Neuroectodermal Tumor
11154,Intermediate Filaments Present,Refractory Ewing Sarcoma
11155,Intracytoplasmic Eosinophilic Inclusion,Refractory Ewing Sarcoma
11156,Neuroectodermal Differentiation,Refractory Ewing Sarcoma
11157,Indolent Clinical Course,Refractory Osteosarcoma
11158,Intermediate Filaments Present,Refractory Osteosarcoma
11159,Indolent Clinical Course,Recurrent Anaplastic Oligodendroglioma
11160,Benign Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma
11161,Precise Histogenesis Unknown,Refractory Glioblastoma
11162,Intermediate Filaments Present,Locally Advanced Angiosarcoma
11163,Borderline Lesion,Locally Advanced Epithelioid Hemangioendothelioma
11164,Indolent Clinical Course,Mediastinal Epithelioid Hemangioendothelioma
11165,Metastatic Lesion,Recurrent Central Nervous System Non-Hodgkin Lymphoma
11166,Indolent Clinical Course,Cardiac Extraskeletal Osteosarcoma
11167,Malignant Germinomatous Cellular Infiltrate,Cardiac teratoma
11168,Intermediate Filaments Present,Pericardial Synovial Sarcoma
11169,Intracytoplasmic Eosinophilic Inclusion,Pericardial Synovial Sarcoma
11170,Seminomatous Component Present,Benign Pericardial Germ Cell Tumor
11171,Multilayered Rosette Formation,"Recurrent Medulloblastoma, SHH-Activated"
11172,Mixed Neoplastic Glandular and Squamous Cell Population,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
11173,Benign Cellular Infiltrate,Refractory Gastric Carcinoma
11174,Indolent Clinical Course,Recurrent WHO Grade III Glioma
11175,Indolent Clinical Course,Uterine Corpus Adenosarcoma
11176,Intracytoplasmic Eosinophilic Inclusion,Uterine Corpus Adenosarcoma
11177,Neuroendocrine Differentiation,Stage IIB Lung Large Cell Carcinoma AJCC v7
11178,Neuroendocrine Differentiation,Occult Lung Large Cell Carcinoma
11179,Mixed Cellular Population,Extraskeletal Osteosarcoma
11180,Intracytoplasmic Eosinophilic Inclusion,Stage I Uterine Corpus Leiomyosarcoma AJCC v8
11181,Intracytoplasmic Eosinophilic Inclusion,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8
11182,Intracytoplasmic Eosinophilic Inclusion,Stage III Uterine Corpus Leiomyosarcoma AJCC v8
11183,Indolent Clinical Course,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8
11184,Indolent Clinical Course,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8
11185,Pushing Tumor Margin,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
11186,Intermediate Filaments Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11187,Indolent Clinical Course,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11188,Pushing Tumor Margin,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11189,Pushing Tumor Margin,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11190,Intracytoplasmic Eosinophilic Inclusion,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11191,Indolent Clinical Course,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11192,Indolent Clinical Course,Stage I Uterine Corpus Adenosarcoma AJCC v8
11193,Intracytoplasmic Eosinophilic Inclusion,Stage IA Uterine Corpus Adenosarcoma AJCC v8
11194,Intracytoplasmic Eosinophilic Inclusion,Stage III Uterine Corpus Adenosarcoma AJCC v8
11195,Intermediate Filaments Present,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
11196,Intermediate Filaments Present,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
11197,Intermediate Filaments Present,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
11198,Indolent Clinical Course,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
11199,Intermediate Filaments Present,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
11200,Intracytoplasmic Eosinophilic Inclusion,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
11201,Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
11202,Nuclear Clearing,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
11203,Mixed Neoplastic Glandular and Squamous Cell Population,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
11204,Mucoid Stroma Formation,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
11205,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
11206,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
11207,Mucoid Stroma Formation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
11208,Nuclear Grooves,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11209,Nuclear Grooves,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
11210,Nuclear Pseudoinclusion,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11211,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
11212,Nuclear Pseudoinclusion,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
11213,Glandular Differentiation,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
11214,Squamous Differentiation,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
11215,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Adrenal Cortex Carcinoma AJCC v8
11216,Histiocytosis,Centroblastic Lymphoma by Ann Arbor Stage
11217,Localized Lesion,RISS Stage III Plasma Cell Myeloma
11218,Chronic Clinical Course,acute undifferentiated leukemia in relapse
11219,Biphasic Pattern,Pulmonary Artery Intimal Sarcoma
11220,CD30-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
11221,Indolent Clinical Course,Refractory Medulloblastoma
11222,Favorable Clinical Outcome,Recurrent Primary Cutaneous Lymphoma
11223,Intermediate Filaments Present,Recurrent Alveolar Rhabdomyosarcoma
11224,Aggressive Clinical Course,Marginal zone lymphoma refractory
11225,Extensive Stage Lesion,Locally Advanced Epithelioid Hemangioendothelioma
11226,Intermediate Filaments Present,Cardiac Myxofibrosarcoma
11227,Intermediate Filaments Present,Pericardial Sarcoma
11228,Intermediate Filaments Present,Pericardial Angiosarcoma
11229,Malignant Germinomatous Cellular Infiltrate,Pericardial Yolk Sac Tumor
11230,High Mitotic Activity,Refractory Ependymoma
11231,Mitotic Activity,Lung Clear Cell Tumor
11232,Indolent Clinical Course,Fallopian Tube Adenosarcoma
11233,Mixed Cellular Population,Extraskeletal Cartilaginous and Osseous Neoplasm
11234,Mixed Cellular Population,Mediastinal Extraskeletal Osteosarcoma
11235,Neuroendocrine Differentiation,Large cell carcinoma with rhabdoid phenotype
11236,Intermediate Filaments Present,Ovarian Adenosarcoma
11237,Indolent Clinical Course,Uterine Ligament Adenosarcoma
11238,Indolent Clinical Course,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8
11239,Intermediate Filaments Present,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8
11240,Intermediate Filaments Present,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8
11241,Indolent Clinical Course,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
11242,Intracytoplasmic Eosinophilic Inclusion,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
11243,Pushing Tumor Margin,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11244,Intracytoplasmic Eosinophilic Inclusion,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11245,Intermediate Filaments Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11246,Intermediate Filaments Present,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11247,Indolent Clinical Course,Stage III Uterine Corpus Adenosarcoma AJCC v8
11248,Intracytoplasmic Eosinophilic Inclusion,Stage IV Uterine Corpus Adenosarcoma AJCC v8
11249,Indolent Clinical Course,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
11250,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
11251,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
11252,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
11253,Mucoid Stroma Formation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
11254,Nuclear Pseudoinclusion,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11255,Nuclear Pseudoinclusion,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
11256,Nuclear Clearing,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
11257,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
11258,Glandular Differentiation,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
11259,Acute Clinical Course,Chronic Lymphocytic Leukemia- Modified Rai Staging System
11260,Acute Clinical Course,Chronic Lymphocytic Leukemia- Binet Staging System
11261,Solid Growth Pattern,Chronic Lymphocytic Leukemia- Binet Staging System
11262,Localized Lesion,Plasma Cell Myeloma by RISS Stage
11263,Chronic Clinical Course,acute biphenotypic leukemia in relapse
11264,Solid Growth Pattern,acute undifferentiated leukemia in relapse
11265,Mitotic Activity,Benign Lung PEComa
11266,Cellular Pleomorphism,Benign Lung PEComa
11267,Premalignant Lesion,Malignant Lung PEComa
11268,Benign Cellular Infiltrate,Refractory Pancreatic Carcinoma
11269,Chronic Clinical Course,Acute lymphoblastic leukemia recurrent
11270,Chronic Clinical Course,Recurrent B Acute Lymphoblastic Leukemia
11271,Solid Growth Pattern,Refractory B Acute Lymphoblastic Leukemia
11272,Intracytoplasmic Eosinophilic Inclusion,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
11273,Intermediate Filaments Present,Refractory Rhabdomyosarcoma
11274,Indolent Clinical Course,Refractory Ewing Sarcoma
11275,Benign Cellular Infiltrate,Refractory Hepatoblastoma
11276,Intracytoplasmic Eosinophilic Inclusion,Refractory Osteosarcoma
11277,Well-Circumscribed Lesion,Refractory Alveolar Rhabdomyosarcoma
11278,Mixed Neoplastic Glandular and Squamous Cell Population,Skin squamous cell carcinoma recurrent
11279,Squamous Differentiation,Mediastinal/Thymic NUT Carcinoma
11280,Indolent Clinical Course,Refractory Glioblastoma
11281,Extensive Stage Lesion,Locally Advanced Angiosarcoma
11282,High Grade Lesion,Metastatic Epithelioid Hemangioendothelioma
11283,Diffuse Lesion,hemangioma of mediastinum
11284,Indolent Clinical Course,Recurrent Central Nervous System Non-Hodgkin Lymphoma
11285,Mixed Cellular Population,Cardiac Extraskeletal Osteosarcoma
11286,Intermediate Filaments Present,Cardiac Extraskeletal Osteosarcoma
11287,Intermediate Filaments Present,Hemangiosarcoma of heart
11288,Intracytoplasmic Eosinophilic Inclusion,Hemangiosarcoma of heart
11289,Malignant Germinomatous Cellular Infiltrate,Pericardial Teratoma
11290,Indolent Clinical Course,Childhood Brain Glioblastoma
11291,Metastatic Lesion,Central Nervous System B-Cell Non-Hodgkin Lymphoma
11292,Indolent Clinical Course,Central Nervous System B-Cell Non-Hodgkin Lymphoma
11293,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Craniopharyngioma
11294,Indolent Clinical Course,Adenosarcoma of cervix uteri
11295,Intracytoplasmic Eosinophilic Inclusion,Adenosarcoma of cervix uteri
11296,Intracytoplasmic Eosinophilic Inclusion,Vaginal Adenosarcoma
11297,Mixed Cellular Population,Kidney Extraskeletal Osteosarcoma
11298,Mixed Cellular Population,Mediastinal Chondroma
11299,Mixed Cellular Population,Central Nervous System Chondroma
11300,Mixed Cellular Population,Duodenal Extraskeletal Osteosarcoma
11301,Neuroendocrine Differentiation,Large cell lung cancer stage I
11302,Composite Lesion,Thymoma by Masaoka-Koga Stage
11303,Composite Lesion,Masaoka-Koga Stage III
11304,Neuroendocrine Differentiation,Lung Large Cell Carcinoma by AJCC v7 Stage
11305,Indolent Clinical Course,Uterine Corpus Sarcoma by AJCC v8 Stage
11306,Intermediate Filaments Present,Uterine Corpus Leiomyosarcoma by AJCC v8 Stage
11307,Indolent Clinical Course,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8
11308,Intracytoplasmic Eosinophilic Inclusion,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11309,Intermediate Filaments Present,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11310,Indolent Clinical Course,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11311,Intermediate Filaments Present,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
11312,Indolent Clinical Course,Stage IB Uterine Corpus Adenosarcoma AJCC v8
11313,Intracytoplasmic Eosinophilic Inclusion,Stage IC Uterine Corpus Adenosarcoma AJCC v8
11314,Indolent Clinical Course,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
11315,Indolent Clinical Course,Stage IV Uterine Corpus Adenosarcoma AJCC v8
11316,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Renal Cell Cancer AJCC v8
11317,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Renal Cell Cancer AJCC v8
11318,Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v8
11319,Mucoid Stroma Formation,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
11320,Mucoid Stroma Formation,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
11321,Nuclear Grooves,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
11322,Nuclear Clearing,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11323,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
11324,Nuclear Clearing,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11325,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
11326,Nuclear Grooves,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
11327,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
11328,Nuclear Pseudoinclusion,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
11329,Nuclear Clearing,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
11330,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
11331,Premalignant Lesion,Refractory Lung Carcinoma
11332,Mixed Neoplastic Glandular and Squamous Cell Population,Adrenal Cortex Carcinoma by AJCC v8 Stage
11333,Aggressive Clinical Course,Lymphoplasmacytic Lymphoma by Ann Arbor Stage
11334,Aggressive Clinical Course,Marginal Zone Lymphoma by Ann Arbor Stage
11335,Localized Lesion,RISS Stage II Plasma Cell Myeloma
11336,Solid Growth Pattern,acute biphenotypic leukemia in relapse
11337,CD35-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
11338,Precise Histogenesis Unknown,Recurrent Malignant Glioma
11339,Indolent Clinical Course,Refractory Rhabdomyosarcoma
11340,Benign Cellular Infiltrate,Advanced Bile Duct Carcinoma
11341,Favorable Clinical Outcome,Refractory Primary Cutaneous Lymphoma
11342,Indolent Clinical Course,Recurrent Alveolar Rhabdomyosarcoma
11343,Intracytoplasmic Eosinophilic Inclusion,Recurrent Alveolar Rhabdomyosarcoma
11344,Favorable Clinical Outcome,Skin squamous cell carcinoma metastatic
11345,High Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma
11346,High Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma
11347,Indolent Clinical Course,Refractory Central Nervous System Non-Hodgkin Lymphoma
11348,Intracytoplasmic Eosinophilic Inclusion,Cardiac Extraskeletal Osteosarcoma
11349,Indolent Clinical Course,Cardiac Myxofibrosarcoma
11350,Low Grade Lesion,Pericardial Angiosarcoma
11351,Seminomatous Component Present,Pericardial Teratoma
11352,Precise Histogenesis Unknown,Childhood Brain Glioblastoma
11353,Precise Histogenesis Unknown,Recurrent WHO Grade III Glioma
11354,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Craniopharyngioma
11355,Intermediate Filaments Present,Adenosarcoma of cervix uteri
11356,Intermediate Filaments Present,Uterine Corpus Adenosarcoma
11357,Neuroendocrine Differentiation,Stage IIA Lung Large Cell Carcinoma AJCC v7
11358,Mixed Cellular Population,Central Nervous System Extraskeletal Osteosarcoma
11359,Neuroendocrine Differentiation,Lung Basaloid Large Cell Carcinoma
11360,Neuroendocrine Differentiation,Large cell lung cancer recurrent
11361,Neuroendocrine Differentiation,Large cell lung cancer stage IV
11362,Mixed Cellular Population,Extraskeletal osteosarcoma metastatic
11363,High Grade Lesion,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
11364,Local disease,Advanced Malignant Solid Neoplasm
11365,High Grade Lesion,Central Nervous System Langerhans Cell Histiocytosis
11366,Local disease,Advanced Head and Neck Squamous Cell Carcinoma
11367,Local disease,Advanced Microsatellite Stable Colorectal Carcinoma
11368,Indolent Clinical Course,Refractory Leiomyosarcoma
11369,Intermediate Filaments Present,Refractory Leiomyosarcoma
11370,Intracytoplasmic Eosinophilic Inclusion,Refractory Undifferentiated Pleomorphic Sarcoma
11371,Intracytoplasmic Eosinophilic Inclusion,Refractory Sarcoma
11372,Indolent Clinical Course,Unresectable Sarcoma
11373,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia
11374,Chronic Clinical Course,Refractory Acute Leukemia
11375,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Intrahepatic Cholangiocarcinoma
11376,Benign Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma
11377,Benign Cellular Infiltrate,Distal Esophagus Squamous Cell Carcinoma
11378,Acute Clinical Course,Recurrent Chronic Leukemia
11379,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Ovarian Endometrioid Adenocarcinoma
11380,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Endometrial Endometrioid Adenocarcinoma
11381,Benign Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver
11382,Chronic Clinical Course,Recurrent T Acute Lymphoblastic Leukemia
11383,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Squamous Cell Carcinoma of the Nasopharynx
11384,Prominent Schwannian Stroma Present,High-Risk Neuroblastoma
11385,Hereditary Lesion,Bilateral Synchronous Sporadic Renal Cell Carcinoma
11386,Chronic Clinical Course,Refractory T Acute Lymphoblastic Leukemia
11387,Indolent Clinical Course,Recurrent Dedifferentiated Liposarcoma
11388,Indolent Clinical Course,Refractory Dedifferentiated Liposarcoma
11389,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Renal Cell Carcinoma
11390,Intermediate Filaments Present,Resectable Undifferentiated Pleomorphic Sarcoma
11391,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Lymphoma
11392,High Grade Lesion,"Langerhans cell histiocytosis, unifocal"
11393,CD1a-Positive Neoplastic Cells Present,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
11394,Chronic Clinical Course,Recurrent Burkitt Leukemia
11395,Indolent Clinical Course,Abdominal Rhabdomyosarcoma
11396,Intracytoplasmic Eosinophilic Inclusion,Abdominal Rhabdomyosarcoma
11397,Intermediate Filaments Present,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
11398,Blasts Expressing CD56 and Immature T-Cell Markers Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11399,Indolent Clinical Course,Metastatic Unresectable Sarcoma
11400,Intermediate Filaments Present,Metastatic Unresectable Sarcoma
11401,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Soft Tissue Sarcoma
11402,Intermediate Filaments Present,Metastatic Bone Sarcoma
11403,Intracytoplasmic Eosinophilic Inclusion,Metastatic Bone Sarcoma
11404,Intermediate Grade Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
11405,Premalignant Lesion,Refractory Lung Non-Small Cell Carcinoma
11406,Intracytoplasmic Eosinophilic Inclusion,Resectable Soft Tissue Sarcoma
11407,CD8-Positive Neoplastic Cells Present,Recurrent Hepatosplenic T-Cell Lymphoma
11408,Local disease,Advanced Lymphoma
11409,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Lung Non-Small Cell Squamous Carcinoma
11410,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic gastric adenocarcinoma
11411,Benign Cellular Infiltrate,Metastatic Gastric Carcinoma
11412,Immunologic Deficiency Syndromes,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
11413,Benign Cellular Infiltrate,Refractory Colon Carcinoma
11414,Benign Cellular Infiltrate,Refractory Liver Carcinoma
11415,Benign Cellular Infiltrate,Locally Advanced Small Intestinal Carcinoma
11416,Benign Cellular Infiltrate,Bile duct cancer recurrent
11417,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Unresectable Soft Tissue Sarcoma
11418,Intermediate Filaments Present,Locally Advanced Unresectable Sarcoma
11419,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Parotid Gland Acinic Cell Carcinoma
11420,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Anal Mucinous Adenocarcinoma
11421,Acinar Cell Differentiation,Recurrent Pancreatic Ductal Adenocarcinoma
11422,Benign Cellular Infiltrate,Recurrent Pancreatic Cystadenocarcinoma
11423,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Thyroid Gland Papillary Carcinoma
11424,Squamous Differentiation,Recurrent Thyroid Gland Anaplastic Carcinoma
11425,Glandular Differentiation,Recurrent Thyroid Gland Anaplastic Carcinoma
11426,Intracytoplasmic Eosinophilic Inclusion,Recurrent Skin Angiosarcoma
11427,Benign Cellular Infiltrate,Recurrent Appendix Carcinoma
11428,Favorable Clinical Outcome,Metastatic Fibrolamellar Carcinoma
11429,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Fibrolamellar Carcinoma
11430,Favorable Clinical Outcome,Hepatic cancer metastatic
11431,Metastatic Lesion,Densely Granulated Corticotroph Adenoma
11432,Metastatic Lesion,Crooke Cell Adenoma
11433,High Grade Lesion,"Histiocytosis, Langerhans-Cell"
11434,Metastatic Lesion,Childhood Cerebral Astrocytoma
11435,Metastatic Lesion,Cerebral meningioma
11436,Metastatic Lesion,Cerebral Convexity Meningioma
11437,Metastatic Lesion,Lipoma of corpus callosum
11438,Architectural Distortion,Infectious mononucleosis-like post-transplant lymphoproliferative disorder
11439,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
11440,Acute Clinical Course,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
11441,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Mixed phenotype acute leukemia B/myeloid
11442,Metastatic Lesion,Central Nervous System Ganglioneuroblastoma
11443,Metastatic Lesion,Childhood Central Nervous System Neuroblastoma
11444,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with mutated RUNX1
11445,Neoplastic Cells with TFH Cell Phenotype Present,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
11446,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of head and neck metastatic
11447,Intermediate Filaments Present,Refractory Synovial Sarcoma
11448,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Hypopharyngeal Squamous Cell Carcinoma
11449,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Paranasal Sinus Squamous Cell Carcinoma
11450,Mixed Neoplastic Glandular and Squamous Cell Population,Distal Esophagus Squamous Cell Carcinoma
11451,Acute Clinical Course,Refractory Chronic Leukemia
11452,Acute Clinical Course,Refractory Chronic Myelomonocytic Leukemia
11453,Benign Cellular Infiltrate,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
11454,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Squamous Cell Carcinoma of the Oropharynx
11455,Local disease,Advanced Hypopharyngeal Squamous Cell Carcinoma
11456,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Hypopharyngeal Squamous Cell Carcinoma
11457,Local disease,Advanced Laryngeal Squamous Cell Carcinoma
11458,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Laryngeal Squamous Cell Carcinoma
11459,Favorable Clinical Outcome,Refractory Malignant Skin Neoplasm
11460,Lymphadenopathy,IgM monoclonal gammopathy of uncertain significance
11461,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Gastroesophageal Junction Adenocarcinoma
11462,Intermediate Filaments Present,Recurrent Myxoid Liposarcoma
11463,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Adrenal Cortex Carcinoma
11464,Intermediate Filaments Present,Refractory Liposarcoma
11465,Indolent Clinical Course,Unresectable Dedifferentiated Liposarcoma
11466,Intermediate Filaments Present,Resectable Liposarcoma
11467,CD35-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
11468,High Grade Lesion,"Langerhans Cell Histiocytosis, Polystotic"
11469,HMB-45-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
11470,CD21-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
11471,CD35-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
11472,Birbeck Granules Present,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
11473,Intermediate Filaments Present,Metastatic Gastrointestinal Stromal Tumor
11474,Intracytoplasmic Eosinophilic Inclusion,Metastatic Gastrointestinal Stromal Tumor
11475,Indolent Clinical Course,Unresectable Gastrointestinal Stromal Tumor
11476,Intermediate Filaments Present,Unresectable Gastrointestinal Stromal Tumor
11477,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction
11478,Chronic Clinical Course,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified"
11479,Indolent Clinical Course,Pelvic Rhabdomyosarcoma
11480,Intermediate Filaments Present,Abdominal Rhabdomyosarcoma
11481,Chronic Clinical Course,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
11482,Solid Growth Pattern,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11483,Blasts Expressing B-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11484,Acinar Cell Differentiation,Locally Advanced Pancreatic Ductal Adenocarcinoma
11485,Intracytoplasmic Eosinophilic Inclusion,Metastatic Unresectable Sarcoma
11486,Intracytoplasmic Eosinophilic Inclusion,"Sarcoma, metastatic"
11487,Indolent Clinical Course,Locally Advanced Soft Tissue Sarcoma
11488,Indolent Clinical Course,Unresectable Soft Tissue Sarcoma
11489,Extensive Stage Lesion,Locally Advanced Sarcoma
11490,Low Grade Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
11491,Indolent Clinical Course,Resectable Soft Tissue Sarcoma
11492,Benign Cellular Infiltrate,Refractory Hepatosplenic T-Cell Lymphoma
11493,CD8-Positive Neoplastic Cells Present,Refractory Hepatosplenic T-Cell Lymphoma
11494,Intracytoplasmic Eosinophilic Inclusion,Advanced Sarcoma
11495,Premalignant Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma
11496,Indolent Clinical Course,Breast Carcinoma Metastatic in the Spine
11497,Benign Cellular Infiltrate,Refractory Bile Duct Carcinoma
11498,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Cervical Adenocarcinoma
11499,Intermediate Filaments Present,Locally Advanced Unresectable Bone Sarcoma
11500,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Unresectable Bone Sarcoma
11501,Benign Cellular Infiltrate,Recurrent Anal Mucinous Adenocarcinoma
11502,Benign Cellular Infiltrate,Recurrent Paget Disease of the Anal Canal
11503,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Appendix Mucinous Adenocarcinoma
11504,Mixed Cellular Population,Recurrent Lobular Breast Carcinoma
11505,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Mucinous Adenocarcinoma
11506,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Clear Cell Adenocarcinoma
11507,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Clear Cell Adenocarcinoma
11508,Benign Cellular Infiltrate,Recurrent Pancreatic Ductal Adenocarcinoma
11509,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Submandibular Gland Squamous Cell Carcinoma
11510,Squamous Differentiation,Recurrent Parotid Gland Undifferentiated Carcinoma
11511,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Malignant Ovarian Transitional Cell Tumor
11512,Indolent Clinical Course,Recurrent Malignant Central Nervous System Neoplasm
11513,Indolent Clinical Course,Refractory Malignant Central Nervous System Neoplasm
11514,Liver Cirrhosis,Metastatic Fibrolamellar Carcinoma
11515,Benign Cellular Infiltrate,Hepatic cancer metastatic
11516,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic hepatocellular carcinoma
11517,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Gastric Adenocarcinoma
11518,Extensive Stage Lesion,Locally Advanced Squamous Cell Carcinoma
11519,Indolent Clinical Course,MGMT-Methylated Glioblastoma
11520,Indolent Clinical Course,Malignant Adult Brain Neoplasm
11521,Metastatic Lesion,Benign Childhood Cerebral Neoplasm
11522,High Grade Lesion,"Histiocytosis, Langerhans-Cell"
11523,Local disease,Mesothelioma malignant advanced
11524,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Mixed phenotype acute leukemia B/myeloid
11525,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Mixed phenotype acute leukemia T/myeloid
11526,Metastatic Lesion,Childhood Cerebral Diffuse Astrocytoma
11527,Metastatic Lesion,Benign cerebral tumor
11528,Benign Cellular Infiltrate,Intestinal T-cell lymphoma stage I
11529,High Grade Lesion,Childhood Langerhans Cell Histiocytosis
11530,Metastatic Lesion,Childhood Cerebral Anaplastic Astrocytoma
11531,Architectural Distortion,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder
11532,Local disease,Advanced B-Cell Neoplasm
11533,Indolent Clinical Course,Refractory Synovial Sarcoma
11534,Indolent Clinical Course,Refractory Sarcoma
11535,Intermediate Filaments Present,Recurrent Sarcoma
11536,Histiocytosis,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes"
11537,Solid Growth Pattern,Recurrent Mixed Phenotype Acute Leukemia
11538,Chronic Clinical Course,Recurrent Acute Leukemia
11539,Solid Growth Pattern,Refractory Mixed Phenotype Acute Leukemia
11540,Favorable Clinical Outcome,Unresectable Intrahepatic Cholangiocarcinoma
11541,Local disease,Advanced Urothelial Carcinoma
11542,Local disease,Advanced Uveal Melanoma
11543,Mixed Neoplastic Glandular and Squamous Cell Population,Thoracic Esophagus Adenocarcinoma
11544,Benign Cellular Infiltrate,Cervical Esophagus Adenocarcinoma
11545,Solid Growth Pattern,Recurrent Chronic Leukemia
11546,Solid Growth Pattern,Recurrent Chronic Myelomonocytic Leukemia
11547,Local disease,Uveal Melanoma Metastatic in the Liver
11548,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Squamous Cell Carcinoma of the Oropharynx
11549,Hepatosplenomegaly,IgM monoclonal gammopathy of uncertain significance
11550,Intracytoplasmic Eosinophilic Inclusion,Recurrent Myxoid Liposarcoma
11551,Indolent Clinical Course,Resectable Dedifferentiated Liposarcoma
11552,Immunosuppression-Related Post-Transplant Toxicity,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
11553,CD30-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
11554,CD30-Positive Neoplastic Cells Present,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
11555,Chronic Clinical Course,Familial Acute Myeloid Leukemia with Mutated Cebpa
11556,Recurrent Genetic Abnormalities Present,Familial Acute Myeloid Leukemia with Mutated Cebpa
11557,Benign Cellular Infiltrate,Recurrent Metastatic Digestive System Carcinoma
11558,Intermediate Filaments Present,Pelvic Rhabdomyosarcoma
11559,Solid Growth Pattern,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
11560,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11561,Solid Growth Pattern,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11562,Blasts Expressing CD56 and Immature T-Cell Markers Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11563,Intermediate Filaments Present,Unresectable Soft Tissue Sarcoma
11564,Intracytoplasmic Eosinophilic Inclusion,Unresectable Soft Tissue Sarcoma
11565,Indolent Clinical Course,Metastatic Soft Tissue Sarcoma
11566,Intermediate Filaments Present,Locally Advanced Sarcoma
11567,Indolent Clinical Course,Unresectable Bone Sarcoma
11568,Indolent Clinical Course,Metastatic Bone Sarcoma
11569,Low Mitotic Activity,Metastatic Pancreatic Neuroendocrine Carcinoma
11570,Benign Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma
11571,CD4-Positive Neoplastic Cells Present,Refractory Hepatosplenic T-Cell Lymphoma
11572,Indolent Clinical Course,Advanced Sarcoma
11573,Premalignant Lesion,Metastatic Lung Carcinoma
11574,Extensive Stage Lesion,Locally Advanced Lung Carcinoma
11575,Extensive Stage Lesion,Locally Advanced Unresectable Malignant Neoplasm
11576,Immunologic Deficiency Syndromes,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
11577,Benign Cellular Infiltrate,Refractory Small Intestinal Carcinoma
11578,Benign Cellular Infiltrate,Locally Advanced Digestive System Carcinoma
11579,Indolent Clinical Course,Locally Advanced Unresectable Bone Sarcoma
11580,Extensive Stage Lesion,Locally Advanced Unresectable Sarcoma
11581,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Prostate Acinar Adenocarcinoma
11582,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Paget Disease of the Anal Canal
11583,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Clear Cell Renal Cell Carcinoma
11584,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Mucinous Adenocarcinoma
11585,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Pancreatic Cystadenocarcinoma
11586,Nuclear Grooves,Recurrent Thyroid Gland Follicular Carcinoma
11587,Low Grade Lesion,Recurrent Skin Angiosarcoma
11588,Glandular Differentiation,Recurrent Parotid Gland Undifferentiated Carcinoma
11589,Liver Cirrhosis,Recurrent Fibrolamellar Carcinoma
11590,Metastatic Lesion,Cerebral Astrocytoma
11591,Metastatic Lesion,Frontal Convexity Meningioma
11592,Metastatic Lesion,Lateral Ventricle Meningioma
11593,Neoplastic Cells with TFH Cell Phenotype Present,Lymphoepithelioid lymphoma (clinical)
11594,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Follicular Lymphoma
11595,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Mixed phenotype acute leukemia T/myeloid
11596,Benign Cellular Infiltrate,Intestinal T-cell lymphoma stage III
11597,Benign Cellular Infiltrate,Intestinal T-cell lymphoma stage IV
11598,Acute Clinical Course,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
11599,Local disease,Advanced cancer
11600,High Grade Lesion,Adult Langerhans Cell Histiocytosis
11601,Hereditary Lesion,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
11602,Angiodestructive Pattern,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
11603,Polymorphic Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
11604,Local disease,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
11605,Benign Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage
11606,Intracytoplasmic Eosinophilic Inclusion,Refractory Leiomyosarcoma
11607,Intermediate Filaments Present,Refractory Myxoid Liposarcoma
11608,Intracytoplasmic Eosinophilic Inclusion,Refractory Myxoid Liposarcoma
11609,Intermediate Filaments Present,Myxoid liposarcoma metastatic
11610,Intermediate Filaments Present,Refractory Sarcoma
11611,Intracytoplasmic Eosinophilic Inclusion,Unresectable Sarcoma
11612,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Oral Cavity Squamous Cell Carcinoma
11613,Histiocytosis,MCD Diffuse Large B-Cell Lymphoma
11614,Histiocytosis,BN2 Diffuse Large B-Cell Lymphoma
11615,Histiocytosis,N1 Diffuse Large B-Cell Lymphoma
11616,Solid Growth Pattern,Leukemia recurrent
11617,Solid Growth Pattern,Recurrent Acute Leukemia
11618,Solid Growth Pattern,Refractory Acute Leukemia
11619,Benign Cellular Infiltrate,Unresectable Intrahepatic Cholangiocarcinoma
11620,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Cardia Squamous Cell Carcinoma
11621,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Endometrioid Adenocarcinoma
11622,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Endometrial Endometrioid Adenocarcinoma
11623,Acute Clinical Course,Recurrent T-Cell Prolymphocytic Leukemia
11624,Tumor Mass,Body Cavity Primary Effusion Lymphoma
11625,Favorable Clinical Outcome,Refractory Cutaneous Melanoma
11626,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Gastroesophageal Junction Adenocarcinoma
11627,Indolent Clinical Course,Recurrent Myxoid Liposarcoma
11628,IgM Monoclonal Gammopathy,Non-IgM Monoclonal Gammopathy of Undetermined Significance
11629,Intracytoplasmic Eosinophilic Inclusion,Refractory Dedifferentiated Liposarcoma
11630,Intracytoplasmic Eosinophilic Inclusion,Resectable Liposarcoma
11631,Intermediate Filaments Present,Unresectable Undifferentiated Pleomorphic Sarcoma
11632,Prominent Schwannian Stroma Present,Resectable Neuroblastoma
11633,CD35-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
11634,CD35-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
11635,Intermediate Filaments Present,Locally Advanced Gastrointestinal Stromal Tumor
11636,Intracytoplasmic Eosinophilic Inclusion,Unresectable Gastrointestinal Stromal Tumor
11637,Pre-existing condition,Familial Acute Myeloid Leukemia with Mutated Cebpa
11638,Extensive Stage Lesion,Locally Advanced Bile Duct Carcinoma
11639,Intracytoplasmic Eosinophilic Inclusion,Pelvic Rhabdomyosarcoma
11640,Intermediate Filaments Present,Unresectable Rhabdomyosarcoma
11641,Blasts Expressing T-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
11642,Blasts Expressing B-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11643,Chronic Clinical Course,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11644,Acinar Cell Differentiation,Resectable Pancreatic Ductal Adenocarcinoma
11645,Indolent Clinical Course,"Sarcoma, metastatic"
11646,Intermediate Filaments Present,Locally Advanced Soft Tissue Sarcoma
11647,Intermediate Filaments Present,Metastatic Soft Tissue Sarcoma
11648,Extensive Stage Lesion,Locally Advanced Bone Sarcoma
11649,Indolent Clinical Course,Unresectable Synovial Sarcoma
11650,Intermediate Filaments Present,Unresectable Synovial Sarcoma
11651,Benign Cellular Infiltrate,Unresectable Pancreatic Neuroendocrine Carcinoma
11652,Low Grade Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
11653,Benign Cellular Infiltrate,Recurrent Hepatosplenic T-Cell Lymphoma
11654,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Renal Cell Carcinoma
11655,Local disease,Advanced Synovial Sarcoma
11656,Intracytoplasmic Eosinophilic Inclusion,Advanced Synovial Sarcoma
11657,Poorly Differentiated Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11658,Local disease,Advanced Lung Carcinoma
11659,Premalignant Lesion,Advanced Lung Carcinoma
11660,Extensive Stage Lesion,Locally Advanced Head and Neck Carcinoma
11661,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Unresectable Gastric Adenocarcinoma
11662,Extensive Stage Lesion,Locally Advanced Digestive System Carcinoma
11663,Intermediate Filaments Present,Locally Advanced Unresectable Soft Tissue Sarcoma
11664,Benign Cellular Infiltrate,Recurrent Ampulla of Vater Adenocarcinoma
11665,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Anal Adenocarcinoma
11666,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Lobular Breast Carcinoma
11667,Nuclear Clearing,Recurrent Thyroid Gland Follicular Carcinoma
11668,Favorable Clinical Outcome,Recurrent Skin Angiosarcoma
11669,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Transitional Cell Carcinoma
11670,Benign Cellular Infiltrate,Metastatic Fibrolamellar Carcinoma
11671,Benign Cellular Infiltrate,Metastatic hepatocellular carcinoma
11672,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Squamous Cell Carcinoma
11673,Neoplastic Cells with TFH Cell Phenotype Present,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified"
11674,Local disease,Advanced Adult Hepatocellular Carcinoma
11675,Neoplastic Cells with TFH Cell Phenotype Present,Peripheral T-Cell Lymphoma
11676,Metastatic Lesion,Benign Adult Cerebral Neoplasm
11677,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Burkitt Lymphoma
11678,Hereditary Lesion,Acute myeloid leukemia with mutated CEBPA
11679,Benign Cellular Infiltrate,Intestinal T-cell lymphoma refractory
11680,Benign Cellular Infiltrate,Intestinal T-cell lymphoma stage II
11681,Local disease,Advanced Head and Neck Carcinoma
11682,High Grade Lesion,Pulmonary Histiocytosis X
11683,Indolent Clinical Course,Refractory Undifferentiated Pleomorphic Sarcoma
11684,Indolent Clinical Course,Myxoid liposarcoma metastatic
11685,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Oropharyngeal Squamous Cell Carcinoma
11686,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Mixed Phenotype Acute Leukemia
11687,Mixed Neoplastic Glandular and Squamous Cell Population,Thoracic Esophagus Squamous Cell Carcinoma
11688,Benign Cellular Infiltrate,Cervical Esophagus Squamous Cell Carcinoma
11689,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Esophagus Squamous Cell Carcinoma
11690,Benign Cellular Infiltrate,Gastric Cardia Squamous Cell Carcinoma
11691,Solid Growth Pattern,Refractory Chronic Leukemia
11692,Solid Growth Pattern,Refractory Chronic Myelomonocytic Leukemia
11693,Solid Growth Pattern,Recurrent T Acute Lymphoblastic Leukemia
11694,Local disease,Advanced Squamous Cell Carcinoma of the Oropharynx
11695,Local disease,Advanced Oral Cavity Squamous Cell Carcinoma
11696,Local disease,Advanced Nasopharyngeal Squamous Cell Carcinoma
11697,Benign Cellular Infiltrate,Intestinal T-Cell Lymphoma
11698,Benign Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma
11699,Benign Cellular Infiltrate,"Intestinal T-Cell Lymphoma, Not Otherwise Specified"
11700,Indolent Clinical Course,Recurrent Malignant Soft Tissue Neoplasm
11701,Intermediate Filaments Present,Recurrent Dedifferentiated Liposarcoma
11702,Intermediate Filaments Present,Resectable Sarcoma
11703,Intracytoplasmic Eosinophilic Inclusion,Resectable Sarcoma
11704,Intracytoplasmic Eosinophilic Inclusion,Unresectable Undifferentiated Pleomorphic Sarcoma
11705,Indolent Clinical Course,Resectable Undifferentiated Pleomorphic Sarcoma
11706,CD21-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
11707,Indolent Clinical Course,Metastatic Gastrointestinal Stromal Tumor
11708,Solid Growth Pattern,Familial Acute Myeloid Leukemia with Mutated Cebpa
11709,Benign Cellular Infiltrate,Refractory Digestive System Carcinoma
11710,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders
11711,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes
11712,Solid Growth Pattern,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified"
11713,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Pancreatic Ductal Adenocarcinoma
11714,Indolent Clinical Course,Locally Advanced Bone Sarcoma
11715,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Bone Sarcoma
11716,Local disease,Advanced Melanoma
11717,Local disease,Advanced Renal Cell Carcinoma
11718,Extensive Stage Lesion,Locally Advanced Skin Squamous Cell Carcinoma
11719,Indolent Clinical Course,Advanced Synovial Sarcoma
11720,Intermediate Filaments Present,Advanced Sarcoma
11721,Squamous Differentiation,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11722,Benign Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Lung
11723,Benign Cellular Infiltrate,Advanced Unresectable Gastric Adenocarcinoma
11724,Indolent Clinical Course,Locally Advanced Chordoma
11725,Favorable Clinical Outcome,Refractory Liver Carcinoma
11726,Extensive Stage Lesion,Locally Advanced Small Intestinal Carcinoma
11727,Extensive Stage Lesion,Locally Advanced Unresectable Bone Sarcoma
11728,Indolent Clinical Course,Locally Advanced Unresectable Soft Tissue Sarcoma
11729,Extensive Stage Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma
11730,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Unresectable Sarcoma
11731,Benign Cellular Infiltrate,Recurrent Pancreatic Acinar Cell Carcinoma
11732,Benign Cellular Infiltrate,Recurrent Anal Adenocarcinoma
11733,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Paget Disease of the Breast
11734,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Thyroid Gland Follicular Carcinoma
11735,Squamous Differentiation,Recurrent Submandibular Gland Undifferentiated Carcinoma
11736,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Malignant Ovarian Brenner Tumor
11737,Metastatic Lesion,Fibrosarcoma non-metastatic
11738,Metastatic Lesion,Cerebral Glioblastoma
11739,Metastatic Lesion,Intracerebral Cystic Meningioma
11740,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Peripheral T-Cell Lymphoma
11741,Immunosuppression-Related Post-Transplant Toxicity,Methotrexate-Associated Hodgkin Lymphoma
11742,Local disease,Peritoneal mesothelioma malignant advanced
11743,High Grade Lesion,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
11744,High Grade Lesion,Recurrent Langerhans Cell Histiocytosis
11745,High Grade Lesion,Refractory Langerhans Cell Histiocytosis
11746,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Laryngeal Squamous Cell Carcinoma
11747,Histiocytosis,EZB Diffuse Large B-Cell Lymphoma
11748,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
11749,Chronic Clinical Course,Refractory Mixed Phenotype Acute Leukemia
11750,Benign Cellular Infiltrate,Thoracic Esophagus Squamous Cell Carcinoma
11751,Acute Clinical Course,Recurrent Chronic Myelomonocytic Leukemia
11752,Solid Growth Pattern,Recurrent T-Cell Prolymphocytic Leukemia
11753,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Squamous Cell Carcinoma of the Larynx
11754,Mixed Neoplastic Glandular and Squamous Cell Population,Bilateral Synchronous Sporadic Renal Cell Carcinoma
11755,Solid Growth Pattern,Refractory T Acute Lymphoblastic Leukemia
11756,Indolent Clinical Course,Refractory Malignant Bone Neoplasm
11757,Indolent Clinical Course,Refractory Malignant Soft Tissue Neoplasm
11758,Favorable Clinical Outcome,Recurrent Malignant Skin Neoplasm
11759,Metastatic Lesion,Primary Cerebral Neoplasm
11760,Benign Cellular Infiltrate,Metastatic Gastroesophageal Junction Adenocarcinoma
11761,Benign Cellular Infiltrate,Unresectable Gastroesophageal Junction Adenocarcinoma
11762,Intermediate Filaments Present,Refractory Dedifferentiated Liposarcoma
11763,Indolent Clinical Course,Resectable Liposarcoma
11764,Intermediate Filaments Present,Resectable Dedifferentiated Liposarcoma
11765,Prominent Schwannian Stroma Present,Unresectable Neuroblastoma
11766,CD21-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
11767,CD30-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
11768,CD21-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
11769,HMB-45-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
11770,CD30-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
11771,HMB-45-Positive Neoplastic Cells Present,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
11772,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Gastrointestinal Stromal Tumor
11773,Benign Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma
11774,Solid Growth Pattern,Refractory Burkitt Leukemia
11775,Indolent Clinical Course,Unresectable Rhabdomyosarcoma
11776,Indolent Clinical Course,Abdominal Undifferentiated Pleomorphic Sarcoma
11777,Intermediate Filaments Present,Abdominal Undifferentiated Pleomorphic Sarcoma
11778,Intracytoplasmic Eosinophilic Inclusion,Abdominal Undifferentiated Pleomorphic Sarcoma
11779,Blasts Expressing B-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
11780,Chronic Clinical Course,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11781,Blasts Expressing T-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
11782,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11783,Blasts Expressing T-Lymphoid and Myeloid Markers Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
11784,Benign Cellular Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma
11785,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Pancreatic Ductal Adenocarcinoma
11786,Intermediate Filaments Present,"Sarcoma, metastatic"
11787,Intracytoplasmic Eosinophilic Inclusion,Unresectable Synovial Sarcoma
11788,Well Differentiated Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
11789,Intermediate Grade Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
11790,Local disease,Advanced Carcinoma
11791,Favorable Clinical Outcome,Locally Advanced Skin Squamous Cell Carcinoma
11792,Intermediate Filaments Present,Advanced Synovial Sarcoma
11793,Premalignant Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11794,Local disease,Advanced Lung Non-Small Cell Squamous Carcinoma
11795,Premalignant Lesion,Colorectal Carcinoma Metastatic in the Lung
11796,Benign Cellular Infiltrate,Metastatic Unresectable Gastric Adenocarcinoma
11797,Indolent Clinical Course,Metastatic Chordoma
11798,Extensive Stage Lesion,Locally Advanced Chordoma
11799,Mixed Neoplastic Glandular and Squamous Cell Population,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
11800,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Acinic Cell Breast Carcinoma
11801,Papillary Pattern,Recurrent Salivary Duct Carcinoma
11802,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Minor Salivary Gland Adenocarcinoma
11803,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Fallopian Tube Serous Adenocarcinoma
11804,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Adenocarcinoma
11805,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Serous Adenocarcinoma
11806,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Serous Adenocarcinoma
11807,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Serous Adenocarcinoma
11808,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Clear Cell Adenocarcinoma
11809,Ground Glass Nuclear Inclusion,Recurrent Thyroid Gland Follicular Carcinoma
11810,Glandular Differentiation,Recurrent Submandibular Gland Undifferentiated Carcinoma
11811,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Malignant Ovarian Brenner Tumor
11812,Indolent Clinical Course,Recurrent Malignant Brain Neoplasm
11813,Indolent Clinical Course,Refractory Malignant Brain Neoplasm
11814,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Fibrolamellar Carcinoma
11815,Benign Cellular Infiltrate,Unresectable Gastric Adenocarcinoma
11816,Extensive Stage Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
11817,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
11818,High Grade Lesion,Letterer-Siwe Disease
11819,Metastatic Lesion,Cerebral hemangioma
11820,Metastatic Lesion,Cerebral Hemisphere Lipoma
11821,Proliferation of High Endothelial Venules Present,Follicular T-cell lymphoma
11822,Benign Cellular Infiltrate,Intestinal T-cell lymphoma recurrent
11823,Local disease,Pericardial mesothelioma malignant advanced
11824,Neoplastic Cells with TFH Cell Phenotype Present,Peripheral T-cell lymphoma unspecified refractory
11825,Metastatic Lesion,Childhood Central Nervous System Ganglioneuroblastoma
11826,Extensive Stage Lesion,Locally Advanced Carcinoma
11827,Aggressive Clinical Course,Refractory Indolent Adult Non-Hodgkin Lymphoma
11828,Favorable Clinical Outcome,Unresectable Cutaneous Melanoma
11829,Intermediate Filaments Present,Refractory Undifferentiated Pleomorphic Sarcoma
11830,Intracytoplasmic Eosinophilic Inclusion,Refractory Synovial Sarcoma
11831,Indolent Clinical Course,Recurrent Sarcoma
11832,Intermediate Filaments Present,Unresectable Sarcoma
11833,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Paranasal Sinus Squamous Cell Carcinoma
11834,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia
11835,Extensive Stage Lesion,Locally Advanced Melanoma
11836,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Oral Cavity Squamous Cell Carcinoma
11837,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Oral Cavity Squamous Cell Carcinoma
11838,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Nasopharyngeal Squamous Cell Carcinoma
11839,Constitutional Symptom,IgM monoclonal gammopathy of uncertain significance
11840,Premalignant Lesion,Refractory Lung Small Cell Carcinoma
11841,Intracytoplasmic Eosinophilic Inclusion,Refractory Liposarcoma
11842,Intracytoplasmic Eosinophilic Inclusion,Unresectable Dedifferentiated Liposarcoma
11843,Indolent Clinical Course,Unresectable Undifferentiated Pleomorphic Sarcoma
11844,Intracytoplasmic Eosinophilic Inclusion,Resectable Undifferentiated Pleomorphic Sarcoma
11845,Indolent Clinical Course,Locally Advanced Gastrointestinal Stromal Tumor
11846,Extensive Stage Lesion,Locally Advanced Gastrointestinal Stromal Tumor
11847,Benign Cellular Infiltrate,Refractory Metastatic Digestive System Carcinoma
11848,Decreased platelet count,Myeloid Neoplasms with Germline GATA2 Mutation
11849,Extensive Stage Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
11850,Benign Cellular Infiltrate,Distal Esophagus Adenocarcinoma
11851,Mixed Neoplastic Glandular and Squamous Cell Population,Distal Esophagus Adenocarcinoma
11852,Intracytoplasmic Eosinophilic Inclusion,Locally Advanced Sarcoma
11853,Intracytoplasmic Eosinophilic Inclusion,Unresectable Bone Sarcoma
11854,Low Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma
11855,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Skin Squamous Cell Carcinoma
11856,Local disease,Advanced Sarcoma
11857,Premalignant Lesion,Locally Advanced Lung Carcinoma
11858,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Unresectable Gastric Adenocarcinoma
11859,Local disease,Advanced Unresectable Gastric Adenocarcinoma
11860,Benign Cellular Infiltrate,Metastatic gastric adenocarcinoma
11861,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Submandibular Gland Acinic Cell Carcinoma
11862,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ampulla of Vater Adenocarcinoma
11863,Benign Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma
11864,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Invasive Ductal Breast Carcinoma
11865,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Salivary Duct Carcinoma
11866,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Fallopian Tube Serous Adenocarcinoma
11867,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Mucinous Adenocarcinoma
11868,Mucoid Stroma Formation,Recurrent Thyroid Gland Papillary Carcinoma
11869,Intermediate Filaments Present,Recurrent Skin Angiosarcoma
11870,Benign Cellular Infiltrate,Recurrent Fibrolamellar Carcinoma
11871,Favorable Clinical Outcome,Recurrent Fibrolamellar Carcinoma
11872,Favorable Clinical Outcome,Metastatic hepatocellular carcinoma
11873,Precise Histogenesis Unknown,MGMT-Methylated Glioblastoma
11874,Metastatic Lesion,Parasagittal Meningioma
11875,Metastatic Lesion,Cerebral Primitive Neuroectodermal Tumor
11876,Metastatic Lesion,Anaplastic Hemispheric Astrocytoma
11877,Architectural Distortion,Non-Destructive Post-Transplant Lymphoproliferative Disorder
11878,Metastatic Lesion,Recurrent Childhood Cerebral Astrocytoma
11879,Hereditary Lesion,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
11880,Necrotic changes (finding),Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
11881,Local disease,Advanced Bile Duct Carcinoma
11882,Local disease,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11883,Extensive Stage Lesion,Locally Advanced Thymic Carcinoma
11884,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Head and Neck Squamous Cell Carcinoma
11885,Indolent Clinical Course,Refractory Myxoid Liposarcoma
11886,Intracytoplasmic Eosinophilic Inclusion,Myxoid liposarcoma metastatic
11887,Intracytoplasmic Eosinophilic Inclusion,Recurrent Sarcoma
11888,Chronic Clinical Course,Recurrent Mixed Phenotype Acute Leukemia
11889,Blasts Expressing CD56 and Immature T-Cell Markers Present,Recurrent Mixed Phenotype Acute Leukemia
11890,Solid Growth Pattern,Refractory Leukemia
11891,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Esophagus Adenocarcinoma
11892,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell carcinoma of the hypopharynx stage IV
11893,Tumor Mass,Fibrin-Associated Diffuse Large B-Cell Lymphoma
11894,Indolent Clinical Course,Recurrent Malignant Bone Neoplasm
11895,Intracytoplasmic Eosinophilic Inclusion,Recurrent Dedifferentiated Liposarcoma
11896,Indolent Clinical Course,Refractory Liposarcoma
11897,Intermediate Filaments Present,Unresectable Dedifferentiated Liposarcoma
11898,Indolent Clinical Course,Resectable Sarcoma
11899,Intracytoplasmic Eosinophilic Inclusion,Resectable Dedifferentiated Liposarcoma
11900,HMB-45-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
11901,HMB-45-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
11902,CD30-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
11903,High Grade Lesion,"Langerhans Cell Histiocytosis, Disseminated"
11904,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction
11905,Pre-existing condition,Myeloid Neoplasms with Germline DDX41 Mutation
11906,Solid Growth Pattern,Recurrent Burkitt Leukemia
11907,Chronic Clinical Course,Refractory Burkitt Leukemia
11908,Intracytoplasmic Eosinophilic Inclusion,Unresectable Rhabdomyosarcoma
11909,Indolent Clinical Course,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
11910,Intracytoplasmic Eosinophilic Inclusion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
11911,Blasts Expressing CD56 and Immature T-Cell Markers Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
11912,Benign Cellular Infiltrate,Locally Advanced Pancreatic Ductal Adenocarcinoma
11913,Extensive Stage Lesion,Locally Advanced Soft Tissue Sarcoma
11914,Intracytoplasmic Eosinophilic Inclusion,Metastatic Soft Tissue Sarcoma
11915,Intermediate Filaments Present,Locally Advanced Bone Sarcoma
11916,Indolent Clinical Course,Locally Advanced Sarcoma
11917,Intermediate Filaments Present,Unresectable Bone Sarcoma
11918,Well Differentiated Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
11919,Intermediate Filaments Present,Resectable Soft Tissue Sarcoma
11920,CD4-Positive Neoplastic Cells Present,Recurrent Hepatosplenic T-Cell Lymphoma
11921,Extensive Stage Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
11922,Indolent Clinical Course,Unresectable Chordoma
11923,Benign Cellular Infiltrate,Recurrent Gastroesophageal Junction Adenocarcinoma
11924,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Gastroesophageal Junction Adenocarcinoma
11925,Indolent Clinical Course,Locally Advanced Unresectable Sarcoma
11926,Fibrotic Stroma Formation,Recurrent Pancreatic Acinar Cell Carcinoma
11927,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Pancreatic Acinar Cell Carcinoma
11928,Mixed Neoplastic Glandular and Squamous Cell Population,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
11929,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Chromophobe Renal Cell Carcinoma
11930,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Ovarian Cystadenocarcinoma
11931,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Pancreatic Ductal Adenocarcinoma
11932,Nuclear Pseudoinclusion,Recurrent Thyroid Gland Follicular Carcinoma
11933,Indolent Clinical Course,Recurrent Skin Angiosarcoma
11934,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Parotid Gland Squamous Cell Carcinoma
11935,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Malignant Ovarian Transitional Cell Tumor
11936,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Transitional Cell Carcinoma
11937,Indolent Clinical Course,Refractory WHO Grade III Glioma
11938,Precise Histogenesis Unknown,Refractory WHO Grade III Glioma
11939,Metastatic Lesion,Sparsely Granulated Corticotroph Adenoma
11940,High Grade Lesion,Eosinophilic Granuloma
11941,Benign Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma
11942,Metastatic Lesion,Neuroblastoma of brain
11943,Immunosuppression-Related Post-Transplant Toxicity,Lymphoproliferative disorder caused by methotrexate
11944,Architectural Distortion,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder
11945,Local disease,Pleural mesothelioma malignant advanced
11946,Benign Cellular Infiltrate,Proneural Glioblastoma
11947,Benign Cellular Infiltrate,Mesenchymal Glioblastoma
11948,Benign Cellular Infiltrate,Rare Childhood Malignant Neoplasm
11949,Benign Cellular Infiltrate,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
11950,Benign Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
11951,Benign Cellular Infiltrate,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
11952,Intermediate Grade Neuroendocrine Lesion,Adult Pleomorphic Hepatocellular Carcinoma
11953,Intermediate Grade Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v7
11954,Low Grade Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v7
11955,Intermediate Grade Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v7
11956,Low Grade Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v7
11957,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v7
11958,Intermediate Grade Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v7
11959,Low Grade Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v7
11960,Well Differentiated Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v7
11961,Benign Cellular Infiltrate,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
11962,Benign Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
11963,Benign Cellular Infiltrate,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
11964,Benign Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
11965,Benign Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7
11966,Well Differentiated Neuroendocrine Lesion,Stage IA Esophageal Cancer AJCC v7
11967,Intermediate Grade Neuroendocrine Lesion,Stage IB Esophageal Cancer AJCC v7
11968,Well Differentiated Neuroendocrine Lesion,BCLC Stage 0 Hepatocellular Carcinoma
11969,Intermediate Grade Neuroendocrine Lesion,BCLC Stage B Hepatocellular Carcinoma
11970,Well Differentiated Neuroendocrine Lesion,BCLC Stage D Hepatocellular Carcinoma
11971,Well Differentiated Neuroendocrine Lesion,BCLC Stage B Adult Hepatocellular Carcinoma
11972,Well Differentiated Neuroendocrine Lesion,BCLC Stage C Adult Hepatocellular Carcinoma
11973,Well Differentiated Neuroendocrine Lesion,BCLC Stage D Adult Hepatocellular Carcinoma
11974,Benign Cellular Infiltrate,Familial Waldenstrom's Macroglobulinaemia
11975,Poorly Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
11976,Benign Cellular Infiltrate,Proximal Urethral Carcinoma
11977,Benign Cellular Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis
11978,Benign Cellular Infiltrate,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
11979,Benign Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis
11980,Benign Cellular Infiltrate,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
11981,Malignant Cellular Infiltrate,Congenital Cystic Hygroma
11982,Low Grade Neuroendocrine Lesion,Childhood Colorectal Carcinoma
11983,Benign Cellular Infiltrate,Childhood Lung Non-Small Cell Carcinoma
11984,Benign Cellular Infiltrate,Childhood Nasal Cavity Carcinoma
11985,Benign Cellular Infiltrate,Childhood Malignant Penile Neoplasm
11986,Benign Cellular Infiltrate,Childhood Thyroid Gland Carcinoma
11987,Benign Cellular Infiltrate,Orbital Melanoma
11988,Benign Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer
11989,Malignant Cellular Infiltrate,Infiltrating Intramuscular Lipoma
11990,Benign Cellular Infiltrate,Leiomyosarcoma of Deep Soft Tissue
11991,Malignant Cellular Infiltrate,Conventional Schwannoma
11992,Benign Cellular Infiltrate,Bone Epithelioid Hemangioendothelioma
11993,Benign Cellular Infiltrate,ROSE Cluster 2
11994,Benign Cellular Infiltrate,ROSE Cluster 4
11995,Benign Cellular Infiltrate,ROSE Cluster 5
11996,Benign Cellular Infiltrate,ROSE Cluster 8
11997,Benign Cellular Infiltrate,Childhood Periosteal Osteosarcoma
11998,Benign Cellular Infiltrate,Fusion-Positive Alveolar Rhabdomyosarcoma
11999,Benign Cellular Infiltrate,Childhood Seminoma
12000,Benign Cellular Infiltrate,Childhood Thyroid Gland Follicular Carcinoma
12001,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
12002,Malignant Cellular Infiltrate,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis
12003,Malignant Cellular Infiltrate,Broad Ligament Serous Cystadenofibroma
12004,Malignant Cellular Infiltrate,Broad Ligament Serous Adenofibroma
12005,Questionable Invasive Lesion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
12006,Benign Cellular Infiltrate,Uterine Corpus Rhabdomyosarcoma
12007,Benign Cellular Infiltrate,Metastatic Malignant Solid Neoplasm
12008,Malignant Cellular Infiltrate,Cervical Leiomyoma
12009,Benign Cellular Infiltrate,Vaginal Large Cell Neuroendocrine Carcinoma
12010,Malignant Cellular Infiltrate,Vaginal Myofibroblastoma
12011,Benign Cellular Infiltrate,Vaginal Rhabdomyosarcoma
12012,Benign Cellular Infiltrate,FIGO Stage II Ovarian Cancer
12013,Benign Cellular Infiltrate,FIGO Stage IIIA1(ii) Ovarian Cancer
12014,Benign Cellular Infiltrate,Vulvar Adenocarcinoma of Sweat Gland Type
12015,Malignant Cellular Infiltrate,Vulvar Fibrolipoma
12016,Benign Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma
12017,Intermediate Grade Neuroendocrine Lesion,Intrahepatic cholangiocarcinoma recurrent
12018,Benign Cellular Infiltrate,"Medulloblastoma, WNT-Activated"
12019,Benign Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH"
12020,Benign Cellular Infiltrate,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
12021,Benign Cellular Infiltrate,histiocytic sarcoma of central nervous system
12022,Benign Cellular Infiltrate,Unresectable Transitional Cell Carcinoma
12023,Benign Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth
12024,Benign Cellular Infiltrate,Sacral Chordoma
12025,Benign Cellular Infiltrate,Hormone refractory prostate cancer
12026,Benign Cellular Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
12027,Benign Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v8
12028,Benign Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v8
12029,Benign Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v8
12030,Benign Cellular Infiltrate,Stage II Major Salivary Gland Cancer AJCC v8
12031,Benign Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v8
12032,Benign Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8
12033,Benign Cellular Infiltrate,Prostate Carcinoma Metastatic in the Soft Tissue
12034,Benign Cellular Infiltrate,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
12035,Benign Cellular Infiltrate,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
12036,Benign Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v8
12037,Benign Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v8
12038,Benign Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8
12039,Benign Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v8
12040,Benign Cellular Infiltrate,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
12041,Benign Cellular Infiltrate,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
12042,Low Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v8 Stage
12043,Well Differentiated Neuroendocrine Lesion,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
12044,Low Grade Neuroendocrine Lesion,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
12045,Intermediate Grade Neuroendocrine Lesion,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
12046,Low Grade Neuroendocrine Lesion,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
12047,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
12048,Intermediate Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
12049,Low Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
12050,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
12051,Low Grade Neuroendocrine Lesion,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
12052,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
12053,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
12054,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
12055,Low Grade Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
12056,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
12057,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
12058,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
12059,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
12060,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
12061,Benign Cellular Infiltrate,Recurrent Atypical Teratoid/Rhabdoid Tumor
12062,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
12063,Low Grade Neuroendocrine Lesion,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
12064,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
12065,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
12066,Intermediate Grade Neuroendocrine Lesion,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
12067,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
12068,Low Grade Neuroendocrine Lesion,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
12069,Low Grade Neuroendocrine Lesion,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
12070,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
12071,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
12072,Low Grade Neuroendocrine Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
12073,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
12074,Low Grade Neuroendocrine Lesion,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
12075,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
12076,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
12077,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
12078,Well Differentiated Neuroendocrine Lesion,Clinical Stage III Gastric Cancer AJCC v8
12079,Low Grade Neuroendocrine Lesion,Clinical Stage III Gastric Cancer AJCC v8
12080,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIA Gastric Cancer AJCC v8
12081,Well Differentiated Neuroendocrine Lesion,Pathologic Stage III Gastric Cancer AJCC v8
12082,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIA Gastric Cancer AJCC v8
12083,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIC Gastric Cancer AJCC v8
12084,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
12085,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
12086,Benign Cellular Infiltrate,Locally Advanced Paraganglioma
12087,Benign Cellular Infiltrate,Refractory Primary Amyloidosis
12088,Intermediate Grade Neuroendocrine Lesion,Appendix Carcinoma by AJCC v7 Stage
12089,Intermediate Grade Neuroendocrine Lesion,Stage III Anal Cancer AJCC v8
12090,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Anal Cancer AJCC v8
12091,Low Grade Neuroendocrine Lesion,Stage IIIC Anal Cancer AJCC v8
12092,Intermediate Grade Neuroendocrine Lesion,Stage IV Anal Cancer AJCC v8
12093,Intermediate Grade Neuroendocrine Lesion,Metastatic Digestive System Carcinoma
12094,Well Differentiated Neuroendocrine Lesion,Stage II Small Intestinal Adenocarcinoma AJCC v8
12095,Intermediate Grade Neuroendocrine Lesion,Stage II Small Intestinal Adenocarcinoma AJCC v8
12096,Well Differentiated Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v8
12097,Low Grade Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v8
12098,Low Grade Neuroendocrine Lesion,Stage II Appendix Carcinoma AJCC v8
12099,Intermediate Grade Neuroendocrine Lesion,Stage III Appendix Carcinoma AJCC v8
12100,Intermediate Grade Neuroendocrine Lesion,Stage IV Appendix Carcinoma AJCC v8
12101,Benign Cellular Infiltrate,Refractory Lymphoma
12102,Low Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v8 Stage
12103,Low Grade Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v8
12104,Well Differentiated Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v8
12105,Well Differentiated Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v8
12106,Well Differentiated Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v8
12107,Well Differentiated Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v8
12108,Intermediate Grade Neuroendocrine Lesion,Colon Cancer by AJCC v8 Stage
12109,Low Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v8 Stage
12110,Well Differentiated Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v8
12111,Intermediate Grade Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v8
12112,Low Grade Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v8
12113,Well Differentiated Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v8
12114,Well Differentiated Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v8
12115,Intermediate Grade Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v8
12116,Low Grade Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v8
12117,Well Differentiated Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v8
12118,Low Grade Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v8
12119,Low Grade Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v8
12120,Benign Cellular Infiltrate,Acute myeloid leukemia refractory
12121,Well Differentiated Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v8 Stage
12122,Intermediate Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v8 Stage
12123,Well Differentiated Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v8
12124,Well Differentiated Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8
12125,Low Grade Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8
12126,Well Differentiated Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v8
12127,Low Grade Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8
12128,Well Differentiated Neuroendocrine Lesion,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
12129,Low Grade Neuroendocrine Lesion,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
12130,Low Grade Neuroendocrine Lesion,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
12131,Well Differentiated Neuroendocrine Lesion,Gallbladder Cancer by AJCC v8 Stage
12132,Low Grade Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v8
12133,Low Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v8
12134,Low Grade Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v8
12135,Low Grade Neuroendocrine Lesion,Stage IVA Gallbladder Cancer AJCC v8
12136,Well Differentiated Neuroendocrine Lesion,Stage IVB Gallbladder Cancer AJCC v8
12137,Low Grade Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v8 Stage
12138,Well Differentiated Neuroendocrine Lesion,Stage III Hilar Cholangiocarcinoma AJCC v8
12139,Intermediate Grade Neuroendocrine Lesion,Stage III Hilar Cholangiocarcinoma AJCC v8
12140,Well Differentiated Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v8
12141,Intermediate Grade Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v8
12142,Low Grade Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v8
12143,Intermediate Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
12144,Low Grade Neuroendocrine Lesion,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
12145,Well Differentiated Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v7 Stage
12146,Intermediate Grade Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v7 Stage
12147,Well Differentiated Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v8
12148,Intermediate Grade Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v8
12149,Low Grade Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v7 Stage
12150,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v8
12151,Low Grade Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v8
12152,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Ampulla of Vater Cancer AJCC v8
12153,Intermediate Grade Neuroendocrine Lesion,Pancreatic Cancer by AJCC v6 and v7 Stage
12154,Intermediate Grade Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v8
12155,Intermediate Grade Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v8
12156,Intermediate Grade Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v8
12157,Poorly Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
12158,Poorly Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8
12159,Poorly Differentiated Neuroendocrine Lesion,Stage III Jejunal Neuroendocrine Tumor AJCC v8
12160,Poorly Differentiated Neuroendocrine Lesion,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
12161,Poorly Differentiated Neuroendocrine Lesion,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
12162,Benign Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage
12163,Benign Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v8
12164,Benign Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v8
12165,Benign Cellular Infiltrate,Malignant Peritoneal Germ Cell Tumor
12166,Benign Cellular Infiltrate,Unresectable Head and Neck Squamous Cell Carcinoma
12167,Benign Cellular Infiltrate,Stage IA3 Lung Cancer AJCC v8
12168,Benign Cellular Infiltrate,Stage IVA Lung Cancer AJCC v8
12169,Benign Cellular Infiltrate,Bone Cancer by AJCC v7 Stage
12170,Benign Cellular Infiltrate,Bone Cancer by AJCC v8 Stage
12171,Benign Cellular Infiltrate,Stage IIB Bone Cancer AJCC v8
12172,Benign Cellular Infiltrate,Osteosarcoma by AJCC v7 Stage
12173,Benign Cellular Infiltrate,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
12174,Benign Cellular Infiltrate,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
12175,Benign Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v7 Stage
12176,Benign Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v7 Stage
12177,Benign Cellular Infiltrate,Lung Mucinous Adenocarcinoma In Situ
12178,Benign Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8
12179,Benign Cellular Infiltrate,Clinical Stage 0 Cutaneous Melanoma AJCC v8
12180,Benign Cellular Infiltrate,Clinical Stage IIC Cutaneous Melanoma AJCC v8
12181,Benign Cellular Infiltrate,Pathologic Stage 0 Cutaneous Melanoma AJCC v8
12182,Benign Cellular Infiltrate,Pathologic Stage IIID Cutaneous Melanoma AJCC v8
12183,Well Differentiated Neuroendocrine Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
12184,Benign Cellular Infiltrate,Basal-Like Prostate Carcinoma
12185,Benign Cellular Infiltrate,Recurrent High Risk Myelodysplastic Syndrome
12186,Benign Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome
12187,Benign Cellular Infiltrate,Anatomic Stage IIA Breast Cancer AJCC v8
12188,Benign Cellular Infiltrate,Anatomic Stage IIIC Breast Cancer AJCC v8
12189,Malignant Cellular Infiltrate,Anal Ectopic Fibroadenoma
12190,Benign Cellular Infiltrate,Prognostic Stage I Breast Cancer AJCC v8
12191,Benign Cellular Infiltrate,Prognostic Stage II Breast Cancer AJCC v8
12192,Benign Cellular Infiltrate,Prognostic Stage IV Breast Cancer AJCC v8
12193,Benign Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v8
12194,Benign Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v8
12195,Benign Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8
12196,Benign Cellular Infiltrate,Stage IA2 Cervical Cancer AJCC v8
12197,Benign Cellular Infiltrate,Uterine Corpus Leiomyosarcoma by AJCC v8 Stage
12198,Benign Cellular Infiltrate,Stage II Uterine Corpus Leiomyosarcoma AJCC v8
12199,Benign Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8
12200,Benign Cellular Infiltrate,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8
12201,Benign Cellular Infiltrate,Stage IB Uterine Corpus Adenosarcoma AJCC v8
12202,Benign Cellular Infiltrate,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
12203,Benign Cellular Infiltrate,Stage IB Ovarian Cancer AJCC v8
12204,Benign Cellular Infiltrate,Stage III Ovarian Cancer AJCC v8
12205,Benign Cellular Infiltrate,Stage IIIA1 Ovarian Cancer AJCC v8
12206,Benign Cellular Infiltrate,Stage IIIC Ovarian Cancer AJCC v8
12207,Benign Cellular Infiltrate,Stage IVA Ovarian Cancer AJCC v8
12208,Benign Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v8
12209,Benign Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v8
12210,Benign Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8
12211,Benign Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v8
12212,Benign Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v8
12213,Benign Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v8
12214,Benign Cellular Infiltrate,Testicular Cancer by AJCC v6 and v7 Stage
12215,Benign Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v8
12216,Benign Cellular Infiltrate,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
12217,Benign Cellular Infiltrate,Renal Pelvis Cancer by AJCC v8 Stage
12218,Benign Cellular Infiltrate,Stage IV Ureter Cancer AJCC v8
12219,Benign Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v7 Stage
12220,Benign Cellular Infiltrate,Stage 0a Bladder Cancer AJCC v8
12221,Benign Cellular Infiltrate,Stage IIIB Bladder Cancer AJCC v8
12222,Benign Cellular Infiltrate,Stage IV Urethral Cancer AJCC v8
12223,Benign Cellular Infiltrate,Stage IIA Eyelid Carcinoma AJCC v8
12224,Benign Cellular Infiltrate,Retinoblastoma by AJCC v8 Stage
12225,Benign Cellular Infiltrate,Pathologic Stage IV Retinoblastoma AJCC v8
12226,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
12227,Benign Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
12228,Benign Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
12229,Benign Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
12230,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
12231,Benign Cellular Infiltrate,Refractory Extensive Stage Lung Small Cell Carcinoma
12232,Benign Cellular Infiltrate,Lymphoma by Ann Arbor Stage
12233,Benign Cellular Infiltrate,Hodgkin Lymphoma by Ann Arbor Stage
12234,Benign Cellular Infiltrate,Lugano Classification Adult Lymphoma by AJCC v8 Stage
12235,Benign Cellular Infiltrate,Lugano Classification Stage IE Adult Lymphoma AJCC v8
12236,Benign Cellular Infiltrate,Lugano Classification Stage IV Adult Lymphoma AJCC v8
12237,Benign Cellular Infiltrate,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8
12238,Benign Cellular Infiltrate,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8
12239,Benign Cellular Infiltrate,Nodal Marginal Zone Lymphoma by Ann Arbor Stage
12240,Benign Cellular Infiltrate,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
12241,Benign Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
12242,Benign Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8
12243,Benign Cellular Infiltrate,RISS Stage II Plasma Cell Myeloma
12244,Benign Cellular Infiltrate,RISS Stage III Plasma Cell Myeloma
12245,Well Differentiated Neuroendocrine Lesion,Refractory Pancreatic Carcinoma
12246,Benign Cellular Infiltrate,Acute lymphoblastic leukemia recurrent
12247,Benign Cellular Infiltrate,Refractory Ewing Sarcoma
12248,Intermediate Grade Neuroendocrine Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma
12249,Intermediate Grade Neuroendocrine Lesion,Metastatic Bile Duct Carcinoma
12250,Benign Cellular Infiltrate,Thymic Hepatoid Adenocarcinoma
12251,Benign Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group
12252,Benign Cellular Infiltrate,Locally Advanced Angiosarcoma
12253,Benign Cellular Infiltrate,Cardiac Extraskeletal Osteosarcoma
12254,Benign Cellular Infiltrate,Pericardial Sarcoma
12255,Benign Cellular Infiltrate,Pericardial Synovial Sarcoma
12256,Benign Cellular Infiltrate,Childhood Brain Glioblastoma
12257,Low Grade Neuroendocrine Lesion,Refractory Colorectal Carcinoma
12258,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome refractory
12259,Benign Cellular Infiltrate,Locally Advanced Carcinoma
12260,Benign Cellular Infiltrate,Refractory Leiomyosarcoma
12261,Benign Cellular Infiltrate,MCD Diffuse Large B-Cell Lymphoma
12262,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia
12263,Benign Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia
12264,Benign Cellular Infiltrate,Refractory Acute Leukemia
12265,Benign Cellular Infiltrate,Recurrent Human Papillomavirus-Related Malignant Neoplasm
12266,Intermediate Grade Neuroendocrine Lesion,Thoracic Esophagus Adenocarcinoma
12267,Intermediate Grade Neuroendocrine Lesion,Cervical Esophagus Squamous Cell Carcinoma
12268,Low Grade Neuroendocrine Lesion,Cervical Esophagus Squamous Cell Carcinoma
12269,Low Grade Neuroendocrine Lesion,Distal Esophagus Squamous Cell Carcinoma
12270,Benign Cellular Infiltrate,Refractory Ovarian Endometrioid Adenocarcinoma
12271,Benign Cellular Infiltrate,Advanced Squamous Cell Carcinoma of the Oropharynx
12272,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage IV
12273,Benign Cellular Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma
12274,Benign Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites
12275,Benign Cellular Infiltrate,Refractory Malignant Mesothelioma
12276,Benign Cellular Infiltrate,Unresectable Adrenal Cortex Carcinoma
12277,Benign Cellular Infiltrate,Metastatic Renal Cell Carcinoma
12278,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline DDX41 Mutation
12279,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline RUNX1 Mutation
12280,Low Grade Neuroendocrine Lesion,Refractory Metastatic Digestive System Carcinoma
12281,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Bile Duct Carcinoma
12282,Low Grade Neuroendocrine Lesion,Locally Advanced Bile Duct Carcinoma
12283,Benign Cellular Infiltrate,Refractory Burkitt Leukemia
12284,Benign Cellular Infiltrate,Pelvic Rhabdomyosarcoma
12285,Benign Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
12286,Benign Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
12287,Intermediate Grade Neuroendocrine Lesion,Resectable Pancreatic Ductal Adenocarcinoma
12288,Benign Cellular Infiltrate,Locally Advanced Bone Sarcoma
12289,Benign Cellular Infiltrate,Locally Advanced Sarcoma
12290,Benign Cellular Infiltrate,Unresectable Synovial Sarcoma
12291,Well Differentiated Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
12292,Benign Cellular Infiltrate,Resectable Soft Tissue Sarcoma
12293,Benign Cellular Infiltrate,Advanced Carcinoma
12294,Benign Cellular Infiltrate,Advanced Sarcoma
12295,Benign Cellular Infiltrate,Metastatic Breast Carcinoma
12296,Well Differentiated Neuroendocrine Lesion,Metastatic Gastric Carcinoma
12297,Low Grade Neuroendocrine Lesion,Metastatic Gastric Carcinoma
12298,Benign Cellular Infiltrate,Recurrent Ovarian Carcinosarcoma
12299,Low Grade Neuroendocrine Lesion,Refractory Liver Carcinoma
12300,Well Differentiated Neuroendocrine Lesion,Bile duct cancer recurrent
12301,Intermediate Grade Neuroendocrine Lesion,Bile duct cancer recurrent
12302,Benign Cellular Infiltrate,Locally Advanced Unresectable Soft Tissue Sarcoma
12303,Well Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Acinar Cell Carcinoma
12304,Well Differentiated Neuroendocrine Lesion,Recurrent Ampulla of Vater Adenocarcinoma
12305,Intermediate Grade Neuroendocrine Lesion,Recurrent Anal Mucinous Adenocarcinoma
12306,Intermediate Grade Neuroendocrine Lesion,Recurrent Appendix Mucinous Adenocarcinoma
12307,Benign Cellular Infiltrate,Recurrent Lobular Breast Carcinoma
12308,Well Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Cystadenocarcinoma
12309,Intermediate Grade Neuroendocrine Lesion,Recurrent Pancreatic Cystadenocarcinoma
12310,Benign Cellular Infiltrate,Recurrent Parotid Gland Carcinoma
12311,Low Grade Neuroendocrine Lesion,Recurrent Appendix Carcinoma
12312,Benign Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma
12313,Benign Cellular Infiltrate,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
12314,Low Grade Neuroendocrine Lesion,Metastatic Fibrolamellar Carcinoma
12315,Metastatic Lesion,Sparsely Granulated Non-Functioning Corticotroph Adenoma
12316,Benign Cellular Infiltrate,Resectable Pleural Malignant Mesothelioma
12317,Intermediate Filaments Present,Anaplastic Sarcoma of the Kidney
12318,Metastatic Lesion,Pituitary Gland Multiple Adenomas
12319,Benign Cellular Infiltrate,Recurrent Metastatic Malignant Neoplasm
12320,Benign Cellular Infiltrate,Advanced Well Differentiated Neuroendocrine Neoplasm
12321,Well Differentiated Neuroendocrine Lesion,Digestive System Small Cell Neuroendocrine Carcinoma
12322,Benign Cellular Infiltrate,Digestive System Small Cell Neuroendocrine Carcinoma
12323,Benign Cellular Infiltrate,Cutaneous Melanoma of the Extremity
12324,Intermediate Filaments Present,Advanced Sarcoma of the Extremity
12325,Malignant Cellular Infiltrate,Sellar Schwannoma
12326,Indolent Clinical Course,Sellar Dedifferentiated Chordoma
12327,Indolent Clinical Course,Metastatic Malignant Neoplasm in the Sellar Region
12328,Malignant Germinomatous Cellular Infiltrate,Sellar Yolk Sac Tumor
12329,Seminomatous Component Present,Sellar Teratoma
12330,Indolent Clinical Course,Sellar Mixed Germ Cell Tumor
12331,Benign Cellular Infiltrate,Sellar Mixed Germ Cell Tumor
12332,Glandular Differentiation,Recurrent Endometrial Undifferentiated Carcinoma
12333,Benign Cellular Infiltrate,Recurrent Uterine Corpus Carcinosarcoma
12334,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Endometrial Mixed Cell Adenocarcinoma
12335,Benign Cellular Infiltrate,"Neuroendocrine carcinoma, metastatic"
12336,Indolent Clinical Course,Chest Wall Sarcoma
12337,Premalignant Lesion,Unresectable Lung Carcinoma
12338,Low Grade Neuroendocrine Lesion,Unresectable Digestive System Carcinoma
12339,Constitutional Symptom,Smoldering Waldenstrom Macroglobulinemia
12340,Well Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
12341,Low Mitotic Activity,Refractory Digestive System Neuroendocrine Carcinoma
12342,Low Grade Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Carcinoma
12343,Benign Cellular Infiltrate,Recurrent Digestive System Neuroendocrine Carcinoma
12344,Mixed Neoplastic Glandular and Squamous Cell Population,Broad Ligament Papillary Cystadenoma
12345,Nuclear Grooves,Thyroid Gland Spindle Cell Follicular Adenoma
12346,Nuclear Clearing,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
12347,Precise Histogenesis Unknown,Refractory Visual Pathway Glioma
12348,Follicular Structures Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma
12349,Metastatic Lesion,Frontal Lobe Anaplastic Astrocytoma
12350,Metastatic Lesion,Temporal Lobe Anaplastic Astrocytoma
12351,Biphasic Pattern,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma
12352,Benign Cellular Infiltrate,Fourth Ventricle Medulloblastoma
12353,Mixed Neoplastic Glandular and Squamous Cell Population,Hobnail Variant Thyroid Gland Papillary Carcinoma
12354,Well Differentiated Neuroendocrine Lesion,Metastatic Esophageal Carcinoma
12355,Intermediate Grade Neuroendocrine Lesion,Metastatic Esophageal Carcinoma
12356,Well Differentiated Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma
12357,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Esophageal Adenocarcinoma
12358,Well Differentiated Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma
12359,Benign Cellular Infiltrate,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
12360,Squamous Differentiation,Metastatic Nasopharyngeal Undifferentiated Carcinoma
12361,Glandular Differentiation,Metastatic Nasopharyngeal Undifferentiated Carcinoma
12362,Benign Cellular Infiltrate,Metastatic Oral Cavity Carcinoma
12363,Benign Cellular Infiltrate,Metastatic Lip Carcinoma
12364,Benign Cellular Infiltrate,Metastatic Lip Squamous Cell Carcinoma
12365,Benign Cellular Infiltrate,Metastatic Lung Small Cell Carcinoma
12366,Premalignant Lesion,Metastatic Lung Small Cell Carcinoma
12367,Low Grade Neuroendocrine Lesion,Metastatic Rectal Carcinoma
12368,Benign Cellular Infiltrate,Metastatic Rectal Carcinoma
12369,Benign Cellular Infiltrate,Metastatic Thyroid Gland Follicular Carcinoma
12370,Benign Cellular Infiltrate,Frontal Lobe Anaplastic Oligodendroglioma
12371,Benign Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
12372,Ground Glass Nuclear Inclusion,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
12373,Well Differentiated Neuroendocrine Lesion,Localized Gastroesophageal Junction Adenocarcinoma
12374,Intermediate Filaments Present,Parotid Gland Liposarcoma
12375,Extensive Stage Lesion,Locally Advanced Unresectable Prostate Carcinoma
12376,Extensive Stage Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma
12377,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Unresectable Prostate Adenocarcinoma
12378,Extensive Stage Lesion,Locally Advanced Cervical Carcinoma
12379,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Unresectable Cervical Adenocarcinoma
12380,Malignant Cellular Infiltrate,Thyroid Gland Benign Vascular Neoplasm
12381,Malignant Cellular Infiltrate,Thyroid Gland Leiomyoma
12382,Mitotic Activity,Grade 1 Teratoma
12383,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
12384,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma
12385,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
12386,Precise Histogenesis Unknown,Brain Ependymoma
12387,Benign Cellular Infiltrate,Refractory Kaposi Sarcoma
12388,Benign Cellular Infiltrate,Advanced Kaposi Sarcoma
12389,Intracytoplasmic Eosinophilic Inclusion,Advanced Kaposi Sarcoma
12390,High Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor
12391,Benign Cellular Infiltrate,Metastatic Breast Neuroendocrine Neoplasm
12392,Glandular Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma
12393,Intermediate Grade Neuroendocrine Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
12394,Well Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
12395,Well Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
12396,Intermediate Grade Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
12397,Local disease,Advanced Small Intestinal Neuroendocrine Carcinoma
12398,Glandular Differentiation,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
12399,Benign Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia
12400,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
12401,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
12402,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
12403,Benign Cellular Infiltrate,Recurrent Acute Monoblastic and Monocytic Leukemia
12404,Well Differentiated Neuroendocrine Lesion,Biliary Tract Carcinoma
12405,Low Grade Neuroendocrine Lesion,Recurrent Biliary Tract Carcinoma
12406,Well Differentiated Neuroendocrine Lesion,Pancreatic adenocarcinoma resectable
12407,Low Grade Neuroendocrine Lesion,Resectable Digestive System Carcinoma
12408,Benign Cellular Infiltrate,Resectable Digestive System Carcinoma
12409,Intermediate Grade Neuroendocrine Lesion,Resectable Extrahepatic Bile Duct Adenocarcinoma
12410,Malignant Cellular Infiltrate,Plantar wart
12411,Benign Cellular Infiltrate,"Sarcoma, Spindle Cell"
12412,Benign Cellular Infiltrate,Adult Yolk Sac Tumor
12413,Benign Cellular Infiltrate,Secondary Myelodysplastic Syndrome
12414,Intermediate Grade Neuroendocrine Lesion,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
12415,Intermediate Grade Neuroendocrine Lesion,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
12416,Intermediate Grade Neuroendocrine Lesion,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
12417,Intermediate Grade Neuroendocrine Lesion,Periampullary Adenocarcinoma
12418,Intermediate Grade Neuroendocrine Lesion,Cholangiocarcinoma non-resectable
12419,Low Grade Neuroendocrine Lesion,Cholangiocarcinoma recurrent
12420,Benign Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma
12421,Benign Cellular Infiltrate,Meningeal Carcinomatosis
12422,Well Differentiated Neuroendocrine Lesion,"Hepatocellular carcinoma, scirrhous"
12423,Malignant Cellular Infiltrate,Parathyroid Gland Oncocytic Adenoma
12424,Poorly Differentiated Neuroendocrine Lesion,Duodenal Somatostatin-Producing Neuroendocrine Tumor
12425,Low Grade Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma
12426,Low Grade Neuroendocrine Lesion,verrucous carcinoma of esophagus
12427,Well Differentiated Neuroendocrine Lesion,adenosquamous carcinoma of esophagus
12428,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
12429,Malignant Cellular Infiltrate,Benign Bone Schwannoma
12430,Benign Cellular Infiltrate,Spindle cell liposarcoma
12431,Benign Cellular Infiltrate,Skin Clear Cell Basal Cell Carcinoma
12432,Benign Cellular Infiltrate,Cystic basal cell carcinoma
12433,Benign Cellular Infiltrate,Basal cell carcinoma - follicular
12434,Benign Cellular Infiltrate,"Basal cell carcinoma, infundibulocystic"
12435,Benign Cellular Infiltrate,Transplant-Related Bladder Urothelial Carcinoma
12436,Low Grade Neuroendocrine Lesion,Transplant-Related Hepatocellular Carcinoma
12437,Benign Cellular Infiltrate,Transplant-Related Lung Carcinoma
12438,Well Differentiated Neuroendocrine Lesion,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
12439,Well Differentiated Neuroendocrine Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma
12440,Intermediate Grade Neuroendocrine Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma
12441,Benign Cellular Infiltrate,EBV-Related Hodgkin Lymphoma
12442,Malignant Cellular Infiltrate,Giant Hemangioma
12443,Benign Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
12444,Benign Cellular Infiltrate,Carcinoma in situ of penis
12445,Low Grade Neuroendocrine Lesion,Bile duct carcinoma
12446,Benign Cellular Infiltrate,Sarcomatoid Renal Cell Carcinoma
12447,Benign Cellular Infiltrate,Localized tumors of the Ewing's family
12448,Benign Cellular Infiltrate,leiomyosarcoma of retroperitoneum
12449,Benign Cellular Infiltrate,Immunodeficiency-associated Burkitt's lymphoma
12450,Well Differentiated Neuroendocrine Lesion,Aflatoxins-Related Hepatocellular Carcinoma
12451,Low Grade Neuroendocrine Lesion,Aflatoxins-Related Hepatocellular Carcinoma
12452,Benign Cellular Infiltrate,Asbestos-Related Lung Carcinoma
12453,Well Differentiated Neuroendocrine Lesion,Alcohol-Related Esophageal Squamous Cell Carcinoma
12454,Benign Cellular Infiltrate,Carcinoma in Situ
12455,Benign Cellular Infiltrate,Female Breast Carcinoma
12456,Benign Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma
12457,Benign Cellular Infiltrate,Noninfiltrating Intraductal Carcinoma
12458,Benign Cellular Infiltrate,Chondrosarcoma
12459,Benign Cellular Infiltrate,Choriocarcinoma
12460,Benign Cellular Infiltrate,Adenoid Cystic Carcinoma
12461,Well Differentiated Neuroendocrine Lesion,Liver carcinoma
12462,Benign Cellular Infiltrate,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12463,Benign Cellular Infiltrate,liposarcoma
12464,Malignant Cellular Infiltrate,Myxoma
12465,Benign Cellular Infiltrate,Myxosarcoma
12466,Malignant Cellular Infiltrate,Cartilaginous exostosis
12467,Benign Cellular Infiltrate,Paget's Disease of the Nipple
12468,Benign Cellular Infiltrate,Polycythemia Vera
12469,Benign Cellular Infiltrate,Rhabdomyosarcoma
12470,Benign Cellular Infiltrate,Squamous cell carcinoma of the head and neck
12471,Benign Cellular Infiltrate,"Lymphoma, Follicular, Grade 1"
12472,Benign Cellular Infiltrate,T-Cell Lymphoma
12473,Malignant Cellular Infiltrate,Thyroid Gland Follicular Adenoma
12474,Low Grade Neuroendocrine Lesion,Esophageal carcinoma
12475,Benign Cellular Infiltrate,Malignant neoplasm of soft palate
12476,Benign Cellular Infiltrate,Malignant Placental Neoplasm
12477,Benign Cellular Infiltrate,Malignant neoplasm of lacrimal duct
12478,Benign Cellular Infiltrate,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma
12479,Benign Cellular Infiltrate,Lymphoma of eye
12480,Benign Cellular Infiltrate,Posterior Pharyngeal Wall Squamous Cell Carcinoma
12481,Benign Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v7
12482,Benign Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v7
12483,Benign Cellular Infiltrate,Epiglottic carcinoma
12484,Benign Cellular Infiltrate,"Cranial Nerve Neoplasms, Malignant"
12485,Benign Cellular Infiltrate,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone
12486,Benign Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm
12487,Malignant Cellular Infiltrate,Benign tumor of nasopharynx
12488,Malignant Cellular Infiltrate,Benign neoplasm of esophagus
12489,Benign Cellular Infiltrate,Moderately Differentiated Malignant Neoplasm
12490,Malignant Cellular Infiltrate,benign neoplasm of heart
12491,Benign Cellular Infiltrate,Peripheral neuroepithelioma of bone metastatic
12492,Malignant Cellular Infiltrate,Benign neoplasm of body of uterus
12493,Benign Cellular Infiltrate,Activated B-cell type diffuse large B-cell lymphoma
12494,Benign Cellular Infiltrate,mucinous adenocarcinoma of cervix
12495,Benign Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
12496,Malignant Cellular Infiltrate,Benign neoplasm of prostate
12497,Malignant Cellular Infiltrate,Benign neoplasm of scrotum
12498,Benign Cellular Infiltrate,Secondary Neoplasm
12499,Benign Cellular Infiltrate,"T-Cell Prolymphocytic Leukemia, Small Cell Variant"
12500,Benign Cellular Infiltrate,Secondary carcinoma
12501,Low Grade Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v6 and v7
12502,Benign Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6
12503,Benign Cellular Infiltrate,"Carcinoma, Cribriform"
12504,Benign Cellular Infiltrate,"Carcinoma, Granular Cell"
12505,Intermediate Grade Neuroendocrine Lesion,"Carcinoid, Goblet Cell"
12506,Malignant Cellular Infiltrate,"Hemangioma, Intramuscular"
12507,Benign Cellular Infiltrate,"Leiomyosarcoma, Myxoid"
12508,Malignant Cellular Infiltrate,Hibernoma
12509,Benign Cellular Infiltrate,Diffuse Blastoid B-Cell Lymphoma
12510,Benign Cellular Infiltrate,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB
12511,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB
12512,Well Differentiated Neuroendocrine Lesion,Colloid Carcinoma of the Pancreas
12513,Intermediate Grade Neuroendocrine Lesion,Colloid Carcinoma of the Pancreas
12514,Benign Cellular Infiltrate,Malignant Mixed Tumor
12515,Benign Cellular Infiltrate,"Sarcoma, Small Cell"
12516,Malignant Cellular Infiltrate,Leiomyomatosis
12517,Benign Cellular Infiltrate,Germinoma
12518,Intermediate Grade Neuroendocrine Lesion,Pancreatic Endocrine Carcinoma
12519,Benign Cellular Infiltrate,Mucoepidermoid Carcinoma
12520,Benign Cellular Infiltrate,"Carcinoma, Neuroendocrine"
12521,Benign Cellular Infiltrate,Ganglioneuroblastoma
12522,Malignant Cellular Infiltrate,Inverted Papilloma
12523,Benign Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor
12524,Malignant Cellular Infiltrate,Angiofibroma
12525,Benign Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of Mucosa Site
12526,Malignant Cellular Infiltrate,Nodular fasciitis
12527,Well Differentiated Neuroendocrine Lesion,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
12528,Low Grade Neuroendocrine Lesion,Pancreatic carcinoma
12529,Malignant Cellular Infiltrate,Intraductal papilloma of breast
12530,Malignant Cellular Infiltrate,Hemangioma of liver
12531,Well Differentiated Neuroendocrine Lesion,Submucosal Invasive Colon Adenocarcinoma
12532,Benign Cellular Infiltrate,mu-Chain Disease
12533,Benign Cellular Infiltrate,Grade III Meningioma
12534,Benign Cellular Infiltrate,Mucosa-Associated Lymphoid Tissue Lymphoma
12535,Low Grade Neuroendocrine Lesion,Carcinoma of ampulla of Vater
12536,Benign Cellular Infiltrate,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant"
12537,Benign Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype"
12538,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
12539,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
12540,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
12541,Malignant Cellular Infiltrate,Bladder Squamous Papilloma
12542,Benign Cellular Infiltrate,mucinous adenocarcinoma of bladder
12543,Benign Cellular Infiltrate,Bladder Urachal Carcinoma
12544,Benign Cellular Infiltrate,Bladder Urachal Urothelial Carcinoma
12545,Benign Cellular Infiltrate,Bladder Urachal Squamous Cell Carcinoma
12546,Benign Cellular Infiltrate,Infiltrating Urothelial Carcinoma
12547,Benign Cellular Infiltrate,Urethral Verrucous Carcinoma
12548,Benign Cellular Infiltrate,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma
12549,Benign Cellular Infiltrate,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
12550,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Papillary Pattern"
12551,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern"
12552,Benign Cellular Infiltrate,Stage IV Breast Cancer AJCC v6 and v7
12553,Benign Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern"
12554,Malignant Cellular Infiltrate,Rete Ovarii Cystadenofibroma
12555,Benign Cellular Infiltrate,Malignant Ovarian Surface Epithelial-Stromal Tumor
12556,Malignant Cellular Infiltrate,Ovarian serous cystadenofibroma
12557,Benign Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma
12558,Benign Cellular Infiltrate,Malignant Ovarian Transitional Cell Tumor
12559,Malignant Cellular Infiltrate,Fallopian Tube Adenomatoid Tumor
12560,Benign Cellular Infiltrate,Endometrial Mucinous Adenocarcinoma
12561,Benign Cellular Infiltrate,Grade 3 Endometrial Endometrioid Adenocarcinoma
12562,Benign Cellular Infiltrate,Malignant Bone Neoplasm
12563,Benign Cellular Infiltrate,Cervical Lymphoepithelioma-Like Carcinoma
12564,Malignant Cellular Infiltrate,Cervical Atypical Polypoid Adenomyoma
12565,Malignant Cellular Infiltrate,"Vaginal Deep ""Aggressive"" Angiomyxoma"
12566,Malignant Cellular Infiltrate,Benign Vaginal Melanocytic Nevus
12567,Benign Cellular Infiltrate,Bartholin Gland Squamous Cell Carcinoma
12568,Benign Cellular Infiltrate,Malignant Vulvar Sweat Gland Neoplasm
12569,Benign Cellular Infiltrate,Vulvar Clear Cell Hidradenocarcinoma
12570,Benign Cellular Infiltrate,lipid-rich carcinoma of breast
12571,Malignant Cellular Infiltrate,Breast Ductal Adenoma
12572,Benign Cellular Infiltrate,carcinoma ex pleomorphic adenoma of salivary gland
12573,Benign Cellular Infiltrate,Anaplastic Ependymoma
12574,Benign Cellular Infiltrate,Meningothelial sarcoma
12575,Benign Cellular Infiltrate,"Testicular Seminoma, Tubular Variant"
12576,Benign Cellular Infiltrate,Lymphoepithelial carcinoma
12577,Benign Cellular Infiltrate,Fibroepithelioma of Pinkus
12578,Malignant Cellular Infiltrate,"Transitional cell papilloma, benign"
12579,Benign Cellular Infiltrate,"Transitional cell carcinoma, spindle cell"
12580,Benign Cellular Infiltrate,"Carcinoma, diffuse type"
12581,Low Grade Neuroendocrine Lesion,Bile duct cystadenocarcinoma
12582,Well Differentiated Neuroendocrine Lesion,Fibrolamellar Hepatocellular Carcinoma
12583,Benign Cellular Infiltrate,Adenocarcinoma in adenomatous polyposis coli
12584,Hemosiderin pigmentation,Chief cell adenoma
12585,Malignant Cellular Infiltrate,Glomerulosa Cell Adrenal Cortical Adenoma
12586,Benign Cellular Infiltrate,Secretory breast carcinoma
12587,Benign Cellular Infiltrate,"Ganglioneuroblastoma, Intermixed"
12588,Benign Cellular Infiltrate,"Extra-adrenal paraganglioma, malignant"
12589,Benign Cellular Infiltrate,Spindle Cell Melanoma
12590,Malignant Cellular Infiltrate,Cellular Blue Nevus
12591,Benign Cellular Infiltrate,"Liposarcoma, well differentiated"
12592,Malignant Cellular Infiltrate,Lipoblastomatosis
12593,Benign Cellular Infiltrate,Pleomorphic Rhabdomyosarcoma
12594,Benign Cellular Infiltrate,Clear cell sarcoma of kidney
12595,Benign Cellular Infiltrate,"Synovial sarcoma, spindle cell"
12596,Seminomatous Component Present,Grade 3 Teratoma
12597,Malignant Cellular Infiltrate,Histiocytoid hemangioma
12598,Malignant Cellular Infiltrate,Verrucous keratotic hemangioma
12599,Malignant Cellular Infiltrate,Cementoma
12600,Malignant Cellular Infiltrate,Adenoameloblastoma
12601,Benign Cellular Infiltrate,Giant Cell Glioblastoma
12602,Intermediate Grade Neuroendocrine Lesion,Hereditary Diffuse Gastric Adenocarcinoma
12603,Malignant Cellular Infiltrate,Piloleiomyoma
12604,Benign Cellular Infiltrate,Eccrine ductal carcinoma
12605,Benign Cellular Infiltrate,Marginal Zone B-Cell Lymphoma
12606,Benign Cellular Infiltrate,Angioendotheliomatosis
12607,Benign Cellular Infiltrate,Acute panmyelosis with myelofibrosis
12608,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of colon
12609,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of colon
12610,Low Grade Neuroendocrine Lesion,Small Intestinal Signet Ring Cell Carcinoma
12611,Well Differentiated Neuroendocrine Lesion,signet ring cell carcinoma of appendix
12612,Low Grade Neuroendocrine Lesion,signet ring cell carcinoma of appendix
12613,Poorly Differentiated Neuroendocrine Lesion,Appendix Tubular Carcinoid
12614,Intermediate Grade Neuroendocrine Lesion,Colorectal Adenosquamous Carcinoma
12615,Low Grade Neuroendocrine Lesion,Colorectal Medullary Carcinoma
12616,Low Grade Neuroendocrine Lesion,Colorectal Undifferentiated Carcinoma
12617,Low Grade Neuroendocrine Lesion,Rectosigmoid Signet Ring Cell Carcinoma
12618,Intermediate Grade Neuroendocrine Lesion,intestinal type adenocarcinoma of gallbladder
12619,Malignant Cellular Infiltrate,Senile angioma
12620,Low Grade Neuroendocrine Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7
12621,Intermediate Grade Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v6 and v7
12622,Malignant Cellular Infiltrate,Benign neoplasm of gallbladder
12623,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of pancreas
12624,Benign Cellular Infiltrate,Malignant mesothelioma
12625,Benign Cellular Infiltrate,Clear cell squamous cell carcinoma of skin
12626,Malignant Cellular Infiltrate,Squamous cell papilloma of skin
12627,Malignant Cellular Infiltrate,"Acanthoma, Pilar Sheath"
12628,Malignant Cellular Infiltrate,Mucinous cystadenoma of ovary
12629,Malignant Cellular Infiltrate,Intravenous leiomyomatosis
12630,Benign Cellular Infiltrate,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
12631,Benign Cellular Infiltrate,Stage 0 Vulvar Carcinoma
12632,Malignant Cellular Infiltrate,"Oncocytoma, renal"
12633,Benign Cellular Infiltrate,Squamous cell carcinoma of cornea
12634,Benign Cellular Infiltrate,Corneal Melanoma
12635,Benign Cellular Infiltrate,Lung Spindle Cell Carcinoma
12636,Malignant Cellular Infiltrate,Benign neoplasm of thorax
12637,Benign Cellular Infiltrate,Pleural mesothelioma malignant localised
12638,Benign Cellular Infiltrate,Pleural Synovial Sarcoma
12639,Benign Cellular Infiltrate,Mediastinal Myeloid Sarcoma
12640,Malignant Cellular Infiltrate,Adult Cardiac Cellular Rhabdomyoma
12641,Malignant Cellular Infiltrate,Ventricular myxoma
12642,Benign Cellular Infiltrate,Cardiac Monophasic Synovial Sarcoma
12643,Benign Cellular Infiltrate,Secondary malignant neoplasm of pericardium
12644,Benign Cellular Infiltrate,Malignant neoplasm of chest wall
12645,Benign Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7
12646,Malignant Cellular Infiltrate,Benign neoplasm of epiglottis
12647,Malignant Cellular Infiltrate,Benign neoplasm of endocardium
12648,Benign Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm
12649,Benign Cellular Infiltrate,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
12650,Benign Cellular Infiltrate,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
12651,Benign Cellular Infiltrate,Sporadic Thyroid Gland Micromedullary Carcinoma
12652,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of intestine
12653,Benign Cellular Infiltrate,Brain Glioblastoma
12654,Benign Cellular Infiltrate,Squamous cell carcinoma of palate
12655,Benign Cellular Infiltrate,Spindle cell squamous cell carcinoma
12656,Benign Cellular Infiltrate,Adenocarcinoma with metaplasia
12657,Benign Cellular Infiltrate,Anaplastic ganglioglioma
12658,Malignant Cellular Infiltrate,Benign neoplasm of kidney
12659,Benign Cellular Infiltrate,Breast Carcinoma with Chondroid Metaplasia
12660,Benign Cellular Infiltrate,Paget Disease of the Breast without Invasive Carcinoma
12661,Benign Cellular Infiltrate,Malignant neoplasm of sweat gland
12662,Benign Cellular Infiltrate,Ewings sarcoma
12663,Perineural spread,Parathyroid Gland Atypical Adenoma
12664,Benign Cellular Infiltrate,Transitional cell carcinoma of ureter
12665,Malignant Cellular Infiltrate,Adrenal Cortex Adenomatoid Tumor
12666,Benign Cellular Infiltrate,malignant neoplasm of epiglottis
12667,Well Differentiated Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v6 and v7
12668,Intermediate Grade Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v6 and v7
12669,Benign Cellular Infiltrate,Desmoplastic Neurotropic Melanoma
12670,Benign Cellular Infiltrate,Malignant neoplasm of soft tissue
12671,Well Differentiated Neuroendocrine Lesion,Carcinoma in situ of small intestine
12672,Malignant Cellular Infiltrate,Benign neoplasm of urinary system
12673,Malignant Cellular Infiltrate,Cavernous Angioleiomyoma
12674,Benign Cellular Infiltrate,Malignant Female Reproductive System Neoplasm
12675,Benign Cellular Infiltrate,Skin carcinoma
12676,Benign Cellular Infiltrate,Ependymoblastoma
12677,Malignant Cellular Infiltrate,Benign Female Reproductive System Neoplasm
12678,Benign Cellular Infiltrate,Pyriform Fossa Squamous Cell Carcinoma
12679,Benign Cellular Infiltrate,"Cancer, Supratentorial"
12680,Benign Cellular Infiltrate,Childhood Leukemia
12681,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma refractory
12682,Benign Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma
12683,Well Differentiated Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
12684,Benign Cellular Infiltrate,AIDS-Related Malignant Cervical Neoplasm
12685,Benign Cellular Infiltrate,Cerebral Lymphoma in Immunocompetent Host
12686,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I supradiaphragmatic
12687,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic
12688,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic
12689,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II
12690,Benign Cellular Infiltrate,Splenic marginal zone lymphoma refractory
12691,Intermediate Grade Neuroendocrine Lesion,Pancreatic carcinoma resectable
12692,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic
12693,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of large intestine
12694,Benign Cellular Infiltrate,Anaplastic Hemispheric Astrocytoma
12695,Benign Cellular Infiltrate,Intraductal Non-Comedo Breast Adenocarcinoma
12696,Benign Cellular Infiltrate,Invasive Cribriform Breast Carcinoma
12697,Benign Cellular Infiltrate,Infratentorial Glioblastoma
12698,Benign Cellular Infiltrate,Supratentorial Glioblastoma
12699,Benign Cellular Infiltrate,Cerebral Glioblastoma
12700,Benign Cellular Infiltrate,sarcoma of central nervous system
12701,Benign Cellular Infiltrate,Metaplastic carcinoma of breast
12702,Benign Cellular Infiltrate,Childhood Lymphoma
12703,Benign Cellular Infiltrate,Squamous cell breast carcinoma
12704,Benign Cellular Infiltrate,liposarcoma of breast
12705,Benign Cellular Infiltrate,Breast Rhabdomyosarcoma
12706,Malignant Cellular Infiltrate,Benign phyllodes neoplasm of breast
12707,Malignant Cellular Infiltrate,Intraductal Breast Papillomatosis
12708,Benign Cellular Infiltrate,Malignant nipple neoplasm
12709,Benign Cellular Infiltrate,mucinous adenocarcinoma of ovary
12710,Malignant Cellular Infiltrate,Gastric Lipoma
12711,Benign Cellular Infiltrate,BALT lymphoma
12712,Benign Cellular Infiltrate,Metastatic Meningioma
12713,Benign Cellular Infiltrate,Meningeal melanoma
12714,Benign Cellular Infiltrate,anaplastic large cell lymphoma of central nervous system
12715,Malignant Cellular Infiltrate,Cavernous lymphangioma
12716,Well Differentiated Neuroendocrine Lesion,mucoepidermoid carcinoma of esophagus
12717,Benign Cellular Infiltrate,Breast Carcinoma by Gene Expression Profile
12718,Benign Cellular Infiltrate,Basal-Like Breast Carcinoma
12719,Benign Cellular Infiltrate,Cardiac Fibrosarcoma
12720,Benign Cellular Infiltrate,Cardiac Lymphoma
12721,Benign Cellular Infiltrate,Cardiac Myeloid Sarcoma
12722,Benign Cellular Infiltrate,Secondary osteosarcoma
12723,Benign Cellular Infiltrate,Radiation-Related Osteosarcoma
12724,Benign Cellular Infiltrate,Osteosarcoma of bone
12725,Benign Cellular Infiltrate,Aortic Angiosarcoma
12726,Benign Cellular Infiltrate,Malignant Inferior Vena Cava Neoplasm
12727,Benign Cellular Infiltrate,Leiomyosarcoma of Vessels
12728,Malignant Cellular Infiltrate,Parotid Gland Hemangioma
12729,Benign Cellular Infiltrate,Gastrointestinal Stromal Sarcoma
12730,Benign Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
12731,Benign Cellular Infiltrate,Chordoma of clivus
12732,Benign Cellular Infiltrate,Secondary Supratentorial Anaplastic Astrocytoma
12733,Malignant Cellular Infiltrate,Pleural Schwannoma
12734,Benign Cellular Infiltrate,Basaloid squamous cell carcinoma
12735,Benign Cellular Infiltrate,Schneiderian carcinoma
12736,Benign Cellular Infiltrate,Sinonasal undifferentiated carcinoma
12737,Malignant Cellular Infiltrate,Calcifying Odontogenic Cyst
12738,Benign Cellular Infiltrate,Laryngeal Acantholytic Squamous Cell Carcinoma
12739,Benign Cellular Infiltrate,Laryngeal Adenosquamous Carcinoma
12740,Benign Cellular Infiltrate,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified"
12741,Benign Cellular Infiltrate,Drop Metastasis in the Spinal Cord
12742,Benign Cellular Infiltrate,Invasive Apocrine Breast Carcinoma
12743,Well Differentiated Neuroendocrine Lesion,Stage IB Gastric Carcinoma
12744,Low Grade Neuroendocrine Lesion,Gastric Tubular Adenocarcinoma
12745,Intermediate Grade Neuroendocrine Lesion,Gastric Adenosquamous Carcinoma
12746,Malignant Cellular Infiltrate,Benign Gastric Granular Cell Tumor
12747,Malignant Cellular Infiltrate,Benign Peripheral Nerve Granular Cell Tumor
12748,Benign Cellular Infiltrate,Central nervous system melanoma
12749,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
12750,Low Grade Neuroendocrine Lesion,Adenocarcinoma of cecum
12751,Malignant Cellular Infiltrate,Rectal Leiomyoma
12752,Low Grade Neuroendocrine Lesion,Squamous cell carcinoma of rectum
12753,Well Differentiated Neuroendocrine Lesion,Rectal Sarcomatoid Carcinoma
12754,Benign Cellular Infiltrate,Stage IV Uveal Melanoma AJCC v7
12755,Well Differentiated Neuroendocrine Lesion,mucinous adenocarcinoma of anus
12756,Low Grade Neuroendocrine Lesion,mucinous adenocarcinoma of anus
12757,Benign Cellular Infiltrate,Carcinoma Metastatic to the Skin
12758,Benign Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia Cutis
12759,Benign Cellular Infiltrate,Stage IB Lung Cancer AJCC v7
12760,Benign Cellular Infiltrate,Stage IIA Lung Cancer AJCC v7
12761,Benign Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v7
12762,Benign Cellular Infiltrate,Papillary Lung Adenocarcinoma
12763,Benign Cellular Infiltrate,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
12764,Benign Cellular Infiltrate,adenoid cystic carcinoma of lung
12765,Well Differentiated Neuroendocrine Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7
12766,Low Grade Neuroendocrine Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
12767,Low Grade Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v6 and v7
12768,Well Differentiated Neuroendocrine Lesion,signet ring cell carcinoma of pancreas
12769,Intermediate Grade Neuroendocrine Lesion,adenosquamous carcinoma of pancreas
12770,Intermediate Grade Neuroendocrine Lesion,Serous cystadenocarcinoma of pancreas
12771,Well Differentiated Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v6
12772,Low Grade Neuroendocrine Lesion,Stage IVB Gallbladder Carcinoma
12773,Intermediate Grade Neuroendocrine Lesion,mucinous adenocarcinoma of gallbladder
12774,Well Differentiated Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7
12775,Well Differentiated Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v6
12776,Low Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v6
12777,Well Differentiated Neuroendocrine Lesion,Squamous Cell Bile Duct Carcinoma
12778,Intermediate Grade Neuroendocrine Lesion,Squamous Cell Bile Duct Carcinoma
12779,Low Grade Neuroendocrine Lesion,Small intestine carcinoma stage II
12780,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma stage IV
12781,Low Grade Neuroendocrine Lesion,small cell carcinoma of extrahepatic bile duct
12782,Benign Cellular Infiltrate,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
12783,Benign Cellular Infiltrate,Stage IVC Basal Cell Lip Carcinoma
12784,Benign Cellular Infiltrate,Stage II Lip Cancer AJCC v6 and v7
12785,Benign Cellular Infiltrate,Stage IV Lip Cancer AJCC v6 and v7
12786,Benign Cellular Infiltrate,Major Salivary Gland Adenoid Cystic Carcinoma
12787,Benign Cellular Infiltrate,Major Salivary Gland Carcinoma
12788,Malignant Cellular Infiltrate,Oral Cavity Leiomyoma
12789,Benign Cellular Infiltrate,Upper Gingival Verrucous Carcinoma
12790,Well Differentiated Neuroendocrine Lesion,Stage IIIA Anal Canal Cancer AJCC v6 and v7
12791,Benign Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma
12792,Benign Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland
12793,Benign Cellular Infiltrate,Minor Salivary Gland Adenoid Cystic Carcinoma
12794,Benign Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma
12795,Benign Cellular Infiltrate,Sublingual Gland Adenocarcinoma
12796,Benign Cellular Infiltrate,Prolactin-Producing Pituitary Gland Carcinoma
12797,Benign Cellular Infiltrate,Posterior Tongue Mucoepidermoid Carcinoma
12798,Benign Cellular Infiltrate,Stage IVA Pharyngeal Carcinoma
12799,Benign Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v7
12800,Benign Cellular Infiltrate,Adenocarcinoma of nasal cavity
12801,Benign Cellular Infiltrate,Metastatic malignant neoplasm to nasopharynx
12802,Benign Cellular Infiltrate,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
12803,Malignant Cellular Infiltrate,Oropharyngeal squamous papilloma
12804,Benign Cellular Infiltrate,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
12805,Benign Cellular Infiltrate,Nasal Cavity Lymphoma
12806,Benign Cellular Infiltrate,Ciliary Body Epithelioid Cell Melanoma
12807,Benign Cellular Infiltrate,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
12808,Benign Cellular Infiltrate,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
12809,Benign Cellular Infiltrate,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
12810,Benign Cellular Infiltrate,Testicular Typical Seminoma
12811,Benign Cellular Infiltrate,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
12812,Benign Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v7
12813,Benign Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v7
12814,Benign Cellular Infiltrate,Stage II Ureter Cancer AJCC v7
12815,Malignant Cellular Infiltrate,Ureter Urothelial Papilloma
12816,Benign Cellular Infiltrate,clear cell adenocarcinoma of urethra
12817,Benign Cellular Infiltrate,Stage I Urethral Cancer AJCC v7
12818,Benign Cellular Infiltrate,Stage II Urethral Cancer AJCC v7
12819,Benign Cellular Infiltrate,Stage III Urethral Cancer AJCC v7
12820,Benign Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v6 and v7
12821,Benign Cellular Infiltrate,Malignant Ovarian Luteinized Thecoma
12822,Benign Cellular Infiltrate,Stage IA Cervical Cancer AJCC v6 and v7
12823,Benign Cellular Infiltrate,Stage IB2 Cervical Cancer
12824,Benign Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7
12825,Benign Cellular Infiltrate,verrucous carcinoma of vagina
12826,Malignant Cellular Infiltrate,Uterine Corpus Adenofibroma
12827,Benign Cellular Infiltrate,undifferentiated carcinoma of cervix
12828,Benign Cellular Infiltrate,Cervical Adenoid Cystic Carcinoma
12829,Benign Cellular Infiltrate,Malignant Bladder Paraganglioma
12830,Benign Cellular Infiltrate,Recurrent Adrenal Cortex Carcinoma
12831,Benign Cellular Infiltrate,Stage IIB Bone Sarcoma AJCC v7
12832,Malignant Cellular Infiltrate,Dermal Fibroma
12833,Malignant Cellular Infiltrate,Benign fibrohistiocytic neoplasm
12834,Malignant Cellular Infiltrate,Lumbosacral Lipoma
12835,Benign Cellular Infiltrate,Inflammatory liposarcoma
12836,Intermediate Grade Neuroendocrine Lesion,Parietal cell carcinoma
12837,Benign Cellular Infiltrate,Papillary mucinous cystadenocarcinoma
12838,Benign Cellular Infiltrate,Malignant Pericytic Neoplasm
12839,Malignant Cellular Infiltrate,Nodular tenosynovitis
12840,Benign Cellular Infiltrate,Malignant Childhood Germ Cell Tumor
12841,Benign Cellular Infiltrate,Childhood Testicular Yolk Sac Tumor
12842,Borderline Lesion,Childhood Ovarian Mature Teratoma
12843,Malignant Cellular Infiltrate,Deep Hemangioma
12844,Benign Cellular Infiltrate,Childhood Osteosarcoma
12845,Benign Cellular Infiltrate,Peripheral neuroblastoma
12846,Benign Cellular Infiltrate,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
12847,Malignant Cellular Infiltrate,Benign Mediastinal Psammomatous Schwannoma
12848,Benign Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v7
12849,Benign Cellular Infiltrate,Stage III Pleural Malignant Mesothelioma AJCC v7
12850,Intermediate Grade Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v7
12851,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Signet Ring Cell Carcinoma
12852,Benign Cellular Infiltrate,Stage IA Lung Adenosquamous Carcinoma AJCC v7
12853,Benign Cellular Infiltrate,atypical medullary carcinoma of breast
12854,Benign Cellular Infiltrate,Malignant melanoma in precancerous melanosis
12855,Malignant Cellular Infiltrate,"Nevus, Spindle Cell"
12856,Benign Cellular Infiltrate,Stage IIB Lung Small Cell Carcinoma AJCC v7
12857,Benign Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements
12858,Malignant Cellular Infiltrate,Ganglioneuromatosis
12859,Benign Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma
12860,Benign Cellular Infiltrate,Stage IB Lung Squamous Cell Carcinoma AJCC v7
12861,Benign Cellular Infiltrate,"Adenocarcinoma, endocervical type"
12862,Benign Cellular Infiltrate,Adenocarcinoma of lung stage IIIB
12863,Mitotic Activity,Benign Teratoma
12864,Malignant Cellular Infiltrate,Sternal Intraosseous Schwannoma
12865,Benign Cellular Infiltrate,Chest Wall Hodgkin Lymphoma
12866,Benign Cellular Infiltrate,Hereditary Non-Polyposis Colon Cancer Type 2
12867,Low Grade Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma
12868,Intermediate Grade Neuroendocrine Lesion,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
12869,Malignant Cellular Infiltrate,Cardiac Lipoma
12870,Poorly Differentiated Neuroendocrine Lesion,malignant gastrinoma of pancreas
12871,Poorly Differentiated Neuroendocrine Lesion,Malignant Pancreatic Vipoma
12872,Benign Cellular Infiltrate,Pineal Region Yolk Sac Tumor
12873,Well Differentiated Neuroendocrine Lesion,Colon Small Cell Neuroendocrine Carcinoma
12874,Well Differentiated Neuroendocrine Lesion,Gastric Small Cell Carcinoma
12875,Low Grade Neuroendocrine Lesion,Gastric Cardia Carcinoma
12876,Well Differentiated Neuroendocrine Lesion,Gastric Pylorus Carcinoma
12877,Intermediate Grade Neuroendocrine Lesion,Gastric Pylorus Carcinoma
12878,Low Grade Neuroendocrine Lesion,Gastric Pylorus Carcinoma
12879,Benign Cellular Infiltrate,Secondary malignant neoplasm of pituitary gland
12880,Benign Cellular Infiltrate,Mediastinal seminoma
12881,Malignant Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma
12882,Malignant Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma
12883,Malignant Cellular Infiltrate,Maxillary Sinus Inverted Papilloma
12884,Benign Cellular Infiltrate,Low Grade Paranasal Sinus Sarcoma
12885,Benign Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
12886,Benign Cellular Infiltrate,Oropharyngeal lymphepithelioma
12887,Benign Cellular Infiltrate,Choroid Spindle Cell Type B Melanoma
12888,Benign Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma
12889,Benign Cellular Infiltrate,Early Favorable Hodgkin Lymphoma
12890,Benign Cellular Infiltrate,Unfavorable Hodgkin Lymphoma
12891,Benign Cellular Infiltrate,Marginal zone lymphoma stage II
12892,Benign Cellular Infiltrate,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma
12893,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
12894,Low Grade Neuroendocrine Lesion,Stage IV Anal Canal Cancer AJCC v6 and v7
12895,Benign Cellular Infiltrate,"Glandular intraepithelial neoplasia, grade III"
12896,Benign Cellular Infiltrate,Unfavorable Non-Hodgkin Lymphoma
12897,Malignant Cellular Infiltrate,Atypical polypoid adenomyoma
12898,Malignant Cellular Infiltrate,Intraneural perineurioma
12899,Malignant Cellular Infiltrate,Soft tissue perineurioma
12900,Benign Cellular Infiltrate,Lymphocyte Rich Classical Hodgkin Lymphoma
12901,Benign Cellular Infiltrate,Anaplastic large B-cell lymphoma
12902,Benign Cellular Infiltrate,basaloid carcinoma of penis
12903,Benign Cellular Infiltrate,Central Nervous System Embryonal Neoplasm
12904,Malignant Cellular Infiltrate,Central Nervous System Chondroma
12905,Malignant Cellular Infiltrate,Solitary Myofibromatosis
12906,Benign Cellular Infiltrate,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma
12907,Benign Cellular Infiltrate,Melanoma recurrent
12908,Benign Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma
12909,Intermediate Grade Neuroendocrine Lesion,Recurrent Liver Carcinoma
12910,Low Grade Neuroendocrine Lesion,Stage IVB Liver Cancer
12911,Malignant Cellular Infiltrate,Benign Non-Epithelial Gallbladder Neoplasm
12912,Benign Cellular Infiltrate,Childhood Grade III Meningioma
12913,Malignant Cellular Infiltrate,Benign Fibroblastic Neoplasm
12914,Benign Cellular Infiltrate,Primary chondrosarcoma of bone
12915,Benign Cellular Infiltrate,Acute monoblastic leukemia
12916,Malignant Cellular Infiltrate,Spindle Cell/Pleomorphic Lipoma
12917,Benign Cellular Infiltrate,Classical Burkitt Lymphoma
12918,Benign Cellular Infiltrate,Grade 3b Follicular Lymphoma
12919,Benign Cellular Infiltrate,Blastic plasmacytoid dendritic cell neoplasm
12920,Benign Cellular Infiltrate,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
12921,Benign Cellular Infiltrate,AIDS-Related Diffuse Large B-cell Lymphoma
12922,Benign Cellular Infiltrate,Plasmablastic lymphoma
12923,Benign Cellular Infiltrate,ALK positive large B-cell lymphoma
12924,Benign Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
12925,Benign Cellular Infiltrate,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
12926,Benign Cellular Infiltrate,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
12927,Benign Cellular Infiltrate,Methotrexate-Associated Burkitt Lymphoma
12928,Benign Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma
12929,Malignant Cellular Infiltrate,Ovarian Surface Papilloma
12930,Malignant Cellular Infiltrate,Ovarian Solid Teratoma
12931,Benign Cellular Infiltrate,Splenic Small Lymphocytic Lymphoma
12932,Benign Cellular Infiltrate,large B-cell diffuse lymphoma of spleen
12933,Benign Cellular Infiltrate,Acute monocytic/monoblastic leukemia
12934,Benign Cellular Infiltrate,Retroperitoneal Lymphoma
12935,Benign Cellular Infiltrate,Malignant Pleural Mesothelioma
12936,Benign Cellular Infiltrate,Hairy Cell Leukemia
12937,Malignant Cellular Infiltrate,Papilloma
12938,Malignant Cellular Infiltrate,Benign myoepithelioma
12939,Malignant Cellular Infiltrate,Odontogenic myxofibroma
12940,Well Differentiated Neuroendocrine Lesion,Anal canal squamous cell carcinoma
12941,Well Differentiated Neuroendocrine Lesion,Anal Verrucous Carcinoma
12942,Low Grade Neuroendocrine Lesion,Anal Verrucous Carcinoma
12943,Intermediate Grade Neuroendocrine Lesion,Anal margin basal cell carcinoma
12944,Well Differentiated Neuroendocrine Lesion,Carcinoma of anal canal
12945,Benign Cellular Infiltrate,Ameloblastic Carcinoma Derived From Odontogenic Cyst
12946,Malignant Cellular Infiltrate,Odontogenic myxoma
12947,Benign Cellular Infiltrate,Malignant neoplasm of urethra
12948,Benign Cellular Infiltrate,Secondary malignant neoplasm of female breast
12949,Benign Cellular Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
12950,Benign Cellular Infiltrate,Retinoblastoma
12951,Benign Cellular Infiltrate,Ovarian Serous Adenocarcinoma
12952,Benign Cellular Infiltrate,Endometrial Carcinoma
12953,Malignant Cellular Infiltrate,Recurrent Nevus
12954,Benign Cellular Infiltrate,Basal cell carcinoma - adamantinoid
12955,Benign Cellular Infiltrate,Malignant basal cell tumor
12956,Low Grade Neuroendocrine Lesion,Pancreatic carcinoma recurrent
12957,Benign Cellular Infiltrate,Malignant mesothelioma of pericardium
12958,Benign Cellular Infiltrate,Posterior Urethral Malignant Neoplasm
12959,Benign Cellular Infiltrate,Adenocarcinoma in tubular adenoma
12960,Benign Cellular Infiltrate,Adenocarcinoma in situ in a polyp
12961,Benign Cellular Infiltrate,Adenocarcinoma with osseous metaplasia
12962,Low Grade Neuroendocrine Lesion,Hepatoma resectable
12963,Intermediate Grade Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor
12964,Low Grade Neuroendocrine Lesion,Adult Liver Carcinoma
12965,Benign Cellular Infiltrate,Uveal melanoma
12966,Benign Cellular Infiltrate,Renal Pelvis and Ureter Urothelial Carcinoma
12967,Low Grade Neuroendocrine Lesion,Small intestine carcinoma
12968,Malignant Cellular Infiltrate,Squamous Papilloma of the Larynx
12969,Malignant Cellular Infiltrate,Mucous Membrane Hemangioma
12970,Well Differentiated Neuroendocrine Lesion,Stage I Gastric Carcinoma
12971,Intermediate Grade Neuroendocrine Lesion,Stage I Gastric Carcinoma
12972,Benign Cellular Infiltrate,Superior Sulcus Lung Carcinoma
12973,Low Grade Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v6 and v7
12974,Low Grade Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v6 and v7
12975,Low Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v6
12976,Benign Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7
12977,Benign Cellular Infiltrate,Recurrent Parathyroid Gland Carcinoma
12978,Benign Cellular Infiltrate,DS Stage I Plasma Cell Myeloma
12979,Intermediate Grade Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1
12980,Low Grade Neuroendocrine Lesion,Localized Non-Resectable Adult Liver Carcinoma
12981,Benign Cellular Infiltrate,recurrent adult acute myeloid leukemia
12982,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of small intestine
12983,Low Grade Neuroendocrine Lesion,Adenocarcinoma of small intestine
12984,Intermediate Grade Neuroendocrine Lesion,Recurrent Extrahepatic Bile Duct Carcinoma
12985,Low Grade Neuroendocrine Lesion,Recurrent Extrahepatic Bile Duct Carcinoma
12986,Benign Cellular Infiltrate,Grade III Lymphomatoid Granulomatosis
12987,Benign Cellular Infiltrate,Childhood Embryonal Rhabdomyosarcoma
12988,Low Grade Neuroendocrine Lesion,mucinous adenocarcinoma of rectum
12989,Low Grade Neuroendocrine Lesion,Anaplastic Carcinoma of the Rectum
12990,Intermediate Grade Neuroendocrine Lesion,Distal 1/3 of the Common Bile Duct Adenocarcinoma
12991,Benign Cellular Infiltrate,"Thymoma, type B3"
12992,Benign Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
12993,Benign Cellular Infiltrate,Acinic cell carcinoma of salivary gland
12994,Benign Cellular Infiltrate,Adenocarcinoma of salivary gland
12995,Benign Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly
12996,Benign Cellular Infiltrate,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable"
12997,Benign Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7
12998,Benign Cellular Infiltrate,Hyperdiploid B Acute Lymphoblastic Leukemia
12999,Benign Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v6
13000,Benign Cellular Infiltrate,Stage III Oropharyngeal Carcinoma AJCC v6
13001,Benign Cellular Infiltrate,Recurrent Childhood Hodgkin Lymphoma
13002,Benign Cellular Infiltrate,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
13003,Benign Cellular Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma
13004,Benign Cellular Infiltrate,Ann Arbor Stage I Grade 1 Follicular Lymphoma
13005,Benign Cellular Infiltrate,Stage I Ovarian Germ Cell Tumor AJCC v6 and v7
13006,Benign Cellular Infiltrate,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7
13007,Benign Cellular Infiltrate,Childhood Alveolar Soft Part Sarcoma
13008,Geographic Necrosis,Mature Ovarian Teratoma
13009,Benign Cellular Infiltrate,Transitional cell cancer of the renal pelvis and ureter localized
13010,Benign Cellular Infiltrate,Hard Palate Squamous Cell Carcinoma
13011,Benign Cellular Infiltrate,Subglottic Squamous Cell Carcinoma
13012,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage I
13013,Benign Cellular Infiltrate,Mixed phenotype acute leukemia
13014,Benign Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage II
13015,Benign Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III
13016,Benign Cellular Infiltrate,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT"
13017,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage III
13018,Benign Cellular Infiltrate,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
13019,Benign Cellular Infiltrate,de novo Myelodysplastic Syndrome
13020,Benign Cellular Infiltrate,Sarcoma of ovary
13021,Benign Cellular Infiltrate,AIDS-Related Primary Central Nervous System Lymphoma
13022,Benign Cellular Infiltrate,Burkitt lymphoma associated with AIDS
13023,Benign Cellular Infiltrate,Adult Papillary Meningioma
13024,Benign Cellular Infiltrate,Giant Cell Fibrous Histiocytoma
13025,Benign Cellular Infiltrate,Carcinoma of hard palate
13026,Malignant Cellular Infiltrate,Benign neoplasm of Bartholin's gland
13027,Benign Cellular Infiltrate,"Acute myeloid leukemia, minimal differentiation"
13028,Malignant Cellular Infiltrate,"Hemangioma, Cavernous, Central Nervous System"
13029,Benign Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma
13030,Benign Cellular Infiltrate,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma
13031,Low Grade Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v6 and v7
13032,Well Differentiated Neuroendocrine Lesion,Stage II Colorectal Cancer
13033,Intermediate Grade Neuroendocrine Lesion,Stage II Colorectal Cancer
13034,Well Differentiated Neuroendocrine Lesion,Stage IV Colorectal Cancer
13035,Malignant Cellular Infiltrate,Benign neoplasm of blood vessel
13036,Malignant Cellular Infiltrate,Benign neoplasm of great vessels
13037,Benign Cellular Infiltrate,Stage IA Soft Tissue Sarcoma AJCC v7
13038,Low Grade Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma AJCC v7
13039,Low Grade Neuroendocrine Lesion,Rectosigmoid cancer recurrent
13040,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV
13041,Benign Cellular Infiltrate,T-cell lymphoma recurrent
13042,Benign Cellular Infiltrate,T-cell lymphoma stage III
13043,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I
13044,Benign Cellular Infiltrate,Angiocentric lymphoma stage II
13045,Benign Cellular Infiltrate,Angiocentric lymphoma stage III
13046,Benign Cellular Infiltrate,Mycosis fungoides refractory
13047,Benign Cellular Infiltrate,Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma
13048,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage I
13049,Benign Cellular Infiltrate,Non-Hodgkin's lymphoma transformed recurrent
13050,Benign Cellular Infiltrate,Pericardial mesothelioma malignant advanced
13051,Benign Cellular Infiltrate,Retinoblastoma bilateral
13052,Benign Cellular Infiltrate,Stage IA Uterine Sarcoma AJCC v7
13053,Benign Cellular Infiltrate,Stage IB Uterine Sarcoma AJCC v7
13054,Benign Cellular Infiltrate,Stage I Bone Cancer AJCC v7
13055,Benign Cellular Infiltrate,Stage IVB Bone Cancer AJCC v7
13056,Benign Cellular Infiltrate,Stage II Fallopian Tube Cancer
13057,Benign Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I
13058,Benign Cellular Infiltrate,Stage II Ovarian Teratoma AJCC v6 and v7
13059,Benign Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7
13060,Benign Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7
13061,Benign Cellular Infiltrate,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
13062,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
13063,Benign Cellular Infiltrate,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
13064,Benign Cellular Infiltrate,Pharyngeal cancer stage I
13065,Intermediate Grade Neuroendocrine Lesion,Stage IIA Gastric Cancer AJCC v7
13066,Intermediate Grade Neuroendocrine Lesion,Stage IIB Gastric Cancer AJCC v7
13067,Low Grade Neuroendocrine Lesion,Stage IIIC Gastric Cancer AJCC v7
13068,Well Differentiated Neuroendocrine Lesion,Stage IB Esophageal Adenocarcinoma AJCC v7
13069,Low Grade Neuroendocrine Lesion,Stage IB Esophageal Adenocarcinoma AJCC v7
13070,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Esophageal Adenocarcinoma AJCC v7
13071,Low Grade Neuroendocrine Lesion,Stage IIIC Esophageal Adenocarcinoma AJCC v7
13072,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
13073,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
13074,Well Differentiated Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v7
13075,Low Grade Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v7
13076,Low Grade Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v7
13077,Low Grade Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v7
13078,Well Differentiated Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v7
13079,Benign Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7
13080,Benign Cellular Infiltrate,Alveolar soft part sarcoma recurrent
13081,Benign Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma
13082,Well Differentiated Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
13083,Intermediate Grade Neuroendocrine Lesion,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
13084,Well Differentiated Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v7
13085,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v7
13086,Intermediate Grade Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v7
13087,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
13088,Benign Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic
13089,Intermediate Grade Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v7
13090,Benign Cellular Infiltrate,Stage IIIb Penile Cancer AJCC v7
13091,Benign Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v7
13092,Benign Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v7
13093,Benign Cellular Infiltrate,Metastatic leiomyosarcoma
13094,Benign Cellular Infiltrate,Stage IIIB Uveal Melanoma AJCC v7
13095,Benign Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7
13096,Benign Cellular Infiltrate,Refractory Hodgkin Lymphoma
13097,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis refractory
13098,Benign Cellular Infiltrate,B-cell lymphoma refractory
13099,Benign Cellular Infiltrate,B-cell lymphoma stage III
13100,Benign Cellular Infiltrate,Refractory Follicular Lymphoma
13101,Benign Cellular Infiltrate,Bladder adenocarcinoma stage I
13102,Benign Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v7
13103,Benign Cellular Infiltrate,Testicular germ cell tumor mixed stage II
13104,Benign Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7
13105,Benign Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7
13106,Benign Cellular Infiltrate,Stage IV Penile Cancer AJCC v7
13107,Benign Cellular Infiltrate,Testicular yolk sac tumor stage I
13108,Benign Cellular Infiltrate,Stage I Prostate Cancer AJCC v7
13109,Benign Cellular Infiltrate,Metastatic melanoma
13110,Well Differentiated Neuroendocrine Lesion,Pancreatic adenocarcinoma metastatic
13111,Low Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma metastatic
13112,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma/leukemia
13113,Benign Cellular Infiltrate,Bladder transitional cell carcinoma stage IV
13114,Benign Cellular Infiltrate,Stage II Vulvar Cancer AJCC v7
13115,Benign Cellular Infiltrate,Adenocarcinoma of the prostate stage II
13116,Benign Cellular Infiltrate,Stage II Lung Cancer AJCC v6
13117,Benign Cellular Infiltrate,Stage I Uterine Corpus Cancer
13118,Benign Cellular Infiltrate,Stage IV Uterine Corpus Cancer
13119,Well Differentiated Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v7
13120,Low Grade Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v7
13121,Low Grade Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v7
13122,Intermediate Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v7
13123,Intermediate Grade Neuroendocrine Lesion,malignant neoplasm of large intestine stage IV
13124,Low Grade Neuroendocrine Lesion,malignant neoplasm of large intestine stage IV
13125,Low Grade Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v7
13126,Well Differentiated Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v7
13127,Benign Cellular Infiltrate,"Acute myeloid leukemia, t(16;16)(p13;q22)"
13128,Well Differentiated Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v7
13129,Intermediate Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v7
13130,Benign Cellular Infiltrate,Sarcoma by FNCLCC Grade
13131,Benign Cellular Infiltrate,FNCLCC Sarcoma Grade 3
13132,Benign Cellular Infiltrate,Cervix carcinoma
13133,Benign Cellular Infiltrate,Small cell lung cancer extensive stage
13134,Intermediate Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v6 Stage
13135,Well Differentiated Neuroendocrine Lesion,Colorectal Cancer by AJCC v6 Stage
13136,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v6 Stage
13137,Benign Cellular Infiltrate,Stage II Vulva Cancer AJCC v6
13138,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage
13139,Benign Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v6
13140,Benign Cellular Infiltrate,Stage II Childhood Lymphoblastic Lymphoma
13141,Low Grade Neuroendocrine Lesion,Localized Resectable Adult Hepatocellular Carcinoma
13142,Well Differentiated Neuroendocrine Lesion,Recurrent Adult Hepatocellular Carcinoma
13143,Benign Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
13144,Benign Cellular Infiltrate,Malignant melanoma of iris
13145,Benign Cellular Infiltrate,Non-small cell lung cancer stage IIIB
13146,Well Differentiated Neuroendocrine Lesion,Pancreatic Ductal Adenocarcinoma
13147,Benign Cellular Infiltrate,Renal Cell Cancer by AJCC v7 Stage
13148,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v7 Stage
13149,Well Differentiated Neuroendocrine Lesion,Colorectal Cancer by AJCC v7 Stage
13150,Low Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v7 Stage
13151,Intermediate Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v7 Stage
13152,Benign Cellular Infiltrate,Adult T Acute Lymphoblastic Leukemia
13153,Benign Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor
13154,Benign Cellular Infiltrate,Lentigo maligna melanoma
13155,Benign Cellular Infiltrate,Adult Acute Erythroid Leukemia
13156,Intermediate Grade Neuroendocrine Lesion,adenocarcinoma of gallbladder with squamous metaplasia
13157,Low Grade Neuroendocrine Lesion,Gallbladder squamous cell carcinoma
13158,Benign Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma
13159,Well Differentiated Neuroendocrine Lesion,Stage II Esophageal Cancer
13160,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophagus Carcinoma
13161,Well Differentiated Neuroendocrine Lesion,recurrent gastric cancer
13162,Benign Cellular Infiltrate,Central Nervous System Ganglioneuroblastoma
13163,Benign Cellular Infiltrate,Salivary gland carcinoma
13164,Benign Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia
13165,Low Grade Neuroendocrine Lesion,Anal carcinoma
13166,Benign Cellular Infiltrate,Malignant Neoplasms
13167,Benign Cellular Infiltrate,Adrenal Cancer
13168,Benign Cellular Infiltrate,Hodgkin Disease
13169,Well Differentiated Neuroendocrine Lesion,Stage I Colon Cancer AJCC v6 and v7
13170,Intermediate Grade Neuroendocrine Lesion,Stage I Colon Cancer AJCC v6 and v7
13171,Low Grade Neuroendocrine Lesion,Rectal Carcinoma
13172,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of rectum
13173,Benign Cellular Infiltrate,AJCC Grade 1 Sarcoma
13174,Low Grade Neuroendocrine Lesion,Grade 2 Colon Adenocarcinoma
13175,Intermediate Grade Neuroendocrine Lesion,Stage I Adult Liver Cancer AJCC v7
13176,Low Grade Neuroendocrine Lesion,Stage I Adult Liver Cancer AJCC v7
13177,Intermediate Grade Neuroendocrine Lesion,Stage II Adult Liver Cancer AJCC v7
13178,Well Differentiated Neuroendocrine Lesion,Stage IIIC Adult Liver Cancer AJCC v7
13179,Benign Cellular Infiltrate,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma
13180,Benign Cellular Infiltrate,Invasive Carcinoma
13181,Benign Cellular Infiltrate,Primary Carcinoma
13182,Benign Cellular Infiltrate,Stage 4S neuroblastoma
13183,Benign Cellular Infiltrate,Thymic Hodgkin Lymphoma
13184,Well Differentiated Neuroendocrine Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma
13185,Intermediate Grade Neuroendocrine Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
13186,Low Grade Neuroendocrine Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
13187,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1
13188,Poorly Differentiated Neuroendocrine Lesion,Glucagonoma
13189,Benign Cellular Infiltrate,Second Primary Cancers
13190,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma
13191,Low Grade Neuroendocrine Lesion,Esophageal Mixed Adenoneuroendocrine Carcinoma
13192,Well Differentiated Neuroendocrine Lesion,Gastric Hepatoid Adenocarcinoma
13193,Low Grade Neuroendocrine Lesion,Gastric Hepatoid Adenocarcinoma
13194,Low Grade Neuroendocrine Lesion,Gastric Carcinoma with Lymphoid Stroma
13195,Malignant Cellular Infiltrate,Gastric Plexiform Fibromyxoma
13196,Low Grade Neuroendocrine Lesion,Ampulla of Vater Hepatoid Adenocarcinoma
13197,Low Grade Neuroendocrine Lesion,Ampulla of Vater Invasive Papillary Adenocarcinoma
13198,Low Grade Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2
13199,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Carcinoma
13200,Poorly Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1
13201,Intermediate Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of appendix
13202,Well Differentiated Neuroendocrine Lesion,Colon Serrated Adenocarcinoma
13203,Low Grade Neuroendocrine Lesion,Colorectal Micropapillary Adenocarcinoma
13204,Well Differentiated Neuroendocrine Lesion,Colon Micropapillary Adenocarcinoma
13205,Intermediate Grade Neuroendocrine Lesion,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
13206,Well Differentiated Neuroendocrine Lesion,Crohn Disease-Associated Colorectal Adenocarcinoma
13207,Malignant Cellular Infiltrate,Colorectal Ganglioneuroma
13208,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor
13209,Low Grade Neuroendocrine Lesion,Early Hepatocellular Carcinoma
13210,Low Grade Neuroendocrine Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma
13211,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of liver
13212,Intermediate Grade Neuroendocrine Lesion,Peripheral Intrahepatic Cholangiocarcinoma
13213,Low Grade Neuroendocrine Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
13214,Malignant Cellular Infiltrate,Infantile hemangioma of liver
13215,Low Grade Neuroendocrine Lesion,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
13216,Well Differentiated Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Biliary Type"
13217,Poorly Differentiated Neuroendocrine Lesion,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
13218,Poorly Differentiated Neuroendocrine Lesion,Gallbladder Tubular Carcinoid
13219,Well Differentiated Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
13220,Well Differentiated Neuroendocrine Lesion,intestinal type adenocarcinoma of extrahepatic bile duct
13221,Poorly Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor G2
13222,Benign Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
13223,Benign Cellular Infiltrate,Contralateral Breast Carcinoma
13224,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
13225,Benign Cellular Infiltrate,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
13226,Benign Cellular Infiltrate,Uveal Melanoma by Gene Expression Profile
13227,Benign Cellular Infiltrate,Classical Glioblastoma
13228,Benign Cellular Infiltrate,Adult Undifferentiated Pleomorphic Sarcoma
13229,Benign Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma
13230,Benign Cellular Infiltrate,Childhood Pineoblastoma
13231,Benign Cellular Infiltrate,Hormone-Resistant Prostate Carcinoma
13232,Benign Cellular Infiltrate,Hodgkin's lymphoma of CNS
13233,Benign Cellular Infiltrate,Childhood Gliomatosis Cerebri
13234,Intermediate Grade Neuroendocrine Lesion,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
13235,Benign Cellular Infiltrate,Stage I Childhood Anaplastic Large Cell Lymphoma
13236,Benign Cellular Infiltrate,Stage II Childhood Anaplastic Large Cell Lymphoma
13237,Intermediate Grade Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v7
13238,Low Grade Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v7
13239,Intermediate Grade Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v7
13240,Well Differentiated Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v7
13241,Low Grade Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v7
13242,Well Differentiated Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v7
13243,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v7
13244,Well Differentiated Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v7
13245,Intermediate Grade Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v7
13246,Benign Cellular Infiltrate,Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
13247,Benign Cellular Infiltrate,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
13248,Benign Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
13249,Benign Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
13250,Benign Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v7
13251,Benign Cellular Infiltrate,Stage IIB Uterine Sarcoma AJCC v7
13252,Intermediate Grade Neuroendocrine Lesion,BCLC Stage C Hepatocellular Carcinoma
13253,Intermediate Grade Neuroendocrine Lesion,BCLC Stage D Hepatocellular Carcinoma
13254,Intermediate Grade Neuroendocrine Lesion,BCLC Stage C Adult Hepatocellular Carcinoma
13255,Benign Cellular Infiltrate,Childhood Cerebral Anaplastic Astrocytoma
13256,Benign Cellular Infiltrate,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
13257,Benign Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis
13258,Benign Cellular Infiltrate,Recurrent Childhood Gliosarcoma
13259,Benign Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis
13260,Malignant Cellular Infiltrate,Recurrent Inverted Schneiderian Papilloma
13261,Well Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
13262,Benign Cellular Infiltrate,Recurrent Merkel Cell Carcinoma
13263,Benign Cellular Infiltrate,Refractory Childhood Hodgkin Lymphoma
13264,Intermediate Grade Neuroendocrine Lesion,Childhood Colorectal Carcinoma
13265,Well Differentiated Neuroendocrine Lesion,Childhood Esophageal Carcinoma
13266,Benign Cellular Infiltrate,Childhood Salivary Gland Carcinoma
13267,Benign Cellular Infiltrate,Refractory cancer
13268,Malignant Cellular Infiltrate,"Myositis, Proliferative"
13269,Benign Cellular Infiltrate,Soft Tissue Angiosarcoma
13270,Benign Cellular Infiltrate,"Malignant Mixed Tumor, Not Otherwise Specified"
13271,Benign Cellular Infiltrate,undifferentiated sarcoma of soft tissue
13272,Benign Cellular Infiltrate,Ph-Like Acute Lymphoblastic Leukemia
13273,Benign Cellular Infiltrate,ROSE Cluster 6
13274,Benign Cellular Infiltrate,ROSE Cluster 7
13275,Low Grade Neuroendocrine Lesion,Childhood Small Intestinal Carcinoma
13276,Benign Cellular Infiltrate,Small cell glioblastoma
13277,Benign Cellular Infiltrate,Urothelial carcinoma bladder recurrent
13278,Benign Cellular Infiltrate,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA
13279,Benign Cellular Infiltrate,Serous Tubal Intraepithelial Carcinoma
13280,Benign Cellular Infiltrate,Low Grade Fallopian Tube Serous Adenocarcinoma
13281,Malignant Cellular Infiltrate,Benign Uterine Corpus PEComa
13282,Benign Cellular Infiltrate,Stage IIIA Ovarian Carcinoma
13283,Benign Cellular Infiltrate,FIGO Stage IIIA1 Ovarian Cancer
13284,Malignant Cellular Infiltrate,Vulvar Papillary Hidradenoma
13285,Benign Cellular Infiltrate,Vulvar Merkel Cell Carcinoma
13286,Benign Cellular Infiltrate,Vulvar Yolk Sac Tumor
13287,Intermediate Grade Neuroendocrine Lesion,Unresectable Esophageal Carcinoma
13288,Benign Cellular Infiltrate,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative"
13289,Benign Cellular Infiltrate,"Medulloblastoma, SHH-Activated"
13290,Benign Cellular Infiltrate,"Medulloblastoma, Not Otherwise Specified"
13291,Benign Cellular Infiltrate,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
13292,Benign Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
13293,Benign Cellular Infiltrate,Advanced Malignant Solid Neoplasm
13294,Benign Cellular Infiltrate,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
13295,Benign Cellular Infiltrate,Advanced Head and Neck Carcinoma
13296,Benign Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
13297,Benign Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7
13298,Benign Cellular Infiltrate,Recurrent Gliosarcoma
13299,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
13300,Benign Cellular Infiltrate,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
13301,Benign Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v8
13302,Benign Cellular Infiltrate,Stage I Major Salivary Gland Cancer AJCC v8
13303,Benign Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v8
13304,Benign Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
13305,Benign Cellular Infiltrate,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage
13306,Benign Cellular Infiltrate,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
13307,Benign Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v8
13308,Benign Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8
13309,Intermediate Grade Neuroendocrine Lesion,AIDS-Related Anal Canal Carcinoma
13310,Benign Cellular Infiltrate,Laryngeal Cancer by AJCC v8 Stage
13311,Benign Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v8
13312,Benign Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
13313,Well Differentiated Neuroendocrine Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
13314,Low Grade Neuroendocrine Lesion,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
13315,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
13316,Low Grade Neuroendocrine Lesion,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
13317,Low Grade Neuroendocrine Lesion,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
13318,Well Differentiated Neuroendocrine Lesion,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
13319,Low Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v7 Stage
13320,Well Differentiated Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
13321,Low Grade Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
13322,Low Grade Neuroendocrine Lesion,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
13323,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
13324,Low Grade Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
13325,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
13326,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
13327,Low Grade Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
13328,Well Differentiated Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
13329,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
13330,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
13331,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
13332,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
13333,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
13334,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
13335,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
13336,Low Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
13337,Well Differentiated Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
13338,Low Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
13339,Well Differentiated Neuroendocrine Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
13340,Intermediate Grade Neuroendocrine Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
13341,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
13342,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
13343,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
13344,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
13345,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
13346,Well Differentiated Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
13347,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
13348,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
13349,Well Differentiated Neuroendocrine Lesion,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
13350,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
13351,Low Grade Neuroendocrine Lesion,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
13352,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
13353,Low Grade Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
13354,Intermediate Grade Neuroendocrine Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
13355,Low Grade Neuroendocrine Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
13356,Intermediate Grade Neuroendocrine Lesion,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
13357,Low Grade Neuroendocrine Lesion,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
13358,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
13359,Well Differentiated Neuroendocrine Lesion,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
13360,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
13361,Low Grade Neuroendocrine Lesion,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
13362,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
13363,Low Grade Neuroendocrine Lesion,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
13364,Low Grade Neuroendocrine Lesion,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
13365,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
13366,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
13367,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
13368,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
13369,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
13370,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
13371,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
13372,Low Grade Neuroendocrine Lesion,Clinical Stage IV Gastric Cancer AJCC v8
13373,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage II Gastric Cancer AJCC v8
13374,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIB Gastric Cancer AJCC v8
13375,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIB Gastric Cancer AJCC v8
13376,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
13377,Low Grade Neuroendocrine Lesion,Clinical Stage IIA Gastric Cancer AJCC v8
13378,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIB Gastric Cancer AJCC v8
13379,Low Grade Neuroendocrine Lesion,Clinical Stage IIB Gastric Cancer AJCC v8
13380,Benign Cellular Infiltrate,Recurrent Head and Neck Squamous Cell Carcinoma
13381,Benign Cellular Infiltrate,Metastatic Paraganglioma
13382,Well Differentiated Neuroendocrine Lesion,Stage 0 Anal Cancer AJCC v8
13383,Low Grade Neuroendocrine Lesion,Stage I Anal Cancer AJCC v8
13384,Intermediate Grade Neuroendocrine Lesion,Stage IIA Anal Cancer AJCC v8
13385,Low Grade Neuroendocrine Lesion,Stage II Small Intestinal Adenocarcinoma AJCC v8
13386,Low Grade Neuroendocrine Lesion,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
13387,Low Grade Neuroendocrine Lesion,Stage III Small Intestinal Adenocarcinoma AJCC v8
13388,Well Differentiated Neuroendocrine Lesion,Appendix Carcinoma by AJCC v8 Stage
13389,Intermediate Grade Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v8
13390,Well Differentiated Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v8
13391,Intermediate Grade Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v8
13392,Well Differentiated Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v8
13393,Intermediate Grade Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v8
13394,Intermediate Grade Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v8
13395,Low Grade Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v8
13396,Low Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v8
13397,Well Differentiated Neuroendocrine Lesion,Stage II Colon Cancer AJCC v8
13398,Low Grade Neuroendocrine Lesion,Stage II Colon Cancer AJCC v8
13399,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v8
13400,Intermediate Grade Neuroendocrine Lesion,Stage III Colon Cancer AJCC v8
13401,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v8
13402,Well Differentiated Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v8
13403,Low Grade Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v8
13404,Well Differentiated Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v8
13405,Well Differentiated Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v8
13406,Intermediate Grade Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v8
13407,Well Differentiated Neuroendocrine Lesion,Stage IVC Rectal Cancer AJCC v8
13408,Low Grade Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v8
13409,Low Grade Neuroendocrine Lesion,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
13410,Well Differentiated Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v8
13411,Well Differentiated Neuroendocrine Lesion,Stage IIA Gallbladder Cancer AJCC v8
13412,Well Differentiated Neuroendocrine Lesion,Stage IIB Gallbladder Cancer AJCC v8
13413,Well Differentiated Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v8
13414,Low Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v8
13415,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v8
13416,Low Grade Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v7 Stage
13417,Intermediate Grade Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v8 Stage
13418,Low Grade Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v8
13419,Low Grade Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v8
13420,Well Differentiated Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
13421,Low Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
13422,Intermediate Grade Neuroendocrine Lesion,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
13423,Low Grade Neuroendocrine Lesion,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
13424,Well Differentiated Neuroendocrine Lesion,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
13425,Well Differentiated Neuroendocrine Lesion,Stage I Distal Bile Duct Cancer AJCC v8
13426,Well Differentiated Neuroendocrine Lesion,Stage II Distal Bile Duct Cancer AJCC v8
13427,Intermediate Grade Neuroendocrine Lesion,Stage II Distal Bile Duct Cancer AJCC v8
13428,Low Grade Neuroendocrine Lesion,Stage II Distal Bile Duct Cancer AJCC v8
13429,Intermediate Grade Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v8
13430,Low Grade Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v8
13431,Low Grade Neuroendocrine Lesion,Stage IIIA Distal Bile Duct Cancer AJCC v8
13432,Low Grade Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v8
13433,Benign Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma
13434,Low Grade Neuroendocrine Lesion,Stage 0 Ampulla of Vater Cancer AJCC v8
13435,Low Grade Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v8
13436,Intermediate Grade Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v8
13437,Well Differentiated Neuroendocrine Lesion,Stage IIIB Ampulla of Vater Cancer AJCC v8
13438,Intermediate Grade Neuroendocrine Lesion,Pancreatic Cancer by AJCC v8 Stage
13439,Low Grade Neuroendocrine Lesion,Pancreatic Cancer by AJCC v8 Stage
13440,Well Differentiated Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v8
13441,Well Differentiated Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v8
13442,Well Differentiated Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v8
13443,Low Grade Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v8
13444,Poorly Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
13445,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
13446,Poorly Differentiated Neuroendocrine Lesion,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
13447,Poorly Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
13448,Poorly Differentiated Neuroendocrine Lesion,Stage I Ileal Neuroendocrine Tumor AJCC v8
13449,Poorly Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor
13450,Poorly Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor by AJCC v8 Stage
13451,Well Differentiated Neuroendocrine Lesion,Rectal Carcinoma Metastatic in the Liver
13452,Low Grade Neuroendocrine Lesion,Rectal Carcinoma Metastatic in the Liver
13453,Benign Cellular Infiltrate,Lung Cancer by AJCC v8 Stage
13454,Benign Cellular Infiltrate,Stage IIB Lung Cancer AJCC v8
13455,Benign Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v8
13456,Benign Cellular Infiltrate,Recurrent Anaplastic Astrocytoma
13457,Benign Cellular Infiltrate,Stage IA Bone Cancer AJCC v8
13458,Benign Cellular Infiltrate,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
13459,Benign Cellular Infiltrate,Invasive Mucinous Lung Adenocarcinoma
13460,Benign Cellular Infiltrate,Lung Non-Keratinizing Squamous Cell Carcinoma
13461,Benign Cellular Infiltrate,Lung Non-Mucinous Adenocarcinoma In Situ
13462,Benign Cellular Infiltrate,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
13463,Benign Cellular Infiltrate,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
13464,Benign Cellular Infiltrate,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
13465,Benign Cellular Infiltrate,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
13466,Benign Cellular Infiltrate,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
13467,Benign Cellular Infiltrate,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
13468,Benign Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage
13469,Benign Cellular Infiltrate,Clinical Stage III Cutaneous Melanoma AJCC v8
13470,Benign Cellular Infiltrate,Pathologic Stage I Cutaneous Melanoma AJCC v8
13471,Intermediate Grade Neuroendocrine Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
13472,Benign Cellular Infiltrate,Refractory Extranodal Diffuse Large B-cell Lymphoma
13473,Benign Cellular Infiltrate,Recurrent Breast Lymphoma
13474,Benign Cellular Infiltrate,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
13475,Benign Cellular Infiltrate,Duodenal-type follicular lymphoma
13476,Benign Cellular Infiltrate,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
13477,Benign Cellular Infiltrate,Refractory Soft Tissue Sarcoma
13478,Benign Cellular Infiltrate,Recurrent Soft Tissue Sarcoma
13479,Benign Cellular Infiltrate,Nodal peripheral T-cell lymphoma with T follicular helper phenotype
13480,Benign Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
13481,Benign Cellular Infiltrate,Breast Cancer by AJCC v8 Stage
13482,Benign Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8
13483,Malignant Cellular Infiltrate,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
13484,Benign Cellular Infiltrate,Prognostic Stage 0 Breast Cancer AJCC v8
13485,Benign Cellular Infiltrate,Prognostic Stage IIIA Breast Cancer AJCC v8
13486,Benign Cellular Infiltrate,Prognostic Stage IIIB Breast Cancer AJCC v8
13487,Benign Cellular Infiltrate,Stage III Vulvar Cancer AJCC v8
13488,Benign Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v8
13489,Benign Cellular Infiltrate,Stage IB Vaginal Cancer AJCC v8
13490,Benign Cellular Infiltrate,Stage IV Vaginal Cancer AJCC v8
13491,Benign Cellular Infiltrate,Stage I Cervical Cancer AJCC v8
13492,Benign Cellular Infiltrate,Stage IIIC2 Uterine Corpus Cancer AJCC v8
13493,Benign Cellular Infiltrate,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8
13494,Benign Cellular Infiltrate,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
13495,Benign Cellular Infiltrate,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
13496,Benign Cellular Infiltrate,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
13497,Benign Cellular Infiltrate,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
13498,Benign Cellular Infiltrate,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
13499,Benign Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8
13500,Benign Cellular Infiltrate,Stage IVB Fallopian Tube Cancer AJCC v8
13501,Benign Cellular Infiltrate,Stage IIA Primary Peritoneal Cancer AJCC v8
13502,Benign Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8
13503,Benign Cellular Infiltrate,Stage I Prostate Cancer AJCC v8
13504,Benign Cellular Infiltrate,Stage IIIB Prostate Cancer AJCC v8
13505,Benign Cellular Infiltrate,Stage IIIC Prostate Cancer AJCC v8
13506,Benign Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v8
13507,Benign Cellular Infiltrate,Stage IIIC Testicular Cancer AJCC v8
13508,Benign Cellular Infiltrate,Ureter Cancer by AJCC v8 Stage
13509,Benign Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v8
13510,Benign Cellular Infiltrate,Bladder Cancer by AJCC v8 Stage
13511,Benign Cellular Infiltrate,Stage IIIA Bladder Cancer AJCC v8
13512,Benign Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v8
13513,Benign Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v8
13514,Benign Cellular Infiltrate,Stage I Choroidal and Ciliary Body Melanoma AJCC v8
13515,Benign Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8
13516,Benign Cellular Infiltrate,Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8
13517,Benign Cellular Infiltrate,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8
13518,Benign Cellular Infiltrate,Clinical Stage III Retinoblastoma AJCC v8
13519,Benign Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
13520,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
13521,Benign Cellular Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
13522,Benign Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
13523,Benign Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
13524,Benign Cellular Infiltrate,Refractory Lung Carcinoma
13525,Benign Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v8
13526,Benign Cellular Infiltrate,Lugano Classification Stage IIE Adult Lymphoma AJCC v8
13527,Benign Cellular Infiltrate,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8
13528,Benign Cellular Infiltrate,Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8
13529,Benign Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8
13530,Benign Cellular Infiltrate,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8
13531,Benign Cellular Infiltrate,Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8
13532,Benign Cellular Infiltrate,Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage
13533,Benign Cellular Infiltrate,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8
13534,Benign Cellular Infiltrate,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage
13535,Benign Cellular Infiltrate,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8
13536,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System
13537,Benign Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8
13538,Benign Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage
13539,Benign Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage
13540,Benign Cellular Infiltrate,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage
13541,Benign Cellular Infiltrate,Mantle Cell Lymphoma by Ann Arbor Stage
13542,Benign Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage
13543,Benign Cellular Infiltrate,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage
13544,Benign Cellular Infiltrate,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage
13545,Benign Cellular Infiltrate,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage
13546,Benign Cellular Infiltrate,Refractory B Acute Lymphoblastic Leukemia
13547,Benign Cellular Infiltrate,Refractory Peripheral Primitive Neuroectodermal Tumor
13548,Low Grade Neuroendocrine Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma
13549,Low Grade Neuroendocrine Lesion,Metastatic Bile Duct Carcinoma
13550,Well Differentiated Neuroendocrine Lesion,Advanced Bile Duct Carcinoma
13551,Benign Cellular Infiltrate,Recurrent Primary Cutaneous Lymphoma
13552,Benign Cellular Infiltrate,Recurrent Alveolar Rhabdomyosarcoma
13553,Benign Cellular Infiltrate,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma
13554,Benign Cellular Infiltrate,Stage I Malignant Mediastinal Germ Cell Tumor
13555,Malignant Cellular Infiltrate,hemangioma of mediastinum
13556,Benign Cellular Infiltrate,Refractory Central Nervous System Non-Hodgkin Lymphoma
13557,Benign Cellular Infiltrate,Recurrent Central Nervous System Non-Hodgkin Lymphoma
13558,Benign Cellular Infiltrate,"Refractory Medulloblastoma, SHH-Activated"
13559,Benign Cellular Infiltrate,Central Nervous System B-Cell Non-Hodgkin Lymphoma
13560,Intermediate Grade Neuroendocrine Lesion,Refractory Colorectal Carcinoma
13561,Benign Cellular Infiltrate,Refractory Melanoma
13562,Intermediate Grade Neuroendocrine Lesion,Refractory Gastric Carcinoma
13563,Low Grade Neuroendocrine Lesion,Refractory Gastric Carcinoma
13564,Benign Cellular Infiltrate,Recurrent BRCA-Mutated Ovarian Carcinoma
13565,Benign Cellular Infiltrate,Childhood Recurrent Malignant Solid Neoplasm
13566,Benign Cellular Infiltrate,Refractory Myxoid Liposarcoma
13567,Benign Cellular Infiltrate,Refractory Sarcoma
13568,Benign Cellular Infiltrate,Refractory Myelodysplastic Syndrome
13569,Benign Cellular Infiltrate,Refractory Laryngeal Squamous Cell Carcinoma
13570,Benign Cellular Infiltrate,Refractory Paranasal Sinus Squamous Cell Carcinoma
13571,Benign Cellular Infiltrate,N1 Diffuse Large B-Cell Lymphoma
13572,Low Grade Neuroendocrine Lesion,Thoracic Esophagus Adenocarcinoma
13573,Well Differentiated Neuroendocrine Lesion,Cervical Esophagus Adenocarcinoma
13574,Benign Cellular Infiltrate,Recurrent Chronic Myelomonocytic Leukemia
13575,Benign Cellular Infiltrate,Refractory Malignant Oral Neoplasm
13576,Benign Cellular Infiltrate,Recurrent Malignant Soft Tissue Neoplasm
13577,Benign Cellular Infiltrate,Refractory Malignant Urinary System Neoplasm
13578,Benign Cellular Infiltrate,Refractory Cutaneous Melanoma
13579,Well Differentiated Neuroendocrine Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma
13580,Intermediate Grade Neuroendocrine Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma
13581,Low Grade Neuroendocrine Lesion,Unresectable Gastroesophageal Junction Adenocarcinoma
13582,Benign Cellular Infiltrate,Refractory Dedifferentiated Liposarcoma
13583,Benign Cellular Infiltrate,Resectable Liposarcoma
13584,Benign Cellular Infiltrate,Unresectable Undifferentiated Pleomorphic Sarcoma
13585,Benign Cellular Infiltrate,Unresectable Neuroblastoma
13586,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction
13587,Well Differentiated Neuroendocrine Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
13588,Benign Cellular Infiltrate,Refractory Female Reproductive System Carcinoma
13589,Well Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
13590,Benign Cellular Infiltrate,Refractory Mediastinal Lymphoma
13591,Benign Cellular Infiltrate,Advanced Synovial Sarcoma
13592,Benign Cellular Infiltrate,Advanced Lung Carcinoma
13593,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Spine
13594,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in Lymph Node
13595,Low Grade Neuroendocrine Lesion,Metastatic Unresectable Gastric Adenocarcinoma
13596,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Small Intestinal Carcinoma
13597,Low Grade Neuroendocrine Lesion,Locally Advanced Digestive System Carcinoma
13598,Well Differentiated Neuroendocrine Lesion,Recurrent Gastroesophageal Junction Adenocarcinoma
13599,Low Grade Neuroendocrine Lesion,Recurrent Anal Adenocarcinoma
13600,Low Grade Neuroendocrine Lesion,Recurrent Anal Mucinous Adenocarcinoma
13601,Benign Cellular Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma
13602,Well Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Ductal Adenocarcinoma
13603,Benign Cellular Infiltrate,Recurrent Thyroid Gland Medullary Carcinoma
13604,Intermediate Grade Neuroendocrine Lesion,Recurrent Appendix Carcinoma
13605,Benign Cellular Infiltrate,Recurrent Ovarian Transitional Cell Carcinoma
13606,Benign Cellular Infiltrate,MiT Family Translocation-Associated Renal Cell Carcinoma
13607,Low Mitotic Activity,Digestive System Large Cell Neuroendocrine Carcinoma
13608,Glandular Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma
13609,Intermediate Grade Neuroendocrine Lesion,Digestive System Small Cell Neuroendocrine Carcinoma
13610,Low Grade Neuroendocrine Lesion,Digestive System Small Cell Neuroendocrine Carcinoma
13611,Favorable Clinical Outcome,Cutaneous Melanoma of the Extremity
13612,Benign Cellular Infiltrate,Advanced Cutaneous Melanoma of the Extremity
13613,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Unresectable Renal Cell Carcinoma
13614,Benign Cellular Infiltrate,Pancreatic adenocarcinoma recurrent
13615,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic adenocarcinoma recurrent
13616,Metastatic Lesion,Pituitary Gland Mixed Gangliocytoma-Adenoma
13617,High Mitotic Activity,Sellar Ependymoma
13618,Necrotic changes (finding),Sellar Schwannoma
13619,Benign Cellular Infiltrate,Sellar Dedifferentiated Chordoma
13620,Indolent Clinical Course,Malignant Skull Base Neoplasm
13621,Indolent Clinical Course,Pituitary Gland Diffuse Large B-Cell Lymphoma
13622,Indolent Clinical Course,Suprasellar Germinoma
13623,Mixture of Germ Cell Neoplastic Components Present,Sellar Choriocarcinoma
13624,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Clear Cell Adenocarcinoma
13625,Squamous Differentiation,Recurrent Endometrial Undifferentiated Carcinoma
13626,Benign Cellular Infiltrate,Chest Wall Sarcoma
13627,Intracytoplasmic Eosinophilic Inclusion,Chest Wall Sarcoma
13628,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Unresectable Gastric Adenocarcinoma
13629,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Thoracic Cavity
13630,Intermediate Grade Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
13631,Benign Cellular Infiltrate,Locally Advanced Digestive System Neuroendocrine Carcinoma
13632,Low Mitotic Activity,Unresectable Digestive System Neuroendocrine Carcinoma
13633,Benign Cellular Infiltrate,Unresectable Digestive System Neuroendocrine Carcinoma
13634,Low Mitotic Activity,Metastatic Digestive System Neuroendocrine Carcinoma
13635,Intermediate Grade Neuroendocrine Lesion,Refractory Digestive System Neuroendocrine Carcinoma
13636,Mixed Neoplastic Glandular and Squamous Cell Population,Epididymal Papillary Cystadenoma
13637,Tumor Vascular Invasion,Thyroid Gland Spindle Cell Follicular Adenoma
13638,Ground Glass Nuclear Inclusion,Thyroid Gland Spindle Cell Follicular Adenoma
13639,Borderline Lesion,Thyroid Gland Spindle Cell Follicular Adenoma
13640,Borderline Lesion,Thyroid Gland Black Follicular Adenoma
13641,Nuclear Grooves,Thyroid Gland Black Follicular Adenoma
13642,Indolent Clinical Course,Recurrent Chordoma
13643,Grade 4 Lesion,Temporal Lobe Anaplastic Astrocytoma
13644,Indolent Clinical Course,Third Ventricle Germinoma
13645,Mucoid Stroma Formation,Hobnail Variant Thyroid Gland Papillary Carcinoma
13646,Benign Cellular Infiltrate,Bladder cancer stage IV
13647,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Adrenal Cortex Carcinoma
13648,Low Grade Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma
13649,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
13650,Benign Cellular Infiltrate,Metastatic Hypopharyngeal Carcinoma
13651,Benign Cellular Infiltrate,Metastatic Lung Adenosquamous Carcinoma
13652,Benign Cellular Infiltrate,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
13653,Benign Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
13654,Nuclear Clearing,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
13655,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Adenocarcinoma
13656,Intracytoplasmic Eosinophilic Inclusion,Tongue Alveolar Soft Part Sarcoma'
13657,Intracytoplasmic Eosinophilic Inclusion,sarcoma of tongue
13658,Intermediate Filaments Present,Orbital Alveolar Soft Part Sarcoma
13659,Intracytoplasmic Eosinophilic Inclusion,Bladder Alveolar Soft Part Sarcoma
13660,Indolent Clinical Course,Colon Liposarcoma
13661,Indolent Clinical Course,Scrotal Liposarcoma
13662,Intracytoplasmic Eosinophilic Inclusion,Scrotal Liposarcoma
13663,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Prostate Adenocarcinoma
13664,Local disease,Advanced Cervical Carcinoma
13665,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Cervical Adenocarcinoma
13666,Extensive Stage Lesion,Locally Advanced Unresectable Cervical Carcinoma
13667,Benign Cellular Infiltrate,Advanced Cervical Adenocarcinoma
13668,Diffuse Lesion,Thyroid Gland Cavernous Hemangioma
13669,Benign Cellular Infiltrate,Thyroid Gland Leiomyosarcoma
13670,CD30-Positive Neoplastic Cells Present,Thyroid Gland Histiocytic and Dendritic Cell Neoplasm
13671,HMB-45-Positive Neoplastic Cells Present,Thyroid Gland Histiocytic and Dendritic Cell Neoplasm
13672,High Grade Lesion,Thyroid Gland Langerhans Cell Histiocytosis
13673,CD30-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
13674,Benign Cellular Infiltrate,follicular dendritic cell sarcoma of thyroid gland
13675,HMB-45-Positive Neoplastic Cells Present,follicular dendritic cell sarcoma of thyroid gland
13676,Malignant Germinomatous Cellular Infiltrate,Grade 1 Teratoma
13677,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Primary Peritoneal Serous Adenocarcinoma
13678,Benign Cellular Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
13679,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Low Grade Ovarian Serous Adenocarcinoma
13680,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
13681,Benign Cellular Infiltrate,Extrapulmonary Small Cell Carcinoma
13682,Mixed Neoplastic Glandular and Squamous Cell Population,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
13683,Intermediate Filaments Present,Refractory Kaposi Sarcoma
13684,Benign Cellular Infiltrate,Genitourinary Cancer
13685,Benign Cellular Infiltrate,Advanced Neuroendocrine Neoplasm
13686,Poorly Differentiated Neuroendocrine Lesion,Pancreatic neuroendocrine tumor metastatic
13687,High Mitotic Activity,Pancreatic neuroendocrine tumor metastatic
13688,Local disease,Advanced Pancreatic Neuroendocrine Tumor
13689,Benign Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Neoplasm
13690,Intermediate Grade Neuroendocrine Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
13691,Low Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma
13692,Benign Cellular Infiltrate,Advanced Gastric Large Cell Neuroendocrine Carcinoma
13693,Well Differentiated Neuroendocrine Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
13694,Low Grade Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
13695,Well Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
13696,Benign Cellular Infiltrate,Pelvic Cancer
13697,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
13698,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
13699,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
13700,Benign Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia
13701,Hemosiderin pigmentation,Benign Parathyroid Gland Adenoma
13702,Benign Cellular Infiltrate,Malignant neoplasm of bronchus
13703,Intermediate Grade Neuroendocrine Lesion,Resectable Pancreatic Acinar Cell Carcinoma
13704,Low Grade Neuroendocrine Lesion,Resectable Pancreatic Acinar Cell Carcinoma
13705,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Pancreatic Acinar Cell Carcinoma
13706,Well Differentiated Neuroendocrine Lesion,Resectable Digestive System Carcinoma
13707,Intermediate Grade Neuroendocrine Lesion,Resectable Digestive System Carcinoma
13708,Mixed Neoplastic Glandular and Squamous Cell Population,Bile duct adenocarcinoma resectable
13709,Benign Cellular Infiltrate,Mucinous Adenocarcinoma
13710,Malignant Cellular Infiltrate,Common wart
13711,Well Differentiated Neuroendocrine Lesion,Early gastric cancer
13712,Benign Cellular Infiltrate,Disseminated adenocarcinoma
13713,Benign Cellular Infiltrate,Tobacco-Related Carcinoma
13714,Malignant Cellular Infiltrate,Borderline Ovarian Endometrioid Cystadenofibroma
13715,Benign Cellular Infiltrate,Recurrent Primitive Neuroectodermal Tumor
13716,Low Grade Neuroendocrine Lesion,Carcinoma duodenum resectable
13717,Intermediate Grade Neuroendocrine Lesion,Cholangiocarcinoma recurrent
13718,Benign Cellular Infiltrate,Peripheral neuroepithelioma of bone recurrent
13719,Benign Cellular Infiltrate,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
13720,Benign Cellular Infiltrate,Adult Systemic Anaplastic Large Cell Lymphoma
13721,Benign Cellular Infiltrate,Adult Anaplastic Large Cell Lymphoma
13722,Benign Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Cortex
13723,Broad Fibrous Bands Formation,Parathyroid Gland Oncocytic Adenoma
13724,Benign Cellular Infiltrate,Metastatic Carcinoma in the Lung
13725,Low Grade Neuroendocrine Lesion,Ampulla of Vater Intestinal-Type Adenocarcinoma
13726,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Mucinous Adenocarcinoma
13727,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Squamous Cell Carcinoma
13728,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Adenosquamous Carcinoma
13729,Low Grade Neuroendocrine Lesion,Ampulla of Vater Adenosquamous Carcinoma
13730,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma
13731,Intermediate Grade Neuroendocrine Lesion,verrucous carcinoma of esophagus
13732,Malignant Cellular Infiltrate,Benign Gastric Soft Tissue Neoplasm
13733,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma
13734,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal VIP-Producing Neuroendocrine Tumor
13735,Benign Cellular Infiltrate,Distal-Type Epithelioid Sarcoma
13736,Malignant Cellular Infiltrate,Lymphangioma of skin
13737,Malignant Cellular Infiltrate,Desmoplastic fibroblastoma
13738,Malignant Cellular Infiltrate,Desmoplastic trichoepithelioma
13739,Benign Cellular Infiltrate,Basal cell carcinoma - adenoid
13740,Benign Cellular Infiltrate,Infiltrating basal cell carcinoma
13741,Benign Cellular Infiltrate,"Basal cell carcinoma, micronodular"
13742,Benign Cellular Infiltrate,Skin Pseudovascular Squamous Cell Carcinoma
13743,Intermediate Grade Neuroendocrine Lesion,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
13744,Benign Cellular Infiltrate,Human Papillomavirus-Related Adenocarcinoma
13745,Intermediate Grade Neuroendocrine Lesion,Hepatitis Virus-Related Hepatocellular Carcinoma
13746,Well Differentiated Neuroendocrine Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma
13747,Low Grade Neuroendocrine Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma
13748,Benign Cellular Infiltrate,Virus-Related Carcinoma
13749,Benign Cellular Infiltrate,Virus-Related Sarcoma
13750,Benign Cellular Infiltrate,Non-Small Cell Adenocarcinoma
13751,Well Differentiated Neuroendocrine Lesion,Opisthorchis Viverrini-Related Cholangiocarcinoma
13752,Benign Cellular Infiltrate,Metastatic Penile Cancer
13753,Benign Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
13754,Intermediate Grade Neuroendocrine Lesion,Bile duct adenocarcinoma
13755,Benign Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v6
13756,Benign Cellular Infiltrate,Papillary serous endometrial carcinoma
13757,Benign Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
13758,Benign Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
13759,Benign Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
13760,Benign Cellular Infiltrate,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease
13761,Benign Cellular Infiltrate,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease
13762,Benign Cellular Infiltrate,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
13763,Benign Cellular Infiltrate,Unclassified Renal Cell Carcinoma
13764,Benign Cellular Infiltrate,Recurrent tumors of the Ewing's family
13765,Benign Cellular Infiltrate,Therapy-related acute myeloid leukemia and myelodysplastic syndrome
13766,Benign Cellular Infiltrate,Old Burn Scar-Related Cutaneous Melanoma
13767,Benign Cellular Infiltrate,Solar Radiation-Related Cutaneous Melanoma
13768,Well Differentiated Neuroendocrine Lesion,Alcohol-Related Hepatocellular Carcinoma
13769,Malignant Cellular Infiltrate,Sclerosing Breast Papilloma
13770,Benign Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple
13771,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Skin
13772,Benign Cellular Infiltrate,Endocervical Carcinoma
13773,Benign Cellular Infiltrate,Nipple Carcinoma
13774,Malignant Cellular Infiltrate,Benign neoplasm of colon
13775,Benign Cellular Infiltrate,Malignant neoplasm of skin
13776,Malignant Cellular Infiltrate,Chondroblastoma
13777,Low Grade Neuroendocrine Lesion,Colorectal Carcinoma
13778,Benign Cellular Infiltrate,Fibrosarcoma
13779,Benign Cellular Infiltrate,Heavy Chain Disease
13780,Benign Cellular Infiltrate,Acute Megakaryocytic Leukemias
13781,Malignant Cellular Infiltrate,Lipoma
13782,Malignant Cellular Infiltrate,Lymphangioendothelioma
13783,Malignant Cellular Infiltrate,Acoustic Neuroma
13784,Malignant Cellular Infiltrate,Osteoma
13785,Malignant Cellular Infiltrate,Osteoid osteoma
13786,Benign Cellular Infiltrate,"Thrombocythemia, Essential"
13787,Malignant Cellular Infiltrate,Infantile digital fibromatosis
13788,Benign Cellular Infiltrate,Immunoblastic Large-Cell Lymphoma
13789,Benign Cellular Infiltrate,Peripheral T-Cell Lymphoma
13790,Benign Cellular Infiltrate,Metastatic Carcinoma
13791,Malignant Cellular Infiltrate,Hamartoma of lung
13792,Well Differentiated Neuroendocrine Lesion,Gastrointestinal carcinoma in situ
13793,Low Grade Neuroendocrine Lesion,Gastrointestinal carcinoma in situ
13794,Benign Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
13795,Benign Cellular Infiltrate,Malignant neoplasm of spleen
13796,Benign Cellular Infiltrate,Malignant neoplasm of sphenoidal sinus
13797,Benign Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
13798,Benign Cellular Infiltrate,Malignant neoplasm of spermatic cord
13799,Benign Cellular Infiltrate,Malignant neoplasm of carotid body
13800,Benign Cellular Infiltrate,Mixed Cell Uveal Melanoma
13801,Benign Cellular Infiltrate,Ciliary Body Mixed Cell Melanoma
13802,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage III
13803,Benign Cellular Infiltrate,Parotid Gland Carcinosarcoma
13804,Benign Cellular Infiltrate,Grade 1 Clear Cell Renal Cell Carcinoma
13805,Benign Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma
13806,Benign Cellular Infiltrate,Grade 4 Clear Cell Renal Cell Carcinoma
13807,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(5;17)(q35;q21)
13808,Well Differentiated Neuroendocrine Lesion,Klatskin Tumor
13809,Malignant Cellular Infiltrate,Testicular Dermoid Cyst
13810,Malignant Cellular Infiltrate,Benign neoplasm of epididymis
13811,Malignant Cellular Infiltrate,Benign neoplasm of urethra
13812,Benign Cellular Infiltrate,Lung Carcinoma Metastatic in the Brain
13813,Intermediate Grade Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v6 and v7
13814,Benign Cellular Infiltrate,basal cell adenocarcinoma of salivary gland
13815,Benign Cellular Infiltrate,Carcinomatosis
13816,Malignant Cellular Infiltrate,Choroid Plexus Papilloma
13817,Well Differentiated Neuroendocrine Lesion,Pancreatic Foamy Gland Adenocarcinoma
13818,Benign Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue
13819,Benign Cellular Infiltrate,"Carcinoma, Giant Cell"
13820,Benign Cellular Infiltrate,Metachronous Wilms Tumor
13821,Intermediate Grade Neuroendocrine Lesion,Pancreatic carcinoma
13822,Geographic Necrosis,Dermoid cyst of ovary
13823,Well Differentiated Neuroendocrine Lesion,Carcinoma of extrahepatic bile duct
13824,Intermediate Grade Neuroendocrine Lesion,Carcinoma of extrahepatic bile duct
13825,Low Grade Neuroendocrine Lesion,Submucosal Invasive Colon Adenocarcinoma
13826,Tumor Vascular Invasion,Parathyroid Adenoma
13827,Benign Cellular Infiltrate,Vagina Carcinoma
13828,Malignant Cellular Infiltrate,Fibrous Hamartoma of Infancy
13829,Benign Cellular Infiltrate,"Glioblastoma, IDH-Mutant"
13830,Benign Cellular Infiltrate,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
13831,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
13832,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
13833,Benign Cellular Infiltrate,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
13834,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
13835,Benign Cellular Infiltrate,Bladder Adenocarcinoma
13836,Benign Cellular Infiltrate,Prostatic Urethral Malignant Neoplasm
13837,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
13838,Benign Cellular Infiltrate,Testicular Seminoma with Syncytiotrophoblastic Cells
13839,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Solid Pattern"
13840,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
13841,Malignant Cellular Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant"
13842,Malignant Cellular Infiltrate,Testicular Sclerosing Sertoli Cell Tumor
13843,Benign Cellular Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor
13844,Benign Cellular Infiltrate,malignant steroid cell tumor of ovary
13845,Benign Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
13846,Mitotic Activity,Grade 1 Ovarian Teratoma
13847,Geographic Necrosis,Ovarian Fetiform Teratoma
13848,Benign Cellular Infiltrate,Extramedullary Plasmacytoma
13849,Benign Cellular Infiltrate,Primary peritoneal carcinoma
13850,Malignant Cellular Infiltrate,Ovarian Serous Adenofibroma
13851,Malignant Cellular Infiltrate,Benign Ovarian Mucinous Tumor
13852,Malignant Cellular Infiltrate,Ovarian Mucinous Adenofibroma
13853,Benign Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v6
13854,Malignant Cellular Infiltrate,benign endometrioid tumor of ovary
13855,Malignant Cellular Infiltrate,Ovarian Endometrioid Cystadenoma
13856,Malignant Cellular Infiltrate,Ovarian Clear Cell Adenofibroma
13857,Benign Cellular Infiltrate,Carcinoma in situ of fallopian tube
13858,Benign Cellular Infiltrate,Malignant Head and Neck Neoplasm
13859,Benign Cellular Infiltrate,Uterine Ligament Adenocarcinoma
13860,Benign Cellular Infiltrate,Uterine Ligament Serous Adenocarcinoma
13861,Benign Cellular Infiltrate,CNS metastases
13862,Malignant Cellular Infiltrate,Uterine Corpus Bizarre Leiomyoma
13863,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyosarcoma
13864,Benign Cellular Infiltrate,Cervical Basaloid Carcinoma
13865,Benign Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma
13866,Benign Cellular Infiltrate,Chondroblastic osteosarcoma
13867,Benign Cellular Infiltrate,Acral Lentiginous Malignant Melanoma
13868,Benign Cellular Infiltrate,Cervical Alveolar Soft Part Sarcoma
13869,Malignant Cellular Infiltrate,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm
13870,Benign Cellular Infiltrate,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm
13871,Benign Cellular Infiltrate,Small cell osteosarcoma
13872,Benign Cellular Infiltrate,Cervical Melanoma
13873,Low Grade Neuroendocrine Lesion,Squamous cell carcinoma of esophagus
13874,Benign Cellular Infiltrate,Vaginal Keratinizing Squamous Cell Carcinoma
13875,Benign Cellular Infiltrate,Vaginal Warty Carcinoma
13876,Benign Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
13877,Benign Cellular Infiltrate,Vaginal Undifferentiated Sarcoma
13878,Malignant Cellular Infiltrate,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm
13879,Benign Cellular Infiltrate,Vulvar Warty Carcinoma
13880,Benign Cellular Infiltrate,Cervical Adenocarcinoma
13881,Benign Cellular Infiltrate,Urothelial Carcinoma
13882,Malignant Cellular Infiltrate,Benign Mixed Tumor of the Vulva
13883,Benign Cellular Infiltrate,Vulvar Proximal-Type Epithelioid Sarcoma
13884,Malignant Cellular Infiltrate,"Vulvar Deep ""Aggressive"" Angiomyxoma"
13885,Benign Cellular Infiltrate,Papillary thyroid carcinoma
13886,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of breast
13887,Benign Cellular Infiltrate,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
13888,Benign Cellular Infiltrate,malignant myoepithelioma of breast
13889,Benign Cellular Infiltrate,Nephroblastoma
13890,Benign Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma
13891,Benign Cellular Infiltrate,Trabecular adenocarcinoma
13892,Malignant Cellular Infiltrate,Benign Epithelioma
13893,Benign Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant"
13894,Benign Cellular Infiltrate,Papillary squamous cell carcinoma
13895,Benign Cellular Infiltrate,Pilomatrix carcinoma of skin
13896,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of appendix
13897,Malignant Cellular Infiltrate,Cellular Neurofibroma
13898,Benign Cellular Infiltrate,Chromophobe Renal Cell Carcinoma
13899,Hemosiderin pigmentation,Water-clear cell adenoma
13900,Well Differentiated Neuroendocrine Lesion,Sarcomatoid Intrahepatic Cholangiocarcinoma
13901,Malignant Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma
13902,Benign Cellular Infiltrate,Adenocarcinoma with squamous metaplasia
13903,Benign Cellular Infiltrate,Nodular melanoma
13904,Malignant Cellular Infiltrate,Balloon cell nevus
13905,Benign Cellular Infiltrate,Sarcomatosis
13906,Malignant Cellular Infiltrate,Fibromyxolipoma
13907,Intermediate Grade Neuroendocrine Lesion,Low grade appendiceal mucinous neoplasm
13908,Benign Cellular Infiltrate,Low Grade Endometrial Stromal Sarcoma
13909,Benign Cellular Infiltrate,Mixed Germ Cell Tumor
13910,Benign Cellular Infiltrate,Malignant Giant Cell Tumor of Bone
13911,Benign Cellular Infiltrate,Ameloblastic fibrosarcoma
13912,Benign Cellular Infiltrate,Anaplastic Oligodendroglioma
13913,Low Grade Neuroendocrine Lesion,Hereditary Diffuse Gastric Adenocarcinoma
13914,Low Grade Neuroendocrine Lesion,"Pancreatic carcinoma, familial"
13915,Benign Cellular Infiltrate,Ocular Sebaceous Carcinoma
13916,Benign Cellular Infiltrate,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
13917,Malignant Cellular Infiltrate,Ancell-Spiegler cylindromas
13918,Malignant Cellular Infiltrate,Syringofibroadenoma
13919,Benign Cellular Infiltrate,Peripheral T-Cell Lymphoma
13920,Well Differentiated Neuroendocrine Lesion,Sporadic Diffuse Gastric Adenocarcinoma
13921,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Squamous Cell Carcinoma
13922,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Signet Ring Cell Carcinoma
13923,Well Differentiated Neuroendocrine Lesion,small cell carcinoma of appendix
13924,Low Grade Neuroendocrine Lesion,Appendix Mixed Adenoneuroendocrine Carcinoma
13925,Malignant Cellular Infiltrate,Capillary hemangioma of eyelid
13926,Intermediate Grade Neuroendocrine Lesion,Colorectal Mucinous Adenocarcinoma
13927,Well Differentiated Neuroendocrine Lesion,Colorectal Small Cell Neuroendocrine Carcinoma
13928,Well Differentiated Neuroendocrine Lesion,Rectosigmoid Signet Ring Cell Carcinoma
13929,Intermediate Grade Neuroendocrine Lesion,Pleomorphic Hepatocellular Carcinoma
13930,Benign Cellular Infiltrate,Lymphoma of retina
13931,Low Grade Neuroendocrine Lesion,Clear Cell Intrahepatic Cholangiocarcinoma
13932,Benign Cellular Infiltrate,Carcinoma ex pleomorphic adenoma
13933,Malignant Cellular Infiltrate,Benign neoplasm of ethmoidal sinus
13934,Well Differentiated Neuroendocrine Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
13935,Well Differentiated Neuroendocrine Lesion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
13936,Well Differentiated Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v6 and v7
13937,Well Differentiated Neuroendocrine Lesion,Carcinoma in situ of ampulla of Vater
13938,Benign Cellular Infiltrate,Epithelioid hemangioendothelioma of lung
13939,Malignant Cellular Infiltrate,Benign neoplasm of lung
13940,Benign Cellular Infiltrate,Acantholytic squamous cell carcinoma of skin
13941,Malignant Cellular Infiltrate,Perifollicular fibroma
13942,Benign Cellular Infiltrate,Adenoid cystic eccrine carcinoma
13943,Benign Cellular Infiltrate,Skin Angiosarcoma
13944,Benign Cellular Infiltrate,Classical Low Grade Fibromyxoid Sarcoma
13945,Benign Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7
13946,Benign Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm
13947,Benign Cellular Infiltrate,Sarcoma of kidney
13948,Benign Cellular Infiltrate,Cutaneous Mantle Cell Lymphoma
13949,Mitotic Activity,Dermoid cyst of orbit
13950,Malignant Cellular Infiltrate,Dermoid cyst of orbit
13951,Malignant Cellular Infiltrate,Lymphangioma circumscriptum
13952,Benign Cellular Infiltrate,Squamous cell carcinoma of conjunctiva
13953,Benign Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
13954,Benign Cellular Infiltrate,Sarcomatoid carcinoma of the lung
13955,Benign Cellular Infiltrate,Malignant melanoma of choroid
13956,Benign Cellular Infiltrate,Chronic eosinophilic leukemia
13957,Benign Cellular Infiltrate,Pleural Lymphoma
13958,Benign Cellular Infiltrate,NUT midline carcinoma
13959,Benign Cellular Infiltrate,Thymic Atypical Carcinoid Tumor
13960,Benign Cellular Infiltrate,Cardiac Malignant Fibrous Histiocytoma
13961,Benign Cellular Infiltrate,Kaposi's sarcoma of conjunctiva
13962,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma
13963,Low Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2
13964,Low Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2
13965,Low Grade Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2
13966,Well Differentiated Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v7
13967,Malignant Cellular Infiltrate,Benign neoplasm of gum
13968,Benign Cellular Infiltrate,Papillary Thyroid Microcarcinoma
13969,Malignant Cellular Infiltrate,Benign neoplasm of nasal cavity
13970,Malignant Cellular Infiltrate,Benign neoplasm of myocardium
13971,Benign Cellular Infiltrate,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
13972,Malignant Cellular Infiltrate,Thyroid Gland Lipoadenoma
13973,Malignant Cellular Infiltrate,Lipoma of skin
13974,Malignant Cellular Infiltrate,Benign neoplasm of male breast
13975,Malignant Cellular Infiltrate,Benign squamous cell tumor
13976,Malignant Cellular Infiltrate,Benign Brenner Tumor
13977,Malignant Cellular Infiltrate,Spindle cell nevus of Reed
13978,Malignant Cellular Infiltrate,Benign neoplasm of rectum
13979,Benign Cellular Infiltrate,Squamous cell carcinoma of skin
13980,Benign Cellular Infiltrate,Adrenal Gland Angiosarcoma
13981,Benign Cellular Infiltrate,Carcinoma of larynx
13982,Benign Cellular Infiltrate,Secondary malignant neoplasm of heart
13983,Malignant Cellular Infiltrate,Subcutaneous Nodular Fasciitis
13984,Malignant Cellular Infiltrate,Myofibroblastoma
13985,Benign Cellular Infiltrate,Parathyroid Gland Adenocarcinoma
13986,Malignant Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
13987,Well Differentiated Neuroendocrine Lesion,Colon Carcinoma
13988,Low Grade Neuroendocrine Lesion,Colon Carcinoma
13989,Benign Cellular Infiltrate,Small cell carcinoma of lung
13990,Malignant Cellular Infiltrate,Capillary hemangioma of retina
13991,Benign Cellular Infiltrate,Aleukemic leukemia
13992,Benign Cellular Infiltrate,Bladder adenocarcinoma recurrent
13993,Benign Cellular Infiltrate,Recurrent Burkitt Lymphoma
13994,Intermediate Grade Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v6
13995,Low Grade Neuroendocrine Lesion,Stage I Rectosigmoid Cancer AJCC v6 and v7
13996,Low Grade Neuroendocrine Lesion,Pancreatic carcinoma non-resectable
13997,Benign Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
13998,Benign Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
13999,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic
14000,Benign Cellular Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma
14001,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic
14002,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV
14003,Benign Cellular Infiltrate,Brain Stem Glioblastoma
14004,Low Grade Neuroendocrine Lesion,Pancreatic carcinoma resectable
14005,Benign Cellular Infiltrate,Malignant Adult Brain Neoplasm
14006,Benign Cellular Infiltrate,Anaplastic Diencephalic Astrocytoma
14007,Benign Cellular Infiltrate,Diencephalic Glioblastoma
14008,Benign Cellular Infiltrate,Intraductal Cribriform Breast Adenocarcinoma
14009,Benign Cellular Infiltrate,Malignant Breast Adenomyoepithelioma
14010,Benign Cellular Infiltrate,Cerebellar Glioblastoma
14011,Benign Cellular Infiltrate,Brain sarcoma
14012,Benign Cellular Infiltrate,Infiltrating duct and lobular carcinoma
14013,Benign Cellular Infiltrate,High Grade Mucoepidermoid Breast Carcinoma
14014,Benign Cellular Infiltrate,Low Grade Mucoepidermoid Breast Carcinoma
14015,Benign Cellular Infiltrate,Malignant Breast Eccrine Spiradenoma
14016,Benign Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC V6 and v7
14017,Malignant Cellular Infiltrate,Ovarian Myxoma
14018,Low Grade Neuroendocrine Lesion,Mucinous adenocarcinoma gastric
14019,Benign Cellular Infiltrate,Cerebellar Papillary Meningioma
14020,Well Differentiated Neuroendocrine Lesion,adenoid cystic carcinoma of esophagus
14021,Malignant Cellular Infiltrate,Esophageal squamous papilloma
14022,Benign Cellular Infiltrate,Metastatic Jugulotympanic Paraganglioma
14023,Benign Cellular Infiltrate,Cardiac Leiomyosarcoma
14024,Benign Cellular Infiltrate,Pulmonary Vein Leiomyosarcoma
14025,Benign Cellular Infiltrate,Pulmonary Artery Choriocarcinoma
14026,Benign Cellular Infiltrate,Uterine Angiosarcoma
14027,Benign Cellular Infiltrate,High grade surface osteosarcoma
14028,Benign Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread
14029,Benign Cellular Infiltrate,Classic medulloblastoma
14030,Benign Cellular Infiltrate,keratinizing squamous cell carcinoma of nasal cavity
14031,Benign Cellular Infiltrate,Laryngeal Basaloid Carcinoma
14032,Malignant Cellular Infiltrate,Lipoma of corpus callosum
14033,Benign Cellular Infiltrate,Malignant Childhood Central Nervous System Neoplasm
14034,Benign Cellular Infiltrate,Nevoid Melanoma
14035,Benign Cellular Infiltrate,Signet Ring Melanoma
14036,Benign Cellular Infiltrate,Sweat gland adenocarcinoma
14037,Intermediate Grade Neuroendocrine Lesion,Stage IA Gastric Carcinoma
14038,Intermediate Grade Neuroendocrine Lesion,Stage IB Gastric Carcinoma
14039,Low Grade Neuroendocrine Lesion,Stage IB Gastric Carcinoma
14040,Low Grade Neuroendocrine Lesion,Stage IIIB Gastric Carcinoma
14041,Low Grade Neuroendocrine Lesion,Stage IIIA Gastric Carcinoma
14042,Well Differentiated Neuroendocrine Lesion,Gastric Papillary Adenocarcinoma
14043,Well Differentiated Neuroendocrine Lesion,Gastric Tubular Adenocarcinoma
14044,Low Grade Neuroendocrine Lesion,Squamous cell carcinoma of colon
14045,Malignant Cellular Infiltrate,Colon Lipoma
14046,Intermediate Grade Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1
14047,Malignant Cellular Infiltrate,Colon Lymphangioma
14048,Mitotic Activity,Central Nervous System Dermoid Cyst
14049,Well Differentiated Neuroendocrine Lesion,Mucinous cystadenocarcinoma appendix
14050,Benign Cellular Infiltrate,embryonal rhabdomyosarcoma of prostate
14051,Benign Cellular Infiltrate,Prostate Adenoid Cystic Carcinoma
14052,Benign Cellular Infiltrate,Malignant Eccrine Neoplasm
14053,Benign Cellular Infiltrate,Recurrent Medulloblastoma
14054,Low Grade Neuroendocrine Lesion,Adenocarcinoma of anus
14055,Benign Cellular Infiltrate,Cutaneous Liposarcoma
14056,Benign Cellular Infiltrate,Ann Arbor Stage IVB Hodgkin Lymphoma
14057,Benign Cellular Infiltrate,Stage IA Lung Cancer AJCC v7
14058,Benign Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7
14059,Benign Cellular Infiltrate,Stage IB Non-Small Cell Lung Carcinoma AJCC v7
14060,Malignant Cellular Infiltrate,Lung Myolipoma
14061,Malignant Cellular Infiltrate,Lung Mucous Gland Adenoma
14062,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of lung
14063,Malignant Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp
14064,Malignant Cellular Infiltrate,neurofibroma of esophagus
14065,Intermediate Grade Neuroendocrine Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7
14066,Well Differentiated Neuroendocrine Lesion,Serous cystadenocarcinoma of pancreas
14067,Well Differentiated Neuroendocrine Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas
14068,Low Grade Neuroendocrine Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas
14069,Intermediate Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v6
14070,Low Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v6
14071,Intermediate Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v6
14072,Well Differentiated Neuroendocrine Lesion,Gallbladder papillary adenocarcinoma
14073,Low Grade Neuroendocrine Lesion,mucinous adenocarcinoma of gallbladder
14074,Well Differentiated Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v6 and v7
14075,Intermediate Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v6
14076,Intermediate Grade Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v7
14077,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of the liver
14078,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1
14079,Intermediate Grade Neuroendocrine Lesion,small cell carcinoma of extrahepatic bile duct
14080,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor
14081,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
14082,Benign Cellular Infiltrate,Stage IVA Basal Cell Lip Carcinoma
14083,Benign Cellular Infiltrate,Stage IV Major Salivary Gland Carcinoma without Metastasis
14084,Benign Cellular Infiltrate,Malignant Mixed Tumor of the Major Salivary Gland
14085,Benign Cellular Infiltrate,Salivary duct carcinoma
14086,Benign Cellular Infiltrate,adenocarcinoma of oral cavity
14087,Benign Cellular Infiltrate,Oral Cavity Mucosal Melanoma
14088,Low Grade Neuroendocrine Lesion,Stage IIIA Anal Canal Cancer AJCC v6 and v7
14089,Benign Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma
14090,Benign Cellular Infiltrate,Minor Salivary Gland Small Cell Carcinoma
14091,Malignant Cellular Infiltrate,Otic polyp
14092,Benign Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland
14093,Benign Cellular Infiltrate,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
14094,Benign Cellular Infiltrate,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
14095,Benign Cellular Infiltrate,Major Salivary Gland Sarcoma
14096,Benign Cellular Infiltrate,Stage IVB Pharyngeal Carcinoma
14097,Benign Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma
14098,Benign Cellular Infiltrate,Stage I Paranasal Sinus Cancer
14099,Benign Cellular Infiltrate,Stage II Nasal Cavity Cancer AJCC v6 and v7
14100,Benign Cellular Infiltrate,mucoepidermoid carcinoma of accessory sinus
14101,Benign Cellular Infiltrate,Metastatic malignant neoplasm to oropharynx
14102,Benign Cellular Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
14103,Benign Cellular Infiltrate,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
14104,Malignant Cellular Infiltrate,Thyroid Gland Oncocytic Adenoma
14105,Benign Cellular Infiltrate,Thyroid Non-Hodgkin's Lymphoma
14106,Benign Cellular Infiltrate,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
14107,Benign Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent
14108,Malignant Cellular Infiltrate,Benign Anterior Tongue Neoplasm
14109,Well Differentiated Neuroendocrine Lesion,Colon Medullary Carcinoma
14110,Low Grade Neuroendocrine Lesion,Colon Medullary Carcinoma
14111,Benign Cellular Infiltrate,Frontal Sinus Squamous Cell Carcinoma
14112,Benign Cellular Infiltrate,External Ear Squamous Cell Carcinoma
14113,Benign Cellular Infiltrate,carcinoma of middle ear
14114,Benign Cellular Infiltrate,Choroid Epithelioid Cell Melanoma
14115,Benign Cellular Infiltrate,Ciliary Body Spindle Cell Melanoma
14116,Benign Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
14117,Benign Cellular Infiltrate,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
14118,Benign Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v7
14119,Benign Cellular Infiltrate,Adult Kidney Wilms Tumor
14120,Benign Cellular Infiltrate,Childhood Central Nervous System Choriocarcinoma
14121,Benign Cellular Infiltrate,Grade III Childhood Astrocytoma
14122,Malignant Cellular Infiltrate,Benign Childhood Cerebral Neoplasm
14123,Malignant Cellular Infiltrate,Pedunculated conjunctival papilloma
14124,Malignant Cellular Infiltrate,Oral Cavity Pleomorphic Adenoma
14125,Benign Cellular Infiltrate,Fallopian Tube Adenocarcinoma
14126,Benign Cellular Infiltrate,Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7
14127,Benign Cellular Infiltrate,Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7
14128,Benign Cellular Infiltrate,Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7
14129,Benign Cellular Infiltrate,Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7
14130,Benign Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v7
14131,Benign Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v7
14132,Benign Cellular Infiltrate,Stage IB Cervical Cancer AJCC v6 and v7
14133,Benign Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v6 and v7
14134,Benign Cellular Infiltrate,Stage IA Vulvar Carcinoma AJCC v6
14135,Malignant Cellular Infiltrate,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
14136,Benign Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
14137,Benign Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma
14138,Benign Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
14139,Malignant Cellular Infiltrate,Mature Testicular Teratoma
14140,Benign Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7
14141,Benign Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v6 and v7
14142,Benign Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v6 and v7
14143,Malignant Cellular Infiltrate,Vaginal Squamous Papilloma
14144,Poorly Differentiated Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1
14145,Benign Cellular Infiltrate,Multifocal osteosarcoma
14146,Malignant Cellular Infiltrate,Hemangioma of bone
14147,Malignant Cellular Infiltrate,Calcifying Fibrous Pseudotumor
14148,Malignant Cellular Infiltrate,Inverted Squamous Cell Papilloma
14149,Benign Cellular Infiltrate,"Squamous cell carcinoma, microinvasive"
14150,Benign Cellular Infiltrate,Squamous cell carcinoma with horn formation
14151,Poorly Differentiated Neuroendocrine Lesion,"Glucagonoma, malignant"
14152,Poorly Differentiated Neuroendocrine Lesion,"Gastrinoma, malignant"
14153,Benign Cellular Infiltrate,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
14154,Malignant Cellular Infiltrate,Childhood Ovarian Mature Teratoma
14155,Malignant Cellular Infiltrate,Degenerated Schwannoma
14156,Malignant Cellular Infiltrate,Palisaded Lymph Node Myofibroblastoma
14157,Benign Cellular Infiltrate,Childhood Conventional Osteosarcoma
14158,Malignant Cellular Infiltrate,Mediastinal Rhabdomyoma
14159,Benign Cellular Infiltrate,Stage IB Osteosarcoma AJCC v7
14160,Malignant Cellular Infiltrate,Ganglioneuroma of mediastinum
14161,Malignant Cellular Infiltrate,Lipoma of pleura
14162,Intermediate Grade Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v7
14163,Intermediate Grade Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v7
14164,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v7
14165,Well Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v7
14166,Benign Cellular Infiltrate,Stage IA Lung Large Cell Carcinoma AJCC v7
14167,Benign Cellular Infiltrate,Stage IIA Lung Adenosquamous Carcinoma AJCC v7
14168,Benign Cellular Infiltrate,Stage IA Lung Small Cell Carcinoma AJCC v7
14169,Malignant Cellular Infiltrate,Epithelioid cell nevus
14170,Benign Cellular Infiltrate,Stage IIIA Lung Small Cell Carcinoma AJCC v7
14171,Benign Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma AJCC v7
14172,Benign Cellular Infiltrate,"Retinoblastoma, differentiated"
14173,Benign Cellular Infiltrate,Stage IA Lung Squamous Cell Carcinoma AJCC v7
14174,Benign Cellular Infiltrate,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
14175,Benign Cellular Infiltrate,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
14176,Benign Cellular Infiltrate,solid type ductal carcinoma in situ of breast
14177,Benign Cellular Infiltrate,serous adenocarcinofibroma of ovary
14178,Seminomatous Component Present,Benign Teratoma
14179,Malignant Cellular Infiltrate,Chest Wall Fibromatosis
14180,Well Differentiated Neuroendocrine Lesion,Stage IIA Esophageal Adenocarcinoma AJCC v7
14181,Intermediate Grade Neuroendocrine Lesion,Stage IIA Esophageal Adenocarcinoma AJCC v7
14182,Low Grade Neuroendocrine Lesion,Stage IIB Esophageal Adenocarcinoma AJCC v7
14183,Malignant Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor
14184,Malignant Cellular Infiltrate,Pineal Region Mature Teratoma
14185,Benign Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
14186,Malignant Cellular Infiltrate,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
14187,Well Differentiated Neuroendocrine Lesion,small cell carcinoma of gallbladder
14188,Benign Cellular Infiltrate,Malignant Pineal Region Germ Cell Tumor
14189,Benign Cellular Infiltrate,Parotid Gland Carcinoma
14190,Malignant Cellular Infiltrate,Benign Eccrine Neoplasm
14191,Benign Cellular Infiltrate,Malignant Apocrine Neoplasm
14192,Geographic Necrosis,Dermoid Cyst of the Spinal Cord
14193,Benign Cellular Infiltrate,High Grade Paranasal Sinus Sarcoma
14194,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
14195,Benign Cellular Infiltrate,Childhood Extragonadal Malignant Germ Cell Tumor
14196,Benign Cellular Infiltrate,Childhood Atypical Teratoid/Rhabdoid Tumor
14197,Benign Cellular Infiltrate,Favorable Hodgkin Lymphoma
14198,Benign Cellular Infiltrate,Advanced Favorable Hodgkin Lymphoma
14199,Benign Cellular Infiltrate,Myelodysplastic Syndrome with Isolated del(5q)
14200,Benign Cellular Infiltrate,Marginal zone lymphoma stage III
14201,Benign Cellular Infiltrate,Marginal zone lymphoma stage IV
14202,Benign Cellular Infiltrate,Marginal zone lymphoma recurrent
14203,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
14204,Benign Cellular Infiltrate,Large cell neuroendocrine carcinoma
14205,Low Grade Neuroendocrine Lesion,mixed acinar-endocrine carcinoma of pancreas
14206,Benign Cellular Infiltrate,Adult Classical Hodgkin Lymphoma
14207,Benign Cellular Infiltrate,Nonanaplastic Kidney Wilms Tumor
14208,Benign Cellular Infiltrate,Anaplastic Kidney Wilms Tumor
14209,Benign Cellular Infiltrate,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
14210,Benign Cellular Infiltrate,Papillary Renal Cell Carcinoma
14211,Benign Cellular Infiltrate,Verrucous carcinoma of penis
14212,Mitotic Activity,Central Nervous System Mature Teratoma
14213,Malignant Cellular Infiltrate,Neurothekeoma
14214,Benign Cellular Infiltrate,Plasma cell myeloma refractory
14215,Low Grade Neuroendocrine Lesion,Barrett's Adenocarcinoma
14216,Benign Cellular Infiltrate,Paget Disease
14217,Well Differentiated Neuroendocrine Lesion,Undifferentiated Carcinoma of Colon
14218,Low Grade Neuroendocrine Lesion,Undifferentiated Carcinoma of Colon
14219,Malignant Cellular Infiltrate,Mature Mediastinal Teratoma
14220,Intermediate Grade Neuroendocrine Lesion,Distal Bile Duct Carcinoma
14221,Intermediate Grade Neuroendocrine Lesion,Stage IVB Liver Cancer
14222,Benign Cellular Infiltrate,Erythroleukemia (Erythroid/Myeloid)
14223,Benign Cellular Infiltrate,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma
14224,Benign Cellular Infiltrate,Triple-Negative Breast Carcinoma
14225,Benign Cellular Infiltrate,Grade 2 Diffuse Follicular Lymphoma
14226,Benign Cellular Infiltrate,Lymphoepithelioid lymphoma (clinical)
14227,Benign Cellular Infiltrate,Common Variant Anaplastic Large Cell Lymphoma
14228,Benign Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
14229,Benign Cellular Infiltrate,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
14230,Benign Cellular Infiltrate,Malignant neoplasm of testis
14231,Benign Cellular Infiltrate,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma
14232,Benign Cellular Infiltrate,Splenic Manifestation of Hairy Cell Leukemia
14233,Benign Cellular Infiltrate,Mantle cell lymphoma of spleen
14234,Benign Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension
14235,Benign Cellular Infiltrate,Extragonadal Seminoma
14236,Benign Cellular Infiltrate,Seminoma
14237,Benign Cellular Infiltrate,Malignant Vascular Neoplasm
14238,Benign Cellular Infiltrate,Lung Hilum Carcinoma
14239,Malignant Cellular Infiltrate,Strawberry nevus of skin
14240,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of anal canal
14241,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of anal canal
14242,Intermediate Grade Neuroendocrine Lesion,Carcinoma of anal margin
14243,Intermediate Grade Neuroendocrine Lesion,Anal Extramucosal (Perianal) Adenocarcinoma
14244,Low Grade Neuroendocrine Lesion,Carcinoma of anal canal
14245,Benign Cellular Infiltrate,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
14246,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm to the Thyroid
14247,Benign Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v7
14248,Benign Cellular Infiltrate,Pancoast Tumor
14249,Benign Cellular Infiltrate,Malignant neoplasm of ureter
14250,Benign Cellular Infiltrate,Stage I Prostate Carcinoma
14251,Malignant Cellular Infiltrate,Skin appendage adenoma
14252,Benign Cellular Infiltrate,Combined Lung Carcinoma
14253,Benign Cellular Infiltrate,olfactory neuroblastoma of nasal cavity
14254,Benign Cellular Infiltrate,Malignant Thymoma
14255,Malignant Cellular Infiltrate,Benign Reproductive System Neoplasm
14256,Benign Cellular Infiltrate,Adenocarcinoma in adenomatous polyp
14257,Benign Cellular Infiltrate,Adenocarcinoma with cartilaginous metaplasia
14258,Benign Cellular Infiltrate,Infiltrating duct and lobular carcinoma
14259,Benign Cellular Infiltrate,carcinoma of gingiva
14260,Benign Cellular Infiltrate,fibrosarcoma of kidney
14261,Benign Cellular Infiltrate,sarcoma of penis
14262,Benign Cellular Infiltrate,Pericarditis malignant
14263,Intermediate Grade Neuroendocrine Lesion,Stage III Colon Cancer
14264,Low Grade Neuroendocrine Lesion,Stage III Colon Cancer
14265,Benign Cellular Infiltrate,Non-small cell lung cancer stage II
14266,Benign Cellular Infiltrate,Osteosarcoma localised
14267,Benign Cellular Infiltrate,Recurrent Childhood Acute Lymphoblastic Leukemia
14268,Well Differentiated Neuroendocrine Lesion,Anal cancer recurrent
14269,Intermediate Grade Neuroendocrine Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7
14270,Benign Cellular Infiltrate,Mycosis fungoides stage I
14271,Benign Cellular Infiltrate,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
14272,Benign Cellular Infiltrate,Ewing's sarcoma recurrent
14273,Benign Cellular Infiltrate,Ovarian epithelial cancer stage II
14274,Benign Cellular Infiltrate,Stage III Kidney Wilms Tumor
14275,Benign Cellular Infiltrate,Stage III Vaginal Cancer AJCC v6 and v7
14276,Poorly Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1
14277,Benign Cellular Infiltrate,Stage II Penile Cancer AJCC v6
14278,Benign Cellular Infiltrate,Chronic lymphocytic leukemia stage 1
14279,Low Grade Neuroendocrine Lesion,Recurrent Adult Liver Carcinoma
14280,Low Grade Neuroendocrine Lesion,Adenocarcinoma of duodenum
14281,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma recurrent
14282,Benign Cellular Infiltrate,Stage III Bladder Cancer AJCC v6 and v7
14283,Benign Cellular Infiltrate,Bladder cancer recurrent
14284,Benign Cellular Infiltrate,Ocular Melanoma with Extraocular Extension
14285,Benign Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6
14286,Benign Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v6
14287,Benign Cellular Infiltrate,Adult Extraskeletal Osteosarcoma
14288,Well Differentiated Neuroendocrine Lesion,Liver and Intrahepatic Biliary Tract Carcinoma
14289,Benign Cellular Infiltrate,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
14290,Benign Cellular Infiltrate,Paget Disease of the Breast with Invasive Ductal Carcinoma
14291,Benign Cellular Infiltrate,Childhood T Acute Lymphoblastic Leukemia
14292,Low Grade Neuroendocrine Lesion,Childhood Hepatocellular Carcinoma
14293,Well Differentiated Neuroendocrine Lesion,Mucinous adenocarcinoma of colon
14294,Intermediate Grade Neuroendocrine Lesion,mucinous adenocarcinoma of rectum
14295,Intermediate Grade Neuroendocrine Lesion,adenocarcinoma of extrahepatic bile duct
14296,Benign Cellular Infiltrate,Carcinoma Arising from Craniopharyngioma
14297,Benign Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma
14298,Benign Cellular Infiltrate,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood
14299,Benign Cellular Infiltrate,Stage I Laryngeal Cancer AJCC v6 and v7
14300,Benign Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v6 and v7
14301,Benign Cellular Infiltrate,Malignant Ovarian Sex Cord-Stromal Tumor
14302,Benign Cellular Infiltrate,Follicular thyroid carcinoma
14303,Benign Cellular Infiltrate,Stage I Childhood Hodgkin Lymphoma
14304,Benign Cellular Infiltrate,Stage III Childhood Hodgkin Lymphoma
14305,Benign Cellular Infiltrate,Stage IV Childhood Hodgkin Lymphoma
14306,Benign Cellular Infiltrate,Metastatic Childhood Soft Tissue Sarcoma
14307,Benign Cellular Infiltrate,Stage I Adult Immunoblastic Lymphoma
14308,Benign Cellular Infiltrate,Stage I Adult Lymphoblastic Lymphoma
14309,Benign Cellular Infiltrate,Childhood Fibrosarcoma
14310,Benign Cellular Infiltrate,Childhood Malignant Peripheral Nerve Sheath Tumor
14311,Benign Cellular Infiltrate,Stage II Adult Non-Hodgkin Lymphoma
14312,Benign Cellular Infiltrate,Stage IV Adult Non-Hodgkin Lymphoma
14313,Benign Cellular Infiltrate,Endodermal sinus tumor of ovary
14314,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 3 Follicular Lymphoma
14315,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma stage III
14316,Benign Cellular Infiltrate,Ann Arbor Stage IV Grade 1 Follicular Lymphoma
14317,Benign Cellular Infiltrate,Recurrent Adult Burkitt Lymphoma
14318,Benign Cellular Infiltrate,Anterior Tongue Squamous Cell Carcinoma
14319,Benign Cellular Infiltrate,Upper Gingival Squamous Cell Carcinoma
14320,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity
14321,Benign Cellular Infiltrate,Posterior Tongue Squamous Cell Carcinoma
14322,Benign Cellular Infiltrate,Tonsillar Undifferentiated Carcinoma
14323,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage IV
14324,Benign Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage IV
14325,Benign Cellular Infiltrate,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
14326,Benign Cellular Infiltrate,Acute Myeloid Leukemia with Gene Mutations
14327,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage II
14328,Low Grade Neuroendocrine Lesion,Cloacogenic carcinoma
14329,Benign Cellular Infiltrate,Stage III Uterine Sarcoma AJCC v7
14330,Benign Cellular Infiltrate,Recurrent Uterine Corpus Sarcoma
14331,Intermediate Grade Neuroendocrine Lesion,Adult Cholangiocarcinoma
14332,Benign Cellular Infiltrate,Adult Anaplastic Oligodendroglioma
14333,Benign Cellular Infiltrate,Localized Unresectable Neuroblastoma
14334,Benign Cellular Infiltrate,bilateral breast cancer
14335,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of pancreas
14336,Well Differentiated Neuroendocrine Lesion,Stage IV Rectal Carcinoma
14337,Malignant Cellular Infiltrate,Benign neoplasm of supraglottis
14338,Benign Cellular Infiltrate,Mantle cell lymphoma stage I
14339,Benign Cellular Infiltrate,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma
14340,Benign Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma
14341,Benign Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma
14342,Benign Cellular Infiltrate,Malignant Leptomeningeal Neoplasm
14343,Benign Cellular Infiltrate,Stage III Non-Hodgkin Lymphoma
14344,Malignant Cellular Infiltrate,Benign neoplasm of sebaceous gland
14345,Benign Cellular Infiltrate,Secondary malignant neoplasm of chest wall
14346,Benign Cellular Infiltrate,Secondary malignant neoplasm of lip
14347,Benign Cellular Infiltrate,Metastatic Neoplasm to the Placenta
14348,Benign Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland
14349,Benign Cellular Infiltrate,"Neoplasms, Unknown Primary"
14350,Benign Cellular Infiltrate,Stage I Merkel Cell Carcinoma AJCC v7
14351,Benign Cellular Infiltrate,Stage IB Merkel Cell Carcinoma AJCC v7
14352,Benign Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7
14353,Benign Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7
14354,Malignant Cellular Infiltrate,Benign chondrogenic neoplasm
14355,Benign Cellular Infiltrate,Anaplastic (Malignant) Intraspinal Meningioma
14356,Benign Cellular Infiltrate,Stage IIIC Cutaneous Melanoma AJCC v7
14357,Malignant Cellular Infiltrate,Benign neoplasm of peritoneum
14358,Benign Cellular Infiltrate,Metastases to abdominal cavity
14359,Intermediate Grade Neuroendocrine Lesion,Stage I Esophageal Adenocarcinoma AJCC v7
14360,Well Differentiated Neuroendocrine Lesion,Esophageal squamous cell carcinoma recurrent
14361,Intermediate Grade Neuroendocrine Lesion,Esophageal squamous cell carcinoma recurrent
14362,Well Differentiated Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v6
14363,Well Differentiated Neuroendocrine Lesion,Bile duct cancer resectable
14364,Benign Cellular Infiltrate,Precursor B-cell lymphoblastic leukemia
14365,Benign Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent
14366,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage III
14367,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia refractory
14368,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II
14369,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV
14370,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage II
14371,Benign Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v7
14372,Benign Cellular Infiltrate,Non-Hodgkin's lymphoma refractory
14373,Benign Cellular Infiltrate,HPV positive oropharyngeal squamous cell carcinoma
14374,Benign Cellular Infiltrate,Retinoblastoma unilateral
14375,Benign Cellular Infiltrate,Stage II Bone Cancer AJCC v7
14376,Benign Cellular Infiltrate,Stage IV Bone Cancer AJCC v7
14377,Benign Cellular Infiltrate,FIGO Stage III Carcinoma of the Fallopian Tube
14378,Benign Cellular Infiltrate,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
14379,Benign Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7
14380,Benign Cellular Infiltrate,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
14381,Benign Cellular Infiltrate,Large cell lung cancer stage I
14382,Benign Cellular Infiltrate,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
14383,Benign Cellular Infiltrate,Stage III Lung Cancer AJCC v6
14384,Low Grade Neuroendocrine Lesion,Stage IIA Gastric Cancer AJCC v7
14385,Low Grade Neuroendocrine Lesion,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
14386,Low Grade Neuroendocrine Lesion,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
14387,Intermediate Grade Neuroendocrine Lesion,Stage IB Esophageal Adenocarcinoma AJCC v7
14388,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Esophageal Adenocarcinoma AJCC v7
14389,Low Grade Neuroendocrine Lesion,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
14390,Benign Cellular Infiltrate,Chondrosarcoma metastatic
14391,Well Differentiated Neuroendocrine Lesion,Stage IIA Small Intestinal Cancer AJCC v7
14392,Low Grade Neuroendocrine Lesion,Stage IIA Small Intestinal Cancer AJCC v7
14393,Intermediate Grade Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v7
14394,Low Grade Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v7
14395,Intermediate Grade Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v7
14396,Intermediate Grade Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v7
14397,Well Differentiated Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v7
14398,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v7
14399,Benign Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7
14400,Benign Cellular Infiltrate,Lentigo maligna recurrent
14401,Poorly Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
14402,Poorly Differentiated Neuroendocrine Lesion,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
14403,Well Differentiated Neuroendocrine Lesion,Stage IIIC Hepatocellular Carcinoma AJCC v7
14404,Well Differentiated Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
14405,Well Differentiated Neuroendocrine Lesion,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
14406,Intermediate Grade Neuroendocrine Lesion,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
14407,Low Grade Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v7
14408,Intermediate Grade Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v7
14409,Low Grade Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v7
14410,Intermediate Grade Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v7
14411,Intermediate Grade Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v7
14412,Low Grade Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v7
14413,Well Differentiated Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v7
14414,Well Differentiated Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v7
14415,Intermediate Grade Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v7
14416,Intermediate Grade Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v6 and v7
14417,Benign Cellular Infiltrate,Stage IC Eyelid Carcinoma AJCC v7
14418,Benign Cellular Infiltrate,Stage IIIA Uveal Melanoma AJCC v7
14419,Benign Cellular Infiltrate,Leiomyosarcoma recurrent
14420,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage IV
14421,Benign Cellular Infiltrate,Diffuse Large B-Cell Lymphoma
14422,Benign Cellular Infiltrate,Diffuse large B-cell lymphoma refractory
14423,Benign Cellular Infiltrate,Ann Arbor Stage I Follicular Lymphoma
14424,Benign Cellular Infiltrate,Ann Arbor Stage III Follicular Lymphoma
14425,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage I
14426,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma refractory
14427,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage I
14428,Benign Cellular Infiltrate,Stage I Lung Cancer AJCC v7
14429,Benign Cellular Infiltrate,Stage II Lung Cancer AJCC v7
14430,Benign Cellular Infiltrate,Bladder adenocarcinoma stage II
14431,Benign Cellular Infiltrate,Bladder adenocarcinoma stage IV
14432,Benign Cellular Infiltrate,Bladder squamous cell carcinoma stage 0
14433,Benign Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7
14434,Benign Cellular Infiltrate,Centroblastic lymphoma stage II
14435,Benign Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7
14436,Benign Cellular Infiltrate,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
14437,Benign Cellular Infiltrate,Bladder transitional cell carcinoma stage II
14438,Benign Cellular Infiltrate,Parosteal Osteosarcoma
14439,Benign Cellular Infiltrate,"Endometrial stromal sarcoma, high grade"
14440,Benign Cellular Infiltrate,Endometrial Stromal Sarcoma
14441,Low Grade Neuroendocrine Lesion,Stage I Esophageal Cancer AJCC v7
14442,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophageal Cancer AJCC v7
14443,Low Grade Neuroendocrine Lesion,Stage IV Esophageal Cancer AJCC v7
14444,Intermediate Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage IV
14445,Intermediate Grade Neuroendocrine Lesion,Stage II Colon Cancer AJCC v7
14446,Low Grade Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v7
14447,Well Differentiated Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v7
14448,Well Differentiated Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v7
14449,Intermediate Grade Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v7
14450,Well Differentiated Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v7
14451,Low Grade Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v7
14452,Benign Cellular Infiltrate,Mixed Germ Cell Tumor
14453,Mitotic Activity,Mature Teratoma
14454,Intermediate Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v7
14455,Low Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v7
14456,Benign Cellular Infiltrate,High Grade Malignant Peripheral Nerve Sheath Tumor
14457,Benign Cellular Infiltrate,Occult Lung Non-Small Cell Carcinoma
14458,Low Grade Neuroendocrine Lesion,Recurrent Childhood Hepatocellular Carcinoma
14459,Intermediate Grade Neuroendocrine Lesion,Colon Cancer by AJCC v6 Stage
14460,Intermediate Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v6 Stage
14461,Benign Cellular Infiltrate,Penile Cancer by AJCC v6 Stage
14462,Benign Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v6 Stage
14463,Benign Cellular Infiltrate,Adult Burkitt Lymphoma
14464,Well Differentiated Neuroendocrine Lesion,Localized Resectable Adult Hepatocellular Carcinoma
14465,Intermediate Grade Neuroendocrine Lesion,Localized Unresectable Adult Hepatocellular Carcinoma
14466,Benign Cellular Infiltrate,recurrent childhood acute myeloid leukemia
14467,Benign Cellular Infiltrate,Thymoma malignant noninvasive
14468,Benign Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
14469,Benign Cellular Infiltrate,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
14470,Benign Cellular Infiltrate,Bladder Cancer by AJCC v7 Stage
14471,Benign Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
14472,Low Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v7 Stage
14473,Low Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v7 Stage
14474,Benign Cellular Infiltrate,Osteosarcoma
14475,Intermediate Grade Neuroendocrine Lesion,Gastric Intestinal-Type Adenocarcinoma
14476,Well Differentiated Neuroendocrine Lesion,adenocarcinoma of gallbladder with squamous metaplasia
14477,Benign Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
14478,Benign Cellular Infiltrate,Childhood Angiosarcoma
14479,Benign Cellular Infiltrate,Intraocular Lymphoma
14480,Benign Cellular Infiltrate,Stage II Childhood Burkitt Lymphoma
14481,Benign Cellular Infiltrate,Carcinosarcoma of ovary
14482,Benign Cellular Infiltrate,Stage III Cervical Cancer AJCC v6 and v7
14483,Well Differentiated Neuroendocrine Lesion,Stage IV Esophagus Carcinoma
14484,Malignant Cellular Infiltrate,Benign Intraocular Schwannoma
14485,Benign Cellular Infiltrate,Intraocular Malignant Peripheral Nerve Sheath Tumor
14486,Benign Cellular Infiltrate,Non-Hematologic Malignancy
14487,Well Differentiated Neuroendocrine Lesion,AIDS-related anal cancer recurrent
14488,Intermediate Grade Neuroendocrine Lesion,AIDS-related anal cancer recurrent
14489,Benign Cellular Infiltrate,Recurrent Non-Hodgkin Lymphoma
14490,Benign Cellular Infiltrate,Oral neoplasm malignant recurrent
14491,Well Differentiated Neuroendocrine Lesion,Recurrent Hepatocellular Carcinoma
14492,Intermediate Grade Neuroendocrine Lesion,Recurrent Hepatocellular Carcinoma
14493,Benign Cellular Infiltrate,Malignant neoplasm of bladder recurrent
14494,Benign Cellular Infiltrate,Acute leukemia
14495,Benign Cellular Infiltrate,Lip and Oral Cavity Carcinoma
14496,Benign Cellular Infiltrate,Malignant neoplasm of adrenal cortex
14497,Well Differentiated Neuroendocrine Lesion,Carcinoma of the Appendix
14498,Benign Cellular Infiltrate,Malignant neoplasm of tongue
14499,Intermediate Grade Neuroendocrine Lesion,Duodenal carcinoma recurrent
14500,Benign Cellular Infiltrate,Precursor cell lymphoblastic lymphoma
14501,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Maturation
14502,Benign Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma
14503,Benign Cellular Infiltrate,Conventional Leiomyosarcoma
14504,Low Grade Neuroendocrine Lesion,Grade 3 Colorectal Adenocarcinoma
14505,Low Grade Neuroendocrine Lesion,Grade 3 Rectal Adenocarcinoma
14506,Low Grade Neuroendocrine Lesion,Grade 1 Colon Adenocarcinoma
14507,Well Differentiated Neuroendocrine Lesion,Grade 2 Colon Adenocarcinoma
14508,Well Differentiated Neuroendocrine Lesion,Stage III Adult Liver Cancer AJCC v7
14509,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Adult Liver Cancer AJCC v7
14510,Benign Cellular Infiltrate,T-cell/histiocyte rich large B-cell lymphoma
14511,Benign Cellular Infiltrate,Melanomatosis
14512,Malignant Cellular Infiltrate,Juvenile papillomatosis of breast
14513,Benign Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v7
14514,Low Grade Neuroendocrine Lesion,Mixed Acinar-Ductal Carcinoma of the Pancreas
14515,Well Differentiated Neuroendocrine Lesion,Pancreatic Medullary Carcinoma
14516,Malignant Cellular Infiltrate,Pancreatic Macrocystic Serous Cystadenoma
14517,Malignant Cellular Infiltrate,Pancreatic Solid Serous Adenoma
14518,Well Differentiated Neuroendocrine Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
14519,Intermediate Grade Neuroendocrine Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
14520,Intermediate Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1
14521,Intermediate Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1
14522,Poorly Differentiated Neuroendocrine Lesion,insulinoma
14523,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Vipoma
14524,Well Differentiated Neuroendocrine Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma
14525,Intermediate Grade Neuroendocrine Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma
14526,Low Grade Neuroendocrine Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma
14527,Intermediate Grade Neuroendocrine Lesion,Esophageal Large Cell Neuroendocrine Carcinoma
14528,Low Grade Neuroendocrine Lesion,Esophageal Large Cell Neuroendocrine Carcinoma
14529,Well Differentiated Neuroendocrine Lesion,Poorly Cohesive Gastric Carcinoma
14530,Low Grade Neuroendocrine Lesion,Gastric Intramucosal Adenocarcinoma
14531,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma
14532,Low Grade Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma
14533,Low Grade Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma
14534,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
14535,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Invasive Papillary Adenocarcinoma
14536,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor
14537,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1
14538,Low Grade Neuroendocrine Lesion,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
14539,Low Grade Neuroendocrine Lesion,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
14540,Poorly Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor
14541,Low Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma
14542,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma
14543,Low Grade Neuroendocrine Lesion,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
14544,Poorly Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2
14545,Poorly Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2
14546,Well Differentiated Neuroendocrine Lesion,Colorectal Serrated Adenocarcinoma
14547,Intermediate Grade Neuroendocrine Lesion,Colorectal Serrated Adenocarcinoma
14548,Well Differentiated Neuroendocrine Lesion,Colon Cribriform Comedo-Type Adenocarcinoma
14549,Intermediate Grade Neuroendocrine Lesion,Colorectal Micropapillary Adenocarcinoma
14550,Low Grade Neuroendocrine Lesion,Crohn Disease-Associated Colorectal Adenocarcinoma
14551,Low Grade Neuroendocrine Lesion,Primary hepatic neuroendocrine carcinoma
14552,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of liver
14553,Malignant Cellular Infiltrate,Liver Lymphangioma
14554,Intermediate Grade Neuroendocrine Lesion,Gallbladder Cribriform Carcinoma
14555,Low Grade Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Biliary Type"
14556,Well Differentiated Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
14557,Poorly Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2
14558,Low Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2
14559,Intermediate Grade Neuroendocrine Lesion,Gallbladder Goblet Cell Carcinoid
14560,Low Grade Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
14561,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
14562,Low Grade Neuroendocrine Lesion,cystadenocarcinoma of intrahepatic bile duct
14563,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Carcinoma
14564,Malignant Cellular Infiltrate,Airway Hemangioma
14565,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with Neuroblastoma
14566,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
14567,Benign Cellular Infiltrate,Squamous cell carcinoma of pharynx
14568,Benign Cellular Infiltrate,ENSAT Stage III Adrenal Cortex Carcinoma
14569,Benign Cellular Infiltrate,Glioblastoma by Gene Expression Profile
14570,Benign Cellular Infiltrate,Childhood Central Nervous System Neuroblastoma
14571,Benign Cellular Infiltrate,Childhood Favorable Prognosis Hodgkin Lymphoma
14572,Benign Cellular Infiltrate,Childhood Central Nervous System Embryonal Neoplasm
14573,Benign Cellular Infiltrate,Malignant Cardiovascular Neoplasm
14574,Benign Cellular Infiltrate,Secondary Central Nervous System Hodgkin Lymphoma
14575,Benign Cellular Infiltrate,Childhood Anaplastic Oligoastrocytoma
14576,Well Differentiated Neuroendocrine Lesion,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
14577,Low Grade Neuroendocrine Lesion,Adult Pleomorphic Hepatocellular Carcinoma
14578,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
14579,Low Grade Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v7
14580,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v7
14581,Benign Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage I
14582,Low Grade Neuroendocrine Lesion,Stage IIIB Esophageal Cancer AJCC v7
14583,Low Grade Neuroendocrine Lesion,BCLC Stage A Adult Hepatocellular Carcinoma
14584,Intermediate Grade Neuroendocrine Lesion,BCLC Stage D Adult Hepatocellular Carcinoma
14585,Benign Cellular Infiltrate,Adult Myelodysplastic Syndrome
14586,Benign Cellular Infiltrate,Childhood Cerebellar Anaplastic Astrocytoma
14587,Benign Cellular Infiltrate,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
14588,Benign Cellular Infiltrate,Recurrent Childhood Anaplastic Astrocytoma
14589,Benign Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma
14590,Benign Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
14591,Low Grade Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
14592,Benign Cellular Infiltrate,Recurrent Combined Thymic Epithelial Neoplasm
14593,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma
14594,Benign Cellular Infiltrate,small cell carcinoma of kidney
14595,Benign Cellular Infiltrate,Childhood Breast Carcinoma
14596,Well Differentiated Neuroendocrine Lesion,Childhood Gastric Carcinoma
14597,Low Grade Neuroendocrine Lesion,Childhood Gastric Carcinoma
14598,Benign Cellular Infiltrate,Familial Colorectal Cancer Type X
14599,Malignant Cellular Infiltrate,Mammary-Type Myofibroblastoma
14600,Benign Cellular Infiltrate,"Ossifying fibromyxoid tumor, malignant"
14601,Benign Cellular Infiltrate,"Perivascular epithelioid tumor, malignant"
14602,Benign Cellular Infiltrate,Refractory Childhood Acute Lymphoblastic Leukemia
14603,Benign Cellular Infiltrate,Lepidic Predominant Adenocarcinoma
14604,Benign Cellular Infiltrate,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
14605,Benign Cellular Infiltrate,Fusion-Negative Rhabdomyosarcoma
14606,Malignant Cellular Infiltrate,Childhood Testicular Mature Teratoma
14607,Geographic Necrosis,Childhood Testicular Mature Teratoma
14608,Benign Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Nodular"
14609,Malignant Cellular Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
14610,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma
14611,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
14612,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
14613,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
14614,Benign Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor
14615,Benign Cellular Infiltrate,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
14616,Benign Cellular Infiltrate,Fallopian Tube Lymphoma
14617,Benign Cellular Infiltrate,Endometrial Dedifferentiated Carcinoma
14618,Benign Cellular Infiltrate,Endometrial Large Cell Neuroendocrine Carcinoma
14619,Benign Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Gastric Type"
14620,Benign Cellular Infiltrate,Cervical Angiosarcoma
14621,Benign Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm
14622,Benign Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer
14623,Benign Cellular Infiltrate,FIGO Stage IIIA2 Ovarian Cancer
14624,Benign Cellular Infiltrate,FIGO Stage IIIC Ovarian Cancer
14625,Benign Cellular Infiltrate,Vulvar Small Cell Carcinoma
14626,Benign Cellular Infiltrate,Lung Micropapillary Adenocarcinoma
14627,Benign Cellular Infiltrate,Glioblastoma
14628,Benign Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Mutant"
14629,Benign Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
14630,Benign Cellular Infiltrate,Central Nervous System Mesenchymal Chondrosarcoma
14631,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A
14632,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4
14633,Benign Cellular Infiltrate,Unresectable Liposarcoma
14634,Benign Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma
14635,Benign Cellular Infiltrate,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
14636,Benign Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v8
14637,Benign Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v8
14638,Benign Cellular Infiltrate,Recurrent Malignant Germ Cell Tumor
14639,Benign Cellular Infiltrate,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
14640,Benign Cellular Infiltrate,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
14641,Benign Cellular Infiltrate,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
14642,Benign Cellular Infiltrate,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
14643,Benign Cellular Infiltrate,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
14644,Benign Cellular Infiltrate,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
14645,Benign Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
14646,Benign Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v8 Stage
14647,Benign Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v8
14648,Benign Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8
14649,Benign Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8
14650,Well Differentiated Neuroendocrine Lesion,AIDS-Related Anal Canal Carcinoma
14651,Low Grade Neuroendocrine Lesion,AIDS-Related Anal Canal Carcinoma
14652,Benign Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8
14653,Benign Cellular Infiltrate,Mucosal Melanoma of the Head and Neck
14654,Benign Cellular Infiltrate,Squamous non-small cell lung cancer
14655,Well Differentiated Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
14656,Low Grade Neuroendocrine Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
14657,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
14658,Intermediate Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v7 Stage
14659,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
14660,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
14661,Low Grade Neuroendocrine Lesion,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
14662,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
14663,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
14664,Low Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
14665,Low Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
14666,Low Grade Neuroendocrine Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
14667,Low Grade Neuroendocrine Lesion,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
14668,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
14669,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
14670,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
14671,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
14672,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
14673,Benign Cellular Infiltrate,Lung Carcinoma Metastatic in the Central Nervous System
14674,Low Grade Neuroendocrine Lesion,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
14675,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
14676,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
14677,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
14678,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
14679,Low Grade Neuroendocrine Lesion,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
14680,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
14681,Well Differentiated Neuroendocrine Lesion,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
14682,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
14683,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
14684,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
14685,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
14686,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Stage
14687,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
14688,Well Differentiated Neuroendocrine Lesion,Clinical Stage IV Gastric Cancer AJCC v8
14689,Low Grade Neuroendocrine Lesion,Clinical Stage IVB Gastric Cancer AJCC v8
14690,Well Differentiated Neuroendocrine Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8
14691,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIC Gastric Cancer AJCC v8
14692,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
14693,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
14694,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIA Gastric Cancer AJCC v8
14695,Well Differentiated Neuroendocrine Lesion,Small Intestinal Cancer by AJCC v7 Stage
14696,Well Differentiated Neuroendocrine Lesion,Appendix Carcinoma by AJCC v7 Stage
14697,Benign Cellular Infiltrate,Refractory Classic Hodgkin Lymphoma
14698,Benign Cellular Infiltrate,Refractory Malignant Solid Neoplasm
14699,Intermediate Grade Neuroendocrine Lesion,Anal Cancer by AJCC v8 Stage
14700,Well Differentiated Neuroendocrine Lesion,Stage II Anal Cancer AJCC v8
14701,Low Grade Neuroendocrine Lesion,Stage IIA Anal Cancer AJCC v8
14702,Low Grade Neuroendocrine Lesion,Stage IIIA Anal Cancer AJCC v8
14703,Well Differentiated Neuroendocrine Lesion,Small Intestinal Adenocarcinoma by AJCC v8 Stage
14704,Well Differentiated Neuroendocrine Lesion,Stage III Small Intestinal Adenocarcinoma AJCC v8
14705,Intermediate Grade Neuroendocrine Lesion,Appendix Carcinoma by AJCC v8 Stage
14706,Low Grade Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v8
14707,Well Differentiated Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v8
14708,Low Grade Neuroendocrine Lesion,Stage III Appendix Carcinoma AJCC v8
14709,Low Grade Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v8
14710,Low Grade Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v8
14711,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v8
14712,Intermediate Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v8 Stage
14713,Intermediate Grade Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v8
14714,Well Differentiated Neuroendocrine Lesion,Stage III Colon Cancer AJCC v8
14715,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v8
14716,Low Grade Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v8
14717,Well Differentiated Neuroendocrine Lesion,Stage IV Colon Cancer AJCC v8
14718,Intermediate Grade Neuroendocrine Lesion,Stage IV Colon Cancer AJCC v8
14719,Intermediate Grade Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v8
14720,Low Grade Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v8
14721,Low Grade Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v8
14722,Low Grade Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v8
14723,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v8
14724,Low Grade Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v8
14725,Low Grade Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v8
14726,Intermediate Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
14727,Well Differentiated Neuroendocrine Lesion,Stage IB Hepatocellular Carcinoma AJCC v8
14728,Well Differentiated Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v8
14729,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8
14730,Well Differentiated Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v8
14731,Intermediate Grade Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v8
14732,Well Differentiated Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8
14733,Well Differentiated Neuroendocrine Lesion,Stage III Intrahepatic Bile Duct Cancer AJCC v8
14734,Low Grade Neuroendocrine Lesion,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
14735,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
14736,Intermediate Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v8
14737,Well Differentiated Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v8
14738,Low Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v8
14739,Intermediate Grade Neuroendocrine Lesion,Stage IVB Gallbladder Cancer AJCC v8
14740,Well Differentiated Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v7 Stage
14741,Intermediate Grade Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v8
14742,Well Differentiated Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
14743,Intermediate Grade Neuroendocrine Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8
14744,Well Differentiated Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
14745,Intermediate Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
14746,Intermediate Grade Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
14747,Intermediate Grade Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v8 Stage
14748,Low Grade Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v8
14749,Low Grade Neuroendocrine Lesion,Stage I Distal Bile Duct Cancer AJCC v8
14750,Well Differentiated Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v8
14751,Well Differentiated Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v8
14752,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v8 Stage
14753,Low Grade Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v8 Stage
14754,Intermediate Grade Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v8
14755,Low Grade Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v8
14756,Intermediate Grade Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v8
14757,Low Grade Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v8
14758,Low Grade Neuroendocrine Lesion,Pancreatic Cancer by AJCC v6 and v7 Stage
14759,Low Grade Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v8
14760,Well Differentiated Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v8
14761,Low Grade Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v8
14762,Intermediate Grade Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v8
14763,Benign Cellular Infiltrate,Non-squamous non-small cell lung cancer
14764,Poorly Differentiated Neuroendocrine Lesion,Stage II Duodenal Neuroendocrine Tumor AJCC v8
14765,Poorly Differentiated Neuroendocrine Lesion,Stage III Duodenal Neuroendocrine Tumor AJCC v8
14766,Poorly Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor
14767,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
14768,Poorly Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v7 Stage
14769,Poorly Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v8
14770,Poorly Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v8
14771,Poorly Differentiated Neuroendocrine Lesion,Stage I Colorectal Neuroendocrine Tumor AJCC v8
14772,Poorly Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8
14773,Poorly Differentiated Neuroendocrine Lesion,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
14774,Intermediate Grade Neuroendocrine Lesion,Rectal Carcinoma Metastatic in the Liver
14775,Benign Cellular Infiltrate,Stage III Pleural Malignant Mesothelioma AJCC v8
14776,Benign Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v8
14777,Benign Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v8
14778,Benign Cellular Infiltrate,Stage IIA Lung Cancer AJCC v8
14779,Benign Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v8
14780,Benign Cellular Infiltrate,Stage IVB Lung Cancer AJCC v8
14781,Benign Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage
14782,Benign Cellular Infiltrate,Recurrent Cervical Adenosquamous Carcinoma
14783,Benign Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v8 Stage
14784,Benign Cellular Infiltrate,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
14785,Benign Cellular Infiltrate,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
14786,Benign Cellular Infiltrate,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
14787,Benign Cellular Infiltrate,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
14788,Benign Cellular Infiltrate,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
14789,Benign Cellular Infiltrate,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
14790,Benign Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8
14791,Benign Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8
14792,Benign Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
14793,Benign Cellular Infiltrate,Clinical Stage II Merkel Cell Carcinoma AJCC v8
14794,Benign Cellular Infiltrate,Clinical Stage IV Cutaneous Melanoma AJCC v8
14795,Intermediate Grade Neuroendocrine Lesion,Refractory Anal Carcinoma
14796,Benign Cellular Infiltrate,Recurrent Intravascular Large B-Cell Lymphoma
14797,Benign Cellular Infiltrate,Refractory Intravascular Large B-Cell Lymphoma
14798,Benign Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
14799,Benign Cellular Infiltrate,Prostate Carcinoma by Gene Expression Profile
14800,Benign Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
14801,Benign Cellular Infiltrate,Plasma Cell Myeloma by ISS Stage
14802,Benign Cellular Infiltrate,Breast implant-associated anaplastic large cell lymphoma
14803,Benign Cellular Infiltrate,Anatomic Stage III Breast Cancer AJCC v8
14804,Benign Cellular Infiltrate,Stage I Vulvar Cancer AJCC v8
14805,Benign Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v8
14806,Benign Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v8
14807,Benign Cellular Infiltrate,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
14808,Benign Cellular Infiltrate,Stage IA Cervical Cancer AJCC v8
14809,Benign Cellular Infiltrate,Stage IB2 Cervical Cancer AJCC v8
14810,Benign Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v8
14811,Benign Cellular Infiltrate,Uterine Corpus Cancer by AJCC v8 Stage
14812,Benign Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v8
14813,Benign Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8
14814,Benign Cellular Infiltrate,Stage I Uterine Corpus Leiomyosarcoma AJCC v8
14815,Benign Cellular Infiltrate,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8
14816,Benign Cellular Infiltrate,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
14817,Benign Cellular Infiltrate,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
14818,Benign Cellular Infiltrate,Fallopian Tube Cancer by AJCC v8 Stage
14819,Benign Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v8
14820,Benign Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8
14821,Benign Cellular Infiltrate,Stage IV Fallopian Tube Cancer AJCC v8
14822,Benign Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage
14823,Benign Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v8
14824,Benign Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v8
14825,Benign Cellular Infiltrate,Stage IVA Primary Peritoneal Cancer AJCC v8
14826,Benign Cellular Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8
14827,Benign Cellular Infiltrate,Stage 0is Penile Cancer AJCC v8
14828,Benign Cellular Infiltrate,Stage IIA Penile Cancer AJCC v8
14829,Benign Cellular Infiltrate,Stage IIB Penile Cancer AJCC v8
14830,Benign Cellular Infiltrate,Stage II Prostate Cancer AJCC v8
14831,Benign Cellular Infiltrate,Stage IA Testicular Cancer AJCC v8
14832,Benign Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v8
14833,Benign Cellular Infiltrate,Stage 0is Bladder Cancer AJCC v8
14834,Benign Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8
14835,Benign Cellular Infiltrate,Urethral Cancer by AJCC v7 Stage
14836,Benign Cellular Infiltrate,Eyelid Carcinoma by AJCC v7 Stage
14837,Benign Cellular Infiltrate,Stage III Eyelid Carcinoma AJCC v8
14838,Benign Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v8
14839,Benign Cellular Infiltrate,Choroidal and Ciliary Body Melanoma by AJCC v8 Stage
14840,Benign Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
14841,Benign Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
14842,Benign Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
14843,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
14844,Benign Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
14845,Benign Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
14846,Benign Cellular Infiltrate,Lugano Classification Stage III Adult Lymphoma AJCC v8
14847,Benign Cellular Infiltrate,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage
14848,Benign Cellular Infiltrate,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8
14849,Benign Cellular Infiltrate,Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage
14850,Benign Cellular Infiltrate,Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
14851,Benign Cellular Infiltrate,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8
14852,Benign Cellular Infiltrate,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8
14853,Benign Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8
14854,Benign Cellular Infiltrate,St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8
14855,Benign Cellular Infiltrate,Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage
14856,Benign Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage
14857,Benign Cellular Infiltrate,Marginal Zone Lymphoma by Ann Arbor Stage
14858,Benign Cellular Infiltrate,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage
14859,Benign Cellular Infiltrate,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
14860,Benign Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8
14861,Benign Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8
14862,Benign Cellular Infiltrate,Refractory Osteosarcoma
14863,Well Differentiated Neuroendocrine Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
14864,Intermediate Grade Neuroendocrine Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
14865,Benign Cellular Infiltrate,Refractory Alveolar Rhabdomyosarcoma
14866,Benign Cellular Infiltrate,Refractory Thyroid Gland Carcinoma
14867,Benign Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor
14868,Benign Cellular Infiltrate,Locally Advanced Epithelioid Hemangioendothelioma
14869,Benign Cellular Infiltrate,Refractory Breast Carcinoma
14870,Benign Cellular Infiltrate,Childhood Refractory Malignant Solid Neoplasm
14871,Benign Cellular Infiltrate,Metastatic thymic carcinoma
14872,Benign Cellular Infiltrate,Squamous cell carcinoma of head and neck metastatic
14873,Benign Cellular Infiltrate,Myxoid liposarcoma metastatic
14874,Benign Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma
14875,Benign Cellular Infiltrate,Refractory Oral Cavity Squamous Cell Carcinoma
14876,Benign Cellular Infiltrate,Recurrent Paranasal Sinus Squamous Cell Carcinoma
14877,Benign Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes"
14878,Benign Cellular Infiltrate,Recurrent Mixed Phenotype Acute Leukemia
14879,Well Differentiated Neuroendocrine Lesion,Unresectable Intrahepatic Cholangiocarcinoma
14880,Benign Cellular Infiltrate,Unresectable Melanoma
14881,Well Differentiated Neuroendocrine Lesion,Thoracic Esophagus Adenocarcinoma
14882,Well Differentiated Neuroendocrine Lesion,Distal Esophagus Squamous Cell Carcinoma
14883,Benign Cellular Infiltrate,Refractory Ovarian Carcinoma
14884,Benign Cellular Infiltrate,Recurrent Endometrial Cancer
14885,Benign Cellular Infiltrate,Recurrent Malignant Male Reproductive System Neoplasm
14886,Benign Cellular Infiltrate,Refractory Malignant Male Reproductive System Neoplasm
14887,Benign Cellular Infiltrate,Refractory Malignant Thyroid Gland Neoplasm
14888,Benign Cellular Infiltrate,Locally Advanced Gastrointestinal Stromal Tumor
14889,Benign Cellular Infiltrate,Familial Acute Myeloid Leukemia with Mutated Cebpa
14890,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation
14891,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline GATA2 Mutation
14892,Low Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
14893,Benign Cellular Infiltrate,Unresectable Bone Sarcoma
14894,Benign Cellular Infiltrate,Locally Advanced Skin Squamous Cell Carcinoma
14895,Benign Cellular Infiltrate,Locally Advanced Head and Neck Carcinoma
14896,Low Grade Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Lung
14897,Benign Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm
14898,Well Differentiated Neuroendocrine Lesion,Advanced Unresectable Gastric Adenocarcinoma
14899,Low Grade Neuroendocrine Lesion,Metastatic gastric adenocarcinoma
14900,Benign Cellular Infiltrate,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
14901,Benign Cellular Infiltrate,Metastatic Triple-Negative Breast Carcinoma
14902,Intermediate Grade Neuroendocrine Lesion,Refractory Liver Carcinoma
14903,Benign Cellular Infiltrate,Recurrent Acinic Cell Breast Carcinoma
14904,Benign Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma
14905,Low Grade Neuroendocrine Lesion,Recurrent Ampulla of Vater Adenocarcinoma
14906,Intermediate Grade Neuroendocrine Lesion,Recurrent Paget Disease of the Anal Canal
14907,Low Grade Neuroendocrine Lesion,Recurrent Paget Disease of the Anal Canal
14908,Benign Cellular Infiltrate,Recurrent Paget Disease of the Breast
14909,Benign Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma
14910,Well Differentiated Neuroendocrine Lesion,Recurrent Appendix Carcinoma
14911,Benign Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma
14912,Benign Cellular Infiltrate,Recurrent Malignant Ovarian Transitional Cell Tumor
14913,Low Grade Neuroendocrine Lesion,Recurrent Fibrolamellar Carcinoma
14914,Intermediate Grade Neuroendocrine Lesion,Unresectable Gastric Adenocarcinoma
14915,Benign Cellular Infiltrate,MGMT-Methylated Glioblastoma
14916,Benign Cellular Infiltrate,Melanoma of Unknown Primary
14917,Metastatic Lesion,Pituitary Gland Double Adenomas
14918,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma gastric recurrent
14919,Mixed Neoplastic Glandular and Squamous Cell Population,Adenocarcinoma gastric recurrent
14920,Favorable Clinical Outcome,Advanced Cutaneous Melanoma of the Extremity
14921,Benign Cellular Infiltrate,Sarcoma of the Extremity
14922,Well Differentiated Neuroendocrine Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
14923,Low Grade Neuroendocrine Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
14924,Extensive Stage Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
14925,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Unresectable Pancreatic Adenocarcinoma
14926,Precise Histogenesis Unknown,Sellar Ependymoma
14927,Benign Cellular Infiltrate,malignant neoplasm of skull
14928,Indolent Clinical Course,Pituitary Gland Non-Hodgkin Lymphoma
14929,Metastatic Lesion,Pituitary Gland Non-Hodgkin Lymphoma
14930,Benign Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma
14931,Malignant Germinomatous Cellular Infiltrate,Sellar Teratoma
14932,Seminomatous Component Present,Sellar Mature Teratoma
14933,Low Grade Neuroendocrine Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
14934,Premalignant Lesion,Unresectable Lung Non-Small Cell Carcinoma
14935,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Lung Adenocarcinoma
14936,Benign Cellular Infiltrate,Smoldering Waldenstrom Macroglobulinemia
14937,Well Differentiated Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
14938,Low Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma
14939,Intermediate Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
14940,Malignant Cellular Infiltrate,Thyroid Gland Spindle Cell Follicular Adenoma
14941,Nuclear Pseudoinclusion,Thyroid Gland Spindle Cell Follicular Adenoma
14942,Tumor Vascular Invasion,Thyroid Gland Black Follicular Adenoma
14943,Nuclear Pseudoinclusion,Thyroid Gland Black Follicular Adenoma
14944,Precise Histogenesis Unknown,Recurrent Visual Pathway Glioma
14945,Benign Cellular Infiltrate,Encapsulated Variant Thyroid Gland Papillary Carcinoma
14946,Anaplasia,Supratentorial Pleomorphic Xanthoastrocytoma
14947,Precise Histogenesis Unknown,Supratentorial Pleomorphic Xanthoastrocytoma
14948,Intermediate Grade Neuroendocrine Lesion,stage IV pancreatic cancer
14949,Benign Cellular Infiltrate,Metastatic Oropharyngeal Carcinoma
14950,Benign Cellular Infiltrate,Metastatic Oral Cavity Mucoepidermoid Carcinoma
14951,Benign Cellular Infiltrate,Lung squamous cell carcinoma stage IV
14952,Well Differentiated Neuroendocrine Lesion,Metastatic Colorectal Carcinoma
14953,Low Grade Neuroendocrine Lesion,Metastatic Colon Carcinoma
14954,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Thyroid Gland Follicular Carcinoma
14955,Favorable Clinical Outcome,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
14956,Nuclear Pseudoinclusion,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
14957,Mixed Neoplastic Glandular and Squamous Cell Population,Localized Gastroesophageal Junction Adenocarcinoma
14958,Well Differentiated Neuroendocrine Lesion,Localized Gastric Carcinoma
14959,Benign Cellular Infiltrate,Recurrent Aggressive Non-Hodgkin Lymphoma
14960,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Pancreatic Adenocarcinoma
14961,Indolent Clinical Course,Tongue Alveolar Soft Part Sarcoma'
14962,Benign Cellular Infiltrate,Tongue Alveolar Soft Part Sarcoma'
14963,Malignant Cellular Infiltrate,Cellular neurothekeoma
14964,Intermediate Filaments Present,Colon Liposarcoma
14965,Favorable Clinical Outcome,Scrotal Sarcoma
14966,Benign Cellular Infiltrate,Advanced Prostate Carcinoma
14967,Extensive Stage Lesion,Locally Advanced Prostate Carcinoma
14968,Benign Cellular Infiltrate,Locally Advanced Unresectable Cervical Carcinoma
14969,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Cervical Adenocarcinoma
14970,Indolent Clinical Course,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
14971,Malignant Cellular Infiltrate,Thyroid Gland Cavernous Hemangioma
14972,Malignant Cellular Infiltrate,Thyroid Gland Lymphangioma
14973,CD35-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
14974,Geographic Necrosis,Grade 1 Teratoma
14975,Seminomatous Component Present,Grade 1 Teratoma
14976,Indolent Clinical Course,"Kaposi's sarcoma, metastatic"
14977,Malignant Cellular Infiltrate,Benign Genitourinary System Neoplasm
14978,Benign Cellular Infiltrate,Advanced Carcinoid Tumor
14979,Well Differentiated Neuroendocrine Lesion,Advanced Gastric Neuroendocrine Carcinoma
14980,Intermediate Grade Neuroendocrine Lesion,Advanced Gastric Neuroendocrine Carcinoma
14981,Local disease,Advanced Gastric Neuroendocrine Carcinoma
14982,Well Differentiated Neuroendocrine Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
14983,Local disease,Advanced Gastric Small Cell Neuroendocrine Carcinoma
14984,Benign Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma
14985,Local disease,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
14986,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
14987,Solid Growth Pattern,Recurrent Acute Myelomonocytic Leukemia
14988,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
14989,Chronic Clinical Course,Recurrent Acute Erythroid Leukemia
14990,Extensive Stage Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
14991,Well Differentiated Neuroendocrine Lesion,Advanced Digestive System Carcinoma
14992,Low Grade Neuroendocrine Lesion,Advanced Digestive System Carcinoma
14993,Local disease,Advanced Digestive System Carcinoma
14994,Benign Cellular Infiltrate,Basal cell carcinoma
14995,Intermediate Grade Neuroendocrine Lesion,Recurrent Biliary Tract Carcinoma
14996,Fibrotic Stroma Formation,Resectable Pancreatic Acinar Cell Carcinoma
14997,Favorable Clinical Outcome,Resectable Intrahepatic Cholangiocarcinoma
14998,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Extrahepatic Bile Duct Adenocarcinoma
14999,Malignant Cellular Infiltrate,Adrenal Gland Schwannoma
15000,Benign Cellular Infiltrate,Refractory Hormone Receptor Positive Breast Carcinoma
15001,Benign Cellular Infiltrate,Testicular cancer metastatic
15002,Benign Cellular Infiltrate,Uterine Corpus Choriocarcinoma
15003,Low Grade Neuroendocrine Lesion,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
15004,Malignant Cellular Infiltrate,endometrioid adenofibroma of ovary
15005,Benign Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma
15006,Well Differentiated Neuroendocrine Lesion,Cholangiocarcinoma recurrent
15007,Intermediate Grade Neuroendocrine Lesion,Cholangiocarcinoma resectable
15008,Low Grade Neuroendocrine Lesion,Cholangiocarcinoma resectable
15009,Benign Cellular Infiltrate,Childhood Myxoid Chondrosarcoma
15010,Benign Cellular Infiltrate,Pleural Carcinomatosis
15011,Low Grade Neuroendocrine Lesion,"Hepatocellular carcinoma, scirrhous"
15012,Malignant Cellular Infiltrate,Adult Central Nervous System Mature Teratoma
15013,Benign Cellular Infiltrate,Childhood Central Nervous System Germinoma
15014,Well Differentiated Neuroendocrine Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma
15015,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Intestinal-Type Adenocarcinoma
15016,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Intestinal-Type Adenocarcinoma
15017,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Squamous Cell Carcinoma
15018,Poorly Differentiated Neuroendocrine Lesion,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15019,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
15020,Benign Cellular Infiltrate,Disseminated carcinoma
15021,Malignant Cellular Infiltrate,Glomangiomatosis
15022,Benign Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma
15023,Diffuse Lesion,Glomeruloid hemangioma
15024,Malignant Cellular Infiltrate,Apocrine adenoma
15025,Benign Cellular Infiltrate,Malignant vascular tumor of skin
15026,Benign Cellular Infiltrate,Digital papillary eccrine carcinoma of skin
15027,Malignant Cellular Infiltrate,Multiple Lobular Capillary Hemangiomas
15028,Well Differentiated Neuroendocrine Lesion,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
15029,Benign Cellular Infiltrate,Virus-Related Lymphoma
15030,Poorly Differentiated Neuroendocrine Lesion,Well Differentiated Pancreatic Endocrine Tumor
15031,Benign Cellular Infiltrate,Alkylating Agent-Related Acute Myeloid Leukemia
15032,Low Grade Neuroendocrine Lesion,Opisthorchis Viverrini-Related Cholangiocarcinoma
15033,Benign Cellular Infiltrate,Solar Radiation-Related Malignant Neoplasm
15034,Benign Cellular Infiltrate,Invasive Breast Carcinoma by Histologic Grade
15035,Benign Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
15036,Benign Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma
15037,Benign Cellular Infiltrate,Classic Variant of Chromophobe Renal Cell Carcinoma
15038,Benign Cellular Infiltrate,Recurrent Peripheral Primitive Neuroectodermal Tumor
15039,Benign Cellular Infiltrate,Moderately Differentiated Prostate Adenocarcinoma
15040,Benign Cellular Infiltrate,Alcohol-Related Carcinoma
15041,Low Grade Neuroendocrine Lesion,Alcohol-Related Esophageal Squamous Cell Carcinoma
15042,Malignant Cellular Infiltrate,Adenolymphoma
15043,Benign Cellular Infiltrate,"Carcinoma, Basal Cell"
15044,Benign Cellular Infiltrate,"Carcinoma, Basosquamous"
15045,Benign Cellular Infiltrate,"Carcinoma, Papillary"
15046,Benign Cellular Infiltrate,"Adenocarcinoma, Scirrhous"
15047,Intermediate Grade Neuroendocrine Lesion,Colorectal Carcinoma
15048,Benign Cellular Infiltrate,Dysgerminoma
15049,Malignant Cellular Infiltrate,Fibroid Tumor
15050,Benign Cellular Infiltrate,leukemia
15051,Benign Cellular Infiltrate,"Leukemia, Myeloid, Accelerated Phase"
15052,Benign Cellular Infiltrate,"Leukemia, Plasma Cell"
15053,Benign Cellular Infiltrate,lymphangiosarcoma
15054,Benign Cellular Infiltrate,Malignant neoplasm of retina
15055,Benign Cellular Infiltrate,melanoma
15056,Benign Cellular Infiltrate,Multiple Myeloma
15057,Benign Cellular Infiltrate,Neuroblastoma
15058,Malignant Cellular Infiltrate,neurofibroma
15059,Malignant Cellular Infiltrate,Osteoblastoma
15060,Poorly Differentiated Neuroendocrine Lesion,Somatostatinoma
15061,Malignant Cellular Infiltrate,Juvenile Xanthogranuloma
15062,Benign Cellular Infiltrate,"Lymphoma, AIDS-Related"
15063,Malignant Cellular Infiltrate,Pyogenic granuloma
15064,Benign Cellular Infiltrate,Lip Carcinoma
15065,Benign Cellular Infiltrate,Squamous cell carcinoma of lung
15066,Intermediate Grade Neuroendocrine Lesion,Esophageal carcinoma
15067,Benign Cellular Infiltrate,Malignant neoplasm of mandible
15068,Benign Cellular Infiltrate,Nodular Sclerosis Classical Hodgkin Lymphoma
15069,Benign Cellular Infiltrate,Malignant neoplasm of submandibular gland
15070,Benign Cellular Infiltrate,Malignant tumor of pyriform fossa
15071,Benign Cellular Infiltrate,Throat cancer
15072,Benign Cellular Infiltrate,Malignant tumor of lacrimal gland
15073,Benign Cellular Infiltrate,Follicular mycosis fungoides
15074,Benign Cellular Infiltrate,Malignant neoplasm of brain stem
15075,Benign Cellular Infiltrate,Testicular Teratoma with Somatic-Type Malignancy
15076,Benign Cellular Infiltrate,Malignant neoplasm of pineal gland
15077,Malignant Cellular Infiltrate,Benign neoplasm of axilla
15078,Benign Cellular Infiltrate,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
15079,Benign Cellular Infiltrate,Malignant neoplasm of thorax
15080,Malignant Cellular Infiltrate,Histiocytoma
15081,Benign Cellular Infiltrate,Grade 2 Clear Cell Renal Cell Carcinoma
15082,Malignant Cellular Infiltrate,Benign neoplasm of larynx
15083,Benign Cellular Infiltrate,Grade 3a Malignant Neoplasm
15084,Benign Cellular Infiltrate,Undifferentiated Malignant Neoplasm
15085,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q23;q21)
15086,Low Grade Neuroendocrine Lesion,Klatskin Tumor
15087,Benign Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
15088,Benign Cellular Infiltrate,Invasive papillary breast carcinoma
15089,Malignant Cellular Infiltrate,Atypical Breast Papilloma
15090,Benign Cellular Infiltrate,Hereditary Female Breast Carcinoma
15091,Benign Cellular Infiltrate,Hereditary clear cell renal cell carcinoma
15092,Benign Cellular Infiltrate,Acute Adult T-Cell Leukemia/Lymphoma
15093,Benign Cellular Infiltrate,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma
15094,Benign Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation
15095,Benign Cellular Infiltrate,Lung Carcinoma Metastatic in the Bone
15096,Benign Cellular Infiltrate,Prostate Carcinoma Metastatic in the Lung
15097,Benign Cellular Infiltrate,"Leiomyosarcoma, Epithelioid"
15098,Low Grade Neuroendocrine Lesion,Colloid Carcinoma of the Pancreas
15099,Low Grade Neuroendocrine Lesion,Pancreatic Foamy Gland Adenocarcinoma
15100,Benign Cellular Infiltrate,Desmoplastic melanoma
15101,Malignant Cellular Infiltrate,Angiomyoma
15102,Malignant Cellular Infiltrate,Syringoma
15103,Benign Cellular Infiltrate,"Adenocarcinoma, Clear Cell"
15104,Benign Cellular Infiltrate,"Carcinoma, Skin Appendage"
15105,Benign Cellular Infiltrate,"Cystadenocarcinoma, Mucinous"
15106,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
15107,Benign Cellular Infiltrate,Epithelioid hemangioendothelioma
15108,Benign Cellular Infiltrate,Metachronous Osteosarcoma
15109,Intermediate Grade Neuroendocrine Lesion,Gallbladder Carcinoma
15110,Malignant Cellular Infiltrate,Dermoid cyst of ovary
15111,Benign Cellular Infiltrate,Lymphangitis carcinomatosa
15112,Benign Cellular Infiltrate,Papillary Meningioma
15113,Well Differentiated Neuroendocrine Lesion,Carcinoma of ampulla of Vater
15114,Benign Cellular Infiltrate,Ann Arbor Stage IIA Hodgkin Lymphoma
15115,Benign Cellular Infiltrate,Ann Arbor Stage IIB Hodgkin Lymphoma
15116,Malignant Cellular Infiltrate,Angioma serpiginosum
15117,Benign Cellular Infiltrate,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma
15118,Benign Cellular Infiltrate,Pleomorphic Variant Mantle Cell Lymphoma
15119,Benign Cellular Infiltrate,Bladder Enteric Type Adenocarcinoma
15120,Benign Cellular Infiltrate,Bladder Urachal Adenocarcinoma
15121,Benign Cellular Infiltrate,Bladder Papillary Clear Cell Adenocarcinoma
15122,Benign Cellular Infiltrate,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
15123,Malignant Cellular Infiltrate,Bladder Urothelial Papilloma
15124,Benign Cellular Infiltrate,Penile Urethral Malignant Neoplasm
15125,Benign Cellular Infiltrate,Bulbomembranous Urethral Malignant Neoplasm
15126,Benign Cellular Infiltrate,Spermatocytic seminoma
15127,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
15128,Benign Cellular Infiltrate,polyembryoma of ovary
15129,Borderline Lesion,Ovarian Fetiform Teratoma
15130,Benign Cellular Infiltrate,Adenocarcinoma of rete ovarii
15131,Benign Cellular Infiltrate,Ovarian Lymphoma
15132,Malignant Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma
15133,Benign Cellular Infiltrate,Malignant Ovarian Clear Cell Tumor
15134,Malignant Cellular Infiltrate,Fallopian tube leiomyoma
15135,Benign Cellular Infiltrate,leiomyosarcoma of fallopian tube
15136,Benign Cellular Infiltrate,Endometrial Small Cell Carcinoma
15137,Benign Cellular Infiltrate,Uterine Corpus Endometrial Stromal Sarcoma
15138,Malignant Cellular Infiltrate,Cervical Adenomyoma
15139,Malignant Cellular Infiltrate,"Cervical Adenomyoma, Endometrial Type"
15140,Malignant Cellular Infiltrate,Cervical Blue Nevus
15141,Benign Cellular Infiltrate,Mucinous cystadenocarcinoma of ovary
15142,Benign Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
15143,Benign Cellular Infiltrate,Vaginal Carcinosarcoma
15144,Benign Cellular Infiltrate,keratinizing squamous cell carcinoma of vulva
15145,Malignant Cellular Infiltrate,Bartholin Gland Adenoma
15146,Benign Cellular Infiltrate,Malignant melanoma of vulva
15147,Benign Cellular Infiltrate,Conventional (Clear Cell) Renal Cell Carcinoma
15148,Malignant Cellular Infiltrate,Vulvar Acquired Melanocytic Nevus
15149,Benign Cellular Infiltrate,Breast Carcinoma with Osteoclastic Giant Cells
15150,Benign Cellular Infiltrate,Low Grade Adenosquamous Breast Carcinoma
15151,Malignant Cellular Infiltrate,Breast Angiomatosis
15152,Benign Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type"
15153,Benign Cellular Infiltrate,Gestational Ovarian Choriocarcinoma
15154,Benign Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant"
15155,Malignant Cellular Infiltrate,Schneiderian papilloma
15156,Benign Cellular Infiltrate,Basaloid carcinoma
15157,Benign Cellular Infiltrate,Post polycythaemia vera myelofibrosis
15158,Intermediate Grade Neuroendocrine Lesion,Fibrolamellar Hepatocellular Carcinoma
15159,Low Grade Neuroendocrine Lesion,Fibrolamellar Hepatocellular Carcinoma
15160,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of appendix
15161,Malignant Cellular Infiltrate,Peripheral Nerve Schwannoma
15162,Low Grade Neuroendocrine Lesion,Cholangiolocellular Carcinoma
15163,Low Grade Neuroendocrine Lesion,Sarcomatoid Intrahepatic Cholangiocarcinoma
15164,Malignant Cellular Infiltrate,Compact Cell Adrenal Cortical Adenoma
15165,Malignant Cellular Infiltrate,Heavily Pigmented Adrenal Cortical Adenoma
15166,Malignant Cellular Infiltrate,Mixed Cell Adrenal Cortical Adenoma
15167,Benign Cellular Infiltrate,Gliomatosis Cerebri Type II
15168,Benign Cellular Infiltrate,Epithelial-myoepithelial carcinoma
15169,Benign Cellular Infiltrate,Poorly Differentiated Neuroblastoma
15170,Malignant Cellular Infiltrate,Junctional nevus
15171,Benign Cellular Infiltrate,Melanoma Arising in Giant Congenital Nevus
15172,Benign Cellular Infiltrate,"Spindle cell melanoma, type A"
15173,Malignant Cellular Infiltrate,Bizarre leiomyoma
15174,Benign Cellular Infiltrate,Malignant Cystosarcoma Phyllodes
15175,Benign Cellular Infiltrate,"Synovial sarcoma, biphasic"
15176,Malignant Germinomatous Cellular Infiltrate,Grade 3 Teratoma
15177,Malignant Cellular Infiltrate,Juxtacortical chondroma
15178,Malignant Cellular Infiltrate,Ameloblastic fibroma
15179,Malignant Cellular Infiltrate,Pacinian tumor
15180,Well Differentiated Neuroendocrine Lesion,Hereditary Diffuse Gastric Adenocarcinoma
15181,Benign Cellular Infiltrate,Malignant Hair Follicle Neoplasm
15182,Malignant Cellular Infiltrate,Benign Outer Hair Sheath and Infundibulum Neoplasm
15183,Benign Cellular Infiltrate,Meningeal sarcomatosis
15184,Benign Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma
15185,Benign Cellular Infiltrate,Mantle cell lymphoma
15186,Intermediate Grade Neuroendocrine Lesion,Sporadic Diffuse Gastric Adenocarcinoma
15187,Well Differentiated Neuroendocrine Lesion,Small Intestinal Squamous Cell Carcinoma
15188,Low Grade Neuroendocrine Lesion,Small Intestinal Adenosquamous Carcinoma
15189,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Undifferentiated Carcinoma
15190,Malignant Cellular Infiltrate,Squamous cell papilloma of eyelid
15191,Low Grade Neuroendocrine Lesion,small cell carcinoma of appendix
15192,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of appendix
15193,Well Differentiated Neuroendocrine Lesion,Appendix Mixed Adenoneuroendocrine Carcinoma
15194,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid Adenocarcinoma
15195,Low Grade Neuroendocrine Lesion,Rectosigmoid Adenocarcinoma
15196,Well Differentiated Neuroendocrine Lesion,Colorectal Squamous Cell Carcinoma
15197,Well Differentiated Neuroendocrine Lesion,Colorectal Medullary Carcinoma
15198,Intermediate Grade Neuroendocrine Lesion,Colorectal Undifferentiated Carcinoma
15199,Well Differentiated Neuroendocrine Lesion,Rectosigmoid Mucinous Adenocarcinoma
15200,Well Differentiated Neuroendocrine Lesion,Rectal Adenosquamous Carcinoma
15201,Low Grade Neuroendocrine Lesion,Pleomorphic Hepatocellular Carcinoma
15202,Malignant Cellular Infiltrate,Erosive Adenomatosis of the Nipple
15203,Malignant Cellular Infiltrate,Benign neoplasm of buccal mucosa
15204,Intermediate Grade Neuroendocrine Lesion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
15205,Intermediate Grade Neuroendocrine Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7
15206,Low Grade Neuroendocrine Lesion,Cholangiocarcinoma
15207,Malignant Cellular Infiltrate,Eccrine mixed tumor of skin
15208,Malignant Cellular Infiltrate,Dartoic myoma
15209,Benign Cellular Infiltrate,Skin Lymphangiosarcoma
15210,Malignant Cellular Infiltrate,Benign lipomatous tumor
15211,Benign Cellular Infiltrate,"Breast Cancer, Familial"
15212,Malignant Cellular Infiltrate,Benign epithelial tumor of ovary
15213,Benign Cellular Infiltrate,Cervical Adenosquamous Carcinoma
15214,Benign Cellular Infiltrate,Cervical Adenocarcinoma In Situ
15215,Benign Cellular Infiltrate,Primary Cutaneous Plasmablastic Lymphoma
15216,Benign Cellular Infiltrate,Cutaneous Precursor Lymphoid Neoplasm
15217,Benign Cellular Infiltrate,Cutaneous B Lymphoblastic Leukemia/Lymphoma
15218,Benign Cellular Infiltrate,Cutaneous Adult T-Cell Leukemia/Lymphoma
15219,Benign Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v7
15220,Benign Cellular Infiltrate,Primary cutaneous gamma-delta T-cell lymphoma
15221,Benign Cellular Infiltrate,Pituitary carcinoma
15222,Intermediate Grade Neuroendocrine Lesion,Colon Intramucosal Adenocarcinoma
15223,Malignant Cellular Infiltrate,Cavernous hemangioma of orbit
15224,Benign Cellular Infiltrate,epithelial-myoepithelial carcinoma of lung
15225,Malignant Cellular Infiltrate,Benign tumor of iris
15226,Malignant Cellular Infiltrate,Leiomyoma of ciliary body
15227,Malignant Cellular Infiltrate,chondroma of lung
15228,Benign Cellular Infiltrate,Lung Melanoma
15229,Benign Cellular Infiltrate,Pleural Sarcomatoid Mesothelioma
15230,Benign Cellular Infiltrate,Pleural Desmoplastic Mesothelioma
15231,Benign Cellular Infiltrate,Pyothorax-Associated Lymphoma
15232,Benign Cellular Infiltrate,Pleural Epithelioid Hemangioendothelioma
15233,Benign Cellular Infiltrate,Pleural Biphasic Synovial Sarcoma
15234,Benign Cellular Infiltrate,Malignant tumor of endocardium
15235,Benign Cellular Infiltrate,Thymic Typical Carcinoid Tumor
15236,Benign Cellular Infiltrate,Cardiac Rhabdomyosarcoma
15237,Poorly Differentiated Neuroendocrine Lesion,Non functioning pancreatic endocrine tumor
15238,Poorly Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2
15239,Well Differentiated Neuroendocrine Lesion,Pancreatic Mixed Adenoneuroendocrine Carcinoma
15240,Low Grade Neuroendocrine Lesion,Pancreatic Mixed Adenoneuroendocrine Carcinoma
15241,Benign Cellular Infiltrate,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
15242,Malignant Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
15243,Malignant Cellular Infiltrate,Thyroid Gland Mucinous Follicular Adenoma
15244,Malignant Cellular Infiltrate,Skin Papilloma
15245,Malignant Cellular Infiltrate,Benign tumor of endocrine gland
15246,Mitotic Activity,Dermoid cyst of skin
15247,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor
15248,Benign Cellular Infiltrate,Acute biphenotypic leukemia
15249,Benign Cellular Infiltrate,Choroid Plexus Carcinoma
15250,Malignant Cellular Infiltrate,Proliferative fasciitis
15251,Malignant Cellular Infiltrate,Spindle cell hemangioma
15252,Low Grade Neuroendocrine Lesion,Duodenal Cancer
15253,Malignant Cellular Infiltrate,Fibromatosis colli
15254,Benign Cellular Infiltrate,Recurrent Malignant Neoplasm
15255,Benign Cellular Infiltrate,Tonsillar Carcinoma
15256,Benign Cellular Infiltrate,Disseminated squamous cell carcinoma
15257,Benign Cellular Infiltrate,Primary Bone Osteosarcoma
15258,Malignant Cellular Infiltrate,estrogen-producing adrenal cortical adenoma
15259,Benign Cellular Infiltrate,CARCINOMA OF VULVA
15260,Benign Cellular Infiltrate,Breast Carcinoma
15261,Benign Cellular Infiltrate,Carcinoma of lung
15262,Benign Cellular Infiltrate,Malignant neoplasm of muscle
15263,Intermediate Grade Neuroendocrine Lesion,Carcinoma in situ of small intestine
15264,Low Grade Neuroendocrine Lesion,Carcinoma in situ of small intestine
15265,Malignant Cellular Infiltrate,Hemangioma of skin
15266,Malignant Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
15267,Malignant Cellular Infiltrate,Solid Angioleiomyoma
15268,Benign Cellular Infiltrate,Carcinoma of bladder
15269,Benign Cellular Infiltrate,Aleukemic Leukemia Cutis
15270,Intermediate Grade Neuroendocrine Lesion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
15271,Well Differentiated Neuroendocrine Lesion,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
15272,Intermediate Grade Neuroendocrine Lesion,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
15273,Well Differentiated Neuroendocrine Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
15274,Low Grade Neuroendocrine Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
15275,Benign Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
15276,Malignant Cellular Infiltrate,Kidney Lipoma
15277,Benign Cellular Infiltrate,Adenoid cystic breast carcinoma
15278,Benign Cellular Infiltrate,Hereditary Leiomyomatosis and Renal Cell Cancer
15279,Benign Cellular Infiltrate,pleomorphic carcinoma of breast
15280,Well Differentiated Neuroendocrine Lesion,Gastric Cardia Adenocarcinoma
15281,Well Differentiated Neuroendocrine Lesion,Signet-ring cell adenocarcinoma gastric
15282,Low Grade Neuroendocrine Lesion,Signet-ring cell adenocarcinoma gastric
15283,Malignant Cellular Infiltrate,Mature Gastric Teratoma
15284,Benign Cellular Infiltrate,Early Unfavorable Non-Hodgkin Lymphoma
15285,Intermediate Grade Neuroendocrine Lesion,mucoepidermoid carcinoma of esophagus
15286,Benign Cellular Infiltrate,mesenchymal chondrosarcoma of bone
15287,Malignant Cellular Infiltrate,Intravascular Angioleiomyoma
15288,Benign Cellular Infiltrate,HER2-positive carcinoma of breast
15289,Benign Cellular Infiltrate,Normal Breast-Like Subtype of Breast Carcinoma
15290,Malignant Cellular Infiltrate,Intravenous leiomyomatosis
15291,Benign Cellular Infiltrate,Cardiac Epithelioid Hemangioendothelioma
15292,Benign Cellular Infiltrate,Cardiac Kaposi's Sarcoma
15293,Malignant Cellular Infiltrate,Benign Connective and Soft Tissue Neoplasm
15294,Benign Cellular Infiltrate,Superior Vena Cava Angiosarcoma
15295,Benign Cellular Infiltrate,Malignant Superior Vena Cava Neoplasm
15296,Benign Cellular Infiltrate,Angiosarcoma recurrent
15297,Malignant Cellular Infiltrate,Parotid Gland Lymphangioma
15298,Malignant Cellular Infiltrate,Bone Epithelioid Hemangioma
15299,Benign Cellular Infiltrate,Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma
15300,Benign Cellular Infiltrate,primitive neuroectodermal tumor (PNET) of spinal cord
15301,Benign Cellular Infiltrate,Central Nervous System T-Cell Non-Hodgkin Lymphoma
15302,Benign Cellular Infiltrate,adenosquamous carcinoma of skin
15303,Benign Cellular Infiltrate,Clivus Chondroid Chordoma
15304,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma
15305,Benign Cellular Infiltrate,Clear cell odontogenic carcinoma
15306,Malignant Cellular Infiltrate,Cerebral hemangioma
15307,Malignant Cellular Infiltrate,Schwannoma of the Twelfth Cranial Nerve
15308,Malignant Cellular Infiltrate,Exophytic Schneiderian Papilloma
15309,Benign Cellular Infiltrate,Kadish Stage C Olfactory Neuroblastoma
15310,Malignant Cellular Infiltrate,Intracranial lipoma
15311,Benign Cellular Infiltrate,Skull Base Chordoma
15312,Benign Cellular Infiltrate,Central Nervous System Rhabdomyosarcoma
15313,Well Differentiated Neuroendocrine Lesion,Stage IIIB Gastric Carcinoma
15314,Well Differentiated Neuroendocrine Lesion,Stage IIIA Gastric Carcinoma
15315,Low Grade Neuroendocrine Lesion,Gastric Papillary Adenocarcinoma
15316,Intermediate Grade Neuroendocrine Lesion,Undifferentiated carcinoma of stomach
15317,Low Grade Neuroendocrine Lesion,Undifferentiated carcinoma of stomach
15318,Low Grade Neuroendocrine Lesion,Colon Adenosquamous Carcinoma
15319,Malignant Cellular Infiltrate,Colon Leiomyoma
15320,Poorly Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1
15321,Malignant Cellular Infiltrate,Prostate Leiomyoma
15322,Intermediate Grade Neuroendocrine Lesion,Rectal Sarcomatoid Carcinoma
15323,Benign Cellular Infiltrate,Prostate Acinar Adenocarcinoma
15324,Intermediate Grade Neuroendocrine Lesion,Paget Disease of the Anus
15325,Well Differentiated Neuroendocrine Lesion,Anal cancer metastatic
15326,Benign Cellular Infiltrate,Malignant Cutaneous Granular Cell Tumor
15327,Benign Cellular Infiltrate,Childhood T Lymphoblastic Leukemia/Lymphoma
15328,Benign Cellular Infiltrate,Non-Hodgkin's lymphoma of lung
15329,Intermediate Grade Neuroendocrine Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
15330,Low Grade Neuroendocrine Lesion,signet ring cell carcinoma of pancreas
15331,Low Grade Neuroendocrine Lesion,adenosquamous carcinoma of pancreas
15332,Well Differentiated Neuroendocrine Lesion,carcinoma of pancreas with osteoclast-like giant cells
15333,Intermediate Grade Neuroendocrine Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas
15334,Poorly Differentiated Neuroendocrine Lesion,Duodenal Gastrin-Producing Neuroendocrine Tumor
15335,Low Grade Neuroendocrine Lesion,Stage IVA Gallbladder Carcinoma
15336,Malignant Cellular Infiltrate,benign neurofibroma of gallbladder
15337,Intermediate Grade Neuroendocrine Lesion,Clear Cell Hepatocellular Carcinoma
15338,Well Differentiated Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v6
15339,Well Differentiated Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v7
15340,Low Grade Neuroendocrine Lesion,Bile duct signet-ring cell carcinoma
15341,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of extrahepatic bile duct
15342,Low Grade Neuroendocrine Lesion,Small intestine carcinoma stage I
15343,Low Grade Neuroendocrine Lesion,Small intestine carcinoma stage IV
15344,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Fibroma
15345,Malignant Cellular Infiltrate,lipoma of extrahepatic bile duct
15346,Malignant Cellular Infiltrate,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm
15347,Benign Cellular Infiltrate,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
15348,Benign Cellular Infiltrate,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
15349,Benign Cellular Infiltrate,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
15350,Benign Cellular Infiltrate,Stage I Oral Cavity Cancer AJCC v6 and v7
15351,Benign Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7
15352,Benign Cellular Infiltrate,Major Salivary Gland Acinic Cell Carcinoma
15353,Malignant Cellular Infiltrate,Oral Cavity Lipoma
15354,Benign Cellular Infiltrate,Squamous cell carcinoma of the parotid gland
15355,Benign Cellular Infiltrate,Minor Salivary Gland Carcinoma
15356,Benign Cellular Infiltrate,Minor Salivary Gland Squamous Cell Carcinoma
15357,Benign Cellular Infiltrate,TSH-Producing Pituitary Gland Carcinoma
15358,Benign Cellular Infiltrate,Anaplastic Brain Stem Astrocytoma
15359,Benign Cellular Infiltrate,Carcinoma of subglottis
15360,Benign Cellular Infiltrate,Stage IVC Oropharyngeal Carcinoma AJCC v7
15361,Benign Cellular Infiltrate,Posterior Tongue Adenoid Cystic Carcinoma
15362,Benign Cellular Infiltrate,Stage IVC Nasopharyngeal Carcinoma AJCC v7
15363,Benign Cellular Infiltrate,Paranasal Sinus Cancer
15364,Malignant Cellular Infiltrate,Subglottic Hemangioma
15365,Benign Cellular Infiltrate,Thyroid Sarcoma
15366,Benign Cellular Infiltrate,Adenoid cystic carcinoma of trachea
15367,Benign Cellular Infiltrate,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
15368,Intermediate Grade Neuroendocrine Lesion,Rectal Small Cell Neuroendocrine Carcinoma
15369,Low Grade Neuroendocrine Lesion,Rectal Small Cell Neuroendocrine Carcinoma
15370,Benign Cellular Infiltrate,Neck Carcinoma
15371,Benign Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland
15372,Benign Cellular Infiltrate,Malignant Uveal Neoplasm
15373,Benign Cellular Infiltrate,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
15374,Benign Cellular Infiltrate,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
15375,Benign Cellular Infiltrate,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7
15376,Benign Cellular Infiltrate,Renal Pelvis Carcinoma
15377,Benign Cellular Infiltrate,adenocarcinoma of renal pelvis
15378,Benign Cellular Infiltrate,papillary carcinoma of renal pelvis
15379,Benign Cellular Infiltrate,Stage 0 Ureter Cancer AJCC v7
15380,Benign Cellular Infiltrate,adenocarcinoma of ureter
15381,Malignant Cellular Infiltrate,Ureter Schwannoma
15382,Benign Cellular Infiltrate,Bladder Signet Ring Cell Adenocarcinoma
15383,Benign Cellular Infiltrate,squamous cell carcinoma of urethra
15384,Malignant Cellular Infiltrate,Urethral Leiomyoma
15385,Benign Cellular Infiltrate,Ureter Lymphoma
15386,Benign Cellular Infiltrate,Kidney Extraskeletal Osteosarcoma
15387,Benign Cellular Infiltrate,Bladder transitional cell carcinoma stage I
15388,Malignant Cellular Infiltrate,Hard Palate Pleomorphic Adenoma
15389,Benign Cellular Infiltrate,Hard Palate Adenoid Cystic Carcinoma
15390,Benign Cellular Infiltrate,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
15391,Benign Cellular Infiltrate,Anterior Tongue Adenoid Cystic Carcinoma
15392,Benign Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v6 and v7
15393,Benign Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v6 and v7
15394,Benign Cellular Infiltrate,germinoma of brain
15395,Benign Cellular Infiltrate,Stage IIB Uterine Corpus Cancer AJCC v6
15396,Benign Cellular Infiltrate,Stage IVB Uterine Corpus Cancer AJCC v7
15397,Benign Cellular Infiltrate,Stage IA1 Cervical Cancer
15398,Benign Cellular Infiltrate,Stage IA2 Cervical Cancer
15399,Benign Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v6
15400,Benign Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7
15401,Benign Cellular Infiltrate,leiomyosarcoma of vagina
15402,Benign Cellular Infiltrate,Uterine Corpus Adenosarcoma
15403,Benign Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma
15404,Benign Cellular Infiltrate,Lymphoma of kidney
15405,Malignant Cellular Infiltrate,Vaginal Leiomyoma
15406,Malignant Cellular Infiltrate,Vestibular Papilloma
15407,Benign Cellular Infiltrate,Vaginal Yolk Sac Tumor
15408,Malignant Cellular Infiltrate,Adenomatoid tumor of epididymis
15409,Benign Cellular Infiltrate,basal cell carcinoma of scrotum
15410,Benign Cellular Infiltrate,Invasive Ductal and Invasive Lobular Breast Carcinoma
15411,Intermediate Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1
15412,Intermediate Grade Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1
15413,Intermediate Grade Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1
15414,Benign Cellular Infiltrate,teratocarcinoma of mediastinum
15415,Malignant Cellular Infiltrate,Benign Mediastinal Germ Cell Tumor
15416,Benign Cellular Infiltrate,Thymic Adenocarcinoma
15417,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of thymus
15418,Benign Cellular Infiltrate,Stage IB Bone Sarcoma AJCC v7
15419,Benign Cellular Infiltrate,Stage III Bone Sarcoma AJCC v7
15420,Benign Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone
15421,Malignant Cellular Infiltrate,Deep histiocytoma
15422,Malignant Cellular Infiltrate,Tendon Sheath Lipoma
15423,Benign Cellular Infiltrate,Sclerosing liposarcoma
15424,Benign Cellular Infiltrate,Malignant Smooth Muscle Neoplasm
15425,Malignant Cellular Infiltrate,Tumorlet
15426,Benign Cellular Infiltrate,"Papillary squamous cell carcinoma, non-invasive"
15427,Malignant Cellular Infiltrate,Intermediate Rhabdomyoma
15428,Low Grade Neuroendocrine Lesion,Malignant Pancreatic Insulinoma
15429,Malignant Cellular Infiltrate,Synovial Hemangioma
15430,Benign Cellular Infiltrate,Childhood Testicular Choriocarcinoma
15431,Benign Cellular Infiltrate,Childhood Ovarian Choriocarcinoma
15432,Malignant Cellular Infiltrate,Schwannomatosis
15433,Malignant Cellular Infiltrate,Benign Soft Tissue Tumor of Uncertain Differentiation
15434,Benign Cellular Infiltrate,Malignant Soft Tissue Tumor of Uncertain Differentiation
15435,Benign Cellular Infiltrate,Mediastinal Angiosarcoma
15436,Benign Cellular Infiltrate,malignant lymphoma of mediastinum
15437,Benign Cellular Infiltrate,Hodgkin's lymphoma of mediastinum
15438,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of ampulla of Vater
15439,Low Grade Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v7
15440,Low Grade Neuroendocrine Lesion,Ampulla of Vater Signet Ring Cell Carcinoma
15441,Benign Cellular Infiltrate,Stage IB Lung Adenosquamous Carcinoma AJCC v7
15442,Malignant Cellular Infiltrate,Periosteal fibroma
15443,Benign Cellular Infiltrate,Stage III Lung Small Cell Carcinoma AJCC v7
15444,Benign Cellular Infiltrate,Occult Lung Adenosquamous Carcinoma
15445,Benign Cellular Infiltrate,"Perineurioma, malignant"
15446,Benign Cellular Infiltrate,Occult Lung Large Cell Carcinoma
15447,Malignant Cellular Infiltrate,Parotid Gland Warthin Tumor
15448,Benign Cellular Infiltrate,Hepatoid adenocarcinoma
15449,Benign Cellular Infiltrate,Adenocarcinoma of lung stage IIIA
15450,Benign Cellular Infiltrate,Stage IV Bone Sarcoma AJCC v7
15451,Benign Cellular Infiltrate,Stage IVB Bone Sarcoma AJCC v7
15452,Benign Cellular Infiltrate,Chest Wall Lymphoma
15453,Well Differentiated Neuroendocrine Lesion,Stage IIB Esophageal Adenocarcinoma AJCC v7
15454,Low Grade Neuroendocrine Lesion,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
15455,Malignant Cellular Infiltrate,Pericardial Leiomyoma
15456,Malignant Cellular Infiltrate,Mature Pericardial Teratoma
15457,Benign Cellular Infiltrate,Pulmonary Artery Angiosarcoma
15458,Benign Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
15459,Benign Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6
15460,Intermediate Grade Neuroendocrine Lesion,Colon Small Cell Neuroendocrine Carcinoma
15461,Benign Cellular Infiltrate,Small cell carcinoma of prostate
15462,Intermediate Grade Neuroendocrine Lesion,Gastric Cardia Carcinoma
15463,Malignant Cellular Infiltrate,Cutaneous Fibrous Histiocytoma
15464,Benign Cellular Infiltrate,Plantar Verrucous Skin Carcinoma
15465,Benign Cellular Infiltrate,Endometrioid carcinoma of prostate
15466,Benign Cellular Infiltrate,Kadish Stage A Olfactory Neuroblastoma
15467,Benign Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma
15468,Benign Cellular Infiltrate,Ciliary Body Spindle Cell Type A Melanoma
15469,Benign Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
15470,Benign Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v6
15471,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
15472,Benign Cellular Infiltrate,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
15473,Intermediate Grade Neuroendocrine Lesion,mixed acinar-endocrine carcinoma of pancreas
15474,Malignant Cellular Infiltrate,Cellular fibroma
15475,Benign Cellular Infiltrate,Malignant Solitary Fibrous Tumor
15476,Benign Cellular Infiltrate,Childhood Classic Hodgkin Lymphoma
15477,Benign Cellular Infiltrate,Burkitt-like lymphoma
15478,Benign Cellular Infiltrate,Subcutaneous panniculitis-like T-cell lymphoma
15479,Benign Cellular Infiltrate,Neuroblastic tumors
15480,Benign Cellular Infiltrate,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System
15481,Benign Cellular Infiltrate,"Supratentorial Embryonal Tumor, Not Otherwise Specified"
15482,Benign Cellular Infiltrate,Intracranial Liposarcoma
15483,Benign Cellular Infiltrate,"Squamous Cell Carcinoma of the Penis, Usual Type"
15484,Benign Cellular Infiltrate,Central Nervous System Germinoma
15485,Benign Cellular Infiltrate,Central Nervous System Choriocarcinoma
15486,Low Grade Neuroendocrine Lesion,Esophageal Basaloid Carcinoma
15487,Benign Cellular Infiltrate,Megakaryocytic Neoplasm
15488,Intermediate Grade Neuroendocrine Lesion,Undifferentiated Carcinoma of Colon
15489,Low Grade Neuroendocrine Lesion,Stage I Liver Carcinoma
15490,Well Differentiated Neuroendocrine Lesion,Stage IV Liver Cancer
15491,Low Grade Neuroendocrine Lesion,Hepatic cancer stage IVA
15492,Benign Cellular Infiltrate,Bone Surface (Peripheral) Osteosarcoma
15493,Benign Cellular Infiltrate,Extra-osseous Ewing's sarcoma
15494,Benign Cellular Infiltrate,Immunoglobulin deposition disease
15495,Malignant Cellular Infiltrate,Benign Dermal Neoplasm
15496,Benign Cellular Infiltrate,Classical Hodgkin's Lymphoma
15497,Benign Cellular Infiltrate,Grade I Nodular Sclerosis Hodgkin's Lymphoma
15498,Benign Cellular Infiltrate,Diffuse large B-cell lymphoma of central nervous system
15499,Benign Cellular Infiltrate,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
15500,Benign Cellular Infiltrate,Thyroid Immunoblastic Lymphoma
15501,Benign Cellular Infiltrate,"Bronchiolo-alveolar carcinoma, non-mucinous"
15502,Malignant Cellular Infiltrate,Ovarian Papillary Cystadenoma
15503,Benign Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
15504,Benign Cellular Infiltrate,follicular lymphoma of spleen
15505,Benign Cellular Infiltrate,Burkitt's tumor of spleen
15506,Benign Cellular Infiltrate,Splenic B Lymphoblastic Lymphoma
15507,Benign Cellular Infiltrate,Splenic Lymphoblastic Lymphoma
15508,Malignant Cellular Infiltrate,Benign Ovarian Serous Tumor
15509,Benign Cellular Infiltrate,Cervical Squamous Cell Carcinoma In Situ
15510,Benign Cellular Infiltrate,melanoma of scrotum
15511,Malignant Cellular Infiltrate,Pilomatrixoma
15512,Benign Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
15513,Benign Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma of the Cervix
15514,Malignant Cellular Infiltrate,Infiltrating angiolipoma
15515,Intermediate Grade Neuroendocrine Lesion,Anal Adenocarcinoma within Anorectal Fistula
15516,Low Grade Neuroendocrine Lesion,Paget disease of anal canal
15517,Benign Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
15518,Benign Cellular Infiltrate,Secondary malignant neoplasm of kidney
15519,Benign Cellular Infiltrate,Prostate cancer stage B
15520,Benign Cellular Infiltrate,Secondary malignant neoplasm of urethra
15521,Benign Cellular Infiltrate,liposarcoma of bone
15522,Benign Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid
15523,Benign Cellular Infiltrate,Recurrent Carcinoma
15524,Low Grade Neuroendocrine Lesion,Recurrent Digestive System Carcinoma
15525,Benign Cellular Infiltrate,Localized Carcinoma
15526,Well Differentiated Neuroendocrine Lesion,Pancreatic carcinoma recurrent
15527,Intermediate Grade Neuroendocrine Lesion,Pancreatic carcinoma recurrent
15528,Benign Cellular Infiltrate,Intracystic Papillary Breast Carcinoma
15529,Benign Cellular Infiltrate,Adenocarcinoma in situ in adenomatous polyp
15530,Benign Cellular Infiltrate,Carcinoma in situ in a polyp
15531,Benign Cellular Infiltrate,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
15532,Benign Cellular Infiltrate,Prostate Sarcoma
15533,Malignant Cellular Infiltrate,Myxoma of the Endocardium
15534,Well Differentiated Neuroendocrine Lesion,Stage III Colon Cancer
15535,Benign Cellular Infiltrate,Stage III Breast Cancer AJCC v6
15536,Intermediate Grade Neuroendocrine Lesion,Stage II Anal Canal Cancer AJCC v6 and v7
15537,Benign Cellular Infiltrate,Non-small cell lung cancer stage III
15538,Benign Cellular Infiltrate,Metastatic osteosarcoma
15539,Intermediate Grade Neuroendocrine Lesion,Stage 0 Gastric Cancer AJCC v6 and v7
15540,Low Grade Neuroendocrine Lesion,Stage 0 Gastric Cancer AJCC v6 and v7
15541,Benign Cellular Infiltrate,Recurrent Adult Hodgkin Lymphoma
15542,Low Grade Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v6 and v7
15543,Well Differentiated Neuroendocrine Lesion,Stage II Rectal Cancer
15544,Low Grade Neuroendocrine Lesion,Stage II Rectal Cancer
15545,Benign Cellular Infiltrate,Mycosis fungoides stage III
15546,Benign Cellular Infiltrate,Adult Fibrosarcoma
15547,Benign Cellular Infiltrate,Adult Liposarcoma
15548,Benign Cellular Infiltrate,Solitary Osseous Plasmacytoma
15549,Benign Cellular Infiltrate,Refractory Plasma Cell Neoplasm
15550,Benign Cellular Infiltrate,Stage IV Adult Soft Tissue Sarcoma AJCC v7
15551,Benign Cellular Infiltrate,Localized Parathyroid Gland Carcinoma
15552,Benign Cellular Infiltrate,Recurrent ovarian cancer
15553,Benign Cellular Infiltrate,Localized Resectable Neuroblastoma
15554,Well Differentiated Neuroendocrine Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
15555,Benign Cellular Infiltrate,Stage V Kidney Wilms Tumor
15556,Benign Cellular Infiltrate,Extraocular retinoblastoma
15557,Benign Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7
15558,Poorly Differentiated Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1
15559,Poorly Differentiated Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1
15560,Benign Cellular Infiltrate,Stage I Penile Cancer AJCC v6
15561,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma recurrent
15562,Benign Cellular Infiltrate,Thymoma malignant recurrent
15563,Benign Cellular Infiltrate,Recurrent Salivary Gland Cancer
15564,Intermediate Grade Neuroendocrine Lesion,Liver and Intrahepatic Biliary Tract Carcinoma
15565,Benign Cellular Infiltrate,Childhood Acute Monoblastic and Monocytic Leukemia
15566,Benign Cellular Infiltrate,Childhood Alveolar Rhabdomyosarcoma
15567,Benign Cellular Infiltrate,Adult Acute Myelomonocytic Leukemia
15568,Well Differentiated Neuroendocrine Lesion,Signet-ring cell adenocarcinoma of colon
15569,Low Grade Neuroendocrine Lesion,Acinar cell carcinoma of pancreas
15570,Benign Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma
15571,Benign Cellular Infiltrate,Spindle Cell Type A Uveal Melanoma
15572,Benign Cellular Infiltrate,Spindle Cell Type B Uveal Melanoma
15573,Hemosiderin pigmentation,Parathyroid transitional clear cell adenoma
15574,Broad Fibrous Bands Formation,Parathyroid transitional clear cell adenoma
15575,Mitotic Activity,Parathyroid mixed cell type adenoma
15576,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Somatostatinoma
15577,Benign Cellular Infiltrate,undifferentiated carcinoma of salivary gland
15578,Benign Cellular Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation
15579,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
15580,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH
15581,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
15582,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1
15583,Benign Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7
15584,Benign Cellular Infiltrate,Follicular T-cell lymphoma
15585,Benign Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v6
15586,Benign Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7
15587,Benign Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v6 and v7
15588,Benign Cellular Infiltrate,Transitional cell cancer of renal pelvis and ureter metastatic
15589,Benign Cellular Infiltrate,Chemotherapy-Related Leukemia
15590,Benign Cellular Infiltrate,Stage II Ovarian Germ Cell Tumor AJCC v6 and v7
15591,Benign Cellular Infiltrate,Childhood Liposarcoma
15592,Benign Cellular Infiltrate,Ann Arbor Stage IV Grade 3 Follicular Lymphoma
15593,Benign Cellular Infiltrate,Stage IV Adult Immunoblastic Lymphoma
15594,Benign Cellular Infiltrate,Recurrent Grade 2 Follicular Lymphoma
15595,Benign Cellular Infiltrate,Squamous cell carcinoma of oropharynx
15596,Benign Cellular Infiltrate,Postcricoid Squamous Cell Carcinoma
15597,Malignant Cellular Infiltrate,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor
15598,Benign Cellular Infiltrate,Glottic Squamous Cell Carcinoma
15599,Benign Cellular Infiltrate,Squamous cell carcinoma of the paranasal sinus
15600,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity recurrent
15601,Benign Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage II
15602,Benign Cellular Infiltrate,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
15603,Benign Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage I
15604,Benign Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II
15605,Benign Cellular Infiltrate,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
15606,Benign Cellular Infiltrate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL
15607,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage III
15608,Benign Cellular Infiltrate,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter
15609,Low Grade Neuroendocrine Lesion,basaloid carcinoma of anus
15610,Benign Cellular Infiltrate,Stage I Uterine Sarcoma AJCC v7
15611,Benign Cellular Infiltrate,Refractory Thrombocytopenia
15612,Benign Cellular Infiltrate,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
15613,Well Differentiated Neuroendocrine Lesion,Adult Cholangiocarcinoma
15614,Benign Cellular Infiltrate,Adult Anaplastic (Malignant) Meningioma
15615,Malignant Cellular Infiltrate,Meyerson Nevus
15616,Benign Cellular Infiltrate,Adult Pineoblastoma
15617,Benign Cellular Infiltrate,Primary Systemic Amyloidosis
15618,Benign Cellular Infiltrate,Lymphoma stage III
15619,Benign Cellular Infiltrate,Carcinoma of upper gum
15620,Intermediate Grade Neuroendocrine Lesion,Gastric Fundus Carcinoma
15621,Low Grade Neuroendocrine Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
15622,Benign Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
15623,Benign Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma
15624,Benign Cellular Infiltrate,Hereditary Kidney Wilms Tumor
15625,Low Grade Neuroendocrine Lesion,Stage II Colorectal Cancer
15626,Low Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer
15627,Malignant Cellular Infiltrate,Benign neoplasm of respiratory tract
15628,Malignant Cellular Infiltrate,Hemangioma of spleen
15629,Benign Cellular Infiltrate,Stage IA Adult Soft Tissue Sarcoma AJCC v7
15630,Benign Cellular Infiltrate,Stage IIB Soft Tissue Sarcoma AJCC v7
15631,Benign Cellular Infiltrate,Stage IA Breast Cancer AJCC v7
15632,Benign Cellular Infiltrate,Stage II Merkel Cell Carcinoma AJCC v7
15633,Benign Cellular Infiltrate,Stage IIB Merkel Cell Carcinoma AJCC v7
15634,Benign Cellular Infiltrate,Malignant melanoma of retina
15635,Benign Cellular Infiltrate,Stage IIC Cutaneous Melanoma AJCC v6 and v7
15636,Benign Cellular Infiltrate,Stage IIIA Cutaneous Melanoma AJCC v7
15637,Well Differentiated Neuroendocrine Lesion,Stage II Esophageal Adenocarcinoma AJCC v7
15638,Well Differentiated Neuroendocrine Lesion,Stage 0 Esophageal Adenocarcinoma AJCC v7
15639,Low Grade Neuroendocrine Lesion,Stage 0 Esophageal Adenocarcinoma AJCC v7
15640,Well Differentiated Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma AJCC v7
15641,Low Grade Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v6
15642,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma metastatic
15643,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma metastatic
15644,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma non-resectable
15645,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma resectable
15646,Benign Cellular Infiltrate,Chronic lymphocytic leukemia stage 4
15647,Benign Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type refractory
15648,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma refractory
15649,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II
15650,Benign Cellular Infiltrate,Stage IV Anaplastic Large Cell Lymphoma
15651,Benign Cellular Infiltrate,T-cell lymphoma stage IV
15652,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent
15653,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage III
15654,Benign Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7
15655,Benign Cellular Infiltrate,Metastatic angiosarcoma
15656,Benign Cellular Infiltrate,Non-Cutaneous Melanoma
15657,Benign Cellular Infiltrate,Stage IIB Bone Cancer AJCC v7
15658,Benign Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
15659,Benign Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7
15660,Benign Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
15661,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage IV
15662,Benign Cellular Infiltrate,Stage III Mucosal Melanoma of the Head and Neck AJCC v7
15663,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
15664,Benign Cellular Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
15665,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
15666,Benign Cellular Infiltrate,"Adenocarcinoma of lung, stage II"
15667,Benign Cellular Infiltrate,Stage IV Pharynx Carcinoma
15668,Well Differentiated Neuroendocrine Lesion,Stage IIB Gastric Cancer AJCC v7
15669,Benign Cellular Infiltrate,Chondrosarcoma localised
15670,Well Differentiated Neuroendocrine Lesion,Stage IIIC Esophageal Adenocarcinoma AJCC v7
15671,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Esophageal Adenocarcinoma AJCC v7
15672,Low Grade Neuroendocrine Lesion,Stage IIB Small Intestinal Cancer AJCC v7
15673,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Small Intestinal Cancer AJCC v7
15674,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v7
15675,Low Grade Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v7
15676,Well Differentiated Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v7
15677,Benign Cellular Infiltrate,Stage I Acral Lentiginous Melanoma AJCC v7
15678,Poorly Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7
15679,Low Grade Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v7
15680,Benign Cellular Infiltrate,Stage III Acral Lentiginous Melanoma AJCC v7
15681,Benign Cellular Infiltrate,Stage I Superficial Spreading Melanoma AJCC v7
15682,Poorly Differentiated Neuroendocrine Lesion,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
15683,Low Grade Neuroendocrine Lesion,Stage IIIC Hepatocellular Carcinoma AJCC v7
15684,Intermediate Grade Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
15685,Well Differentiated Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v7
15686,Well Differentiated Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v7
15687,Well Differentiated Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v7
15688,Intermediate Grade Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v7
15689,Well Differentiated Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v7
15690,Intermediate Grade Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v7
15691,Low Grade Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v7
15692,Well Differentiated Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v7
15693,Benign Cellular Infiltrate,Extraskeletal Osteosarcoma
15694,Low Grade Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v6 and v7
15695,Low Grade Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v6 and v7
15696,Benign Cellular Infiltrate,Stage IIIa Penile Cancer AJCC v7
15697,Benign Cellular Infiltrate,Fibrosarcoma metastatic
15698,Benign Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7
15699,Benign Cellular Infiltrate,Stage IIA Uveal Melanoma AJCC v7
15700,Benign Cellular Infiltrate,Stage IIB Uveal Melanoma AJCC v7
15701,Benign Cellular Infiltrate,Ocular Adnexal Lymphoma
15702,Benign Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7
15703,Benign Cellular Infiltrate,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7
15704,Benign Cellular Infiltrate,Liposarcoma recurrent
15705,Benign Cellular Infiltrate,Recurrent Malignant Peripheral Nerve Sheath Tumor
15706,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I
15707,Benign Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7
15708,Benign Cellular Infiltrate,Diffuse large B-cell lymphoma recurrent
15709,Benign Cellular Infiltrate,Stage IV Diffuse Large B-Cell Lymphoma
15710,Benign Cellular Infiltrate,B Lymphoblastic Lymphoma
15711,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent
15712,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage IV
15713,Benign Cellular Infiltrate,"Carcinoma bladder stage I, without cancer in situ"
15714,Benign Cellular Infiltrate,Stage III Oropharyngeal Carcinoma AJCC v7
15715,Benign Cellular Infiltrate,Testicular germ cell tumor mixed stage III
15716,Benign Cellular Infiltrate,"Seminoma of testis, stage 1"
15717,Benign Cellular Infiltrate,Stage I Carcinoma of Penis
15718,Benign Cellular Infiltrate,Testicular yolk sac tumor stage II
15719,Benign Cellular Infiltrate,Acute Erythroblastic Leukemia
15720,Benign Cellular Infiltrate,Stage II Prostate Cancer AJCC v7
15721,Benign Cellular Infiltrate,Stage III Prostate Cancer AJCC v7
15722,Benign Cellular Infiltrate,Centroblastic lymphoma stage I
15723,Benign Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v7
15724,Well Differentiated Neuroendocrine Lesion,Small intestine adenocarcinoma metastatic NOS
15725,Low Grade Neuroendocrine Lesion,Small intestine adenocarcinoma metastatic NOS
15726,Benign Cellular Infiltrate,Stage I Vulvar Cancer
15727,Benign Cellular Infiltrate,Stage 0 Vaginal Cancer AJCC v7
15728,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIA
15729,Benign Cellular Infiltrate,Adenocarcinoma of the rete testis
15730,Benign Cellular Infiltrate,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
15731,Benign Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v7
15732,Benign Cellular Infiltrate,Stage IV Fallopian Tube Cancer AJCC v6 and v7
15733,Benign Cellular Infiltrate,Stage 0 Uterine Corpus Cancer
15734,Benign Cellular Infiltrate,Periosteal Osteosarcoma
15735,Benign Cellular Infiltrate,Embryonal Rhabdomyosarcoma
15736,Well Differentiated Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v7
15737,Low Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage III
15738,Well Differentiated Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v7
15739,Intermediate Grade Neuroendocrine Lesion,Stage III Colon Cancer AJCC v7
15740,Well Differentiated Neuroendocrine Lesion,malignant neoplasm of large intestine stage IV
15741,Well Differentiated Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v7
15742,Geographic Necrosis,Dermoid Cyst
15743,Benign Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa
15744,Low Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v7
15745,Benign Cellular Infiltrate,Grade I Chondrosarcoma
15746,Benign Cellular Infiltrate,Stage II Adult Hodgkin Lymphoma
15747,Benign Cellular Infiltrate,Renal Cell Cancer by AJCC v6 Stage
15748,Well Differentiated Neuroendocrine Lesion,Recurrent Childhood Hepatocellular Carcinoma
15749,Well Differentiated Neuroendocrine Lesion,Esophageal Cancer by AJCC v6 Stage
15750,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v6 Stage
15751,Low Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v6 Stage
15752,Low Grade Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v6 Stage
15753,Low Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v6 Stage
15754,Benign Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma
15755,Benign Cellular Infiltrate,Penis carcinoma
15756,Intermediate Grade Neuroendocrine Lesion,Recurrent Adult Hepatocellular Carcinoma
15757,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor
15758,Benign Cellular Infiltrate,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
15759,Well Differentiated Neuroendocrine Lesion,Colon Cancer by AJCC v7 Stage
15760,Benign Cellular Infiltrate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma
15761,Benign Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v7 Stage
15762,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage
15763,Benign Cellular Infiltrate,Adenosquamous cell lung cancer
15764,Benign Cellular Infiltrate,combined small cell carcinoma of lung
15765,Benign Cellular Infiltrate,Adult Acute Promyelocytic Leukemia with PML-RARA
15766,Benign Cellular Infiltrate,Adult Acute Monoblastic Leukemia
15767,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia without Maturation
15768,Intermediate Grade Neuroendocrine Lesion,Diffuse Gastric Adenocarcinoma
15769,Benign Cellular Infiltrate,Stage I Childhood Burkitt Lymphoma
15770,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma
15771,Benign Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v6
15772,Benign Cellular Infiltrate,Recurrent Childhood Malignant Germ Cell Tumor
15773,Benign Cellular Infiltrate,Juvenile Myelomonocytic Leukemia
15774,Benign Cellular Infiltrate,Relapsed Hypopharynx Carcinoma
15775,Benign Cellular Infiltrate,Pericardial mesothelioma malignant recurrent
15776,Benign Cellular Infiltrate,Large cell lung cancer stage III
15777,Low Grade Neuroendocrine Lesion,Recurrent Hepatocellular Carcinoma
15778,Benign Cellular Infiltrate,Aggressive Systemic Mastocytosis
15779,Intermediate Grade Neuroendocrine Lesion,Anal carcinoma
15780,Benign Cellular Infiltrate,Cancer of Urinary Tract
15781,Benign Cellular Infiltrate,Malignant tumor of gum
15782,Benign Cellular Infiltrate,Malignant neoplasm of floor of mouth
15783,Benign Cellular Infiltrate,Peripheral T-cell lymphoma unspecified refractory
15784,Benign Cellular Infiltrate,Ureteric cancer regional
15785,Benign Cellular Infiltrate,Testis cancer recurrent
15786,Benign Cellular Infiltrate,Adult Brain Glioblastoma
15787,Benign Cellular Infiltrate,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
15788,Well Differentiated Neuroendocrine Lesion,Rectal Carcinoma
15789,Benign Cellular Infiltrate,Renal carcinoma
15790,Benign Cellular Infiltrate,Sarcoma by NCI Grade
15791,Benign Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 2
15792,Benign Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 3
15793,Low Grade Neuroendocrine Lesion,Grade 1 Colorectal Adenocarcinoma
15794,Intermediate Grade Neuroendocrine Lesion,Grade 1 Rectal Adenocarcinoma
15795,Low Grade Neuroendocrine Lesion,Grade 1 Rectal Adenocarcinoma
15796,Well Differentiated Neuroendocrine Lesion,Grade 3 Colon Adenocarcinoma
15797,Benign Cellular Infiltrate,Intermediate Grade Ductal Breast Carcinoma In Situ
15798,Benign Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ
15799,Benign Cellular Infiltrate,Hypopharyngeal Carcinoma
15800,Benign Cellular Infiltrate,Multifocal breast carcinoma
15801,Benign Cellular Infiltrate,Multicentric Breast Carcinoma
15802,Low Grade Neuroendocrine Lesion,Stage IIIB Adult Liver Cancer AJCC v7
15803,Well Differentiated Neuroendocrine Lesion,Stage IV Adult Liver Cancer AJCC v7
15804,Low Grade Neuroendocrine Lesion,Stage IV Adult Liver Cancer AJCC v7
15805,Benign Cellular Infiltrate,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma
15806,Benign Cellular Infiltrate,Ann Arbor Stage II AIDS-Related Lymphoma
15807,Benign Cellular Infiltrate,Stage IIA1 Cervical Cancer AJCC v7
15808,Benign Cellular Infiltrate,Intramucosal Adenocarcinoma
15809,Poorly Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor
15810,Malignant Cellular Infiltrate,benign mature teratoma of pancreas
15811,Low Grade Neuroendocrine Lesion,Esophageal Spindle Cell Carcinoma
15812,Well Differentiated Neuroendocrine Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma
15813,Well Differentiated Neuroendocrine Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma
15814,Intermediate Grade Neuroendocrine Lesion,Esophageal Mixed Adenoneuroendocrine Carcinoma
15815,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
15816,Intermediate Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma
15817,Well Differentiated Neuroendocrine Lesion,Colorectal Large Cell Neuroendocrine Carcinoma
15818,Low Grade Neuroendocrine Lesion,Colorectal Mixed Adenoneuroendocrine Carcinoma
15819,Poorly Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor
15820,Poorly Differentiated Neuroendocrine Lesion,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
15821,Low Grade Neuroendocrine Lesion,High Grade Appendix Mucinous Adenocarcinoma
15822,Poorly Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor
15823,Intermediate Grade Neuroendocrine Lesion,Neuroendocrine carcinoma of appendix
15824,Low Grade Neuroendocrine Lesion,Colon Serrated Adenocarcinoma
15825,Intermediate Grade Neuroendocrine Lesion,Rectal Serrated Adenocarcinoma
15826,Low Grade Neuroendocrine Lesion,Rectal Cribriform Comedo-Type Adenocarcinoma
15827,Intermediate Grade Neuroendocrine Lesion,Rectal Micropapillary Adenocarcinoma
15828,Intermediate Grade Neuroendocrine Lesion,Colorectal Sarcomatoid Carcinoma
15829,Malignant Cellular Infiltrate,Colorectal Perineurioma
15830,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of anal canal
15831,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of anal canal
15832,Well Differentiated Neuroendocrine Lesion,neuroendocrine carcinoma of anal canal
15833,Low Grade Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma
15834,Low Grade Neuroendocrine Lesion,Well Differentiated Hepatocellular Carcinoma
15835,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of liver
15836,Intermediate Grade Neuroendocrine Lesion,Perihilar Intrahepatic Cholangiocarcinoma
15837,Low Grade Neuroendocrine Lesion,Perihilar Intrahepatic Cholangiocarcinoma
15838,Well Differentiated Neuroendocrine Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
15839,Intermediate Grade Neuroendocrine Lesion,hepatoid adenocarcinoma of gallbladder
15840,Intermediate Grade Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
15841,Intermediate Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of gallbladder
15842,Well Differentiated Neuroendocrine Lesion,Gallbladder Goblet Cell Carcinoid
15843,Low Grade Neuroendocrine Lesion,Gallbladder Goblet Cell Carcinoid
15844,Low Grade Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
15845,Intermediate Grade Neuroendocrine Lesion,carcinosarcoma of extrahepatic bile duct
15846,Well Differentiated Neuroendocrine Lesion,cystadenocarcinoma of intrahepatic bile duct
15847,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Carcinoma
15848,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Carcinoma
15849,Low Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct
15850,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
15851,Benign Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
15852,Benign Cellular Infiltrate,ENSAT Stage II Adrenal Cortex Carcinoma
15853,Benign Cellular Infiltrate,Class 1 Uveal Melanoma
15854,Benign Cellular Infiltrate,Class 1b Uveal Melanoma
15855,Benign Cellular Infiltrate,"Uterine Carcinosarcoma, Heterologous Type"
15856,Benign Cellular Infiltrate,Non-Hodgkin Lymphoma During Pregnancy
15857,Benign Cellular Infiltrate,Recurrent Childhood Central Nervous System Embryonal Neoplasm
15858,Low Grade Neuroendocrine Lesion,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
15859,Intermediate Grade Neuroendocrine Lesion,Adult Fibrolamellar Carcinoma
15860,Low Grade Neuroendocrine Lesion,Adult Fibrolamellar Carcinoma
15861,Well Differentiated Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v7
15862,Intermediate Grade Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v7
15863,Low Grade Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v7
15864,Low Grade Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v7
15865,Well Differentiated Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v7
15866,Low Grade Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v7
15867,Intermediate Grade Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v7
15868,Well Differentiated Neuroendocrine Lesion,Stage IIIB Esophageal Cancer AJCC v7
15869,Well Differentiated Neuroendocrine Lesion,Stage IIIC Esophageal Cancer AJCC v7
15870,Intermediate Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by BCLC Stage
15871,Low Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by BCLC Stage
15872,Low Grade Neuroendocrine Lesion,BCLC Stage A Hepatocellular Carcinoma
15873,Intermediate Grade Neuroendocrine Lesion,BCLC Stage B Adult Hepatocellular Carcinoma
15874,Benign Cellular Infiltrate,adult nasal type extranodal NK/T-cell lymphoma
15875,Benign Cellular Infiltrate,Recurrent Childhood Anaplastic Large Cell Lymphoma
15876,Benign Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor
15877,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome recurrent
15878,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
15879,Benign Cellular Infiltrate,Childhood Paranasal Sinus Carcinoma
15880,Well Differentiated Neuroendocrine Lesion,Childhood Rectal Carcinoma
15881,Benign Cellular Infiltrate,Adult Salivary Gland Carcinoma
15882,Benign Cellular Infiltrate,Malignant Fibrohistiocytic Neoplasm
15883,Malignant Cellular Infiltrate,Palisaded encapsulated neuroma
15884,Malignant Cellular Infiltrate,Hybrid nerve sheath tumor
15885,Malignant Cellular Infiltrate,Ectomesenchymal Chondromyxoid Tumor
15886,Benign Cellular Infiltrate,Undifferentiated spindle cell sarcoma
15887,Malignant Cellular Infiltrate,Subungual exostoses
15888,Benign Cellular Infiltrate,Grade III Chondrosarcoma
15889,Malignant Cellular Infiltrate,Bone island
15890,Benign Cellular Infiltrate,Primary Non-Hodgkin Lymphoma of Bone
15891,Benign Cellular Infiltrate,Acute Lymphoblastic Leukemia by Gene Expression Profile
15892,Benign Cellular Infiltrate,Acute Lymphoblastic Leukemia by ROSE Cluster
15893,Benign Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia
15894,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia Not Otherwise Specified
15895,Benign Cellular Infiltrate,Childhood Spindle Cell Rhabdomyosarcoma
15896,Geographic Necrosis,Childhood Mature Teratoma
15897,Mitotic Activity,Childhood Testicular Mature Teratoma
15898,Benign Cellular Infiltrate,Childhood Choriocarcinoma
15899,Benign Cellular Infiltrate,Childhood Mixed Germ Cell Tumor
15900,Benign Cellular Infiltrate,Childhood Ovarian Mixed Germ Cell Tumor
15901,Benign Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Intermixed"
15902,Benign Cellular Infiltrate,Infant Acute Undifferentiated Leukemia
15903,Malignant Cellular Infiltrate,Ovarian Seromucinous Cystadenoma
15904,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma
15905,Malignant Cellular Infiltrate,Ovarian Adenomatoid Tumor
15906,Benign Cellular Infiltrate,High Grade Broad Ligament Serous Adenocarcinoma
15907,Benign Cellular Infiltrate,Oropharyngeal Poorly Differentiated Carcinoma
15908,Benign Cellular Infiltrate,"Endocervical Adenocarcinoma, Usual Type"
15909,Benign Cellular Infiltrate,Cervical Malignant Peripheral Nerve Sheath Tumor
15910,Benign Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma
15911,Benign Cellular Infiltrate,FIGO Stage IVB Ovarian Cancer
15912,Benign Cellular Infiltrate,Ovarian Cancer by AJCC v6 and v7 Stage
15913,Benign Cellular Infiltrate,Malignant Vulvar Phyllodes Tumor
15914,Malignant Cellular Infiltrate,Vulvar Lipoma
15915,Malignant Cellular Infiltrate,Cutaneous neurofibroma
15916,Well Differentiated Neuroendocrine Lesion,Unresectable Esophageal Carcinoma
15917,Benign Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Mutant"
15918,Benign Cellular Infiltrate,Epithelioid glioblastoma
15919,Benign Cellular Infiltrate,Glioblastoma with Primitive Neuronal Component
15920,Benign Cellular Infiltrate,Anaplastic Oligodendroglioma
15921,Benign Cellular Infiltrate,Central Nervous System Embryonal Tumor with Rhabdoid Features
15922,Well Differentiated Neuroendocrine Lesion,Unresectable Digestive System Adenocarcinoma
15923,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition
15924,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
15925,Benign Cellular Infiltrate,Early T Acute Lymphoblastic Leukemia
15926,Benign Cellular Infiltrate,Recurrent Primary Malignant Neoplasm
15927,Benign Cellular Infiltrate,Triple hit lymphoma
15928,Benign Cellular Infiltrate,Unresectable Leiomyosarcoma
15929,Benign Cellular Infiltrate,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
15930,Benign Cellular Infiltrate,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
15931,Benign Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage
15932,Benign Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v8 Stage
15933,Benign Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor
15934,Benign Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
15935,Benign Cellular Infiltrate,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
15936,Benign Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8
15937,Malignant Cellular Infiltrate,Lung Adenofibroma
15938,Benign Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v8
15939,Benign Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v8
15940,Benign Cellular Infiltrate,Metastatic Thyroid Gland Carcinoma
15941,Benign Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck
15942,Low Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Stage
15943,Intermediate Grade Neuroendocrine Lesion,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
15944,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
15945,Low Grade Neuroendocrine Lesion,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
15946,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
15947,Low Grade Neuroendocrine Lesion,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
15948,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
15949,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
15950,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
15951,Well Differentiated Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
15952,Well Differentiated Neuroendocrine Lesion,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
15953,Intermediate Grade Neuroendocrine Lesion,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
15954,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
15955,Benign Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System
15956,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
15957,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
15958,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
15959,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
15960,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
15961,Well Differentiated Neuroendocrine Lesion,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
15962,Well Differentiated Neuroendocrine Lesion,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
15963,Low Grade Neuroendocrine Lesion,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
15964,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
15965,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
15966,Low Grade Neuroendocrine Lesion,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
15967,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
15968,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
15969,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
15970,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
15971,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IV Gastric Cancer AJCC v8
15972,Low Grade Neuroendocrine Lesion,Pathologic Stage I Gastric Cancer AJCC v8
15973,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IB Gastric Cancer AJCC v8
15974,Well Differentiated Neuroendocrine Lesion,Pathologic Stage II Gastric Cancer AJCC v8
15975,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIA Gastric Cancer AJCC v8
15976,Low Grade Neuroendocrine Lesion,Pathologic Stage IV Gastric Cancer AJCC v8
15977,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
15978,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
15979,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
15980,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIB Gastric Cancer AJCC v8
15981,Low Grade Neuroendocrine Lesion,Stage II Anal Cancer AJCC v8
15982,Well Differentiated Neuroendocrine Lesion,Stage IIB Anal Cancer AJCC v8
15983,Low Grade Neuroendocrine Lesion,Stage IV Anal Cancer AJCC v8
15984,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Adenocarcinoma by AJCC v8 Stage
15985,Well Differentiated Neuroendocrine Lesion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
15986,Low Grade Neuroendocrine Lesion,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
15987,Low Grade Neuroendocrine Lesion,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
15988,Low Grade Neuroendocrine Lesion,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
15989,Intermediate Grade Neuroendocrine Lesion,Stage IV Small Intestinal Adenocarcinoma AJCC v8
15990,Intermediate Grade Neuroendocrine Lesion,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
15991,Low Grade Neuroendocrine Lesion,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
15992,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Carcinoma AJCC v8
15993,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Carcinoma AJCC v8
15994,Intermediate Grade Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v8
15995,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v8
15996,Low Grade Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v8
15997,Intermediate Grade Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v8
15998,Low Grade Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v8
15999,Benign Cellular Infiltrate,Refractory Neuroblastoma
16000,Benign Cellular Infiltrate,Recurrent Lymphoma
16001,Intermediate Grade Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v8
16002,Intermediate Grade Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v8
16003,Well Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v8
16004,Intermediate Grade Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v8
16005,Low Grade Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v8
16006,Well Differentiated Neuroendocrine Lesion,Stage IVC Colorectal Cancer AJCC v8
16007,Low Grade Neuroendocrine Lesion,Colon Cancer by AJCC v8 Stage
16008,Intermediate Grade Neuroendocrine Lesion,Stage I Colon Cancer AJCC v8
16009,Low Grade Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v8
16010,Intermediate Grade Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v8
16011,Intermediate Grade Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v8
16012,Low Grade Neuroendocrine Lesion,Stage III Colon Cancer AJCC v8
16013,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v8
16014,Intermediate Grade Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v8
16015,Well Differentiated Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v8
16016,Low Grade Neuroendocrine Lesion,Stage I Intrahepatic Bile Duct Cancer AJCC v8
16017,Well Differentiated Neuroendocrine Lesion,Stage II Intrahepatic Bile Duct Cancer AJCC v8
16018,Low Grade Neuroendocrine Lesion,Stage II Intrahepatic Bile Duct Cancer AJCC v8
16019,Well Differentiated Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v8
16020,Intermediate Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v8
16021,Intermediate Grade Neuroendocrine Lesion,Stage IVA Gallbladder Cancer AJCC v8
16022,Intermediate Grade Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v7 Stage
16023,Well Differentiated Neuroendocrine Lesion,Stage 0 Hilar Cholangiocarcinoma AJCC v8
16024,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
16025,Well Differentiated Neuroendocrine Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8
16026,Intermediate Grade Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v8
16027,Intermediate Grade Neuroendocrine Lesion,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
16028,Low Grade Neuroendocrine Lesion,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
16029,Low Grade Neuroendocrine Lesion,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
16030,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
16031,Intermediate Grade Neuroendocrine Lesion,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
16032,Intermediate Grade Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v8
16033,Low Grade Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v8
16034,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Distal Bile Duct Cancer AJCC v8
16035,Well Differentiated Neuroendocrine Lesion,Stage IIIB Distal Bile Duct Cancer AJCC v8
16036,Low Grade Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v8
16037,Intermediate Grade Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v8
16038,Intermediate Grade Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v8
16039,Low Grade Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v8
16040,Well Differentiated Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v8
16041,Low Grade Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v8
16042,Well Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v8
16043,Poorly Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor
16044,Poorly Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor by AJCC v8 Stage
16045,Poorly Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v8
16046,Poorly Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor
16047,Poorly Differentiated Neuroendocrine Lesion,Stage I Colon Neuroendocrine Tumor AJCC v8
16048,Poorly Differentiated Neuroendocrine Lesion,Stage IIA Colon Neuroendocrine Tumor AJCC v8
16049,Poorly Differentiated Neuroendocrine Lesion,Stage I Rectal Neuroendocrine Tumor AJCC v8
16050,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
16051,Poorly Differentiated Neuroendocrine Lesion,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
16052,Poorly Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
16053,Benign Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v7 Stage
16054,Benign Cellular Infiltrate,Stage IIIA Pleural Malignant Mesothelioma AJCC v8
16055,Benign Cellular Infiltrate,Stage 0 Lung Cancer AJCC v8
16056,Benign Cellular Infiltrate,Stage IA1 Lung Cancer AJCC v8
16057,Benign Cellular Infiltrate,Stage IV Lung Cancer AJCC v8
16058,Benign Cellular Infiltrate,Refractory Acute Lymphoblastic Leukemia
16059,Benign Cellular Infiltrate,Lung Adenocarcinoma by AJCC v7 Stage
16060,Benign Cellular Infiltrate,Stage IB Bone Cancer AJCC v8
16061,Benign Cellular Infiltrate,Stage IV Bone Cancer AJCC v8
16062,Benign Cellular Infiltrate,Lung Enteric Adenocarcinoma
16063,Benign Cellular Infiltrate,keratinizing squamous cell carcinoma of lung
16064,Benign Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ
16065,Benign Cellular Infiltrate,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
16066,Benign Cellular Infiltrate,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
16067,Benign Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8
16068,Benign Cellular Infiltrate,Stage IIIB Retroperitoneal Sarcoma AJCC v8
16069,Benign Cellular Infiltrate,Stage IV Retroperitoneal Sarcoma AJCC v8
16070,Benign Cellular Infiltrate,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
16071,Benign Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
16072,Benign Cellular Infiltrate,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
16073,Benign Cellular Infiltrate,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
16074,Benign Cellular Infiltrate,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma
16075,Benign Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8
16076,Benign Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Pathologic Stage
16077,Benign Cellular Infiltrate,Pathologic Stage IB Cutaneous Melanoma AJCC v8
16078,Benign Cellular Infiltrate,Pathologic Stage IIB Cutaneous Melanoma AJCC v8
16079,Benign Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
16080,Benign Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma
16081,Benign Cellular Infiltrate,Luminal B Prostate Carcinoma
16082,Benign Cellular Infiltrate,Anatomic Stage 0 Breast Cancer AJCC v8
16083,Benign Cellular Infiltrate,Vulvar Cancer by AJCC v8 Stage
16084,Benign Cellular Infiltrate,Vaginal Cancer by AJCC v8 Stage
16085,Benign Cellular Infiltrate,Stage IA Vaginal Cancer AJCC v8
16086,Benign Cellular Infiltrate,Stage IIA Vaginal Cancer AJCC v8
16087,Benign Cellular Infiltrate,Stage III Vaginal Cancer AJCC v8
16088,Benign Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v8
16089,Benign Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v8
16090,Benign Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v8
16091,Benign Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v8
16092,Benign Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v8
16093,Benign Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v8 Stage
16094,Benign Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8
16095,Benign Cellular Infiltrate,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
16096,Benign Cellular Infiltrate,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
16097,Benign Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8
16098,Benign Cellular Infiltrate,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
16099,Benign Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v8
16100,Benign Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8
16101,Benign Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v8
16102,Benign Cellular Infiltrate,Stage IIIA2 Fallopian Tube Cancer AJCC v8
16103,Benign Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8
16104,Benign Cellular Infiltrate,Penile Cancer by AJCC v8 Stage
16105,Benign Cellular Infiltrate,Stage III Penile Cancer AJCC v8
16106,Benign Cellular Infiltrate,Stage IV Penile Cancer AJCC v8
16107,Benign Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v8
16108,Benign Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v8
16109,Benign Cellular Infiltrate,Renal Cell Cancer by AJCC v8 Stage
16110,Benign Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v8
16111,Benign Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v8
16112,Benign Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v8
16113,Benign Cellular Infiltrate,Stage I Bladder Cancer AJCC v8
16114,Benign Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8
16115,Benign Cellular Infiltrate,Stage I Urethral Cancer AJCC v8
16116,Benign Cellular Infiltrate,Eyelid Carcinoma by AJCC v8 Stage
16117,Benign Cellular Infiltrate,Stage I Eyelid Carcinoma AJCC v8
16118,Benign Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v8
16119,Benign Cellular Infiltrate,Clinical Stage IV Retinoblastoma AJCC v8
16120,Benign Cellular Infiltrate,Pathologic Stage III Retinoblastoma AJCC v8
16121,Benign Cellular Infiltrate,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
16122,Benign Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
16123,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
16124,Benign Cellular Infiltrate,Recurrent Extensive Stage Lung Small Cell Carcinoma
16125,Benign Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v7 Stage
16126,Benign Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v8
16127,Benign Cellular Infiltrate,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8
16128,Benign Cellular Infiltrate,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8
16129,Benign Cellular Infiltrate,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage
16130,Benign Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage
16131,Benign Cellular Infiltrate,Centroblastic Lymphoma by Ann Arbor Stage
16132,Benign Cellular Infiltrate,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8
16133,Benign Cellular Infiltrate,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
16134,Benign Cellular Infiltrate,Plasma Cell Myeloma by RISS Stage
16135,Benign Cellular Infiltrate,Thoracic NUT Carcinoma
16136,Malignant Cellular Infiltrate,Benign Lung PEComa
16137,Low Grade Neuroendocrine Lesion,Refractory Pancreatic Carcinoma
16138,Benign Cellular Infiltrate,Refractory Medulloblastoma
16139,Well Differentiated Neuroendocrine Lesion,Metastatic Bile Duct Carcinoma
16140,Intermediate Grade Neuroendocrine Lesion,Advanced Bile Duct Carcinoma
16141,Benign Cellular Infiltrate,Stage III Malignant Mediastinal Germ Cell Tumor
16142,Benign Cellular Infiltrate,Metastatic Epithelioid Hemangioendothelioma
16143,Benign Cellular Infiltrate,Cardiac Myxofibrosarcoma
16144,Benign Cellular Infiltrate,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
16145,Well Differentiated Neuroendocrine Lesion,Refractory Gastric Carcinoma
16146,Benign Cellular Infiltrate,Advanced B-Cell Neoplasm
16147,Benign Cellular Infiltrate,Unresectable Carcinoma
16148,Benign Cellular Infiltrate,Refractory Thymic Carcinoma
16149,Benign Cellular Infiltrate,Refractory Indolent Adult Non-Hodgkin Lymphoma
16150,Benign Cellular Infiltrate,Refractory Stage 0 Bladder Cancer AJCC v6 and v7
16151,Benign Cellular Infiltrate,Refractory Undifferentiated Pleomorphic Sarcoma
16152,Benign Cellular Infiltrate,Refractory Synovial Sarcoma
16153,Benign Cellular Infiltrate,Recurrent Sarcoma
16154,Benign Cellular Infiltrate,Unresectable Sarcoma
16155,Benign Cellular Infiltrate,Refractory Leukemia
16156,Benign Cellular Infiltrate,Refractory Nasopharyngeal Carcinoma
16157,Benign Cellular Infiltrate,Advanced Uveal Melanoma
16158,Well Differentiated Neuroendocrine Lesion,Cervical Esophagus Squamous Cell Carcinoma
16159,Benign Cellular Infiltrate,Refractory Uterine Corpus Carcinoma
16160,Benign Cellular Infiltrate,Refractory Endometrial Carcinoma
16161,Benign Cellular Infiltrate,Recurrent Ovarian Endometrioid Adenocarcinoma
16162,Benign Cellular Infiltrate,Refractory Endometrial Endometrioid Adenocarcinoma
16163,Benign Cellular Infiltrate,Refractory Bladder Carcinoma
16164,Benign Cellular Infiltrate,Platinum-Resistant Urothelial Carcinoma
16165,Benign Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma
16166,Benign Cellular Infiltrate,Urothelial carcinoma ureter metastatic
16167,Benign Cellular Infiltrate,Recurrent Malignant Skin Neoplasm
16168,Benign Cellular Infiltrate,Unresectable Dedifferentiated Liposarcoma
16169,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction
16170,Benign Cellular Infiltrate,Refractory Head and Neck Carcinoma
16171,Benign Cellular Infiltrate,Recurrent Burkitt Leukemia
16172,Benign Cellular Infiltrate,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
16173,Benign Cellular Infiltrate,Abdominal Rhabdomyosarcoma
16174,Benign Cellular Infiltrate,Unresectable Rhabdomyosarcoma
16175,Low Grade Neuroendocrine Lesion,Resectable Pancreatic Ductal Adenocarcinoma
16176,Intermediate Grade Neuroendocrine Lesion,Distal Esophagus Adenocarcinoma
16177,Low Grade Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
16178,Benign Cellular Infiltrate,Refractory Lung Non-Small Cell Carcinoma
16179,Benign Cellular Infiltrate,Recurrent Mediastinal Lymphoma
16180,Benign Cellular Infiltrate,Metastatic Lung Carcinoma
16181,Well Differentiated Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Lung
16182,Benign Cellular Infiltrate,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
16183,Benign Cellular Infiltrate,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
16184,Well Differentiated Neuroendocrine Lesion,Refractory Colon Carcinoma
16185,Low Grade Neuroendocrine Lesion,Refractory Colon Carcinoma
16186,Low Grade Neuroendocrine Lesion,Refractory Bile Duct Carcinoma
16187,Intermediate Grade Neuroendocrine Lesion,Recurrent Gastroesophageal Junction Adenocarcinoma
16188,Low Grade Neuroendocrine Lesion,Recurrent Gastroesophageal Junction Adenocarcinoma
16189,Benign Cellular Infiltrate,Metastatic Cervical Adenocarcinoma
16190,Benign Cellular Infiltrate,Metastatic Cervical Adenosquamous Carcinoma
16191,Benign Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma
16192,Benign Cellular Infiltrate,Recurrent Skin Angiosarcoma
16193,Benign Cellular Infiltrate,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
16194,Benign Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
16195,Benign Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
16196,Well Differentiated Neuroendocrine Lesion,Recurrent Fibrolamellar Carcinoma
16197,Low Grade Neuroendocrine Lesion,Hepatic cancer metastatic
16198,Benign Cellular Infiltrate,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified"
16199,Metastatic Lesion,Plurimorphous Plurihormonal Pituitary Gland Adenoma
16200,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Renal Cell Carcinoma
16201,Indolent Clinical Course,Recurrent Sarcoma of the Extremity
16202,Benign Cellular Infiltrate,Recurrent Sarcoma of the Extremity
16203,Intracytoplasmic Eosinophilic Inclusion,Advanced Sarcoma of the Extremity
16204,Extensive Stage Lesion,Locally Advanced Unresectable Carcinoma
16205,Anaplasia,Sellar Ependymoma
16206,Metastatic Lesion,Pituitary Gland Diffuse Large B-Cell Lymphoma
16207,Mitotic Activity,Sellar Mature Teratoma
16208,Indolent Clinical Course,Sellar Teratoma with Malignant Transformation
16209,Well Differentiated Neuroendocrine Lesion,Unresectable Digestive System Carcinoma
16210,Poorly Differentiated Lesion,Metastatic Lung Adenocarcinoma
16211,Squamous Differentiation,Metastatic Lung Adenocarcinoma
16212,Low Mitotic Activity,Locally Advanced Pancreatic Neuroendocrine Carcinoma
16213,Benign Cellular Infiltrate,Locally Advanced Pancreatic Neuroendocrine Carcinoma
16214,Extensive Stage Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
16215,Benign Cellular Infiltrate,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome
16216,Mixed Neoplastic Glandular and Squamous Cell Population,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome
16217,Mucoid Stroma Formation,Epididymal Papillary Cystadenoma
16218,Malignant Cellular Infiltrate,Epididymal Papillary Cystadenoma
16219,Capsular Invasion,Thyroid Gland Spindle Cell Follicular Adenoma
16220,Nuclear Clearing,Thyroid Gland Black Follicular Adenoma
16221,Invasive Lesion,Encapsulated Variant Thyroid Gland Papillary Carcinoma
16222,Precise Histogenesis Unknown,Third Ventricle Pilocytic Astrocytoma
16223,Multilayered Rosette Formation,Fourth Ventricle Medulloblastoma
16224,Mixed Neoplastic Glandular and Squamous Cell Population,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
16225,Benign Cellular Infiltrate,Hobnail Variant Thyroid Gland Papillary Carcinoma
16226,Benign Cellular Infiltrate,Metastatic Esophageal Carcinoma
16227,Low Grade Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma
16228,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Lip Squamous Cell Carcinoma
16229,Premalignant Lesion,Lung squamous cell carcinoma stage IV
16230,Low Grade Neuroendocrine Lesion,Metastatic Colorectal Carcinoma
16231,Benign Cellular Infiltrate,Metastatic Colorectal Carcinoma
16232,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Thyroid Gland Papillary Carcinoma
16233,Benign Cellular Infiltrate,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
16234,Benign Cellular Infiltrate,Localized Gastric Carcinoma
16235,Intermediate Filaments Present,sarcoma of tongue
16236,Intracytoplasmic Eosinophilic Inclusion,Colon Liposarcoma
16237,Indolent Clinical Course,Parotid Gland Liposarcoma
16238,Intracytoplasmic Eosinophilic Inclusion,Parotid Gland Liposarcoma
16239,Indolent Clinical Course,Scrotal Sarcoma
16240,Benign Cellular Infiltrate,Scrotal Sarcoma
16241,Benign Cellular Infiltrate,Locally Advanced Prostate Carcinoma
16242,Benign Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma
16243,Benign Cellular Infiltrate,Locally Advanced Unresectable Prostate Adenocarcinoma
16244,Benign Cellular Infiltrate,Locally Advanced Cervical Adenocarcinoma
16245,Benign Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma
16246,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma
16247,Benign Cellular Infiltrate,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
16248,High Mitotic Activity,Brain Ependymoma
16249,Local disease,Advanced Carcinoid Tumor
16250,Severe cytologic atypia,Pancreatic neuroendocrine tumor metastatic
16251,Benign Cellular Infiltrate,Advanced Pancreatic Neuroendocrine Tumor
16252,Low Mitotic Activity,Metastatic Gastric Neuroendocrine Carcinoma
16253,Low Grade Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
16254,Low Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma
16255,Intermediate Grade Neuroendocrine Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
16256,Low Grade Neuroendocrine Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
16257,Benign Cellular Infiltrate,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
16258,Benign Cellular Infiltrate,Malignant Peritoneal and Retroperitoneal Neoplasm
16259,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myelomonocytic Leukemia
16260,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
16261,Secondary Lesion,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
16262,Intermediate Grade Neuroendocrine Lesion,Advanced Digestive System Carcinoma
16263,Low Grade Neuroendocrine Lesion,Biliary Tract Carcinoma
16264,Premalignant Lesion,Malignant neoplasm of bronchus
16265,Benign Cellular Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma
16266,Well Differentiated Neuroendocrine Lesion,Resectable Intrahepatic Cholangiocarcinoma
16267,Intermediate Grade Neuroendocrine Lesion,Bile duct adenocarcinoma resectable
16268,Low Grade Neuroendocrine Lesion,Bile duct adenocarcinoma resectable
16269,Indolent Clinical Course,Adrenal Gland Sarcoma
16270,Benign Cellular Infiltrate,Secondary Acute Myeloid Leukemia
16271,Poorly Differentiated Neuroendocrine Lesion,Vipoma
16272,Benign Cellular Infiltrate,"Carcinoma, Spindle-Cell"
16273,Malignant Cellular Infiltrate,Epithelioid and spindle cell nevus
16274,Benign Cellular Infiltrate,Stage IVB Vulvar Cancer AJCC v6 and v7
16275,Poorly Differentiated Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
16276,Benign Cellular Infiltrate,Eccrine carcinoma of skin
16277,Low Grade Neuroendocrine Lesion,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
16278,Low Grade Neuroendocrine Lesion,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
16279,Well Differentiated Neuroendocrine Lesion,Periampullary Adenocarcinoma
16280,Low Grade Neuroendocrine Lesion,Periampullary Adenocarcinoma
16281,Intermediate Grade Neuroendocrine Lesion,Carcinoma duodenum resectable
16282,Benign Cellular Infiltrate,Childhood Yolk Sac Tumor
16283,Benign Cellular Infiltrate,Adult Pleomorphic Rhabdomyosarcoma
16284,Benign Cellular Infiltrate,Childhood Desmoplastic Small Round Cell Tumor
16285,Benign Cellular Infiltrate,Mucin-producing adenocarcinoma
16286,Benign Cellular Infiltrate,Carcinomatosis of peritoneal cavity
16287,Intermediate Grade Neuroendocrine Lesion,"Hepatocellular carcinoma, scirrhous"
16288,Benign Cellular Infiltrate,Carcinoma Arising in Nasal Papillomatosis
16289,Mitotic Activity,Childhood Central Nervous System Mature Teratoma
16290,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Mucinous Adenocarcinoma
16291,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Adenosquamous Carcinoma
16292,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma
16293,Well Differentiated Neuroendocrine Lesion,Undifferentiated carcinoma of esophagus
16294,Low Grade Neuroendocrine Lesion,Undifferentiated carcinoma of esophagus
16295,Benign Cellular Infiltrate,Disseminated Malignant Neoplasm
16296,Benign Cellular Infiltrate,Secondary Chondrosarcoma
16297,Benign Cellular Infiltrate,Granular Cell Leiomyosarcoma
16298,Benign Cellular Infiltrate,Extraskeletal Myxoid Chondrosarcoma
16299,Malignant Cellular Infiltrate,Glomeruloid hemangioma
16300,Malignant Cellular Infiltrate,Hobnail Hemangioma
16301,Malignant Cellular Infiltrate,Hemangioma of Peripheral Nerve
16302,Malignant Cellular Infiltrate,Epidermolytic acanthoma
16303,Malignant Cellular Infiltrate,Desmoplastic trichilemmoma
16304,Benign Cellular Infiltrate,Transplant-Related Malignant Neoplasm
16305,Low Grade Neuroendocrine Lesion,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
16306,Benign Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
16307,Benign Cellular Infiltrate,EBV-Related Carcinoma
16308,Benign Cellular Infiltrate,Therapy-related myelodysplastic syndrome
16309,Benign Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
16310,Benign Cellular Infiltrate,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
16311,Low Grade Neuroendocrine Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma
16312,Benign Cellular Infiltrate,Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
16313,Benign Cellular Infiltrate,Metastatic Urethral Carcinoma
16314,Benign Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma
16315,Benign Cellular Infiltrate,Papillary renal cell carcinoma type 2
16316,Benign Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor
16317,Benign Cellular Infiltrate,Poorly Differentiated Prostate Adenocarcinoma
16318,Well Differentiated Neuroendocrine Lesion,Advanced Adult Hepatocellular Carcinoma
16319,Poorly Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
16320,Benign Cellular Infiltrate,Adenocarcinoma of prostate
16321,Poorly Differentiated Neuroendocrine Lesion,insulinoma
16322,Benign Cellular Infiltrate,Acute Basophilic Leukemia
16323,Benign Cellular Infiltrate,Acute lymphocytic leukemia
16324,Benign Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
16325,Benign Cellular Infiltrate,Prolymphocytic Leukemia
16326,Benign Cellular Infiltrate,Acute Promyelocytic Leukemia
16327,Malignant Cellular Infiltrate,"Lipomatosis, Multiple Symmetrical"
16328,Benign Cellular Infiltrate,Mycosis Fungoides
16329,Benign Cellular Infiltrate,Pseudomyxoma Peritonei
16330,Benign Cellular Infiltrate,Sezary Syndrome
16331,Malignant Cellular Infiltrate,benign neoplasm of lower jaw bone
16332,Benign Cellular Infiltrate,Chronic leukemia (category)
16333,Malignant Cellular Infiltrate,Atrial myxoma
16334,Benign Cellular Infiltrate,Adenocarcinoma of lung (disorder)
16335,Benign Cellular Infiltrate,Malignant tumor of peritoneum
16336,Well Differentiated Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma
16337,Benign Cellular Infiltrate,Malignant neoplasm of subglottis
16338,Benign Cellular Infiltrate,Malignant Uterine Corpus Neoplasm
16339,Benign Cellular Infiltrate,Malignant neoplasm of cornea
16340,Benign Cellular Infiltrate,Malignant neoplasm of choroid
16341,Benign Cellular Infiltrate,Malignant neoplasm of cerebellum
16342,Benign Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7
16343,Benign Cellular Infiltrate,epithelial-myoepithelial carcinoma of salivary gland
16344,Benign Cellular Infiltrate,adenosquamous carcinoma of salivary gland
16345,Malignant Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland
16346,Benign Cellular Infiltrate,Epithelioid Cell Uveal Melanoma
16347,Benign Cellular Infiltrate,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites"
16348,Benign Cellular Infiltrate,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
16349,Benign Cellular Infiltrate,Head and Neck Carcinoma
16350,Benign Cellular Infiltrate,Endemic African Kaposi Sarcoma
16351,Benign Cellular Infiltrate,Bronchogenic Carcinoma
16352,Malignant Cellular Infiltrate,Benign neoplasm of the lip
16353,Malignant Cellular Infiltrate,Benign neoplasm of tongue
16354,Benign Cellular Infiltrate,Locally Metastatic Malignant Neoplasm
16355,Malignant Cellular Infiltrate,Benign neoplasm of small intestine
16356,Malignant Cellular Infiltrate,Benign tumor of mediastinum
16357,Benign Cellular Infiltrate,Intermediate Grade Malignant Neoplasm
16358,Benign Cellular Infiltrate,Acute Myeloid Leukemia with a Variant RARA Translocation
16359,Intermediate Grade Neuroendocrine Lesion,Klatskin Tumor
16360,Geographic Necrosis,Testicular Dermoid Cyst
16361,Benign Cellular Infiltrate,Early Invasive Cervical Squamous Cell Carcinoma
16362,Malignant Cellular Infiltrate,Benign neoplasm vagina
16363,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation
16364,Malignant Cellular Infiltrate,Benign neoplasm of thyroid gland
16365,Malignant Cellular Infiltrate,Benign neoplasm of parathyroid gland
16366,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Brain
16367,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
16368,Low Grade Neuroendocrine Lesion,"Carcinoid, Goblet Cell"
16369,Benign Cellular Infiltrate,"Liposarcoma, Pleomorphic"
16370,Malignant Cellular Infiltrate,"Fibro-odontoma, Ameloblastic"
16371,Benign Cellular Infiltrate,"Neuroectodermal Tumor, Primitive"
16372,Benign Cellular Infiltrate,alk-positive anaplastic large cell lymphoma
16373,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
16374,Malignant Cellular Infiltrate,"Histiocytoma, Benign Fibrous"
16375,Benign Cellular Infiltrate,Embryonal Carcinoma
16376,Benign Cellular Infiltrate,Teratocarcinoma
16377,Malignant Cellular Infiltrate,Adenomatoid Tumor
16378,Low Grade Neuroendocrine Lesion,Pancreatic Endocrine Carcinoma
16379,Benign Cellular Infiltrate,gliosarcoma
16380,Benign Cellular Infiltrate,"Melanoma, Amelanotic"
16381,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges
16382,Intermediate Grade Neuroendocrine Lesion,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
16383,Malignant Cellular Infiltrate,Bladder papilloma
16384,Well Differentiated Neuroendocrine Lesion,Gallbladder Carcinoma
16385,Borderline Lesion,Dermoid cyst of ovary
16386,Benign Cellular Infiltrate,Carcinoma of Male Breast
16387,Benign Cellular Infiltrate,Composite Lymphoma
16388,Benign Cellular Infiltrate,Nasopharyngeal carcinoma
16389,Benign Cellular Infiltrate,"Carcinoma, Small Cell"
16390,Capsular Invasion,Parathyroid Adenoma
16391,Perineural spread,Parathyroid Adenoma
16392,Benign Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta
16393,Benign Cellular Infiltrate,Hereditary Renal Cell Carcinoma
16394,Benign Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma
16395,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
16396,Benign Cellular Infiltrate,verrucous carcinoma of bladder
16397,Benign Cellular Infiltrate,hepatoid adenocarcinoma of bladder
16398,Benign Cellular Infiltrate,Bladder Mixed Adenocarcinoma
16399,Benign Cellular Infiltrate,Bladder Diffuse Clear Cell Adenocarcinoma
16400,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
16401,Benign Cellular Infiltrate,Secondary Prostate Urothelial Carcinoma
16402,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Microcystic Pattern"
16403,Low Grade Neuroendocrine Lesion,Stage II Colon Cancer
16404,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
16405,Benign Cellular Infiltrate,Testicular Monophasic Choriocarcinoma
16406,Intermediate Grade Neuroendocrine Lesion,Stage IV Colon Carcinoma
16407,Malignant Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor
16408,Malignant Cellular Infiltrate,fibroma of testis
16409,Benign Cellular Infiltrate,Mixed Squamous Cell Carcinoma of the Penis
16410,Malignant Cellular Infiltrate,Ovarian Stromal-Leydig Cell Tumor
16411,Low Grade Neuroendocrine Lesion,Colon cancer recurrent
16412,Benign Cellular Infiltrate,Ovarian Primitive Germ Cell Tumor
16413,Low Grade Neuroendocrine Lesion,Esophageal carcinoma recurrent
16414,Benign Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma
16415,Malignant Cellular Infiltrate,Adenoma of rete ovarii
16416,Benign Cellular Infiltrate,Malignant Ovarian Mucinous Tumor
16417,Benign Cellular Infiltrate,mucinous adenocarcinofibroma of ovary
16418,Benign Cellular Infiltrate,Malignant Childhood Neoplasm
16419,Benign Cellular Infiltrate,undifferentiated sarcoma of ovary
16420,Malignant Cellular Infiltrate,Borderline Ovarian Endometrioid Adenofibroma
16421,Intermediate Grade Neuroendocrine Lesion,Recurrent Cancer of Gallbladder
16422,Malignant Cellular Infiltrate,Borderline Ovarian Clear Cell Cystadenofibroma
16423,Benign Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma
16424,Benign Cellular Infiltrate,Fallopian Tube Transitional Cell Carcinoma
16425,Malignant Cellular Infiltrate,Fallopian Tube Serous Adenofibroma
16426,Malignant Cellular Infiltrate,Cystadenofibroma of fallopian tube
16427,Malignant Cellular Infiltrate,Fallopian Tube Metaplastic Papillary Tumor
16428,Benign Cellular Infiltrate,Metastatic non-small cell lung cancer
16429,Benign Cellular Infiltrate,carcinosarcoma of fallopian tube
16430,Benign Cellular Infiltrate,Fallopian Tube Adenosarcoma
16431,Benign Cellular Infiltrate,Uterine Ligament Mucinous Adenocarcinoma
16432,Benign Cellular Infiltrate,Uterine Ligament Clear Cell Adenocarcinoma
16433,Benign Cellular Infiltrate,Grade 1 Endometrial Mucinous Adenocarcinoma
16434,Benign Cellular Infiltrate,Endometrial Undifferentiated Carcinoma
16435,Malignant Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma
16436,Malignant Cellular Infiltrate,Uterine Corpus Lipoleiomyoma
16437,Benign Cellular Infiltrate,Cervical Verrucous Carcinoma
16438,Benign Cellular Infiltrate,Cervical Warty Carcinoma
16439,Benign Cellular Infiltrate,Fibroblastic osteosarcoma
16440,Benign Cellular Infiltrate,Cervical Serous Adenocarcinoma
16441,Benign Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
16442,Benign Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
16443,Benign Cellular Infiltrate,Adenoid basal carcinoma of cervix uteri
16444,Malignant Cellular Infiltrate,Cervical Mullerian Papilloma
16445,Benign Cellular Infiltrate,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
16446,Benign Cellular Infiltrate,Undifferentiated Endocervical Sarcoma
16447,Benign Cellular Infiltrate,Adenosarcoma of cervix uteri
16448,Well Differentiated Neuroendocrine Lesion,Squamous cell carcinoma of esophagus
16449,Intermediate Grade Neuroendocrine Lesion,Squamous cell carcinoma of esophagus
16450,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma Of Esophagus
16451,Benign Cellular Infiltrate,Cervical Mesonephric Adenocarcinoma
16452,Benign Cellular Infiltrate,Vaginal Adenosquamous Carcinoma
16453,Malignant Cellular Infiltrate,Cervical Rhabdomyoma
16454,Benign Cellular Infiltrate,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm
16455,Benign Cellular Infiltrate,Cervical Squamous Cell Carcinoma
16456,Benign Cellular Infiltrate,basaloid squamous cell carcinoma of vulva
16457,Benign Cellular Infiltrate,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
16458,Malignant Cellular Infiltrate,Bartholin Gland Adenomyoma
16459,Malignant Cellular Infiltrate,Vulvar Syringoma
16460,Malignant Cellular Infiltrate,Vulvar Trichoepithelioma
16461,Malignant Cellular Infiltrate,Vulvar Congenital Melanocytic Nevus
16462,Malignant Cellular Infiltrate,Vulvar Blue Nevus
16463,Benign Cellular Infiltrate,adenosquamous carcinoma of breast
16464,Benign Cellular Infiltrate,Burkitt's lymphoma of breast
16465,Benign Cellular Infiltrate,Post-Radiotherapy Breast Angiosarcoma
16466,Malignant Cellular Infiltrate,Breast Pleomorphic Adenoma
16467,Malignant Cellular Infiltrate,Ovarian Cystadenoma
16468,Malignant Cellular Infiltrate,Papilloma of eyelid
16469,Benign Cellular Infiltrate,"Malignant tumor, giant cell type"
16470,Benign Cellular Infiltrate,polyembryoma of testis
16471,Benign Cellular Infiltrate,Acantholytic squamous cell carcinoma
16472,Benign Cellular Infiltrate,Multifocal superficial basal cell carcinoma
16473,Benign Cellular Infiltrate,"Polycythemia Vera, Polycythemic Phase"
16474,Benign Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
16475,Intermediate Grade Neuroendocrine Lesion,Bile duct cystadenocarcinoma
16476,Malignant Cellular Infiltrate,Alveolar adenoma
16477,Malignant Cellular Infiltrate,Chief cell adenoma
16478,Low Grade Neuroendocrine Lesion,Mucin-Producing Intrahepatic Cholangiocarcinoma
16479,Malignant Cellular Infiltrate,Syringocystadenoma Papilliferum
16480,Malignant Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor
16481,Benign Cellular Infiltrate,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
16482,Benign Cellular Infiltrate,Balloon cell malignant melanoma
16483,Benign Cellular Infiltrate,Malignant melanoma in junctional nevus
16484,Malignant Cellular Infiltrate,Benign neoplasm of soft tissue
16485,Malignant Cellular Infiltrate,Fibrolipoma
16486,Benign Cellular Infiltrate,Mixed Liposarcoma
16487,Malignant Cellular Infiltrate,Endometrial stromal nodule
16488,Benign Cellular Infiltrate,Myxoid chondrosarcoma
16489,Malignant Cellular Infiltrate,"Odontogenic tumor, benign"
16490,Benign Cellular Infiltrate,Medulloepithelioma
16491,Malignant Cellular Infiltrate,Benign Germinative Follicular Epithelium Neoplasm
16492,Malignant Cellular Infiltrate,Benign Pilar-Associated Mesenchyme Neoplasm
16493,Benign Cellular Infiltrate,Trichilemmocarcinoma
16494,Malignant Cellular Infiltrate,Superficial Epithelioma with Sebaceous Differentiation
16495,Malignant Cellular Infiltrate,Sebaceoma
16496,Benign Cellular Infiltrate,Extraocular Cutaneous Sebaceous Carcinoma
16497,Benign Cellular Infiltrate,Ductal Eccrine Carcinoma with Spindle Cell Elements
16498,Malignant Cellular Infiltrate,Sporadic Cylindroma
16499,Malignant Cellular Infiltrate,Hidroacanthoma simplex
16500,Benign Cellular Infiltrate,Hutchinson's Melanotic Freckle
16501,Intermediate Grade Neuroendocrine Lesion,Sporadic Gastric Adenocarcinoma
16502,Well Differentiated Neuroendocrine Lesion,Small Intestinal Adenosquamous Carcinoma
16503,Well Differentiated Neuroendocrine Lesion,Small Intestinal Signet Ring Cell Carcinoma
16504,Intermediate Grade Neuroendocrine Lesion,Appendix Mixed Adenoneuroendocrine Carcinoma
16505,Intermediate Grade Neuroendocrine Lesion,Colorectal Small Cell Neuroendocrine Carcinoma
16506,Low Grade Neuroendocrine Lesion,Rectosigmoid Mucinous Adenocarcinoma
16507,Intermediate Grade Neuroendocrine Lesion,Rectal Adenosquamous Carcinoma
16508,Intermediate Grade Neuroendocrine Lesion,Sarcomatoid Hepatocellular Carcinoma
16509,Malignant Cellular Infiltrate,Benign neoplasm of hard palate
16510,Intermediate Grade Neuroendocrine Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
16511,Malignant Cellular Infiltrate,Benign neoplasm of retroperitoneum
16512,Malignant Cellular Infiltrate,Adenoma of lung
16513,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of skin
16514,Malignant Cellular Infiltrate,Desmoplastic Nevus
16515,Malignant Cellular Infiltrate,Benign neoplasm of breast
16516,Benign Cellular Infiltrate,Choriocarcinoma of ovary
16517,Benign Cellular Infiltrate,Primary cutaneous diffuse large cell B-cell lymphoma
16518,Benign Cellular Infiltrate,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
16519,Benign Cellular Infiltrate,Malignant tumor of choroid plexus
16520,Benign Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype"
16521,Benign Cellular Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
16522,Benign Cellular Infiltrate,Adenocarcinoma of lacrimal gland
16523,Well Differentiated Neuroendocrine Lesion,Colon Intramucosal Adenocarcinoma
16524,Malignant Cellular Infiltrate,Vulvar Angiomyofibroblastoma
16525,Benign Cellular Infiltrate,Fetal Lung Adenocarcinoma
16526,Benign Cellular Infiltrate,High Grade Lung Neuroendocrine Neoplasm
16527,Benign Cellular Infiltrate,Lung Synovial Sarcoma
16528,Benign Cellular Infiltrate,Lung Biphasic Synovial Sarcoma
16529,Benign Cellular Infiltrate,Malignant neoplasm of epicardium
16530,Benign Cellular Infiltrate,Malignant tumor of myocardium
16531,Benign Cellular Infiltrate,Malignant neoplasm of respiratory system
16532,Benign Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy
16533,Benign Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy
16534,Benign Cellular Infiltrate,Mediastinal T Acute Lymphoblastic Leukemia
16535,Malignant Cellular Infiltrate,Cystic tumor of atrio-ventricular node
16536,Benign Cellular Infiltrate,Malignant neoplasm of cerebrum
16537,Benign Cellular Infiltrate,Kaposi's sarcoma of cornea
16538,Benign Cellular Infiltrate,Secondary malignant neoplasm of eye
16539,Benign Cellular Infiltrate,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
16540,Low Grade Neuroendocrine Lesion,Carcinoma in situ of cecum
16541,Benign Cellular Infiltrate,squamous cell carcinoma of the thyroid gland
16542,Malignant Cellular Infiltrate,Benign neoplasm of middle ear
16543,Benign Cellular Infiltrate,Clear Cell Variant Thyroid Gland Follicular Carcinoma
16544,Malignant Cellular Infiltrate,Thyroid Gland Clear Cell Follicular Adenoma
16545,Malignant Cellular Infiltrate,Lipoma of external auditory meatus
16546,Malignant Cellular Infiltrate,Lipoma of spinal cord
16547,Benign Cellular Infiltrate,Primary malignant neoplasm of glomus jugulare
16548,Geographic Necrosis,Dermoid cyst of skin
16549,Benign Cellular Infiltrate,Amelanotic Skin Melanoma
16550,Intermediate Grade Neuroendocrine Lesion,Gastric Carcinoid Tumor
16551,Benign Cellular Infiltrate,Squamous cell carcinoma of scrotum
16552,Benign Cellular Infiltrate,Squamous cell carcinoma of tongue
16553,Benign Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia
16554,Benign Cellular Infiltrate,T-Cell Prolymphocytic Leukemia
16555,Benign Cellular Infiltrate,Malignant neoplasm of pituitary gland
16556,Malignant Cellular Infiltrate,Benign male reproductive tract neoplasm
16557,Malignant Cellular Infiltrate,Benign neoplasm of ciliary body
16558,Benign Cellular Infiltrate,Breast Carcinoma with Osseous Metaplasia
16559,Malignant Cellular Infiltrate,Benign digestive system neoplasms
16560,Malignant Cellular Infiltrate,Left atrial myxoma
16561,Malignant Cellular Infiltrate,Right atrial myxoma
16562,Benign Cellular Infiltrate,Thyroid carcinoma
16563,Benign Cellular Infiltrate,Neuroblastoma of brain
16564,Benign Cellular Infiltrate,Adrenal neuroblastoma
16565,Broad Fibrous Bands Formation,Parathyroid Gland Lipoadenoma
16566,Benign Cellular Infiltrate,Retroperitoneal sarcoma
16567,Malignant Cellular Infiltrate,Aldosterone-Producing Adrenal Cortex Adenoma
16568,Benign Cellular Infiltrate,Invasive Prostate Carcinoma
16569,Benign Cellular Infiltrate,M5b Acute differentiated monocytic leukemia
16570,Benign Cellular Infiltrate,Melanoma in Congenital Melanocytic Nevus
16571,Benign Cellular Infiltrate,Mucosal lentiginous melanoma
16572,Malignant Cellular Infiltrate,Benign neoplasm of pyriform sinus
16573,Malignant Cellular Infiltrate,Benign neoplasm of endometrium
16574,Well Differentiated Neuroendocrine Lesion,Stomach Carcinoma
16575,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of ileum
16576,Benign Cellular Infiltrate,Supraglottic Squamous Cell Carcinoma
16577,Benign Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant"
16578,Benign Cellular Infiltrate,Malignant neoplasm of thymus
16579,Benign Cellular Infiltrate,Infratentorial Cancer
16580,Benign Cellular Infiltrate,Primary Carcinoma Unspecified Site
16581,Benign Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma
16582,Well Differentiated Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v6
16583,Well Differentiated Neuroendocrine Lesion,Stage I Rectosigmoid Cancer AJCC v6 and v7
16584,Low Grade Neuroendocrine Lesion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
16585,Intermediate Grade Neuroendocrine Lesion,Pancreatic carcinoma non-resectable
16586,Benign Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma
16587,Benign Cellular Infiltrate,Fibrosarcoma non-metastatic
16588,Benign Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
16589,Benign Cellular Infiltrate,Stage IV Burkitt Lymphoma
16590,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent
16591,Well Differentiated Neuroendocrine Lesion,Pancreatic carcinoma resectable
16592,Malignant Cellular Infiltrate,Spinal Cord Neurofibroma
16593,Malignant Cellular Infiltrate,Benign Breast Eccrine Spiradenoma
16594,Benign Cellular Infiltrate,Stage IA Ovarian Cancer
16595,Benign Cellular Infiltrate,Thyroid Lymphoma
16596,Benign Cellular Infiltrate,Advanced Unfavorable Non-Hodgkin Lymphoma
16597,Malignant Cellular Infiltrate,Benign Cardiac Germ Cell Tumor
16598,Malignant Cellular Infiltrate,Benign Cardiac Schwannoma
16599,Malignant Cellular Infiltrate,Cardiac neurofibroma
16600,Benign Cellular Infiltrate,Malignant Pulmonary Vein Neoplasm
16601,Malignant Cellular Infiltrate,Colon Cavernous Hemangioma
16602,Benign Cellular Infiltrate,Osteoblastic Osteosarcoma
16603,Malignant Cellular Infiltrate,benign fibrous histiocytoma of bone
16604,Benign Cellular Infiltrate,Cerebellar Vermis Medulloblastoma
16605,Benign Cellular Infiltrate,Malignant Central Nervous System Germ Cell Tumor
16606,Malignant Cellular Infiltrate,Epidural Spinal Canal Angiolipoma
16607,Benign Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma
16608,Benign Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
16609,Benign Cellular Infiltrate,papillary squamous cell carcinoma of larynx
16610,Malignant Cellular Infiltrate,Oncocytic Schneiderian papilloma
16611,Benign Cellular Infiltrate,Meningeal Gliomatosis
16612,Benign Cellular Infiltrate,Childhood Anaplastic Oligodendroglioma
16613,Benign Cellular Infiltrate,Intracranial Extraskeletal Myxoid Chondrosarcoma
16614,Low Grade Neuroendocrine Lesion,Stage IA Gastric Carcinoma
16615,Intermediate Grade Neuroendocrine Lesion,Gastric Tubular Adenocarcinoma
16616,Well Differentiated Neuroendocrine Lesion,Squamous cell carcinoma of colon
16617,Intermediate Grade Neuroendocrine Lesion,Colon Adenosquamous Carcinoma
16618,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of the cecum
16619,Low Grade Neuroendocrine Lesion,Mucinous cystadenocarcinoma appendix
16620,Benign Cellular Infiltrate,Prostate Kaposi Sarcoma
16621,Benign Cellular Infiltrate,Prostate Leiomyosarcoma
16622,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of rectum
16623,Intermediate Grade Neuroendocrine Lesion,Squamous cell carcinoma of rectum
16624,Intermediate Grade Neuroendocrine Lesion,cloacogenic carcinoma of rectum
16625,Low Grade Neuroendocrine Lesion,Rectal Sarcomatoid Carcinoma
16626,Benign Cellular Infiltrate,Stage III Uveal Melanoma AJCC v7
16627,Benign Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma
16628,Benign Cellular Infiltrate,Pleuropulmonary blastoma
16629,Malignant Cellular Infiltrate,lipoma of large intestine
16630,Well Differentiated Neuroendocrine Lesion,Stage IIA Esophagus Carcinoma
16631,Well Differentiated Neuroendocrine Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
16632,Well Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v6 and v7
16633,Intermediate Grade Neuroendocrine Lesion,Stage IV Pancreatic Cancer AJCC v6 and v7
16634,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of pancreas
16635,Low Grade Neuroendocrine Lesion,Acinar cell cystadenocarcinoma
16636,Intermediate Grade Neuroendocrine Lesion,Stage IVA Gallbladder Carcinoma
16637,Intermediate Grade Neuroendocrine Lesion,Stage IVB Gallbladder Carcinoma
16638,Intermediate Grade Neuroendocrine Lesion,Gallbladder papillary adenocarcinoma
16639,Low Grade Neuroendocrine Lesion,signet ring cell carcinoma of gallbladder
16640,Malignant Cellular Infiltrate,Leiomyoma of Gallbladder
16641,Low Grade Neuroendocrine Lesion,Clear Cell Hepatocellular Carcinoma
16642,Low Grade Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v6 and v7
16643,Intermediate Grade Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7
16644,Well Differentiated Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7
16645,Well Differentiated Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7
16646,Low Grade Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7
16647,Intermediate Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v6
16648,Low Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v6
16649,Well Differentiated Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7
16650,Benign Cellular Infiltrate,Adult Central Nervous System Germinoma
16651,Well Differentiated Neuroendocrine Lesion,Bile duct mucinous adenocarcinoma
16652,Benign Cellular Infiltrate,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
16653,Benign Cellular Infiltrate,Stage I Lip Carcinoma
16654,Benign Cellular Infiltrate,Stage IVA Oral Cavity Cancer AJCC v6 and v7
16655,Benign Cellular Infiltrate,Stage IVC Oral Cavity Cancer AJCC v6 and v7
16656,Benign Cellular Infiltrate,Major Salivary Gland Adenocarcinoma
16657,Well Differentiated Neuroendocrine Lesion,Stage IIIB Anal Canal Cancer AJCC v6 and v7
16658,Low Grade Neuroendocrine Lesion,Stage IIIB Anal Canal Cancer AJCC v6 and v7
16659,Benign Cellular Infiltrate,Malignant Submandibular Gland Mixed Tumor
16660,Benign Cellular Infiltrate,Parotid Gland Undifferentiated Carcinoma
16661,Benign Cellular Infiltrate,Submandibular Gland Undifferentiated Carcinoma
16662,Benign Cellular Infiltrate,Minor Salivary Gland Mucoepidermoid Carcinoma
16663,Benign Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma
16664,Benign Cellular Infiltrate,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
16665,Benign Cellular Infiltrate,Major Salivary Gland Non-Hodgkin Lymphoma
16666,Benign Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7
16667,Benign Cellular Infiltrate,Stage IVB Oropharyngeal Carcinoma AJCC v7
16668,Malignant Cellular Infiltrate,Tonsillar Lipoma
16669,Benign Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v7
16670,Benign Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7
16671,Benign Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v7
16672,Benign Cellular Infiltrate,Stage II Paranasal Sinus Cancer AJCC v6 and v7
16673,Benign Cellular Infiltrate,Stage IV Paranasal Sinus Cancer AJCC v7
16674,Benign Cellular Infiltrate,Stage IV Nasal Cavity Carcinoma AJCC v7
16675,Benign Cellular Infiltrate,Stage III Nasal Cavity Cancer AJCC v6 and v7
16676,Malignant Cellular Infiltrate,Squamous Papilloma of the Nasopharynx
16677,Benign Cellular Infiltrate,Thyroid Angiosarcoma
16678,Benign Cellular Infiltrate,Thyroid Diffuse Large B-Cell Lymphoma
16679,Benign Cellular Infiltrate,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
16680,Benign Cellular Infiltrate,non-Hodgkin's lymphoma of accessory sinus
16681,Benign Cellular Infiltrate,Stage IVC Paranasal Sinus Cancer AJCC v7
16682,Malignant Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma
16683,Benign Cellular Infiltrate,Intermediate Cell Type Choroid Melanoma
16684,Benign Cellular Infiltrate,carcinoma of lacrimal gland
16685,Benign Cellular Infiltrate,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7
16686,Benign Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
16687,Benign Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
16688,Benign Cellular Infiltrate,Stage III Ureter Cancer AJCC v7
16689,Benign Cellular Infiltrate,Bladder Lymphoma
16690,Benign Cellular Infiltrate,Transitional cell carcinoma urethra
16691,Malignant Cellular Infiltrate,Urethral Inverted Papilloma
16692,Benign Cellular Infiltrate,Childhood Central Nervous System Embryonal Carcinoma
16693,Benign Cellular Infiltrate,Tracheal Lymphoma
16694,Benign Cellular Infiltrate,Anterior Tongue Carcinoma
16695,Benign Cellular Infiltrate,Bowen's Disease
16696,Benign Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v7
16697,Benign Cellular Infiltrate,Fallopian Tube Clear Cell Adenocarcinoma
16698,Benign Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v7
16699,Benign Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
16700,Benign Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v6
16701,Benign Cellular Infiltrate,Secondary malignant neoplasm of vulva
16702,Benign Cellular Infiltrate,Secondary malignant neoplasm of vagina
16703,Benign Cellular Infiltrate,Testicular embryonal carcinoma
16704,Benign Cellular Infiltrate,Cervical Clear Cell Adenocarcinoma
16705,Benign Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v6 and v7
16706,Benign Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v6 and v7
16707,Benign Cellular Infiltrate,Vulvar adenocarcinoma
16708,Benign Cellular Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma
16709,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of the duodenum
16710,Intermediate Grade Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1
16711,Benign Cellular Infiltrate,Metastatic carcinoid tumor
16712,Benign Cellular Infiltrate,choriocarcinoma of mediastinum
16713,Benign Cellular Infiltrate,Stage IIA Bone Sarcoma AJCC v7
16714,Benign Cellular Infiltrate,Non-small cell carcinoma
16715,Benign Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm
16716,Poorly Differentiated Neuroendocrine Lesion,Malignant Pancreatic Insulinoma
16717,Low Grade Neuroendocrine Lesion,Parietal cell carcinoma
16718,Benign Cellular Infiltrate,minimally invasive follicular carcinoma of the thyroid gland
16719,Malignant Cellular Infiltrate,Benign Testicular Sertoli Cell Tumor
16720,Benign Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7
16721,Benign Cellular Infiltrate,Stage II Soft Tissue Sarcoma AJCC v7
16722,Benign Cellular Infiltrate,Childhood Testicular Mixed Germ Cell Tumor
16723,Benign Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma
16724,Geographic Necrosis,Childhood Ovarian Mature Teratoma
16725,Malignant Cellular Infiltrate,Benign Childhood Germ Cell Tumor
16726,Malignant Cellular Infiltrate,Epithelioid neurofibroma
16727,Benign Cellular Infiltrate,Glandular malignant peripheral nerve sheath tumor
16728,Benign Cellular Infiltrate,Childhood Renal Cell Carcinoma
16729,Malignant Cellular Infiltrate,Intramuscular Myxoma
16730,Benign Cellular Infiltrate,Extrarenal rhabdoid tumor
16731,Benign Cellular Infiltrate,Fibrosarcoma of bone
16732,Benign Cellular Infiltrate,sarcoma of mediastinum
16733,Benign Cellular Infiltrate,Stage IIA Osteosarcoma AJCC v7
16734,Benign Cellular Infiltrate,liposarcoma of mediastinum
16735,Benign Cellular Infiltrate,leiomyosarcoma of mediastinum
16736,Benign Cellular Infiltrate,Mediastinal Neuroblastoma
16737,Benign Cellular Infiltrate,Stage 2 Neuroblastoma
16738,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v7
16739,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
16740,Benign Cellular Infiltrate,Mixed epithelioid and spindle cell melanoma
16741,Malignant Cellular Infiltrate,Benign Intraocular Teratoid Medulloepithelioma
16742,Malignant Cellular Infiltrate,Retinoma
16743,Benign Cellular Infiltrate,"Retinoblastoma, undifferentiated"
16744,Benign Cellular Infiltrate,Stage IV Lung Small Cell Carcinoma AJCC v7
16745,Benign Cellular Infiltrate,Skin Metatypical Carcinoma
16746,Benign Cellular Infiltrate,Stage IB Lung Adenocarcinoma AJCC v7
16747,Benign Cellular Infiltrate,Stage IIA Lung Adenocarcinoma AJCC v7
16748,Malignant Cellular Infiltrate,Benign Teratoma
16749,Geographic Necrosis,Benign Teratoma
16750,Benign Cellular Infiltrate,Desmoplastic mesothelioma
16751,Malignant Cellular Infiltrate,Benign Glomus Tumor
16752,Benign Cellular Infiltrate,Kaposi's sarcoma of palate
16753,Intermediate Grade Neuroendocrine Lesion,Biliary Intraepithelial Neoplasia-3
16754,Benign Cellular Infiltrate,Biliary Intraepithelial Neoplasia-3
16755,Geographic Necrosis,Pineal Region Mature Teratoma
16756,Benign Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
16757,Benign Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
16758,Benign Cellular Infiltrate,Recurrent Childhood Medulloblastoma
16759,Malignant Cellular Infiltrate,Benign tumor of external ear
16760,Malignant Cellular Infiltrate,Dermoid Cyst of the Spinal Cord
16761,Benign Cellular Infiltrate,Malignant lymphoma of testis
16762,Malignant Cellular Infiltrate,Adenoma of middle ear
16763,Malignant Cellular Infiltrate,Sphenoid Sinus Inverted Papilloma
16764,Benign Cellular Infiltrate,Well Differentiated Adrenal Cortex Carcinoma
16765,Benign Cellular Infiltrate,Choroid Necrotic Melanoma
16766,Benign Cellular Infiltrate,Advanced Unfavorable Hodgkin Lymphoma
16767,Benign Cellular Infiltrate,Solid Papillary Breast Carcinoma
16768,Malignant Cellular Infiltrate,"Schneiderian papilloma, inverted"
16769,Malignant Cellular Infiltrate,Glandular papilloma
16770,Benign Cellular Infiltrate,Cystic Partially Differentiated Nephroblastoma
16771,Benign Cellular Infiltrate,Acute bilineal leukemia
16772,Benign Cellular Infiltrate,Acute Myeloid Leukemia with Variant MLL Translocations
16773,Benign Cellular Infiltrate,Infiltrating duct and lobular carcinoma
16774,Benign Cellular Infiltrate,Sarcomatoid Carcinoma of the Penis
16775,Benign Cellular Infiltrate,Ductal Breast Carcinoma with Squamous Metaplasia
16776,Benign Cellular Infiltrate,Central Nervous System Embryonal Carcinoma
16777,Benign Cellular Infiltrate,Prostate Cancer by Whitmore-Jewett Stage
16778,Benign Cellular Infiltrate,Recurrent Non-Cutaneous Melanoma
16779,Well Differentiated Neuroendocrine Lesion,Stage II Liver Cancer
16780,Low Grade Neuroendocrine Lesion,Stage II Liver Cancer
16781,Intermediate Grade Neuroendocrine Lesion,Stage III Liver Cancer
16782,Low Grade Neuroendocrine Lesion,Stage IV Liver Cancer
16783,Well Differentiated Neuroendocrine Lesion,Stage IVB Liver Cancer
16784,Benign Cellular Infiltrate,Refractory anemia with excess blasts I
16785,Benign Cellular Infiltrate,Refractory anemia with excess blasts II
16786,Benign Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia
16787,Benign Cellular Infiltrate,Burkitt Lymphoma with Plasmacytoid Differentiation
16788,Benign Cellular Infiltrate,Methotrexate-Associated Peripheral T-Cell Lymphoma
16789,Benign Cellular Infiltrate,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
16790,Benign Cellular Infiltrate,Methotrexate-Associated Follicular Lymphoma
16791,Benign Cellular Infiltrate,Methotrexate-Associated Hodgkin Lymphoma
16792,Mitotic Activity,Ovarian Solid Teratoma
16793,Benign Cellular Infiltrate,Malignant Splenic Soft Tissue Neoplasm
16794,Benign Cellular Infiltrate,non-Hodgkin's lymphoma of spleen
16795,Benign Cellular Infiltrate,Ovarian Adenosarcoma
16796,Benign Cellular Infiltrate,Stage 0 Testicular Seminoma AJCC v6 and v7
16797,Malignant Cellular Infiltrate,Benign epithelial neoplasm of skin
16798,Malignant Cellular Infiltrate,Benign fibrohistiocytic neoplasm of skin
16799,Intermediate Grade Neuroendocrine Lesion,Gallbladder adenosquamous carcinoma
16800,Low Grade Neuroendocrine Lesion,Gallbladder adenosquamous carcinoma
16801,Benign Cellular Infiltrate,Juxtacortical chondrosarcoma
16802,Benign Cellular Infiltrate,Accessory Urethral Gland Carcinoma
16803,Benign Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma
16804,Benign Cellular Infiltrate,Intraductal papillary adenocarcinoma with invasion
16805,Well Differentiated Neuroendocrine Lesion,Anal Adenocarcinoma within Anorectal Fistula
16806,Low Grade Neuroendocrine Lesion,Anal Adenocarcinoma within Anorectal Fistula
16807,Benign Cellular Infiltrate,Malignant tumor of nasal sinuses
16808,Intermediate Grade Neuroendocrine Lesion,Carcinoma of anal canal
16809,Benign Cellular Infiltrate,Primary solid type intraosseous squamous cell carcinoma
16810,Benign Cellular Infiltrate,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
16811,Benign Cellular Infiltrate,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
16812,Benign Cellular Infiltrate,Refractory anaemia with excess blasts
16813,Benign Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7
16814,Benign Cellular Infiltrate,Lymphoid leukemia
16815,Benign Cellular Infiltrate,Secondary malignant neoplasm of ureter
16816,Benign Cellular Infiltrate,Prostate cancer stage A
16817,Benign Cellular Infiltrate,Adamantinoma
16818,Benign Cellular Infiltrate,Adenocarcinoma in situ in tubular adenoma
16819,Benign Cellular Infiltrate,Invasive Ductal and Lobular Carcinoma
16820,Benign Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma
16821,Benign Cellular Infiltrate,Childhood Hodgkin Lymphoma
16822,Benign Cellular Infiltrate,Childhood Soft Tissue Sarcoma
16823,Benign Cellular Infiltrate,Bartholin Gland Adenocarcinoma
16824,Benign Cellular Infiltrate,Vaginal clear cell adenocarcinoma
16825,Benign Cellular Infiltrate,Osteosclerotic Plasma Cell Myeloma
16826,Well Differentiated Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v6 and v7
16827,Intermediate Grade Neuroendocrine Lesion,Stage I Pancreatic Cancer AJCC v6 and v7
16828,Intermediate Grade Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v6 and v7
16829,Well Differentiated Neuroendocrine Lesion,Stage 0 Gastric Cancer AJCC v6 and v7
16830,Well Differentiated Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v6 and v7
16831,Low Grade Neuroendocrine Lesion,Anal cancer recurrent
16832,Benign Cellular Infiltrate,Stage II Cervical Cancer AJCC v6
16833,Benign Cellular Infiltrate,Adult Leiomyosarcoma
16834,Benign Cellular Infiltrate,Stage I Adult Soft Tissue Sarcoma AJCC v7
16835,Benign Cellular Infiltrate,Recurrent Adult Soft Tissue Sarcoma
16836,Benign Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland
16837,Benign Cellular Infiltrate,Stage I Ovarian Cancer AJCC v6 and v7
16838,Low Grade Neuroendocrine Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
16839,Benign Cellular Infiltrate,Mesothelioma malignant advanced
16840,Benign Cellular Infiltrate,Stage III Penile Cancer AJCC v6
16841,Low Grade Neuroendocrine Lesion,Localized Resectable Adult Liver Carcinoma
16842,Benign Cellular Infiltrate,Recurrent Adult Acute Lymphoblastic Leukemia
16843,Benign Cellular Infiltrate,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
16844,Benign Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7
16845,Benign Cellular Infiltrate,Stage IV Bladder Cancer AJCC v6
16846,Benign Cellular Infiltrate,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
16847,Benign Cellular Infiltrate,Stage II Cutaneous Melanoma AJCC v6 and v7
16848,Benign Cellular Infiltrate,Recurrent Lymphomatoid Granulomatosis
16849,Benign Cellular Infiltrate,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
16850,Benign Cellular Infiltrate,Childhood Burkitt Leukemia
16851,Benign Cellular Infiltrate,Adult Burkitt Leukemia
16852,Benign Cellular Infiltrate,Childhood Pleomorphic Rhabdomyosarcoma
16853,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with Maturation
16854,Low Grade Neuroendocrine Lesion,Mucinous adenocarcinoma of colon
16855,Low Grade Neuroendocrine Lesion,Signet-ring cell adenocarcinoma of colon
16856,Benign Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia
16857,Well Differentiated Neuroendocrine Lesion,mucinous adenocarcinoma of rectum
16858,Well Differentiated Neuroendocrine Lesion,adenocarcinoma of extrahepatic bile duct
16859,Well Differentiated Neuroendocrine Lesion,Distal 1/3 of the Common Bile Duct Adenocarcinoma
16860,Well Differentiated Neuroendocrine Lesion,Acinar cell carcinoma of pancreas
16861,Benign Cellular Infiltrate,Serous cystadenocarcinoma ovary
16862,Benign Cellular Infiltrate,Endometrioid carcinoma ovary
16863,Benign Cellular Infiltrate,squamous cell carcinoma of salivary gland
16864,Benign Cellular Infiltrate,Squamous cell carcinoma of nasopharynx
16865,Benign Cellular Infiltrate,Dedifferentiated Solitary Fibrous Tumor
16866,Benign Cellular Infiltrate,Testicular yolk sac tumor
16867,Benign Cellular Infiltrate,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
16868,Benign Cellular Infiltrate,High Grade Salivary Gland Carcinoma
16869,Benign Cellular Infiltrate,Adenoid cystic carcinoma of salivary gland
16870,Benign Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
16871,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with hyperdiploidy
16872,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
16873,Benign Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood
16874,Benign Cellular Infiltrate,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma
16875,Benign Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma
16876,Benign Cellular Infiltrate,Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7
16877,Benign Cellular Infiltrate,Recurrent Ovarian Germ Cell Tumor
16878,Benign Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary
16879,Malignant Cellular Infiltrate,Mature Ovarian Teratoma
16880,Borderline Lesion,Mature Ovarian Teratoma
16881,Benign Cellular Infiltrate,Ovarian germ cell tumor mixed
16882,Benign Cellular Infiltrate,Stage II Adult Lymphoblastic Lymphoma
16883,Benign Cellular Infiltrate,Stage IV Adult Lymphoblastic Lymphoma
16884,Benign Cellular Infiltrate,Retromolar Trigone Squamous Cell Carcinoma
16885,Benign Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma
16886,Benign Cellular Infiltrate,Squamous cell carcinoma of tonsil
16887,Benign Cellular Infiltrate,Squamous cell carcinoma of the nasal cavity
16888,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage I
16889,Benign Cellular Infiltrate,Recurrent Lip Basal Cell Carcinoma
16890,Benign Cellular Infiltrate,Verrucous carcinoma of the oral cavity recurrent
16891,Benign Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
16892,Benign Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent
16893,Benign Cellular Infiltrate,Laryngeal squamous cell carcinoma recurrent
16894,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage I
16895,Intermediate Grade Neuroendocrine Lesion,basaloid carcinoma of anus
16896,Malignant Cellular Infiltrate,Respiratory papilloma
16897,Benign Cellular Infiltrate,Leptomeningeal sarcoma
16898,Benign Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma
16899,Benign Cellular Infiltrate,Carcinoma of lower gum
16900,Benign Cellular Infiltrate,Carcinoma of sublingual gland
16901,Low Grade Neuroendocrine Lesion,Gastric Fundus Carcinoma
16902,Well Differentiated Neuroendocrine Lesion,Gastric Body Carcinoma
16903,Benign Cellular Infiltrate,Malignant Ovarian Granulosa Cell Tumor
16904,Benign Cellular Infiltrate,Carcinoma of base of tongue
16905,Benign Cellular Infiltrate,Malignant Sternal Neoplasm
16906,Benign Cellular Infiltrate,Malignant melanoma of breast
16907,Malignant Cellular Infiltrate,Benign neoplasm of ear
16908,Benign Cellular Infiltrate,Diffuse malignant mesothelioma
16909,Benign Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma
16910,Benign Cellular Infiltrate,Stage III Indolent Adult Non-Hodgkin Lymphoma
16911,Benign Cellular Infiltrate,Lynch Syndrome
16912,Benign Cellular Infiltrate,Invasive Malignant Neoplasm
16913,Benign Cellular Infiltrate,Refractory Carcinoma
16914,Benign Cellular Infiltrate,Malignant Neoplasm with Regional Lymph Node Involvement
16915,Intermediate Grade Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v6 and v7
16916,Well Differentiated Neuroendocrine Lesion,Stage III Colorectal Cancer
16917,Low Grade Neuroendocrine Lesion,Stage III Colorectal Cancer
16918,Intermediate Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer
16919,Benign Cellular Infiltrate,Stage I Hodgkin Lymphoma
16920,Benign Cellular Infiltrate,Stage II Non-Hodgkin Lymphoma
16921,Malignant Cellular Infiltrate,Benign neoplasm of pericardium
16922,Benign Cellular Infiltrate,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
16923,Benign Cellular Infiltrate,Stage III Soft Tissue Sarcoma AJCC v7
16924,Benign Cellular Infiltrate,Stage IV Soft Tissue Sarcoma AJCC v7
16925,Benign Cellular Infiltrate,Stage 0 Merkel Cell Carcinoma AJCC v7
16926,Benign Cellular Infiltrate,Stage IIC Merkel Cell Carcinoma AJCC v7
16927,Benign Cellular Infiltrate,Testicular choriocarcinoma stage II
16928,Benign Cellular Infiltrate,Metastases to adrenals
16929,Low Grade Neuroendocrine Lesion,Colorectal cancer recurrent
16930,Low Grade Neuroendocrine Lesion,Stage II Esophageal Adenocarcinoma AJCC v7
16931,Low Grade Neuroendocrine Lesion,Stage I Esophageal Adenocarcinoma AJCC v7
16932,Low Grade Neuroendocrine Lesion,Small intestine carcinoma resectable
16933,Benign Cellular Infiltrate,Aggressive natural killer-cell leukemia
16934,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage IV
16935,Benign Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v7
16936,Benign Cellular Infiltrate,Stage IA Bone Cancer AJCC v7
16937,Benign Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7
16938,Benign Cellular Infiltrate,Stage III Ovarian Teratoma AJCC v6 and v7
16939,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
16940,Benign Cellular Infiltrate,Large cell lung cancer stage IV
16941,Benign Cellular Infiltrate,Lung squamous cell carcinoma stage I
16942,Benign Cellular Infiltrate,Lung squamous cell carcinoma stage III
16943,Benign Cellular Infiltrate,Stage I Lung Cancer AJCC v6
16944,Benign Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor
16945,Low Grade Neuroendocrine Lesion,Stage IIB Gastric Cancer AJCC v7
16946,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Gastric Cancer AJCC v7
16947,Intermediate Grade Neuroendocrine Lesion,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
16948,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
16949,Well Differentiated Neuroendocrine Lesion,Stage IIB Small Intestinal Cancer AJCC v7
16950,Low Grade Neuroendocrine Lesion,Stage IIIA Small Intestinal Cancer AJCC v7
16951,Well Differentiated Neuroendocrine Lesion,Stage IIIB Small Intestinal Cancer AJCC v7
16952,Low Grade Neuroendocrine Lesion,Stage IIIB Small Intestinal Cancer AJCC v7
16953,Benign Cellular Infiltrate,Secondary Central Nervous System Lymphoma
16954,Low Grade Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v7
16955,Benign Cellular Infiltrate,Chondrosarcoma recurrent
16956,Well Differentiated Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v7
16957,Low Grade Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v7
16958,Well Differentiated Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v7
16959,Low Grade Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v7
16960,Benign Cellular Infiltrate,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7
16961,Benign Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
16962,Benign Cellular Infiltrate,Malignant fibrous histiocytoma recurrent
16963,Benign Cellular Infiltrate,Epithelioid sarcoma metastatic
16964,Poorly Differentiated Neuroendocrine Lesion,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
16965,Intermediate Grade Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
16966,Low Grade Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
16967,Low Grade Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v7
16968,Well Differentiated Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v7
16969,Intermediate Grade Neuroendocrine Lesion,Stage IB Distal Bile Duct Cancer AJCC v7
16970,Intermediate Grade Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v7
16971,Low Grade Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v7
16972,Low Grade Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v6 and v7
16973,Well Differentiated Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v6 and v7
16974,Benign Cellular Infiltrate,Primary leiomyosarcoma
16975,Benign Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7
16976,Benign Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7
16977,Benign Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7
16978,Benign Cellular Infiltrate,Metastatic Malignant Peripheral Nerve Sheath Tumor
16979,Benign Cellular Infiltrate,Stage III Breast Cancer AJCC v7
16980,Benign Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v7
16981,Benign Cellular Infiltrate,B-cell lymphoma stage II
16982,Benign Cellular Infiltrate,B-cell lymphoma stage IV
16983,Benign Cellular Infiltrate,Stage II Diffuse Large B-Cell Lymphoma
16984,Benign Cellular Infiltrate,Stage III Diffuse Large B-Cell Lymphoma
16985,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage II
16986,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage IV
16987,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory
16988,Benign Cellular Infiltrate,Extragonadal primary embryonal carcinoma
16989,Benign Cellular Infiltrate,Placental Choriocarcinoma
16990,Benign Cellular Infiltrate,Bladder adenocarcinoma stage 0
16991,Benign Cellular Infiltrate,Testicular choriocarcinoma stage III
16992,Benign Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v7
16993,Benign Cellular Infiltrate,Centroblastic lymphoma refractory
16994,Benign Cellular Infiltrate,Centroblastic lymphoma stage III
16995,Intermediate Grade Neuroendocrine Lesion,Small intestine adenocarcinoma metastatic NOS
16996,Benign Cellular Infiltrate,Vaginal adenocarcinoma metastatic
16997,Benign Cellular Infiltrate,Stage IB Vulvar Cancer AJCC v7
16998,Benign Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v7
16999,Benign Cellular Infiltrate,Adenocarcinoma of the prostate stage IV
17000,Benign Cellular Infiltrate,Recurrent Lung Carcinoma Cell Type Unspecified
17001,Benign Cellular Infiltrate,"Lymphoma, Mixed-Cell, Follicular"
17002,Intermediate Grade Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v7
17003,Low Grade Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v7
17004,Low Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage I
17005,Intermediate Grade Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v7
17006,Low Grade Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v7
17007,Well Differentiated Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v7
17008,Malignant Cellular Infiltrate,inverted follicular keratosis
17009,Well Differentiated Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v7
17010,Benign Cellular Infiltrate,Acute myelomonocytic leukemia with abnormal eosinophils
17011,Intermediate Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v7
17012,Benign Cellular Infiltrate,FNCLCC Sarcoma Grade 1
17013,Intermediate Grade Neuroendocrine Lesion,Gastric carcinoma stage IV
17014,Benign Cellular Infiltrate,Adult Angiosarcoma
17015,Benign Cellular Infiltrate,Metastatic Parathyroid Gland Carcinoma
17016,Benign Cellular Infiltrate,Pediatric Extraocular Retinoblastoma
17017,Well Differentiated Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v6 Stage
17018,Well Differentiated Neuroendocrine Lesion,Gallbladder Cancer by AJCC v6 Stage
17019,Benign Cellular Infiltrate,Cutaneous Melanoma by AJCC v6 Stage
17020,Low Grade Neuroendocrine Lesion,Recurrent Adult Hepatocellular Carcinoma
17021,Benign Cellular Infiltrate,Stage II Testicular Cancer AJCC v6 and v7
17022,Benign Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
17023,Benign Cellular Infiltrate,Small Size Posterior Uveal Melanoma
17024,Benign Cellular Infiltrate,Medium/Large Size Posterior Uveal Melanoma
17025,Benign Cellular Infiltrate,Adult Glioblastoma
17026,Benign Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
17027,Benign Cellular Infiltrate,Oropharyngeal Carcinoma
17028,Benign Cellular Infiltrate,Medullary carcinoma of breast
17029,Intermediate Grade Neuroendocrine Lesion,Pancreatic Ductal Adenocarcinoma
17030,Benign Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage
17031,Intermediate Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v7 Stage
17032,Low Grade Neuroendocrine Lesion,Colon Cancer by AJCC v7 Stage
17033,Well Differentiated Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v7 Stage
17034,Benign Cellular Infiltrate,Childhood Lymphoblastic Lymphoma
17035,Benign Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v7 Stage
17036,Benign Cellular Infiltrate,Laryngeal Cancer by AJCC v7 Stage
17037,Benign Cellular Infiltrate,Stromal Predominant Kidney Wilms Tumor
17038,Well Differentiated Neuroendocrine Lesion,Anal squamous cell carcinoma
17039,Benign Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Seminoma
17040,Benign Cellular Infiltrate,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
17041,Benign Cellular Infiltrate,Stage IV Childhood Burkitt Lymphoma
17042,Benign Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma
17043,Benign Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma
17044,Benign Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v6
17045,Intermediate Grade Neuroendocrine Lesion,Stage II Esophageal Cancer
17046,Low Grade Neuroendocrine Lesion,Stage II Esophageal Cancer
17047,Low Grade Neuroendocrine Lesion,Stage III Esophageal Cancer
17048,Benign Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v7
17049,Benign Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma
17050,Benign Cellular Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma
17051,Intermediate Grade Neuroendocrine Lesion,recurrent gastric cancer
17052,Benign Cellular Infiltrate,Nasopharyngeal cancer recurrent
17053,Benign Cellular Infiltrate,Invasive carcinoma of breast
17054,Low Grade Neuroendocrine Lesion,AIDS-related anal cancer recurrent
17055,Benign Cellular Infiltrate,Recurrent Anaplastic Large Cell Lymphoma
17056,Benign Cellular Infiltrate,Recurrent Ureter Carcinoma
17057,Benign Cellular Infiltrate,Anaplastic Medulloblastoma
17058,Benign Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm
17059,Benign Cellular Infiltrate,Angiosarcoma non-metastatic
17060,Benign Cellular Infiltrate,AIDS-Related Hodgkin Lymphoma
17061,Well Differentiated Neuroendocrine Lesion,Anal carcinoma
17062,Benign Cellular Infiltrate,Acute Undifferentiated Leukemia
17063,Benign Cellular Infiltrate,Sarcoma of soft tissue
17064,Benign Cellular Infiltrate,Malignant neoplasm of mouth
17065,Benign Cellular Infiltrate,Carcinoma of the Floor of the Mouth
17066,Benign Cellular Infiltrate,Malignant Mesothelioma of Peritoneum
17067,Benign Cellular Infiltrate,Adult Lymphoblastic Lymphoma
17068,Low Grade Neuroendocrine Lesion,Adenocarcinoma of rectum
17069,Benign Cellular Infiltrate,Sarcoma NCI Grade 2
17070,Benign Cellular Infiltrate,Angiosarcoma NCI Grade 3
17071,Benign Cellular Infiltrate,AJCC Grade 4 Sarcoma
17072,Low Grade Neuroendocrine Lesion,Grade 2 Colorectal Adenocarcinoma
17073,Intermediate Grade Neuroendocrine Lesion,Grade 2 Rectal Adenocarcinoma
17074,Benign Cellular Infiltrate,Small cell neuroendocrine carcinoma of bladder
17075,Benign Cellular Infiltrate,Systemic Anaplastic Large Cell Lymphoma
17076,Benign Cellular Infiltrate,Adenosarcoma
17077,Benign Cellular Infiltrate,Meningeal Lymphoma
17078,Benign Cellular Infiltrate,Early-Stage Breast Carcinoma
17079,Low Grade Neuroendocrine Lesion,Stage IIIA Adult Liver Cancer AJCC v7
17080,Benign Cellular Infiltrate,Locally Recurrent Malignant Neoplasm
17081,Benign Cellular Infiltrate,Ann Arbor Stage IV AIDS-Related Lymphoma
17082,Malignant Cellular Infiltrate,Soft tissue chondroma
17083,Benign Cellular Infiltrate,Melanotic medulloblastoma
17084,Low Grade Neuroendocrine Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma
17085,Well Differentiated Neuroendocrine Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
17086,Well Differentiated Neuroendocrine Lesion,Pancreatic Hepatoid Adenocarcinoma
17087,Low Grade Neuroendocrine Lesion,Pancreatic Hepatoid Adenocarcinoma
17088,Malignant Cellular Infiltrate,Pancreatic Acinar Cell Cystadenoma
17089,Well Differentiated Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
17090,Intermediate Grade Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
17091,Poorly Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1
17092,Intermediate Grade Neuroendocrine Lesion,Esophageal Spindle Cell Carcinoma
17093,Intermediate Grade Neuroendocrine Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma
17094,Low Grade Neuroendocrine Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma
17095,Poorly Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor
17096,Well Differentiated Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma
17097,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
17098,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Hepatoid Adenocarcinoma
17099,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Invasive Papillary Adenocarcinoma
17100,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
17101,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma
17102,Low Grade Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma
17103,Intermediate Grade Neuroendocrine Lesion,Colorectal Large Cell Neuroendocrine Carcinoma
17104,Low Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2
17105,Well Differentiated Neuroendocrine Lesion,High Grade Appendix Mucinous Adenocarcinoma
17106,Well Differentiated Neuroendocrine Lesion,Neuroendocrine carcinoma of appendix
17107,Well Differentiated Neuroendocrine Lesion,Rectal Cribriform Comedo-Type Adenocarcinoma
17108,Well Differentiated Neuroendocrine Lesion,Colorectal Micropapillary Adenocarcinoma
17109,Intermediate Grade Neuroendocrine Lesion,Colon Micropapillary Adenocarcinoma
17110,Low Grade Neuroendocrine Lesion,Rectal Micropapillary Adenocarcinoma
17111,Well Differentiated Neuroendocrine Lesion,Colorectal Sarcomatoid Carcinoma
17112,Well Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal
17113,Intermediate Grade Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma
17114,Intermediate Grade Neuroendocrine Lesion,Anal Canal Mixed Adenoneuroendocrine Carcinoma
17115,Well Differentiated Neuroendocrine Lesion,Early Hepatocellular Carcinoma
17116,Well Differentiated Neuroendocrine Lesion,Primary hepatic neuroendocrine carcinoma
17117,Intermediate Grade Neuroendocrine Lesion,Well Differentiated Hepatocellular Carcinoma
17118,Well Differentiated Neuroendocrine Lesion,Moderately Differentiated Hepatocellular Carcinoma
17119,Low Grade Neuroendocrine Lesion,Moderately Differentiated Hepatocellular Carcinoma
17120,Well Differentiated Neuroendocrine Lesion,Peripheral Intrahepatic Cholangiocarcinoma
17121,Well Differentiated Neuroendocrine Lesion,carcinosarcoma of liver
17122,Intermediate Grade Neuroendocrine Lesion,carcinosarcoma of liver
17123,Well Differentiated Neuroendocrine Lesion,carcinosarcoma of gallbladder
17124,Low Grade Neuroendocrine Lesion,carcinosarcoma of gallbladder
17125,Low Grade Neuroendocrine Lesion,hepatoid adenocarcinoma of gallbladder
17126,Poorly Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1
17127,Well Differentiated Neuroendocrine Lesion,Gallbladder Mixed Adenoneuroendocrine Carcinoma
17128,Well Differentiated Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
17129,Well Differentiated Neuroendocrine Lesion,carcinosarcoma of extrahepatic bile duct
17130,Low Grade Neuroendocrine Lesion,carcinosarcoma of extrahepatic bile duct
17131,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
17132,Intermediate Grade Neuroendocrine Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
17133,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
17134,Malignant Cellular Infiltrate,"Acanthoma, Clear Cell"
17135,Benign Cellular Infiltrate,Human Papillomavirus-Related Adenosquamous Carcinoma
17136,Benign Cellular Infiltrate,Stage 2B Neuroblastoma
17137,Benign Cellular Infiltrate,High Grade Astrocytic Tumor
17138,Benign Cellular Infiltrate,Low Grade Ovarian Serous Adenocarcinoma
17139,Benign Cellular Infiltrate,"Uterine Carcinosarcoma, Homologous Type"
17140,Benign Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy
17141,Benign Cellular Infiltrate,Childhood Giant Cell Glioblastoma
17142,Well Differentiated Neuroendocrine Lesion,Adult Fibrolamellar Carcinoma
17143,Benign Cellular Infiltrate,Stage III Childhood Anaplastic Large Cell Lymphoma
17144,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
17145,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
17146,Well Differentiated Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v7
17147,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v7
17148,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v7
17149,Low Grade Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v7
17150,Low Grade Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v7
17151,Intermediate Grade Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v7
17152,Well Differentiated Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v7
17153,Benign Cellular Infiltrate,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
17154,Benign Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
17155,Benign Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
17156,Benign Cellular Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
17157,Benign Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v7
17158,Low Grade Neuroendocrine Lesion,Stage IA Esophageal Cancer AJCC v7
17159,Low Grade Neuroendocrine Lesion,Stage IIIA Esophageal Cancer AJCC v7
17160,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Esophageal Cancer AJCC v7
17161,Low Grade Neuroendocrine Lesion,Stage IIIC Esophageal Cancer AJCC v7
17162,Intermediate Grade Neuroendocrine Lesion,BCLC Stage A Hepatocellular Carcinoma
17163,Well Differentiated Neuroendocrine Lesion,BCLC Stage C Hepatocellular Carcinoma
17164,Intermediate Grade Neuroendocrine Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma
17165,Benign Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis
17166,Benign Cellular Infiltrate,Distal Urethral Carcinoma
17167,Benign Cellular Infiltrate,Familial Neuroblastoma
17168,Benign Cellular Infiltrate,Recurrent Childhood Giant Cell Glioblastoma
17169,Benign Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
17170,Benign Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
17171,Benign Cellular Infiltrate,Recurrent Childhood Non-Hodgkin Lymphoma
17172,Benign Cellular Infiltrate,Recurrent Extragonadal Seminoma
17173,Benign Cellular Infiltrate,Plasmacytoma anaplastic
17174,Well Differentiated Neuroendocrine Lesion,Liver Adenosquamous Carcinoma
17175,Low Grade Neuroendocrine Lesion,Liver Adenosquamous Carcinoma
17176,Benign Cellular Infiltrate,Childhood Lung Small Cell Carcinoma
17177,Low Grade Neuroendocrine Lesion,Childhood Rectal Carcinoma
17178,Benign Cellular Infiltrate,CIC-DUX Sarcoma
17179,Benign Cellular Infiltrate,Malignant nipple neoplasm male
17180,Benign Cellular Infiltrate,Malignant neoplasm of nipple of female breast
17181,Malignant Cellular Infiltrate,Dermal nerve sheath myxoma
17182,Malignant Cellular Infiltrate,Acral Fibromyxoma
17183,Malignant Cellular Infiltrate,Bizarre parosteal osteochondromatous proliferation
17184,Benign Cellular Infiltrate,Grade II Chondrosarcoma
17185,Benign Cellular Infiltrate,Secondary Peripheral Chondrosarcoma
17186,Malignant Cellular Infiltrate,Non-Ossifying Fibroma
17187,Benign Cellular Infiltrate,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
17188,Benign Cellular Infiltrate,Fusion-Negative Alveolar Rhabdomyosarcoma
17189,Benign Cellular Infiltrate,Refractory Childhood Malignant Germ Cell Tumor
17190,Benign Cellular Infiltrate,Childhood Malignant Kidney Neoplasm
17191,Benign Cellular Infiltrate,Childhood Neuroblastoma
17192,Benign Cellular Infiltrate,Childhood Central Nervous System Ganglioneuroblastoma
17193,Benign Cellular Infiltrate,Metastatic urothelial carcinoma
17194,Benign Cellular Infiltrate,Infant Acute Biphenotypic Leukemia
17195,Benign Cellular Infiltrate,Tubulocystic renal cell carcinoma
17196,Benign Cellular Infiltrate,Refractory Adult Acute Lymphoblastic Leukemia
17197,Malignant Cellular Infiltrate,Ovarian Seromucinous Adenofibroma
17198,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma
17199,Benign Cellular Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
17200,Malignant Cellular Infiltrate,Broad Ligament Serous Cystadenoma
17201,Benign Cellular Infiltrate,Waldenstrom's macroglobulinemia recurrent
17202,Benign Cellular Infiltrate,Leiomyosarcoma of cervix uteri
17203,Benign Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri
17204,Benign Cellular Infiltrate,Cervical Yolk Sac Tumor
17205,Benign Cellular Infiltrate,FIGO Stage IIIB Ovarian Cancer
17206,Benign Cellular Infiltrate,FIGO Stage IVA Ovarian Cancer
17207,Benign Cellular Infiltrate,Vulvar Neuroendocrine Carcinoma
17208,Benign Cellular Infiltrate,Vulvar Large Cell Neuroendocrine Carcinoma
17209,Well Differentiated Neuroendocrine Lesion,Intrahepatic cholangiocarcinoma recurrent
17210,Benign Cellular Infiltrate,Anaplastic astrocytoma
17211,Benign Cellular Infiltrate,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
17212,Benign Cellular Infiltrate,"Medulloblastoma, Genetically Defined"
17213,Benign Cellular Infiltrate,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
17214,Benign Cellular Infiltrate,Central Nervous System Intravascular Large B-Cell Lymphoma
17215,Low Grade Neuroendocrine Lesion,Unresectable Digestive System Adenocarcinoma
17216,Benign Cellular Infiltrate,Chronic Myelomonocytic Leukemia-0
17217,Benign Cellular Infiltrate,Recurrent Childhood T Acute Lymphoblastic Leukemia
17218,Benign Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage
17219,Benign Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage
17220,Benign Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v8
17221,Benign Cellular Infiltrate,MGMT-Unmethylated Glioblastoma
17222,Benign Cellular Infiltrate,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
17223,Benign Cellular Infiltrate,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
17224,Benign Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v8
17225,Benign Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8
17226,Benign Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
17227,Benign Cellular Infiltrate,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
17228,Benign Cellular Infiltrate,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
17229,Well Differentiated Neuroendocrine Lesion,Esophageal Cancer by AJCC v8 Stage
17230,Intermediate Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v8 Stage
17231,Well Differentiated Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Stage
17232,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
17233,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
17234,Low Grade Neuroendocrine Lesion,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
17235,Well Differentiated Neuroendocrine Lesion,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
17236,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
17237,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
17238,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
17239,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
17240,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
17241,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
17242,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
17243,Well Differentiated Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
17244,Low Grade Neuroendocrine Lesion,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
17245,Well Differentiated Neuroendocrine Lesion,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
17246,Low Grade Neuroendocrine Lesion,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
17247,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
17248,Low Grade Neuroendocrine Lesion,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
17249,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
17250,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
17251,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
17252,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
17253,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
17254,Low Grade Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
17255,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
17256,Low Grade Neuroendocrine Lesion,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
17257,Well Differentiated Neuroendocrine Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
17258,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
17259,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
17260,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
17261,Low Grade Neuroendocrine Lesion,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
17262,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
17263,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
17264,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Pathologic Stage
17265,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
17266,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
17267,Low Grade Neuroendocrine Lesion,Clinical Stage 0 Gastric Cancer AJCC v8
17268,Well Differentiated Neuroendocrine Lesion,Clinical Stage I Gastric Cancer AJCC v8
17269,Intermediate Grade Neuroendocrine Lesion,Clinical Stage I Gastric Cancer AJCC v8
17270,Low Grade Neuroendocrine Lesion,Clinical Stage I Gastric Cancer AJCC v8
17271,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVA Gastric Cancer AJCC v8
17272,Low Grade Neuroendocrine Lesion,Clinical Stage IVA Gastric Cancer AJCC v8
17273,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IA Gastric Cancer AJCC v8
17274,Low Grade Neuroendocrine Lesion,Pathologic Stage IIB Gastric Cancer AJCC v8
17275,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIB Gastric Cancer AJCC v8
17276,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IV Gastric Cancer AJCC v8
17277,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
17278,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Cancer by AJCC v7 Stage
17279,Benign Cellular Infiltrate,Recurrent Primary Amyloidosis
17280,Intermediate Grade Neuroendocrine Lesion,Stage I Anal Cancer AJCC v8
17281,Intermediate Grade Neuroendocrine Lesion,Stage II Anal Cancer AJCC v8
17282,Low Grade Neuroendocrine Lesion,Stage III Anal Cancer AJCC v8
17283,Well Differentiated Neuroendocrine Lesion,Stage IIIB Anal Cancer AJCC v8
17284,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Anal Cancer AJCC v8
17285,Intermediate Grade Neuroendocrine Lesion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
17286,Intermediate Grade Neuroendocrine Lesion,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
17287,Well Differentiated Neuroendocrine Lesion,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
17288,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
17289,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
17290,Well Differentiated Neuroendocrine Lesion,Stage IV Small Intestinal Adenocarcinoma AJCC v8
17291,Well Differentiated Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v8
17292,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v8
17293,Low Grade Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v8
17294,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Carcinoma AJCC v8
17295,Low Grade Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v8
17296,Well Differentiated Neuroendocrine Lesion,Colorectal Cancer by AJCC v8 Stage
17297,Low Grade Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v8
17298,Intermediate Grade Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v8
17299,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v8
17300,Low Grade Neuroendocrine Lesion,Stage IVC Colorectal Cancer AJCC v8
17301,Low Grade Neuroendocrine Lesion,Stage I Colon Cancer AJCC v8
17302,Low Grade Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v8
17303,Low Grade Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v8
17304,Well Differentiated Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v8
17305,Low Grade Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v8
17306,Well Differentiated Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v8
17307,Low Grade Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v8
17308,Low Grade Neuroendocrine Lesion,Stage IVC Colon Cancer AJCC v8
17309,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v8
17310,Well Differentiated Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v8
17311,Well Differentiated Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v8
17312,Well Differentiated Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
17313,Low Grade Neuroendocrine Lesion,Stage IA Hepatocellular Carcinoma AJCC v8
17314,Low Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v8
17315,Well Differentiated Neuroendocrine Lesion,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
17316,Intermediate Grade Neuroendocrine Lesion,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
17317,Intermediate Grade Neuroendocrine Lesion,Stage II Intrahepatic Bile Duct Cancer AJCC v8
17318,Intermediate Grade Neuroendocrine Lesion,Stage III Intrahepatic Bile Duct Cancer AJCC v8
17319,Low Grade Neuroendocrine Lesion,Stage III Intrahepatic Bile Duct Cancer AJCC v8
17320,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
17321,Well Differentiated Neuroendocrine Lesion,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
17322,Intermediate Grade Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v8
17323,Low Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v8
17324,Intermediate Grade Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v8
17325,Low Grade Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
17326,Low Grade Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
17327,Well Differentiated Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v8
17328,Well Differentiated Neuroendocrine Lesion,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
17329,Intermediate Grade Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
17330,Low Grade Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
17331,Well Differentiated Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v8
17332,Intermediate Grade Neuroendocrine Lesion,Stage I Distal Bile Duct Cancer AJCC v8
17333,Intermediate Grade Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v8
17334,Low Grade Neuroendocrine Lesion,Stage IIIB Distal Bile Duct Cancer AJCC v8
17335,Well Differentiated Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v8
17336,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v7 Stage
17337,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v8 Stage
17338,Intermediate Grade Neuroendocrine Lesion,Stage 0 Ampulla of Vater Cancer AJCC v8
17339,Low Grade Neuroendocrine Lesion,Stage IIIA Ampulla of Vater Cancer AJCC v8
17340,Low Grade Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v8
17341,Well Differentiated Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v8
17342,Poorly Differentiated Neuroendocrine Lesion,Stage I Gastric Neuroendocrine Tumor AJCC v8
17343,Poorly Differentiated Neuroendocrine Lesion,Stage III Gastric Neuroendocrine Tumor AJCC v8
17344,Poorly Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
17345,Poorly Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
17346,Poorly Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v8
17347,Poorly Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
17348,Poorly Differentiated Neuroendocrine Lesion,Stage IV Colon Neuroendocrine Tumor AJCC v8
17349,Poorly Differentiated Neuroendocrine Lesion,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
17350,Poorly Differentiated Neuroendocrine Lesion,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
17351,Benign Cellular Infiltrate,Stage I Lung Cancer AJCC v8
17352,Benign Cellular Infiltrate,Stage IA2 Lung Cancer AJCC v8
17353,Benign Cellular Infiltrate,Stage IB Lung Cancer AJCC v8
17354,Benign Cellular Infiltrate,Stage II Lung Cancer AJCC v8
17355,Benign Cellular Infiltrate,Stage III Lung Cancer AJCC v8
17356,Benign Cellular Infiltrate,Lung Adenocarcinoma In Situ
17357,Benign Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage
17358,Benign Cellular Infiltrate,Stage II Bone Cancer AJCC v8
17359,Benign Cellular Infiltrate,Stage IVB Bone Cancer AJCC v8
17360,Benign Cellular Infiltrate,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
17361,Benign Cellular Infiltrate,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
17362,Benign Cellular Infiltrate,Stage IA Retroperitoneal Sarcoma AJCC v8
17363,Benign Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v7 Stage
17364,Benign Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Stage
17365,Benign Cellular Infiltrate,Clinical Stage I Merkel Cell Carcinoma AJCC v8
17366,Benign Cellular Infiltrate,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
17367,Benign Cellular Infiltrate,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
17368,Benign Cellular Infiltrate,Clinical Stage IA Cutaneous Melanoma AJCC v8
17369,Benign Cellular Infiltrate,Clinical Stage II Cutaneous Melanoma AJCC v8
17370,Benign Cellular Infiltrate,Pathologic Stage III Cutaneous Melanoma AJCC v8
17371,Benign Cellular Infiltrate,Pathologic Stage IV Cutaneous Melanoma AJCC v8
17372,Low Grade Neuroendocrine Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
17373,Benign Cellular Infiltrate,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
17374,Benign Cellular Infiltrate,Recurrent Testicular Lymphoma
17375,Benign Cellular Infiltrate,Refractory Testicular Lymphoma
17376,Benign Cellular Infiltrate,Leukemic Nonnodal Mantle Cell Lymphoma
17377,Benign Cellular Infiltrate,High grade B-cell lymphoma
17378,Benign Cellular Infiltrate,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
17379,Benign Cellular Infiltrate,Plasma Cell Myeloma by DS Stage
17380,Benign Cellular Infiltrate,Primary cutaneous acral CD8 positive T-cell lymphoma
17381,Benign Cellular Infiltrate,Anatomic Stage I Breast Cancer AJCC v8
17382,Benign Cellular Infiltrate,Anatomic Stage IV Breast Cancer AJCC v8
17383,Benign Cellular Infiltrate,Breast Cancer by AJCC v8 Prognostic Stage
17384,Benign Cellular Infiltrate,Prognostic Stage IIIC Breast Cancer AJCC v8
17385,Benign Cellular Infiltrate,Stage II Vulvar Cancer AJCC v8
17386,Benign Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v8
17387,Benign Cellular Infiltrate,Cervical Cancer by AJCC v8 Stage
17388,Benign Cellular Infiltrate,Stage IB Cervical Cancer AJCC v8
17389,Benign Cellular Infiltrate,Stage IB1 Cervical Cancer AJCC v8
17390,Benign Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v8
17391,Benign Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v8
17392,Benign Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v8
17393,Benign Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v8
17394,Benign Cellular Infiltrate,Stage III Uterine Corpus Leiomyosarcoma AJCC v8
17395,Benign Cellular Infiltrate,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8
17396,Benign Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage
17397,Benign Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8
17398,Benign Cellular Infiltrate,Stage IIIA2 Ovarian Cancer AJCC v8
17399,Benign Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v8
17400,Benign Cellular Infiltrate,Stage I Penile Cancer AJCC v8
17401,Benign Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v8
17402,Benign Cellular Infiltrate,Stage III Prostate Cancer AJCC v8
17403,Benign Cellular Infiltrate,Stage IVA Prostate Cancer AJCC v8
17404,Benign Cellular Infiltrate,Stage II Testicular Cancer AJCC v8
17405,Benign Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v8
17406,Benign Cellular Infiltrate,Stage I Renal Cell Cancer AJCC v8
17407,Benign Cellular Infiltrate,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
17408,Benign Cellular Infiltrate,Stage 0a Ureter Cancer AJCC v8
17409,Benign Cellular Infiltrate,Stage II Ureter Cancer AJCC v8
17410,Benign Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8
17411,Benign Cellular Infiltrate,Stage III Bladder Cancer AJCC v8
17412,Benign Cellular Infiltrate,Stage IV Bladder Cancer AJCC v8
17413,Benign Cellular Infiltrate,Stage 0is Urethral Cancer AJCC v8
17414,Benign Cellular Infiltrate,Stage II Urethral Cancer AJCC v8
17415,Benign Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v8
17416,Benign Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v8
17417,Benign Cellular Infiltrate,Pathologic Stage II Retinoblastoma AJCC v8
17418,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
17419,Benign Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
17420,Benign Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
17421,Benign Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
17422,Benign Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
17423,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
17424,Benign Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
17425,Benign Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
17426,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
17427,Benign Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8
17428,Benign Cellular Infiltrate,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8
17429,Benign Cellular Infiltrate,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8
17430,Benign Cellular Infiltrate,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8
17431,Benign Cellular Infiltrate,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage
17432,Benign Cellular Infiltrate,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage
17433,Benign Cellular Infiltrate,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage
17434,Benign Cellular Infiltrate,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8
17435,Benign Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
17436,Benign Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
17437,Benign Cellular Infiltrate,RISS Stage I Plasma Cell Myeloma
17438,Intermediate Grade Neuroendocrine Lesion,Refractory Pancreatic Carcinoma
17439,Malignant Cellular Infiltrate,Lung Myoepithelioma
17440,Benign Cellular Infiltrate,Primary myoepithelial carcinoma of lung
17441,Benign Cellular Infiltrate,Refractory Malignant Glioma
17442,Benign Cellular Infiltrate,Refractory Rhabdoid Tumor
17443,Low Grade Neuroendocrine Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
17444,Benign Cellular Infiltrate,Cardiac Yolk Sac Tumor
17445,Benign Cellular Infiltrate,Malignant Pericardial Germ Cell Tumor
17446,Benign Cellular Infiltrate,Platinum-Resistant Ovarian Carcinoma
17447,Well Differentiated Neuroendocrine Lesion,Refractory Colorectal Carcinoma
17448,Benign Cellular Infiltrate,Recurrent Grade 3a Follicular Lymphoma
17449,Benign Cellular Infiltrate,EZB Diffuse Large B-Cell Lymphoma
17450,Benign Cellular Infiltrate,Recurrent Acute Leukemia
17451,Benign Cellular Infiltrate,Metastatic Uveal Melanoma
17452,Benign Cellular Infiltrate,Recurrent Endometrial Endometrioid Adenocarcinoma
17453,Benign Cellular Infiltrate,Advanced Hypopharyngeal Squamous Cell Carcinoma
17454,Benign Cellular Infiltrate,Body Cavity Primary Effusion Lymphoma
17455,Benign Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma
17456,Benign Cellular Infiltrate,Recurrent Renal Pelvis Urothelial Carcinoma
17457,Benign Cellular Infiltrate,Recurrent Malignant Pharyngeal Neoplasm
17458,Benign Cellular Infiltrate,Infiltrating Bladder Carcinoma
17459,Benign Cellular Infiltrate,Resectable Malignant Neoplasm
17460,Benign Cellular Infiltrate,Resectable Carcinoma
17461,Intermediate Grade Neuroendocrine Lesion,Recurrent Metastatic Digestive System Carcinoma
17462,Intermediate Grade Neuroendocrine Lesion,Refractory Digestive System Carcinoma
17463,Well Differentiated Neuroendocrine Lesion,Locally Advanced Bile Duct Carcinoma
17464,Benign Cellular Infiltrate,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
17465,Benign Cellular Infiltrate,Refractory Primary Peritoneal Carcinoma
17466,Benign Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm
17467,Low Grade Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
17468,Benign Cellular Infiltrate,Advanced Lymphoma
17469,Benign Cellular Infiltrate,Metastatic Unresectable Carcinoma
17470,Well Differentiated Neuroendocrine Lesion,Metastatic Unresectable Gastric Adenocarcinoma
17471,Intermediate Grade Neuroendocrine Lesion,Advanced Unresectable Gastric Adenocarcinoma
17472,Well Differentiated Neuroendocrine Lesion,Metastatic gastric adenocarcinoma
17473,Benign Cellular Infiltrate,Metastatic Chordoma
17474,Benign Cellular Infiltrate,Unresectable Chordoma
17475,Low Grade Neuroendocrine Lesion,Refractory Small Intestinal Carcinoma
17476,Well Differentiated Neuroendocrine Lesion,Locally Advanced Small Intestinal Carcinoma
17477,Well Differentiated Neuroendocrine Lesion,Locally Advanced Digestive System Carcinoma
17478,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Digestive System Carcinoma
17479,Benign Cellular Infiltrate,Metastatic Cervical Carcinoma
17480,Benign Cellular Infiltrate,Locally Advanced Unresectable Sarcoma
17481,Low Grade Neuroendocrine Lesion,Recurrent Pancreatic Acinar Cell Carcinoma
17482,Benign Cellular Infiltrate,Recurrent Submandibular Gland Acinic Cell Carcinoma
17483,Benign Cellular Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
17484,Well Differentiated Neuroendocrine Lesion,Recurrent Anal Adenocarcinoma
17485,Benign Cellular Infiltrate,Recurrent Clear Cell Renal Cell Carcinoma
17486,Benign Cellular Infiltrate,Recurrent Ovarian Serous Adenocarcinoma
17487,Benign Cellular Infiltrate,Recurrent Parotid Gland Mucoepidermoid Carcinoma
17488,Benign Cellular Infiltrate,Recurrent Parotid Gland Undifferentiated Carcinoma
17489,Benign Cellular Infiltrate,Recurrent Malignant Central Nervous System Neoplasm
17490,Well Differentiated Neuroendocrine Lesion,Metastatic Fibrolamellar Carcinoma
17491,Intermediate Grade Neuroendocrine Lesion,Metastatic Fibrolamellar Carcinoma
17492,Intermediate Grade Neuroendocrine Lesion,Recurrent Fibrolamellar Carcinoma
17493,Benign Cellular Infiltrate,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
17494,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
17495,Benign Cellular Infiltrate,Unresectable Pleural Malignant Mesothelioma
17496,Indolent Clinical Course,Anaplastic Sarcoma of the Kidney
17497,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Renal Cell Carcinoma
17498,Low Grade Neuroendocrine Lesion,Adenocarcinoma gastric recurrent
17499,Intracytoplasmic Eosinophilic Inclusion,Recurrent Sarcoma of the Extremity
17500,Indolent Clinical Course,Advanced Sarcoma of the Extremity
17501,Intermediate Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma recurrent
17502,Indolent Clinical Course,Sellar Chordoma
17503,Benign Cellular Infiltrate,Sellar Chordoma
17504,Benign Cellular Infiltrate,Sellar Germinoma
17505,Malignant Germinomatous Cellular Infiltrate,Sellar Embryonal Carcinoma
17506,Malignant Germinomatous Cellular Infiltrate,Sellar Choriocarcinoma
17507,Benign Cellular Infiltrate,Recurrent Endometrial Clear Cell Adenocarcinoma
17508,Well Differentiated Neuroendocrine Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
17509,Benign Cellular Infiltrate,Unresectable Digestive System Carcinoma
17510,Premalignant Lesion,Metastatic Lung Adenocarcinoma
17511,Hyperviscosity,Smoldering Waldenstrom Macroglobulinemia
17512,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
17513,Low Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
17514,Extensive Stage Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
17515,Intermediate Grade Neuroendocrine Lesion,Unresectable Digestive System Neuroendocrine Carcinoma
17516,Well Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Carcinoma
17517,Malignant Cellular Infiltrate,Thyroid Gland Black Follicular Adenoma
17518,Indolent Clinical Course,Refractory Malignant Peripheral Nerve Sheath Tumor
17519,Benign Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor
17520,Necrotic changes (finding),Temporal Lobe Anaplastic Astrocytoma
17521,Precise Histogenesis Unknown,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma
17522,Grade 4 Lesion,Supratentorial Pleomorphic Xanthoastrocytoma
17523,Precise Histogenesis Unknown,Temporal Lobe Pleomorphic Xanthoastrocytoma
17524,Mucoid Stroma Formation,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
17525,Benign Cellular Infiltrate,Metastatic Vaginal Carcinoma
17526,Benign Cellular Infiltrate,Metastatic Vulvar Carcinoma
17527,Benign Cellular Infiltrate,Metastatic Adrenal Cortex Carcinoma
17528,Indolent Clinical Course,Stage IV adult soft tissue sarcoma
17529,Benign Cellular Infiltrate,Stage IV adult soft tissue sarcoma
17530,Low Grade Neuroendocrine Lesion,Metastatic Esophageal Carcinoma
17531,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma
17532,Benign Cellular Infiltrate,Metastatic Oral Cavity Adenoid Cystic Carcinoma
17533,Prominent Schwannian Stroma Present,Metastatic Neuroblastoma
17534,Ground Glass Nuclear Inclusion,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
17535,Mixed Neoplastic Glandular and Squamous Cell Population,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
17536,Benign Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma
17537,Benign Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma
17538,Benign Cellular Infiltrate,Scrotal Liposarcoma
17539,Intermediate Filaments Present,Scrotal Sarcoma
17540,Benign Cellular Infiltrate,Advanced Prostate Adenocarcinoma
17541,Extensive Stage Lesion,Locally Advanced Prostate Adenocarcinoma
17542,Benign Cellular Infiltrate,Locally Advanced Unresectable Cervical Adenocarcinoma
17543,Diffuse Lesion,Thyroid Gland Hemangioma
17544,High Mitotic Activity,Thyroid Gland Leiomyoma
17545,Intermediate Filaments Present,Thyroid Gland Leiomyosarcoma
17546,CD21-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
17547,Birbeck Granules Present,follicular dendritic cell sarcoma of thyroid gland
17548,Intracytoplasmic Eosinophilic Inclusion,Refractory Kaposi Sarcoma
17549,Benign Cellular Infiltrate,"Kaposi's sarcoma, metastatic"
17550,Intracytoplasmic Eosinophilic Inclusion,"Kaposi's sarcoma, metastatic"
17551,Poorly Differentiated Neuroendocrine Lesion,Advanced Pancreatic Neuroendocrine Tumor
17552,Intermediate Grade Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma
17553,Low Grade Neuroendocrine Lesion,Advanced Gastric Neuroendocrine Carcinoma
17554,Local disease,Advanced Gastric Large Cell Neuroendocrine Carcinoma
17555,Benign Cellular Infiltrate,Advanced Gastric Small Cell Neuroendocrine Carcinoma
17556,Intermediate Grade Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
17557,Well Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
17558,Low Grade Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
17559,Benign Cellular Infiltrate,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
17560,Chronic Clinical Course,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
17561,Therapy-Related Toxicity,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
17562,Benign Cellular Infiltrate,Advanced Digestive System Carcinoma
17563,Broad Fibrous Bands Formation,Benign Parathyroid Gland Adenoma
17564,Capsular Invasion,Benign Parathyroid Gland Adenoma
17565,Perineural spread,Benign Parathyroid Gland Adenoma
17566,Extensive Stage Lesion,Locally Advanced Basal Cell Carcinoma
17567,Benign Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma
17568,Benign Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma
17569,Intermediate Grade Neuroendocrine Lesion,Resectable Intrahepatic Cholangiocarcinoma
17570,Well Differentiated Neuroendocrine Lesion,Bile duct adenocarcinoma resectable
17571,Low Grade Neuroendocrine Lesion,Resectable Extrahepatic Bile Duct Adenocarcinoma
17572,Benign Cellular Infiltrate,Adrenal Gland Sarcoma
17573,Intracytoplasmic Eosinophilic Inclusion,Adrenal Gland Sarcoma
17574,Malignant Cellular Infiltrate,Benign Cutaneous Vascular Neoplasm
17575,Intermediate Grade Neuroendocrine Lesion,Early gastric cancer
17576,Benign Cellular Infiltrate,Morpheic basal cell carcinoma
17577,Benign Cellular Infiltrate,Radiation-Induced Cancer
17578,Malignant Cellular Infiltrate,Cranial Nodular Fasciitis
17579,Malignant Cellular Infiltrate,Giant cell angiofibroma
17580,Well Differentiated Neuroendocrine Lesion,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
17581,Low Grade Neuroendocrine Lesion,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
17582,Well Differentiated Neuroendocrine Lesion,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
17583,Benign Cellular Infiltrate,Localized Primitive Neuroectodermal Tumor
17584,Well Differentiated Neuroendocrine Lesion,Cholangiocarcinoma resectable
17585,Benign Cellular Infiltrate,PNET of bone localized
17586,Benign Cellular Infiltrate,Refractory Hematologic Malignancy
17587,Benign Cellular Infiltrate,Recurrent Hematologic Malignancy
17588,Benign Cellular Infiltrate,Unresectable Malignant Neoplasm
17589,Benign Cellular Infiltrate,Adult Clear Cell Sarcoma of Soft Parts
17590,Benign Cellular Infiltrate,Small cell carcinoma of ovary
17591,Geographic Necrosis,Adult Central Nervous System Mature Teratoma
17592,Intermediate Grade Neuroendocrine Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma
17593,Low Grade Neuroendocrine Lesion,Ampulla of Vater Clear Cell Adenocarcinoma
17594,Low Grade Neuroendocrine Lesion,Ampulla of Vater Squamous Cell Carcinoma
17595,Benign Cellular Infiltrate,mantle cell lymphoma of stomach
17596,Poorly Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
17597,Poorly Differentiated Neuroendocrine Lesion,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
17598,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
17599,Malignant Cellular Infiltrate,Steroid Lipomatosis
17600,Benign Cellular Infiltrate,Inflammatory Leiomyosarcoma
17601,Malignant Cellular Infiltrate,Follicular Myxoma
17602,Malignant Cellular Infiltrate,Conventional Lipoma
17603,Benign Cellular Infiltrate,Primary Cutaneous Mucinous Carcinoma
17604,Benign Cellular Infiltrate,Skin Basaloid Carcinoma
17605,Benign Cellular Infiltrate,Transplant-Related Carcinoma
17606,Benign Cellular Infiltrate,Transplant-Related Skin Squamous Cell Carcinoma
17607,Benign Cellular Infiltrate,Transplant-Related Renal Cell Carcinoma
17608,Benign Cellular Infiltrate,Transplant-Related Kaposi Sarcoma
17609,Low Grade Neuroendocrine Lesion,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
17610,Benign Cellular Infiltrate,Human Papillomavirus-Related Squamous Cell Carcinoma
17611,Low Grade Neuroendocrine Lesion,Hepatitis Virus-Related Hepatocellular Carcinoma
17612,Benign Cellular Infiltrate,EBV-Related Lymphoma
17613,Benign Cellular Infiltrate,EBV-Related Burkitt Lymphoma
17614,Benign Cellular Infiltrate,Childhood Kidney Wilms Tumor
17615,Benign Cellular Infiltrate,Acute promyelocytic leukemia - hypogranular variant
17616,Benign Cellular Infiltrate,Helicobacter Pylori-Related Non-Hodgkin Lymphoma
17617,Benign Cellular Infiltrate,Parasite-Related Carcinoma
17618,Benign Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
17619,Benign Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm
17620,Benign Cellular Infiltrate,Tobacco Chewing-Related Carcinoma
17621,Benign Cellular Infiltrate,Lymphohistiocytoid Mesothelioma
17622,Benign Cellular Infiltrate,Metastatic Ureter Carcinoma
17623,Benign Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
17624,Benign Cellular Infiltrate,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
17625,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
17626,Benign Cellular Infiltrate,Sporadic Burkitt's lymphoma
17627,Intermediate Grade Neuroendocrine Lesion,Aflatoxins-Related Hepatocellular Carcinoma
17628,Low Grade Neuroendocrine Lesion,Alcohol-Related Hepatocellular Carcinoma
17629,Benign Cellular Infiltrate,Metaplastic carcinoma
17630,Malignant Cellular Infiltrate,Benign Ovarian Neoplasm
17631,Benign Cellular Infiltrate,Skin Squamous Cell Carcinoma In Situ
17632,Benign Cellular Infiltrate,Cystadenocarcinoma
17633,Malignant Cellular Infiltrate,Enchondroma
17634,Malignant Cellular Infiltrate,Enchondromatosis
17635,Benign Cellular Infiltrate,Yolk Sac Tumor
17636,Benign Cellular Infiltrate,Myeloid Leukemia
17637,Benign Cellular Infiltrate,Philadelphia-Positive Myelogenous Leukemia
17638,Benign Cellular Infiltrate,Chronic Neutrophilic Leukemia
17639,Benign Cellular Infiltrate,Lymphoma
17640,Benign Cellular Infiltrate,"Lymphoma, Non-Hodgkin"
17641,Benign Cellular Infiltrate,Medulloblastoma
17642,Benign Cellular Infiltrate,"Acute Myeloid Leukemia, M1"
17643,Benign Cellular Infiltrate,Acute Myeloid Leukemia (AML-M2)
17644,Malignant Cellular Infiltrate,Myoblastoma
17645,Benign Cellular Infiltrate,Nephroblastoma
17646,Malignant Cellular Infiltrate,Neurilemmoma
17647,Benign Cellular Infiltrate,synovial sarcoma
17648,Benign Cellular Infiltrate,Carcinosarcoma
17649,Malignant Cellular Infiltrate,Ovarian Fibromata
17650,Malignant Cellular Infiltrate,Chondromatosis
17651,Benign Cellular Infiltrate,Malignant neoplasm of maxillary sinus
17652,Malignant Cellular Infiltrate,Lipoma of axilla
17653,Benign Cellular Infiltrate,Malignant neoplasms of independent (primary) multiple sites
17654,Benign Cellular Infiltrate,Malignant tumor of supraglottis
17655,Benign Cellular Infiltrate,Granulomatous slack skin disease
17656,Benign Cellular Infiltrate,Kaposi's sarcoma of skin
17657,Benign Cellular Infiltrate,Malignant neoplasm of exocervix
17658,Benign Cellular Infiltrate,Tall Cell Variant Thyroid Gland Papillary Carcinoma
17659,Benign Cellular Infiltrate,Malignant neoplasm of clitoris
17660,Benign Cellular Infiltrate,Malignant neoplasm of scrotum
17661,Benign Cellular Infiltrate,Malignant neoplasm of conjunctiva
17662,Benign Cellular Infiltrate,Recurrent Malignant Neoplasm of Salivary Gland
17663,Benign Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma
17664,Benign Cellular Infiltrate,large cell carcinoma of salivary gland
17665,Benign Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
17666,Benign Cellular Infiltrate,Secondary malignant neoplasm of lung
17667,Benign Cellular Infiltrate,Secondary malignant neoplasm of pleura
17668,Benign Cellular Infiltrate,Pagetoid reticulosis
17669,Benign Cellular Infiltrate,Secondary malignant neoplasm of bone
17670,Benign Cellular Infiltrate,Monoblastic Sarcoma
17671,Benign Cellular Infiltrate,Differentiated Granulocytic Sarcoma
17672,Malignant Cellular Infiltrate,Benign neoplasm of tonsil
17673,Benign Cellular Infiltrate,Microinvasive Malignant Neoplasm
17674,Benign Cellular Infiltrate,Malignant Neoplasm by Grade
17675,Benign Cellular Infiltrate,Well Differentiated Malignant Neoplasm
17676,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q13;q21)
17677,Benign Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia
17678,Benign Cellular Infiltrate,Malignant Reproductive System Neoplasm
17679,Malignant Cellular Infiltrate,Central Breast Papilloma
17680,Benign Cellular Infiltrate,Early Invasive Cervical Adenocarcinoma
17681,Benign Cellular Infiltrate,Hereditary Ovarian Carcinoma
17682,Malignant Cellular Infiltrate,Benign neoplasm of vulva
17683,Malignant Cellular Infiltrate,Benign neoplasm of testis
17684,Malignant Cellular Infiltrate,Benign neoplasm of retina
17685,Benign Cellular Infiltrate,Non-Hereditary Clear Cell Renal Cell Carcinoma
17686,Malignant Cellular Infiltrate,Hemangioma of intracranial structure
17687,Malignant Cellular Infiltrate,Hemangioma of intra-abdominal structure
17688,Malignant Cellular Infiltrate,benign neoplasm of lymph nodes
17689,Well Differentiated Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v6 and v7
17690,Benign Cellular Infiltrate,Carcinoma in situ of trachea
17691,Malignant Cellular Infiltrate,Papillary fibroelastoma
17692,Benign Cellular Infiltrate,"Liposarcoma, Dedifferentiated"
17693,Benign Cellular Infiltrate,"Neuroectodermal Tumor, Melanotic"
17694,Benign Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
17695,Benign Cellular Infiltrate,Malignant Kidney Mixed Epithelial and Stromal Tumor
17696,Benign Cellular Infiltrate,Multicentric Thyroid Gland Papillary Carcinoma
17697,Benign Cellular Infiltrate,Mesenchymal Chondrosarcoma
17698,Benign Cellular Infiltrate,Alveolar Soft Part Sarcoma
17699,Malignant Cellular Infiltrate,Hidrocystoma
17700,Benign Cellular Infiltrate,"Carcinoma, Endometrioid"
17701,Benign Cellular Infiltrate,"Carcinoma, Lobular"
17702,Benign Cellular Infiltrate,"Carcinoma, Signet Ring Cell"
17703,Benign Cellular Infiltrate,Olfactory Neuroblastoma
17704,Benign Cellular Infiltrate,Skin Basal Cell Carcinoma with Adnexal Differentiation
17705,Benign Cellular Infiltrate,Malignant neoplasm of salivary gland
17706,Benign Cellular Infiltrate,Skin Sarcomatoid Basal Cell Carcinoma
17707,Malignant Cellular Infiltrate,Lung Clear Cell Tumor
17708,Benign Cellular Infiltrate,Metachronous Malignant Neoplasm
17709,Malignant Cellular Infiltrate,Kasabach-Merritt syndrome
17710,Benign Cellular Infiltrate,Neonatal leukemia
17711,Malignant Cellular Infiltrate,Benign neoplasm of female breast
17712,Well Differentiated Neuroendocrine Lesion,Pancreatic carcinoma
17713,Low Grade Neuroendocrine Lesion,Carcinoma of extrahepatic bile duct
17714,Low Grade Neuroendocrine Lesion,Cystadenocarcinoma of pancreas
17715,Intermediate Grade Neuroendocrine Lesion,Submucosal Invasive Colon Adenocarcinoma
17716,Benign Cellular Infiltrate,Mycosis Fungoides Variant
17717,Benign Cellular Infiltrate,"Glioblastoma, IDH-Wildtype"
17718,Benign Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
17719,Benign Cellular Infiltrate,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
17720,Malignant Cellular Infiltrate,Inverted papilloma of urinary bladder
17721,Benign Cellular Infiltrate,Male Urethral Malignant Neoplasm
17722,Benign Cellular Infiltrate,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma
17723,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
17724,Benign Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Solid Pattern"
17725,Benign Cellular Infiltrate,Prostatic Duct Urothelial Carcinoma
17726,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
17727,Benign Cellular Infiltrate,Childhood Medulloblastoma
17728,Well Differentiated Neuroendocrine Lesion,Esophageal carcinoma recurrent
17729,Geographic Necrosis,Grade 1 Ovarian Teratoma
17730,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant Ovarian Teratoma
17731,Malignant Cellular Infiltrate,Borderline Ovarian Serous Adenofibroma
17732,Benign Cellular Infiltrate,Stage IV Renal Cell Cancer
17733,Well Differentiated Neuroendocrine Lesion,Gastric Adenocarcinoma
17734,Benign Cellular Infiltrate,adenosquamous carcinoma of ovary
17735,Malignant Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma
17736,Malignant Cellular Infiltrate,Benign Ovarian Transitional Cell Tumor
17737,Benign Cellular Infiltrate,Ovarian mixed epithelial carcinoma
17738,Benign Cellular Infiltrate,"Cystadenocarcinoma, Serous"
17739,Malignant Cellular Infiltrate,Fallopian Tube Papilloma
17740,Benign Cellular Infiltrate,Grade 2 Endometrial Mucinous Adenocarcinoma
17741,Benign Cellular Infiltrate,Ductal Breast Carcinoma
17742,Malignant Cellular Infiltrate,Uterine Corpus Dissecting Leiomyoma
17743,Malignant Cellular Infiltrate,Benign Metastasizing Leiomyoma of the Uterine Corpus
17744,Malignant Cellular Infiltrate,Uterine Corpus Atypical Polypoid Adenomyoma
17745,Benign Cellular Infiltrate,Vaginal Non-Keratinizing Squamous Cell Carcinoma
17746,Benign Cellular Infiltrate,Vaginal Mucinous Adenocarcinoma
17747,Benign Cellular Infiltrate,Vaginal Mesonephric Adenocarcinoma
17748,Benign Cellular Infiltrate,Vaginal Adenoid Cystic Carcinoma
17749,Benign Cellular Infiltrate,Bartholin Gland Adenosquamous Carcinoma
17750,Benign Cellular Infiltrate,Bartholin Gland Small Cell Carcinoma
17751,Benign Cellular Infiltrate,Vulvar Sebaceous Carcinoma
17752,Benign Cellular Infiltrate,Bladder Squamous Cell Carcinoma
17753,Benign Cellular Infiltrate,Breast Mucinous Cystadenocarcinoma
17754,Benign Cellular Infiltrate,Breast Columnar Cell Mucinous Carcinoma
17755,Benign Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
17756,Benign Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
17757,Benign Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
17758,Benign Cellular Infiltrate,Sebaceous Breast Carcinoma
17759,Benign Cellular Infiltrate,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
17760,Benign Cellular Infiltrate,Synchronous Bilateral Breast Carcinoma
17761,Benign Cellular Infiltrate,Ductal Carcinoma In Situ with Microinvasion
17762,Malignant Cellular Infiltrate,Breast Apocrine Adenoma
17763,Benign Cellular Infiltrate,Squamous cell carcinoma of lip
17764,Benign Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
17765,Benign Cellular Infiltrate,Ovarian Wilms Tumor
17766,Benign Cellular Infiltrate,AIDS-Related Malignant Neoplasm
17767,Benign Cellular Infiltrate,Squamous cell carcinoma of vulva
17768,Benign Cellular Infiltrate,"Adenocarcinoma, metastatic"
17769,Benign Cellular Infiltrate,"Adenocarcinoma, intestinal type"
17770,Benign Cellular Infiltrate,Solid carcinoma
17771,Benign Cellular Infiltrate,Adenocarcinoma in villous adenoma
17772,Malignant Cellular Infiltrate,Atypical neurofibroma
17773,Benign Cellular Infiltrate,Lipid-rich carcinoma
17774,Well Differentiated Neuroendocrine Lesion,Mucin-Producing Intrahepatic Cholangiocarcinoma
17775,Benign Cellular Infiltrate,Ceruminous adenocarcinoma
17776,Malignant Cellular Infiltrate,Serous surface papilloma
17777,Benign Cellular Infiltrate,Comedocarcinoma
17778,Benign Cellular Infiltrate,Noninfiltrating intraductal papillary adenocarcinoma
17779,Benign Cellular Infiltrate,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
17780,Benign Cellular Infiltrate,Adenocarcinoma with spindle cell metaplasia
17781,Malignant Cellular Infiltrate,Mature Ganglioneuroma
17782,Malignant Cellular Infiltrate,Neuronevus
17783,Benign Cellular Infiltrate,Malignant blue nevus of skin
17784,Benign Cellular Infiltrate,Infantile fibrosarcoma
17785,Malignant Cellular Infiltrate,Elastofibroma
17786,Low Grade Neuroendocrine Lesion,Low grade appendiceal mucinous neoplasm
17787,Benign Cellular Infiltrate,Malignant Brenner Tumor
17788,"Fully Differentiated ""Adult-Type"" Tissues Present",Grade 3 Teratoma
17789,Benign Cellular Infiltrate,"Struma ovarii, malignant"
17790,Intermediate Grade Neuroendocrine Lesion,"Pancreatic carcinoma, familial"
17791,Malignant Cellular Infiltrate,Trichoadenoma
17792,Malignant Cellular Infiltrate,Fibrofolliculoma
17793,Malignant Cellular Infiltrate,Apocrine cystadenoma
17794,Benign Cellular Infiltrate,Ductal Eccrine Carcinoma with Squamous Metaplasia
17795,Low Grade Neuroendocrine Lesion,Small Intestinal Mucinous Adenocarcinoma
17796,Intermediate Grade Neuroendocrine Lesion,Mucinous adenocarcinoma of appendix
17797,Benign Cellular Infiltrate,Malignant melanoma of eyelid
17798,Well Differentiated Neuroendocrine Lesion,Rectosigmoid Adenocarcinoma
17799,Low Grade Neuroendocrine Lesion,Colorectal Mucinous Adenocarcinoma
17800,Low Grade Neuroendocrine Lesion,Colorectal Small Cell Neuroendocrine Carcinoma
17801,Low Grade Neuroendocrine Lesion,Colorectal Squamous Cell Carcinoma
17802,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid Mucinous Adenocarcinoma
17803,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid Signet Ring Cell Carcinoma
17804,Well Differentiated Neuroendocrine Lesion,clear cell adenocarcinoma of gallbladder
17805,Low Grade Neuroendocrine Lesion,clear cell adenocarcinoma of gallbladder
17806,Low Grade Neuroendocrine Lesion,Sarcomatoid Hepatocellular Carcinoma
17807,Malignant Cellular Infiltrate,Polyp of external auditory meatus
17808,Malignant Cellular Infiltrate,Cystadenoma of pancreas
17809,Malignant Cellular Infiltrate,"Lipomatosis, Multiple Symmetrical"
17810,Malignant Cellular Infiltrate,Benign neoplasm of base of tongue
17811,Benign Cellular Infiltrate,Malignant tumor of minor salivary gland
17812,Malignant Cellular Infiltrate,Benign neoplasm of frontal sinus
17813,Malignant Cellular Infiltrate,Benign neoplasm of sphenoidal sinus
17814,Malignant Cellular Infiltrate,Benign neoplasm of subglottis
17815,Malignant Cellular Infiltrate,Dermal Duct Tumor
17816,Malignant Cellular Infiltrate,Nevus spilus
17817,Benign Cellular Infiltrate,Undifferentiated carcinoma of ovary
17818,Benign Cellular Infiltrate,Malignant Ovarian Germ Cell Neoplasm
17819,Benign Cellular Infiltrate,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
17820,Malignant Cellular Infiltrate,Benign neoplasm of fallopian tube
17821,Benign Cellular Infiltrate,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
17822,Benign Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile"
17823,Benign Cellular Infiltrate,"Diffuse large B-cell lymphoma, unclassifiable, NOS"
17824,Malignant Cellular Infiltrate,Ureteric polyp
17825,Benign Cellular Infiltrate,Stage 0is Urethral Cancer AJCC v7
17826,Benign Cellular Infiltrate,Thymic Mucosa-Associated Lymphoid Tissue Lymphoma
17827,Benign Cellular Infiltrate,Adenoid cystic carcinoma of lacrimal gland
17828,Malignant Cellular Infiltrate,Vaginal Angiomyofibroblastoma
17829,Malignant Cellular Infiltrate,Capillary hemangioma of orbit
17830,Benign Cellular Infiltrate,Lung Lymphoepithelioma-Like Carcinoma
17831,Benign Cellular Infiltrate,carcinosarcoma of lung
17832,Malignant Cellular Infiltrate,Lung Pleomorphic Adenoma
17833,Malignant Cellular Infiltrate,Lung Mucinous Cystadenoma
17834,Benign Cellular Infiltrate,Primary Pulmonary Diffuse Large B-Cell Lymphoma
17835,Benign Cellular Infiltrate,Malignant neoplasm of great vessels
17836,Malignant Cellular Infiltrate,Cardiac Intramuscular Hemangioma
17837,Benign Cellular Infiltrate,Cardiac Biphasic Synovial Sarcoma
17838,Benign Cellular Infiltrate,Malignant neoplasm of thalamus
17839,Poorly Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2
17840,Benign Cellular Infiltrate,Secondary malignant neoplasm of testis
17841,Poorly Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor
17842,Benign Cellular Infiltrate,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8"
17843,Benign Cellular Infiltrate,Stage 0 Oropharyngeal Carcinoma
17844,Intermediate Grade Neuroendocrine Lesion,Carcinoma in situ of cecum
17845,Malignant Cellular Infiltrate,Benign neoplasm of oropharynx
17846,Malignant Cellular Infiltrate,Benign neoplasm of glottis
17847,Malignant Cellular Infiltrate,Benign neoplasm of intestinal tract
17848,Malignant Cellular Infiltrate,Benign tumor of exocrine pancreas
17849,Malignant Cellular Infiltrate,Benign neoplasm of adnexa of skin
17850,Benign Cellular Infiltrate,Malignant neoplasm of meninges
17851,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of intestine
17852,Benign Cellular Infiltrate,Gestational choriocarcinoma
17853,Malignant Cellular Infiltrate,Lipoma of breast
17854,Malignant Cellular Infiltrate,Trigeminal schwannoma
17855,Benign Cellular Infiltrate,Sarcoma of breast
17856,Malignant Cellular Infiltrate,Intravascular fasciitis
17857,Malignant Cellular Infiltrate,Skin Cavernous Hemangioma
17858,Benign Cellular Infiltrate,"Leukemia, Prolymphocytic, B-Cell"
17859,Benign Cellular Infiltrate,Malignant neoplasm of middle ear
17860,Benign Cellular Infiltrate,Malignant neoplasm of olfactory nerve
17861,Malignant Cellular Infiltrate,"Benign neoplasm of eye, unspecified"
17862,Benign Cellular Infiltrate,"Paget's Disease, Mammary"
17863,Malignant Cellular Infiltrate,calcifying aponeurotic fibroma
17864,Malignant Cellular Infiltrate,Parathyroid Gland Lipoadenoma
17865,Malignant Cellular Infiltrate,Hemangioma of gingiva
17866,Malignant Cellular Infiltrate,Benign neuroendocrine tumor
17867,Malignant Cellular Infiltrate,Androgen-Producing Adrenal Cortex Adenoma
17868,Malignant Cellular Infiltrate,Benign neoplasm of sweat gland
17869,Malignant Cellular Infiltrate,Benign neoplasm of neck
17870,Benign Cellular Infiltrate,Malignant lymphoma of spleen
17871,Malignant Cellular Infiltrate,Benign neoplasm of hilus of lung
17872,Malignant Cellular Infiltrate,Benign neoplasm of adrenal medulla
17873,Benign Cellular Infiltrate,Myxoinflammatory fibroblastic sarcoma
17874,Benign Cellular Infiltrate,Sclerosing Epithelioid Fibrosarcoma
17875,Low Grade Neuroendocrine Lesion,Stomach Carcinoma
17876,Malignant Cellular Infiltrate,Venous Angioleiomyoma
17877,Malignant Cellular Infiltrate,Extracardiac Rhabdomyoma
17878,Benign Cellular Infiltrate,Anaplastic Embryonal Rhabdomyosarcoma
17879,Benign Cellular Infiltrate,Malignant germ cell neoplasm
17880,Benign Cellular Infiltrate,Malignant fibrous histiocytoma metastatic
17881,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of ileum
17882,Benign Cellular Infiltrate,Stage 0 Pharynx Carcinoma
17883,Benign Cellular Infiltrate,Desmoplastic Medulloblastoma
17884,Benign Cellular Infiltrate,Adult Acute Lymphocytic Leukemia
17885,Malignant Cellular Infiltrate,Perineurioma
17886,Benign Cellular Infiltrate,Environment-Related Malignant Neoplasm
17887,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma recurrent
17888,Benign Cellular Infiltrate,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb
17889,Benign Cellular Infiltrate,Hodgkin's disease of intrapelvic lymph nodes
17890,Benign Cellular Infiltrate,Lung squamous cell carcinoma recurrent
17891,Low Grade Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v6
17892,Well Differentiated Neuroendocrine Lesion,Pancreatic carcinoma non-resectable
17893,Low Grade Neuroendocrine Lesion,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
17894,Benign Cellular Infiltrate,Malignant Testicular Non-Seminomatous Germ Cell Tumor
17895,Benign Cellular Infiltrate,Epithelioid sarcoma recurrent
17896,Malignant Cellular Infiltrate,Urethral Urothelial Papilloma
17897,Benign Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
17898,Benign Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
17899,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II
17900,Malignant Cellular Infiltrate,Kidney Fibroma
17901,Benign Cellular Infiltrate,Pharyngeal cancer recurrent
17902,Benign Cellular Infiltrate,Malignant eccrine spiradenoma
17903,Benign Cellular Infiltrate,sarcoma of spinal cord
17904,Benign Cellular Infiltrate,lymphoma of spinal cord
17905,Benign Cellular Infiltrate,adenocarcinoma of breast with squamous metaplasia
17906,Benign Cellular Infiltrate,Metastatic Breast Carcinoid Tumor
17907,Benign Cellular Infiltrate,Non-Hodgkin Breast Lymphoma
17908,Benign Cellular Infiltrate,Breast T-Cell Non-Hodgkin Lymphoma
17909,Benign Cellular Infiltrate,leiomyosarcoma of breast
17910,Benign Cellular Infiltrate,Breast adenocarcinoma
17911,Benign Cellular Infiltrate,leiomyosarcoma of ovary
17912,Intermediate Grade Neuroendocrine Lesion,Mucinous adenocarcinoma gastric
17913,Benign Cellular Infiltrate,Childhood Meningeal Melanoma
17914,Poorly Differentiated Neuroendocrine Lesion,Intestinal Gangliocytic Paraganglioma
17915,Benign Cellular Infiltrate,Early Favorable Non-Hodgkin Lymphoma
17916,Intermediate Grade Neuroendocrine Lesion,adenoid cystic carcinoma of esophagus
17917,Malignant Cellular Infiltrate,Hemangioma of breast
17918,Benign Cellular Infiltrate,Luminal A Breast Carcinoma
17919,Benign Cellular Infiltrate,Cardiac Malignant Peripheral Nerve Sheath Tumor
17920,Benign Cellular Infiltrate,Malignant Aortic Neoplasm
17921,Benign Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified"
17922,Benign Cellular Infiltrate,Region 17p13 Allelic Loss Associated Medulloblastoma
17923,Benign Cellular Infiltrate,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
17924,Malignant Cellular Infiltrate,Sympathetic Schwannoma
17925,Benign Cellular Infiltrate,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
17926,Malignant Cellular Infiltrate,Lipomatosis of Nerve
17927,Malignant Cellular Infiltrate,Inner Ear Lipoma
17928,Benign Cellular Infiltrate,Basal cell carcinoma - keratotic
17929,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Gastric Carcinoma
17930,Malignant Cellular Infiltrate,Appendix Leiomyoma
17931,Benign Cellular Infiltrate,rhabdomyosarcoma of prostate
17932,Benign Cellular Infiltrate,Squamous cell carcinoma of prostate
17933,Benign Cellular Infiltrate,Acinar Prostate Mucinous Adenocarcinoma
17934,Benign Cellular Infiltrate,Prostate Adenosquamous Carcinoma
17935,Intermediate Grade Neuroendocrine Lesion,Carcinoid tumor of rectum
17936,Well Differentiated Neuroendocrine Lesion,Squamous cell carcinoma of rectum
17937,Low Grade Neuroendocrine Lesion,cloacogenic carcinoma of rectum
17938,Malignant Cellular Infiltrate,Benign Dermal Schwannoma
17939,Benign Cellular Infiltrate,Stage II Uveal Melanoma AJCC v7
17940,Benign Cellular Infiltrate,Stage II Skin Cancer
17941,Benign Cellular Infiltrate,Stage IV Skin Cancer
17942,Benign Cellular Infiltrate,Sarcoma of skin
17943,Benign Cellular Infiltrate,Prostate Undifferentiated Carcinoma
17944,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of anal glands
17945,Benign Cellular Infiltrate,Aleukemic Monocytic Leukemia Cutis
17946,Benign Cellular Infiltrate,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma
17947,Benign Cellular Infiltrate,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
17948,Benign Cellular Infiltrate,Lung Acinar Adenocarcinoma
17949,Benign Cellular Infiltrate,Solid Lung Adenocarcinoma
17950,Benign Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
17951,Malignant Cellular Infiltrate,Fibroma of lung
17952,Malignant Cellular Infiltrate,Endobronchial Hamartoma
17953,Well Differentiated Neuroendocrine Lesion,Stage IIB Esophageal Carcinoma
17954,Intermediate Grade Neuroendocrine Lesion,Stage IIB Esophageal Carcinoma
17955,Malignant Cellular Infiltrate,lipoma of esophagus
17956,Malignant Cellular Infiltrate,Esophageal Fibroma
17957,Malignant Cellular Infiltrate,Benign Esophageal Schwannoma
17958,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of pancreas
17959,Intermediate Grade Neuroendocrine Lesion,carcinoma of pancreas with osteoclast-like giant cells
17960,Well Differentiated Neuroendocrine Lesion,Acinar cell cystadenocarcinoma
17961,Intermediate Grade Neuroendocrine Lesion,Acinar cell cystadenocarcinoma
17962,Low Grade Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v6 and v7
17963,Well Differentiated Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v6
17964,Low Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v6
17965,Well Differentiated Neuroendocrine Lesion,mucinous adenocarcinoma of gallbladder
17966,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7
17967,Low Grade Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7
17968,Intermediate Grade Neuroendocrine Lesion,Bile duct clear cell adenocarcinoma
17969,Well Differentiated Neuroendocrine Lesion,Bile duct signet-ring cell carcinoma
17970,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of extrahepatic bile duct
17971,Benign Cellular Infiltrate,Adult Central Nervous System Embryonal Carcinoma
17972,Intermediate Grade Neuroendocrine Lesion,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
17973,Malignant Cellular Infiltrate,leiomyoma of extrahepatic bile duct
17974,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
17975,Benign Cellular Infiltrate,Stage IVB Lip Cancer AJCC v6 and v7
17976,Benign Cellular Infiltrate,Stage IV Oral Cavity Cancer AJCC v6 and v7
17977,Benign Cellular Infiltrate,Stage IVB Oral Cavity Cancer AJCC v6 and v7
17978,Benign Cellular Infiltrate,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
17979,Benign Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v7
17980,Benign Cellular Infiltrate,Stage IV Major Salivary Gland Carcinoma with Metastasis
17981,Benign Cellular Infiltrate,Adenoid cystic carcinoma of parotid gland
17982,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of submandibular gland
17983,Benign Cellular Infiltrate,Submandibular Gland Adenocarcinoma
17984,Benign Cellular Infiltrate,Growth Hormone-Producing Pituitary Gland Carcinoma
17985,Benign Cellular Infiltrate,cystadenocarcinoma of salivary gland
17986,Benign Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v7
17987,Benign Cellular Infiltrate,Laryngeal Liposarcoma
17988,Benign Cellular Infiltrate,Laryngeal Leiomyosarcoma
17989,Benign Cellular Infiltrate,small cell carcinoma of larynx
17990,Malignant Cellular Infiltrate,Laryngeal Leiomyoma
17991,Malignant Cellular Infiltrate,leiomyoma of trachea
17992,Benign Cellular Infiltrate,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
17993,Benign Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage I
17994,Benign Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage III
17995,Benign Cellular Infiltrate,Malignant Anterior Tongue Neoplasm
17996,Benign Cellular Infiltrate,Maxillary Sinus Squamous Cell Carcinoma
17997,Intermediate Grade Neuroendocrine Lesion,Rectal Medullary Carcinoma
17998,Benign Cellular Infiltrate,Sphenoid Sinus Squamous Cell Carcinoma
17999,Benign Cellular Infiltrate,non-Hodgkin's lymphoma of nasal cavity
18000,Benign Cellular Infiltrate,carcinoma of eye
18001,Benign Cellular Infiltrate,squamous cell carcinoma of lacrimal gland
18002,Benign Cellular Infiltrate,Sarcoma of orbit
18003,Malignant Cellular Infiltrate,Benign Uveal Neoplasm
18004,Benign Cellular Infiltrate,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
18005,Benign Cellular Infiltrate,Uterine Corpus Cancer
18006,Malignant Cellular Infiltrate,Ureter Leiomyoma
18007,Benign Cellular Infiltrate,undifferentiated carcinoma of urethra
18008,Benign Cellular Infiltrate,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
18009,Benign Cellular Infiltrate,Stage 0 Renal Pelvis Cancer AJCC v7
18010,Benign Cellular Infiltrate,Collecting Duct Carcinoma of the Kidney
18011,Benign Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v7
18012,Benign Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor
18013,Malignant Cellular Infiltrate,Soft Palate Benign Granular Cell Tumor
18014,Malignant Cellular Infiltrate,Cerebral Hemisphere Lipoma
18015,Benign Cellular Infiltrate,Superficial basal cell carcinoma
18016,Benign Cellular Infiltrate,Central Nervous System Carcinoma
18017,Benign Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma
18018,Benign Cellular Infiltrate,Orbital lymphoma
18019,Benign Cellular Infiltrate,alveolar rhabdomyosarcoma of orbit
18020,Benign Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7
18021,Malignant Cellular Infiltrate,Benign Ovarian Luteinized Thecoma
18022,Benign Cellular Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v7
18023,Benign Cellular Infiltrate,Fallopian Tube Gestational Choriocarcinoma
18024,Benign Cellular Infiltrate,Fallopian Tube Endometrioid Adenocarcinoma
18025,Benign Cellular Infiltrate,Fallopian Tube Squamous Cell Carcinoma
18026,Benign Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma
18027,Benign Cellular Infiltrate,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7
18028,Benign Cellular Infiltrate,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7
18029,Benign Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v7
18030,Malignant Cellular Infiltrate,Uterine Corpus Adenomyoma
18031,Benign Cellular Infiltrate,Leiomyosarcoma of uterus
18032,Benign Cellular Infiltrate,Cervical Endometrioid Adenocarcinoma
18033,Benign Cellular Infiltrate,Stage IS Testicular Cancer AJCC v6 and v7
18034,Malignant Cellular Infiltrate,Vulvar Seborrheic Keratosis
18035,Benign Cellular Infiltrate,rhabdomyosarcoma of testis
18036,Benign Cellular Infiltrate,verrucous carcinoma of vulva
18037,Benign Cellular Infiltrate,Ovarian Liposarcoma
18038,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of the duodenum
18039,Poorly Differentiated Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1
18040,Poorly Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1
18041,Malignant Cellular Infiltrate,Endometrial Polyp
18042,Benign Cellular Infiltrate,embryonal carcinoma of mediastinum
18043,Benign Cellular Infiltrate,yolk sac tumor of mediastinum
18044,Malignant Cellular Infiltrate,Benign germ cell neoplasm
18045,Benign Cellular Infiltrate,Thymic Lymphoma
18046,Benign Cellular Infiltrate,Dedifferentiated chondrosarcoma
18047,Malignant Cellular Infiltrate,Fibroma of tendon sheath
18048,Malignant Cellular Infiltrate,Deep Lipoma
18049,Malignant Cellular Infiltrate,Benign Smooth Muscle Neoplasm
18050,Benign Cellular Infiltrate,"Neoplasm, malignant, uncertain whether primary or metastatic"
18051,Benign Cellular Infiltrate,Squamous cell carcinoma in situ with questionable stromal invasion
18052,Benign Cellular Infiltrate,"Papillary transitional cell carcinoma, non-invasive"
18053,Poorly Differentiated Neuroendocrine Lesion,Malignant Vipoma
18054,Benign Cellular Infiltrate,"Adenocarcinoma, Tubular"
18055,Benign Cellular Infiltrate,Monophasic Synovial Sarcoma
18056,Benign Cellular Infiltrate,Malignant tenosynovial giant cell tumor
18057,Mitotic Activity,Childhood Ovarian Mature Teratoma
18058,Benign Cellular Infiltrate,Childhood Ovarian Dysgerminoma
18059,Benign Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor
18060,Malignant Cellular Infiltrate,Benign Extraskeletal Cartilaginous and Osseous Neoplasm
18061,Malignant Cellular Infiltrate,Juxta-Articular Myxoma
18062,Malignant Cellular Infiltrate,Benign Mediastinal Soft Tissue Neoplasm
18063,Benign Cellular Infiltrate,Peripheral Ganglioneuroblastoma
18064,Malignant Cellular Infiltrate,Mediastinal Chondroma
18065,Malignant Cellular Infiltrate,Benign Osteogenic Neoplasm
18066,Benign Cellular Infiltrate,Stage IA Osteosarcoma AJCC v7
18067,Benign Cellular Infiltrate,Stage IIB Osteosarcoma AJCC v7
18068,Benign Cellular Infiltrate,rhabdomyosarcoma of mediastinum
18069,Benign Cellular Infiltrate,Mediastinal Synovial Sarcoma
18070,Benign Cellular Infiltrate,Localized Bone Ewing Sarcoma
18071,Benign Cellular Infiltrate,Stage 1 Neuroblastoma
18072,Benign Cellular Infiltrate,Stage IIB Lung Large Cell Carcinoma AJCC v7
18073,Benign Cellular Infiltrate,Non-small cell lung cancer stage I
18074,Benign Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7
18075,Benign Cellular Infiltrate,Gonadal Polyembryoma
18076,Malignant Cellular Infiltrate,Benign Intraocular Medulloepithelioma
18077,Benign Cellular Infiltrate,"Retinoblastoma, diffuse"
18078,Benign Cellular Infiltrate,"Mucinous adenocarcinoma, endocervical type"
18079,Benign Cellular Infiltrate,Stage IIB Lung Adenocarcinoma AJCC v7
18080,Benign Cellular Infiltrate,Pyriform Fossa Carcinoma
18081,Benign Cellular Infiltrate,Stage IVA Osteosarcoma AJCC v7
18082,Benign Cellular Infiltrate,Stage I Bone Sarcoma AJCC v7
18083,Benign Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7
18084,Benign Cellular Infiltrate,Stage I Osteosarcoma AJCC v7
18085,Benign Cellular Infiltrate,Malignant Chest Wall Bone Neoplasm
18086,Low Grade Neuroendocrine Lesion,Stage IIA Esophageal Adenocarcinoma AJCC v7
18087,Intermediate Grade Neuroendocrine Lesion,Stage IIB Esophageal Adenocarcinoma AJCC v7
18088,Well Differentiated Neuroendocrine Lesion,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
18089,Low Grade Neuroendocrine Lesion,malignant gastrinoma of pancreas
18090,Low Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma
18091,Mitotic Activity,Pineal Region Mature Teratoma
18092,Benign Cellular Infiltrate,Malignant sex-cord stromal tumor
18093,Intermediate Grade Neuroendocrine Lesion,small cell carcinoma of gallbladder
18094,Low Grade Neuroendocrine Lesion,small cell carcinoma of gallbladder
18095,Benign Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
18096,Malignant Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm
18097,Benign Cellular Infiltrate,adenocarcinoma of middle ear
18098,Benign Cellular Infiltrate,Grade 3 Cutaneous Follicular Lymphoma
18099,Benign Cellular Infiltrate,Childhood Malignant Ovarian Germ Cell Tumor
18100,Benign Cellular Infiltrate,Marginal zone lymphoma stage I
18101,Intermediate Grade Neuroendocrine Lesion,Stage IV Anal Canal Cancer AJCC v6 and v7
18102,Benign Cellular Infiltrate,Papillary serous cystadenocarcinoma
18103,Benign Cellular Infiltrate,"Thymoma, type AB, malignant"
18104,Benign Cellular Infiltrate,Atypical Teratoid Rhabdoid Tumor
18105,Benign Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis
18106,Low Grade Neuroendocrine Lesion,Squamous Cell Carcinoma of Anal Margin
18107,Benign Cellular Infiltrate,Sweat gland carcinoma
18108,Benign Cellular Infiltrate,Anaplastic Oligoastrocytoma
18109,Malignant Cellular Infiltrate,Plexiform Schwannoma
18110,Benign Cellular Infiltrate,papillary carcinoma of penis
18111,Malignant Cellular Infiltrate,Central Nervous System Hibernoma
18112,Benign Cellular Infiltrate,Central Nervous System Leiomyosarcoma
18113,Malignant Cellular Infiltrate,Central Nervous System Hemangioma
18114,Benign Cellular Infiltrate,Central Nervous System Yolk Sac Tumor
18115,Geographic Necrosis,Central Nervous System Mature Teratoma
18116,Benign Cellular Infiltrate,Central Nervous System Mixed Germ Cell Tumor
18117,Benign Cellular Infiltrate,Trilateral Retinoblastoma
18118,Benign Cellular Infiltrate,Plasma cell myeloma recurrent
18119,Well Differentiated Neuroendocrine Lesion,Barrett's Adenocarcinoma
18120,Intermediate Grade Neuroendocrine Lesion,Barrett's Adenocarcinoma
18121,Benign Cellular Infiltrate,Malignant Intracranial Neoplasms By Morphology
18122,Malignant Cellular Infiltrate,Cavernous hemangioma of the face
18123,Benign Cellular Infiltrate,Precursor Lymphoid Neoplasm
18124,Well Differentiated Neuroendocrine Lesion,Distal Bile Duct Carcinoma
18125,Low Grade Neuroendocrine Lesion,Recurrent Liver Carcinoma
18126,Malignant Cellular Infiltrate,Benign Ameloblastoma
18127,Malignant Cellular Infiltrate,Squamous odontogenic tumor
18128,Well Differentiated Neuroendocrine Lesion,Hepatic cancer stage IVA
18129,Benign Cellular Infiltrate,Indolent multiple myeloma
18130,Benign Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma
18131,Benign Cellular Infiltrate,Chronic Adult T-Cell Leukemia/Lymphoma
18132,Benign Cellular Infiltrate,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
18133,Benign Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course
18134,Benign Cellular Infiltrate,Adult T Lymphoblastic Lymphoma
18135,Benign Cellular Infiltrate,Refractory T Lymphoblastic Lymphoma
18136,Benign Cellular Infiltrate,Blastoid Variant Mantle Cell Lymphoma
18137,Benign Cellular Infiltrate,Skin-associated lymphoid tissue lymphoma
18138,Benign Cellular Infiltrate,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
18139,Benign Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
18140,Benign Cellular Infiltrate,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
18141,Benign Cellular Infiltrate,Heavy Chain Deposition Disease
18142,Benign Cellular Infiltrate,Endometrial adenocarcinoma
18143,Benign Cellular Infiltrate,Malignant neoplasm of prostate
18144,Malignant Cellular Infiltrate,Benign vascular neoplasm
18145,Benign Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v6
18146,Benign Cellular Infiltrate,Burkitt Leukemia
18147,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid cancer
18148,Benign Cellular Infiltrate,Exocervical Carcinoma
18149,Benign Cellular Infiltrate,Secondary malignant neoplasm of ovary
18150,Benign Cellular Infiltrate,Pure Erythroid Leukemia
18151,Well Differentiated Neuroendocrine Lesion,Carcinoma of anal margin
18152,Low Grade Neuroendocrine Lesion,Carcinoma of anal margin
18153,Well Differentiated Neuroendocrine Lesion,Anal Extramucosal (Perianal) Adenocarcinoma
18154,Intermediate Grade Neuroendocrine Lesion,Anal margin Paget's disease
18155,Low Grade Neuroendocrine Lesion,Anal margin Paget's disease
18156,Benign Cellular Infiltrate,Malignant neoplasm of fallopian tube
18157,Benign Cellular Infiltrate,Malignant neoplasm of larynx
18158,Benign Cellular Infiltrate,Cancer of Lip
18159,Benign Cellular Infiltrate,Recurrent Urethral Cancer
18160,Benign Cellular Infiltrate,Malignant tumor of renal pelvis
18161,Benign Cellular Infiltrate,Angioimmunoblastic Lymphadenopathy
18162,Benign Cellular Infiltrate,Small Lymphocytic Lymphoma
18163,Benign Cellular Infiltrate,Askin's tumor
18164,Malignant Cellular Infiltrate,Clear cell hidradenoma
18165,Malignant Cellular Infiltrate,Eccrine acrospiroma
18166,Benign Cellular Infiltrate,Renal medullary carcinoma
18167,Benign Cellular Infiltrate,Adult Lymphoma
18168,Well Differentiated Neuroendocrine Lesion,Recurrent Digestive System Carcinoma
18169,Benign Cellular Infiltrate,Metastatic Lobular Breast Carcinoma
18170,Benign Cellular Infiltrate,Infiltrating duct and lobular carcinoma
18171,Benign Cellular Infiltrate,Ovarian adenocarcinoma
18172,Poorly Differentiated Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor
18173,Well Differentiated Neuroendocrine Lesion,Adult Liver Carcinoma
18174,Low Grade Neuroendocrine Lesion,Adenocarcinoma of appendix
18175,Malignant Cellular Infiltrate,Leiomyoma of small intestine
18176,Benign Cellular Infiltrate,Choriocarcinoma of the Testis
18177,Benign Cellular Infiltrate,Stage II Breast Cancer AJCC v6 and v7
18178,Intermediate Grade Neuroendocrine Lesion,Stage II Gastric Carcinoma
18179,Low Grade Neuroendocrine Lesion,Stage II Gastric Carcinoma
18180,Well Differentiated Neuroendocrine Lesion,Stage III Carcinoma of Stomach
18181,Well Differentiated Neuroendocrine Lesion,Stage II Anal Canal Cancer AJCC v6 and v7
18182,Intermediate Grade Neuroendocrine Lesion,Stage II Rectal Cancer
18183,Well Differentiated Neuroendocrine Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7
18184,Benign Cellular Infiltrate,Mycosis fungoides stage II
18185,Benign Cellular Infiltrate,Mycosis fungoides stage IV
18186,Benign Cellular Infiltrate,Localized Ewing Sarcoma
18187,Benign Cellular Infiltrate,Metastatic Ewing's Sarcoma
18188,Benign Cellular Infiltrate,Adult Synovial Sarcoma
18189,Benign Cellular Infiltrate,Stage III Adult Soft Tissue Sarcoma AJCC v7
18190,Benign Cellular Infiltrate,Renal cell carcinoma recurrent
18191,Benign Cellular Infiltrate,Stage I Kidney Wilms Tumor
18192,Benign Cellular Infiltrate,Recurrent Kidney Wilms Tumor
18193,Benign Cellular Infiltrate,Chronic lymphocytic leukemia stage 0
18194,Benign Cellular Infiltrate,Carcinoma in situ of vagina
18195,Benign Cellular Infiltrate,Stage II Vaginal Cancer AJCC v6 and v7
18196,Benign Cellular Infiltrate,Vaginal cancer recurrent
18197,Intermediate Grade Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1
18198,Benign Cellular Infiltrate,Chronic lymphocytic leukemia stage 3
18199,Well Differentiated Neuroendocrine Lesion,Localized Non-Resectable Adult Liver Carcinoma
18200,Benign Cellular Infiltrate,Osteosarcoma recurrent
18201,Benign Cellular Infiltrate,Chronic lymphocytic leukemia refractory
18202,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of duodenum
18203,Well Differentiated Neuroendocrine Lesion,Unresectable Extrahepatic Bile Duct Carcinoma
18204,Benign Cellular Infiltrate,Stage 0 Bladder Carcinoma
18205,Benign Cellular Infiltrate,Stage I Testicular Cancer AJCC v6 and v7
18206,Intermediate Grade Neuroendocrine Lesion,Childhood Hepatocellular Carcinoma
18207,Well Differentiated Neuroendocrine Lesion,Adult Hepatocellular Carcinoma
18208,Benign Cellular Infiltrate,Childhood Acute Promyelocytic Leukemia with PML-RARA
18209,Benign Cellular Infiltrate,Childhood Acute Megakaryoblastic Leukemia
18210,Intermediate Grade Neuroendocrine Lesion,Anaplastic Carcinoma of the Rectum
18211,Benign Cellular Infiltrate,Small cell carcinoma of the cervix
18212,Benign Cellular Infiltrate,"Intraocular melanoma, spindle cell"
18213,Benign Cellular Infiltrate,Necrotic intraocular melanoma
18214,Malignant Cellular Infiltrate,Parathyroid mixed cell type adenoma
18215,Benign Cellular Infiltrate,Endometrial Clear Cell Adenocarcinoma
18216,Benign Cellular Infiltrate,Plasmablastic Lymphoma of the Oral Mucosa
18217,Benign Cellular Infiltrate,"High Grade B-Cell Lymphoma, Not Otherwise Specified"
18218,Benign Cellular Infiltrate,Waldenstrom Macroglobulinemia
18219,Benign Cellular Infiltrate,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified"
18220,Benign Cellular Infiltrate,Recurrent Lip and Oral Cavity Carcinoma
18221,Benign Cellular Infiltrate,Metastatic Adrenal Gland Pheochromocytoma
18222,Benign Cellular Infiltrate,Ann Arbor Stage I Grade 3 Follicular Lymphoma
18223,Benign Cellular Infiltrate,Childhood Synovial Sarcoma
18224,Benign Cellular Infiltrate,Childhood Leiomyosarcoma
18225,Benign Cellular Infiltrate,Stage III Adult Non-Hodgkin Lymphoma
18226,Benign Cellular Infiltrate,Ovarian Embryonal Carcinoma
18227,Benign Cellular Infiltrate,Stage II Adult Burkitt Lymphoma
18228,Benign Cellular Infiltrate,Ann Arbor Stage III Grade 1 Follicular Lymphoma
18229,Benign Cellular Infiltrate,Stage III Adult Burkitt Lymphoma
18230,Benign Cellular Infiltrate,Recurrent Grade 3 Follicular Lymphoma
18231,Benign Cellular Infiltrate,Recurrent Adult Lymphoblastic Lymphoma
18232,Benign Cellular Infiltrate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
18233,Benign Cellular Infiltrate,Lower Gingival Squamous Cell Carcinoma
18234,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity
18235,Benign Cellular Infiltrate,adenoid cystic carcinoma of floor of mouth
18236,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II
18237,Benign Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent
18238,Benign Cellular Infiltrate,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
18239,Benign Cellular Infiltrate,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
18240,Benign Cellular Infiltrate,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
18241,Benign Cellular Infiltrate,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
18242,Benign Cellular Infiltrate,Laryngeal verrucous carcinoma stage IV
18243,Well Differentiated Neuroendocrine Lesion,Cloacogenic carcinoma
18244,Well Differentiated Neuroendocrine Lesion,basaloid carcinoma of anus
18245,Benign Cellular Infiltrate,Refractory cytopenia with unilineage dysplasia
18246,Benign Cellular Infiltrate,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
18247,Benign Cellular Infiltrate,Adult Anaplastic Ependymoma
18248,Malignant Cellular Infiltrate,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
18249,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of pancreas
18250,Benign Cellular Infiltrate,Lymphoma stage II
18251,Low Grade Neuroendocrine Lesion,Gastric Body Carcinoma
18252,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
18253,Benign Cellular Infiltrate,Mantle cell lymphoma stage IV
18254,Benign Cellular Infiltrate,Stage IV Non-Hodgkin Lymphoma
18255,Benign Cellular Infiltrate,Locally Advanced Malignant Neoplasm
18256,Benign Cellular Infiltrate,Secondary malignant neoplasm of sternum
18257,Benign Cellular Infiltrate,Secondary malignant neoplasm of neck
18258,Benign Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v6
18259,Malignant Cellular Infiltrate,Benign neoplasm of epicardium
18260,Benign Cellular Infiltrate,Secondary malignant neoplasm of epididymis
18261,Benign Cellular Infiltrate,Malignant Paraganglionic Neoplasm
18262,Benign Cellular Infiltrate,Malignant melanoma of eye
18263,Benign Cellular Infiltrate,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
18264,Benign Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia
18265,Benign Cellular Infiltrate,Stage IB Breast Cancer AJCC v7
18266,Benign Cellular Infiltrate,Stage IA Merkel Cell Carcinoma AJCC v7
18267,Benign Cellular Infiltrate,Stage IIIA Merkel Cell Carcinoma AJCC v7
18268,Benign Cellular Infiltrate,Inflammatory carcinoma of breast recurrent
18269,Well Differentiated Neuroendocrine Lesion,Esophageal adenocarcinoma recurrent
18270,Intermediate Grade Neuroendocrine Lesion,Stage 0 Esophageal Adenocarcinoma AJCC v7
18271,Intermediate Grade Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v6
18272,Benign Cellular Infiltrate,Recurrent Chronic Lymphoid Leukemia
18273,Benign Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type stage IV
18274,Benign Cellular Infiltrate,Stage III Anaplastic Large Cell Lymphoma
18275,Benign Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma refractory
18276,Benign Cellular Infiltrate,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
18277,Benign Cellular Infiltrate,Ann Arbor Stage I Mature T- and NK-Cell Lymphoma
18278,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia recurrent
18279,Benign Cellular Infiltrate,Peritoneal mesothelioma malignant advanced
18280,Benign Cellular Infiltrate,Stage IC Uterine Sarcoma AJCC v7
18281,Benign Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7
18282,Benign Cellular Infiltrate,Stage III Bone Cancer AJCC v7
18283,Benign Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v7
18284,Benign Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7
18285,Benign Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7
18286,Benign Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7
18287,Benign Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7
18288,Benign Cellular Infiltrate,Stage I Ovarian Teratoma AJCC v6 and v7
18289,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage I
18290,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage II
18291,Benign Cellular Infiltrate,Large cell lung cancer recurrent
18292,Benign Cellular Infiltrate,Stage III Pharynx Carcinoma
18293,Benign Cellular Infiltrate,Stage IV Lung Cancer AJCC v6
18294,Intermediate Grade Neuroendocrine Lesion,Stage IA Esophageal Adenocarcinoma AJCC v7
18295,Intermediate Grade Neuroendocrine Lesion,Stage IIA Small Intestinal Cancer AJCC v7
18296,Intermediate Grade Neuroendocrine Lesion,Stage IIB Small Intestinal Cancer AJCC v7
18297,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Small Intestinal Cancer AJCC v7
18298,Low Grade Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v7
18299,Well Differentiated Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v7
18300,Poorly Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v7
18301,Poorly Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7
18302,Poorly Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7
18303,Well Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v7
18304,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v7
18305,Low Grade Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v7
18306,Benign Cellular Infiltrate,Stage II Lentigo Maligna Melanoma AJCC v6 and v7
18307,Benign Cellular Infiltrate,Stage III Lentigo Maligna Melanoma AJCC v7
18308,Benign Cellular Infiltrate,Extra-osseous Ewing's sarcoma metastatic
18309,Poorly Differentiated Neuroendocrine Lesion,Stage I Digestive System Neuroendocrine Tumor AJCC v7
18310,Benign Cellular Infiltrate,Extra-osseous Ewing's sarcoma recurrent
18311,Well Differentiated Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
18312,Intermediate Grade Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
18313,Low Grade Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
18314,Well Differentiated Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v7
18315,Low Grade Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v7
18316,Intermediate Grade Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v7
18317,Well Differentiated Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
18318,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
18319,Low Grade Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
18320,Well Differentiated Neuroendocrine Lesion,Stage IA Distal Bile Duct Cancer AJCC v7
18321,Intermediate Grade Neuroendocrine Lesion,Stage IA Distal Bile Duct Cancer AJCC v7
18322,Low Grade Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v7
18323,Well Differentiated Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v7
18324,Intermediate Grade Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v7
18325,Well Differentiated Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v6 and v7
18326,Well Differentiated Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v6 and v7
18327,Benign Cellular Infiltrate,Stage IIIC Uveal Melanoma AJCC v7
18328,Benign Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7
18329,Benign Cellular Infiltrate,Burkitt's lymphoma refractory
18330,Benign Cellular Infiltrate,Stage I Burkitt Lymphoma
18331,Benign Cellular Infiltrate,Monocytoid B-cell lymphoma
18332,Benign Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage III
18333,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I
18334,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV
18335,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage II
18336,Benign Cellular Infiltrate,Stage III Lung Cancer AJCC v7
18337,Benign Cellular Infiltrate,Bladder adenocarcinoma stage III
18338,Benign Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v7
18339,Benign Cellular Infiltrate,Bladder squamous cell carcinoma stage I
18340,Benign Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v7
18341,Benign Cellular Infiltrate,Testicular embryonal carcinoma stage III
18342,Benign Cellular Infiltrate,Testicular germ cell tumor mixed stage I
18343,Benign Cellular Infiltrate,Stage 0 Penile Cancer AJCC v7
18344,Benign Cellular Infiltrate,Stage III Carcinoma of Penis
18345,Well Differentiated Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v6 and v7
18346,Benign Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v7
18347,Benign Cellular Infiltrate,Stage III Vulvar Cancer AJCC v7
18348,Benign Cellular Infiltrate,Adenocarcinoma of the prostate stage III
18349,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIB
18350,Malignant Cellular Infiltrate,Fundic gland polyp
18351,Benign Cellular Infiltrate,Stage III Uterine Corpus Cancer
18352,Benign Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor
18353,Well Differentiated Neuroendocrine Lesion,Stage II Esophageal Cancer AJCC v7
18354,Low Grade Neuroendocrine Lesion,Stage III Esophageal Cancer AJCC v7
18355,Intermediate Grade Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Lung
18356,Low Grade Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Lung
18357,Malignant Cellular Infiltrate,Cystadenofibroma
18358,Intermediate Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage II
18359,Low Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage II
18360,Low Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage IV
18361,Intermediate Grade Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v7
18362,Intermediate Grade Neuroendocrine Lesion,Stage II Rectosigmoid Cancer AJCC v7
18363,Low Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v7
18364,Malignant Cellular Infiltrate,Dermoid Cyst
18365,Malignant Cellular Infiltrate,Mature Teratoma
18366,Intermediate Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v7
18367,Intermediate Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v7
18368,Low Grade Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v7
18369,Benign Cellular Infiltrate,Poorly Differentiated Angiosarcoma
18370,Benign Cellular Infiltrate,Stage I Adult Hodgkin Lymphoma
18371,Benign Cellular Infiltrate,Bladder Cancer by AJCC v6 Stage
18372,Benign Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma
18373,Well Differentiated Neuroendocrine Lesion,Stage I Anal Canal Cancer AJCC v6 and v7
18374,Benign Cellular Infiltrate,Uterine Corpus Cancer by AJCC v6 Stage
18375,Low Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v6 Stage
18376,Low Grade Neuroendocrine Lesion,Colon Cancer by AJCC v6 Stage
18377,Well Differentiated Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v6 Stage
18378,Intermediate Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v6 Stage
18379,Benign Cellular Infiltrate,Breast Cancer by AJCC v6 Stage
18380,Benign Cellular Infiltrate,Prostate Cancer by AJCC v6 Stage
18381,Benign Cellular Infiltrate,Stage III Childhood Lymphoblastic Lymphoma
18382,Intermediate Grade Neuroendocrine Lesion,Localized Resectable Adult Hepatocellular Carcinoma
18383,Low Grade Neuroendocrine Lesion,Localized Unresectable Adult Hepatocellular Carcinoma
18384,Benign Cellular Infiltrate,Refractory Malignant Testicular Germ Cell Tumor
18385,Benign Cellular Infiltrate,Kaposi Sarcoma
18386,Benign Cellular Infiltrate,Non-small cell lung cancer stage IIIA
18387,Benign Cellular Infiltrate,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
18388,Benign Cellular Infiltrate,Kaposi's sarcoma classical type
18389,Benign Cellular Infiltrate,Vaginal Cancer by AJCC v7 Stage
18390,Benign Cellular Infiltrate,Uterine Corpus Cancer by AJCC v7 Stage
18391,Intermediate Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v7 Stage
18392,Intermediate Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v7 Stage
18393,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v7 Stage
18394,Benign Cellular Infiltrate,Lung Cancer by AJCC v7 Stage
18395,Benign Cellular Infiltrate,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
18396,Benign Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia
18397,Well Differentiated Neuroendocrine Lesion,Gastric Intestinal-Type Adenocarcinoma
18398,Low Grade Neuroendocrine Lesion,Diffuse Gastric Adenocarcinoma
18399,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia
18400,Well Differentiated Neuroendocrine Lesion,Gallbladder adenocarcinoma
18401,Intermediate Grade Neuroendocrine Lesion,Gallbladder adenocarcinoma
18402,Low Grade Neuroendocrine Lesion,Gallbladder adenocarcinoma
18403,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of gallbladder
18404,Well Differentiated Neuroendocrine Lesion,Rectal Signet Ring Cell Adenocarcinoma
18405,Intermediate Grade Neuroendocrine Lesion,Rectal Signet Ring Cell Adenocarcinoma
18406,Low Grade Neuroendocrine Lesion,Rectal Signet Ring Cell Adenocarcinoma
18407,Benign Cellular Infiltrate,Recurrent Carcinoma of Unknown Primary
18408,Benign Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma
18409,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
18410,Benign Cellular Infiltrate,Stage IV Cervical Cancer AJCC v6 and v7
18411,Well Differentiated Neuroendocrine Lesion,Stage I Esophageal Cancer
18412,Intermediate Grade Neuroendocrine Lesion,Stage I Esophageal Cancer
18413,Low Grade Neuroendocrine Lesion,Stage I Esophageal Cancer
18414,Intermediate Grade Neuroendocrine Lesion,Stage III Esophageal Cancer
18415,Benign Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v7
18416,Intermediate Grade Neuroendocrine Lesion,Recurrent Rectal Cancer
18417,Benign Cellular Infiltrate,Mesothelioma malignant localized
18418,Benign Cellular Infiltrate,testicular leukemia
18419,Low Grade Neuroendocrine Lesion,AIDS-Related Anal Carcinoma
18420,Benign Cellular Infiltrate,"Dendritic Cell Sarcoma, Follicular"
18421,Benign Cellular Infiltrate,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
18422,Benign Cellular Infiltrate,Radiation-Related Sarcoma
18423,Benign Cellular Infiltrate,Malignant neoplasm of nasopharynx
18424,Benign Cellular Infiltrate,Malignant tumor of parathyroid gland
18425,Benign Cellular Infiltrate,Nasal cavity carcinoma
18426,Benign Cellular Infiltrate,Malignant neoplasm of trachea
18427,Benign Cellular Infiltrate,Mast-Cell Sarcoma
18428,Benign Cellular Infiltrate,Malignant neoplasm of hypopharynx recurrent
18429,Benign Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7
18430,Benign Cellular Infiltrate,Labia Majora Carcinoma
18431,Benign Cellular Infiltrate,Labia Minora Carcinoma
18432,Benign Cellular Infiltrate,Kaposi Sarcoma NCI Grade 3
18433,Benign Cellular Infiltrate,Sarcoma NCI Grade 3
18434,Intermediate Grade Neuroendocrine Lesion,Grade 3 Colorectal Adenocarcinoma
18435,Benign Cellular Infiltrate,Laryngeal Adenoid Cystic Carcinoma
18436,Benign Cellular Infiltrate,Laryngeal Mucoepidermoid Carcinoma
18437,Well Differentiated Neuroendocrine Lesion,Stage II Adult Liver Cancer AJCC v7
18438,Well Differentiated Neuroendocrine Lesion,Stage IIIA Adult Liver Cancer AJCC v7
18439,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Adult Liver Cancer AJCC v7
18440,Well Differentiated Neuroendocrine Lesion,Stage IIIB Adult Liver Cancer AJCC v7
18441,Intermediate Grade Neuroendocrine Lesion,Stage IV Adult Liver Cancer AJCC v7
18442,Benign Cellular Infiltrate,Hereditary Malignant Neoplasm
18443,Benign Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v7
18444,Benign Cellular Infiltrate,Stage IIIC2 Uterine Corpus Cancer AJCC v7
18445,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma
18446,Well Differentiated Neuroendocrine Lesion,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
18447,Low Grade Neuroendocrine Lesion,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
18448,Low Grade Neuroendocrine Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
18449,Well Differentiated Neuroendocrine Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
18450,Well Differentiated Neuroendocrine Lesion,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
18451,Low Grade Neuroendocrine Lesion,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
18452,Intermediate Grade Neuroendocrine Lesion,Pancreatic Hepatoid Adenocarcinoma
18453,Intermediate Grade Neuroendocrine Lesion,Pancreatic Medullary Carcinoma
18454,Low Grade Neuroendocrine Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
18455,Poorly Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2
18456,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma
18457,Well Differentiated Neuroendocrine Lesion,Esophageal Large Cell Neuroendocrine Carcinoma
18458,Intermediate Grade Neuroendocrine Lesion,Gastric Carcinoma with Lymphoid Stroma
18459,Intermediate Grade Neuroendocrine Lesion,Gastric Intramucosal Adenocarcinoma
18460,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor
18461,Well Differentiated Neuroendocrine Lesion,Gastric Mixed Adenoneuroendocrine Carcinoma
18462,Intermediate Grade Neuroendocrine Lesion,Gastric Mixed Adenoneuroendocrine Carcinoma
18463,Benign Cellular Infiltrate,Malignant Gastric Gastrointestinal Stromal Tumor
18464,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
18465,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2
18466,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Carcinoma
18467,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma
18468,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma
18469,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma
18470,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Gangliocytic Paraganglioma
18471,Intermediate Grade Neuroendocrine Lesion,Colorectal Mixed Adenoneuroendocrine Carcinoma
18472,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2
18473,Intermediate Grade Neuroendocrine Lesion,High Grade Appendix Mucinous Adenocarcinoma
18474,Low Grade Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2
18475,Low Grade Neuroendocrine Lesion,Neuroendocrine carcinoma of appendix
18476,Low Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of appendix
18477,Low Grade Neuroendocrine Lesion,Rectal Serrated Adenocarcinoma
18478,Low Grade Neuroendocrine Lesion,Colorectal Cribriform Comedo-Type Adenocarcinoma
18479,Intermediate Grade Neuroendocrine Lesion,Colon Cribriform Comedo-Type Adenocarcinoma
18480,Low Grade Neuroendocrine Lesion,Colon Cribriform Comedo-Type Adenocarcinoma
18481,Intermediate Grade Neuroendocrine Lesion,Rectal Cribriform Comedo-Type Adenocarcinoma
18482,Low Grade Neuroendocrine Lesion,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
18483,Malignant Cellular Infiltrate,Colorectal Schwannoma
18484,Malignant Cellular Infiltrate,Colorectal Benign Granular Cell Tumor
18485,Low Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2
18486,Low Grade Neuroendocrine Lesion,neuroendocrine carcinoma of anal canal
18487,Well Differentiated Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma
18488,Malignant Cellular Infiltrate,Anal Canal Squamous Papilloma
18489,Malignant Cellular Infiltrate,Anal Papillary Hidradenoma
18490,Intermediate Grade Neuroendocrine Lesion,Primary hepatic neuroendocrine carcinoma
18491,Intermediate Grade Neuroendocrine Lesion,Moderately Differentiated Hepatocellular Carcinoma
18492,Well Differentiated Neuroendocrine Lesion,Poorly Differentiated Hepatocellular Carcinoma
18493,Intermediate Grade Neuroendocrine Lesion,Poorly Differentiated Hepatocellular Carcinoma
18494,Malignant Cellular Infiltrate,Liver Cavernous Hemangioma
18495,Intermediate Grade Neuroendocrine Lesion,carcinosarcoma of gallbladder
18496,Well Differentiated Neuroendocrine Lesion,hepatoid adenocarcinoma of gallbladder
18497,Well Differentiated Neuroendocrine Lesion,Gallbladder Cribriform Carcinoma
18498,Low Grade Neuroendocrine Lesion,Gallbladder Cribriform Carcinoma
18499,Intermediate Grade Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Biliary Type"
18500,Intermediate Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1
18501,Intermediate Grade Neuroendocrine Lesion,Gallbladder Mixed Adenoneuroendocrine Carcinoma
18502,Intermediate Grade Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
18503,Intermediate Grade Neuroendocrine Lesion,intestinal type adenocarcinoma of extrahepatic bile duct
18504,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
18505,Well Differentiated Neuroendocrine Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
18506,Benign Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Solid Variant"
18507,Benign Cellular Infiltrate,Breast Solid Neuroendocrine Carcinoma
18508,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
18509,Benign Cellular Infiltrate,Adrenal Cortex Carcinoma by ENSAT Stage
18510,Benign Cellular Infiltrate,ENSAT Stage I Adrenal Cortex Carcinoma
18511,Benign Cellular Infiltrate,ENSAT Stage IV Adrenal Cortex Carcinoma
18512,Benign Cellular Infiltrate,High Grade Ovarian Serous Adenocarcinoma
18513,Benign Cellular Infiltrate,Class 2 Uveal Melanoma
18514,Benign Cellular Infiltrate,Adult Unfavorable Prognosis Hodgkin Lymphoma
18515,Benign Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
18516,Benign Cellular Infiltrate,Mucosal Melanoma
18517,Benign Cellular Infiltrate,Childhood Epithelioid Hemangioendothelioma
18518,Benign Cellular Infiltrate,Stage IV Childhood Anaplastic Large Cell Lymphoma
18519,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
18520,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
18521,Low Grade Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v7
18522,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Cancer AJCC v7
18523,Low Grade Neuroendocrine Lesion,Stage IIB Rectal Cancer AJCC v7
18524,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v7
18525,Low Grade Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v7
18526,Benign Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage III
18527,Benign Cellular Infiltrate,Recurrent Oropharyngeal Undifferentiated Carcinoma
18528,Benign Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v7
18529,Intermediate Grade Neuroendocrine Lesion,Stage IA Esophageal Cancer AJCC v7
18530,Well Differentiated Neuroendocrine Lesion,Stage IIIA Esophageal Cancer AJCC v7
18531,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Esophageal Cancer AJCC v7
18532,Well Differentiated Neuroendocrine Lesion,BCLC Stage A Hepatocellular Carcinoma
18533,Well Differentiated Neuroendocrine Lesion,BCLC Stage B Hepatocellular Carcinoma
18534,Low Grade Neuroendocrine Lesion,BCLC Stage D Hepatocellular Carcinoma
18535,Well Differentiated Neuroendocrine Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma
18536,Well Differentiated Neuroendocrine Lesion,BCLC Stage A Adult Hepatocellular Carcinoma
18537,Intermediate Grade Neuroendocrine Lesion,BCLC Stage A Adult Hepatocellular Carcinoma
18538,Low Grade Neuroendocrine Lesion,BCLC Stage B Adult Hepatocellular Carcinoma
18539,Low Grade Neuroendocrine Lesion,BCLC Stage C Adult Hepatocellular Carcinoma
18540,Intermediate Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
18541,Benign Cellular Infiltrate,Recurrent Childhood Anaplastic Oligodendroglioma
18542,Benign Cellular Infiltrate,Recurrent Childhood Glioblastoma
18543,Intermediate Grade Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
18544,Benign Cellular Infiltrate,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
18545,Benign Cellular Infiltrate,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
18546,Benign Cellular Infiltrate,Intestinal-Type Sinonasal Adenocarcinoma
18547,Intermediate Grade Neuroendocrine Lesion,Liver Adenosquamous Carcinoma
18548,Benign Cellular Infiltrate,Familial Nonmedullary Thyroid Gland Carcinoma
18549,Benign Cellular Infiltrate,"Malignant neoplasm of kidney, except pelvis"
18550,Benign Cellular Infiltrate,Spindle Cell/Sclerosing Rhabdomyosarcoma
18551,Malignant Cellular Infiltrate,"Perivascular epithelioid tumor, benign"
18552,Benign Cellular Infiltrate,Undifferentiated Epithelioid Sarcoma
18553,Malignant Cellular Infiltrate,Giant Cell Lesion of Small Bones
18554,Malignant Cellular Infiltrate,Ovarian Microcystic Stromal Tumor
18555,Benign Cellular Infiltrate,ROSE Cluster 3
18556,Benign Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
18557,Benign Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
18558,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7
18559,Benign Cellular Infiltrate,Mammary Analog Secretory Carcinoma of Salivary Gland
18560,Mitotic Activity,Childhood Mature Teratoma
18561,Malignant Cellular Infiltrate,Childhood Mature Teratoma
18562,Benign Cellular Infiltrate,Childhood Embryonal Carcinoma
18563,Benign Cellular Infiltrate,Childhood Choroid Plexus Carcinoma
18564,Benign Cellular Infiltrate,Double-Hit Lymphoma
18565,Benign Cellular Infiltrate,Recurrent Glioblastoma
18566,Benign Cellular Infiltrate,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
18567,Benign Cellular Infiltrate,High Grade Fallopian Tube Serous Adenocarcinoma
18568,Benign Cellular Infiltrate,Head and neck cancer metastatic
18569,Benign Cellular Infiltrate,Acute Myeloid Leukemia with FLT3/ITD Mutation
18570,Malignant Cellular Infiltrate,Uterine Corpus Hydropic Leiomyoma
18571,Benign Cellular Infiltrate,Recurrent Malignant Solid Neoplasm
18572,Benign Cellular Infiltrate,Neuroendocrine cervical carcinoma
18573,Benign Cellular Infiltrate,FIGO Stage IC2 Ovarian Cancer
18574,Benign Cellular Infiltrate,FIGO Stage IC3 Ovarian Cancer
18575,Malignant Cellular Infiltrate,Vulvar Ectopic Fibroadenoma
18576,Low Grade Neuroendocrine Lesion,Unresectable Esophageal Carcinoma
18577,Benign Cellular Infiltrate,"NK-Cell Lymphoma, Unclassifiable"
18578,Benign Cellular Infiltrate,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
18579,Benign Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Wildtype"
18580,Benign Cellular Infiltrate,Large Cell/Anaplastic Medulloblastoma
18581,Malignant Cellular Infiltrate,Central Nervous System Angiolipoma
18582,Malignant Cellular Infiltrate,Central Nervous System Myofibroblastoma
18583,Malignant Cellular Infiltrate,Osteoma of skull
18584,Benign Cellular Infiltrate,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
18585,Intermediate Grade Neuroendocrine Lesion,Unresectable Digestive System Adenocarcinoma
18586,Benign Cellular Infiltrate,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
18587,Benign Cellular Infiltrate,Unresectable Thyroid Gland Carcinoma
18588,Benign Cellular Infiltrate,Acute myeloid leukemia with BCR-ABL1
18589,Benign Cellular Infiltrate,Acute myeloid leukemia with mutated RUNX1
18590,Benign Cellular Infiltrate,Transitional cell carcinoma metastatic
18591,Benign Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12)
18592,Benign Cellular Infiltrate,Gingival Squamous Cell Carcinoma
18593,Benign Cellular Infiltrate,Recurrent Subsequent Malignant Neoplasm
18594,Benign Cellular Infiltrate,Burkitt-like lymphoma with 11q aberration
18595,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10
18596,Benign Cellular Infiltrate,Malignant Solid Neoplasm
18597,Benign Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v8
18598,Benign Cellular Infiltrate,Unresectable Osteosarcoma
18599,Benign Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage
18600,Benign Cellular Infiltrate,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
18601,Benign Cellular Infiltrate,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
18602,Benign Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v8
18603,Benign Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8
18604,Benign Cellular Infiltrate,Mucosal Melanoma of the Head and Neck by AJCC v7 Stage
18605,Low Grade Neuroendocrine Lesion,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
18606,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
18607,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
18608,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
18609,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
18610,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
18611,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
18612,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
18613,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
18614,Well Differentiated Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
18615,Intermediate Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
18616,Intermediate Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
18617,Well Differentiated Neuroendocrine Lesion,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
18618,Low Grade Neuroendocrine Lesion,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
18619,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
18620,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
18621,Benign Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement
18622,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Central Nervous System
18623,Well Differentiated Neuroendocrine Lesion,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
18624,Well Differentiated Neuroendocrine Lesion,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
18625,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
18626,Low Grade Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
18627,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
18628,Low Grade Neuroendocrine Lesion,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
18629,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
18630,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
18631,Well Differentiated Neuroendocrine Lesion,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
18632,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
18633,Low Grade Neuroendocrine Lesion,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
18634,Well Differentiated Neuroendocrine Lesion,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
18635,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
18636,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
18637,Low Grade Neuroendocrine Lesion,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
18638,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
18639,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
18640,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
18641,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
18642,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
18643,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
18644,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
18645,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Stage
18646,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Clinical Stage
18647,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Clinical Stage
18648,Intermediate Grade Neuroendocrine Lesion,Clinical Stage III Gastric Cancer AJCC v8
18649,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVB Gastric Cancer AJCC v8
18650,Low Grade Neuroendocrine Lesion,Pathologic Stage IA Gastric Cancer AJCC v8
18651,Low Grade Neuroendocrine Lesion,Pathologic Stage II Gastric Cancer AJCC v8
18652,Low Grade Neuroendocrine Lesion,Pathologic Stage IIA Gastric Cancer AJCC v8
18653,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIB Gastric Cancer AJCC v8
18654,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIC Gastric Cancer AJCC v8
18655,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IV Gastric Cancer AJCC v8
18656,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIA Gastric Cancer AJCC v8
18657,Well Differentiated Neuroendocrine Lesion,Stage IIIA Anal Cancer AJCC v8
18658,Well Differentiated Neuroendocrine Lesion,Metastatic Digestive System Carcinoma
18659,Low Grade Neuroendocrine Lesion,Stage I Small Intestinal Adenocarcinoma AJCC v8
18660,Intermediate Grade Neuroendocrine Lesion,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
18661,Well Differentiated Neuroendocrine Lesion,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
18662,Well Differentiated Neuroendocrine Lesion,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
18663,Well Differentiated Neuroendocrine Lesion,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
18664,Low Grade Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v8
18665,Well Differentiated Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v8
18666,Well Differentiated Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v8
18667,Low Grade Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v8
18668,Low Grade Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v8
18669,Low Grade Neuroendocrine Lesion,Stage IIB Colorectal Cancer AJCC v8
18670,Well Differentiated Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v8
18671,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v8
18672,Well Differentiated Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v8
18673,Intermediate Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v8
18674,Low Grade Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v8
18675,Well Differentiated Neuroendocrine Lesion,Colon Cancer by AJCC v8 Stage
18676,Well Differentiated Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v8
18677,Low Grade Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v8
18678,Intermediate Grade Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v8
18679,Intermediate Grade Neuroendocrine Lesion,Stage IVC Colon Cancer AJCC v8
18680,Well Differentiated Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v8
18681,Well Differentiated Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v8
18682,Well Differentiated Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v8
18683,Intermediate Grade Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v8
18684,Intermediate Grade Neuroendocrine Lesion,Stage IVC Rectal Cancer AJCC v8
18685,Low Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v8 Stage
18686,Well Differentiated Neuroendocrine Lesion,Stage IA Hepatocellular Carcinoma AJCC v8
18687,Low Grade Neuroendocrine Lesion,Stage IB Hepatocellular Carcinoma AJCC v8
18688,Low Grade Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v8
18689,Intermediate Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v8
18690,Intermediate Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v8
18691,Intermediate Grade Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8
18692,Well Differentiated Neuroendocrine Lesion,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
18693,Intermediate Grade Neuroendocrine Lesion,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
18694,Intermediate Grade Neuroendocrine Lesion,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
18695,Low Grade Neuroendocrine Lesion,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
18696,Intermediate Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v8 Stage
18697,Low Grade Neuroendocrine Lesion,Stage IIA Gallbladder Cancer AJCC v8
18698,Intermediate Grade Neuroendocrine Lesion,Stage IIB Gallbladder Cancer AJCC v8
18699,Intermediate Grade Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v8
18700,Well Differentiated Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v8
18701,Well Differentiated Neuroendocrine Lesion,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
18702,Low Grade Neuroendocrine Lesion,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
18703,Low Grade Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v8
18704,Intermediate Grade Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
18705,Low Grade Neuroendocrine Lesion,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
18706,Well Differentiated Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
18707,Low Grade Neuroendocrine Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
18708,Well Differentiated Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v8 Stage
18709,Intermediate Grade Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v8
18710,Well Differentiated Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v8
18711,Intermediate Grade Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v8
18712,Well Differentiated Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v8
18713,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Ampulla of Vater Cancer AJCC v8
18714,Low Grade Neuroendocrine Lesion,Stage IIIB Ampulla of Vater Cancer AJCC v8
18715,Well Differentiated Neuroendocrine Lesion,Pancreatic Cancer by AJCC v8 Stage
18716,Intermediate Grade Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v8
18717,Low Grade Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v8
18718,Intermediate Grade Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v8
18719,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage
18720,Poorly Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
18721,Poorly Differentiated Neuroendocrine Lesion,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
18722,Poorly Differentiated Neuroendocrine Lesion,Stage III Ileal Neuroendocrine Tumor AJCC v8
18723,Poorly Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage
18724,Poorly Differentiated Neuroendocrine Lesion,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
18725,Poorly Differentiated Neuroendocrine Lesion,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
18726,Benign Cellular Infiltrate,Stage IIIC Lung Cancer AJCC v8
18727,Benign Cellular Infiltrate,Lung Adenosquamous Carcinoma by AJCC v7 Stage
18728,Benign Cellular Infiltrate,Lung Small Cell Carcinoma by AJCC v7 Stage
18729,Benign Cellular Infiltrate,Recurrent Cervical Adenocarcinoma
18730,Benign Cellular Infiltrate,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
18731,Benign Cellular Infiltrate,Gastrointestinal Stromal Tumor by AJCC v8 Stage
18732,Benign Cellular Infiltrate,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
18733,Benign Cellular Infiltrate,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
18734,Benign Cellular Infiltrate,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
18735,Benign Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
18736,Benign Cellular Infiltrate,Retroperitoneal Sarcoma by AJCC v8 Stage
18737,Benign Cellular Infiltrate,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
18738,Benign Cellular Infiltrate,Intermediate Atypical Prostate Carcinoma
18739,Benign Cellular Infiltrate,Clinical Stage I Cutaneous Melanoma AJCC v8
18740,Benign Cellular Infiltrate,Clinical Stage IIA Cutaneous Melanoma AJCC v8
18741,Benign Cellular Infiltrate,Pathologic Stage IA Cutaneous Melanoma AJCC v8
18742,Benign Cellular Infiltrate,Pathologic Stage II Cutaneous Melanoma AJCC v8
18743,Benign Cellular Infiltrate,Pathologic Stage IIC Cutaneous Melanoma AJCC v8
18744,Benign Cellular Infiltrate,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
18745,Benign Cellular Infiltrate,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
18746,Benign Cellular Infiltrate,Occult Breast Carcinoma
18747,Well Differentiated Neuroendocrine Lesion,Refractory Anal Carcinoma
18748,Benign Cellular Infiltrate,Luminal A Prostate Carcinoma
18749,Benign Cellular Infiltrate,Anatomic Stage IB Breast Cancer AJCC v8
18750,Benign Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8
18751,Malignant Cellular Infiltrate,Perineal Ectopic Fibroadenoma
18752,Benign Cellular Infiltrate,Prognostic Stage IA Breast Cancer AJCC v8
18753,Benign Cellular Infiltrate,Prognostic Stage IB Breast Cancer AJCC v8
18754,Benign Cellular Infiltrate,Prognostic Stage III Breast Cancer AJCC v8
18755,Benign Cellular Infiltrate,Stage IB Vulvar Cancer AJCC v8
18756,Benign Cellular Infiltrate,Stage I Vaginal Cancer AJCC v8
18757,Benign Cellular Infiltrate,Stage II Vaginal Cancer AJCC v8
18758,Benign Cellular Infiltrate,Stage II Cervical Cancer AJCC v8
18759,Benign Cellular Infiltrate,Stage IIA1 Cervical Cancer AJCC v8
18760,Benign Cellular Infiltrate,Stage IV Cervical Cancer AJCC v8
18761,Benign Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v8
18762,Benign Cellular Infiltrate,Stage IC Uterine Corpus Adenosarcoma AJCC v8
18763,Benign Cellular Infiltrate,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
18764,Benign Cellular Infiltrate,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
18765,Benign Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v8
18766,Benign Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC v8
18767,Benign Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8
18768,Benign Cellular Infiltrate,Stage 0 Penile Cancer AJCC v8
18769,Benign Cellular Infiltrate,Stage 0a Penile Cancer AJCC v8
18770,Benign Cellular Infiltrate,Refractory Transformed Non-Hodgkin Lymphoma
18771,Benign Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage
18772,Benign Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8
18773,Benign Cellular Infiltrate,Stage I Ureter Cancer AJCC v8
18774,Benign Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v8
18775,Benign Cellular Infiltrate,Stage III Ureter Cancer AJCC v8
18776,Benign Cellular Infiltrate,Stage IVB Bladder Cancer AJCC v8
18777,Benign Cellular Infiltrate,Stage III Urethral Cancer AJCC v8
18778,Benign Cellular Infiltrate,Stage IIB Eyelid Carcinoma AJCC v8
18779,Benign Cellular Infiltrate,Stage II Choroidal and Ciliary Body Melanoma AJCC v8
18780,Benign Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8
18781,Benign Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8
18782,Benign Cellular Infiltrate,Retinoblastoma by AJCC v8 Clinical Stage
18783,Benign Cellular Infiltrate,Clinical Stage II Retinoblastoma AJCC v8
18784,Benign Cellular Infiltrate,Pathologic Stage I Retinoblastoma AJCC v8
18785,Benign Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
18786,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
18787,Benign Cellular Infiltrate,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
18788,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
18789,Benign Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
18790,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
18791,Benign Cellular Infiltrate,Non-Hodgkin Lymphoma by Ann Arbor Stage
18792,Benign Cellular Infiltrate,Lugano Classification Limited Stage Adult Lymphoma AJCC v8
18793,Benign Cellular Infiltrate,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8
18794,Benign Cellular Infiltrate,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8
18795,Benign Cellular Infiltrate,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8
18796,Benign Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8
18797,Benign Cellular Infiltrate,Childhood Lymphoma by AJCC v8 Stage
18798,Benign Cellular Infiltrate,Lymphoma by AJCC v8 Stage
18799,Benign Cellular Infiltrate,Stage C Chronic Lymphocytic Leukemia
18800,Benign Cellular Infiltrate,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage
18801,Benign Cellular Infiltrate,B Lymphoblastic Lymphoma by Ann Arbor Stage
18802,Benign Cellular Infiltrate,Small Lymphocytic Lymphoma by Ann Arbor Stage
18803,Benign Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
18804,Benign Cellular Infiltrate,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8
18805,Benign Cellular Infiltrate,acute biphenotypic leukemia in relapse
18806,Benign Cellular Infiltrate,Malignant Lung PEComa
18807,Benign Cellular Infiltrate,Recurrent B Acute Lymphoblastic Leukemia
18808,Benign Cellular Infiltrate,Refractory Rhabdomyosarcoma
18809,Benign Cellular Infiltrate,Recurrent Anaplastic Oligodendroglioma
18810,Benign Cellular Infiltrate,Skin squamous cell carcinoma metastatic
18811,Benign Cellular Infiltrate,Mediastinal Granulocytic Sarcoma
18812,Benign Cellular Infiltrate,Metastatic Well Differentiated Neuroendocrine Neoplasm
18813,Benign Cellular Infiltrate,"Recurrent Medulloblastoma, SHH-Activated"
18814,Benign Cellular Infiltrate,BRCA-Mutated Ovarian Carcinoma
18815,Benign Cellular Infiltrate,Unresectable Malignant Solid Neoplasm
18816,Benign Cellular Infiltrate,Recurrent WHO Grade III Glioma
18817,Benign Cellular Infiltrate,Recurrent Thymic Carcinoma
18818,Benign Cellular Infiltrate,Recurrent Myelodysplastic Syndrome
18819,Benign Cellular Infiltrate,Refractory Oropharyngeal Squamous Cell Carcinoma
18820,Benign Cellular Infiltrate,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
18821,Low Grade Neuroendocrine Lesion,Unresectable Intrahepatic Cholangiocarcinoma
18822,Well Differentiated Neuroendocrine Lesion,Thoracic Esophagus Squamous Cell Carcinoma
18823,Intermediate Grade Neuroendocrine Lesion,Thoracic Esophagus Squamous Cell Carcinoma
18824,Intermediate Grade Neuroendocrine Lesion,Distal Esophagus Squamous Cell Carcinoma
18825,Benign Cellular Infiltrate,Recurrent T Acute Lymphoblastic Leukemia
18826,Benign Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Oropharynx
18827,Benign Cellular Infiltrate,Metastatic Oral Cavity Squamous Cell Carcinoma
18828,Benign Cellular Infiltrate,Advanced Nasopharyngeal Squamous Cell Carcinoma
18829,Benign Cellular Infiltrate,Advanced Laryngeal Squamous Cell Carcinoma
18830,Benign Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Larynx
18831,Benign Cellular Infiltrate,Extracavitary Primary Effusion Lymphoma
18832,Benign Cellular Infiltrate,Refractory T Acute Lymphoblastic Leukemia
18833,Benign Cellular Infiltrate,Metastatic Bladder Urothelial Carcinoma
18834,Benign Cellular Infiltrate,Recurrent Malignant Female Reproductive System Neoplasm
18835,Benign Cellular Infiltrate,Refractory Malignant Female Reproductive System Neoplasm
18836,Benign Cellular Infiltrate,Refractory Malignant Neoplasm of Multiple Primary Sites
18837,Benign Cellular Infiltrate,Refractory Malignant Pharyngeal Neoplasm
18838,Benign Cellular Infiltrate,Refractory Malignant Soft Tissue Neoplasm
18839,Benign Cellular Infiltrate,Recurrent Malignant Endocrine Neoplasm
18840,Well Differentiated Neuroendocrine Lesion,Unresectable Gastroesophageal Junction Adenocarcinoma
18841,Benign Cellular Infiltrate,Recurrent Myxoid Liposarcoma
18842,Benign Cellular Infiltrate,Testicular Follicular Lymphoma
18843,Benign Cellular Infiltrate,Refractory Liposarcoma
18844,Benign Cellular Infiltrate,Methotrexate-Associated Lymphoma
18845,Benign Cellular Infiltrate,Unresectable Gastrointestinal Stromal Tumor
18846,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders
18847,Well Differentiated Neuroendocrine Lesion,Refractory Metastatic Digestive System Carcinoma
18848,Low Grade Neuroendocrine Lesion,Recurrent Metastatic Digestive System Carcinoma
18849,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes
18850,Benign Cellular Infiltrate,Refractory Lymphoblastic Lymphoma
18851,Well Differentiated Neuroendocrine Lesion,Resectable Pancreatic Ductal Adenocarcinoma
18852,Benign Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm
18853,Benign Cellular Infiltrate,Locally Advanced Soft Tissue Sarcoma
18854,Benign Cellular Infiltrate,Metastatic Soft Tissue Sarcoma
18855,Benign Cellular Infiltrate,Advanced Renal Cell Carcinoma
18856,Benign Cellular Infiltrate,Advanced Lung Non-Small Cell Squamous Carcinoma
18857,Intermediate Grade Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Lung
18858,Benign Cellular Infiltrate,Metastatic Unresectable Malignant Neoplasm
18859,Well Differentiated Neuroendocrine Lesion,Refractory Bile Duct Carcinoma
18860,Intermediate Grade Neuroendocrine Lesion,Refractory Bile Duct Carcinoma
18861,Intermediate Grade Neuroendocrine Lesion,Refractory Small Intestinal Carcinoma
18862,Benign Cellular Infiltrate,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
18863,Benign Cellular Infiltrate,Locally Advanced Unresectable Bone Sarcoma
18864,Benign Cellular Infiltrate,Recurrent Parotid Gland Acinic Cell Carcinoma
18865,Well Differentiated Neuroendocrine Lesion,Recurrent Appendix Mucinous Adenocarcinoma
18866,Benign Cellular Infiltrate,Recurrent Ovarian Adenocarcinoma
18867,Benign Cellular Infiltrate,Recurrent Ovarian Mucinous Adenocarcinoma
18868,Benign Cellular Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma
18869,Intermediate Grade Neuroendocrine Lesion,Recurrent Pancreatic Ductal Adenocarcinoma
18870,Benign Cellular Infiltrate,Recurrent Thyroid Gland Follicular Carcinoma
18871,Benign Cellular Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma
18872,Benign Cellular Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma
18873,Benign Cellular Infiltrate,Refractory Malignant Brain Neoplasm
18874,Intermediate Grade Neuroendocrine Lesion,Hepatic cancer metastatic
18875,Low Grade Neuroendocrine Lesion,Metastatic hepatocellular carcinoma
18876,Low Grade Neuroendocrine Lesion,Unresectable Gastric Adenocarcinoma
18877,Metastatic Lesion,Non-Functioning Corticotroph Adenoma
18878,Benign Cellular Infiltrate,Anaplastic Sarcoma of the Kidney
18879,Intracytoplasmic Eosinophilic Inclusion,Anaplastic Sarcoma of the Kidney
18880,Metastatic Lesion,Monomorphous Plurihormonal Pituitary Gland Adenoma
18881,Benign Cellular Infiltrate,Resectable Renal Cell Carcinoma
18882,Well Differentiated Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma
18883,Benign Cellular Infiltrate,Digestive System Large Cell Neuroendocrine Carcinoma
18884,Benign Cellular Infiltrate,Adenocarcinoma gastric recurrent
18885,Indolent Clinical Course,Pituitary Gland Blastoma
18886,Benign Cellular Infiltrate,Pituitary Gland Blastoma
18887,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of the Extremity
18888,Benign Cellular Infiltrate,Advanced Sarcoma of the Extremity
18889,Local disease,Advanced Sarcoma of the Extremity
18890,Benign Cellular Infiltrate,Locally Advanced Unresectable Carcinoma
18891,Benign Cellular Infiltrate,Locally Advanced Unresectable Renal Cell Carcinoma
18892,Low Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma recurrent
18893,Prominent Schwannian Stroma Present,Sellar Neuroblastoma
18894,Indolent Clinical Course,Sellar Chondroid Chordoma
18895,Benign Cellular Infiltrate,Sellar Chondroid Chordoma
18896,Benign Cellular Infiltrate,Pituitary Gland Non-Hodgkin Lymphoma
18897,Indolent Clinical Course,Sellar Yolk Sac Tumor
18898,Malignant Cellular Infiltrate,Sellar Mature Teratoma
18899,Geographic Necrosis,Sellar Mature Teratoma
18900,Malignant Germinomatous Cellular Infiltrate,Sellar Immature Teratoma
18901,Seminomatous Component Present,Sellar Immature Teratoma
18902,Malignant Germinomatous Cellular Infiltrate,Sellar Teratoma with Malignant Transformation
18903,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Endometrial Clear Cell Adenocarcinoma
18904,Benign Cellular Infiltrate,Recurrent Endometrial Mixed Cell Adenocarcinoma
18905,Benign Cellular Infiltrate,Advanced Neuroendocrine Carcinoma
18906,Intermediate Filaments Present,Chest Wall Sarcoma
18907,Benign Cellular Infiltrate,Locally Advanced Unresectable Gastric Adenocarcinoma
18908,Well-Circumscribed Lesion,Unresectable Desmoid-Type Fibromatosis
18909,Benign Cellular Infiltrate,Metastatic Lung Adenocarcinoma
18910,Aggressive Clinical Course,Smoldering Waldenstrom Macroglobulinemia
18911,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
18912,Low Grade Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
18913,Well Differentiated Neuroendocrine Lesion,Unresectable Digestive System Neuroendocrine Carcinoma
18914,Low Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
18915,Benign Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Carcinoma
18916,Well Differentiated Neuroendocrine Lesion,Refractory Digestive System Neuroendocrine Carcinoma
18917,Benign Cellular Infiltrate,Refractory Digestive System Neuroendocrine Carcinoma
18918,Benign Cellular Infiltrate,Hereditary Malignant Urinary System Neoplasm
18919,Mucoid Stroma Formation,Broad Ligament Papillary Cystadenoma
18920,Nuclear Clearing,Thyroid Gland Spindle Cell Follicular Adenoma
18921,Ground Glass Nuclear Inclusion,Thyroid Gland Black Follicular Adenoma
18922,Capsular Invasion,Thyroid Gland Black Follicular Adenoma
18923,Nuclear Grooves,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
18924,Intermediate Filaments Present,Refractory Malignant Peripheral Nerve Sheath Tumor
18925,Mucoid Stroma Formation,Encapsulated Variant Thyroid Gland Papillary Carcinoma
18926,Indolent Clinical Course,Frontal Lobe Anaplastic Astrocytoma
18927,Grade 4 Lesion,Frontal Lobe Anaplastic Astrocytoma
18928,Necrotic changes (finding),Frontal Lobe Anaplastic Astrocytoma
18929,Precise Histogenesis Unknown,Frontal Lobe Anaplastic Astrocytoma
18930,Benign Cellular Infiltrate,Temporal Lobe Anaplastic Astrocytoma
18931,Microvascular Proliferation,Temporal Lobe Anaplastic Astrocytoma
18932,Grade 4 Lesion,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma
18933,Indolent Clinical Course,Fourth Ventricle Medulloblastoma
18934,Anaplasia,Temporal Lobe Pleomorphic Xanthoastrocytoma
18935,Benign Cellular Infiltrate,Metastatic Endometrial Carcinoma
18936,Low Grade Neuroendocrine Lesion,stage IV pancreatic cancer
18937,Benign Cellular Infiltrate,stage IV pancreatic cancer
18938,Benign Cellular Infiltrate,Stage IV Skin Melanoma
18939,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma
18940,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Esophageal Squamous Cell Carcinoma
18941,Benign Cellular Infiltrate,Metastatic Nasopharyngeal Undifferentiated Carcinoma
18942,Benign Cellular Infiltrate,Metastatic Lip and Oral Cavity Carcinoma
18943,Premalignant Lesion,Metastatic Lung Adenosquamous Carcinoma
18944,Benign Cellular Infiltrate,Metastatic Lung Non-Small Cell Carcinoma
18945,Well Differentiated Neuroendocrine Lesion,Metastatic Colon Carcinoma
18946,Nuclear Grooves,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
18947,Low Grade Neuroendocrine Lesion,Localized Gastroesophageal Junction Adenocarcinoma
18948,Low Grade Neuroendocrine Lesion,Localized Gastric Carcinoma
18949,Intermediate Filaments Present,Tongue Alveolar Soft Part Sarcoma'
18950,Benign Cellular Infiltrate,sarcoma of tongue
18951,Indolent Clinical Course,Parotid Gland Sarcoma
18952,Intermediate Filaments Present,Parotid Gland Sarcoma
18953,Local disease,Advanced Prostate Carcinoma
18954,Benign Cellular Infiltrate,Locally Advanced Prostate Adenocarcinoma
18955,Benign Cellular Infiltrate,Locally Advanced Cervical Carcinoma
18956,Extensive Stage Lesion,Locally Advanced Cervical Adenocarcinoma
18957,Benign Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
18958,Intracytoplasmic Eosinophilic Inclusion,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
18959,Indolent Clinical Course,Thyroid Gland Leiomyosarcoma
18960,Benign Cellular Infiltrate,follicular lymphoma of thyroid gland
18961,Benign Cellular Infiltrate,Recurrent Primary Peritoneal Serous Adenocarcinoma
18962,Intermediate Filaments Present,Advanced Kaposi Sarcoma
18963,Local disease,Advanced Neuroendocrine Neoplasm
18964,Low Mitotic Activity,Advanced Gastric Neuroendocrine Carcinoma
18965,Benign Cellular Infiltrate,Advanced Gastric Neuroendocrine Carcinoma
18966,Benign Cellular Infiltrate,Metastatic Small Intestinal Neuroendocrine Carcinoma
18967,Low Mitotic Activity,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
18968,Squamous Differentiation,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
18969,Benign Cellular Infiltrate,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
18970,Benign Cellular Infiltrate,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
18971,Solid Growth Pattern,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
18972,Chronic Clinical Course,Recurrent Acute Myelomonocytic Leukemia
18973,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Monoblastic and Monocytic Leukemia
18974,Solid Growth Pattern,Recurrent Acute Erythroid Leukemia
18975,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Megakaryoblastic Leukemia
18976,Well Differentiated Neuroendocrine Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
18977,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
18978,Benign Cellular Infiltrate,Locally Advanced Microsatellite Stable Colorectal Carcinoma
18979,Mitotic Activity,Benign Parathyroid Gland Adenoma
18980,Tumor Vascular Invasion,Benign Parathyroid Gland Adenoma
18981,Benign Cellular Infiltrate,Locally Advanced Basal Cell Carcinoma
18982,Intermediate Grade Neuroendocrine Lesion,Biliary Tract Carcinoma
18983,Benign Cellular Infiltrate,Recurrent Biliary Tract Carcinoma
18984,Low Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma resectable
18985,Benign Cellular Infiltrate,Pancreatic adenocarcinoma resectable
18986,Intermediate Filaments Present,Adrenal Gland Sarcoma
18987,Benign Cellular Infiltrate,Hormone Receptor Positive Breast Carcinoma
18988,Benign Cellular Infiltrate,"Leukemia, Radiation-Induced"
18989,Benign Cellular Infiltrate,Intraepithelial Squamous Cell Carcinoma
18990,Malignant Cellular Infiltrate,Trichoepithelioma
18991,Malignant Cellular Infiltrate,Uterine Corpus Adenomatoid Tumor
18992,Intermediate Grade Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
18993,Benign Cellular Infiltrate,Papillary Eccrine Carcinoma
18994,Benign Cellular Infiltrate,Lymphoma stage
18995,Well Differentiated Neuroendocrine Lesion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
18996,Well Differentiated Neuroendocrine Lesion,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
18997,Well Differentiated Neuroendocrine Lesion,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
18998,Benign Cellular Infiltrate,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
18999,Benign Cellular Infiltrate,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
19000,Benign Cellular Infiltrate,B-cell lymphoma stage I
19001,Well Differentiated Neuroendocrine Lesion,Carcinoma duodenum resectable
19002,Well Differentiated Neuroendocrine Lesion,Unresectable Hepatocellular Carcinoma
19003,Intermediate Grade Neuroendocrine Lesion,Unresectable Hepatocellular Carcinoma
19004,Benign Cellular Infiltrate,"Myeloproliferative Neoplasm, Unclassifiable"
19005,Benign Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor
19006,Benign Cellular Infiltrate,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
19007,Benign Cellular Infiltrate,Vaginal Melanoma
19008,Benign Cellular Infiltrate,Childhood Central Nervous System Mixed Germ Cell Tumor
19009,Geographic Necrosis,Childhood Central Nervous System Mature Teratoma
19010,Low Grade Neuroendocrine Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma
19011,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Clear Cell Adenocarcinoma
19012,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Clear Cell Adenocarcinoma
19013,Well Differentiated Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma
19014,Low Grade Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma
19015,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
19016,Benign Cellular Infiltrate,Peripheral primitive neuroectodermal tumor of soft tissue
19017,Benign Cellular Infiltrate,Angiosarcoma Associated with Lymphedema
19018,Benign Cellular Infiltrate,Radiation-Related Angiosarcoma
19019,Malignant Cellular Infiltrate,Acantholytic acanthoma
19020,Malignant Cellular Infiltrate,Benign Hair Follicle Neoplasm
19021,Low Grade Neuroendocrine Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma
19022,Benign Cellular Infiltrate,EBV-Related Non-Hodgkin Lymphoma
19023,Benign Cellular Infiltrate,AIDS-Related Carcinoma
19024,Benign Cellular Infiltrate,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable"
19025,Benign Cellular Infiltrate,Metastatic Kidney Carcinoma
19026,Well Differentiated Neuroendocrine Lesion,Bile duct adenocarcinoma
19027,Benign Cellular Infiltrate,Mucin-producing adenocarcinoma
19028,Benign Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
19029,Benign Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma
19030,Benign Cellular Infiltrate,Well Differentiated Prostate Adenocarcinoma
19031,Benign Cellular Infiltrate,Solar Radiation-Related Skin Squamous Cell Carcinoma
19032,Intermediate Grade Neuroendocrine Lesion,Alcohol-Related Hepatocellular Carcinoma
19033,Benign Cellular Infiltrate,Asbestos-Related Malignant Mesothelioma
19034,Benign Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma
19035,Benign Cellular Infiltrate,Ionizing Radiation-Related Malignant Neoplasm
19036,Benign Cellular Infiltrate,Thymic Papillary Adenocarcinoma
19037,Low Grade Neuroendocrine Lesion,Advanced Adult Hepatocellular Carcinoma
19038,Benign Cellular Infiltrate,Papillary adenocarcinoma
19039,Malignant Cellular Infiltrate,Adrenal Rest Tumor
19040,Benign Cellular Infiltrate,Burkitt Lymphoma
19041,Benign Cellular Infiltrate,Non-Small Cell Lung Carcinoma
19042,Benign Cellular Infiltrate,Squamous cell carcinoma
19043,Benign Cellular Infiltrate,Chordoma
19044,Benign Cellular Infiltrate,Glioblastoma
19045,Intermediate Grade Neuroendocrine Lesion,Liver carcinoma
19046,Benign Cellular Infiltrate,"Leukemia, Mast-Cell"
19047,Benign Cellular Infiltrate,"Leukemia, Myelocytic, Acute"
19048,Malignant Cellular Infiltrate,Benign Mastocytoma
19049,Benign Cellular Infiltrate,Paget Disease Extramammary
19050,Malignant Cellular Infiltrate,Pigmented villonodular synovitis
19051,Intermediate Grade Neuroendocrine Lesion,Cecum Carcinoma
19052,Low Grade Neuroendocrine Lesion,Cecum Carcinoma
19053,Malignant Cellular Infiltrate,Bronchial adenoma
19054,Benign Cellular Infiltrate,Mixed Cellularity Hodgkin Lymphoma
19055,Benign Cellular Infiltrate,"Sarcoma, Myeloid"
19056,Benign Cellular Infiltrate,Malignant tumor of base of tongue
19057,Benign Cellular Infiltrate,Malignant tumor of mediastinum
19058,Benign Cellular Infiltrate,Malignant neoplasm of endocervix
19059,Benign Cellular Infiltrate,Malignant tumor of orbit
19060,Benign Cellular Infiltrate,Malignant neoplasm of brain
19061,Benign Cellular Infiltrate,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
19062,Benign Cellular Infiltrate,small cell carcinoma of salivary gland
19063,Benign Cellular Infiltrate,Malignant neoplasm of spinal cord
19064,Benign Cellular Infiltrate,Secondary malignant neoplasm of axilla
19065,Benign Cellular Infiltrate,Malignant neoplasm of endocrine gland
19066,Benign Cellular Infiltrate,Choroid Mixed Cell Melanoma
19067,Benign Cellular Infiltrate,Immature Granulocytic Sarcoma
19068,Benign Cellular Infiltrate,"Hodgkin's disease, lymphocytic depletion of lymph nodes of multiple sites"
19069,Malignant Cellular Infiltrate,ductal papilloma of salivary gland
19070,Benign Cellular Infiltrate,Stage III Hodgkin Lymphoma
19071,Malignant Cellular Infiltrate,Benign neoplasm of trachea
19072,Benign Cellular Infiltrate,Grade 2 Malignant Neoplasm
19073,Benign Cellular Infiltrate,Grade 3 Malignant Neoplasm
19074,Benign Cellular Infiltrate,High Grade Malignant Neoplasm
19075,Benign Cellular Infiltrate,Low Grade Malignant Neoplasm
19076,Benign Cellular Infiltrate,Chronic Myelomonocytic Leukemia-1
19077,Benign Cellular Infiltrate,Chronic Myelomonocytic Leukemia-2
19078,Malignant Cellular Infiltrate,Benign neoplasm of uterine cervix
19079,Benign Cellular Infiltrate,Carcinoma bone
19080,Malignant Cellular Infiltrate,Peripheral Breast Papilloma
19081,Benign Cellular Infiltrate,Hereditary Male Breast Carcinoma
19082,Malignant Cellular Infiltrate,Benign neoplasm of renal pelvis
19083,Malignant Cellular Infiltrate,Benign neoplasm of bladder
19084,Malignant Cellular Infiltrate,Benign neoplasm of conjunctiva
19085,Malignant Cellular Infiltrate,Benign neoplasm of choroid
19086,Malignant Cellular Infiltrate,Benign tumor of lacrimal drainage structure
19087,Benign Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma
19088,Malignant Cellular Infiltrate,Benign neoplasm of adrenal gland
19089,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Lung
19090,Benign Cellular Infiltrate,Breast Carcinoma Metastatic in the Bone
19091,Intermediate Grade Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v6
19092,Malignant Cellular Infiltrate,"Adenoma, Monomorphic"
19093,Well Differentiated Neuroendocrine Lesion,"Carcinoid, Goblet Cell"
19094,Benign Cellular Infiltrate,"Anaplastic large cell lymphoma, ALK negative"
19095,Benign Cellular Infiltrate,Ki-1+ Anaplastic Large Cell Lymphoma
19096,Malignant Cellular Infiltrate,"Lymphangioma, Cystic"
19097,Malignant Cellular Infiltrate,Adenomyoma
19098,Benign Cellular Infiltrate,Adenosquamous carcinoma
19099,Benign Cellular Infiltrate,Head and Neck Basaloid Carcinoma
19100,Malignant Cellular Infiltrate,Angiolipoma
19101,Benign Cellular Infiltrate,Alveolar rhabdomyosarcoma
19102,Benign Cellular Infiltrate,"Carcinoma, Large Cell"
19103,Benign Cellular Infiltrate,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
19104,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
19105,Malignant Cellular Infiltrate,Plexiform Neurofibroma
19106,Benign Cellular Infiltrate,Metastatic malignant neoplasm to brain
19107,Benign Cellular Infiltrate,Plasmablastic Lymphoma of Mucosa Site
19108,Malignant Cellular Infiltrate,"Synovioma, benign"
19109,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(17;17)(q21;q21)
19110,Intermediate Grade Neuroendocrine Lesion,Cystadenocarcinoma of pancreas
19111,Malignant Cellular Infiltrate,Gastric Leiomyoma
19112,Benign Cellular Infiltrate,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
19113,Malignant Cellular Infiltrate,Compound nevus of skin
19114,Intermediate Grade Neuroendocrine Lesion,Carcinoma of ampulla of Vater
19115,Benign Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma
19116,Malignant Cellular Infiltrate,Leiomyomatosis peritonealis disseminata
19117,Benign Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype"
19118,Benign Cellular Infiltrate,Type II Endometrial Adenocarcinoma
19119,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
19120,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
19121,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
19122,Benign Cellular Infiltrate,Adenocarcinoma of Skene Gland Origin
19123,Benign Cellular Infiltrate,Female Urethral Malignant Neoplasm
19124,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
19125,Benign Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
19126,Benign Cellular Infiltrate,Primary Prostate Urothelial Carcinoma
19127,Benign Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma
19128,Intermediate Grade Neuroendocrine Lesion,Stage II Colon Cancer
19129,Low Grade Neuroendocrine Lesion,Stage IV Colon Carcinoma
19130,Intermediate Grade Neuroendocrine Lesion,Colon cancer recurrent
19131,Benign Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern"
19132,Intermediate Grade Neuroendocrine Lesion,Esophageal carcinoma recurrent
19133,Malignant Cellular Infiltrate,Grade 1 Ovarian Teratoma
19134,Benign Cellular Infiltrate,Inflammatory Breast Carcinoma
19135,Malignant Cellular Infiltrate,Rete Ovarii Cystadenoma
19136,Intermediate Grade Neuroendocrine Lesion,Gastric Adenocarcinoma
19137,Low Grade Neuroendocrine Lesion,Gastric Adenocarcinoma
19138,Benign Cellular Infiltrate,Clear cell adenocarcinoma of ovary
19139,Benign Cellular Infiltrate,clear cell adenocarcinofibroma of ovary
19140,Malignant Cellular Infiltrate,Benign Ovarian Clear Cell Tumor
19141,Benign Cellular Infiltrate,Adult Medulloblastoma
19142,Benign Cellular Infiltrate,Grade 1 Endometrial Endometrioid Adenocarcinoma
19143,Benign Cellular Infiltrate,Grade 3 Endometrial Mucinous Adenocarcinoma
19144,Benign Cellular Infiltrate,Serous Endometrial Intraepithelial Carcinoma
19145,Benign Cellular Infiltrate,Endometrial Mixed Cell Adenocarcinoma
19146,Benign Cellular Infiltrate,Endometrial Transitional Cell Carcinoma
19147,Malignant Cellular Infiltrate,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
19148,Malignant Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma
19149,Benign Cellular Infiltrate,Uterine Corpus Carcinofibroma
19150,Benign Cellular Infiltrate,Cervical Wilms Tumor
19151,Benign Cellular Infiltrate,Vaginal Basaloid Carcinoma
19152,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma Of Esophagus
19153,Benign Cellular Infiltrate,Vaginal Adenoid Basal Carcinoma
19154,Benign Cellular Infiltrate,Vaginal Undifferentiated Carcinoma
19155,Benign Cellular Infiltrate,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
19156,Malignant Cellular Infiltrate,Vestibular Micropapillomatosis
19157,Malignant Cellular Infiltrate,Vulvar Inverted Follicular Keratosis
19158,Benign Cellular Infiltrate,Vulvar Eccrine Porocarcinoma
19159,Benign Cellular Infiltrate,Sebaceous Adenocarcinoma
19160,Malignant Cellular Infiltrate,Vulvar Nodular Hidradenoma
19161,Benign Cellular Infiltrate,leiomyosarcoma of vulva
19162,Benign Cellular Infiltrate,liposarcoma of vulva
19163,Malignant Cellular Infiltrate,Superficial angiomyxoma
19164,Benign Cellular Infiltrate,Invasive Mixed Breast Carcinoma
19165,Benign Cellular Infiltrate,Breast Carcinoma with Choriocarcinomatous Features
19166,Benign Cellular Infiltrate,Breast Carcinoma with Melanotic Features
19167,Benign Cellular Infiltrate,Refractory anemia with ringed sideroblasts
19168,Benign Cellular Infiltrate,Acinic Cell Breast Carcinoma
19169,Benign Cellular Infiltrate,follicular malignant lymphoma of breast
19170,Malignant Cellular Infiltrate,Breast Leiomyoma
19171,Benign Cellular Infiltrate,Ovarian Malignant Mesothelioma
19172,Benign Cellular Infiltrate,Malignant Meningioma
19173,Benign Cellular Infiltrate,Ann Arbor Stage IVA Hodgkin Lymphoma
19174,Malignant Cellular Infiltrate,Trichilemmoma
19175,Benign Cellular Infiltrate,Villous adenocarcinoma
19176,Benign Cellular Infiltrate,Glycogen-rich carcinoma
19177,Mitotic Activity,Water-clear cell adenoma
19178,Malignant Cellular Infiltrate,Water-clear cell adenoma
19179,Intermediate Grade Neuroendocrine Lesion,Cholangiolocellular Carcinoma
19180,Well Differentiated Neuroendocrine Lesion,Signet Ring Cell Intrahepatic Cholangiocarcinoma
19181,Low Grade Neuroendocrine Lesion,Signet Ring Cell Intrahepatic Cholangiocarcinoma
19182,Intermediate Grade Neuroendocrine Lesion,Sarcomatoid Intrahepatic Cholangiocarcinoma
19183,Malignant Cellular Infiltrate,Apocrine adenoma
19184,Malignant Cellular Infiltrate,Adenoma of the nipple
19185,Malignant Cellular Infiltrate,Maturing Ganglioneuroma
19186,Benign Cellular Infiltrate,"Pheochromocytoma, malignant"
19187,Malignant Cellular Infiltrate,Spindle cell lipoma
19188,Benign Cellular Infiltrate,Sporadic Retinoblastoma
19189,Malignant Cellular Infiltrate,Adult Extracardiac Rhabdomyoma
19190,Benign Cellular Infiltrate,Uterine Carcinosarcoma
19191,Benign Cellular Infiltrate,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
19192,Benign Cellular Infiltrate,Grade 3 Teratoma
19193,Malignant Cellular Infiltrate,Central odontogenic fibroma
19194,Benign Cellular Infiltrate,Gliomatosis cerebri
19195,Benign Cellular Infiltrate,Malignant Outer Hair Sheath and Infundibulum Neoplasm
19196,Benign Cellular Infiltrate,Malignant Germinative Follicular Epithelium Neoplasm
19197,Malignant Cellular Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
19198,Benign Cellular Infiltrate,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
19199,Benign Cellular Infiltrate,Aleukemic Lymphoid Leukemia
19200,Low Grade Neuroendocrine Lesion,Adenocarcinoma of colon
19201,Low Grade Neuroendocrine Lesion,Sporadic Gastric Adenocarcinoma
19202,Low Grade Neuroendocrine Lesion,Small Intestinal Squamous Cell Carcinoma
19203,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Adenosquamous Carcinoma
19204,Well Differentiated Neuroendocrine Lesion,Small Intestinal Mucinous Adenocarcinoma
19205,Well Differentiated Neuroendocrine Lesion,Small Intestinal Medullary Carcinoma
19206,Low Grade Neuroendocrine Lesion,Small Intestinal Medullary Carcinoma
19207,Well Differentiated Neuroendocrine Lesion,Small Intestinal Undifferentiated Carcinoma
19208,Malignant Cellular Infiltrate,Benign tumor of eyelid
19209,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of appendix
19210,Low Grade Neuroendocrine Lesion,Mucinous adenocarcinoma of appendix
19211,Well Differentiated Neuroendocrine Lesion,Colorectal Mucinous Adenocarcinoma
19212,Well Differentiated Neuroendocrine Lesion,Colorectal Signet Ring Cell Carcinoma
19213,Intermediate Grade Neuroendocrine Lesion,Colorectal Medullary Carcinoma
19214,Intermediate Grade Neuroendocrine Lesion,clear cell adenocarcinoma of gallbladder
19215,Well Differentiated Neuroendocrine Lesion,Pleomorphic Hepatocellular Carcinoma
19216,Benign Cellular Infiltrate,Malignant Adrenal Medulla Neoplasm
19217,Malignant Cellular Infiltrate,Benign neoplasm of maxillary sinus
19218,Well Differentiated Neuroendocrine Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7
19219,Intermediate Grade Neuroendocrine Lesion,Cholangiocarcinoma
19220,Benign Cellular Infiltrate,Large cell carcinoma of lung
19221,Benign Cellular Infiltrate,"Lung Large Cell Carcinoma, Clear Cell Variant"
19222,Malignant Cellular Infiltrate,Ganglioneuroma of skin
19223,Benign Cellular Infiltrate,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
19224,Malignant Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura
19225,Benign Cellular Infiltrate,Malignant Lipomatous Neoplasm
19226,Benign Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma
19227,Malignant Cellular Infiltrate,Benign Accessory Urethral Gland Neoplasm
19228,Benign Cellular Infiltrate,Malignant neoplasm of acoustic nerve
19229,Malignant Cellular Infiltrate,Pleomorphic adenoma of lacrimal gland
19230,Benign Cellular Infiltrate,Rhabdomyosarcoma of the orbit
19231,Benign Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Small Cell Variant"
19232,Benign Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma
19233,Benign Cellular Infiltrate,Lung Pleomorphic Carcinoma
19234,Benign Cellular Infiltrate,Malignant medulloepithelioma of ciliary body
19235,Malignant Cellular Infiltrate,Hemangioma of choroid
19236,Benign Cellular Infiltrate,Malignant Lung and Pleural Neoplasm
19237,Benign Cellular Infiltrate,Angiosarcoma of spleen
19238,Benign Cellular Infiltrate,Pleural Epithelioid Mesothelioma
19239,Benign Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma
19240,Benign Cellular Infiltrate,Malignant tumor of dermis
19241,Benign Cellular Infiltrate,Mediastinal T Lymphoblastic Lymphoma
19242,Malignant Cellular Infiltrate,Cardiac hemangioma
19243,Benign Cellular Infiltrate,Stage 0 Lip Carcinoma
19244,Intermediate Grade Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v7
19245,Low Grade Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v7
19246,Benign Cellular Infiltrate,Clear Cell Variant Thyroid Gland Papillary Carcinoma
19247,Benign Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma
19248,Malignant Cellular Infiltrate,Benign neoplasm of large intestine
19249,Malignant Cellular Infiltrate,Benign tumor of pancreas
19250,Malignant Cellular Infiltrate,Thyroid Gland Hyperfunctioning Adenoma
19251,Malignant Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
19252,Benign Cellular Infiltrate,Malignant Central Nervous System Neoplasm
19253,Malignant Cellular Infiltrate,Dermoid cyst of skin
19254,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor
19255,Benign Cellular Infiltrate,Splenic Marginal Zone B-Cell Lymphoma
19256,Benign Cellular Infiltrate,Bladder Sarcoma
19257,Malignant Cellular Infiltrate,Cellular Schwannoma
19258,Benign Cellular Infiltrate,Non-Secretory Plasma Cell Myeloma
19259,Benign Cellular Infiltrate,Malignant neoplasm of major salivary gland
19260,Benign Cellular Infiltrate,Malignant neoplasm of ciliary body
19261,Benign Cellular Infiltrate,Malignant tumor of eye
19262,Benign Cellular Infiltrate,Malignant odontogenic tumor
19263,Benign Cellular Infiltrate,Malignant Glioma
19264,Tumor Vascular Invasion,Parathyroid Gland Atypical Adenoma
19265,Capsular Invasion,Parathyroid Gland Atypical Adenoma
19266,Benign Cellular Infiltrate,Squamous cell carcinoma of mouth
19267,Benign Cellular Infiltrate,Ewing's sarcoma of bone
19268,Benign Cellular Infiltrate,Invasive Cutaneous Melanoma
19269,Malignant Cellular Infiltrate,Chorioangioma
19270,Benign Cellular Infiltrate,Secondary malignant neoplasm of trachea
19271,Malignant Cellular Infiltrate,HIV lipodystrophy
19272,Malignant Cellular Infiltrate,Benign neoplasm of spleen
19273,Benign Cellular Infiltrate,Secondary malignant neoplasm of lymph node
19274,Malignant Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
19275,Intermediate Grade Neuroendocrine Lesion,Colon Carcinoma
19276,Malignant Cellular Infiltrate,Conventional Cardiac Rhabdomyoma
19277,Benign Cellular Infiltrate,Thyroid Hurthle Cell Carcinoma
19278,Benign Cellular Infiltrate,Primary malignant neoplasm of brain
19279,Benign Cellular Infiltrate,Secondary Malignant Neoplasm
19280,Benign Cellular Infiltrate,Treatment related secondary malignancy
19281,Benign Cellular Infiltrate,"Follicle center lymphoma, follicular grade I, II, III stage IV"
19282,Well Differentiated Neuroendocrine Lesion,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
19283,Well Differentiated Neuroendocrine Lesion,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
19284,Intermediate Grade Neuroendocrine Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
19285,Benign Cellular Infiltrate,Angiocentric lymphoma recurrent
19286,Benign Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
19287,Benign Cellular Infiltrate,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma
19288,Benign Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
19289,Benign Cellular Infiltrate,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma
19290,Low Grade Neuroendocrine Lesion,Adenocarcinoma of large intestine
19291,Benign Cellular Infiltrate,Apocrine breast carcinoma
19292,Benign Cellular Infiltrate,neuroblastoma of spinal cord
19293,Benign Cellular Infiltrate,Vertebral chordoma
19294,Benign Cellular Infiltrate,Spinal Cord Melanoma
19295,Benign Cellular Infiltrate,signet ring cell carcinoma of breast
19296,Benign Cellular Infiltrate,Metastatic Squamous Cell Breast Carcinoma
19297,Benign Cellular Infiltrate,Angiosarcoma of the breast
19298,Benign Cellular Infiltrate,Breast Extraskeletal Osteosarcoma
19299,Benign Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v6 and v7
19300,Benign Cellular Infiltrate,Ovarian Angiosarcoma
19301,Benign Cellular Infiltrate,fibrosarcoma of ovary
19302,Benign Cellular Infiltrate,Ovarian Myxoid Liposarcoma
19303,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of ovary
19304,Intermediate Grade Neuroendocrine Lesion,Gastric Cardia Adenocarcinoma
19305,Low Grade Neuroendocrine Lesion,Gastric Cardia Adenocarcinoma
19306,Intermediate Grade Neuroendocrine Lesion,Signet-ring cell adenocarcinoma gastric
19307,Benign Cellular Infiltrate,Adult Meningeal Melanoma
19308,Malignant Cellular Infiltrate,Microcystic/Reticular Schwannoma
19309,Malignant Cellular Infiltrate,Lipoma of small intestine
19310,Low Grade Neuroendocrine Lesion,adenoid cystic carcinoma of esophagus
19311,Malignant Cellular Infiltrate,Solitary Osteochondroma
19312,Malignant Cellular Infiltrate,Osteochondromatosis
19313,Malignant Cellular Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue
19314,Malignant Cellular Infiltrate,Ectopic hamartomatous thymoma
19315,Benign Cellular Infiltrate,Secondary Heart Lymphoma
19316,Benign Cellular Infiltrate,Malignant Pulmonary Artery Neoplasm
19317,Benign Cellular Infiltrate,Renal Vein Leiomyosarcoma
19318,Benign Cellular Infiltrate,Malignant Cardiac Paraganglioma
19319,Malignant Cellular Infiltrate,Bone Leiomyoma
19320,Malignant Cellular Infiltrate,"Gastrointestinal stromal tumor, benign"
19321,Malignant Cellular Infiltrate,Cerebellopontine Angle Schwannoma
19322,Benign Cellular Infiltrate,Ear carcinoma
19323,Benign Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
19324,Benign Cellular Infiltrate,Intracranial Germinoma
19325,Benign Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
19326,Benign Cellular Infiltrate,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
19327,Benign Cellular Infiltrate,Laryngeal Lymphoepithelial Carcinoma
19328,Benign Cellular Infiltrate,Extracranial Neuroblastoma
19329,Benign Cellular Infiltrate,Central nervous system leukemia
19330,Benign Cellular Infiltrate,Intracranial Melanoma
19331,Benign Cellular Infiltrate,Central Nervous System Fibrosarcoma
19332,Benign Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
19333,Intermediate Grade Neuroendocrine Lesion,Gastric Papillary Adenocarcinoma
19334,Well Differentiated Neuroendocrine Lesion,Gastric Adenosquamous Carcinoma
19335,Low Grade Neuroendocrine Lesion,Gastric Adenosquamous Carcinoma
19336,Intermediate Grade Neuroendocrine Lesion,Gastric Squamous Cell Carcinoma
19337,Intermediate Grade Neuroendocrine Lesion,Squamous cell carcinoma of colon
19338,Geographic Necrosis,Central Nervous System Dermoid Cyst
19339,Benign Cellular Infiltrate,Prostate Stromal Sarcoma
19340,Benign Cellular Infiltrate,Prostate Angiosarcoma
19341,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
19342,Benign Cellular Infiltrate,Non-Hodgkin's lymphoma of prostate
19343,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of cecum
19344,Malignant Cellular Infiltrate,Benign Childhood Central Nervous System Neoplasm
19345,Well Differentiated Neuroendocrine Lesion,Paget Disease of the Anus
19346,Malignant Cellular Infiltrate,Benign Anal Granular Cell Tumor
19347,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of anal glands
19348,Benign Cellular Infiltrate,Secondary malignant neoplasm of skin
19349,Malignant Cellular Infiltrate,Endobronchial Leiomyoma
19350,Malignant Cellular Infiltrate,Multiple hamartoma of lung
19351,Benign Cellular Infiltrate,leiomyosarcoma of lung
19352,Low Grade Neuroendocrine Lesion,Stage IIA Esophagus Carcinoma
19353,Low Grade Neuroendocrine Lesion,Stage IIB Esophageal Carcinoma
19354,Malignant Cellular Infiltrate,Serous cystadenoma of pancreas
19355,Intermediate Grade Neuroendocrine Lesion,signet ring cell carcinoma of pancreas
19356,Low Grade Neuroendocrine Lesion,carcinoma of pancreas with osteoclast-like giant cells
19357,Intermediate Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v6
19358,Well Differentiated Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v6
19359,Low Grade Neuroendocrine Lesion,Gallbladder papillary adenocarcinoma
19360,Malignant Cellular Infiltrate,Liver Lipoma
19361,Malignant Cellular Infiltrate,Liver Leiomyoma
19362,Low Grade Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7
19363,Intermediate Grade Neuroendocrine Lesion,Bile duct signet-ring cell carcinoma
19364,Malignant Cellular Infiltrate,Benign Childhood Brain Neoplasm
19365,Malignant Cellular Infiltrate,Childhood Choroid Plexus Papilloma
19366,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma stage II
19367,Poorly Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1
19368,Low Grade Neuroendocrine Lesion,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
19369,Well Differentiated Neuroendocrine Lesion,small cell carcinoma of extrahepatic bile duct
19370,Poorly Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor
19371,Benign Cellular Infiltrate,Stage IVB Basal Cell Lip Carcinoma
19372,Benign Cellular Infiltrate,Stage III Oral Cavity Cancer AJCC v6 and v7
19373,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Anal Canal Cancer AJCC v6 and v7
19374,Benign Cellular Infiltrate,Parotid Gland Acinic Cell Carcinoma
19375,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of parotid gland
19376,Benign Cellular Infiltrate,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
19377,Malignant Cellular Infiltrate,Oropharyngeal Polyp
19378,Benign Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7
19379,Benign Cellular Infiltrate,Stage III Paranasal Sinus Cancer AJCC v6 and v7
19380,Benign Cellular Infiltrate,Adenocarcinoma of Accessory Sinus
19381,Well Differentiated Neuroendocrine Lesion,Rectal Small Cell Neuroendocrine Carcinoma
19382,Benign Cellular Infiltrate,Stage IVB Paranasal Sinus Cancer AJCC v7
19383,Benign Cellular Infiltrate,Recurrent Oral Cavity Carcinoma
19384,Benign Cellular Infiltrate,External Ear Carcinoma
19385,Benign Cellular Infiltrate,Choroid Spindle Cell Melanoma
19386,Benign Cellular Infiltrate,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7
19387,Benign Cellular Infiltrate,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
19388,Benign Cellular Infiltrate,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
19389,Benign Cellular Infiltrate,Stage IV Ureter Cancer AJCC v7
19390,Benign Cellular Infiltrate,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
19391,Benign Cellular Infiltrate,undifferentiated carcinoma of ureter
19392,Benign Cellular Infiltrate,adenocarcinoma of urethra
19393,Benign Cellular Infiltrate,clear cell adenocarcinoma of bladder
19394,Malignant Cellular Infiltrate,Renal Pelvis Inverted Papilloma
19395,Benign Cellular Infiltrate,mucinous adenocarcinoma of salivary gland
19396,Benign Cellular Infiltrate,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
19397,Benign Cellular Infiltrate,Maxillary Sinus Adenocarcinoma
19398,Malignant Cellular Infiltrate,Hemangioma of orbit
19399,Benign Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v6 and v7
19400,Benign Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v6 and v7
19401,Benign Cellular Infiltrate,Stage IIC Fallopian Tube Cancer AJCC v6 and v7
19402,Benign Cellular Infiltrate,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7
19403,Benign Cellular Infiltrate,Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7
19404,Benign Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v7
19405,Benign Cellular Infiltrate,Stage IB1 Cervical Cancer
19406,Geographic Necrosis,Mature Testicular Teratoma
19407,Benign Cellular Infiltrate,Stage IB Testicular Cancer AJCC v6 and v7
19408,Malignant Cellular Infiltrate,Vaginal Rhabdomyoma
19409,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm to the Cervix
19410,Malignant Cellular Infiltrate,Scrotal Hemangioma
19411,Benign Cellular Infiltrate,Thymic Carcinoid Tumor
19412,Benign Cellular Infiltrate,Thymic Basaloid Carcinoma
19413,Benign Cellular Infiltrate,Stage IA Bone Sarcoma AJCC v7
19414,Benign Cellular Infiltrate,Synchronous Multifocal Osteosarcoma
19415,Benign Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma
19416,Benign Cellular Infiltrate,Intraosseous well differentiated osteosarcoma
19417,Benign Cellular Infiltrate,Fibromyxosarcoma
19418,Malignant Cellular Infiltrate,Chondroid lipoma
19419,Malignant Cellular Infiltrate,Deep Leiomyoma
19420,Malignant Cellular Infiltrate,Genital rhabdomyoma
19421,Benign Cellular Infiltrate,"Squamous cell carcinoma, large cell, nonkeratinizing"
19422,Benign Cellular Infiltrate,"Squamous cell carcinoma, small cell, nonkeratinizing"
19423,Benign Cellular Infiltrate,"Squamous cell carcinoma, clear cell type"
19424,Benign Cellular Infiltrate,"Transitional cell carcinoma, micropapillary"
19425,Low Grade Neuroendocrine Lesion,"Glucagonoma, malignant"
19426,Benign Cellular Infiltrate,Spindle cell rhabdomyosarcoma
19427,Malignant Cellular Infiltrate,Perineural Hemangioma
19428,Malignant Cellular Infiltrate,Benign Pericytic Neoplasm
19429,Benign Cellular Infiltrate,Congenital Mesoblastic Nephroma
19430,Malignant Cellular Infiltrate,Cutaneous myxoma
19431,Benign Cellular Infiltrate,Metastatic Bone Ewing Sarcoma
19432,Benign Cellular Infiltrate,ganglioneuroblastoma of mediastinum
19433,Benign Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm
19434,Malignant Cellular Infiltrate,Infantile hemangioma
19435,Well Differentiated Neuroendocrine Lesion,Stage II Ampulla of Vater Cancer AJCC v7
19436,Low Grade Neuroendocrine Lesion,Stage III Ampulla of Vater Cancer AJCC v7
19437,Intermediate Grade Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v7
19438,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
19439,Low Grade Neuroendocrine Lesion,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
19440,Benign Cellular Infiltrate,Stage IIIB Lung Large Cell Carcinoma AJCC v7
19441,Benign Cellular Infiltrate,Stage IIIA Lung Large Cell Carcinoma AJCC v7
19442,Benign Cellular Infiltrate,Metastatic signet ring cell carcinoma
19443,Benign Cellular Infiltrate,Adenocarcinoma with neuroendocrine differentiation
19444,Benign Cellular Infiltrate,Stage IB Lung Small Cell Carcinoma AJCC v7
19445,Benign Cellular Infiltrate,Fascial fibrosarcoma
19446,Malignant Cellular Infiltrate,Borderline Ovarian Mucinous Adenofibroma
19447,Benign Cellular Infiltrate,Stage II Lung Small Cell Carcinoma AJCC v7
19448,Malignant Cellular Infiltrate,Hemolymphangioma
19449,Benign Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
19450,Benign Cellular Infiltrate,Stage IVB Osteosarcoma AJCC v7
19451,Malignant Cellular Infiltrate,Serous adenofibroma
19452,Malignant Germinomatous Cellular Infiltrate,Benign Teratoma
19453,Benign Cellular Infiltrate,Chest Wall Solitary Plasmacytoma
19454,Benign Cellular Infiltrate,"Hodgkin lymphoma, nodular sclerosis, cellular phase"
19455,Malignant Cellular Infiltrate,Lipoma of chest wall
19456,Benign Cellular Infiltrate,"Colorectal cancer, hereditary nonpolyposis, type 1"
19457,Malignant Cellular Infiltrate,Epicardial Lipoma
19458,Benign Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma
19459,Benign Cellular Infiltrate,"Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
19460,Benign Cellular Infiltrate,Pineal Region Choriocarcinoma
19461,Benign Cellular Infiltrate,small cell carcinoma of breast
19462,Low Grade Neuroendocrine Lesion,Colon Small Cell Neuroendocrine Carcinoma
19463,Intermediate Grade Neuroendocrine Lesion,Small cell carcinoma of esophagus
19464,Low Grade Neuroendocrine Lesion,Gastric Small Cell Carcinoma
19465,Mitotic Activity,Dermoid Cyst of the Spinal Cord
19466,Benign Cellular Infiltrate,sarcoma of accessory sinus
19467,Benign Cellular Infiltrate,Stage II Indolent Adult Non-Hodgkin Lymphoma
19468,Benign Cellular Infiltrate,Adult Erythroleukemia
19469,Benign Cellular Infiltrate,Adult Giant Cell Glioblastoma
19470,Well Differentiated Neuroendocrine Lesion,Stage IV Anal Canal Cancer AJCC v6 and v7
19471,Benign Cellular Infiltrate,Childhood Myelodysplastic Syndrome
19472,Benign Cellular Infiltrate,Large cell carcinoma with rhabdoid phenotype
19473,Well Differentiated Neuroendocrine Lesion,Mixed Ductal-Endocrine Carcinoma
19474,Low Grade Neuroendocrine Lesion,Mixed Ductal-Endocrine Carcinoma
19475,Benign Cellular Infiltrate,Chondroid chordoma
19476,Benign Cellular Infiltrate,Rhabdoid meningioma
19477,Benign Cellular Infiltrate,Stromal sarcoma
19478,Benign Cellular Infiltrate,Primary malignant neoplasm of oculomotor nerve
19479,Malignant Cellular Infiltrate,Central Nervous System Leiomyoma
19480,Benign Cellular Infiltrate,Central Nervous System Kaposi Sarcoma
19481,Benign Cellular Infiltrate,Intracranial Myeloid Sarcoma
19482,Well Differentiated Neuroendocrine Lesion,Esophageal Basaloid Carcinoma
19483,Malignant Cellular Infiltrate,Colon Ganglioneuroma
19484,Benign Cellular Infiltrate,Secondary malignant neoplasm of prostate
19485,Benign Cellular Infiltrate,regressing melanoma of skin
19486,Benign Cellular Infiltrate,Prostate cancer stage D
19487,Geographic Necrosis,Mature Mediastinal Teratoma
19488,Low Grade Neuroendocrine Lesion,Distal Bile Duct Carcinoma
19489,Well Differentiated Neuroendocrine Lesion,Recurrent Liver Carcinoma
19490,Intermediate Grade Neuroendocrine Lesion,Stage II Liver Cancer
19491,Well Differentiated Neuroendocrine Lesion,Stage III Liver Cancer
19492,Intermediate Grade Neuroendocrine Lesion,Hepatic cancer stage IVA
19493,Benign Cellular Infiltrate,Smoldering myeloma
19494,Benign Cellular Infiltrate,Childhood B Lymphoblastic Lymphoma
19495,Benign Cellular Infiltrate,Childhood T Lymphoblastic Lymphoma
19496,Benign Cellular Infiltrate,Cutaneous Follicular Lymphoma
19497,Benign Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma
19498,Benign Cellular Infiltrate,Monomorphic Post-Transplant Lymphoproliferative Disorder
19499,Benign Cellular Infiltrate,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
19500,Benign Cellular Infiltrate,Combined Lung Large Cell Neuroendocrine Carcinoma
19501,Benign Cellular Infiltrate,Minimally Invasive Mucinous Lung Adenocarcinoma
19502,Geographic Necrosis,Ovarian Solid Teratoma
19503,Benign Cellular Infiltrate,Splenic Manifestation of Leukemia
19504,Benign Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia
19505,Benign Cellular Infiltrate,Splenic T Lymphoblastic Lymphoma
19506,Benign Cellular Infiltrate,Adult Acute Monoblastic and Monocytic Leukemia
19507,Benign Cellular Infiltrate,Scirrhous carcinoma of breast
19508,Benign Cellular Infiltrate,Malignant neoplasm of lung
19509,Benign Cellular Infiltrate,Bladder Papillary Urothelial Carcinoma
19510,Benign Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma
19511,Malignant Cellular Infiltrate,Acanthoma
19512,Low Grade Neuroendocrine Lesion,Rectosigmoid cancer
19513,Benign Cellular Infiltrate,Malignant neoplasm of ovary
19514,Benign Cellular Infiltrate,Anaplastic Brain Stem Glioma
19515,Malignant Cellular Infiltrate,Intramuscular lipoma
19516,Benign Cellular Infiltrate,Acute myelomonocytic leukemia
19517,Benign Cellular Infiltrate,Acute Leukemia of Ambiguous Lineage
19518,Low Grade Neuroendocrine Lesion,Anal canal squamous cell carcinoma
19519,Low Grade Neuroendocrine Lesion,Adenocarcinoma of anal canal
19520,Low Grade Neuroendocrine Lesion,Anal margin basal cell carcinoma
19521,Low Grade Neuroendocrine Lesion,Anal Extramucosal (Perianal) Adenocarcinoma
19522,Benign Cellular Infiltrate,Ameloblastic Carcinoma
19523,Benign Cellular Infiltrate,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
19524,Benign Cellular Infiltrate,Renal Pelvis and Ureter Carcinoma
19525,Benign Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v7
19526,Benign Cellular Infiltrate,Malignant neoplasm of pharynx
19527,Benign Cellular Infiltrate,Malignant neoplasm of kidney
19528,Benign Cellular Infiltrate,Stage II Prostate Carcinoma
19529,Malignant Cellular Infiltrate,"Adenoma, Sweat Gland"
19530,Malignant Cellular Infiltrate,Deep Penetrating Nevus
19531,Benign Cellular Infiltrate,Stage IV Vaginal Cancer AJCC v6 and v7
19532,Benign Cellular Infiltrate,Recurrent Male Reproductive System Carcinoma
19533,Benign Cellular Infiltrate,Recurrent Head and Neck Carcinoma
19534,Benign Cellular Infiltrate,Malignant neoplasm of labium minus
19535,Benign Cellular Infiltrate,Malignant neoplasm of labium majus
19536,Benign Cellular Infiltrate,Anterior Urethral Malignant Neoplasm
19537,Low Grade Neuroendocrine Lesion,Localized Gallbladder Carcinoma
19538,Benign Cellular Infiltrate,Metastatic Neoplasm to the Bladder
19539,Benign Cellular Infiltrate,Carcinoma in a polyp
19540,Benign Cellular Infiltrate,Adenocarcinoma with cartilaginous and osseous metaplasia
19541,Intermediate Grade Neuroendocrine Lesion,Adult Liver Carcinoma
19542,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma
19543,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma
19544,Benign Cellular Infiltrate,Light chain disease
19545,Benign Cellular Infiltrate,Paget Disease of the Scrotum
19546,Benign Cellular Infiltrate,Squamous cell carcinoma of vagina
19547,Benign Cellular Infiltrate,Carcinoma breast stage I
19548,Well Differentiated Neuroendocrine Lesion,Stage II Gastric Carcinoma
19549,Well Differentiated Neuroendocrine Lesion,Stage III Anal Canal Cancer AJCC v6 and v7
19550,Low Grade Neuroendocrine Lesion,Stage III Anal Canal Cancer AJCC v6 and v7
19551,Benign Cellular Infiltrate,Stage IIIB Breast Carcinoma
19552,Benign Cellular Infiltrate,Non-small cell lung cancer recurrent
19553,Well Differentiated Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v6 and v7
19554,Well Differentiated Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v6 and v7
19555,Well Differentiated Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v6
19556,Benign Cellular Infiltrate,Adult Malignant Peripheral Nerve Sheath Tumor
19557,Benign Cellular Infiltrate,Regional Neuroblastoma
19558,Benign Cellular Infiltrate,Stage II Kidney Wilms Tumor
19559,Benign Cellular Infiltrate,Recurrent Retinoblastoma
19560,Intermediate Grade Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1
19561,Benign Cellular Infiltrate,Mesothelioma malignant recurrent
19562,Benign Cellular Infiltrate,Chronic lymphocytic leukemia stage 2
19563,Intermediate Grade Neuroendocrine Lesion,Localized Non-Resectable Adult Liver Carcinoma
19564,Low Grade Neuroendocrine Lesion,Unresectable Gallbladder Carcinoma
19565,Low Grade Neuroendocrine Lesion,Unresectable Extrahepatic Bile Duct Carcinoma
19566,Low Grade Neuroendocrine Lesion,Small intestine carcinoma recurrent
19567,Benign Cellular Infiltrate,Prostate cancer recurrent
19568,Benign Cellular Infiltrate,Thymoma malignant invasive
19569,Benign Cellular Infiltrate,Adult Extraskeletal Myxoid Chondrosarcoma
19570,Benign Cellular Infiltrate,Adult Epithelioid Sarcoma
19571,Benign Cellular Infiltrate,High Grade Ductal Breast Carcinoma In Situ
19572,Low Grade Neuroendocrine Lesion,Adult Hepatocellular Carcinoma
19573,Benign Cellular Infiltrate,Adult Acute Megakaryoblastic Leukemia
19574,Benign Cellular Infiltrate,Childhood Acute Basophilic Leukemia
19575,Low Grade Neuroendocrine Lesion,adenocarcinoma of extrahepatic bile duct
19576,Benign Cellular Infiltrate,"Epithelioid mesothelioma, malignant"
19577,Malignant Cellular Infiltrate,Parathyroid transitional clear cell adenoma
19578,Hemosiderin pigmentation,Parathyroid mixed cell type adenoma
19579,Malignant Cellular Infiltrate,Benign Carotid Body Paraganglioma
19580,Benign Cellular Infiltrate,"Thymoma, type B1, malignant"
19581,Benign Cellular Infiltrate,Low Grade Salivary Gland Carcinoma
19582,Benign Cellular Infiltrate,Lip basal cell carcinoma
19583,Benign Cellular Infiltrate,Low Grade Salivary Gland Mucoepidermoid Carcinoma
19584,Benign Cellular Infiltrate,Undifferentiated carcinoma of nasopharynx
19585,Benign Cellular Infiltrate,Refractory Hairy Cell Leukemia
19586,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
19587,Benign Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
19588,Benign Cellular Infiltrate,Treatment related leukaemia
19589,Benign Cellular Infiltrate,Childhood Epithelioid Sarcoma
19590,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma stage II
19591,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 2 Follicular Lymphoma
19592,Benign Cellular Infiltrate,Stage II Adult Immunoblastic Lymphoma
19593,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent
19594,Benign Cellular Infiltrate,Recurrent Grade 1 Follicular Lymphoma
19595,Benign Cellular Infiltrate,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
19596,Benign Cellular Infiltrate,Glottis Verrucous Carcinoma
19597,Malignant Cellular Infiltrate,Inverting papilloma of the paranasal sinus
19598,Benign Cellular Infiltrate,Stage I Lip Basal Cell Carcinoma
19599,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage II
19600,Benign Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage I
19601,Benign Cellular Infiltrate,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
19602,Benign Cellular Infiltrate,Nasopharyngeal lymphoepithelioma recurrent
19603,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage II
19604,Benign Cellular Infiltrate,Laryngeal verrucous carcinoma recurrent
19605,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent
19606,Intermediate Grade Neuroendocrine Lesion,Cloacogenic carcinoma
19607,Benign Cellular Infiltrate,Refractory Cytopenia of Childhood
19608,Benign Cellular Infiltrate,Immunoblastic lymphoma associated with AIDS
19609,Benign Cellular Infiltrate,AIDS-Related Lymphoblastic Lymphoma
19610,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation
19611,Benign Cellular Infiltrate,Lymphoma stage I
19612,Benign Cellular Infiltrate,Lymphoma stage IV
19613,Benign Cellular Infiltrate,Carcinoma of submandibular gland
19614,Intermediate Grade Neuroendocrine Lesion,Gastric Body Carcinoma
19615,Intermediate Grade Neuroendocrine Lesion,Stage IV Rectal Carcinoma
19616,Benign Cellular Infiltrate,"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"
19617,Benign Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
19618,Benign Cellular Infiltrate,Primary malignant neoplasm
19619,Benign Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma
19620,Benign Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma
19621,Benign Cellular Infiltrate,Aggressive Adult Non-Hodgkin Lymphoma
19622,Benign Cellular Infiltrate,Hereditary Melanoma
19623,Intermediate Grade Neuroendocrine Lesion,Stage III Colorectal Cancer
19624,Benign Cellular Infiltrate,Malignant Blood Vessel Neoplasm
19625,Malignant Cellular Infiltrate,Hemangioma of subcutaneous tissue
19626,Benign Cellular Infiltrate,Secondary malignant neoplasm of brain stem
19627,Benign Cellular Infiltrate,Secondary malignant neoplasm of orbit
19628,Benign Cellular Infiltrate,malignant tumor of male genital organ
19629,Benign Cellular Infiltrate,Stage IIA Soft Tissue Sarcoma AJCC v7
19630,Benign Cellular Infiltrate,Stage IIIB Merkel Cell Carcinoma AJCC v7
19631,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent
19632,Well Differentiated Neuroendocrine Lesion,Colorectal cancer recurrent
19633,Intermediate Grade Neuroendocrine Lesion,Colorectal cancer recurrent
19634,Intermediate Grade Neuroendocrine Lesion,Stage II Esophageal Adenocarcinoma AJCC v7
19635,Well Differentiated Neuroendocrine Lesion,Stage III Esophageal Adenocarcinoma AJCC v7
19636,Low Grade Neuroendocrine Lesion,Stage III Esophageal Adenocarcinoma AJCC v7
19637,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophageal Adenocarcinoma AJCC v7
19638,Low Grade Neuroendocrine Lesion,Esophageal squamous cell carcinoma recurrent
19639,Well Differentiated Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v6
19640,Benign Cellular Infiltrate,Angiocentric lymphoma refractory
19641,Benign Cellular Infiltrate,Mycosis fungoides recurrent
19642,Benign Cellular Infiltrate,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma
19643,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage III
19644,Benign Cellular Infiltrate,Peritoneal mesothelioma malignant recurrent
19645,Benign Cellular Infiltrate,Pleural mesothelioma malignant advanced
19646,Benign Cellular Infiltrate,Pineal germinoma
19647,Benign Cellular Infiltrate,Stage IVB Uterine Sarcoma AJCC v7
19648,Benign Cellular Infiltrate,Stage IB Bone Cancer AJCC v7
19649,Benign Cellular Infiltrate,Stage IIA Bone Cancer AJCC v7
19650,Benign Cellular Infiltrate,Stage IVA Bone Cancer AJCC v7
19651,Benign Cellular Infiltrate,Endometrial Squamous Cell Carcinoma
19652,Benign Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7
19653,Benign Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7
19654,Benign Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7
19655,Benign Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage III
19656,Benign Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7
19657,Benign Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7
19658,Benign Cellular Infiltrate,Stage IV Ovarian Polyembryoma AJCC v6 and v7
19659,Benign Cellular Infiltrate,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
19660,Benign Cellular Infiltrate,Adenosquamous cell lung cancer stage III
19661,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
19662,Benign Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
19663,Benign Cellular Infiltrate,Lung adenocarcinoma recurrent
19664,Benign Cellular Infiltrate,"Adenocarcinoma of lung, stage I"
19665,Benign Cellular Infiltrate,Lung squamous cell carcinoma stage II
19666,Intermediate Grade Neuroendocrine Lesion,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
19667,Well Differentiated Neuroendocrine Lesion,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
19668,Well Differentiated Neuroendocrine Lesion,Stage IA Esophageal Adenocarcinoma AJCC v7
19669,Well Differentiated Neuroendocrine Lesion,Stage IIIB Esophageal Adenocarcinoma AJCC v7
19670,Well Differentiated Neuroendocrine Lesion,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
19671,Well Differentiated Neuroendocrine Lesion,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
19672,Well Differentiated Neuroendocrine Lesion,Stage IIIA Small Intestinal Cancer AJCC v7
19673,Well Differentiated Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v7
19674,Intermediate Grade Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v7
19675,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v7
19676,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v7
19677,Intermediate Grade Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v7
19678,Intermediate Grade Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v7
19679,Low Grade Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v7
19680,Well Differentiated Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v7
19681,Intermediate Grade Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v7
19682,Benign Cellular Infiltrate,Alveolar soft part sarcoma non-metastatic
19683,Benign Cellular Infiltrate,Epithelioid sarcoma non-metastatic
19684,Poorly Differentiated Neuroendocrine Lesion,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
19685,Low Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
19686,Low Grade Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
19687,Well Differentiated Neuroendocrine Lesion,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
19688,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v7
19689,Well Differentiated Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v7
19690,Well Differentiated Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
19691,Well Differentiated Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v7
19692,Low Grade Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v7
19693,Intermediate Grade Neuroendocrine Lesion,Stage 0 Distal Bile Duct Cancer AJCC v7
19694,Low Grade Neuroendocrine Lesion,Stage IIB Distal Bile Duct Cancer AJCC v7
19695,Well Differentiated Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v7
19696,Low Grade Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v7
19697,Low Grade Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v7
19698,Intermediate Grade Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v6 and v7
19699,Intermediate Grade Neuroendocrine Lesion,Stage IIB Pancreatic Cancer AJCC v6 and v7
19700,Benign Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v7
19701,Benign Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v7
19702,Benign Cellular Infiltrate,Extraskeletal osteosarcoma recurrent
19703,Benign Cellular Infiltrate,Stage IIIC Eyelid Carcinoma AJCC v7
19704,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage I
19705,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage II
19706,Benign Cellular Infiltrate,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7
19707,Benign Cellular Infiltrate,Liposarcoma metastatic
19708,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity recurrent
19709,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity refractory
19710,Benign Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v7
19711,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma refractory
19712,Benign Cellular Infiltrate,Stage III Burkitt Lymphoma
19713,Benign Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v7
19714,Benign Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v7
19715,Benign Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7
19716,Benign Cellular Infiltrate,Bladder squamous cell carcinoma stage III
19717,Benign Cellular Infiltrate,Bladder squamous cell carcinoma stage IV
19718,Benign Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v7
19719,Benign Cellular Infiltrate,Stage II Carcinoma of Penis
19720,Benign Cellular Infiltrate,Testicular yolk sac tumor stage III
19721,Benign Cellular Infiltrate,Centroblastic lymphoma stage IV
19722,Low Grade Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v6 and v7
19723,Benign Cellular Infiltrate,Stage IV Bladder Cancer AJCC v7
19724,Benign Cellular Infiltrate,Bladder transitional cell carcinoma stage III
19725,Benign Cellular Infiltrate,Adenocarcinoma of the prostate metastatic
19726,Malignant Cellular Infiltrate,Lymphangioma
19727,Malignant Cellular Infiltrate,Mucinous adenofibroma
19728,Malignant Cellular Infiltrate,Mucinous cystadenofibroma
19729,Well Differentiated Neuroendocrine Lesion,Stage I Esophageal Cancer AJCC v7
19730,Intermediate Grade Neuroendocrine Lesion,Stage III Esophageal Cancer AJCC v7
19731,Well Differentiated Neuroendocrine Lesion,Malignant neoplasm of stomach stage I
19732,Well Differentiated Neuroendocrine Lesion,Malignant neoplasm of stomach stage IV
19733,Malignant Cellular Infiltrate,Clear cell cystadenofibroma
19734,Well Differentiated Neuroendocrine Lesion,Stage II Colon Cancer AJCC v7
19735,Intermediate Grade Neuroendocrine Lesion,Stage III Colorectal Cancer AJCC v7
19736,Low Grade Neuroendocrine Lesion,Stage III Colon Cancer AJCC v7
19737,Malignant Cellular Infiltrate,Benign neoplasm of adrenal cortex
19738,Malignant Cellular Infiltrate,Seborrheic keratosis
19739,Mitotic Activity,Dermoid Cyst
19740,Low Grade Neuroendocrine Lesion,Stage IV Hepatocellular Carcinoma AJCC v7
19741,Well Differentiated Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v7
19742,Intermediate Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v7
19743,Well Differentiated Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v7
19744,Benign Cellular Infiltrate,Vulvar Cancer by AJCC v6 Stage
19745,Intermediate Grade Neuroendocrine Lesion,Recurrent Childhood Hepatocellular Carcinoma
19746,Benign Cellular Infiltrate,Cervical Cancer by AJCC v6 Stage
19747,Benign Cellular Infiltrate,Fallopian Tube Cancer by AJCC v6 Stage
19748,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v6 Stage
19749,Intermediate Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v6 Stage
19750,Intermediate Grade Neuroendocrine Lesion,Rectal Cancer by AJCC v6 Stage
19751,Benign Cellular Infiltrate,Stage III Vulvar Cancer AJCC v6
19752,Benign Cellular Infiltrate,Laryngeal Cancer by AJCC v6 Stage
19753,Benign Cellular Infiltrate,Stage IV Childhood Lymphoblastic Lymphoma
19754,Benign Cellular Infiltrate,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
19755,Benign Cellular Infiltrate,Childhood Immunoblastic Lymphoma
19756,Benign Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
19757,Benign Cellular Infiltrate,Melanoma recurrent
19758,Benign Cellular Infiltrate,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
19759,Benign Cellular Infiltrate,Kaposi Sarcoma Related to Immunosuppressive Treatment
19760,Benign Cellular Infiltrate,Cervical Cancer by AJCC v7 Stage
19761,Low Grade Neuroendocrine Lesion,Esophageal Cancer by AJCC v7 Stage
19762,Well Differentiated Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v7 Stage
19763,Benign Cellular Infiltrate,Breast Cancer by AJCC v7 Stage
19764,Benign Cellular Infiltrate,Mucinous carcinoma of breast
19765,Benign Cellular Infiltrate,Papillary carcinoma of the breast
19766,Benign Cellular Infiltrate,Tubular breast carcinoma
19767,Benign Cellular Infiltrate,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
19768,Benign Cellular Infiltrate,Blastema Predominant Kidney Wilms Tumor
19769,Intermediate Grade Neuroendocrine Lesion,Anal squamous cell carcinoma
19770,Low Grade Neuroendocrine Lesion,Anal squamous cell carcinoma
19771,Benign Cellular Infiltrate,Childhood Acute Monoblastic Leukemia
19772,Well Differentiated Neuroendocrine Lesion,Gallbladder squamous cell carcinoma
19773,Intermediate Grade Neuroendocrine Lesion,Gallbladder squamous cell carcinoma
19774,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
19775,Benign Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma
19776,Benign Cellular Infiltrate,Stage I Cervical Cancer AJCC v6 and v7
19777,Benign Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v6
19778,Benign Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v7
19779,Malignant Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma
19780,Benign Cellular Infiltrate,Merkel cell carcinoma
19781,Benign Cellular Infiltrate,Aggressive Non-Hodgkin Lymphoma
19782,Benign Cellular Infiltrate,Inflammatory carcinoma of breast stage III
19783,Benign Cellular Infiltrate,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
19784,Benign Cellular Infiltrate,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
19785,Benign Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Medulla
19786,Well Differentiated Neuroendocrine Lesion,AIDS-Related Anal Carcinoma
19787,Benign Cellular Infiltrate,"Hodgkin lymphoma, lymphocyte depletion"
19788,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of the gastroesophageal junction
19789,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of the gastroesophageal junction
19790,Benign Cellular Infiltrate,Seminoma
19791,Benign Cellular Infiltrate,Bone Sarcoma
19792,Benign Cellular Infiltrate,Malignant neoplasm of mouth
19793,Benign Cellular Infiltrate,Malignant neoplasm of cheek mucosa
19794,Intermediate Grade Neuroendocrine Lesion,Carcinoma of the Appendix
19795,Benign Cellular Infiltrate,pineoblastoma
19796,Benign Cellular Infiltrate,Plasmacytoma
19797,Benign Cellular Infiltrate,Clitoral Carcinoma
19798,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia without Maturation
19799,Intermediate Grade Neuroendocrine Lesion,Rectal Carcinoma
19800,Benign Cellular Infiltrate,Renal Cell Carcinoma
19801,Benign Cellular Infiltrate,Leiomyosarcoma NCI Grade 2
19802,Benign Cellular Infiltrate,Poorly Differentiated Fibrosarcoma
19803,Benign Cellular Infiltrate,Kaposi Sarcoma NCI Grade 2
19804,Benign Cellular Infiltrate,Sarcoma by AJCC Grade
19805,Benign Cellular Infiltrate,AJCC Grade 2 Sarcoma
19806,Benign Cellular Infiltrate,Conventional Fibrosarcoma
19807,Intermediate Grade Neuroendocrine Lesion,Grade 1 Colorectal Adenocarcinoma
19808,Well Differentiated Neuroendocrine Lesion,Grade 3 Colorectal Adenocarcinoma
19809,Low Grade Neuroendocrine Lesion,Grade 2 Rectal Adenocarcinoma
19810,Well Differentiated Neuroendocrine Lesion,Grade 1 Colon Adenocarcinoma
19811,Intermediate Grade Neuroendocrine Lesion,Grade 2 Colon Adenocarcinoma
19812,Low Grade Neuroendocrine Lesion,Grade 3 Colon Adenocarcinoma
19813,Benign Cellular Infiltrate,Grade 1 Diffuse Follicular Lymphoma
19814,Benign Cellular Infiltrate,Pharyngeal Carcinoma
19815,Benign Cellular Infiltrate,Meningeal Leukemia
19816,Benign Cellular Infiltrate,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8"
19817,Low Grade Neuroendocrine Lesion,Stage III Adult Liver Cancer AJCC v7
19818,Benign Cellular Infiltrate,Stage III Childhood Non-Hodgkin Lymphoma
19819,Benign Cellular Infiltrate,Stage IV Childhood Non-Hodgkin Lymphoma
19820,Intermediate Grade Neuroendocrine Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma
19821,Intermediate Grade Neuroendocrine Lesion,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
19822,Malignant Cellular Infiltrate,Pancreatic Serous Adenoma
19823,Malignant Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma
19824,Low Grade Neuroendocrine Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
19825,Well Differentiated Neuroendocrine Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
19826,Low Grade Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
19827,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor
19828,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2
19829,Intermediate Grade Neuroendocrine Lesion,Poorly Cohesive Gastric Carcinoma
19830,Intermediate Grade Neuroendocrine Lesion,Gastric Hepatoid Adenocarcinoma
19831,Well Differentiated Neuroendocrine Lesion,Gastric Intramucosal Adenocarcinoma
19832,Low Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2
19833,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma
19834,Malignant Cellular Infiltrate,Benign Gastric Gastrointestinal Stromal Tumor
19835,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
19836,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1
19837,Low Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2
19838,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Carcinoma
19839,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
19840,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
19841,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2
19842,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Carcinoma
19843,Intermediate Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1
19844,Low Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2
19845,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2
19846,Well Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of appendix
19847,Intermediate Grade Neuroendocrine Lesion,Colon Serrated Adenocarcinoma
19848,Intermediate Grade Neuroendocrine Lesion,Colorectal Cribriform Comedo-Type Adenocarcinoma
19849,Low Grade Neuroendocrine Lesion,Anal Canal Mixed Adenoneuroendocrine Carcinoma
19850,Intermediate Grade Neuroendocrine Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma
19851,Low Grade Neuroendocrine Lesion,Peripheral Intrahepatic Cholangiocarcinoma
19852,Well Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Carcinoma
19853,Intermediate Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Carcinoma
19854,Low Grade Neuroendocrine Lesion,Gallbladder Mixed Adenoneuroendocrine Carcinoma
19855,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor G2
19856,Intermediate Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct
19857,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
19858,Well Differentiated Neuroendocrine Lesion,Gastrointestinal carcinoma
19859,Benign Cellular Infiltrate,Mixed Congenital Mesoblastic Nephroma
19860,Benign Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
19861,Benign Cellular Infiltrate,Stage 2A Neuroblastoma
19862,Benign Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor
19863,Benign Cellular Infiltrate,Neural Glioblastoma
19864,Benign Cellular Infiltrate,Endometrial Adenosquamous Carcinoma
19865,Benign Cellular Infiltrate,Childhood Brain Stem Gliosarcoma
19866,Benign Cellular Infiltrate,Non-Hodgkin's lymphoma of central nervous system
19867,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues
19868,Benign Cellular Infiltrate,Secondary Central Nervous System Non-Hodgkin Lymphoma
19869,Benign Cellular Infiltrate,Childhood Gliosarcoma
19870,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
19871,Intermediate Grade Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v7
19872,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v7
19873,Well Differentiated Neuroendocrine Lesion,Stage IIIC Rectal Cancer AJCC v7
19874,Low Grade Neuroendocrine Lesion,Stage IVA Rectal Cancer AJCC v7
19875,Benign Cellular Infiltrate,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
19876,Benign Cellular Infiltrate,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
19877,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Esophageal Cancer AJCC v7
19878,Low Grade Neuroendocrine Lesion,BCLC Stage B Hepatocellular Carcinoma
19879,Low Grade Neuroendocrine Lesion,BCLC Stage C Hepatocellular Carcinoma
19880,Low Grade Neuroendocrine Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma
19881,Benign Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma
19882,Benign Cellular Infiltrate,Recurrent Childhood Gliomatosis Cerebri
19883,Benign Cellular Infiltrate,Recurrent Childhood Pineoblastoma
19884,Benign Cellular Infiltrate,Recurrent Fallopian Tube Carcinoma
19885,Benign Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
19886,Well Differentiated Neuroendocrine Lesion,Childhood Colorectal Carcinoma
19887,Benign Cellular Infiltrate,Childhood Laryngeal Carcinoma
19888,Intermediate Grade Neuroendocrine Lesion,Childhood Esophageal Carcinoma
19889,Intermediate Grade Neuroendocrine Lesion,Childhood Gastric Carcinoma
19890,Benign Cellular Infiltrate,Childhood Parathyroid Gland Carcinoma
19891,Benign Cellular Infiltrate,Adult Penile Carcinoma
19892,Intermediate Grade Neuroendocrine Lesion,Childhood Rectal Carcinoma
19893,Malignant Cellular Infiltrate,"Mixed Tumor, Not Otherwise Specified"
19894,Benign Cellular Infiltrate,"Phosphaturic mesenchymal tumor, malignant"
19895,Benign Cellular Infiltrate,"Undifferentiated Sarcoma, Not Otherwise Specified"
19896,Benign Cellular Infiltrate,Secondary Central Chondrosarcoma
19897,Malignant Cellular Infiltrate,Benign Notochordal Cell Tumor
19898,Malignant Cellular Infiltrate,Ivory Exostosis
19899,Benign Cellular Infiltrate,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
19900,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement
19901,Benign Cellular Infiltrate,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
19902,Benign Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q
19903,Benign Cellular Infiltrate,Childhood Thyroid Gland Papillary Carcinoma
19904,Well Differentiated Neuroendocrine Lesion,Childhood Small Intestinal Carcinoma
19905,Benign Cellular Infiltrate,Childhood Anaplastic Ependymoma
19906,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
19907,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
19908,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
19909,Benign Cellular Infiltrate,Low Grade Broad Ligament Serous Adenocarcinoma
19910,Malignant Cellular Infiltrate,Benign Uterine Ligament Neoplasm
19911,Benign Cellular Infiltrate,Malignant Uterine Ligament Neoplasm
19912,Benign Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma
19913,Benign Cellular Infiltrate,Malignant Uterine Corpus PEComa
19914,Benign Cellular Infiltrate,WHO Grade III Glioma
19915,Benign Cellular Infiltrate,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
19916,Malignant Cellular Infiltrate,Benign Cervical Soft Tissue Neoplasm
19917,Benign Cellular Infiltrate,FIGO Stage III Ovarian Cancer
19918,Benign Cellular Infiltrate,FIGO Stage IIIA1(i) Ovarian Cancer
19919,Mitotic Activity,Vaginal Dermoid Cyst
19920,Malignant Cellular Infiltrate,Vaginal Dermoid Cyst
19921,Geographic Necrosis,Vaginal Dermoid Cyst
19922,Benign Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type
19923,Benign Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type"
19924,Malignant Cellular Infiltrate,Vulvar Superficial Myofibroblastoma
19925,Benign Cellular Infiltrate,"Peripheral T-Cell Lymphoma, Unclassifiable"
19926,Benign Cellular Infiltrate,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
19927,Benign Cellular Infiltrate,Cutaneous Malignant Melanoma 2
19928,Low Grade Neuroendocrine Lesion,Intrahepatic cholangiocarcinoma recurrent
19929,Benign Cellular Infiltrate,Anaplastic Oligoastrocytoma
19930,Benign Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
19931,Benign Cellular Infiltrate,Central Nervous System Epithelioid Hemangioendothelioma
19932,Benign Cellular Infiltrate,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
19933,Benign Cellular Infiltrate,Central Nervous System Undifferentiated Pleomorphic Sarcoma
19934,Benign Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
19935,Benign Cellular Infiltrate,B-lymphoblastic leukemia lymphoma BCR-ABL1-like
19936,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with iAMP21
19937,Benign Cellular Infiltrate,Stage IA Mycosis Fungoides AJCC v7
19938,Benign Cellular Infiltrate,Resectable Head and Neck Squamous Cell Carcinoma
19939,Benign Cellular Infiltrate,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
19940,Benign Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v8
19941,Benign Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v7 Stage
19942,Benign Cellular Infiltrate,Stage 0 Major Salivary Gland Cancer AJCC v8
19943,Benign Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v8
19944,Benign Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v8 Stage
19945,Benign Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v8
19946,Benign Cellular Infiltrate,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
19947,Benign Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v8
19948,Benign Cellular Infiltrate,Locally Advanced Malignant Solid Neoplasm
19949,Benign Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v8
19950,Intermediate Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
19951,Low Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
19952,Intermediate Grade Neuroendocrine Lesion,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
19953,Well Differentiated Neuroendocrine Lesion,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
19954,Low Grade Neuroendocrine Lesion,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
19955,Well Differentiated Neuroendocrine Lesion,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
19956,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
19957,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
19958,Well Differentiated Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v7 Stage
19959,Well Differentiated Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
19960,Low Grade Neuroendocrine Lesion,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
19961,Low Grade Neuroendocrine Lesion,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
19962,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
19963,Low Grade Neuroendocrine Lesion,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
19964,Well Differentiated Neuroendocrine Lesion,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
19965,Intermediate Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
19966,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
19967,Low Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
19968,Intermediate Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
19969,Low Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
19970,Well Differentiated Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
19971,Intermediate Grade Neuroendocrine Lesion,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
19972,Intermediate Grade Neuroendocrine Lesion,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
19973,Low Grade Neuroendocrine Lesion,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
19974,Well Differentiated Neuroendocrine Lesion,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
19975,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
19976,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
19977,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
19978,Low Grade Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
19979,Low Grade Neuroendocrine Lesion,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
19980,Low Grade Neuroendocrine Lesion,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
19981,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
19982,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
19983,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
19984,Well Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
19985,Low Grade Neuroendocrine Lesion,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
19986,Low Grade Neuroendocrine Lesion,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
19987,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
19988,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
19989,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
19990,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
19991,Low Grade Neuroendocrine Lesion,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
19992,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
19993,Low Grade Neuroendocrine Lesion,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
19994,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
19995,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
19996,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
19997,Intermediate Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
19998,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
19999,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
20000,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Stage
20001,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Clinical Stage
20002,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Pathologic Stage
20003,Well Differentiated Neuroendocrine Lesion,Clinical Stage II Gastric Cancer AJCC v8
20004,Intermediate Grade Neuroendocrine Lesion,Clinical Stage II Gastric Cancer AJCC v8
20005,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVA Gastric Cancer AJCC v8
20006,Low Grade Neuroendocrine Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8
20007,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage I Gastric Cancer AJCC v8
20008,Low Grade Neuroendocrine Lesion,Pathologic Stage IB Gastric Cancer AJCC v8
20009,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage III Gastric Cancer AJCC v8
20010,Low Grade Neuroendocrine Lesion,Small Intestinal Cancer by AJCC v7 Stage
20011,Malignant Cellular Infiltrate,Pterygium Of Conjunctiva And Cornea
20012,Well Differentiated Neuroendocrine Lesion,Anal Canal Cancer by AJCC v6 and v7 Stage
20013,Well Differentiated Neuroendocrine Lesion,Anal Cancer by AJCC v8 Stage
20014,Intermediate Grade Neuroendocrine Lesion,Stage 0 Anal Cancer AJCC v8
20015,Low Grade Neuroendocrine Lesion,Stage 0 Anal Cancer AJCC v8
20016,Well Differentiated Neuroendocrine Lesion,Stage IIA Anal Cancer AJCC v8
20017,Intermediate Grade Neuroendocrine Lesion,Stage IIB Anal Cancer AJCC v8
20018,Low Grade Neuroendocrine Lesion,Stage IIB Anal Cancer AJCC v8
20019,Well Differentiated Neuroendocrine Lesion,Stage III Anal Cancer AJCC v8
20020,Low Grade Neuroendocrine Lesion,Stage IIIB Anal Cancer AJCC v8
20021,Well Differentiated Neuroendocrine Lesion,Stage IIIC Anal Cancer AJCC v8
20022,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Anal Cancer AJCC v8
20023,Low Grade Neuroendocrine Lesion,Metastatic Digestive System Carcinoma
20024,Intermediate Grade Neuroendocrine Lesion,Stage I Small Intestinal Adenocarcinoma AJCC v8
20025,Well Differentiated Neuroendocrine Lesion,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
20026,Intermediate Grade Neuroendocrine Lesion,Stage III Small Intestinal Adenocarcinoma AJCC v8
20027,Low Grade Neuroendocrine Lesion,Stage IV Small Intestinal Adenocarcinoma AJCC v8
20028,Low Grade Neuroendocrine Lesion,Appendix Carcinoma by AJCC v8 Stage
20029,Intermediate Grade Neuroendocrine Lesion,Stage 0 Appendix Carcinoma AJCC v8
20030,Intermediate Grade Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v8
20031,Low Grade Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v8
20032,Intermediate Grade Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v8
20033,Low Grade Neuroendocrine Lesion,Stage IIC Appendix Carcinoma AJCC v8
20034,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Carcinoma AJCC v8
20035,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v8
20036,Intermediate Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v8 Stage
20037,Well Differentiated Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v8
20038,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v8
20039,Low Grade Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v8
20040,Low Grade Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v8
20041,Intermediate Grade Neuroendocrine Lesion,Stage IVC Colorectal Cancer AJCC v8
20042,Well Differentiated Neuroendocrine Lesion,Rectal Cancer by AJCC v8 Stage
20043,Low Grade Neuroendocrine Lesion,Stage 0 Colon Cancer AJCC v8
20044,Well Differentiated Neuroendocrine Lesion,Stage I Colon Cancer AJCC v8
20045,Intermediate Grade Neuroendocrine Lesion,Stage II Colon Cancer AJCC v8
20046,Intermediate Grade Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v8
20047,Low Grade Neuroendocrine Lesion,Stage IIC Colon Cancer AJCC v8
20048,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v8
20049,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Colon Cancer AJCC v8
20050,Low Grade Neuroendocrine Lesion,Stage IV Colon Cancer AJCC v8
20051,Well Differentiated Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v8
20052,Intermediate Grade Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v8
20053,Intermediate Grade Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v8
20054,Low Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
20055,Intermediate Grade Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v8
20056,Intermediate Grade Neuroendocrine Lesion,Stage II Hepatocellular Carcinoma AJCC v8
20057,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v8
20058,Low Grade Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v8
20059,Low Grade Neuroendocrine Lesion,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
20060,Intermediate Grade Neuroendocrine Lesion,Stage I Intrahepatic Bile Duct Cancer AJCC v8
20061,Well Differentiated Neuroendocrine Lesion,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
20062,Well Differentiated Neuroendocrine Lesion,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
20063,Well Differentiated Neuroendocrine Lesion,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
20064,Low Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v8 Stage
20065,Well Differentiated Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v8
20066,Intermediate Grade Neuroendocrine Lesion,Stage IIA Gallbladder Cancer AJCC v8
20067,Low Grade Neuroendocrine Lesion,Stage IIB Gallbladder Cancer AJCC v8
20068,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v8
20069,Low Grade Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v8
20070,Well Differentiated Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v8
20071,Well Differentiated Neuroendocrine Lesion,Stage IVA Gallbladder Cancer AJCC v8
20072,Low Grade Neuroendocrine Lesion,Stage IVB Gallbladder Cancer AJCC v8
20073,Well Differentiated Neuroendocrine Lesion,Stage I Hilar Cholangiocarcinoma AJCC v8
20074,Well Differentiated Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
20075,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
20076,Low Grade Neuroendocrine Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8
20077,Low Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
20078,Low Grade Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
20079,Well Differentiated Neuroendocrine Lesion,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
20080,Well Differentiated Neuroendocrine Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
20081,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
20082,Low Grade Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v7 Stage
20083,Low Grade Neuroendocrine Lesion,Distal Bile Duct Cancer by AJCC v8 Stage
20084,Intermediate Grade Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v8
20085,Well Differentiated Neuroendocrine Lesion,Stage IIIA Distal Bile Duct Cancer AJCC v8
20086,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Distal Bile Duct Cancer AJCC v8
20087,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Cancer by AJCC v7 Stage
20088,Well Differentiated Neuroendocrine Lesion,Stage 0 Ampulla of Vater Cancer AJCC v8
20089,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v8
20090,Low Grade Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v8
20091,Well Differentiated Neuroendocrine Lesion,Stage IIIA Ampulla of Vater Cancer AJCC v8
20092,Well Differentiated Neuroendocrine Lesion,Pancreatic Cancer by AJCC v6 and v7 Stage
20093,Intermediate Grade Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v8
20094,Low Grade Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v8
20095,Well Differentiated Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v8
20096,Intermediate Grade Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v8
20097,Intermediate Grade Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v8
20098,Low Grade Neuroendocrine Lesion,Stage III Pancreatic Cancer AJCC v8
20099,Poorly Differentiated Neuroendocrine Lesion,Stage II Ileal Neuroendocrine Tumor AJCC v8
20100,Poorly Differentiated Neuroendocrine Lesion,Stage IV Ileal Neuroendocrine Tumor AJCC v8
20101,Poorly Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
20102,Poorly Differentiated Neuroendocrine Lesion,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
20103,Poorly Differentiated Neuroendocrine Lesion,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
20104,Poorly Differentiated Neuroendocrine Lesion,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
20105,Poorly Differentiated Neuroendocrine Lesion,Stage IV Rectal Neuroendocrine Tumor AJCC v8
20106,Benign Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8
20107,Benign Cellular Infiltrate,Occult Lung Cancer AJCC v8
20108,Benign Cellular Infiltrate,Stage I Bone Cancer AJCC v8
20109,Benign Cellular Infiltrate,Stage IVA Bone Cancer AJCC v8
20110,Benign Cellular Infiltrate,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage
20111,Benign Cellular Infiltrate,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
20112,Benign Cellular Infiltrate,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
20113,Benign Cellular Infiltrate,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
20114,Benign Cellular Infiltrate,Clinical Stage III Merkel Cell Carcinoma AJCC v8
20115,Low Grade Neuroendocrine Lesion,Refractory Anal Carcinoma
20116,Benign Cellular Infiltrate,Recurrent Central Nervous System Lymphoma
20117,Benign Cellular Infiltrate,Refractory Central Nervous System Lymphoma
20118,Benign Cellular Infiltrate,Refractory Breast Lymphoma
20119,Benign Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion
20120,Benign Cellular Infiltrate,Double expressor lymphoma
20121,Benign Cellular Infiltrate,High Risk Myelodysplastic Syndrome
20122,Benign Cellular Infiltrate,Advanced Head and Neck Squamous Cell Carcinoma
20123,Benign Cellular Infiltrate,Anatomic Stage II Breast Cancer AJCC v8
20124,Benign Cellular Infiltrate,Stage IIB Vaginal Cancer AJCC v8
20125,Benign Cellular Infiltrate,Stage III Cervical Cancer AJCC v8
20126,Benign Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8
20127,Benign Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8
20128,Benign Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v8
20129,Benign Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v8
20130,Benign Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v8
20131,Benign Cellular Infiltrate,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
20132,Benign Cellular Infiltrate,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
20133,Benign Cellular Infiltrate,Stage I Uterine Corpus Adenosarcoma AJCC v8
20134,Benign Cellular Infiltrate,Stage III Uterine Corpus Adenosarcoma AJCC v8
20135,Benign Cellular Infiltrate,Ovarian Cancer by AJCC v8 Stage
20136,Benign Cellular Infiltrate,Stage II Ovarian Cancer AJCC v8
20137,Benign Cellular Infiltrate,Stage I Fallopian Tube Cancer AJCC v8
20138,Benign Cellular Infiltrate,Stage II Fallopian Tube Cancer AJCC v8
20139,Benign Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v8
20140,Benign Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v8 Stage
20141,Benign Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8
20142,Benign Cellular Infiltrate,Stage IIIB Penile Cancer AJCC v8
20143,Benign Cellular Infiltrate,Stage IIIA Prostate Cancer AJCC v8
20144,Benign Cellular Infiltrate,Stage I Testicular Cancer AJCC v8
20145,Benign Cellular Infiltrate,Stage IB Testicular Cancer AJCC v8
20146,Benign Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v8
20147,Benign Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v8
20148,Benign Cellular Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
20149,Benign Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v8
20150,Benign Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v8
20151,Benign Cellular Infiltrate,Ureter Cancer by AJCC v7 Stage
20152,Benign Cellular Infiltrate,Stage II Bladder Cancer AJCC v8
20153,Benign Cellular Infiltrate,Urethral Cancer by AJCC v8 Stage
20154,Benign Cellular Infiltrate,Stage III Choroidal and Ciliary Body Melanoma AJCC v8
20155,Benign Cellular Infiltrate,Uveal Melanoma by AJCC v7 Stage
20156,Benign Cellular Infiltrate,Retinoblastoma by AJCC v8 Pathologic Stage
20157,Benign Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
20158,Benign Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
20159,Benign Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
20160,Benign Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
20161,Benign Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
20162,Benign Cellular Infiltrate,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
20163,Benign Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v8
20164,Benign Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v8
20165,Benign Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage
20166,Benign Cellular Infiltrate,Lugano Classification Stage I Adult Lymphoma AJCC v8
20167,Benign Cellular Infiltrate,Lugano Classification Stage II Adult Lymphoma AJCC v8
20168,Benign Cellular Infiltrate,Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8
20169,Benign Cellular Infiltrate,Lugano Classification Stage III Hodgkin Lymphoma AJCC v8
20170,Benign Cellular Infiltrate,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8
20171,Benign Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8
20172,Benign Cellular Infiltrate,Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8
20173,Benign Cellular Infiltrate,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8
20174,Benign Cellular Infiltrate,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8
20175,Benign Cellular Infiltrate,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8
20176,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System
20177,Benign Cellular Infiltrate,Stage A Chronic Lymphocytic Leukemia
20178,Benign Cellular Infiltrate,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8
20179,Benign Cellular Infiltrate,Adult Hodgkin Lymphoma by Ann Arbor Stage
20180,Benign Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage
20181,Benign Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage
20182,Benign Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage
20183,Benign Cellular Infiltrate,Burkitt Lymphoma by Ann Arbor Stage
20184,Benign Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
20185,Benign Cellular Infiltrate,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8
20186,Benign Cellular Infiltrate,acute undifferentiated leukemia in relapse
20187,Benign Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory
20188,Benign Cellular Infiltrate,Pulmonary Artery Intimal Sarcoma
20189,Benign Cellular Infiltrate,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
20190,Benign Cellular Infiltrate,Recurrent Rhabdoid Tumor
20191,Low Grade Neuroendocrine Lesion,Advanced Bile Duct Carcinoma
20192,Benign Cellular Infiltrate,Skin squamous cell carcinoma recurrent
20193,Benign Cellular Infiltrate,Marginal zone lymphoma refractory
20194,Benign Cellular Infiltrate,Mediastinal Mixed Germ Cell Tumor
20195,Benign Cellular Infiltrate,Pericardial Angiosarcoma
20196,Benign Cellular Infiltrate,Pericardial Yolk Sac Tumor
20197,Malignant Cellular Infiltrate,Benign Pericardial Germ Cell Tumor
20198,Benign Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
20199,Benign Cellular Infiltrate,Locally Advanced Thymic Carcinoma
20200,Benign Cellular Infiltrate,Refractory Head and Neck Squamous Cell Carcinoma
20201,Benign Cellular Infiltrate,BN2 Diffuse Large B-Cell Lymphoma
20202,Intermediate Grade Neuroendocrine Lesion,Unresectable Intrahepatic Cholangiocarcinoma
20203,Benign Cellular Infiltrate,Locally Advanced Melanoma
20204,Benign Cellular Infiltrate,Refractory Human Papillomavirus-Related Malignant Neoplasm
20205,Benign Cellular Infiltrate,Castration-Naive Prostate Carcinoma
20206,Low Grade Neuroendocrine Lesion,Thoracic Esophagus Squamous Cell Carcinoma
20207,Intermediate Grade Neuroendocrine Lesion,Cervical Esophagus Adenocarcinoma
20208,Low Grade Neuroendocrine Lesion,Cervical Esophagus Adenocarcinoma
20209,Well Differentiated Neuroendocrine Lesion,Gastric Cardia Squamous Cell Carcinoma
20210,Low Grade Neuroendocrine Lesion,Gastric Cardia Squamous Cell Carcinoma
20211,Benign Cellular Infiltrate,Recurrent Chronic Leukemia
20212,Benign Cellular Infiltrate,Refractory Chronic Myelomonocytic Leukemia
20213,Benign Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia
20214,Benign Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Nasopharynx
20215,Benign Cellular Infiltrate,Bilateral Synchronous Sporadic Renal Cell Carcinoma
20216,Benign Cellular Infiltrate,Refractory Urothelial Carcinoma
20217,Benign Cellular Infiltrate,Unresectable Urothelial Carcinoma
20218,Benign Cellular Infiltrate,Recurrent Malignant Bone Neoplasm
20219,Benign Cellular Infiltrate,Refractory Malignant Bone Neoplasm
20220,Benign Cellular Infiltrate,Recurrent Malignant Thyroid Gland Neoplasm
20221,Benign Cellular Infiltrate,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
20222,Low Grade Neuroendocrine Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma
20223,Benign Cellular Infiltrate,Refractory Lung Small Cell Carcinoma
20224,Benign Cellular Infiltrate,Resectable Undifferentiated Pleomorphic Sarcoma
20225,Benign Cellular Infiltrate,Resectable Neuroblastoma
20226,Intermediate Grade Neuroendocrine Lesion,Refractory Metastatic Digestive System Carcinoma
20227,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline ANKRD26 Mutation
20228,Benign Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders
20229,Benign Cellular Infiltrate,Transformed Non-Hodgkin Lymphoma
20230,Benign Cellular Infiltrate,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified"
20231,Benign Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
20232,Benign Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
20233,Well Differentiated Neuroendocrine Lesion,Distal Esophagus Adenocarcinoma
20234,Benign Cellular Infiltrate,Refractory Fallopian Tube Carcinoma
20235,Benign Cellular Infiltrate,Metastatic Unresectable Sarcoma
20236,Benign Cellular Infiltrate,"Sarcoma, metastatic"
20237,Benign Cellular Infiltrate,Metastatic Bone Sarcoma
20238,Intermediate Grade Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
20239,Benign Cellular Infiltrate,Advanced Melanoma
20240,Intermediate Grade Neuroendocrine Lesion,Metastatic Unresectable Gastric Adenocarcinoma
20241,Low Grade Neuroendocrine Lesion,Advanced Unresectable Gastric Adenocarcinoma
20242,Benign Cellular Infiltrate,Locally Advanced Chordoma
20243,Benign Cellular Infiltrate,Castration-Sensitive Prostate Carcinoma
20244,Intermediate Grade Neuroendocrine Lesion,Refractory Colon Carcinoma
20245,Well Differentiated Neuroendocrine Lesion,Refractory Small Intestinal Carcinoma
20246,Intermediate Grade Neuroendocrine Lesion,Recurrent Anal Adenocarcinoma
20247,Low Grade Neuroendocrine Lesion,Recurrent Appendix Mucinous Adenocarcinoma
20248,Benign Cellular Infiltrate,Recurrent Invasive Ductal Breast Carcinoma
20249,Benign Cellular Infiltrate,Recurrent Salivary Duct Carcinoma
20250,Benign Cellular Infiltrate,Recurrent Thyroid Gland Papillary Carcinoma
20251,Benign Cellular Infiltrate,Recurrent Thyroid Gland Anaplastic Carcinoma
20252,Benign Cellular Infiltrate,Refractory Malignant Central Nervous System Neoplasm
20253,Benign Cellular Infiltrate,Refractory WHO Grade III Glioma
20254,Well Differentiated Neuroendocrine Lesion,Hepatic cancer metastatic
20255,Benign Cellular Infiltrate,Locally Advanced Squamous Cell Carcinoma
20256,Metastatic Lesion,Densely Granulated Non-Functioning Corticotroph Adenoma
20257,Mixed Neoplastic Glandular and Squamous Cell Population,MiT Family Translocation-Associated Renal Cell Carcinoma
20258,Benign Cellular Infiltrate,Unresectable Renal Cell Carcinoma
20259,Squamous Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma
20260,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma gastric recurrent
20261,Low Mitotic Activity,Digestive System Small Cell Neuroendocrine Carcinoma
20262,Indolent Clinical Course,Transplant-Related Squamous Cell Carcinoma
20263,Indolent Clinical Course,Sarcoma of the Extremity
20264,Intermediate Filaments Present,Recurrent Sarcoma of the Extremity
20265,Well Differentiated Neuroendocrine Lesion,Pancreatic adenocarcinoma recurrent
20266,Benign Cellular Infiltrate,Locally Advanced Unresectable Pancreatic Adenocarcinoma
20267,Indolent Clinical Course,Sellar Neuroblastoma
20268,High Grade Lesion,Sellar Chondroid Chordoma
20269,Benign Cellular Infiltrate,Malignant Skull Base Neoplasm
20270,Indolent Clinical Course,Sellar Embryonal Carcinoma
20271,Benign Cellular Infiltrate,Sellar Embryonal Carcinoma
20272,Indolent Clinical Course,Sellar Choriocarcinoma
20273,Benign Cellular Infiltrate,Sellar Choriocarcinoma
20274,Malignant Germinomatous Cellular Infiltrate,Sellar Mature Teratoma
20275,"Undifferentiated ""Fetal-Type"" Tissues Present",Sellar Mature Teratoma
20276,Seminomatous Component Present,Sellar Teratoma with Malignant Transformation
20277,Benign Cellular Infiltrate,Unresectable Lung Carcinoma
20278,Intermediate Grade Neuroendocrine Lesion,Unresectable Digestive System Carcinoma
20279,Low Grade Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
20280,Low Grade Neuroendocrine Lesion,Refractory Digestive System Neuroendocrine Carcinoma
20281,Intermediate Grade Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Carcinoma
20282,Low Mitotic Activity,Recurrent Digestive System Neuroendocrine Carcinoma
20283,Intracytoplasmic Eosinophilic Inclusion,Refractory Malignant Peripheral Nerve Sheath Tumor
20284,Mixed Neoplastic Glandular and Squamous Cell Population,Encapsulated Variant Thyroid Gland Papillary Carcinoma
20285,Microvascular Proliferation,Frontal Lobe Anaplastic Astrocytoma
20286,Precise Histogenesis Unknown,Temporal Lobe Anaplastic Astrocytoma
20287,Benign Cellular Infiltrate,Third Ventricle Germinoma
20288,Benign Cellular Infiltrate,Metastatic Fallopian Tube Carcinoma
20289,Benign Cellular Infiltrate,Stage IV Ovarian Carcinoma
20290,Intracytoplasmic Eosinophilic Inclusion,Stage IV adult soft tissue sarcoma
20291,Benign Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma
20292,Benign Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma
20293,Benign Cellular Infiltrate,Stage IV Laryngeal Carcinoma
20294,Premalignant Lesion,Metastatic Lung Non-Small Cell Carcinoma
20295,Intermediate Grade Neuroendocrine Lesion,Metastatic Colon Carcinoma
20296,Benign Cellular Infiltrate,Metastatic Colon Carcinoma
20297,Well Differentiated Neuroendocrine Lesion,Metastatic Rectal Carcinoma
20298,Intermediate Grade Neuroendocrine Lesion,Metastatic Rectal Carcinoma
20299,Benign Cellular Infiltrate,Metastatic Neuroblastoma
20300,Favorable Clinical Outcome,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
20301,Indolent Clinical Course,Frontal Lobe Anaplastic Oligodendroglioma
20302,Intermediate Grade Neuroendocrine Lesion,Localized Gastroesophageal Junction Adenocarcinoma
20303,Composite Lesion,Ectopic Thyroid Gland Thymoma
20304,Low Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Adenocarcinoma
20305,Benign Cellular Infiltrate,Parotid Gland Sarcoma
20306,Intracytoplasmic Eosinophilic Inclusion,Parotid Gland Sarcoma
20307,Local disease,Advanced Prostate Adenocarcinoma
20308,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Prostate Adenocarcinoma
20309,Benign Cellular Infiltrate,Advanced Cervical Carcinoma
20310,Extensive Stage Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma
20311,Local disease,Advanced Cervical Adenocarcinoma
20312,Aggressive Clinical Course,Thyroid Gland Schwannoma
20313,Intermediate Filaments Present,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
20314,Diffuse Lesion,Thyroid Gland Lymphangioma
20315,Intracytoplasmic Eosinophilic Inclusion,Thyroid Gland Leiomyosarcoma
20316,HMB-45-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
20317,CD1a-Positive Neoplastic Cells Present,follicular dendritic cell sarcoma of thyroid gland
20318,Benign Cellular Infiltrate,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
20319,Indolent Clinical Course,Refractory Kaposi Sarcoma
20320,Indolent Clinical Course,Advanced Kaposi Sarcoma
20321,Benign Cellular Infiltrate,Metastatic Neuroendocrine Neoplasm
20322,Benign Cellular Infiltrate,Pancreatic neuroendocrine tumor metastatic
20323,Severe cytologic atypia,Advanced Pancreatic Neuroendocrine Tumor
20324,Intermediate Grade Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
20325,Benign Cellular Infiltrate,Malignant Abdominal Neoplasm
20326,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
20327,Benign Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
20328,Low Grade Neuroendocrine Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
20329,Malignant Cellular Infiltrate,Benign Parathyroid Gland Adenoma
20330,Benign Cellular Infiltrate,Biliary Tract Carcinoma
20331,Well Differentiated Neuroendocrine Lesion,Recurrent Biliary Tract Carcinoma
20332,Benign Cellular Infiltrate,Locally Advanced Unresectable Basal Cell Carcinoma
20333,Extensive Stage Lesion,Locally Advanced Unresectable Basal Cell Carcinoma
20334,Benign Cellular Infiltrate,Metastatic Human Papillomavirus-Related Malignant Neoplasm
20335,Intermediate Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma resectable
20336,Benign Cellular Infiltrate,Resectable Intrahepatic Cholangiocarcinoma
20337,Benign Cellular Infiltrate,Bile duct adenocarcinoma resectable
20338,Well Differentiated Neuroendocrine Lesion,Resectable Extrahepatic Bile Duct Adenocarcinoma
20339,Aggressive Clinical Course,Adrenal Gland Schwannoma
20340,Necrotic changes (finding),Adrenal Gland Schwannoma
20341,Malignant Cellular Infiltrate,Hemangioma acquired
20342,Malignant Cellular Infiltrate,Eccrine dermal cylindroma
20343,Benign Cellular Infiltrate,African Burkitt's lymphoma
20344,Low Grade Neuroendocrine Lesion,Early gastric cancer
20345,Malignant Cellular Infiltrate,Metanephric adenoma
20346,Malignant Cellular Infiltrate,Cellular angiofibroma
20347,Benign Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases
20348,Malignant Cellular Infiltrate,Eccrine Poroma
20349,Intermediate Grade Neuroendocrine Lesion,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
20350,Malignant Cellular Infiltrate,Ovarian Endometrioid Cystadenofibroma
20351,Low Grade Neuroendocrine Lesion,Unresectable Hepatocellular Carcinoma
20352,Benign Cellular Infiltrate,Childhood Clear Cell Sarcoma of Soft Parts
20353,Benign Cellular Infiltrate,Adult Myxoid Chondrosarcoma
20354,Benign Cellular Infiltrate,Thyroid Gland Adenocarcinoma
20355,Perineural spread,Parathyroid Gland Oncocytic Adenoma
20356,Mitotic Activity,Adult Central Nervous System Mature Teratoma
20357,Intermediate Grade Neuroendocrine Lesion,Undifferentiated carcinoma of esophagus
20358,Poorly Differentiated Neuroendocrine Lesion,Gastric Gastrin-Producing Neuroendocrine Tumor
20359,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Vipoma
20360,Poorly Differentiated Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor
20361,Low Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor
20362,Benign Cellular Infiltrate,Proximal-Type Epithelioid Sarcoma
20363,Malignant Cellular Infiltrate,Classic Rhabdomyoma
20364,Malignant Cellular Infiltrate,mediastinal lipomatosis
20365,Benign Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma
20366,Malignant Cellular Infiltrate,Intra-Abdominal Lymphangioma
20367,Benign Cellular Infiltrate,Human Papillomavirus-Related Carcinoma
20368,Benign Cellular Infiltrate,Human Papillomavirus-Related Cervical Carcinoma
20369,Benign Cellular Infiltrate,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
20370,Well Differentiated Neuroendocrine Lesion,Hepatitis Virus-Related Hepatocellular Carcinoma
20371,Benign Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
20372,Benign Cellular Infiltrate,"Leukemia, Myelocytic, Acute"
20373,Well Differentiated Neuroendocrine Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma
20374,Benign Cellular Infiltrate,Cigarette Smoking-Related Carcinoma
20375,Well Differentiated Neuroendocrine Lesion,Bile duct carcinoma
20376,Intermediate Grade Neuroendocrine Lesion,Bile duct carcinoma
20377,Benign Cellular Infiltrate,Malignant neoplasm of endometrium
20378,Benign Cellular Infiltrate,Paget's disease of penis
20379,Benign Cellular Infiltrate,Grade 1 Invasive Breast Carcinoma
20380,Benign Cellular Infiltrate,Grade 3 Invasive Breast Carcinoma
20381,Benign Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma
20382,Benign Cellular Infiltrate,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
20383,Benign Cellular Infiltrate,"Papillary renal cell carcinoma, sporadic"
20384,Benign Cellular Infiltrate,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
20385,Benign Cellular Infiltrate,Old Burn Scar-Related Skin Squamous Cell Carcinoma
20386,Intermediate Grade Neuroendocrine Lesion,Alcohol-Related Esophageal Squamous Cell Carcinoma
20387,Intermediate Grade Neuroendocrine Lesion,Advanced Adult Hepatocellular Carcinoma
20388,Benign Cellular Infiltrate,Primary Myelofibrosis
20389,Benign Cellular Infiltrate,Refractory anemias
20390,Benign Cellular Infiltrate,Carcinoma
20391,Benign Cellular Infiltrate,"Carcinoma, Transitional Cell"
20392,Malignant Cellular Infiltrate,Ganglioneuroma
20393,Poorly Differentiated Neuroendocrine Lesion,Gastrinoma
20394,Malignant Cellular Infiltrate,"Hemangioma, Cavernous"
20395,Benign Cellular Infiltrate,Hemangiosarcoma
20396,Benign Cellular Infiltrate,Krukenberg Tumor
20397,Benign Cellular Infiltrate,Childhood Acute Lymphoblastic Leukemia
20398,Benign Cellular Infiltrate,"Leukemia, Myelomonocytic, Chronic"
20399,Benign Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic
20400,Benign Cellular Infiltrate,MYELODYSPLASTIC SYNDROME
20401,Benign Cellular Infiltrate,B-Cell Lymphomas
20402,Malignant Cellular Infiltrate,Endocervical polyp
20403,Benign Cellular Infiltrate,"Lymphoma, Large-Cell, Follicular"
20404,Well Differentiated Neuroendocrine Lesion,Cecum Carcinoma
20405,Malignant Cellular Infiltrate,Pyogenic granuloma of skin and subcutaneous tissue
20406,Benign Cellular Infiltrate,Malignant neoplasm of uvula
20407,Intermediate Grade Neuroendocrine Lesion,Gastrointestinal carcinoma in situ
20408,Benign Cellular Infiltrate,Malignant tumour of parotid gland
20409,Benign Cellular Infiltrate,Malignant Hard Palate Neoplasm
20410,Benign Cellular Infiltrate,Malignant tumor of ethmoid sinus
20411,Intermediate Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma
20412,Low Grade Neuroendocrine Lesion,Intrahepatic Cholangiocarcinoma
20413,Benign Cellular Infiltrate,Malignant Frontal Sinus Neoplasm
20414,Benign Cellular Infiltrate,Malignant neoplasm of glottis
20415,Benign Cellular Infiltrate,Malignant tumor of pleura
20416,Benign Cellular Infiltrate,Uterine Cancer
20417,Benign Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
20418,Benign Cellular Infiltrate,Malignant tumor of epididymis
20419,Benign Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm
20420,Benign Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of breast
20421,Malignant Cellular Infiltrate,sebaceous adenoma of salivary gland
20422,Benign Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
20423,Benign Cellular Infiltrate,Blastic Granulocytic Sarcoma
20424,Malignant Cellular Infiltrate,cystadenoma of salivary gland
20425,Malignant Cellular Infiltrate,benign neoplasm of floor of mouth
20426,Malignant Cellular Infiltrate,benign tumor of hypopharynx
20427,Malignant Cellular Infiltrate,Benign neoplasm of pleura
20428,Benign Cellular Infiltrate,Grade 3b Malignant Neoplasm
20429,Benign Cellular Infiltrate,Invasive micropapillary carcinoma of breast
20430,Malignant Cellular Infiltrate,Benign neoplasm of uterus
20431,Benign Cellular Infiltrate,Carcinosarcoma of cervix uteri
20432,Malignant Cellular Infiltrate,Benign neoplasm of ureter
20433,Malignant Cellular Infiltrate,Benign neoplasm of lacrimal gland
20434,Malignant Cellular Infiltrate,Benign neoplasm of cornea
20435,Malignant Cellular Infiltrate,Metastatic Benign Neoplasm
20436,Benign Cellular Infiltrate,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant"
20437,Benign Cellular Infiltrate,Prostate Carcinoma Metastatic in the Bone
20438,Low Grade Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Liver
20439,Malignant Cellular Infiltrate,Hemangioma of retina
20440,Benign Cellular Infiltrate,Stage 0 Breast Cancer AJCC v6 and v7
20441,Benign Cellular Infiltrate,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
20442,Benign Cellular Infiltrate,Sweat Gland Tubular Carcinoma
20443,Benign Cellular Infiltrate,Undifferentiated carcinoma
20444,Benign Cellular Infiltrate,Medullomyoblastoma
20445,Benign Cellular Infiltrate,"Sarcoma, Epithelioid"
20446,Benign Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
20447,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
20448,Benign Cellular Infiltrate,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
20449,Malignant Cellular Infiltrate,Benign mixed epithelial and stromal tumor of kidney
20450,Benign Cellular Infiltrate,Pulmonary Blastoma
20451,Benign Cellular Infiltrate,Acinar Cell Carcinoma
20452,Well Differentiated Neuroendocrine Lesion,Pancreatic Endocrine Carcinoma
20453,Benign Cellular Infiltrate,Verrucous carcinoma
20454,Malignant Cellular Infiltrate,"Papilloma, Intraductal"
20455,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
20456,Benign Cellular Infiltrate,Skin Signet Ring Cell Basal Cell Carcinoma
20457,Benign Cellular Infiltrate,Primary amyloidosis
20458,Low Grade Neuroendocrine Lesion,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
20459,Malignant Cellular Infiltrate,Chondromyxoid fibroma
20460,Malignant Cellular Infiltrate,Congenital hemangioma
20461,Benign Cellular Infiltrate,Neoplasm malignant aggravated
20462,Malignant Cellular Infiltrate,Leiomyoma of esophagus
20463,Benign Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma
20464,Malignant Cellular Infiltrate,Pyogenic granuloma of oral mucosa
20465,Malignant Cellular Infiltrate,Fibroma of prostate
20466,Benign Cellular Infiltrate,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
20467,Malignant Cellular Infiltrate,Nephrogenic adenofibroma
20468,Benign Cellular Infiltrate,Classic Congenital Mesoblastic Nephroma
20469,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
20470,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
20471,Benign Cellular Infiltrate,Transitional cell carcinoma of bladder
20472,Benign Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
20473,Benign Cellular Infiltrate,Prostatic Urethra Urothelial Carcinoma
20474,Benign Cellular Infiltrate,Seminal Vesicle Adenocarcinoma
20475,Benign Cellular Infiltrate,AIDS with Kaposi's sarcoma
20476,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
20477,Malignant Cellular Infiltrate,Rete Testis Adenoma
20478,Benign Cellular Infiltrate,basal cell carcinoma of penis
20479,Malignant Cellular Infiltrate,Ovarian Fetiform Teratoma
20480,Benign Cellular Infiltrate,Stage 0 Cervical Cancer AJCC v6
20481,Benign Cellular Infiltrate,Malignant Ovarian Serous Tumor
20482,Malignant Cellular Infiltrate,Borderline Ovarian Serous Cystadenofibroma
20483,Benign Cellular Infiltrate,Adenocarcinofibroma
20484,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenofibroma
20485,Benign Cellular Infiltrate,Fallopian Tube Serous Adenocarcinoma
20486,Benign Cellular Infiltrate,Uterine Ligament Endometrioid Adenocarcinoma
20487,Benign Cellular Infiltrate,Grade 2 Endometrial Endometrioid Adenocarcinoma
20488,Malignant Cellular Infiltrate,Uterine Corpus Apoplectic Leiomyoma
20489,Malignant Cellular Infiltrate,Uterine Corpus Diffuse Leiomyomatosis
20490,Benign Cellular Infiltrate,Lobular carcinoma in situ of breast
20491,Benign Cellular Infiltrate,Cervical Squamotransitional Carcinoma
20492,Benign Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
20493,Benign Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
20494,Benign Cellular Infiltrate,Cervical Villoglandular Adenocarcinoma
20495,Malignant Cellular Infiltrate,Cervical Adenofibroma
20496,Malignant Cellular Infiltrate,"Cervical Adenomyoma, Endocervical Type"
20497,Low Grade Neuroendocrine Lesion,Adenocarcinoma Of Esophagus
20498,Benign Cellular Infiltrate,Vaginal Endometrioid Adenocarcinoma
20499,Benign Cellular Infiltrate,Vaginal Small Cell Carcinoma
20500,Benign Cellular Infiltrate,Paget's disease of vulva
20501,Malignant Cellular Infiltrate,Benign Vaginal Mixed Tumor
20502,Malignant Cellular Infiltrate,Vaginal Blue Nevus
20503,Benign Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells
20504,Benign Cellular Infiltrate,eccrine adenocarcinoma of vulva
20505,Benign Cellular Infiltrate,Bladder Adenocarcinoma
20506,Malignant Cellular Infiltrate,Vulvar Superficial Angiomyxoma
20507,Malignant Cellular Infiltrate,Vulvar Angiomyxoma
20508,Malignant Cellular Infiltrate,Vulvar Leiomyoma
20509,Benign Cellular Infiltrate,Larynx carcinoma recurrent
20510,Benign Cellular Infiltrate,Oncocytic Breast Carcinoma
20511,Benign Cellular Infiltrate,Adenocarcinoma of Unknown Primary
20512,Malignant Cellular Infiltrate,Breast Myofibroblastoma
20513,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx
20514,Benign Cellular Infiltrate,Hereditary Fallopian Tube Carcinoma
20515,Benign Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma
20516,Benign Cellular Infiltrate,"Malignant lymphoma centroblastic, diffuse"
20517,Benign Cellular Infiltrate,Pleomorphic carcinoma
20518,Benign Cellular Infiltrate,"Squamous cell carcinoma, keratinizing"
20519,Benign Cellular Infiltrate,Papillary transitional cell carcinoma
20520,Benign Cellular Infiltrate,Adenocarcinoma in Situ
20521,Benign Cellular Infiltrate,Prefibrotic/Early Primary Myelofibrosis
20522,Benign Cellular Infiltrate,Adenocarcinoma in multiple adenomatous polyps
20523,Benign Cellular Infiltrate,Adenocarcinoma in situ in tubulovillous adenoma
20524,Benign Cellular Infiltrate,Basophilic Adenocarcinoma
20525,Broad Fibrous Bands Formation,Chief cell adenoma
20526,Malignant Cellular Infiltrate,Microfollicular adenoma
20527,Malignant Cellular Infiltrate,Macrofollicular adenoma
20528,Intermediate Grade Neuroendocrine Lesion,Mucin-Producing Intrahepatic Cholangiocarcinoma
20529,Intermediate Grade Neuroendocrine Lesion,Signet Ring Cell Intrahepatic Cholangiocarcinoma
20530,Malignant Cellular Infiltrate,Eccrine spiradenoma
20531,Benign Cellular Infiltrate,Gliomatosis Cerebri Type I
20532,Benign Cellular Infiltrate,Intraductal carcinoma and lobular carcinoma in situ
20533,Benign Cellular Infiltrate,Undifferentiated Neuroblastoma
20534,Benign Cellular Infiltrate,Differentiating Neuroblastoma
20535,Benign Cellular Infiltrate,"Glomus tumor, malignant"
20536,Benign Cellular Infiltrate,Epithelioid Cell Melanoma
20537,Malignant Cellular Infiltrate,Fetal rhabdomyoma
20538,Benign Cellular Infiltrate,Myeloid leukemia associated with Down Syndrome
20539,Well Differentiated Neuroendocrine Lesion,"Pancreatic carcinoma, familial"
20540,Benign Cellular Infiltrate,Malignant Proliferating Pilar Tumor
20541,Malignant Cellular Infiltrate,Classical Poroma
20542,Well Differentiated Neuroendocrine Lesion,Sporadic Gastric Adenocarcinoma
20543,Low Grade Neuroendocrine Lesion,Small Intestinal Undifferentiated Carcinoma
20544,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of appendix
20545,Malignant Cellular Infiltrate,Appendix Lipoma
20546,Well Differentiated Neuroendocrine Lesion,Colorectal Adenosquamous Carcinoma
20547,Low Grade Neuroendocrine Lesion,Colorectal Adenosquamous Carcinoma
20548,Well Differentiated Neuroendocrine Lesion,Colorectal Undifferentiated Carcinoma
20549,Low Grade Neuroendocrine Lesion,Rectal Adenosquamous Carcinoma
20550,Well Differentiated Neuroendocrine Lesion,intestinal type adenocarcinoma of gallbladder
20551,Low Grade Neuroendocrine Lesion,intestinal type adenocarcinoma of gallbladder
20552,Well Differentiated Neuroendocrine Lesion,Sarcomatoid Hepatocellular Carcinoma
20553,Malignant Cellular Infiltrate,Senile hemangioma of lip
20554,Well Differentiated Neuroendocrine Lesion,Clear Cell Intrahepatic Cholangiocarcinoma
20555,Low Grade Neuroendocrine Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
20556,Well Differentiated Neuroendocrine Lesion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
20557,Low Grade Neuroendocrine Lesion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
20558,Low Grade Neuroendocrine Lesion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
20559,Intermediate Grade Neuroendocrine Lesion,Carcinoma in situ of ampulla of Vater
20560,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of pancreas
20561,Malignant Cellular Infiltrate,Blue rubber bleb nevus syndrome
20562,Malignant Cellular Infiltrate,Cockade nevus
20563,Malignant Cellular Infiltrate,Common blue nevus of skin
20564,Benign Cellular Infiltrate,Malignant phyllodes tumor of breast
20565,Malignant Cellular Infiltrate,Serous cystadenoma of ovary
20566,Benign Cellular Infiltrate,Low-grade fibromyxoid sarcoma
20567,Benign Cellular Infiltrate,Cutaneous Chronic Lymphocytic Leukemia
20568,Benign Cellular Infiltrate,Cutaneous Lymphomatoid Granulomatosis
20569,Malignant Cellular Infiltrate,Renal Pelvis Urothelial Papilloma
20570,Benign Cellular Infiltrate,Hydroa vacciniforme-like lymphoma
20571,Benign Cellular Infiltrate,Malignant melanoma of conjunctiva
20572,Benign Cellular Infiltrate,Malignant tumor of iris
20573,Benign Cellular Infiltrate,mucoepidermoid carcinoma of lung
20574,Malignant Cellular Infiltrate,Lung Glandular Papilloma
20575,Benign Cellular Infiltrate,Pleuropulmonary blastoma type III
20576,Benign Cellular Infiltrate,Sarcomatoid Mesothelioma
20577,Benign Cellular Infiltrate,Pleural Biphasic Mesothelioma
20578,Benign Cellular Infiltrate,Primary malignant neoplasm of pericardium
20579,Benign Cellular Infiltrate,Combined Thymic Epithelial Neoplasm
20580,Benign Cellular Infiltrate,Malignant tumor of epidermal appendage
20581,Malignant Cellular Infiltrate,Cardiac Cavernous Hemangioma
20582,Benign Cellular Infiltrate,Cardiac Synovial Sarcoma
20583,Benign Cellular Infiltrate,Oncocytic Variant Thyroid Gland Papillary Carcinoma
20584,Benign Cellular Infiltrate,Familial medullary thyroid carcinoma
20585,Benign Cellular Infiltrate,Thyroid Gland Mixed Medullary and Papillary Carcinoma
20586,Poorly Differentiated Neuroendocrine Lesion,Gastric Carcinoid Tumor
20587,Benign Cellular Infiltrate,Breast Lymphoma
20588,Malignant Cellular Infiltrate,Encephalocraniocutaneous lipomatosis
20589,Malignant Cellular Infiltrate,Benign neoplasm of cecum
20590,Benign Cellular Infiltrate,malignant neurologic neoplasms
20591,Well Differentiated Neuroendocrine Lesion,Duodenal Cancer
20592,Intermediate Grade Neuroendocrine Lesion,Duodenal Cancer
20593,Malignant Cellular Infiltrate,Cortisol-Producing Adrenal Cortex Adenoma
20594,Malignant Cellular Infiltrate,Sex Hormone-Producing Adrenal Cortex Adenoma
20595,Malignant Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma
20596,Low Grade Neuroendocrine Lesion,Stage 0 Rectal Cancer AJCC v6 and v7
20597,Benign Cellular Infiltrate,Minimal Deviation Melanoma
20598,Benign Cellular Infiltrate,Prostate carcinoma
20599,Malignant Cellular Infiltrate,Benign bone neoplasm
20600,Malignant Cellular Infiltrate,Gardner Fibroma
20601,Benign Cellular Infiltrate,Low grade myofibroblastic sarcoma
20602,Benign Cellular Infiltrate,Secondary malignant neoplasm of thymus
20603,Malignant Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
20604,Benign Cellular Infiltrate,"Carcinoma, Ovarian Epithelial"
20605,Intermediate Grade Neuroendocrine Lesion,Stomach Carcinoma
20606,Malignant Cellular Infiltrate,Cavernous hemangioma of retina
20607,Benign Cellular Infiltrate,Localized Lymphoma
20608,Benign Cellular Infiltrate,Cancer of Neck
20609,Benign Cellular Infiltrate,Cerebral Primitive Neuroectodermal Tumor
20610,Benign Cellular Infiltrate,Recurrent Follicular Lymphoma
20611,Intermediate Grade Neuroendocrine Lesion,Stage I Rectosigmoid Cancer AJCC v6 and v7
20612,Well Differentiated Neuroendocrine Lesion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
20613,Intermediate Grade Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
20614,Low Grade Neuroendocrine Lesion,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
20615,Low Grade Neuroendocrine Lesion,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
20616,Intermediate Grade Neuroendocrine Lesion,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
20617,Intermediate Grade Neuroendocrine Lesion,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
20618,Low Grade Neuroendocrine Lesion,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
20619,Benign Cellular Infiltrate,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma
20620,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic
20621,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic
20622,Benign Cellular Infiltrate,Childhood Glioblastoma
20623,Benign Cellular Infiltrate,Metastatic Signet Ring Cell Breast Carcinoma
20624,Malignant Cellular Infiltrate,Breast Epithelioid Hemangioma
20625,Malignant Cellular Infiltrate,Benign Ovarian Thecoma
20626,Benign Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v6 and v7
20627,Benign Cellular Infiltrate,Stage IIC Ovarian Carcinoma
20628,Well Differentiated Neuroendocrine Lesion,Mucinous adenocarcinoma gastric
20629,Malignant Cellular Infiltrate,Chondroma
20630,Malignant Cellular Infiltrate,Benign Atrial Neoplasm
20631,Malignant Cellular Infiltrate,Solitary Adult Fibroma
20632,Benign Cellular Infiltrate,Undifferentiated Stromal Sarcoma
20633,Benign Cellular Infiltrate,Malignant Intracranial Germ Cell Tumor
20634,Malignant Cellular Infiltrate,Intracranial cavernous hemangioma
20635,Benign Cellular Infiltrate,undifferentiated carcinoma of larynx
20636,Benign Cellular Infiltrate,Nasopharyngeal Differentiated Carcinoma
20637,Malignant Cellular Infiltrate,Central Nervous System Lipoma
20638,Benign Cellular Infiltrate,Stage IIA Breast Carcinoma
20639,Benign Cellular Infiltrate,Stage IIB Breast Carcinoma
20640,Well Differentiated Neuroendocrine Lesion,Stage IA Gastric Carcinoma
20641,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Gastric Carcinoma
20642,Well Differentiated Neuroendocrine Lesion,Gastric Squamous Cell Carcinoma
20643,Low Grade Neuroendocrine Lesion,Gastric Squamous Cell Carcinoma
20644,Malignant Cellular Infiltrate,Gastric Hemangioma
20645,Poorly Differentiated Neuroendocrine Lesion,Carcinoid tumor of the cecum
20646,Benign Cellular Infiltrate,Prostate Myeloid Sarcoma
20647,Malignant Cellular Infiltrate,Benign Prostate Phyllodes Tumor
20648,Well Differentiated Neuroendocrine Lesion,cloacogenic carcinoma of rectum
20649,Benign Cellular Infiltrate,Eccrine porocarcinoma
20650,Benign Cellular Infiltrate,Nodulo-ulcerative basal cell carcinoma
20651,Benign Cellular Infiltrate,Stage I Uveal Melanoma AJCC v7
20652,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of anus
20653,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of anus
20654,Malignant Cellular Infiltrate,Anal Leiomyoma
20655,Intermediate Grade Neuroendocrine Lesion,Anal cancer metastatic
20656,Low Grade Neuroendocrine Lesion,Anal cancer metastatic
20657,Benign Cellular Infiltrate,Occult Lung Carcinoma
20658,Malignant Cellular Infiltrate,Pulmonary Sclerosing Hemangioma
20659,Malignant Cellular Infiltrate,Leiomyoma of lung
20660,Low Grade Neuroendocrine Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7
20661,Well Differentiated Neuroendocrine Lesion,adenosquamous carcinoma of pancreas
20662,Well Differentiated Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v6 and v7
20663,Well Differentiated Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v6
20664,Intermediate Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v6
20665,Low Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v6
20666,Well Differentiated Neuroendocrine Lesion,Stage IVB Gallbladder Carcinoma
20667,Well Differentiated Neuroendocrine Lesion,signet ring cell carcinoma of gallbladder
20668,Intermediate Grade Neuroendocrine Lesion,signet ring cell carcinoma of gallbladder
20669,Intermediate Grade Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v6 and v7
20670,Low Grade Neuroendocrine Lesion,Stage IVA Hepatocellular Carcinoma AJCC v7
20671,Intermediate Grade Neuroendocrine Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7
20672,Well Differentiated Neuroendocrine Lesion,Bile duct clear cell adenocarcinoma
20673,Low Grade Neuroendocrine Lesion,Bile duct clear cell adenocarcinoma
20674,Low Grade Neuroendocrine Lesion,Squamous Cell Bile Duct Carcinoma
20675,Low Grade Neuroendocrine Lesion,Adenosquamous Bile Duct Carcinoma
20676,Poorly Differentiated Neuroendocrine Lesion,Jejunal Somatostatin-Producing Neuroendocrine Tumor
20677,Malignant Cellular Infiltrate,Benign Childhood Supratentorial Neoplasm
20678,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma stage I
20679,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma stage II
20680,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma stage III
20681,Low Grade Neuroendocrine Lesion,Small intestine carcinoma stage III
20682,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma stage IV
20683,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Adult Brain
20684,Benign Cellular Infiltrate,"Intracranial Embryonal Tumor, Not Otherwise Specified"
20685,Benign Cellular Infiltrate,adenoid cystic carcinoma of pharynx
20686,Malignant Cellular Infiltrate,Papilloma of buccal mucosa
20687,Malignant Cellular Infiltrate,benign lipoma of gallbladder
20688,Well Differentiated Neuroendocrine Lesion,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
20689,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Benign Granular Cell Tumor
20690,Benign Cellular Infiltrate,Stage III Lip Cancer AJCC v6 and v7
20691,Benign Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7
20692,Benign Cellular Infiltrate,Stage II Oral Cavity Cancer AJCC v6 and v7
20693,Benign Cellular Infiltrate,Stage II Major Salivary Gland Cancer AJCC v7
20694,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of salivary gland
20695,Malignant Cellular Infiltrate,Benign oncocytoma of salivary gland
20696,Malignant Cellular Infiltrate,"Adenoma, Basal Cell"
20697,Benign Cellular Infiltrate,Malignant Mixed Tumor of the Minor Salivary Gland
20698,Malignant Cellular Infiltrate,benign myoepithelioma of salivary gland
20699,Malignant Cellular Infiltrate,canalicular adenoma of salivary gland
20700,Malignant Cellular Infiltrate,Parotid Gland Lipoma
20701,Benign Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7
20702,Benign Cellular Infiltrate,sarcoma of larynx
20703,Benign Cellular Infiltrate,Secondary malignant neoplasm of hypopharynx
20704,Malignant Cellular Infiltrate,Polyp in nasopharynx
20705,Benign Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV
20706,Low Grade Neuroendocrine Lesion,Rectal Medullary Carcinoma
20707,Intermediate Grade Neuroendocrine Lesion,Colon Medullary Carcinoma
20708,Benign Cellular Infiltrate,Ethmoid Sinus Squamous Cell Carcinoma
20709,Benign Cellular Infiltrate,large B-cell diffuse lymphoma of accessory sinus
20710,Benign Cellular Infiltrate,Blepharal carcinoma
20711,Benign Cellular Infiltrate,External Ear Basal Cell Carcinoma
20712,Benign Cellular Infiltrate,squamous cell carcinoma of middle ear
20713,Benign Cellular Infiltrate,Iris Spindle Cell Melanoma
20714,Benign Cellular Infiltrate,Intermediate Cell Type Ciliary Body Melanoma
20715,Benign Cellular Infiltrate,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
20716,Benign Cellular Infiltrate,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
20717,Benign Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
20718,Benign Cellular Infiltrate,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
20719,Malignant Cellular Infiltrate,Ureter Inverted Papilloma
20720,Benign Cellular Infiltrate,Bladder transitional cell carcinoma stage 0
20721,Benign Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v7
20722,Benign Cellular Infiltrate,Stage 0a Ureter Cancer AJCC v7
20723,Benign Cellular Infiltrate,Childhood Brain Germinoma
20724,Benign Cellular Infiltrate,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
20725,Benign Cellular Infiltrate,Skin Nodular Basal Cell Carcinoma
20726,Benign Cellular Infiltrate,Minor Salivary Gland Acinic Cell Carcinoma
20727,Benign Cellular Infiltrate,Anterior Tongue Mucoepidermoid Carcinoma
20728,Benign Cellular Infiltrate,Childhood Brain Anaplastic Astrocytoma
20729,Benign Cellular Infiltrate,Fallopian Tube Papillary Adenocarcinoma
20730,Benign Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v6 and v7
20731,Benign Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v7
20732,Benign Cellular Infiltrate,Stage IC Uterine Corpus Cancer AJCC v6
20733,Benign Cellular Infiltrate,Stage IIA Uterine Corpus Cancer AJCC v6
20734,Benign Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v7
20735,Benign Cellular Infiltrate,Uterine Corpus Sarcoma
20736,Malignant Cellular Infiltrate,Cervical Squamous Papilloma
20737,Benign Cellular Infiltrate,Testicular germ cell tumor mixed
20738,Benign Cellular Infiltrate,large B-cell diffuse lymphoma of kidney
20739,Mitotic Activity,Mature Testicular Teratoma
20740,Benign Cellular Infiltrate,sarcoma of testis
20741,Benign Cellular Infiltrate,Stage IIIC Testicular Cancer AJCC v6 and v7
20742,Benign Cellular Infiltrate,Kaposi's sarcoma of penis
20743,Benign Cellular Infiltrate,Basal cell carcinoma of vulva
20744,Malignant Cellular Infiltrate,Paratesticular Lipoma
20745,Poorly Differentiated Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1
20746,Poorly Differentiated Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1
20747,Benign Cellular Infiltrate,Malignant Mediastinal Non-Seminomatous Germ Cell Tumor
20748,Benign Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma
20749,Benign Cellular Infiltrate,Thymic Clear Cell Carcinoma
20750,Benign Cellular Infiltrate,hemangioendothelial sarcoma of bone
20751,Benign Cellular Infiltrate,Inflammatory malignant fibrous histiocytoma
20752,Benign Cellular Infiltrate,Papillary carcinoma in situ
20753,Malignant Cellular Infiltrate,Benign neoplasm of lymph vessels
20754,Benign Cellular Infiltrate,Malignant Synovial Neoplasm
20755,Benign Cellular Infiltrate,Childhood Ovarian Embryonal Carcinoma
20756,Benign Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor
20757,Benign Cellular Infiltrate,Childhood Parosteal Osteosarcoma
20758,Malignant Cellular Infiltrate,Mediastinal Lymphangioma
20759,Malignant Cellular Infiltrate,Mediastinal Leiomyoma
20760,Malignant Cellular Infiltrate,lipoma of mediastinum
20761,Benign Cellular Infiltrate,Mediastinal Extraskeletal Osteosarcoma
20762,Benign Cellular Infiltrate,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
20763,Malignant Cellular Infiltrate,Mediastinal Neurofibroma
20764,Benign Cellular Infiltrate,Stage 3 Neuroblastoma
20765,Benign Cellular Infiltrate,Disseminated neuroblastoma
20766,Malignant Cellular Infiltrate,Mediastinal Schwannoma
20767,Benign Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v7
20768,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of ampulla of Vater
20769,Low Grade Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v7
20770,Benign Cellular Infiltrate,Large cell lung cancer stage II
20771,Benign Cellular Infiltrate,Stage IIB Lung Adenosquamous Carcinoma AJCC v7
20772,Malignant Cellular Infiltrate,Ossifying Renal Tumor of Infancy
20773,Malignant Cellular Infiltrate,Melanotic neurofibroma
20774,Benign Cellular Infiltrate,Stage IA Lung Adenocarcinoma AJCC v7
20775,Benign Cellular Infiltrate,Occult Lung Adenocarcinoma
20776,Benign Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7
20777,Benign Cellular Infiltrate,Stage IVA Bone Sarcoma AJCC v7
20778,Benign Cellular Infiltrate,Stage II Osteosarcoma AJCC v7
20779,Intermediate Grade Neuroendocrine Lesion,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
20780,Well Differentiated Neuroendocrine Lesion,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
20781,Well Differentiated Neuroendocrine Lesion,Biliary Intraepithelial Neoplasia-3
20782,Well Differentiated Neuroendocrine Lesion,Gastric Mixed Adenocarcinoma
20783,Low Grade Neuroendocrine Lesion,Gastric Mixed Adenocarcinoma
20784,Well Differentiated Neuroendocrine Lesion,Small cell carcinoma of esophagus
20785,Low Grade Neuroendocrine Lesion,Small cell carcinoma of esophagus
20786,Well Differentiated Neuroendocrine Lesion,Gastric Cardia Carcinoma
20787,Malignant Cellular Infiltrate,Sphenoid Sinus Schneiderian Papilloma
20788,Malignant Cellular Infiltrate,Maxillary Sinus Schneiderian Papilloma
20789,Malignant Cellular Infiltrate,Hard Palate Monomorphic Adenoma
20790,Malignant Cellular Infiltrate,Parotid monomorphic adenoma
20791,Benign Cellular Infiltrate,Anaplastic adrenocortical carcinoma
20792,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
20793,Benign Cellular Infiltrate,Adult Gliosarcoma
20794,Well Differentiated Neuroendocrine Lesion,mixed acinar-endocrine carcinoma of pancreas
20795,Benign Cellular Infiltrate,Favorable Non-Hodgkin Lymphoma
20796,Benign Cellular Infiltrate,Meningeal melanomatosis
20797,Benign Cellular Infiltrate,Large cell medulloblastoma
20798,Benign Cellular Infiltrate,Primary Effusion Lymphoma
20799,Well Differentiated Neuroendocrine Lesion,Squamous Cell Carcinoma of Anal Margin
20800,Benign Cellular Infiltrate,Malignant Ovarian Thecoma
20801,Malignant Cellular Infiltrate,Polyp of middle ear
20802,Malignant Cellular Infiltrate,Cardiac fibroma
20803,Benign Cellular Infiltrate,Central Nervous System Extraskeletal Osteosarcoma
20804,Intermediate Grade Neuroendocrine Lesion,Esophageal Basaloid Carcinoma
20805,Benign Cellular Infiltrate,ISS Stage II Plasma Cell Myeloma
20806,Benign Cellular Infiltrate,Regressing Non-Cutaneous Melanoma
20807,Well Differentiated Neuroendocrine Lesion,Stage I Liver Carcinoma
20808,Low Grade Neuroendocrine Lesion,Stage III Liver Cancer
20809,Intermediate Grade Neuroendocrine Lesion,Stage IV Liver Cancer
20810,Malignant Cellular Infiltrate,benign granular cell tumor of gallbladder
20811,Benign Cellular Infiltrate,Aleukemic Chronic Lymphocytic Leukemia
20812,Benign Cellular Infiltrate,Smoldering Adult T-Cell Leukemia/Lymphoma
20813,Benign Cellular Infiltrate,Hypopharyngeal Cancer
20814,Benign Cellular Infiltrate,Grade 3a Follicular Lymphoma
20815,Benign Cellular Infiltrate,Grade 2 Cutaneous Follicular Lymphoma
20816,Benign Cellular Infiltrate,Grade 1 Cutaneous Follicular Lymphoma
20817,Benign Cellular Infiltrate,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma
20818,Benign Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma
20819,Malignant Cellular Infiltrate,Benign Ovarian Seromucinous Tumor
20820,Borderline Lesion,Ovarian Solid Teratoma
20821,Malignant Cellular Infiltrate,Ovarian Cellular Fibroma
20822,Benign Cellular Infiltrate,Splenic Manifestation of T-Cell Prolymphocytic Leukemia
20823,Benign Cellular Infiltrate,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
20824,Benign Cellular Infiltrate,Nasopharyngeal Nonkeratinizing Carcinoma
20825,Malignant Cellular Infiltrate,Epithelioid hemangioma of skin
20826,Benign Cellular Infiltrate,Malignant neoplasm of oropharynx
20827,Benign Cellular Infiltrate,Malignant neoplasm tonsil
20828,Benign Cellular Infiltrate,Malignant Vaginal Neoplasm
20829,Benign Cellular Infiltrate,AIDS-Related Cervical Carcinoma
20830,Benign Cellular Infiltrate,AIDS-Related Cervical Kaposi Sarcoma
20831,Intermediate Grade Neuroendocrine Lesion,Anal canal squamous cell carcinoma
20832,Benign Cellular Infiltrate,Primary ameloblastic carcinoma
20833,Benign Cellular Infiltrate,Secondary malignant neoplasm of pharynx
20834,Benign Cellular Infiltrate,Prostate cancer stage C
20835,Malignant Cellular Infiltrate,"Adenoma, Sweat Gland"
20836,Benign Cellular Infiltrate,Thymic Carcinoma
20837,Malignant Cellular Infiltrate,Benign melanocytic nevus
20838,Benign Cellular Infiltrate,Malignant myoepithelioma
20839,Malignant Cellular Infiltrate,Oral Cavity Benign Granular Cell Tumor
20840,Malignant Cellular Infiltrate,Benign neoplasm of oral cavity
20841,Malignant Cellular Infiltrate,Benign neoplasm of oral cavity
20842,Benign Cellular Infiltrate,Primary cerebral lymphoma
20843,Benign Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma
20844,Benign Cellular Infiltrate,Recurrent Female Reproductive System Carcinoma
20845,Intermediate Grade Neuroendocrine Lesion,Recurrent Digestive System Carcinoma
20846,Benign Cellular Infiltrate,Bilateral Malignant Neoplasm
20847,Benign Cellular Infiltrate,Metastatic Ductal Breast Carcinoma
20848,Benign Cellular Infiltrate,Epipodophyllotoxin-Related Myelodysplastic Syndrome
20849,Benign Cellular Infiltrate,Alkylating Agent-Related Myelodysplastic Syndrome
20850,Benign Cellular Infiltrate,malignant ganglioneuroblastoma of adrenal gland
20851,Intermediate Grade Neuroendocrine Lesion,Hepatoma resectable
20852,Benign Cellular Infiltrate,Adult Non-Hodgkin Lymphoma
20853,Benign Cellular Infiltrate,Childhood Rhabdomyosarcoma
20854,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of appendix
20855,Benign Cellular Infiltrate,Cardiac Sarcoma
20856,Benign Cellular Infiltrate,Squamous cell carcinoma of penis
20857,Benign Cellular Infiltrate,sarcoma of vagina
20858,Malignant Cellular Infiltrate,Brain Hemangioma
20859,Malignant Cellular Infiltrate,Digestive System Hemangioma
20860,Intermediate Grade Neuroendocrine Lesion,Stage III Carcinoma of Stomach
20861,Intermediate Grade Neuroendocrine Lesion,Stage III Anal Canal Cancer AJCC v6 and v7
20862,Intermediate Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v6
20863,Low Grade Neuroendocrine Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7
20864,Benign Cellular Infiltrate,Recurrent Childhood Rhabdomyosarcoma
20865,Benign Cellular Infiltrate,Stage I Renal Cell Carcinoma
20866,Benign Cellular Infiltrate,Stage II Renal Cell Cancer
20867,Benign Cellular Infiltrate,Ovarian cancer stage III
20868,Benign Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v6 and v7
20869,Benign Cellular Infiltrate,Intraocular retinoblastoma
20870,Benign Cellular Infiltrate,DS Stage II Plasma Cell Myeloma
20871,Benign Cellular Infiltrate,Small cell lung cancer limited stage
20872,Benign Cellular Infiltrate,Stage I Vulvar Carcinoma
20873,Well Differentiated Neuroendocrine Lesion,Localized Resectable Adult Liver Carcinoma
20874,Intermediate Grade Neuroendocrine Lesion,Localized Resectable Adult Liver Carcinoma
20875,Intermediate Grade Neuroendocrine Lesion,Recurrent Adult Liver Carcinoma
20876,Intermediate Grade Neuroendocrine Lesion,Unresectable Gallbladder Carcinoma
20877,Well Differentiated Neuroendocrine Lesion,Localized Extrahepatic Bile Duct Carcinoma
20878,Intermediate Grade Neuroendocrine Lesion,Localized Extrahepatic Bile Duct Carcinoma
20879,Intermediate Grade Neuroendocrine Lesion,Unresectable Extrahepatic Bile Duct Carcinoma
20880,Benign Cellular Infiltrate,Stage I Carcinoma of Bladder
20881,Benign Cellular Infiltrate,Recurrent Skin Carcinoma
20882,Benign Cellular Infiltrate,Recurrent Kaposi Sarcoma
20883,Well Differentiated Neuroendocrine Lesion,Childhood Hepatocellular Carcinoma
20884,Intermediate Grade Neuroendocrine Lesion,Adult Hepatocellular Carcinoma
20885,Benign Cellular Infiltrate,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
20886,Intermediate Grade Neuroendocrine Lesion,Mucinous adenocarcinoma of colon
20887,Well Differentiated Neuroendocrine Lesion,Anaplastic Carcinoma of the Rectum
20888,Intermediate Grade Neuroendocrine Lesion,Acinar cell carcinoma of pancreas
20889,Benign Cellular Infiltrate,Intermediate Cell Type Uveal Melanoma
20890,Mitotic Activity,Parathyroid transitional clear cell adenoma
20891,Broad Fibrous Bands Formation,Parathyroid mixed cell type adenoma
20892,Benign Cellular Infiltrate,"Thymoma, type A, malignant"
20893,Benign Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma
20894,Benign Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities
20895,Benign Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7
20896,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
20897,Benign Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
20898,Benign Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
20899,Benign Cellular Infiltrate,Oropharyngeal cancer recurrent
20900,Benign Cellular Infiltrate,Stage II Childhood Hodgkin Lymphoma
20901,Benign Cellular Infiltrate,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma
20902,Benign Cellular Infiltrate,Stage I Adult Burkitt Lymphoma
20903,Benign Cellular Infiltrate,Recurrent Adult Non-Hodgkin Lymphoma
20904,Benign Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary
20905,Benign Cellular Infiltrate,Dysgerminoma of ovary
20906,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 1 Follicular Lymphoma
20907,Benign Cellular Infiltrate,Ann Arbor Stage III Grade 3 Follicular Lymphoma
20908,Benign Cellular Infiltrate,Stage III Adult Immunoblastic Lymphoma
20909,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma stage IV
20910,Benign Cellular Infiltrate,Ann Arbor Stage IV Grade 2 Follicular Lymphoma
20911,Benign Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma
20912,Benign Cellular Infiltrate,Verrucous carcinoma of oral cavity
20913,Malignant Cellular Infiltrate,Disseminated Juvenile Xanthogranuloma
20914,Benign Cellular Infiltrate,mucoepidermoid carcinoma of floor of mouth
20915,Benign Cellular Infiltrate,Laryngeal verrucous carcinoma
20916,Benign Cellular Infiltrate,Subglottic Verrucous Carcinoma
20917,Malignant Cellular Infiltrate,Inverting papilloma of the nasal cavity
20918,Benign Cellular Infiltrate,Stage II Lip Basal Cell Carcinoma
20919,Benign Cellular Infiltrate,Stage III Lip Basal Cell Carcinoma
20920,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage III
20921,Benign Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage III
20922,Benign Cellular Infiltrate,Stage IV Lip Basal Cell Carcinoma
20923,Benign Cellular Infiltrate,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
20924,Benign Cellular Infiltrate,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
20925,Benign Cellular Infiltrate,Mixed phenotype acute leukemia B/myeloid
20926,Benign Cellular Infiltrate,Mixed phenotype acute leukemia T/myeloid
20927,Benign Cellular Infiltrate,NK-lymphoblastic leukemia/lymphoma
20928,Benign Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage I
20929,Benign Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage III
20930,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage I
20931,Benign Cellular Infiltrate,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
20932,Benign Cellular Infiltrate,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
20933,Benign Cellular Infiltrate,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
20934,Benign Cellular Infiltrate,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
20935,Benign Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage IV
20936,Benign Cellular Infiltrate,Treatment related acute myeloid leukaemia
20937,Benign Cellular Infiltrate,Adult Anaplastic Astrocytoma
20938,Benign Cellular Infiltrate,Stage II Uterine Sarcoma AJCC v7
20939,Benign Cellular Infiltrate,Refractory Neutropenia
20940,Low Grade Neuroendocrine Lesion,Adenocarcinoma of pancreas
20941,Benign Cellular Infiltrate,Desmoplastic Small Round Cell Tumor
20942,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with Minimal Differentiation
20943,Benign Cellular Infiltrate,Carcinoma of soft palate
20944,Intermediate Grade Neuroendocrine Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
20945,Malignant Cellular Infiltrate,Ossifying Fibroma
20946,Benign Cellular Infiltrate,Stage 0 Cutaneous Melanoma AJCC v6 and v7
20947,Benign Cellular Infiltrate,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement
20948,Benign Cellular Infiltrate,Tibial adamantinoma
20949,Benign Cellular Infiltrate,Stage I Indolent Adult Non-Hodgkin Lymphoma
20950,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
20951,Benign Cellular Infiltrate,Mantle cell lymphoma stage III
20952,Benign Cellular Infiltrate,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma
20953,Benign Cellular Infiltrate,Recurrent Indolent Adult Non-Hodgkin Lymphoma
20954,Benign Cellular Infiltrate,Stage II Hodgkin Lymphoma
20955,Malignant Cellular Infiltrate,Benign neoplasm of chest wall
20956,Malignant Cellular Infiltrate,Benign neoplasm of accessory sinus
20957,Benign Cellular Infiltrate,Secondary malignant neoplasm of choroid
20958,Benign Cellular Infiltrate,Secondary malignant neoplasm of retina
20959,Benign Cellular Infiltrate,Stage IB Adult Soft Tissue Sarcoma AJCC v7
20960,Benign Cellular Infiltrate,Localized Malignant Neoplasm
20961,Benign Cellular Infiltrate,Stage IB Soft Tissue Sarcoma AJCC v7
20962,Benign Cellular Infiltrate,Postcricoid cancer
20963,Benign Cellular Infiltrate,Stage IA Cutaneous Melanoma AJCC v7
20964,Benign Cellular Infiltrate,Stage IB Cutaneous Melanoma AJCC v7
20965,Benign Cellular Infiltrate,Stage IIA Cutaneous Melanoma AJCC v6 and v7
20966,Intermediate Grade Neuroendocrine Lesion,Esophageal adenocarcinoma recurrent
20967,Intermediate Grade Neuroendocrine Lesion,Stage III Esophageal Adenocarcinoma AJCC v7
20968,Low Grade Neuroendocrine Lesion,Stage III Rectosigmoid Cancer AJCC v6
20969,Low Grade Neuroendocrine Lesion,Small intestine carcinoma non-resectable
20970,Benign Cellular Infiltrate,"Myelodysplastic syndrome, no ICD-O subtype"
20971,Benign Cellular Infiltrate,Anaplastic large cell lymphoma T- and null-cell types refractory
20972,Benign Cellular Infiltrate,Angiocentric lymphoma stage IV
20973,Benign Cellular Infiltrate,Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
20974,Benign Cellular Infiltrate,Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma
20975,Benign Cellular Infiltrate,Pleural mesothelioma malignant recurrent
20976,Benign Cellular Infiltrate,Stage IIIB Uterine Sarcoma AJCC v7
20977,Benign Cellular Infiltrate,Stage IIIC Uterine Sarcoma AJCC v7
20978,Benign Cellular Infiltrate,Ureteric cancer regional
20979,Benign Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v7
20980,Benign Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
20981,Benign Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage II
20982,Benign Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
20983,Benign Cellular Infiltrate,Stage IV Ovarian Teratoma AJCC v6 and v7
20984,Benign Cellular Infiltrate,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8"
20985,Benign Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7
20986,Benign Cellular Infiltrate,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7
20987,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
20988,Benign Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
20989,Benign Cellular Infiltrate,"Adenocarcinoma of lung, stage III"
20990,Well Differentiated Neuroendocrine Lesion,Stage IIA Gastric Cancer AJCC v7
20991,Well Differentiated Neuroendocrine Lesion,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
20992,Low Grade Neuroendocrine Lesion,Stage IIIA Esophageal Adenocarcinoma AJCC v7
20993,Low Grade Neuroendocrine Lesion,Stage IIIB Esophageal Adenocarcinoma AJCC v7
20994,Well Differentiated Neuroendocrine Lesion,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
20995,Low Grade Neuroendocrine Lesion,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
20996,Well Differentiated Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v7
20997,Intermediate Grade Neuroendocrine Lesion,Stage IIA Appendix Carcinoma AJCC v7
20998,Intermediate Grade Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v7
20999,Well Differentiated Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v7
21000,Low Grade Neuroendocrine Lesion,Stage IIIB Appendix Carcinoma AJCC v7
21001,Intermediate Grade Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v7
21002,Low Grade Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v7
21003,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v7
21004,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Cancer AJCC v7
21005,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Colorectal Cancer AJCC v7
21006,Intermediate Grade Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v7
21007,Benign Cellular Infiltrate,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
21008,Benign Cellular Infiltrate,Stage II Superficial Spreading Melanoma AJCC v6 and v7
21009,Benign Cellular Infiltrate,Extra-osseous Ewing's sarcoma non-metastatic
21010,Poorly Differentiated Neuroendocrine Lesion,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
21011,Low Grade Neuroendocrine Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
21012,Intermediate Grade Neuroendocrine Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v7
21013,Low Grade Neuroendocrine Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v7
21014,Benign Cellular Infiltrate,Recurrent Extraskeletal Myxoid Chondrosarcoma
21015,Well Differentiated Neuroendocrine Lesion,Stage IB Distal Bile Duct Cancer AJCC v7
21016,Low Grade Neuroendocrine Lesion,Stage IB Distal Bile Duct Cancer AJCC v7
21017,Intermediate Grade Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v7
21018,Well Differentiated Neuroendocrine Lesion,Stage III Distal Bile Duct Cancer AJCC v7
21019,Low Grade Neuroendocrine Lesion,Stage IV Distal Bile Duct Cancer AJCC v7
21020,Well Differentiated Neuroendocrine Lesion,Stage IIB Ampulla of Vater Cancer AJCC v7
21021,Low Grade Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v6 and v7
21022,Well Differentiated Neuroendocrine Lesion,Stage IB Pancreatic Cancer AJCC v6 and v7
21023,Benign Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v7
21024,Benign Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v7
21025,Benign Cellular Infiltrate,Leukemic infiltration of skin
21026,Benign Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7
21027,Benign Cellular Infiltrate,Liposarcoma non-metastatic
21028,Benign Cellular Infiltrate,Synovial sarcoma metastatic
21029,Benign Cellular Infiltrate,Synovial sarcoma non-metastatic
21030,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified
21031,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis recurrent
21032,Benign Cellular Infiltrate,malignant neoplasm of breast stage I
21033,Benign Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage IV
21034,Benign Cellular Infiltrate,Stage II Burkitt Lymphoma
21035,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma recurrent
21036,Benign Cellular Infiltrate,Malignant Extragonadal Germ Cell Tumor
21037,Benign Cellular Infiltrate,Testicular choriocarcinoma stage I
21038,Benign Cellular Infiltrate,Testicular embryonal carcinoma stage I
21039,Benign Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7
21040,Benign Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7
21041,Intermediate Grade Neuroendocrine Lesion,Pancreatic adenocarcinoma metastatic
21042,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage II
21043,Benign Cellular Infiltrate,Stage 0 Vulvar Cancer
21044,Malignant Cellular Infiltrate,Hereditary Kidney Oncocytoma
21045,Well Differentiated Neuroendocrine Lesion,Stage III Esophageal Cancer AJCC v7
21046,Well Differentiated Neuroendocrine Lesion,Stage IV Esophageal Cancer AJCC v7
21047,Intermediate Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage I
21048,Well Differentiated Neuroendocrine Lesion,Malignant neoplasm of stomach stage II
21049,Benign Cellular Infiltrate,Ureter Carcinoma
21050,Low Grade Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v7
21051,Low Grade Neuroendocrine Lesion,Stage II Colon Cancer AJCC v7
21052,Well Differentiated Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v7
21053,Low Grade Neuroendocrine Lesion,Stage IV Colorectal Cancer AJCC v7
21054,Intermediate Grade Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v7
21055,Intermediate Grade Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v7
21056,Malignant Cellular Infiltrate,Adrenal Cortical Adenoma
21057,Geographic Necrosis,Mature Teratoma
21058,Benign Cellular Infiltrate,AIDS-Related Primary Effusion Lymphoma
21059,Benign Cellular Infiltrate,"Acute myeloid leukemia, inv(16)(p13q22)"
21060,Benign Cellular Infiltrate,Well Differentiated Fibrosarcoma
21061,Benign Cellular Infiltrate,FNCLCC Sarcoma Grade 2
21062,Benign Cellular Infiltrate,Vaginal Cancer by AJCC v6 Stage
21063,Well Differentiated Neuroendocrine Lesion,Gastric carcinoma stage IV
21064,Low Grade Neuroendocrine Lesion,Gastric carcinoma stage IV
21065,Benign Cellular Infiltrate,Pediatric Intraocular Retinoblastoma
21066,Benign Cellular Infiltrate,Small cell lung cancer recurrent
21067,Well Differentiated Neuroendocrine Lesion,Rectal Cancer by AJCC v6 Stage
21068,Benign Cellular Infiltrate,Lung Cancer by AJCC v6 Stage
21069,Benign Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v6 Stage
21070,Benign Cellular Infiltrate,Recurrent Vulvar Carcinoma
21071,Benign Cellular Infiltrate,Bartholin's gland carcinoma
21072,Benign Cellular Infiltrate,Malignant Testicular Germ Cell Tumor
21073,Benign Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
21074,Benign Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
21075,Benign Cellular Infiltrate,Childhood Burkitt Lymphoma
21076,Benign Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7
21077,Benign Cellular Infiltrate,Urethral Carcinoma
21078,Benign Cellular Infiltrate,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
21079,Benign Cellular Infiltrate,Sarcoma
21080,Low Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v7 Stage
21081,Low Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v7 Stage
21082,Intermediate Grade Neuroendocrine Lesion,Colon Cancer by AJCC v7 Stage
21083,Low Grade Neuroendocrine Lesion,Rectosigmoid Cancer by AJCC v7 Stage
21084,Intermediate Grade Neuroendocrine Lesion,Hepatocellular Carcinoma by AJCC v7 Stage
21085,Benign Cellular Infiltrate,Penile Cancer by AJCC v7 Stage
21086,Benign Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v7 Stage
21087,Benign Cellular Infiltrate,Adult Nodular Sclerosis Classical Hodgkin Lymphoma
21088,Benign Cellular Infiltrate,Philadelphia chromosome positive chronic myelogenous leukemia
21089,Benign Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia
21090,Benign Cellular Infiltrate,Superficial spreading malignant melanoma of skin
21091,Benign Cellular Infiltrate,Adult Acute Myeloblastic Leukemia
21092,Benign Cellular Infiltrate,Childhood Acute Monocytic Leukemia
21093,Intermediate Grade Neuroendocrine Lesion,undifferentiated carcinoma of gallbladder
21094,Benign Cellular Infiltrate,Carcinoma in situ of middle ear
21095,Benign Cellular Infiltrate,Stage IV Uterine Sarcoma AJCC v7
21096,Benign Cellular Infiltrate,Uterine Corpus Carcinosarcoma
21097,Benign Cellular Infiltrate,Stage III Childhood Burkitt Lymphoma
21098,Benign Cellular Infiltrate,Stage III renal cell cancer
21099,Benign Cellular Infiltrate,Hereditary Papillary Renal Carcinoma
21100,Well Differentiated Neuroendocrine Lesion,Recurrent Rectal Cancer
21101,Low Grade Neuroendocrine Lesion,Recurrent Rectal Cancer
21102,Benign Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
21103,Benign Cellular Infiltrate,Mycosis fungoides/Sezary syndrome NOS
21104,Benign Cellular Infiltrate,Advanced cancer
21105,Benign Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)"
21106,Low Grade Neuroendocrine Lesion,Adenocarcinoma of the gastroesophageal junction
21107,Benign Cellular Infiltrate,Malignant neoplasm of postcricoid region
21108,Low Grade Neuroendocrine Lesion,Carcinoma of the Appendix
21109,Benign Cellular Infiltrate,Malignant neoplasm of urinary bladder
21110,Benign Cellular Infiltrate,Malignant neoplasm of breast
21111,Benign Cellular Infiltrate,Cancer of Ear
21112,Low Grade Neuroendocrine Lesion,Duodenal carcinoma recurrent
21113,Benign Cellular Infiltrate,Pigmented Basal Cell Carcinoma
21114,Benign Cellular Infiltrate,Adult Brain Stem Gliosarcoma
21115,Benign Cellular Infiltrate,Adult Brain Medulloblastoma
21116,Benign Cellular Infiltrate,Angiosarcoma NCI Grade 2
21117,Benign Cellular Infiltrate,Low Grade Sarcoma
21118,Benign Cellular Infiltrate,Conventional Angiosarcoma
21119,Well Differentiated Neuroendocrine Lesion,Grade 1 Colorectal Adenocarcinoma
21120,Intermediate Grade Neuroendocrine Lesion,Grade 2 Colorectal Adenocarcinoma
21121,Well Differentiated Neuroendocrine Lesion,Grade 1 Rectal Adenocarcinoma
21122,Well Differentiated Neuroendocrine Lesion,Stage I Adult Liver Cancer AJCC v7
21123,Low Grade Neuroendocrine Lesion,Stage II Adult Liver Cancer AJCC v7
21124,Intermediate Grade Neuroendocrine Lesion,Stage III Adult Liver Cancer AJCC v7
21125,Low Grade Neuroendocrine Lesion,Stage IIIC Adult Liver Cancer AJCC v7
21126,Benign Cellular Infiltrate,Ann Arbor Stage I AIDS-Related Lymphoma
21127,Benign Cellular Infiltrate,Ann Arbor Stage III AIDS-Related Lymphoma
21128,Benign Cellular Infiltrate,Thymoliposarcoma
21129,Intermediate Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma
21130,Low Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma
21131,Intermediate Grade Neuroendocrine Lesion,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
21132,Intermediate Grade Neuroendocrine Lesion,Mixed Acinar-Ductal Carcinoma of the Pancreas
21133,Low Grade Neuroendocrine Lesion,Pancreatic Medullary Carcinoma
21134,Intermediate Grade Neuroendocrine Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
21135,Mitotic Activity,benign mature teratoma of pancreas
21136,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Somatostatinoma
21137,Well Differentiated Neuroendocrine Lesion,Esophageal Spindle Cell Carcinoma
21138,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma
21139,Low Grade Neuroendocrine Lesion,Poorly Cohesive Gastric Carcinoma
21140,Intermediate Grade Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma
21141,Low Grade Neuroendocrine Lesion,Gastric Mixed Adenoneuroendocrine Carcinoma
21142,Malignant Cellular Infiltrate,Gastric Schwannoma
21143,Low Grade Neuroendocrine Lesion,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
21144,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Hepatoid Adenocarcinoma
21145,Low Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Carcinoma
21146,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
21147,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor
21148,Well Differentiated Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma
21149,Poorly Differentiated Neuroendocrine Lesion,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
21150,Poorly Differentiated Neuroendocrine Lesion,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
21151,Well Differentiated Neuroendocrine Lesion,Rectal Serrated Adenocarcinoma
21152,Low Grade Neuroendocrine Lesion,Colon Micropapillary Adenocarcinoma
21153,Low Grade Neuroendocrine Lesion,Colorectal Sarcomatoid Carcinoma
21154,Well Differentiated Neuroendocrine Lesion,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
21155,Intermediate Grade Neuroendocrine Lesion,Crohn Disease-Associated Colorectal Adenocarcinoma
21156,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of anal canal
21157,Intermediate Grade Neuroendocrine Lesion,neuroendocrine carcinoma of anal canal
21158,Well Differentiated Neuroendocrine Lesion,Anal Canal Mixed Adenoneuroendocrine Carcinoma
21159,Well Differentiated Neuroendocrine Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma
21160,Well Differentiated Neuroendocrine Lesion,Well Differentiated Hepatocellular Carcinoma
21161,Low Grade Neuroendocrine Lesion,Poorly Differentiated Hepatocellular Carcinoma
21162,Low Grade Neuroendocrine Lesion,carcinosarcoma of liver
21163,Well Differentiated Neuroendocrine Lesion,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
21164,Low Grade Neuroendocrine Lesion,intestinal type adenocarcinoma of extrahepatic bile duct
21165,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
21166,Well Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct
21167,Intermediate Grade Neuroendocrine Lesion,Gastrointestinal carcinoma
21168,Low Grade Neuroendocrine Lesion,Gastrointestinal carcinoma
21169,Benign Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
21170,Benign Cellular Infiltrate,Myelodysplastic Syndrome with Gene Mutation
21171,Benign Cellular Infiltrate,Uterine Ligament Adenosarcoma
21172,Benign Cellular Infiltrate,Hereditary Prostate Carcinoma
21173,Benign Cellular Infiltrate,Class 1a Uveal Melanoma
21174,Benign Cellular Infiltrate,Adult Favorable Prognosis Hodgkin Lymphoma
21175,Benign Cellular Infiltrate,Childhood Unfavorable Prognosis Hodgkin Lymphoma
21176,Benign Cellular Infiltrate,Adult Epithelioid Hemangioendothelioma
21177,Benign Cellular Infiltrate,Hormone refractory breast cancer
21178,Well Differentiated Neuroendocrine Lesion,Adult Pleomorphic Hepatocellular Carcinoma
21179,Well Differentiated Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v7
21180,Well Differentiated Neuroendocrine Lesion,Stage IIA Rectal Cancer AJCC v7
21181,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v7
21182,Low Grade Neuroendocrine Lesion,Stage IIIC Colon Cancer AJCC v7
21183,Well Differentiated Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v7
21184,Well Differentiated Neuroendocrine Lesion,Stage IVA Colon Cancer AJCC v7
21185,Benign Cellular Infiltrate,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
21186,Benign Cellular Infiltrate,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
21187,Benign Cellular Infiltrate,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
21188,Benign Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
21189,Benign Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
21190,Benign Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v7
21191,Well Differentiated Neuroendocrine Lesion,Stage IB Esophageal Cancer AJCC v7
21192,Low Grade Neuroendocrine Lesion,Stage IB Esophageal Cancer AJCC v7
21193,Benign Cellular Infiltrate,Stage IIA Uterine Sarcoma AJCC v7
21194,Well Differentiated Neuroendocrine Lesion,Hepatocellular Carcinoma by BCLC Stage
21195,Intermediate Grade Neuroendocrine Lesion,BCLC Stage 0 Hepatocellular Carcinoma
21196,Low Grade Neuroendocrine Lesion,BCLC Stage 0 Hepatocellular Carcinoma
21197,Low Grade Neuroendocrine Lesion,BCLC Stage D Adult Hepatocellular Carcinoma
21198,Benign Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Tumor G1
21199,Benign Cellular Infiltrate,Recurrent Olfactory Neuroblastoma
21200,Benign Cellular Infiltrate,Recurrent Primary Peritoneal Carcinoma
21201,Low Grade Neuroendocrine Lesion,Childhood Esophageal Carcinoma
21202,Benign Cellular Infiltrate,Childhood Bladder Carcinoma
21203,Benign Cellular Infiltrate,Sclerosing rhabdomyosarcoma
21204,Benign Cellular Infiltrate,Undifferentiated round cell sarcoma
21205,Malignant Cellular Infiltrate,Osteochondromyxoma
21206,Benign Cellular Infiltrate,DDIT4L Acute Lymphoblastic Leukemia
21207,Benign Cellular Infiltrate,ROSE Cluster 1
21208,Benign Cellular Infiltrate,Infant Leukemia
21209,Benign Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome
21210,Benign Cellular Infiltrate,Cytogenetically normal acute myeloid leukemia
21211,Benign Cellular Infiltrate,Core binding factor acute myeloid leukemia
21212,Benign Cellular Infiltrate,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
21213,Benign Cellular Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis
21214,Benign Cellular Infiltrate,Fusion-Positive Rhabdomyosarcoma
21215,Benign Cellular Infiltrate,Refractory Malignant Germ Cell Tumor
21216,Benign Cellular Infiltrate,Childhood Thyroid Gland Medullary Carcinoma
21217,Intermediate Grade Neuroendocrine Lesion,Childhood Small Intestinal Carcinoma
21218,Benign Cellular Infiltrate,Childhood Ganglioneuroblastoma
21219,Benign Cellular Infiltrate,Infant T Acute Lymphoblastic Leukemia
21220,Benign Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma
21221,Benign Cellular Infiltrate,Follicular Variant Thyroid Gland Papillary Carcinoma
21222,Benign Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma
21223,Benign Cellular Infiltrate,Vaginal Papillary Carcinoma
21224,Benign Cellular Infiltrate,Ovarian Cancer by FIGO Stage
21225,Benign Cellular Infiltrate,Gingival Spindle Cell Carcinoma
21226,Benign Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Wildtype"
21227,Benign Cellular Infiltrate,Small Cell Adenocarcinoma
21228,Malignant Cellular Infiltrate,Intracranial Benign Fibrous Histiocytoma
21229,Benign Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PCM1-JAK2
21230,Benign Cellular Infiltrate,Urothelial carcinoma urethra recurrent
21231,Benign Cellular Infiltrate,Childhood Melanoma
21232,Malignant Cellular Infiltrate,Anastomosing Hemangioma
21233,Benign Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2
21234,Benign Cellular Infiltrate,Acute Megakaryoblastic Leukemia with NUP98-KDM5A
21235,Benign Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v8
21236,Benign Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v8
21237,Benign Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v8
21238,Benign Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v8
21239,Benign Cellular Infiltrate,Unresectable Ewing Sarcoma
21240,Benign Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage
21241,Benign Cellular Infiltrate,Recurrent Breast Angiosarcoma
21242,Benign Cellular Infiltrate,Stage I Laryngeal Cancer AJCC v8
21243,Intermediate Grade Neuroendocrine Lesion,Esophageal Adenocarcinoma by AJCC v8 Stage
21244,Intermediate Grade Neuroendocrine Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
21245,Well Differentiated Neuroendocrine Lesion,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
21246,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
21247,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21248,Well Differentiated Neuroendocrine Lesion,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
21249,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
21250,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
21251,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
21252,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
21253,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
21254,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
21255,Intermediate Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
21256,Intermediate Grade Neuroendocrine Lesion,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
21257,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21258,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
21259,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21260,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
21261,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
21262,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21263,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
21264,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
21265,Low Grade Neuroendocrine Lesion,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21266,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
21267,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21268,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21269,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
21270,Well Differentiated Neuroendocrine Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
21271,Intermediate Grade Neuroendocrine Lesion,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21272,Well Differentiated Neuroendocrine Lesion,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21273,Intermediate Grade Neuroendocrine Lesion,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21274,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
21275,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21276,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21277,Well Differentiated Neuroendocrine Lesion,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21278,Low Grade Neuroendocrine Lesion,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21279,Low Grade Neuroendocrine Lesion,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
21280,Low Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
21281,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
21282,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21283,Benign Cellular Infiltrate,Recurrent Classic Hodgkin Lymphoma
21284,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v8 Pathologic Stage
21285,Well Differentiated Neuroendocrine Lesion,Clinical Stage 0 Gastric Cancer AJCC v8
21286,Intermediate Grade Neuroendocrine Lesion,Clinical Stage 0 Gastric Cancer AJCC v8
21287,Low Grade Neuroendocrine Lesion,Clinical Stage II Gastric Cancer AJCC v8
21288,Well Differentiated Neuroendocrine Lesion,Clinical Stage IVB Gastric Cancer AJCC v8
21289,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8
21290,Well Differentiated Neuroendocrine Lesion,Pathologic Stage I Gastric Cancer AJCC v8
21291,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IA Gastric Cancer AJCC v8
21292,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IB Gastric Cancer AJCC v8
21293,Low Grade Neuroendocrine Lesion,Pathologic Stage III Gastric Cancer AJCC v8
21294,Intermediate Grade Neuroendocrine Lesion,Pathologic Stage IIIA Gastric Cancer AJCC v8
21295,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIA Gastric Cancer AJCC v8
21296,Low Grade Neuroendocrine Lesion,Pathologic Stage IIIB Gastric Cancer AJCC v8
21297,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
21298,Well Differentiated Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
21299,Intermediate Grade Neuroendocrine Lesion,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
21300,Low Grade Neuroendocrine Lesion,Appendix Carcinoma by AJCC v7 Stage
21301,Intermediate Grade Neuroendocrine Lesion,Anal Canal Cancer by AJCC v6 and v7 Stage
21302,Low Grade Neuroendocrine Lesion,Anal Canal Cancer by AJCC v6 and v7 Stage
21303,Low Grade Neuroendocrine Lesion,Anal Cancer by AJCC v8 Stage
21304,Well Differentiated Neuroendocrine Lesion,Stage I Anal Cancer AJCC v8
21305,Well Differentiated Neuroendocrine Lesion,Stage IV Anal Cancer AJCC v8
21306,Low Grade Neuroendocrine Lesion,Small Intestinal Adenocarcinoma by AJCC v8 Stage
21307,Low Grade Neuroendocrine Lesion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
21308,Well Differentiated Neuroendocrine Lesion,Stage I Small Intestinal Adenocarcinoma AJCC v8
21309,Intermediate Grade Neuroendocrine Lesion,Stage II Appendix Carcinoma AJCC v8
21310,Well Differentiated Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v8
21311,Well Differentiated Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v8
21312,Well Differentiated Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v8
21313,Low Grade Neuroendocrine Lesion,Stage IV Appendix Carcinoma AJCC v8
21314,Low Grade Neuroendocrine Lesion,Stage IVA Appendix Carcinoma AJCC v8
21315,Intermediate Grade Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v8
21316,Well Differentiated Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v8
21317,Well Differentiated Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v8
21318,Intermediate Grade Neuroendocrine Lesion,Stage II Colorectal Cancer AJCC v8
21319,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v8
21320,Low Grade Neuroendocrine Lesion,Stage IIIA Colorectal Cancer AJCC v8
21321,Well Differentiated Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v8
21322,Intermediate Grade Neuroendocrine Lesion,Stage IVA Colorectal Cancer AJCC v8
21323,Intermediate Grade Neuroendocrine Lesion,Stage IVB Colorectal Cancer AJCC v8
21324,Well Differentiated Neuroendocrine Lesion,Stage IIA Colon Cancer AJCC v8
21325,Intermediate Grade Neuroendocrine Lesion,Stage IIIB Colon Cancer AJCC v8
21326,Intermediate Grade Neuroendocrine Lesion,Stage IVB Colon Cancer AJCC v8
21327,Well Differentiated Neuroendocrine Lesion,Stage IVC Colon Cancer AJCC v8
21328,Low Grade Neuroendocrine Lesion,Stage II Rectal Cancer AJCC v8
21329,Intermediate Grade Neuroendocrine Lesion,Stage IIC Rectal Cancer AJCC v8
21330,Intermediate Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v8
21331,Low Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v8
21332,Well Differentiated Neuroendocrine Lesion,Stage IIIA Rectal Cancer AJCC v8
21333,Low Grade Neuroendocrine Lesion,Stage IIIB Rectal Cancer AJCC v8
21334,Well Differentiated Neuroendocrine Lesion,Stage IVB Rectal Cancer AJCC v8
21335,Low Grade Neuroendocrine Lesion,Stage IVC Rectal Cancer AJCC v8
21336,Low Grade Neuroendocrine Lesion,Stage I Hepatocellular Carcinoma AJCC v8
21337,Intermediate Grade Neuroendocrine Lesion,Stage IA Hepatocellular Carcinoma AJCC v8
21338,Intermediate Grade Neuroendocrine Lesion,Stage IB Hepatocellular Carcinoma AJCC v8
21339,Low Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v8
21340,Well Differentiated Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v8
21341,Intermediate Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
21342,Low Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
21343,Well Differentiated Neuroendocrine Lesion,Stage I Intrahepatic Bile Duct Cancer AJCC v8
21344,Intermediate Grade Neuroendocrine Lesion,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
21345,Intermediate Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v8
21346,Well Differentiated Neuroendocrine Lesion,Stage IIIB Gallbladder Cancer AJCC v8
21347,Intermediate Grade Neuroendocrine Lesion,Stage IV Gallbladder Cancer AJCC v8
21348,Well Differentiated Neuroendocrine Lesion,Hilar Cholangiocarcinoma by AJCC v8 Stage
21349,Low Grade Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v8
21350,Low Grade Neuroendocrine Lesion,Stage III Hilar Cholangiocarcinoma AJCC v8
21351,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
21352,Well Differentiated Neuroendocrine Lesion,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
21353,Well Differentiated Neuroendocrine Lesion,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
21354,Well Differentiated Neuroendocrine Lesion,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
21355,Low Grade Neuroendocrine Lesion,Stage IIA Distal Bile Duct Cancer AJCC v8
21356,Benign Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia
21357,Benign Cellular Infiltrate,Refractory Ph-Like Acute Lymphoblastic Leukemia
21358,Low Grade Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v8
21359,Well Differentiated Neuroendocrine Lesion,Stage IA Ampulla of Vater Cancer AJCC v8
21360,Well Differentiated Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v8
21361,Intermediate Grade Neuroendocrine Lesion,Stage IB Ampulla of Vater Cancer AJCC v8
21362,Well Differentiated Neuroendocrine Lesion,Stage IIA Ampulla of Vater Cancer AJCC v8
21363,Well Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v8
21364,Low Grade Neuroendocrine Lesion,Stage IV Ampulla of Vater Cancer AJCC v8
21365,Well Differentiated Neuroendocrine Lesion,Stage IA Pancreatic Cancer AJCC v8
21366,Poorly Differentiated Neuroendocrine Lesion,Stage II Gastric Neuroendocrine Tumor AJCC v8
21367,Poorly Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8
21368,Poorly Differentiated Neuroendocrine Lesion,Stage I Duodenal Neuroendocrine Tumor AJCC v8
21369,Poorly Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor
21370,Poorly Differentiated Neuroendocrine Lesion,Stage I Jejunal Neuroendocrine Tumor AJCC v8
21371,Poorly Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
21372,Poorly Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor by AJCC v8 Stage
21373,Poorly Differentiated Neuroendocrine Lesion,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
21374,Benign Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8
21375,Benign Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage
21376,Benign Cellular Infiltrate,Lung Large Cell Carcinoma by AJCC v7 Stage
21377,Benign Cellular Infiltrate,Stage IIA Bone Cancer AJCC v8
21378,Benign Cellular Infiltrate,Stage III Bone Cancer AJCC v8
21379,Benign Cellular Infiltrate,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
21380,Benign Cellular Infiltrate,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
21381,Benign Cellular Infiltrate,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
21382,Benign Cellular Infiltrate,Stage II Retroperitoneal Sarcoma AJCC v8
21383,Benign Cellular Infiltrate,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
21384,Benign Cellular Infiltrate,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
21385,Benign Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Stage
21386,Benign Cellular Infiltrate,Clinical Stage IIB Cutaneous Melanoma AJCC v8
21387,Benign Cellular Infiltrate,Pathologic Stage IIA Cutaneous Melanoma AJCC v8
21388,Benign Cellular Infiltrate,Pleomorphic lobular carcinoma in situ of breast
21389,Benign Cellular Infiltrate,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
21390,Benign Cellular Infiltrate,Breast Cancer by AJCC v8 Anatomic Stage
21391,Benign Cellular Infiltrate,Anatomic Stage IIIA Breast Cancer AJCC v8
21392,Benign Cellular Infiltrate,Anatomic Stage IIIB Breast Cancer AJCC v8
21393,Benign Cellular Infiltrate,Malignant Neoplasm of Lung - Multiple Primary Sites
21394,Benign Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8
21395,Benign Cellular Infiltrate,Prognostic Stage IIB Breast Cancer AJCC v8
21396,Benign Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v8
21397,Benign Cellular Infiltrate,Stage IVB Vulvar Cancer AJCC v8
21398,Benign Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v8
21399,Benign Cellular Infiltrate,Stage IVB Uterine Corpus Cancer AJCC v8
21400,Benign Cellular Infiltrate,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8
21401,Benign Cellular Infiltrate,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
21402,Benign Cellular Infiltrate,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
21403,Benign Cellular Infiltrate,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
21404,Benign Cellular Infiltrate,Stage IV Uterine Corpus Adenosarcoma AJCC v8
21405,Benign Cellular Infiltrate,Stage I Ovarian Cancer AJCC v8
21406,Benign Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v8
21407,Benign Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v8
21408,Benign Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v8
21409,Benign Cellular Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v8
21410,Benign Cellular Infiltrate,Stage IVA Fallopian Tube Cancer AJCC v8
21411,Benign Cellular Infiltrate,Stage IIB Primary Peritoneal Cancer AJCC v8
21412,Benign Cellular Infiltrate,Stage II Penile Cancer AJCC v8
21413,Benign Cellular Infiltrate,Stage IIIA Penile Cancer AJCC v8
21414,Benign Cellular Infiltrate,Stage IV Prostate Cancer AJCC v8
21415,Benign Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8
21416,Benign Cellular Infiltrate,Testicular Cancer by AJCC v8 Stage
21417,Benign Cellular Infiltrate,Stage IS Testicular Cancer AJCC v8
21418,Benign Cellular Infiltrate,Stage III Testicular Cancer AJCC v8
21419,Benign Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8
21420,Benign Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v8 Stage
21421,Benign Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
21422,Benign Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8
21423,Benign Cellular Infiltrate,Stage II Renal Pelvis Cancer AJCC v8
21424,Benign Cellular Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage
21425,Benign Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v8
21426,Benign Cellular Infiltrate,Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8
21427,Benign Cellular Infiltrate,Clinical Stage I Retinoblastoma AJCC v8
21428,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
21429,Benign Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
21430,Benign Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
21431,Benign Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
21432,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
21433,Benign Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
21434,Benign Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
21435,Benign Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
21436,Benign Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
21437,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
21438,Benign Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v8 Stage
21439,Benign Cellular Infiltrate,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage
21440,Benign Cellular Infiltrate,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8
21441,Benign Cellular Infiltrate,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8
21442,Benign Cellular Infiltrate,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8
21443,Benign Cellular Infiltrate,Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8
21444,Benign Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8
21445,Benign Cellular Infiltrate,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
21446,Benign Cellular Infiltrate,Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8
21447,Benign Cellular Infiltrate,Stage B Chronic Lymphocytic Leukemia
21448,Benign Cellular Infiltrate,Follicular Lymphoma by Ann Arbor Stage
21449,Benign Cellular Infiltrate,Recurrent Malignant Glioma
21450,Benign Cellular Infiltrate,Recurrent Anaplastic Oligoastrocytoma
21451,Well Differentiated Neuroendocrine Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma
21452,Benign Cellular Infiltrate,Refractory Primary Cutaneous Lymphoma
21453,Benign Cellular Infiltrate,Recurrent Hairy Cell Leukemia
21454,Benign Cellular Infiltrate,Mediastinal/Thymic NUT Carcinoma
21455,Benign Cellular Infiltrate,Refractory Glioblastoma
21456,Benign Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor
21457,Benign Cellular Infiltrate,Metastatic Genitourinary System Carcinoma
21458,Benign Cellular Infiltrate,Mediastinal Epithelioid Hemangioendothelioma
21459,Benign Cellular Infiltrate,Hemangiosarcoma of heart
21460,Benign Cellular Infiltrate,Recurrent EBV-Related Lymphoma
21461,Benign Cellular Infiltrate,Childhood Malignant Solid Neoplasm
21462,Benign Cellular Infiltrate,Refractory Malignant Thymoma
21463,Benign Cellular Infiltrate,Unresectable Thymic Carcinoma
21464,Benign Cellular Infiltrate,Unresectable Cutaneous Melanoma
21465,Benign Cellular Infiltrate,Leukemia recurrent
21466,Benign Cellular Infiltrate,Advanced Urothelial Carcinoma
21467,Intermediate Grade Neuroendocrine Lesion,Gastric Cardia Squamous Cell Carcinoma
21468,Benign Cellular Infiltrate,Refractory Chronic Leukemia
21469,Benign Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma
21470,Benign Cellular Infiltrate,High-Risk Neuroblastoma
21471,Benign Cellular Infiltrate,Urothelial carcinoma ureter recurrent
21472,Benign Cellular Infiltrate,Refractory Malignant Endocrine Neoplasm
21473,Benign Cellular Infiltrate,Recurrent Malignant Urinary System Neoplasm
21474,Benign Cellular Infiltrate,Refractory Malignant Skin Neoplasm
21475,Intermediate Grade Neuroendocrine Lesion,Unresectable Gastroesophageal Junction Adenocarcinoma
21476,Benign Cellular Infiltrate,Recurrent Dedifferentiated Liposarcoma
21477,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Viscera
21478,Benign Cellular Infiltrate,Resectable Sarcoma
21479,Benign Cellular Infiltrate,Resectable Dedifferentiated Liposarcoma
21480,Benign Cellular Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
21481,Benign Cellular Infiltrate,Metastatic Gastrointestinal Stromal Tumor
21482,Well Differentiated Neuroendocrine Lesion,Recurrent Metastatic Digestive System Carcinoma
21483,Well Differentiated Neuroendocrine Lesion,Refractory Digestive System Carcinoma
21484,Low Grade Neuroendocrine Lesion,Refractory Digestive System Carcinoma
21485,Benign Cellular Infiltrate,Abdominal Undifferentiated Pleomorphic Sarcoma
21486,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
21487,Low Grade Neuroendocrine Lesion,Distal Esophagus Adenocarcinoma
21488,Benign Cellular Infiltrate,Unresectable Soft Tissue Sarcoma
21489,Intermediate Grade Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
21490,Benign Cellular Infiltrate,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
21491,Benign Cellular Infiltrate,Locally Advanced Lung Carcinoma
21492,Intermediate Grade Neuroendocrine Lesion,Metastatic gastric adenocarcinoma
21493,Intermediate Grade Neuroendocrine Lesion,Metastatic Gastric Carcinoma
21494,Well Differentiated Neuroendocrine Lesion,Refractory Liver Carcinoma
21495,Low Grade Neuroendocrine Lesion,Locally Advanced Small Intestinal Carcinoma
21496,Low Grade Neuroendocrine Lesion,Bile duct cancer recurrent
21497,Intermediate Grade Neuroendocrine Lesion,Recurrent Pancreatic Acinar Cell Carcinoma
21498,Intermediate Grade Neuroendocrine Lesion,Recurrent Ampulla of Vater Adenocarcinoma
21499,Well Differentiated Neuroendocrine Lesion,Recurrent Anal Mucinous Adenocarcinoma
21500,Well Differentiated Neuroendocrine Lesion,Recurrent Paget Disease of the Anal Canal
21501,Benign Cellular Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma
21502,Benign Cellular Infiltrate,Recurrent Minor Salivary Gland Adenocarcinoma
21503,Low Grade Neuroendocrine Lesion,Recurrent Pancreatic Ductal Adenocarcinoma
21504,Low Grade Neuroendocrine Lesion,Recurrent Pancreatic Cystadenocarcinoma
21505,Benign Cellular Infiltrate,Recurrent Malignant Ovarian Brenner Tumor
21506,Benign Cellular Infiltrate,Recurrent Malignant Brain Neoplasm
21507,Well Differentiated Neuroendocrine Lesion,Metastatic hepatocellular carcinoma
21508,Intermediate Grade Neuroendocrine Lesion,Metastatic hepatocellular carcinoma
21509,Well Differentiated Neuroendocrine Lesion,Unresectable Gastric Adenocarcinoma
21510,Benign Cellular Infiltrate,Resectable Malignant Mesothelioma
21511,Benign Cellular Infiltrate,Unresectable Malignant Mesothelioma
21512,Intermediate Grade Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma
21513,Low Grade Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma
21514,Local disease,Advanced Well Differentiated Neuroendocrine Neoplasm
21515,Benign Cellular Infiltrate,Transplant-Related Squamous Cell Carcinoma
21516,Mixed Neoplastic Glandular and Squamous Cell Population,Transplant-Related Squamous Cell Carcinoma
21517,Benign Cellular Infiltrate,Recurrent Cutaneous Melanoma of the Extremity
21518,Favorable Clinical Outcome,Recurrent Cutaneous Melanoma of the Extremity
21519,Local disease,Advanced Cutaneous Melanoma of the Extremity
21520,Intermediate Filaments Present,Sarcoma of the Extremity
21521,Extensive Stage Lesion,Locally Advanced Unresectable Renal Cell Carcinoma
21522,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
21523,Benign Cellular Infiltrate,Sellar Neuroblastoma
21524,Aggressive Clinical Course,Sellar Schwannoma
21525,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Sellar Region
21526,Indolent Clinical Course,Sellar Germinoma
21527,Benign Cellular Infiltrate,Suprasellar Germinoma
21528,Benign Cellular Infiltrate,Sellar Yolk Sac Tumor
21529,Benign Cellular Infiltrate,Sellar Teratoma with Malignant Transformation
21530,Benign Cellular Infiltrate,Recurrent Endometrial Undifferentiated Carcinoma
21531,Precise Histogenesis Unknown,Unresectable Low Grade Glioma
21532,Benign Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm
21533,Local disease,Advanced Neuroendocrine Carcinoma
21534,Intermediate Grade Neuroendocrine Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
21535,Extensive Stage Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
21536,Superficial Lesion,Recurrent Desmoid-Type Fibromatosis
21537,Well-Circumscribed Lesion,Recurrent Desmoid-Type Fibromatosis
21538,Superficial Lesion,Unresectable Desmoid-Type Fibromatosis
21539,Benign Cellular Infiltrate,Unresectable Lung Non-Small Cell Carcinoma
21540,Well Differentiated Neuroendocrine Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
21541,Well Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
21542,Low Grade Neuroendocrine Lesion,Unresectable Digestive System Neuroendocrine Carcinoma
21543,Benign Cellular Infiltrate,Recurrent Chordoma
21544,Ground Glass Nuclear Inclusion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
21545,Benign Cellular Infiltrate,Frontal Lobe Anaplastic Astrocytoma
21546,Indolent Clinical Course,Temporal Lobe Anaplastic Astrocytoma
21547,Grade 4 Lesion,Third Ventricle Pilocytic Astrocytoma
21548,Grade 4 Lesion,Temporal Lobe Pleomorphic Xanthoastrocytoma
21549,Benign Cellular Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
21550,Well Differentiated Neuroendocrine Lesion,stage IV pancreatic cancer
21551,Intermediate Filaments Present,Stage IV adult soft tissue sarcoma
21552,Favorable Clinical Outcome,Stage IV Skin Melanoma
21553,Benign Cellular Infiltrate,Stage IV Esophageal Adenocarcinoma
21554,Keratin pearl formation,Metastatic Nasopharyngeal Undifferentiated Carcinoma
21555,Benign Cellular Infiltrate,Metastatic Pharyngeal Carcinoma
21556,Mixed Neoplastic Glandular and Squamous Cell Population,Lung squamous cell carcinoma stage IV
21557,Intermediate Grade Neuroendocrine Lesion,Metastatic Colorectal Carcinoma
21558,Benign Cellular Infiltrate,Metastatic Thyroid Gland Papillary Carcinoma
21559,Precise Histogenesis Unknown,Frontal Lobe Anaplastic Oligodendroglioma
21560,Nuclear Pseudoinclusion,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
21561,Nuclear Clearing,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
21562,Nuclear Grooves,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
21563,Mixed Neoplastic Glandular and Squamous Cell Population,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
21564,Benign Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma
21565,Intermediate Grade Neuroendocrine Lesion,Localized Gastric Carcinoma
21566,Benign Cellular Infiltrate,Thyroid Gland Mucinous Carcinoma
21567,Well Differentiated Neuroendocrine Lesion,Locally Advanced Pancreatic Adenocarcinoma
21568,Extensive Stage Lesion,Locally Advanced Pancreatic Adenocarcinoma
21569,Indolent Clinical Course,sarcoma of tongue
21570,Indolent Clinical Course,Orbital Alveolar Soft Part Sarcoma
21571,Benign Cellular Infiltrate,Orbital Alveolar Soft Part Sarcoma
21572,Intracytoplasmic Eosinophilic Inclusion,Orbital Alveolar Soft Part Sarcoma
21573,Indolent Clinical Course,Bladder Alveolar Soft Part Sarcoma
21574,Benign Cellular Infiltrate,Bladder Alveolar Soft Part Sarcoma
21575,Intermediate Filaments Present,Bladder Alveolar Soft Part Sarcoma
21576,Benign Cellular Infiltrate,Colon Liposarcoma
21577,Benign Cellular Infiltrate,Parotid Gland Liposarcoma
21578,Favorable Clinical Outcome,Scrotal Liposarcoma
21579,Intermediate Filaments Present,Scrotal Liposarcoma
21580,Intracytoplasmic Eosinophilic Inclusion,Scrotal Sarcoma
21581,Malignant Cellular Infiltrate,Thyroid Gland Schwannoma
21582,Necrotic changes (finding),Thyroid Gland Schwannoma
21583,Malignant Cellular Infiltrate,Thyroid Gland Hemangioma
21584,CD30-Positive Neoplastic Cells Present,follicular dendritic cell sarcoma of thyroid gland
21585,Malignant Cellular Infiltrate,Grade 1 Teratoma
21586,Anaplasia,Brain Ependymoma
21587,Intermediate Filaments Present,"Kaposi's sarcoma, metastatic"
21588,Local disease,Advanced Kaposi Sarcoma
21589,Well Differentiated Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma
21590,Low Grade Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma
21591,Benign Cellular Infiltrate,Metastatic Gastric Neuroendocrine Carcinoma
21592,Low Grade Neuroendocrine Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
21593,Squamous Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma
21594,Low Grade Neuroendocrine Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
21595,Low Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma
21596,Low Mitotic Activity,Metastatic Small Intestinal Neuroendocrine Carcinoma
21597,Low Mitotic Activity,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
21598,Local disease,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
21599,Malignant Cellular Infiltrate,Benign Peritoneal and Retroperitoneal Neoplasm
21600,Chronic Clinical Course,Recurrent Acute Monoblastic and Monocytic Leukemia
21601,Solid Growth Pattern,Recurrent Acute Monoblastic and Monocytic Leukemia
21602,Benign Cellular Infiltrate,Recurrent Acute Erythroid Leukemia
21603,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Erythroid Leukemia
21604,Chronic Clinical Course,Recurrent Acute Megakaryoblastic Leukemia
21605,Solid Growth Pattern,Recurrent Acute Megakaryoblastic Leukemia
21606,Borderline Lesion,Benign Parathyroid Gland Adenoma
21607,Benign Cellular Infiltrate,Metastatic basal cell carcinoma
21608,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic adenocarcinoma resectable
21609,Well Differentiated Neuroendocrine Lesion,Resectable Pancreatic Acinar Cell Carcinoma
21610,Low Grade Neuroendocrine Lesion,Resectable Intrahepatic Cholangiocarcinoma
21611,Mixed Neoplastic Glandular and Squamous Cell Population,Resectable Intrahepatic Cholangiocarcinoma
21612,Benign Cellular Infiltrate,Resectable Extrahepatic Bile Duct Adenocarcinoma
21613,Benign Cellular Infiltrate,Adrenal Gland Lymphoma
21614,Benign Cellular Infiltrate,Spindle cell squamous cell carcinoma
21615,Benign Cellular Infiltrate,Glioblastoma multiforme of spinal cord
21616,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
21617,Benign Cellular Infiltrate,Nipple Duct Carcinoma
21618,Benign Cellular Infiltrate,Familial Adenomatous Polyposis Associated Medulloblastoma
21619,Intermediate Grade Neuroendocrine Lesion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
21620,Low Grade Neuroendocrine Lesion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
21621,Well Differentiated Neuroendocrine Lesion,Cholangiocarcinoma non-resectable
21622,Low Grade Neuroendocrine Lesion,Cholangiocarcinoma non-resectable
21623,Benign Cellular Infiltrate,Histiocytic sarcoma
21624,Benign Cellular Infiltrate,Adult Mesenchymal Chondrosarcoma
21625,Benign Cellular Infiltrate,Childhood Extraskeletal Osteosarcoma
21626,Benign Cellular Infiltrate,Pericardial Carcinomatosis
21627,Mitotic Activity,Parathyroid Gland Oncocytic Adenoma
21628,Hemosiderin pigmentation,Parathyroid Gland Oncocytic Adenoma
21629,Benign Cellular Infiltrate,Adult Central Nervous System Mixed Germ Cell Tumor
21630,Malignant Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma
21631,Low Grade Neuroendocrine Lesion,Ampulla of Vater Mucinous Adenocarcinoma
21632,Well Differentiated Neuroendocrine Lesion,verrucous carcinoma of esophagus
21633,Intermediate Grade Neuroendocrine Lesion,adenosquamous carcinoma of esophagus
21634,Low Grade Neuroendocrine Lesion,adenosquamous carcinoma of esophagus
21635,Poorly Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
21636,Poorly Differentiated Neuroendocrine Lesion,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
21637,Benign Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7
21638,Benign Cellular Infiltrate,"Carcinoma of urinary bladder, superficial"
21639,Malignant Cellular Infiltrate,lipoma of bone
21640,Malignant Cellular Infiltrate,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
21641,Malignant Cellular Infiltrate,Gingival Angiofibroma
21642,Malignant Cellular Infiltrate,Nasopharyngeal Angiofibroma
21643,Malignant Cellular Infiltrate,Lipoblastoma
21644,Malignant Cellular Infiltrate,Pelvic lipomatosis
21645,Benign Cellular Infiltrate,Conventional Alveolar Rhabdomyosarcoma
21646,Benign Cellular Infiltrate,Lymphadenopathic Kaposi Sarcoma
21647,Malignant Cellular Infiltrate,Angiomatosis
21648,Malignant Cellular Infiltrate,Large cell acanthoma
21649,Malignant Cellular Infiltrate,Classic Type Trichilemmoma
21650,Malignant Cellular Infiltrate,Melanoacanthoma
21651,Well Differentiated Neuroendocrine Lesion,Transplant-Related Hepatocellular Carcinoma
21652,Intermediate Grade Neuroendocrine Lesion,Transplant-Related Hepatocellular Carcinoma
21653,Benign Cellular Infiltrate,Transplant-Related Hematologic Malignancy
21654,Benign Cellular Infiltrate,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
21655,Benign Cellular Infiltrate,Human Papillomavirus-Related Endocervical Adenocarcinoma
21656,Benign Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma
21657,Intermediate Grade Neuroendocrine Lesion,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
21658,Intermediate Grade Neuroendocrine Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma
21659,Benign Cellular Infiltrate,Cutaneous Radiation-Related Angiosarcoma
21660,Benign Cellular Infiltrate,Stage IIB Cutaneous Melanoma AJCC v6 and v7
21661,Benign Cellular Infiltrate,Hypergranular promyelocytic leukemia
21662,Benign Cellular Infiltrate,Helicobacter Pylori-Related Carcinoma
21663,Intermediate Grade Neuroendocrine Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma
21664,Intermediate Grade Neuroendocrine Lesion,Opisthorchis Viverrini-Related Cholangiocarcinoma
21665,Benign Cellular Infiltrate,Myxoid/Round Cell Liposarcoma
21666,Benign Cellular Infiltrate,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion"
21667,Low Grade Neuroendocrine Lesion,Bile duct adenocarcinoma
21668,Benign Cellular Infiltrate,Grade 2 Invasive Breast Carcinoma
21669,Benign Cellular Infiltrate,Oxyphilic Endometrial Endometrioid Adenocarcinoma
21670,Benign Cellular Infiltrate,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation
21671,Benign Cellular Infiltrate,Recurrent tumors of the Ewing's family
21672,Benign Cellular Infiltrate,Localized Askin Tumor
21673,Benign Cellular Infiltrate,Benzene-Related Acute Myeloid Leukemia
21674,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Delta Cell Neoplasm
21675,Benign Cellular Infiltrate,Adenocarcinoma
21676,Malignant Cellular Infiltrate,Benign neoplasm of skin
21677,Well Differentiated Neuroendocrine Lesion,Colorectal Carcinoma
21678,Poorly Differentiated Neuroendocrine Lesion,Glucagonoma
21679,Benign Cellular Infiltrate,gamma-Chain Disease
21680,Malignant Cellular Infiltrate,Hemangioma
21681,Low Grade Neuroendocrine Lesion,Liver carcinoma
21682,Benign Cellular Infiltrate,leiomyosarcoma
21683,Benign Cellular Infiltrate,Chronic Lymphocytic Leukemia
21684,Benign Cellular Infiltrate,"Myeloid Leukemia, Chronic"
21685,Benign Cellular Infiltrate,"Leukemia, Myeloid, Chronic-Phase"
21686,Benign Cellular Infiltrate,Adult T-Cell Lymphoma/Leukemia
21687,Benign Cellular Infiltrate,"Lymphoma, Follicular"
21688,Malignant Cellular Infiltrate,Rhabdomyoma
21689,Malignant Cellular Infiltrate,Uterine Fibroids
21690,Malignant Cellular Infiltrate,"Chondromatosis, Synovial"
21691,Benign Cellular Infiltrate,"Lymphoma, T-Cell, Cutaneous"
21692,Malignant Cellular Infiltrate,Benign tumor of penis
21693,Benign Cellular Infiltrate,Cutaneous Melanoma
21694,Malignant Cellular Infiltrate,Degeneration of uterine fibroid
21695,Well Differentiated Neuroendocrine Lesion,Esophageal carcinoma
21696,Benign Cellular Infiltrate,Malignant neoplasm of sublingual gland
21697,Benign Cellular Infiltrate,Malignant tumor of palate
21698,Benign Cellular Infiltrate,Malignant retroperitoneal tumor
21699,Benign Cellular Infiltrate,Malignant neoplasm of heart
21700,Benign Cellular Infiltrate,malignant neoplasm of bone marrow
21701,Benign Cellular Infiltrate,Kaposi's sarcoma of lung
21702,Benign Cellular Infiltrate,Posterior Pharyngeal Wall Carcinoma
21703,Benign Cellular Infiltrate,Polymorphous low grade adenocarcinoma of salivary gland
21704,Benign Cellular Infiltrate,Thymic Undifferentiated Carcinoma
21705,Benign Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland
21706,Benign Cellular Infiltrate,Secondary malignant neoplasm of mediastinum
21707,Benign Cellular Infiltrate,Cancer of lymph node
21708,Benign Cellular Infiltrate,Granulocytic Sarcoma
21709,Benign Cellular Infiltrate,carcinosarcoma of salivary gland
21710,Malignant Cellular Infiltrate,intraductal papilloma of salivary gland
21711,Malignant Cellular Infiltrate,inverted ductal papilloma of salivary gland
21712,Malignant Cellular Infiltrate,sialadenoma papilliferum of salivary gland
21713,Benign Cellular Infiltrate,Intracortical osteosarcoma
21714,Benign Cellular Infiltrate,Iatrogenic Kaposi Sarcoma
21715,Malignant Cellular Infiltrate,Benign neoplasm of pharynx
21716,Malignant Cellular Infiltrate,Benign neoplasm of stomach
21717,Benign Cellular Infiltrate,Anaplastic Malignant Neoplasm
21718,Benign Cellular Infiltrate,Grade 1 Malignant Neoplasm
21719,Benign Cellular Infiltrate,Grade 4 Malignant Neoplasm
21720,Benign Cellular Infiltrate,Poorly Differentiated Malignant Neoplasm
21721,Malignant Cellular Infiltrate,Lipoma of spermatic cord
21722,Mitotic Activity,Testicular Dermoid Cyst
21723,Benign Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
21724,Well Differentiated Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Liver
21725,Intermediate Grade Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Liver
21726,Well Differentiated Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v6
21727,Low Grade Neuroendocrine Lesion,Stage 0 Esophageal Cancer AJCC v6
21728,Benign Cellular Infiltrate,Carcinoma in situ of skin
21729,Benign Cellular Infiltrate,Carcinoma in situ of prostate
21730,Malignant Cellular Infiltrate,Benign Neoplasm
21731,Benign Cellular Infiltrate,"Adenocarcinoma, Oxyphilic"
21732,Malignant Cellular Infiltrate,Pleomorphic Lipoma
21733,Malignant Cellular Infiltrate,"Papilloma, Squamous Cell"
21734,Benign Cellular Infiltrate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
21735,Intermediate Grade Neuroendocrine Lesion,Pancreatic Foamy Gland Adenocarcinoma
21736,Malignant Cellular Infiltrate,Paraganglioma-Like Dermal Melanocytic Tumor
21737,Malignant Cellular Infiltrate,Myofibromatosis
21738,Benign Cellular Infiltrate,"Cystadenocarcinoma, Papillary"
21739,Benign Cellular Infiltrate,"Cystadenocarcinoma, Serous"
21740,Benign Cellular Infiltrate,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
21741,Malignant Cellular Infiltrate,"Nevus, Blue"
21742,Malignant Cellular Infiltrate,"Nevus, Intradermal"
21743,Benign Cellular Infiltrate,Carcinoma of unknown primary
21744,Benign Cellular Infiltrate,Malignant ovarian cyst
21745,Low Grade Neuroendocrine Lesion,Gallbladder Carcinoma
21746,Mitotic Activity,Dermoid cyst of ovary
21747,Benign Cellular Infiltrate,Fallopian Tube Carcinoma
21748,Well Differentiated Neuroendocrine Lesion,Cystadenocarcinoma of pancreas
21749,Benign Cellular Infiltrate,Thyroid Gland Mucoepidermoid Carcinoma
21750,Benign Cellular Infiltrate,Anaplastic thyroid carcinoma
21751,Benign Cellular Infiltrate,Medullary carcinoma of thyroid
21752,Benign Cellular Infiltrate,Telangiectatic osteosarcoma
21753,Benign Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype"
21754,Benign Cellular Infiltrate,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
21755,Benign Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
21756,Benign Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
21757,Benign Cellular Infiltrate,Carcinoma of Cowper Glands
21758,Benign Cellular Infiltrate,Carcinoma of Littre Glands
21759,Benign Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
21760,Benign Cellular Infiltrate,Prostate Basal Cell Carcinoma
21761,Malignant Cellular Infiltrate,Seminal Vesicle Cystadenoma
21762,Benign Cellular Infiltrate,"Seminoma, anaplastic"
21763,Well Differentiated Neuroendocrine Lesion,Stage II Colon Cancer
21764,Benign Cellular Infiltrate,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
21765,Well Differentiated Neuroendocrine Lesion,Stage IV Colon Carcinoma
21766,Benign Cellular Infiltrate,adenocarcinoma of epididymis
21767,Benign Cellular Infiltrate,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
21768,Well Differentiated Neuroendocrine Lesion,Colon cancer recurrent
21769,Benign Cellular Infiltrate,Malignant Ovarian Teratoma
21770,Mitotic Activity,Ovarian Fetiform Teratoma
21771,Benign Cellular Infiltrate,Malignant Ovarian Endometrioid Tumor
21772,Well Differentiated Neuroendocrine Lesion,Recurrent Cancer of Gallbladder
21773,Low Grade Neuroendocrine Lesion,Recurrent Cancer of Gallbladder
21774,Malignant Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
21775,Benign Cellular Infiltrate,squamous cell carcinoma of ovary
21776,Malignant Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
21777,Benign Cellular Infiltrate,Type I Endometrial Adenocarcinoma
21778,Malignant Cellular Infiltrate,Uterine Corpus Myxoid Leiomyoma
21779,Benign Cellular Infiltrate,Uterine Corpus Myxoid Leiomyosarcoma
21780,Benign Cellular Infiltrate,Cervical Keratinizing Squamous Cell Carcinoma
21781,Benign Cellular Infiltrate,Cervical Non-Keratinizing Squamous Cell Carcinoma
21782,Benign Cellular Infiltrate,Paget's disease and intraductal carcinoma of breast
21783,Benign Cellular Infiltrate,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
21784,Benign Cellular Infiltrate,Cervical Large Cell Neuroendocrine Carcinoma
21785,Benign Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix
21786,Malignant Cellular Infiltrate,Vaginal Mullerian Papilloma
21787,Benign Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Vagina
21788,Benign Cellular Infiltrate,Vaginal Adenosarcoma
21789,Benign Cellular Infiltrate,Vulvar Non-Keratinizing Squamous Cell Carcinoma
21790,Benign Cellular Infiltrate,Bartholin Gland Adenoid Cystic Carcinoma
21791,Benign Cellular Infiltrate,Bartholin Gland Transitional Cell Carcinoma
21792,Malignant Cellular Infiltrate,Adenoma of Minor Vestibular Glands
21793,Benign Cellular Infiltrate,apocrine adenocarcinoma of vulva
21794,Benign Cellular Infiltrate,Sarcoma of vulva
21795,Benign Cellular Infiltrate,Vulvar Alveolar Soft Part Sarcoma
21796,Malignant Cellular Infiltrate,Vulvar Cellular Angiofibroma
21797,Benign Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified"
21798,Benign Cellular Infiltrate,adenocarcinoma of breast with spindle cell metaplasia
21799,Benign Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma"
21800,Benign Cellular Infiltrate,Breast Diffuse Large B-Cell Lymphoma
21801,Benign Cellular Infiltrate,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
21802,Malignant Cellular Infiltrate,Breast adenoma
21803,Benign Cellular Infiltrate,Squamous cell carcinoma of buccal mucosa
21804,Benign Cellular Infiltrate,Squamous cell carcinoma of floor of mouth
21805,Malignant Cellular Infiltrate,Polyp of esophagus
21806,Benign Cellular Infiltrate,Mesonephroma
21807,Malignant Cellular Infiltrate,Warty dyskeratoma
21808,Benign Cellular Infiltrate,"Squamous cell carcinoma, metastatic"
21809,Benign Cellular Infiltrate,Transitional cell carcinoma in situ
21810,Malignant Cellular Infiltrate,"Transitional cell papilloma, inverted"
21811,Benign Cellular Infiltrate,Overt Primary Myelofibrosis
21812,Well Differentiated Neuroendocrine Lesion,Bile duct cystadenocarcinoma
21813,Benign Cellular Infiltrate,Adenocarcinoid tumor
21814,Benign Cellular Infiltrate,Adenocarcinoma in tubulovillous adenoma
21815,Mitotic Activity,Chief cell adenoma
21816,Broad Fibrous Bands Formation,Water-clear cell adenoma
21817,Well Differentiated Neuroendocrine Lesion,Cholangiolocellular Carcinoma
21818,Malignant Cellular Infiltrate,Juxtaglomerular tumor
21819,Benign Cellular Infiltrate,Carcinoma of apocrine gland
21820,Malignant Cellular Infiltrate,Hidradenoma Papilliferum
21821,Malignant Cellular Infiltrate,Sebaceous adenoma
21822,Benign Cellular Infiltrate,Serous surface papillary carcinoma
21823,Malignant Cellular Infiltrate,Intracystic papillary adenoma
21824,Benign Cellular Infiltrate,Invasive Ductal Breast Carcinoma
21825,Benign Cellular Infiltrate,Adenocarcinoma with apocrine metaplasia
21826,Benign Cellular Infiltrate,"Ganglioneuroblastoma, Nodular"
21827,Benign Cellular Infiltrate,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
21828,Benign Cellular Infiltrate,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor
21829,Benign Cellular Infiltrate,"Malignant melanoma, regressing"
21830,Benign Cellular Infiltrate,"Spindle cell melanoma, type B"
21831,Benign Cellular Infiltrate,Malignant Fibrous Histiocytoma
21832,Malignant Cellular Infiltrate,Cellular leiomyoma
21833,Benign Cellular Infiltrate,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
21834,Well Differentiated Neuroendocrine Lesion,Low grade appendiceal mucinous neoplasm
21835,Benign Cellular Infiltrate,Lip and Oral Cavity Squamous Cell Carcinoma
21836,Benign Cellular Infiltrate,"Synovial sarcoma, epithelioid cell"
21837,Benign Cellular Infiltrate,"Mesothelioma, biphasic, malignant"
21838,Malignant Cellular Infiltrate,Venous hemangioma
21839,Benign Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma
21840,Malignant Cellular Infiltrate,Peripheral Odontogenic Fibroma
21841,Malignant Cellular Infiltrate,Trichodiscoma
21842,Benign Cellular Infiltrate,Chronic myeloproliferative disorder
21843,Benign Cellular Infiltrate,Skin Basal Cell Carcinoma with Sebaceous Differentiation
21844,Low Grade Neuroendocrine Lesion,Sporadic Diffuse Gastric Adenocarcinoma
21845,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Mucinous Adenocarcinoma
21846,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Medullary Carcinoma
21847,Intermediate Grade Neuroendocrine Lesion,signet ring cell carcinoma of appendix
21848,Intermediate Grade Neuroendocrine Lesion,small cell carcinoma of appendix
21849,Well Differentiated Neuroendocrine Lesion,Mucinous adenocarcinoma of appendix
21850,Malignant Cellular Infiltrate,Seborrheic keratosis of eyelid
21851,Intermediate Grade Neuroendocrine Lesion,Colorectal Signet Ring Cell Carcinoma
21852,Low Grade Neuroendocrine Lesion,Colorectal Signet Ring Cell Carcinoma
21853,Intermediate Grade Neuroendocrine Lesion,Colorectal Squamous Cell Carcinoma
21854,Malignant Cellular Infiltrate,Papilloma of nasal vestibule
21855,Intermediate Grade Neuroendocrine Lesion,Clear Cell Intrahepatic Cholangiocarcinoma
21856,Intermediate Grade Neuroendocrine Lesion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
21857,Well Differentiated Neuroendocrine Lesion,Cholangiocarcinoma
21858,Low Grade Neuroendocrine Lesion,Stage 0 Gallbladder Cancer AJCC v6 and v7
21859,Low Grade Neuroendocrine Lesion,Carcinoma in situ of ampulla of Vater
21860,Benign Cellular Infiltrate,Squamous cell carcinoma of trachea
21861,Benign Cellular Infiltrate,Giant cell carcinoma of lung
21862,Malignant Cellular Infiltrate,Tumor of follicular infundibulum
21863,Malignant Cellular Infiltrate,Cutaneous leiomyoma
21864,Malignant Cellular Infiltrate,Tufted angioma of skin
21865,Malignant Cellular Infiltrate,Benign germ cell tumor of ovary
21866,Benign Cellular Infiltrate,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
21867,Benign Cellular Infiltrate,Primary Cutaneous Intravascular Large B-Cell Lymphoma
21868,Benign Cellular Infiltrate,Cutaneous T Lymphoblastic Leukemia/Lymphoma
21869,Benign Cellular Infiltrate,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma
21870,Low Grade Neuroendocrine Lesion,Colon Intramucosal Adenocarcinoma
21871,Geographic Necrosis,Dermoid cyst of orbit
21872,Benign Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Papillary Variant"
21873,Benign Cellular Infiltrate,mucinous adenocarcinoma of lung
21874,Malignant Cellular Infiltrate,Lung Squamous Cell Papilloma
21875,Benign Cellular Infiltrate,Malignant melanoma of ciliary body
21876,Malignant Cellular Infiltrate,Lung Mixed Squamous Cell and Glandular Papilloma
21877,Benign Cellular Infiltrate,Pleuropulmonary blastoma type I
21878,Benign Cellular Infiltrate,Pleuropulmonary blastoma type II
21879,Benign Cellular Infiltrate,Lung Monophasic Synovial Sarcoma
21880,Benign Cellular Infiltrate,Malignant Lung Hilum Neoplasm
21881,Benign Cellular Infiltrate,Mediastinal T Lymphoblastic Leukemia/Lymphoma
21882,Malignant Cellular Infiltrate,Cardiac Capillary Hemangioma
21883,Benign Cellular Infiltrate,Secondary malignant neoplasm of bone marrow
21884,Benign Cellular Infiltrate,Secondary malignant neoplasm of peritoneum
21885,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2
21886,Intermediate Grade Neuroendocrine Lesion,Pancreatic Mixed Adenoneuroendocrine Carcinoma
21887,Benign Cellular Infiltrate,Secondary malignant neoplasm of spinal cord
21888,Benign Cellular Infiltrate,Stage 0 Oral Cavity Cancer AJCC v6 and v7
21889,Well Differentiated Neuroendocrine Lesion,Carcinoma in situ of cecum
21890,Benign Cellular Infiltrate,Unilateral Breast Carcinoma
21891,Malignant Cellular Infiltrate,Benign neoplasm of anus
21892,Malignant Cellular Infiltrate,Thyroid Gland Signet Ring Cell Follicular Adenoma
21893,Benign Cellular Infiltrate,Malignant tumor of external ear
21894,Benign Cellular Infiltrate,Nasal Type Extranodal NK/T-Cell Lymphoma
21895,Benign Cellular Infiltrate,Rhabdomyosarcoma with ganglionic differentiation
21896,Benign Cellular Infiltrate,Melanotic malignant nerve sheath tumor
21897,Malignant Cellular Infiltrate,Benign neoplasm of appendix
21898,Malignant Cellular Infiltrate,Benign neoplasm of duodenum
21899,Benign Cellular Infiltrate,Primary Lung Lymphoma
21900,Malignant Cellular Infiltrate,Prostatic Adenoma
21901,Benign Cellular Infiltrate,Tongue Carcinoma
21902,Mitotic Activity,Parathyroid Gland Lipoadenoma
21903,Hemosiderin pigmentation,Parathyroid Gland Lipoadenoma
21904,Malignant Cellular Infiltrate,Benign pheochromocytoma of adrenal gland
21905,Malignant Cellular Infiltrate,Adrenal Cortex Oncocytic Adenoma
21906,Benign Cellular Infiltrate,sarcoma of lung
21907,Benign Cellular Infiltrate,Secondary malignant neoplasm of vertebral column
21908,Malignant Cellular Infiltrate,Myoma
21909,Benign Cellular Infiltrate,Dedifferentiated chordoma
21910,Malignant Cellular Infiltrate,Angiomyofibroblastoma
21911,Benign Cellular Infiltrate,Malignant neoplasm of nasal cavity
21912,Benign Cellular Infiltrate,Carcinoma of glottis
21913,Benign Cellular Infiltrate,Recurrent Hodgkin Lymphoma
21914,Benign Cellular Infiltrate,Soft Palate Squamous Cell Carcinoma
21915,Benign Cellular Infiltrate,Bladder squamous cell carcinoma stage II
21916,Benign Cellular Infiltrate,Cerebral Hodgkin Lymphoma
21917,Benign Cellular Infiltrate,Secondary Cerebral Hodgkin Lymphoma
21918,Malignant Cellular Infiltrate,Endobronchial lipoma
21919,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage I
21920,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage III
21921,Benign Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) refractory
21922,Benign Cellular Infiltrate,Splenic marginal zone lymphoma recurrent
21923,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of large intestine
21924,Benign Cellular Infiltrate,Malignant Intracranial Neoplasm
21925,Benign Cellular Infiltrate,Malignant Diencephalic Neoplasm
21926,Benign Cellular Infiltrate,intraductal micropapillary carcinoma of breast
21927,Benign Cellular Infiltrate,Apocrine Breast Carcinoma In Situ
21928,Malignant Cellular Infiltrate,Benign Breast Adenomyoepithelioma
21929,Benign Cellular Infiltrate,Mucoepidermoid Breast Carcinoma
21930,Benign Cellular Infiltrate,fibrosarcoma of breast
21931,Malignant Cellular Infiltrate,Breast Capillary Hemangioma
21932,Benign Cellular Infiltrate,Stage IB Ovarian Cancer AJCC v6 and v7
21933,Benign Cellular Infiltrate,Ovarian Cystadenocarcinoma
21934,Benign Cellular Infiltrate,Ovarian Rhabdomyosarcoma
21935,Benign Cellular Infiltrate,Ovarian Transitional Cell Carcinoma
21936,Mitotic Activity,Mature Gastric Teratoma
21937,Geographic Necrosis,Mature Gastric Teratoma
21938,Benign Cellular Infiltrate,Peripheral Intraneural Angiosarcoma
21939,Malignant Cellular Infiltrate,Jugular Foramen Schwannoma
21940,Benign Cellular Infiltrate,Advanced Favorable Non-Hodgkin Lymphoma
21941,Low Grade Neuroendocrine Lesion,mucoepidermoid carcinoma of esophagus
21942,Benign Cellular Infiltrate,Luminal B Breast Carcinoma
21943,Malignant Cellular Infiltrate,Cellular Myxoma
21944,Benign Cellular Infiltrate,Intimal sarcoma
21945,Benign Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor
21946,Benign Cellular Infiltrate,Inferior Vena Cava Leiomyosarcoma
21947,Benign Cellular Infiltrate,Pulmonary Artery Leiomyosarcoma
21948,Benign Cellular Infiltrate,Medulloblastoma with extensive nodularity
21949,Malignant Cellular Infiltrate,Retroperitoneal Ganglioneuroma
21950,Benign Cellular Infiltrate,Keratinizing Head and Neck Squamous Cell Carcinoma
21951,Benign Cellular Infiltrate,Laryngeal Giant Cell Carcinoma
21952,Benign Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma
21953,Benign Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma
21954,Benign Cellular Infiltrate,Central Nervous System Angiosarcoma
21955,Well Differentiated Neuroendocrine Lesion,Undifferentiated carcinoma of stomach
21956,Malignant Cellular Infiltrate,Gastric Lymphangioma
21957,Well Differentiated Neuroendocrine Lesion,Colon Adenosquamous Carcinoma
21958,Malignant Cellular Infiltrate,Central Nervous System Dermoid Cyst
21959,Intermediate Grade Neuroendocrine Lesion,Mucinous cystadenocarcinoma appendix
21960,Benign Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate
21961,Benign Cellular Infiltrate,Prostate Lymphoma
21962,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of cecum
21963,Malignant Cellular Infiltrate,Rectal Lipoma
21964,Benign Cellular Infiltrate,Malignant fibrous histiocytoma of skin
21965,Benign Cellular Infiltrate,Stage I Skin Cancer
21966,Benign Cellular Infiltrate,Stage III Skin Cancer
21967,Low Grade Neuroendocrine Lesion,Paget Disease of the Anus
21968,Intermediate Grade Neuroendocrine Lesion,mucinous adenocarcinoma of anus
21969,Low Grade Neuroendocrine Lesion,Adenocarcinoma of anal glands
21970,Benign Cellular Infiltrate,Skin Nodular Solid Basal Cell Carcinoma
21971,Benign Cellular Infiltrate,Ann Arbor Stage IB Hodgkin Lymphoma
21972,Benign Cellular Infiltrate,Stage IIB Lung Cancer AJCC v7
21973,Benign Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7
21974,Malignant Cellular Infiltrate,Colorectal Leiomyoma
21975,Intermediate Grade Neuroendocrine Lesion,Stage IIA Esophagus Carcinoma
21976,Intermediate Grade Neuroendocrine Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
21977,Well Differentiated Neuroendocrine Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
21978,Low Grade Neuroendocrine Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
21979,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of pancreas
21980,Low Grade Neuroendocrine Lesion,Serous cystadenocarcinoma of pancreas
21981,Intermediate Grade Neuroendocrine Lesion,Stage 0 Pancreatic Cancer AJCC v6 and v7
21982,Low Grade Neuroendocrine Lesion,Stage II Gallbladder Cancer AJCC v6
21983,Well Differentiated Neuroendocrine Lesion,Stage IVA Gallbladder Carcinoma
21984,Well Differentiated Neuroendocrine Lesion,Clear Cell Hepatocellular Carcinoma
21985,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7
21986,Low Grade Neuroendocrine Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7
21987,Well Differentiated Neuroendocrine Lesion,Adenosquamous Bile Duct Carcinoma
21988,Intermediate Grade Neuroendocrine Lesion,Adenosquamous Bile Duct Carcinoma
21989,Low Grade Neuroendocrine Lesion,undifferentiated carcinoma of extrahepatic bile duct
21990,Benign Cellular Infiltrate,Adult Central Nervous System Choriocarcinoma
21991,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma stage I
21992,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma stage III
21993,Intermediate Grade Neuroendocrine Lesion,Bile duct mucinous adenocarcinoma
21994,Low Grade Neuroendocrine Lesion,Bile duct mucinous adenocarcinoma
21995,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
21996,Benign Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
21997,Benign Cellular Infiltrate,Stage IVA Lip Cancer AJCC v6 and v7
21998,Benign Cellular Infiltrate,Stage I Major Salivary Gland Cancer AJCC v7
21999,Benign Cellular Infiltrate,Major Salivary Gland Mucoepidermoid Carcinoma
22000,Malignant Cellular Infiltrate,Oral Cavity Adenoma
22001,Benign Cellular Infiltrate,sarcoma of oral cavity
22002,Benign Cellular Infiltrate,Tonsillar Lymphoma
22003,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Anal Canal Cancer AJCC v6 and v7
22004,Benign Cellular Infiltrate,Parotid Gland Adenocarcinoma
22005,Benign Cellular Infiltrate,Submandibular Gland Squamous Cell Carcinoma
22006,Benign Cellular Infiltrate,Malignant Parotid Gland Mixed Tumor
22007,Benign Cellular Infiltrate,Parotid Gland Kaposi Sarcoma
22008,Benign Cellular Infiltrate,ACTH-Producing Pituitary Gland Carcinoma
22009,Benign Cellular Infiltrate,Carcinoma of supraglottis
22010,Benign Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v7
22011,Benign Cellular Infiltrate,Stage I Nasal Cavity Cancer AJCC v6 and v7
22012,Benign Cellular Infiltrate,Olfactory Neuroblastoma
22013,Benign Cellular Infiltrate,adenoid cystic carcinoma of accessory sinus
22014,Benign Cellular Infiltrate,Secondary malignant neoplasm of larynx
22015,Benign Cellular Infiltrate,Poorly Differentiated Thyroid Carcinoma
22016,Benign Cellular Infiltrate,sarcoma of trachea
22017,Benign Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage II
22018,Well Differentiated Neuroendocrine Lesion,Rectal Medullary Carcinoma
22019,Benign Cellular Infiltrate,Paranasal Sinus Lymphoma
22020,Benign Cellular Infiltrate,Stage IVA Paranasal Sinus Cancer AJCC v7
22021,Benign Cellular Infiltrate,Intermediate Cell Type Iris Melanoma
22022,Benign Cellular Infiltrate,Metastatic Malignant Neoplasm in the Iris
22023,Benign Cellular Infiltrate,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
22024,Benign Cellular Infiltrate,Stage II Renal Pelvis Cancer AJCC v7
22025,Benign Cellular Infiltrate,Stage I Ureter Cancer AJCC v7
22026,Benign Cellular Infiltrate,squamous cell carcinoma of ureter
22027,Benign Cellular Infiltrate,small cell carcinoma of ureter
22028,Malignant Cellular Infiltrate,Bladder Leiomyoma
22029,Benign Cellular Infiltrate,leiomyosarcoma of kidney
22030,Benign Cellular Infiltrate,liposarcoma of kidney
22031,Malignant Cellular Infiltrate,Inverted urothelial papilloma
22032,Benign Cellular Infiltrate,Stage 0 Urethral Cancer AJCC v7
22033,Benign Cellular Infiltrate,Stage IV Urethral Cancer AJCC v7
22034,Malignant Cellular Infiltrate,Soft Palate Pleomorphic Adenoma
22035,Benign Cellular Infiltrate,Hard Palate Mucoepidermoid Carcinoma
22036,Benign Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified"
22037,Benign Cellular Infiltrate,Salivary Gland Oncocytic Carcinoma
22038,Malignant Cellular Infiltrate,Tubular adenoma of breast
22039,Benign Cellular Infiltrate,Ethmoid Sinus Adenocarcinoma
22040,Benign Cellular Infiltrate,Ethmoid Sinus Adenoid Cystic Carcinoma
22041,Benign Cellular Infiltrate,Adenoid cystic carcinoma of oropharynx
22042,Benign Cellular Infiltrate,embryonal rhabdomyosarcoma of orbit
22043,Benign Cellular Infiltrate,serous surface papillary carcinoma of ovary
22044,Benign Cellular Infiltrate,Stage IIIC Ovarian Cancer
22045,Benign Cellular Infiltrate,Undifferentiated Fallopian Tube Carcinoma
22046,Benign Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
22047,Benign Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7
22048,Benign Cellular Infiltrate,Stage IIIA Cervical Carcinoma
22049,Benign Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v6 and v7
22050,Benign Cellular Infiltrate,Stage IB Vulvar Carcinoma AJCC v6
22051,Benign Cellular Infiltrate,Metastatic Carcinoma to the Uterine Cervix
22052,Benign Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Teratoma
22053,Benign Cellular Infiltrate,Stage IA Testicular Cancer AJCC v6 and v7
22054,Benign Cellular Infiltrate,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
22055,Benign Cellular Infiltrate,Scrotal Carcinoma
22056,Intermediate Grade Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1
22057,Benign Cellular Infiltrate,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor
22058,Benign Cellular Infiltrate,Malignant germ cell neoplasm of mediastinum
22059,Benign Cellular Infiltrate,Thymic Squamous Cell Carcinoma
22060,Benign Cellular Infiltrate,Thymic Adenosquamous Carcinoma
22061,Benign Cellular Infiltrate,Thymic Small Cell Carcinoma
22062,Benign Cellular Infiltrate,Thymic Sarcomatoid Carcinoma
22063,Benign Cellular Infiltrate,"Chondrosarcoma, Clear Cell"
22064,Malignant Cellular Infiltrate,Nuchal-type fibroma
22065,Malignant Cellular Infiltrate,Diffuse Lipomatosis
22066,Malignant Cellular Infiltrate,Benign Skeletal Muscle Neoplasm
22067,Poorly Differentiated Neuroendocrine Lesion,"Somatostatinoma, malignant"
22068,Well Differentiated Neuroendocrine Lesion,Parietal cell carcinoma
22069,Angioinvasion,minimally invasive follicular carcinoma of the thyroid gland
22070,Malignant Cellular Infiltrate,Myxoma
22071,Benign Cellular Infiltrate,fibrosarcoma of soft tissue
22072,Benign Cellular Infiltrate,Stage III Osteosarcoma AJCC v7
22073,Benign Cellular Infiltrate,Primary bone lymphoma
22074,Benign Cellular Infiltrate,Recurrent Bone Ewing Sarcoma
22075,Benign Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v7
22076,Low Grade Neuroendocrine Lesion,Adenocarcinoma of ampulla of Vater
22077,Low Grade Neuroendocrine Lesion,Stage I Ampulla of Vater Cancer AJCC v7
22078,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Signet Ring Cell Carcinoma
22079,Benign Cellular Infiltrate,Stage IB Lung Large Cell Carcinoma AJCC v7
22080,Benign Cellular Infiltrate,Stage IIA Lung Large Cell Carcinoma AJCC v7
22081,Benign Cellular Infiltrate,Stage I Lung Small Cell Carcinoma AJCC v7
22082,Malignant Cellular Infiltrate,Ameloblastic fibrodentinoma
22083,Benign Cellular Infiltrate,Occult Lung Small Cell Carcinoma
22084,Benign Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
22085,Benign Cellular Infiltrate,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
22086,Malignant Cellular Infiltrate,Sternal Chondromyxoid Fibroma
22087,Benign Cellular Infiltrate,Sternal Lymphoma
22088,Benign Cellular Infiltrate,Peripheral Primitive Neuroectodermal Tumor of the Kidney
22089,Poorly Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma
22090,Low Grade Neuroendocrine Lesion,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
22091,Malignant Cellular Infiltrate,Cardiac rhabdomyoma
22092,Benign Cellular Infiltrate,Superior Vena Cava Leiomyosarcoma
22093,Low Grade Neuroendocrine Lesion,Biliary Intraepithelial Neoplasia-3
22094,Intermediate Grade Neuroendocrine Lesion,Gastric Mixed Adenocarcinoma
22095,Malignant Cellular Infiltrate,Myxoid leiomyoma
22096,Intermediate Grade Neuroendocrine Lesion,Gastric Small Cell Carcinoma
22097,Benign Cellular Infiltrate,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
22098,Benign Cellular Infiltrate,Malignant neoplasm of skin of eyelid
22099,Malignant Cellular Infiltrate,Benign Apocrine Neoplasm
22100,Malignant Cellular Infiltrate,Benign Ovarian Sex Cord-Stromal Tumor
22101,Benign Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of lacrimal gland
22102,Malignant Cellular Infiltrate,Frontal Sinus Schneiderian Papilloma
22103,Malignant Cellular Infiltrate,Frontal Sinus Inverted Papilloma
22104,Malignant Cellular Infiltrate,Ethmoid Sinus Inverted Papilloma
22105,Malignant Cellular Infiltrate,Oral Cavity Monomorphic Adenoma
22106,Benign Cellular Infiltrate,Kadish Stage B Olfactory Neuroblastoma
22107,Malignant Cellular Infiltrate,Cervical Microglandular Polyp
22108,Benign Cellular Infiltrate,Choroid Spindle Cell Type A Melanoma
22109,Benign Cellular Infiltrate,Childhood Malignant Testicular Germ Cell Tumor
22110,Benign Cellular Infiltrate,Early Unfavorable Hodgkin Lymphoma
22111,Benign Cellular Infiltrate,Hodgkin Lymphoma by Clinical Course
22112,Benign Cellular Infiltrate,childhood nasal type extranodal NK/T-cell lymphoma
22113,Benign Cellular Infiltrate,Adult Pure Erythroid Leukemia
22114,Benign Cellular Infiltrate,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
22115,Intermediate Grade Neuroendocrine Lesion,Mixed Ductal-Endocrine Carcinoma
22116,Benign Cellular Infiltrate,"Thymoma, type B2, malignant"
22117,Benign Cellular Infiltrate,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
22118,Benign Cellular Infiltrate,Precursor T-cell lymphoblastic lymphoma
22119,Benign Cellular Infiltrate,Langerhans Cell Sarcoma
22120,Intermediate Grade Neuroendocrine Lesion,Squamous Cell Carcinoma of Anal Margin
22121,Benign Cellular Infiltrate,Plasmacytoma
22122,Malignant Cellular Infiltrate,Aggressive angiomyxoma
22123,Benign Cellular Infiltrate,Retinoblastoma
22124,Malignant Cellular Infiltrate,Breast Papillomatosis
22125,Benign Cellular Infiltrate,Warty Carcinoma of the Penis
22126,Malignant Cellular Infiltrate,Central Nervous System Rhabdomyoma
22127,Malignant Cellular Infiltrate,Central Nervous System Mature Teratoma
22128,Benign Cellular Infiltrate,Central Nervous System Teratoma with Malignant Transformation
22129,Benign Cellular Infiltrate,Mature B-Cell Non-Hodgkin Lymphoma
22130,Benign Cellular Infiltrate,Erythroid Neoplasm
22131,Benign Cellular Infiltrate,ISS Stage I Plasma Cell Myeloma
22132,Benign Cellular Infiltrate,ISS Stage III Plasma Cell Myeloma
22133,Mitotic Activity,Mature Mediastinal Teratoma
22134,Intermediate Grade Neuroendocrine Lesion,Stage I Liver Carcinoma
22135,Benign Cellular Infiltrate,Adult Grade III Meningioma
22136,Benign Cellular Infiltrate,leiomyosarcoma of bone
22137,Benign Cellular Infiltrate,Primary cutaneous lymphoma
22138,Benign Cellular Infiltrate,Acute myeloid leukemia with recurrent genetic abnormality
22139,Benign Cellular Infiltrate,Lymphoma by Site
22140,Benign Cellular Infiltrate,Anaplastic small cell lymphoma
22141,Benign Cellular Infiltrate,Non-Hodgkin Lymphoma with Variable Clinical Course
22142,Benign Cellular Infiltrate,Primary Cutaneous Follicle Center Lymphoma
22143,Benign Cellular Infiltrate,Primary Cutaneous Hodgkin Lymphoma
22144,Benign Cellular Infiltrate,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
22145,Benign Cellular Infiltrate,Plasma Cell Post-Transplant Lymphoproliferative Disorder
22146,Benign Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
22147,Benign Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
22148,Benign Cellular Infiltrate,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma
22149,Benign Cellular Infiltrate,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma
22150,Benign Cellular Infiltrate,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma
22151,Benign Cellular Infiltrate,Diffuse follicle center lymphoma
22152,Benign Cellular Infiltrate,Hodgkin's disease of spleen
22153,Benign Cellular Infiltrate,Splenic Manifestation of Chronic Lymphocytic Leukemia
22154,Benign Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia
22155,Benign Cellular Infiltrate,Splenic Lymphoplasmacytic Lymphoma
22156,Benign Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
22157,Benign Cellular Infiltrate,Adult B Lymphoblastic Lymphoma
22158,Benign Cellular Infiltrate,Retroperitoneal Carcinoma
22159,Malignant Cellular Infiltrate,Benign neoplasm of mesothelial tissue of peritoneum
22160,Benign Cellular Infiltrate,Urothelial cancer of renal pelvis
22161,Well Differentiated Neuroendocrine Lesion,Gallbladder adenosquamous carcinoma
22162,Benign Cellular Infiltrate,Hairy cell leukemia variant
22163,Well Differentiated Neuroendocrine Lesion,Rectosigmoid cancer
22164,Benign Cellular Infiltrate,Nonencapsulated sclerosing tumor
22165,Benign Cellular Infiltrate,Infiltrating papillary adenocarcinoma
22166,Malignant Cellular Infiltrate,Intramuscular lipoma
22167,Intermediate Grade Neuroendocrine Lesion,Anal Verrucous Carcinoma
22168,Well Differentiated Neuroendocrine Lesion,Anal margin basal cell carcinoma
22169,Well Differentiated Neuroendocrine Lesion,Anal margin Paget's disease
22170,Well Differentiated Neuroendocrine Lesion,Paget disease of anal canal
22171,Intermediate Grade Neuroendocrine Lesion,Paget disease of anal canal
22172,Benign Cellular Infiltrate,Malignant neoplasm of vulva
22173,Benign Cellular Infiltrate,Malignant neoplasm of thyroid
22174,Benign Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v7
22175,Benign Cellular Infiltrate,Malignant neoplasm of penis
22176,Benign Cellular Infiltrate,Stage III Prostate Carcinoma
22177,Malignant Cellular Infiltrate,Eccrine hidrocystoma
22178,Benign Cellular Infiltrate,Sporadic Breast Carcinoma
22179,Benign Cellular Infiltrate,Microcystic adnexal carcinoma
22180,Benign Cellular Infiltrate,Acute Myeloid Leukemia with Myelodysplasia-Related Changes
22181,Malignant Cellular Infiltrate,Halo nevus
22182,Malignant Cellular Infiltrate,Regressing nevus
22183,Benign Cellular Infiltrate,Cerebral Non-Hodgkin Lymphoma
22184,Benign Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma
22185,Benign Cellular Infiltrate,Recurrent Urinary System Carcinoma
22186,Benign Cellular Infiltrate,Urethral cancer regional
22187,Well Differentiated Neuroendocrine Lesion,Localized Gallbladder Carcinoma
22188,Intermediate Grade Neuroendocrine Lesion,Localized Gallbladder Carcinoma
22189,Well Differentiated Neuroendocrine Lesion,Hepatoma resectable
22190,Benign Cellular Infiltrate,Inflammatory carcinoma of breast stage IV
22191,Benign Cellular Infiltrate,Adult Hodgkin Lymphoma
22192,Benign Cellular Infiltrate,Adult Soft Tissue Sarcoma
22193,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of appendix
22194,Benign Cellular Infiltrate,squamous cell carcinoma of renal pelvis
22195,Malignant Cellular Infiltrate,Lipoma of the tongue
22196,Benign Cellular Infiltrate,Stage IIIA Breast Carcinoma
22197,Benign Cellular Infiltrate,Breast cancer recurrent
22198,Low Grade Neuroendocrine Lesion,Stage I Gastric Carcinoma
22199,Low Grade Neuroendocrine Lesion,Stage III Carcinoma of Stomach
22200,Low Grade Neuroendocrine Lesion,Stage II Anal Canal Cancer AJCC v6 and v7
22201,Intermediate Grade Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v6 and v7
22202,Low Grade Neuroendocrine Lesion,Stage II Pancreatic Cancer AJCC v6 and v7
22203,Intermediate Grade Neuroendocrine Lesion,Stage I Rectal Cancer AJCC v6 and v7
22204,Intermediate Grade Neuroendocrine Lesion,Anal cancer recurrent
22205,Benign Cellular Infiltrate,Cervix carcinoma recurrent
22206,Benign Cellular Infiltrate,Neuroblastoma recurrent
22207,Intermediate Grade Neuroendocrine Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
22208,Benign Cellular Infiltrate,Stage IV Kidney Wilms Tumor
22209,Benign Cellular Infiltrate,DS Stage III Plasma Cell Myeloma
22210,Benign Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v6 and v7
22211,Benign Cellular Infiltrate,Penis carcinoma recurrent
22212,Benign Cellular Infiltrate,Adult Immunoblastic Lymphoma
22213,Well Differentiated Neuroendocrine Lesion,Recurrent Adult Liver Carcinoma
22214,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of small intestine
22215,Well Differentiated Neuroendocrine Lesion,Adenocarcinoma of duodenum
22216,Well Differentiated Neuroendocrine Lesion,Unresectable Gallbladder Carcinoma
22217,Low Grade Neuroendocrine Lesion,Localized Extrahepatic Bile Duct Carcinoma
22218,Well Differentiated Neuroendocrine Lesion,Recurrent Extrahepatic Bile Duct Carcinoma
22219,Benign Cellular Infiltrate,Recurrent Thyroid Carcinoma
22220,Benign Cellular Infiltrate,Recurrent Uveal Melanoma
22221,Benign Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v6
22222,Low Grade Neuroendocrine Lesion,Liver and Intrahepatic Biliary Tract Carcinoma
22223,Benign Cellular Infiltrate,Adult Alveolar Soft Part Sarcoma
22224,Benign Cellular Infiltrate,Invasive Lobular Breast Carcinoma
22225,Benign Cellular Infiltrate,Adult Acute Basophilic Leukemia
22226,Intermediate Grade Neuroendocrine Lesion,Signet-ring cell adenocarcinoma of colon
22227,Low Grade Neuroendocrine Lesion,Distal 1/3 of the Common Bile Duct Adenocarcinoma
22228,Benign Cellular Infiltrate,Vaginal adenocarcinoma
22229,Benign Cellular Infiltrate,Lymphoepithelial malignant thymoma
22230,Benign Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma
22231,Benign Cellular Infiltrate,High Grade Salivary Gland Mucoepidermoid Carcinoma
22232,Benign Cellular Infiltrate,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
22233,Benign Cellular Infiltrate,Malignant mixed salivary gland tumor
22234,Benign Cellular Infiltrate,Progressive Hairy Cell Leukemia Initial Treatment
22235,Benign Cellular Infiltrate,Pediatric follicular lymphoma
22236,Benign Cellular Infiltrate,Pediatric nodal marginal zone lymphoma
22237,Benign Cellular Infiltrate,Hypodiploid B Acute Lymphoblastic Leukemia
22238,Benign Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7
22239,Benign Cellular Infiltrate,Stage I Oropharyngeal Carcinoma
22240,Benign Cellular Infiltrate,Stage II Oropharyngeal Carcinoma
22241,Benign Cellular Infiltrate,Recurrent Childhood Soft Tissue Sarcoma
22242,Benign Cellular Infiltrate,B-cell small lymphocytic lymphoma stage I
22243,Benign Cellular Infiltrate,Ann Arbor Stage I Grade 2 Follicular Lymphoma
22244,Benign Cellular Infiltrate,Stage I Adult Non-Hodgkin Lymphoma
22245,Mitotic Activity,Mature Ovarian Teratoma
22246,Benign Cellular Infiltrate,Ann Arbor Stage III Grade 2 Follicular Lymphoma
22247,Benign Cellular Infiltrate,Stage III Adult Lymphoblastic Lymphoma
22248,Benign Cellular Infiltrate,Recurrent Adult Immunoblastic Lymphoma
22249,Benign Cellular Infiltrate,Fibroblastic reticular cell tumor
22250,Benign Cellular Infiltrate,Lower Gingival Verrucous Carcinoma
22251,Benign Cellular Infiltrate,Supraglottic Verrucous Carcinoma
22252,Benign Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity recurrent
22253,Benign Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage III
22254,Benign Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx recurrent
22255,Benign Cellular Infiltrate,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
22256,Benign Cellular Infiltrate,Acute myeloid leukemia with mutated NPM1
22257,Benign Cellular Infiltrate,Acute myeloid leukemia with mutated CEBPA
22258,Benign Cellular Infiltrate,Adult Acute Monocytic Leukemia
22259,Low Grade Neuroendocrine Lesion,Adult Cholangiocarcinoma
22260,Benign Cellular Infiltrate,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
22261,Benign Cellular Infiltrate,Papillary serous cystadenocarcinoma
22262,Well Differentiated Neuroendocrine Lesion,Gastric Fundus Carcinoma
22263,Well Differentiated Neuroendocrine Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
22264,Benign Cellular Infiltrate,Malignant Sebaceous Neoplasm
22265,Low Grade Neuroendocrine Lesion,Stage IV Rectal Carcinoma
22266,Malignant Cellular Infiltrate,Benign neoplasm of sternum
22267,Malignant Cellular Infiltrate,Diffuse neurofibroma
22268,Benign Cellular Infiltrate,Palate carcinoma
22269,Benign Cellular Infiltrate,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma
22270,Benign Cellular Infiltrate,Ann Arbor Stage II Contiguous Mantle Cell Lymphoma
22271,Benign Cellular Infiltrate,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma
22272,Benign Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma
22273,Benign Cellular Infiltrate,Mantle cell lymphoma recurrent
22274,Benign Cellular Infiltrate,Indolent Adult Non-Hodgkin Lymphoma
22275,Benign Cellular Infiltrate,Familial Retinoblastoma
22276,Benign Cellular Infiltrate,Bilateral Carcinoma
22277,Benign Cellular Infiltrate,Indolent Non-Hodgkin Lymphoma
22278,Well Differentiated Neuroendocrine Lesion,Stage I Colorectal Cancer AJCC v6 and v7
22279,Benign Cellular Infiltrate,Stage IV Hodgkin Lymphoma
22280,Benign Cellular Infiltrate,Stage I Non-Hodgkin Lymphoma
22281,Benign Cellular Infiltrate,Secondary malignant neoplasm of nervous system
22282,Benign Cellular Infiltrate,Secondary malignant neoplasm of ciliary body
22283,Benign Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
22284,Benign Cellular Infiltrate,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
22285,Benign Cellular Infiltrate,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
22286,Benign Cellular Infiltrate,Infiltrating Cervical Carcinoma
22287,Benign Cellular Infiltrate,Stage IIA Merkel Cell Carcinoma AJCC v7
22288,Benign Cellular Infiltrate,Leukemic Phase of Non-Hodgkin's Lymphoma
22289,Benign Cellular Infiltrate,Stage IIIB Cutaneous Melanoma AJCC v7
22290,Low Grade Neuroendocrine Lesion,Esophageal adenocarcinoma recurrent
22291,Well Differentiated Neuroendocrine Lesion,Stage I Esophageal Adenocarcinoma AJCC v7
22292,Well Differentiated Neuroendocrine Lesion,Rectosigmoid cancer recurrent
22293,Intermediate Grade Neuroendocrine Lesion,Rectosigmoid cancer recurrent
22294,Intermediate Grade Neuroendocrine Lesion,Stage IV Rectosigmoid Cancer AJCC v6
22295,Low Grade Neuroendocrine Lesion,Small intestine carcinoma metastatic
22296,Well Differentiated Neuroendocrine Lesion,Small intestine carcinoma non-resectable
22297,Intermediate Grade Neuroendocrine Lesion,Small intestine carcinoma resectable
22298,Intermediate Grade Neuroendocrine Lesion,Bile duct cancer resectable
22299,Low Grade Neuroendocrine Lesion,Bile duct cancer resectable
22300,Benign Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I
22301,Benign Cellular Infiltrate,Stage I Anaplastic Large Cell Lymphoma
22302,Benign Cellular Infiltrate,Stage II Anaplastic Large Cell Lymphoma
22303,Benign Cellular Infiltrate,T-cell lymphoma refractory
22304,Benign Cellular Infiltrate,T-cell lymphoma stage I
22305,Benign Cellular Infiltrate,T-cell lymphoma stage II
22306,Benign Cellular Infiltrate,Angiocentric lymphoma stage I
22307,Benign Cellular Infiltrate,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma
22308,Benign Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia refractory
22309,Benign Cellular Infiltrate,Stage IIIA Uterine Sarcoma AJCC v7
22310,Benign Cellular Infiltrate,Rhabdoid Tumor of the Kidney
22311,Benign Cellular Infiltrate,Stage I Fallopian Tube Cancer
22312,Benign Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7
22313,Benign Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage IV
22314,Benign Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7
22315,Benign Cellular Infiltrate,Adenosquamous cell lung cancer recurrent
22316,Benign Cellular Infiltrate,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7
22317,Benign Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
22318,Benign Cellular Infiltrate,"Adenocarcinoma of lung, stage IV"
22319,Benign Cellular Infiltrate,Stage IV Lung Squamous Cell Carcinoma AJCC v7
22320,Benign Cellular Infiltrate,Stage II Pharynx Carcinoma
22321,Well Differentiated Neuroendocrine Lesion,Stage IIIC Gastric Cancer AJCC v7
22322,Low Grade Neuroendocrine Lesion,Stage IA Esophageal Adenocarcinoma AJCC v7
22323,Well Differentiated Neuroendocrine Lesion,Stage IIIA Esophageal Adenocarcinoma AJCC v7
22324,Low Grade Neuroendocrine Lesion,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
22325,Low Grade Neuroendocrine Lesion,Stage IIB Appendix Carcinoma AJCC v7
22326,Intermediate Grade Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v7
22327,Low Grade Neuroendocrine Lesion,Stage IIIA Appendix Carcinoma AJCC v7
22328,Well Differentiated Neuroendocrine Lesion,Stage IIIC Appendix Carcinoma AJCC v7
22329,Low Grade Neuroendocrine Lesion,Stage IVB Appendix Carcinoma AJCC v7
22330,Well Differentiated Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v7
22331,Intermediate Grade Neuroendocrine Lesion,Stage IVC Appendix Carcinoma AJCC v7
22332,Well Differentiated Neuroendocrine Lesion,Stage IIA Colorectal Cancer AJCC v7
22333,Low Grade Neuroendocrine Lesion,Stage IIC Colorectal Cancer AJCC v7
22334,Benign Cellular Infiltrate,Stage III Superficial Spreading Melanoma AJCC v7
22335,Benign Cellular Infiltrate,Alveolar soft part sarcoma metastatic
22336,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Hepatocellular Carcinoma AJCC v7
22337,Well Differentiated Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
22338,Intermediate Grade Neuroendocrine Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
22339,Low Grade Neuroendocrine Lesion,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
22340,Low Grade Neuroendocrine Lesion,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
22341,Low Grade Neuroendocrine Lesion,Stage IIIA Gallbladder Cancer AJCC v7
22342,Low Grade Neuroendocrine Lesion,Stage II Hilar Cholangiocarcinoma AJCC v7
22343,Benign Cellular Infiltrate,Extraskeletal osteosarcoma metastatic
22344,Low Grade Neuroendocrine Lesion,Stage IA Distal Bile Duct Cancer AJCC v7
22345,Intermediate Grade Neuroendocrine Lesion,Stage IIA Pancreatic Cancer AJCC v6 and v7
22346,Benign Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v7
22347,Benign Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7
22348,Benign Cellular Infiltrate,Recurrent Rhabdomyosarcoma
22349,Benign Cellular Infiltrate,Synovial sarcoma recurrent
22350,Benign Cellular Infiltrate,Hodgkin's disease mixed cellularity stage IV
22351,Benign Cellular Infiltrate,B-cell lymphoma recurrent
22352,Benign Cellular Infiltrate,Stage I Diffuse Large B-Cell Lymphoma
22353,Benign Cellular Infiltrate,Ann Arbor Stage II Follicular Lymphoma
22354,Benign Cellular Infiltrate,Mantle cell lymphoma refractory
22355,Benign Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage III
22356,Benign Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage III
22357,Benign Cellular Infiltrate,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
22358,Benign Cellular Infiltrate,Stage IV Lung Cancer AJCC v7
22359,Benign Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ"
22360,Benign Cellular Infiltrate,Bladder squamous cell carcinoma recurrent
22361,Benign Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma AJCC v7
22362,Benign Cellular Infiltrate,Testicular embryonal carcinoma stage II
22363,Benign Cellular Infiltrate,Stage II Immature Testicular Teratoma AJCC v6 and v7
22364,Benign Cellular Infiltrate,Stage IV Prostate Cancer AJCC v7
22365,Benign Cellular Infiltrate,Centroblastic lymphoma recurrent
22366,Benign Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v7
22367,Intermediate Grade Neuroendocrine Lesion,Stage 0 Colorectal Cancer AJCC v6 and v7
22368,Benign Cellular Infiltrate,Endometrial adenocarcinoma metastatic
22369,Benign Cellular Infiltrate,Endometrioid adenocarcinoma metastatic
22370,Benign Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v7
22371,Benign Cellular Infiltrate,Metastatic Prostate Carcinoma
22372,Benign Cellular Infiltrate,Adenocarcinoma of the prostate stage I
22373,Benign Cellular Infiltrate,Cervical carcinoma stage II AJCC v7
22374,Benign Cellular Infiltrate,Stage IV Penile Cancer AJCC v6
22375,Benign Cellular Infiltrate,Stage II Uterine Corpus Cancer
22376,Benign Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v7
22377,Intermediate Grade Neuroendocrine Lesion,Stage I Esophageal Cancer AJCC v7
22378,Intermediate Grade Neuroendocrine Lesion,Stage II Esophageal Cancer AJCC v7
22379,Low Grade Neuroendocrine Lesion,Stage II Esophageal Cancer AJCC v7
22380,Well Differentiated Neuroendocrine Lesion,Colon Carcinoma Metastatic in the Lung
22381,Malignant Cellular Infiltrate,Female Reproductive System Adenofibroma
22382,Malignant Cellular Infiltrate,Papillary adenofibroma
22383,Well Differentiated Neuroendocrine Lesion,Malignant neoplasm of stomach stage III
22384,Intermediate Grade Neuroendocrine Lesion,Malignant neoplasm of stomach stage III
22385,Malignant Cellular Infiltrate,Cystadenofibroma
22386,Benign Cellular Infiltrate,Oral Cavity Carcinoma
22387,Benign Cellular Infiltrate,Malignant mastocytosis
22388,Well Differentiated Neuroendocrine Lesion,Stage III Colon Cancer AJCC v7
22389,Intermediate Grade Neuroendocrine Lesion,Stage III Rectal Cancer AJCC v7
22390,Well Differentiated Neuroendocrine Lesion,Stage IV Rectal Cancer AJCC v7
22391,Low Grade Neuroendocrine Lesion,Stage III Hepatocellular Carcinoma AJCC v7
22392,Well Differentiated Neuroendocrine Lesion,Stage I Gallbladder Cancer AJCC v7
22393,Low Grade Neuroendocrine Lesion,Stage III Gallbladder Cancer AJCC v7
22394,Benign Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor
22395,Benign Cellular Infiltrate,Stage III Adult Hodgkin Lymphoma
22396,Intermediate Grade Neuroendocrine Lesion,Stage I Anal Canal Cancer AJCC v6 and v7
22397,Low Grade Neuroendocrine Lesion,Stage I Anal Canal Cancer AJCC v6 and v7
22398,Well Differentiated Neuroendocrine Lesion,Gastric Cancer by AJCC v6 Stage
22399,Low Grade Neuroendocrine Lesion,Colorectal Cancer by AJCC v6 Stage
22400,Well Differentiated Neuroendocrine Lesion,Colon Cancer by AJCC v6 Stage
22401,Low Grade Neuroendocrine Lesion,Gallbladder Cancer by AJCC v6 Stage
22402,Benign Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v6 Stage
22403,Benign Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v6 Stage
22404,Benign Cellular Infiltrate,Recurrent Childhood Lymphoblastic Lymphoma
22405,Well Differentiated Neuroendocrine Lesion,Localized Unresectable Adult Hepatocellular Carcinoma
22406,Benign Cellular Infiltrate,Stage 0 Uterine Corpus Cancer AJCC v6
22407,Benign Cellular Infiltrate,Recurrent Uterine Corpus Carcinoma
22408,Benign Cellular Infiltrate,Stage III Testicular Cancer AJCC v6 and v7
22409,Benign Cellular Infiltrate,Stage IV Prostate Carcinoma
22410,Benign Cellular Infiltrate,Blast Phase
22411,Low Grade Neuroendocrine Lesion,Pancreatic Ductal Adenocarcinoma
22412,Benign Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage
22413,Benign Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
22414,Well Differentiated Neuroendocrine Lesion,Esophageal Cancer by AJCC v7 Stage
22415,Intermediate Grade Neuroendocrine Lesion,Gastric Cancer by AJCC v7 Stage
22416,Well Differentiated Neuroendocrine Lesion,Rectal Cancer by AJCC v7 Stage
22417,Well Differentiated Neuroendocrine Lesion,Gallbladder Cancer by AJCC v7 Stage
22418,Benign Cellular Infiltrate,Cutaneous Melanoma by AJCC v7 Stage
22419,Benign Cellular Infiltrate,Prostate Cancer by AJCC v7 Stage
22420,Benign Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v7 Stage
22421,Benign Cellular Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma
22422,Benign Cellular Infiltrate,Philadelphia chromosome negative chronic myelogenous leukemia
22423,Benign Cellular Infiltrate,Adult Rhabdomyosarcoma
22424,Benign Cellular Infiltrate,Mixed Cell Type Kidney Wilms Tumor
22425,Benign Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma
22426,Low Grade Neuroendocrine Lesion,Gastric Intestinal-Type Adenocarcinoma
22427,Well Differentiated Neuroendocrine Lesion,Diffuse Gastric Adenocarcinoma
22428,Benign Cellular Infiltrate,Childhood Acute Erythroid Leukemia
22429,Well Differentiated Neuroendocrine Lesion,undifferentiated carcinoma of gallbladder
22430,Low Grade Neuroendocrine Lesion,adenocarcinoma of gallbladder with squamous metaplasia
22431,Well Differentiated Neuroendocrine Lesion,Stage III Esophageal Cancer
22432,Low Grade Neuroendocrine Lesion,Stage IV Esophagus Carcinoma
22433,Benign Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v7
22434,Malignant Cellular Infiltrate,Pericardial Adenomatoid Tumor
22435,Low Grade Neuroendocrine Lesion,recurrent gastric cancer
22436,Benign Cellular Infiltrate,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma
22437,Benign Cellular Infiltrate,Multifocal Glioblastomas
22438,Benign Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent
22439,Intermediate Grade Neuroendocrine Lesion,AIDS-Related Anal Carcinoma
22440,Benign Cellular Infiltrate,Mediastinal (Thymic) Large B-Cell Lymphoma
22441,Benign Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating"
22442,Benign Cellular Infiltrate,Acute myeloid leukemia with abnormal marrow eosinophils
22443,Benign Cellular Infiltrate,Primary central nervous system lymphoma
22444,Benign Cellular Infiltrate,Malignant tumor of cervix
22445,Benign Cellular Infiltrate,Adrenocortical carcinoma
22446,Benign Cellular Infiltrate,Maxillary Sinus Carcinoma
22447,Benign Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET)
22448,Benign Cellular Infiltrate,Tracheal Carcinoma
22449,Well Differentiated Neuroendocrine Lesion,Duodenal carcinoma recurrent
22450,Low Grade Neuroendocrine Lesion,Stage I Colon Cancer AJCC v6 and v7
22451,Intermediate Grade Neuroendocrine Lesion,Adenocarcinoma of rectum
22452,Benign Cellular Infiltrate,Sarcoma NCI Grade 1
22453,Benign Cellular Infiltrate,Well Differentiated Leiomyosarcoma
22454,Benign Cellular Infiltrate,Leiomyosarcoma NCI Grade 3
22455,Benign Cellular Infiltrate,High Grade Sarcoma
22456,Benign Cellular Infiltrate,AJCC Grade 3 Sarcoma
22457,Well Differentiated Neuroendocrine Lesion,Grade 2 Colorectal Adenocarcinoma
22458,Well Differentiated Neuroendocrine Lesion,Grade 3 Rectal Adenocarcinoma
22459,Intermediate Grade Neuroendocrine Lesion,Grade 3 Rectal Adenocarcinoma
22460,Well Differentiated Neuroendocrine Lesion,Grade 2 Rectal Adenocarcinoma
22461,Intermediate Grade Neuroendocrine Lesion,Grade 1 Colon Adenocarcinoma
22462,Intermediate Grade Neuroendocrine Lesion,Grade 3 Colon Adenocarcinoma
22463,Benign Cellular Infiltrate,Childhood Systemic Anaplastic Large Cell Lymphoma
22464,Malignant Cellular Infiltrate,Lactating adenoma
22465,Benign Cellular Infiltrate,Anaplastic astrocytoma
22466,Intermediate Grade Neuroendocrine Lesion,Stage IIIC Adult Liver Cancer AJCC v7
22467,Malignant Cellular Infiltrate,Myolipoma
22468,Intermediate Grade Neuroendocrine Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
22469,Well Differentiated Neuroendocrine Lesion,Mixed Acinar-Ductal Carcinoma of the Pancreas
22470,Geographic Necrosis,benign mature teratoma of pancreas
22471,Low Grade Neuroendocrine Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma
22472,Intermediate Grade Neuroendocrine Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma
22473,Well Differentiated Neuroendocrine Lesion,Esophageal Mixed Adenoneuroendocrine Carcinoma
22474,Malignant Cellular Infiltrate,Esophageal hemangioma
22475,Well Differentiated Neuroendocrine Lesion,Gastric Carcinoma with Lymphoid Stroma
22476,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2
22477,Low Grade Neuroendocrine Lesion,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
22478,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
22479,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
22480,Benign Cellular Infiltrate,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
22481,Low Grade Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma
22482,Well Differentiated Neuroendocrine Lesion,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
22483,Intermediate Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Carcinoma
22484,Low Grade Neuroendocrine Lesion,Colorectal Large Cell Neuroendocrine Carcinoma
22485,Well Differentiated Neuroendocrine Lesion,Colorectal Mixed Adenoneuroendocrine Carcinoma
22486,Poorly Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2
22487,Low Grade Neuroendocrine Lesion,Colorectal Serrated Adenocarcinoma
22488,Well Differentiated Neuroendocrine Lesion,Colorectal Cribriform Comedo-Type Adenocarcinoma
22489,Well Differentiated Neuroendocrine Lesion,Rectal Micropapillary Adenocarcinoma
22490,Intermediate Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1
22491,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1
22492,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2
22493,Intermediate Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal
22494,Low Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal
22495,Intermediate Grade Neuroendocrine Lesion,Early Hepatocellular Carcinoma
22496,Well Differentiated Neuroendocrine Lesion,Perihilar Intrahepatic Cholangiocarcinoma
22497,Intermediate Grade Neuroendocrine Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
22498,Intermediate Grade Neuroendocrine Lesion,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
22499,Low Grade Neuroendocrine Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
22500,Low Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Carcinoma
22501,Well Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of gallbladder
22502,Low Grade Neuroendocrine Lesion,large cell neuroendocrine carcinoma of gallbladder
22503,Intermediate Grade Neuroendocrine Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
22504,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
22505,Intermediate Grade Neuroendocrine Lesion,cystadenocarcinoma of intrahepatic bile duct
22506,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
22507,Low Grade Neuroendocrine Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
22508,Poorly Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor
22509,Metastatic Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22510,Benign Cellular Infiltrate,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22511,Benign Cellular Infiltrate,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22512,Metastatic Lesion,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22513,Extensive Stage Lesion,Locally Advanced Adrenal Gland Pheochromocytoma
22514,Benign Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Nodular"
22515,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Skin Squamous Cell Carcinoma
22516,Favorable Clinical Outcome,Unresectable Skin Basal Cell Carcinoma
22517,Benign Cellular Infiltrate,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
22518,Benign Cellular Infiltrate,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
22519,Well Differentiated Neuroendocrine Lesion,Anal Intraepithelial Neoplasia 3
22520,Low Grade Neuroendocrine Lesion,Anal Intraepithelial Neoplasia 3
22521,Anaplasia,Recurrent Ependymoma
22522,Premalignant Lesion,Metastatic Lung Neuroendocrine Neoplasm
22523,Mixed Neoplastic Glandular and Squamous Cell Population,BAP1-Mutant Clear Cell Renal Cell Carcinoma
22524,Mixed Neoplastic Glandular and Squamous Cell Population,Cholangiocarcinoma metastatic
22525,Benign Cellular Infiltrate,Sarcoma of pelvis
22526,Benign Cellular Infiltrate,Refractory Primary Effusion Lymphoma
22527,Benign Cellular Infiltrate,Refractory Plasmablastic Lymphoma
22528,Acute Clinical Course,Refractory T-Cell Prolymphocytic Leukemia
22529,Epidermotropic Lymphocytic Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22530,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
22531,Glandular Differentiation,large cell neuroendocrine carcinoma of bladder
22532,Benign Cellular Infiltrate,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
22533,Benign Cellular Infiltrate,Metastatic Bladder Small Cell Carcinoma
22534,Local disease,Advanced Digestive System Neuroendocrine Neoplasm
22535,Benign Cellular Infiltrate,Refractory Endometrial Mixed Cell Adenocarcinoma
22536,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Endometrial Mixed Cell Adenocarcinoma
22537,Benign Cellular Infiltrate,Refractory Endometrial Clear Cell Adenocarcinoma
22538,Indolent Clinical Course,Recurrent Fibrosarcoma
22539,Extensive Stage Lesion,Locally Advanced Salivary Gland Carcinoma
22540,Metastatic Lesion,Lymphoma of retina
22541,Indolent Clinical Course,Clear cell papillary renal cell carcinoma
22542,Benign Cellular Infiltrate,Refractory Primary Vitreoretinal Lymphoma
22543,Benign Cellular Infiltrate,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22544,Benign Cellular Infiltrate,Locally Advanced Adrenal Gland Pheochromocytoma
22545,Benign Cellular Infiltrate,Borderline Resectable Malignant Neoplasm
22546,Well Differentiated Neuroendocrine Lesion,Borderline Resectable Pancreatic Adenocarcinoma
22547,Low Grade Neuroendocrine Lesion,Colorectal Adenocarcinoma Metastatic in the Liver
22548,Benign Cellular Infiltrate,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
22549,Indolent Clinical Course,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
22550,Intermediate Grade Neuroendocrine Lesion,Anal Intraepithelial Neoplasia 3
22551,Benign Cellular Infiltrate,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
22552,Benign Cellular Infiltrate,Recurrent Adenoid Cystic Carcinoma
22553,Benign Cellular Infiltrate,Refractory Primary Lymphoma of Bone
22554,Benign Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia
22555,Solid Growth Pattern,Refractory Aggressive NK-Cell Leukemia
22556,Aggressive Clinical Course,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22557,Favorable Clinical Outcome,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22558,CD4-Positive Neoplastic Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22559,Mucoid Stroma Formation,Laryngeal papillomatosis
22560,Indolent Clinical Course,Kidney Synovial Sarcoma
22561,Intermediate Filaments Present,Kidney Synovial Sarcoma
22562,Malignant Cellular Infiltrate,Metanephric Tumor
22563,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Sarcomatoid Renal Cell Carcinoma
22564,Squamous Differentiation,large cell neuroendocrine carcinoma of bladder
22565,Squamous Differentiation,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
22566,Benign Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
22567,Well Differentiated Neuroendocrine Lesion,Refractory Cholangiocarcinoma
22568,Benign Cellular Infiltrate,Refractory Transformed B-cell Non-Hodgkin Lymphoma
22569,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Endometrial Clear Cell Adenocarcinoma
22570,Biphasic Pattern,Recurrent Spindle Cell Sarcoma
22571,Intracytoplasmic Eosinophilic Inclusion,Refractory Spindle Cell Sarcoma
22572,Benign Cellular Infiltrate,Metastatic Salivary Gland Carcinoma
22573,Benign Cellular Infiltrate,Locally Advanced Salivary Gland Carcinoma
22574,Papillary Pattern,Bladder Urothelial Proliferation of Uncertain Malignant Potential
22575,Benign Cellular Infiltrate,Diffuse Intrinsic Pontine Glioma
22576,Metastatic Lesion,Recurrent Primary Vitreoretinal Lymphoma
22577,Metastatic Lesion,Refractory Primary Vitreoretinal Lymphoma
22578,Indolent Clinical Course,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22579,Metastatic Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22580,Indolent Clinical Course,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22581,Hemorrhagic Neuroblastic Nodules Present,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
22582,Scattered Collections of Differentiating Neuroblasts Present,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
22583,Benign Cellular Infiltrate,Unresectable Skin Squamous Cell Carcinoma
22584,Benign Cellular Infiltrate,Unresectable Basal Cell Carcinoma
22585,Local disease,Advanced Extracranial Malignant Solid Neoplasm
22586,Intermediate Grade Neuroendocrine Lesion,Borderline Resectable Pancreatic Adenocarcinoma
22587,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Lung Non-Small Cell Squamous Carcinoma
22588,Well Differentiated Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Liver
22589,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Intraepithelial Neoplasia 1
22590,Invasive Lesion,Anal Intraepithelial Neoplasia 2
22591,Invasive Lesion,Anal Intraepithelial Neoplasia 3
22592,Benign Cellular Infiltrate,Anal Intraepithelial Neoplasia 3
22593,Benign Cellular Infiltrate,BAP1-Mutant Clear Cell Renal Cell Carcinoma
22594,Benign Cellular Infiltrate,Metastatic Adenoid Cystic Carcinoma
22595,Intermediate Filaments Present,Sarcoma of pelvis
22596,Acute Clinical Course,Recurrent Aggressive NK-Cell Leukemia
22597,Benign Cellular Infiltrate,Acquired cystic disease associated renal cell carcinoma
22598,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Bladder Squamous Cell Carcinoma
22599,Benign Cellular Infiltrate,Neuroendocrine carcinoma of the bladder
22600,Benign Cellular Infiltrate,Metastatic Prostate Small Cell Carcinoma
22601,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
22602,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
22603,Benign Cellular Infiltrate,Recurrent B-Cell Prolymphocytic Leukemia
22604,Acute Clinical Course,Recurrent B-Cell Prolymphocytic Leukemia
22605,Intermediate Grade Neuroendocrine Lesion,Refractory Cholangiocarcinoma
22606,Intracytoplasmic Eosinophilic Inclusion,Refractory Desmoplastic Small Round Cell Tumor
22607,Indolent Clinical Course,Refractory Fibrosarcoma
22608,Benign Cellular Infiltrate,Refractory Fibrosarcoma
22609,Indolent Clinical Course,Recurrent Spindle Cell Sarcoma
22610,Intracytoplasmic Eosinophilic Inclusion,Recurrent Spindle Cell Sarcoma
22611,Biphasic Pattern,Refractory Spindle Cell Sarcoma
22612,Intermediate Filaments Present,Refractory Spindle Cell Sarcoma
22613,Biphasic Pattern,Benign cystic nephroma
22614,Indolent Clinical Course,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22615,Indolent Clinical Course,Refractory Primary Vitreoretinal Lymphoma
22616,Benign Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
22617,Composite Lesion,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
22618,Mixed Neoplastic Glandular and Squamous Cell Population,Colorectal Adenocarcinoma Metastatic in the Liver
22619,Low Grade Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Liver
22620,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Intraepithelial Neoplasia 3
22621,Indolent Clinical Course,Recurrent Giant Cell Glioblastoma
22622,Benign Cellular Infiltrate,Recurrent Giant Cell Glioblastoma
22623,Benign Cellular Infiltrate,Recurrent Primary Effusion Lymphoma
22624,Benign Cellular Infiltrate,Recurrent Primary Lymphoma of Bone
22625,Benign Cellular Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22626,Dermal Involvement,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22627,Mixed Neoplastic Glandular and Squamous Cell Population,Acquired cystic disease associated renal cell carcinoma
22628,Borderline Lesion,Metanephric Tumor
22629,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
22630,Benign Cellular Infiltrate,large cell neuroendocrine carcinoma of bladder
22631,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
22632,Benign Cellular Infiltrate,Recurrent Transformed B-cell Non-Hodgkin Lymphoma
22633,Acute Clinical Course,Refractory Transformed Chronic Lymphocytic Leukemia
22634,Benign Cellular Infiltrate,Refractory Endometrial Serous Adenocarcinoma
22635,Indolent Clinical Course,Recurrent Desmoplastic Small Round Cell Tumor
22636,Benign Cellular Infiltrate,Refractory Desmoplastic Small Round Cell Tumor
22637,Benign Cellular Infiltrate,Recurrent Fibrosarcoma
22638,Intermediate Filaments Present,Recurrent Spindle Cell Sarcoma
22639,Benign Cellular Infiltrate,Refractory Spindle Cell Sarcoma
22640,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrioid adenocarcinoma recurrent
22641,Benign Cellular Infiltrate,Platinum-Resistant Lung Small Cell Carcinoma
22642,Premalignant Lesion,Platinum-Resistant Lung Small Cell Carcinoma
22643,Benign Cellular Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma
22644,Malignant Cellular Infiltrate,Clonal Hematopoiesis of Indeterminate Potential
22645,atypia morphology,Bladder Urothelial Proliferation of Uncertain Malignant Potential
22646,Borderline Lesion,Nephrogenic adenofibroma
22647,Indolent Clinical Course,Refractory Diffuse Intrinsic Pontine Glioma
22648,Benign Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma
22649,Benign Cellular Infiltrate,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22650,Benign Cellular Infiltrate,Histiocytoid Breast Carcinoma
22651,Scattered Collections of Differentiating Neuroblasts Present,"Adrenal Gland Ganglioneuroblastoma, Nodular"
22652,Malignant Cellular Infiltrate,Adrenal Gland Ganglioneuroma
22653,Favorable Clinical Outcome,Unresectable Skin Carcinoma
22654,Well Differentiated Neuroendocrine Lesion,Borderline Resectable Pancreatic Carcinoma
22655,Benign Cellular Infiltrate,Borderline Resectable Pancreatic Carcinoma
22656,Benign Cellular Infiltrate,Borderline Resectable Carcinoma
22657,Benign Cellular Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma
22658,Intermediate Grade Neuroendocrine Lesion,Colorectal Adenocarcinoma Metastatic in the Liver
22659,Benign Cellular Infiltrate,Colorectal Adenocarcinoma Metastatic in the Liver
22660,Benign Cellular Infiltrate,Metastatic Lung Non-Small Cell Squamous Carcinoma
22661,Premalignant Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma
22662,Premalignant Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
22663,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
22664,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
22665,Benign Cellular Infiltrate,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
22666,Polymorphic Cellular Infiltrate,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
22667,Precise Histogenesis Unknown,Recurrent Giant Cell Glioblastoma
22668,Precise Histogenesis Unknown,Recurrent Ependymoma
22669,Benign Cellular Infiltrate,Locally Advanced Urothelial Carcinoma
22670,Indolent Clinical Course,Sarcoma of pelvis
22671,Benign Cellular Infiltrate,"Recurrent NK-Cell Lymphoma, Unclassifiable"
22672,Benign Cellular Infiltrate,"Refractory NK-Cell Lymphoma, Unclassifiable"
22673,Solid Growth Pattern,Refractory T-Cell Prolymphocytic Leukemia
22674,Solid Growth Pattern,Recurrent Aggressive NK-Cell Leukemia
22675,Acute Clinical Course,Refractory Aggressive NK-Cell Leukemia
22676,CD56-Positive Neoplastic Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22677,Borderline Lesion,Metanephric stromal tumor
22678,Solid Growth Pattern,Recurrent B-Cell Prolymphocytic Leukemia
22679,Benign Cellular Infiltrate,Recurrent Transformed Chronic Lymphocytic Leukemia
22680,Acute Clinical Course,Recurrent Transformed Chronic Lymphocytic Leukemia
22681,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Endometrial Clear Cell Adenocarcinoma
22682,Mucoid Stroma Formation,Bladder Non-Invasive Papillary Urothelial Carcinoma
22683,Mixed Neoplastic Glandular and Squamous Cell Population,Endometrioid adenocarcinoma recurrent
22684,Benign Cellular Infiltrate,Recurrent Spindle Cell Sarcoma
22685,Benign Cellular Infiltrate,Unresectable Urethral Urothelial Carcinoma
22686,Benign Cellular Infiltrate,Unresectable Renal Pelvis Urothelial Carcinoma
22687,Indolent Clinical Course,Lymphoma of retina
22688,Necrotic changes (finding),Clear cell papillary renal cell carcinoma
22689,Indolent Clinical Course,Recurrent Diffuse Intrinsic Pontine Glioma
22690,Benign Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma
22691,Mucoid Stroma Formation,Stage 0a Bladder Cancer AJCC v8
22692,Papillary Pattern,Stage 0is Bladder Cancer AJCC v8
22693,Metastatic Lesion,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22694,Mixed Cellular Population,Histiocytoid Breast Carcinoma
22695,Mixed Neoplastic Glandular and Squamous Cell Population,Histiocytoid Breast Carcinoma
22696,Benign Cellular Infiltrate,Advanced Extracranial Malignant Solid Neoplasm
22697,Low Grade Neuroendocrine Lesion,Borderline Resectable Pancreatic Carcinoma
22698,Low Grade Neuroendocrine Lesion,Borderline Resectable Pancreatic Adenocarcinoma
22699,Extensive Stage Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
22700,Benign Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Liver
22701,Indolent Clinical Course,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
22702,Benign Cellular Infiltrate,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
22703,High Mitotic Activity,Recurrent Ependymoma
22704,Benign Cellular Infiltrate,Platinum-Resistant Primary Peritoneal Carcinoma
22705,Well Differentiated Neuroendocrine Lesion,Cholangiocarcinoma metastatic
22706,Intermediate Grade Neuroendocrine Lesion,Cholangiocarcinoma metastatic
22707,Benign Cellular Infiltrate,Urothelial carcinoma recurrent
22708,Extensive Stage Lesion,Locally Advanced Urothelial Carcinoma
22709,Intracytoplasmic Eosinophilic Inclusion,Sarcoma of pelvis
22710,Indolent Clinical Course,Refractory Primary Lymphoma of Bone
22711,Benign Cellular Infiltrate,Recurrent Aggressive NK-Cell Leukemia
22712,Benign Cellular Infiltrate,Refractory Aggressive NK-Cell Leukemia
22713,Dermal Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22714,Aggressive Clinical Course,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22715,Intracytoplasmic Eosinophilic Inclusion,Kidney Synovial Sarcoma
22716,Malignant Cellular Infiltrate,Metanephric stromal tumor
22717,Benign Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma
22718,Benign Cellular Infiltrate,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
22719,Low Grade Neuroendocrine Lesion,Refractory Cholangiocarcinoma
22720,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Cholangiocarcinoma
22721,Precise Histogenesis Unknown,Refractory WHO Grade II Glioma
22722,Benign Cellular Infiltrate,Refractory Transformed Chronic Lymphocytic Leukemia
22723,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Endometrial Serous Adenocarcinoma
22724,Benign Cellular Infiltrate,Refractory Uterine Corpus Carcinosarcoma
22725,Benign Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma
22726,Local disease,Advanced Uterine Corpus Carcinosarcoma
22727,Intracytoplasmic Eosinophilic Inclusion,Recurrent Fibrosarcoma
22728,Intermediate Filaments Present,Refractory Fibrosarcoma
22729,Premalignant Lesion,Platinum-Sensitive Lung Small Cell Carcinoma
22730,Indolent Clinical Course,Diffuse Intrinsic Pontine Glioma
22731,Tumor Vascular Invasion,Clear cell papillary renal cell carcinoma
22732,Indolent Clinical Course,Primary Vitreoretinal Lymphoma
22733,Benign Cellular Infiltrate,Primary Vitreoretinal Lymphoma
22734,Metastatic Lesion,Primary Vitreoretinal Lymphoma
22735,Indolent Clinical Course,Recurrent Primary Vitreoretinal Lymphoma
22736,Metastatic Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22737,Indolent Clinical Course,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22738,Favorable Clinical Outcome,Unresectable Skin Squamous Cell Carcinoma
22739,Benign Cellular Infiltrate,Unresectable Skin Carcinoma
22740,Benign Cellular Infiltrate,Unresectable Skin Basal Cell Carcinoma
22741,Benign Cellular Infiltrate,Metastatic Extracranial Malignant Solid Neoplasm
22742,Mixed Neoplastic Glandular and Squamous Cell Population,Borderline Resectable Pancreatic Adenocarcinoma
22743,Invasive Lesion,Anal Intraepithelial Neoplasia 1
22744,Mixed Neoplastic Glandular and Squamous Cell Population,Anal Intraepithelial Neoplasia 2
22745,Benign Cellular Infiltrate,Metastatic Lung Neuroendocrine Neoplasm
22746,Low Grade Neuroendocrine Lesion,Cholangiocarcinoma metastatic
22747,Benign Cellular Infiltrate,Unresectable Lymphoma
22748,Indolent Clinical Course,Recurrent Primary Lymphoma of Bone
22749,Benign Cellular Infiltrate,Recurrent Plasmablastic Lymphoma
22750,Favorable Clinical Outcome,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22751,CD56-Positive Neoplastic Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22752,Acute Clinical Course,Refractory B-Cell Prolymphocytic Leukemia
22753,Benign Cellular Infiltrate,Kidney Synovial Sarcoma
22754,Benign Cellular Infiltrate,Metastatic Sarcomatoid Renal Cell Carcinoma
22755,Benign Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm
22756,Extensive Stage Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
22757,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Endometrial Serous Adenocarcinoma
22758,Benign Cellular Infiltrate,Advanced Uterine Corpus Carcinosarcoma
22759,Benign Cellular Infiltrate,Endometrioid adenocarcinoma recurrent
22760,Benign Cellular Infiltrate,Recurrent Desmoplastic Small Round Cell Tumor
22761,Intracytoplasmic Eosinophilic Inclusion,Recurrent Desmoplastic Small Round Cell Tumor
22762,Intermediate Filaments Present,Refractory Desmoplastic Small Round Cell Tumor
22763,Intermediate Filaments Present,Recurrent Fibrosarcoma
22764,Intracytoplasmic Eosinophilic Inclusion,Refractory Fibrosarcoma
22765,Indolent Clinical Course,Refractory Spindle Cell Sarcoma
22766,Benign Cellular Infiltrate,Endometrioid adenocarcinoma recurrent
22767,Benign Cellular Infiltrate,Unresectable Bladder Urothelial Carcinoma
22768,Nuclear Atypia,Clear cell papillary renal cell carcinoma
22769,Mucoid Stroma Formation,Clear cell papillary renal cell carcinoma
22770,Benign Cellular Infiltrate,Recurrent Primary Vitreoretinal Lymphoma
22771,Benign Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
22772,Indolent Clinical Course,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
22773,Nodular lesions,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
22774,Intermediate Grade Neuroendocrine Lesion,Borderline Resectable Pancreatic Carcinoma
22775,Well Differentiated Neuroendocrine Lesion,Colorectal Adenocarcinoma Metastatic in the Liver
22776,Intermediate Grade Neuroendocrine Lesion,Colorectal Carcinoma Metastatic in the Liver
22777,Polymorphic Cellular Infiltrate,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
22778,Benign Cellular Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
22779,Benign Cellular Infiltrate,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
22780,Benign Cellular Infiltrate,Platinum-Resistant Fallopian Tube Carcinoma
22781,Benign Cellular Infiltrate,Cholangiocarcinoma metastatic
22782,Acute Clinical Course,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
22783,Solid Growth Pattern,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
22784,Benign Cellular Infiltrate,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
22785,Benign Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
22786,Benign Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
22787,CD4-Positive Neoplastic Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
22788,Benign Cellular Infiltrate,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22789,Epidermotropic Lymphocytic Infiltrate,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
22790,Benign Cellular Infiltrate,Refractory B-Cell Prolymphocytic Leukemia
22791,Solid Growth Pattern,Refractory B-Cell Prolymphocytic Leukemia
22792,Malignant Cellular Infiltrate,Childhood Cystic Nephroma
22793,Benign Cellular Infiltrate,Metastatic Bladder Squamous Cell Carcinoma
22794,Metaplasia of Malignant Cells Present,Metastatic Bladder Squamous Cell Carcinoma
22795,Glandular Differentiation,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
22796,Mucoid Stroma Formation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
22797,Benign Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
22798,Benign Cellular Infiltrate,Metastatic Malignant Genitourinary System Neoplasm
22799,Benign Cellular Infiltrate,Refractory Cholangiocarcinoma
22800,Solid Growth Pattern,Recurrent Transformed Chronic Lymphocytic Leukemia
22801,Solid Growth Pattern,Refractory Transformed Chronic Lymphocytic Leukemia
22802,Intermediate Filaments Present,Recurrent Desmoplastic Small Round Cell Tumor
22803,Indolent Clinical Course,Refractory Desmoplastic Small Round Cell Tumor
22804,Benign Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma
22805,Benign Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ
